ALTERNATIVE TOXICOLOGICAL METHODS
ALTERNATIVE TOXICOLOGICAL METHODS
Edited by
Harry Salem Sidney A. Katz
CRC PR E ...
122 downloads
992 Views
7MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
ALTERNATIVE TOXICOLOGICAL METHODS
ALTERNATIVE TOXICOLOGICAL METHODS
Edited by
Harry Salem Sidney A. Katz
CRC PR E S S Boca Raton London New York Washington, D.C.
This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.”
/LEUDU\RI&RQJUHVV&DWDORJLQJLQ3XEOLFDWLRQ'DWD $OWHUQDWLYHWR[LFRORJLFDOPHWKRGVHGLWHGE\6LGQH\$.DW]+DUU\6DOHP SFP ,QFOXGHVELEOLRJUDSKLFDOUHIHUHQFHVDQGLQGH[ ,6%1;DONSDSHU $OWHUQDWLYHWR[LFLW\WHVWLQJ,.DW]6LGQH\$,,6DOHP+DUU\ 5$$$ GF
7KLVERRNFRQWDLQVLQIRUPDWLRQREWDLQHGIURPDXWKHQWLFDQGKLJKO\UHJDUGHGVRXUFHV5HSULQWHGPDWHULDO LVTXRWHGZLWKSHUPLVVLRQDQGVRXUFHVDUHLQGLFDWHG$ZLGHYDULHW\RIUHIHUHQFHVDUHOLVWHG5HDVRQDEOH HIIRUWVKDYHEHHQPDGHWRSXEOLVKUHOLDEOHGDWDDQGLQIRUPDWLRQEXWWKHDXWKRUDQGWKHSXEOLVKHUFDQQRW DVVXPHUHVSRQVLELOLW\IRUWKHYDOLGLW\RIDOOPDWHULDOVRUIRUWKHFRQVHTXHQFHVRIWKHLUXVH 1HLWKHUWKLVERRNQRUDQ\SDUWPD\EHUHSURGXFHGRUWUDQVPLWWHGLQDQ\IRUPRUE\DQ\PHDQVHOHFWURQLF RUPHFKDQLFDOLQFOXGLQJSKRWRFRS\LQJPLFURÀOPLQJDQGUHFRUGLQJRUE\DQ\LQIRUPDWLRQVWRUDJHRU UHWULHYDOV\VWHPZLWKRXWSULRUSHUPLVVLRQLQZULWLQJIURPWKHSXEOLVKHU $OO ULJKWV UHVHUYHG$XWKRUL]DWLRQ WR SKRWRFRS\ LWHPV IRU LQWHUQDO RU SHUVRQDO XVH RU WKH SHUVRQDO RU LQWHUQDO XVH RI VSHFLÀF FOLHQWV PD\ EH JUDQWHG E\ &5& 3UHVV //& SURYLGHG WKDW SHU SDJH SKRWRFRSLHGLVSDLGGLUHFWO\WR&RS\ULJKW&OHDUDQFH&HQWHU5RVHZRRG'ULYH'DQYHUV0$ 86$ 7KH IHH FRGH IRU XVHUV RI WKH 7UDQVDFWLRQDO 5HSRUWLQJ 6HUYLFH LV ,6%1 ;7KHIHHLVVXEMHFWWRFKDQJHZLWKRXWQRWLFH)RURUJDQL]DWLRQVWKDWKDYHEHHQJUDQWHG DSKRWRFRS\OLFHQVHE\WKH&&&DVHSDUDWHV\VWHPRISD\PHQWKDVEHHQDUUDQJHG 7KHFRQVHQWRI&5&3UHVV//&GRHVQRWH[WHQGWRFRS\LQJIRUJHQHUDOGLVWULEXWLRQIRUSURPRWLRQIRU FUHDWLQJQHZZRUNVRUIRUUHVDOH6SHFLÀFSHUPLVVLRQPXVWEHREWDLQHGLQZULWLQJIURP&5&3UHVV//& IRUVXFKFRS\LQJ 'LUHFWDOOLQTXLULHVWR&5&3UHVV//&1:&RUSRUDWH%OYG%RFD5DWRQ)ORULGD 7UDGHPDUN1RWLFH 3URGXFWRUFRUSRUDWHQDPHVPD\EHWUDGHPDUNVRUUHJLVWHUHGWUDGHPDUNVDQGDUH XVHGRQO\IRULGHQWLÀFDWLRQDQGH[SODQDWLRQZLWKRXWLQWHQWWRLQIULQJH
9LVLWWKH&5&3UHVV:HEVLWHDWZZZFUFSUHVVFRP E\&5&3UHVV//& 1RFODLPWRRULJLQDO86*RYHUQPHQWZRUNV ,QWHUQDWLRQDO6WDQGDUG%RRN1XPEHU; /LEUDU\RI&RQJUHVV&DUG1XPEHU ISBN 0-203-00879-0 Master e-book ISBN
Dedication 7KLVERRNLVGHGLFDWHGWRDOOVFLHQWLÀFLQYHVWLJDWRUV ZKRDUHFRPPLWWHGWRWKHSULQFLSOHVRIWKHWKUHH5V SOXVWKHIRXUWK5ZKLFKVLJQLÀHVUHVSRQVLELOLW\ ZLWKRXWFRPSURPLVLQJKXPDQDQGDQLPDOKHDOWKDQGZHOIDUH DVZHOODVWRRXUIDPLOLHVZKRHQFRPSDVVFRPSDVVLRQ DQGJHQWOHQHVVLQWKHLUOLYHVWR)OR-HUU\$P\ -RHO0DUVKDOODQG$EE\5RVHDQGWR6KHLOD&UDLJ -L.HYLQ+DQD-HII:HQG\6\GQH\DQG'DQLHO ZKRFRQWLQXHWRHQFRXUDJHDQGLQVSLUH XVWRIROORZRXUGUHDPV
Preface $OWHUQDWLYH7R[LFRORJLFDO0HWKRGVEULQJVWRJHWKHUWKHUHFHQWDQGUHOHYDQWFRQ WULEXWLRQVRIRYHUVFLHQWLVWVIURPJRYHUQPHQWLQGXVWU\DQGDFDGHPLDLQ1RUWK $PHULFDQWKH8.DQG:HVWHUQ(XURSHIRUPHHWLQJWKHQHHGVIRUGHYHORSLQJDQG YDOLGDWLQJ UHSODFHPHQW UHGXFWLRQ DQG UHÀQHPHQW DOWHUQDWLYHV WR DQLPDO WHVWLQJ 7KHVHLQWHUQDWLRQDOO\UHFRJQL]HGVFLHQWLVWVSUHVHQWZKDWKDVEHHQDFFRPSOLVKHGWKXV IDULQGHYHORSLQJDFFHSWDEOHDOWHUQDWLYHVWRWUDGLWLRQDODQLPDOWR[LFRORJLFDODVVHVV PHQW DV ZHOO DV SURYLGLQJ SRWHQWLDOO\ QHZ LQLWLDWLYHV7KLV LV GRQH LQ FKDSWHUV IRFXVLQJRQVHYHQWKHPHV 7KHÀ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À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ÀQHPHQW DOWHUQDWLYHVDQGWRHVWDEOLVKWKHFULWHULDIRUYDOLGDWLRQRIUHJXODWRU\DFFHSWDQFHDV ZHOODVWRUHFRPPHQGDSURFHVVIRUVFLHQWLÀFDOO\YDOLGDWHGDOWHUQDWLYHVWREHDFFHSWHG IRUUHJXODWRU\XVH,&&9$0EHFDPHHVWDEOLVKHGDVDFRPPLWWHHLQDQGZDV PDGHRIÀFLDOLQWKH\HDU2QHRIXVKDVVHUYHGDVWKHRIÀFLDO'HSDUWPHQWRI 'HIHQVH'R' UHSUHVHQWDWLYHVLQFHDQGFRQWLQXHVWRVHUYHRQWKHFRPPLWWHH $WWKHVDPHWLPHLQWKH1DWLRQDO'HIHQVH$XWKRUL]DWLRQ$FW+5 QG&RQJUHVVVHFRQGVHVVLRQ GLUHFWHGWKH6HFUHWDU\RI'HIHQVHWRHVWDEOLVK DJJUHVVLYH DQG WDUJHWHG SURJUDPV WR UHSODFH UHGXFH DQG UHÀQH WKH FXUUHQW XVH RI DQLPDOVLQWKH'R'
(YHQSULRUWRWKLVLQZHVSRQVRUHGRXUÀUVWELHQQLDO$OWHUQDWLYH&RQIHUHQFH WLWOHG 'R' ,QLWLDWLYHV LQ $OWHUQDWLYHV WR $QLPDO 7HVWLQJ 7KLV ZDV IROORZHG XQWLO E\ ELHQQLDO FRQIHUHQFHV FRVSRQVRUHG E\ WKH 1,(+6 WKH )'$ WKH (3$ WKH &RQVXPHU3URGXFW6DIHW\&RPPLVVLRQ&36& WKH$UP\6ROGLHUDQG%LRORJLFDO &KHPLFDO&RPPDQG0HGLFDO5HVHDUFK,QVWLWXWHRI&KHPLFDO'HIHQVH&HQWHUIRU +HDOWK 3URPRWLRQ DQG 3UHYHQWLYH 0HGLFLQH WKH $LU )RUFH WKH 1DY\ DQG WKH $VVRFLDWLRQ RI *RYHUQPHQW 7R[LFRORJLVWV 1DWLRQDO &DSLWDO $UHD &KDSWHU RI WKH 6RFLHW\RI7R[LFRORJ\6LJPD;LDQGRWKHUDJHQFLHVDQGLQGXVWULDOÀUPV 7KHVFLHQWLVWVZKRKDYHFRQWULEXWHGFKDSWHUVWRWKLVERRNLQFOXGHWKRVHZKRDUH ZHOO NQRZQ LQ WKH DOWHUQDWLYH ÀHOG DQG KDYH SUHVHQWHG DQG SXEOLVKHG LQ YDULRXV DOWHUQDWLYH IRUXPV DV ZHOO DV WKRVH ZKRVH PHWKRGRORJLHV DUH FRQVLVWHQW ZLWK WKH WKUHH5VDQGDUHDSSOLFDEOHWRWKHDOWHUQDWLYHÀHOGEXWZKRKDYHURXWLQHO\SUHVHQWHG DQGSXEOLVKHGLQRWKHUVFLHQWLÀ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
The Editors +DUU\6DOHPLVFKLHIVFLHQWLVWDWWKH86$UP\(GJHZRRG&KHPLFDO%LRORJLFDO &HQWHU +H KDV EHHQ D YLVLWLQJ SURIHVVRU DW 'UH[HO 8QLYHUVLW\ 5XWJHUV 8QLYHUVLW\ 7HPSOH8QLYHUVLW\DQGWKH8QLYHUVLW\RI3HQQV\OYDQLDDQGKHKDVKHOGDYDULHW\RI SRVLWLRQVLQWKHSKDUPDFHXWLFDOLQGXVWU\DQGLQFRPPHUFLDOWR[LFRORJ\ODERUDWRULHV +HLVWKHHGLWRULQFKLHIRIWKH-RXUQDORI$SSOLHG7R[LFRORJ\'XULQJKHZDV WKH6RFLHW\RI7R[LFRORJ\·V&RQJUHVVLRQDO)HOORZ 6LGQH\$.DW]LVSURIHVVRURIFKHPLVWU\DW5XWJHUV8QLYHUVLW\+HKDVEHHQ DYLVLWLQJSURIHVVRULQ&DQDGD(QJODQG*HUPDQ\+XQJDU\DQG<XJRVODYLDDQG KHZDVHPSOR\HGDVDFKHPLVWE\(,GX3RQWGH1HPRXUVDQGE\50+ROOLQJ VKHDG+LVUHVHDUFKDFWLYLW\LVLQWKHDUHDRIHQYLURQPHQWDOELRDQDO\WLFDOFKHPLVWU\ 8QWLO -XO\ KH ZDV D 1HZ -HUVH\ VWDWH FRPPLVVLRQHU IRU KD]DUGRXV ZDVWH IDFLOLWLHVVLWLQJ
Contributors .DVKLI$OL $SSOLHG3KDUPDFRORJ\%UDQFK 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
+LOPD5%HQMDPLQ $SSOLHG3KDUPDFRORJ\%UDQFK 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
'RXJODV3$YHU\ $SSOLHG3KDUPDFRORJ\%UDQFK 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
5RJHU:%HXHUPDQ /RXLVLDQD6WDWH8QLYHUVLW\6FKRRO RI0HGLFLQH 'HSDUWPHQWRI2SKWKDOPRORJ\ /LRQV(\H5HVHDUFK/DERUDWRULHV /DERUDWRU\IRU0ROHFXODU%LRORJ\RI WKH2FXODU6XUIDFH /68(\H&HQWHU 1HZ2UOHDQV/RXLVLDQD
6H\RXP$\HKXQLH 0DW7HN&RUSRUDWLRQ $VKODQG0DVVDFKXVHWWV 0LFKDHO&%DELQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG 0LFKDHO%DOOV )5$0( 1RWWLQJKDP8.
%DV%ODDXERHU 'LYLVLRQRI7R[LFRORJ\ ,QVWLWXWHIRU5LVN$VVHVVPHQW6FLHQFHV 'LYLVLRQRI7R[LFRORJ\ 8WUHFKW8QLYHUVLW\ 8WUHFKW7KH1HWKHUODQGV %ULGJHW$%UH\IRJOH 0DW7HN&RUSRUDWLRQ $VKODQG0DVVDFKXVHWWV
6WHYHQ,%DVNLQ 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
5REHUW/%URQDXJK 6NLQ$EVRUSWLRQDQG0HWDEROLVP 6HFWLRQ 86)RRGDQG'UXJ$GPLQLVWUDWLRQ /DXUHO0DU\ODQG
0DUWLQ%pOLYHDX 8QLYHUVLW\RI0RQWUHDO 5HVHDUFK*URXSLQ+XPDQ7R[LFRORJ\ )DFXOW\RI0HGLFLQH 0RQWUHDO4XHEHF&DQDGD
&ODUHQFH$%URRPÀHOG 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
.ULVWHQ/%HOODYDQFH 0DW7HN&RUSRUDWLRQ $VKODQG0DVVDFKXVHWWV
&KULVWRI%XHKOHU 3DXO6FKHUUHU,QVWLWXW 9LOOLQJHQ6ZLW]HUODQG
0DULD%\NKRYVNDLD 'HSDUWPHQWRI%LRORJLFDO6FLHQFHV /HKLJK8QLYHUVLW\ %HWKOHKHP3HQQV\OYDQLD -HDQ/XG&DGHW 0ROHFXODU1HXURSV\FKLDWU\6HFWLRQ 1DWLRQDO,QVWLWXWHVRI+HDOWK %DOWLPRUH0DU\ODQG 5REHUW3&DVLOODV 0HGLFDO5HVHDUFK DQG(YDOXDWLRQ)DFLOLW\ %DWWHOOH0HPRULDO,QVWLWXWH &ROXPEXV2KLR 3KLOOLS/&DVWHUWRQ $OWLFRU&RUSRUDWLRQ $GD0LFKLJDQ
2IÀH(&ODUN,,, &HOOXODU3KDUPDFRORJ\7HDP 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG .DWKOHHQ0&RQOHH 7KH+XPDQH6RFLHW\RIWKH8QLWHG 6WDWHV :DVKLQJWRQ'& &KDUOHQH0&RUXQ 'UXJ$VVHVVPHQW'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
'DQLHO5&HUYHQ 0%5HVHDUFK/DERUDWRULHV 6SLQQHUVWRZQ3HQQV\OYDQLD
)UHG0&RZDQ &HOOXODU3KDUPDFRORJ\7HDP 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
:LOH\$&KDPEHUV 'LYLVLRQRI$QWL,QÁDPPDWRU\ $QDOJHVLFDQG2SKWKDOPRORJLF 'UXJ3URGXFWV 86)RRGDQG'UXJ$GPLQLVWUDWLRQ 5RFNYLOOH0DU\ODQG
&KDULVVH'DYHQSRUW &HOOXODU3KDUPDFRORJ\7HDP 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
6WHSKHQ&KHYDOLHU 0ROHFXODUDQG&HOOXODU7R[LFRORJ\ 'HSDUWPHQW 3À]HU*OREDO5HVHDUFKDQG 'HYHORSPHQW $PERLVH)UDQFH -DPHV+&ODUN $SSOLHG3KDUPDFRORJ\%UDQFK 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
*HRUJH/'H*HRUJH 0%5HVHDUFK/DERUDWRULHV 6SLQQHUVWRZQ3HQQV\OYDQLD 0DXUD('H-RVHSK &HOOXODU3KDUPDFRORJ\7HDP 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG 0LFKDHO'HOODUFR 86(QYLURQPHQWDO3URWHFWLRQ$JHQF\ :DVKLQJWRQ'&
%DUW'H:HYHU 6NLQ(WKLF/DERUDWRULHV 1LFH)UDQFH )UDQFLQH'ROLQV 'HSDUWPHQWRI3V\FKRORJ\ 3RO\WHFKQLF8QLYHUVLW\ %URRNO\Q1HZ
$QQD)RUVE\ 7KH$UUKHQLXV/DERUDWRULHV IRU1DWXUDO6FLHQFHV 'HSDUWPHQWRI1HXURFKHPLVWU\ DQG1HXURWR[LFRORJ\ 6WRFNKROP8QLYHUVLW\ 6WRFNKROP6ZHGHQ 0D[LPR*DFXOD-U *DFXOD$VVRFLDWHV 6FRWWVGDOH$UL]RQD DQG $UL]RQD6WDWH8QLYHUVLW\ 7HPSH$UL]RQD %RULV/*HOPRQW 'HSDUWPHQWRI(OHFWULFDO(QJLQHHULQJ 8QLYHUVLW\RI9LUJLQLD &KDUORWWHVYLOOH9LUJLQLD 75*OREXV 'HSDUWPHQWRIFRPSXWHU(QJLQHHULQJ 8QLYHUVLW\RI9LUJLQLD &KDUORWWHVYLOOH9LUJLQLD 6LGQH\*UHHQ 'HSDUWPHQWRI3KDUPDFRORJ\ +RZDUG8QLYHUVLW\&ROOHJHRI0HGLFLQH :DVKLQJWRQ'& 0D\*ULIÀWK 8QLYHUVLW\RI2WWDZD(\H,QVWLWXWH 2WWDZD2QWDULR&DQDGD &ODUN/*URVV &HOOXODU3KDUPDFRORJ\7HDP 3KDUPDFRORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG -XDQLWD-*X]PDQ 'UXJ$VVHVVPHQW'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
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
1LUPDOD-D\DNXPDU 'HUP7HFK,QWHUQDWLRQDO 6DQ'LHJR&DOLIRUQLD
.L+HDQ.LP 'HSDUWPHQWRI0HFKDQLFDO(QJLQHHULQJ 0DVVDFKXVHWWV,QVWLWXWH RI7HFKQRORJ\ 1RUWK&DPEULGJH0DVVDFKXVHWWV
-2-HQVHQ 86$UP\(GJHZRRG&KHPLFDO %LRORJLFDO&HQWHU $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
,DQ.LPEHU 6\QJHQWD&HQWUDO 7R[LFRORJ\/DERUDWRU\ 0DFFOHVÀHOG&KHVKLUH8.
5RE\Q&.LVHU 0HGLFDO5HVHDUFK DQG(YDOXDWLRQ)DFLOLW\ %DWWHOOH0HPRULDO,QVWLWXWH &ROXPEXV2KLR 0LWFKHOO.ODXVQHU 0DW7HN&RUSRUDWLRQ $VKODQG0DVVDFKXVHWWV +DUYH\-.OLPDQ 'HSDUWPHQWRI2EVWHWULFVDQG *\QHFRORJ\
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ÀFHRI5HVHDUFK6HUYLFHV 1DWLRQDO,QVWLWXWHVRI+HDOWK %HWKHVGD0DU\ODQG
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À]HU*OREDO5HVHDUFK DQG'HYHORSPHQW *URWRQ&RQQHFWLFXW 3HWHU/3ODWWHERUH] 9LURORJ\'LYLVLRQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI,QIHFWLRXV'LVHDVHV )UHGHULFN0DU\ODQG
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
+DUU\6DOHP 86$UP\6%&&20 (GJHZRRG&KHPLFDO%LRORJLFDO&HQWHU $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
3HWHU7&6R 'HSDUWPHQWRI0HFKDQLFDO(QJLQHHULQJ 0DVVDFKXVHWWV,QVWLWXWHRI7HFKQRORJ\ 1RUWK&DPEULGJH0DVVDFKXVHWWV
$&6DPXHOV 86$UP\(GJHZRRG&KHPLFDO %LRORJLFDO&HQWHU $EHUGHHQ3URYLQJ*URXQG0DU\ODQG
7KRPDV-6RERWND &HQWHUIRU)RRG6DIHW\DQG$SSOLHG 1XWULWLRQ 86)RRGDQG'UXJ$GPLQLVWUDWLRQ /DXUHO0DU\ODQG
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
6KHUU\/:DUG 86$UP\0HGLFDO5HVHDUFK 0DWHULDO&RPPDQG &RQJUHVVLRQDOO\'LUHFWHG0HGLFDO 5HVHDUFK3URJUDPV )W'HWULFN0DU\ODQG 5REHUW-:HUUOHLQ 86$UP\0HGLFDO5HVHDUFK,QVWLWXWH RI&KHPLFDO'HIHQVH $EHUGHHQ3URYLQJ*URXQG0DU\ODQG 3KLOLS:H[OHU 'LYLVLRQRI6SHFLDOL]HG,QIRUPDWLRQ 6HUYLFHV 7R[LFRORJ\DQG(QYLURQPHQWDO+HDOWK ,QIRUPDWLRQ3URJUDP 1DWLRQDO/LEUDU\RI0HGLFLQH %HWKHVGD0DU\ODQG :LOOLDP:KLWH 86$UP\(GJHZRRG&KHPLFDO %LRORJLFDO&HQWHU $EHUGHHQ3URYLQJ*URXQG0DU\ODQG *HRUJHWWH:KLWLQJ 'LYLVLRQRI6SHFLDOL]HG,QIRUPDWLRQ 6HUYLFHV 7R[LFRORJ\DQG(QYLURQPHQWDO+HDOWK ,QIRUPDWLRQ3URJUDP 1DWLRQDO/LEUDU\RI0HGLFLQH %HWKHVGD0DU\ODQG 1HLO/:LOFR[ *LOOHWWH0HGLFDO(YDOXDWLRQ /DERUDWRULHV 7KH*LOOHWWH&RPSDQ\ *DLWKHUVEXUJ0DU\ODQG
'/:RRODUG $UP\5HVHDUFK2IÀ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
Contents 3DUW, 3URJUHVVLQWKH9DOLGDWLRQDQG5HJXODWRU\$FFHSWDQFHRI$OWHUQDWLYHV 1HLO/:LOFR[ &KDSWHU +LVWRULFDO'HYHORSPHQWVLQWKH+XPDQH&DUHDQG8VHRI5HVHDUFK$QLPDOV 7KH)LUVW
3DUW,, 'HYHORSPHQWRI3UHGLFWLYH0HWKRGV%DVHGRQ0HFKDQLVPV RI(\H,UULWDWLRQDWWKH2FXODU6XUIDFH0HHWLQJ,QGXVWU\ DQG5HJXODWRU\1HHGV 6KHUU\/:DUGDQG:LOH\$&KDPEHUV &KDSWHU 0HHWLQJ,QGXVWU\DQG5HJXODWRU\1HHGVIRU$OWHUQDWLYH7HVW0HWKRGV WRWKH'UDL]H5DEELW(\H,UULWDWLRQ7HVW 6KHUU\/:DUG &KDSWHU 7KH2FXODU6XUIDFH%DUULHU)XQFWLRQDQG0HFKDQLVPVRI,QMXU\DQG5HSDLU 0DUWLQ5HLP &KDSWHU (YDOXDWLRQDQG5HÀQHPHQWRIWKH%RYLQH&RUQHD2SDFLW\ DQG3HUPHDELOLW\$VVD\ -RKQ/8EHOV-DPHV'3DDXZDQG3KLOOLS/&DVWHUWRQ &KDSWHU &RUQHDO2UJDQ&XOWXUHIRU2FXODU7R[LFLW\7HVWRI&RPPHUFLDO +DLU&DUH3URGXFWV )X6KLQ;<XDQG.H3LQJ;X &KDSWHU +XPDQ&RUQHDO(TXLYDOHQWVIRU,Q9LWUR7HVWLQJ 0D\*ULIÀWKDQG(ULN6XXURQHQ &KDSWHU 7KH(SL2FXODU3UHGLFWLRQ0RGHO$5HSURGXFLEOH,Q9LWUR0HDQV RI$VVHVVLQJ2FXODU,UULWDQF\ 0LWFKHOO.ODXVQHU3DWULFN-+D\GHQ%ULGJHW$%UH\IRJOH .ULVWHQ/%HOODYDQFH0HOLVVD02VERUQ'DQLHO5&HUYHQ *HRUJH/'H*HRUJHDQG-RVHSK.XELOXV &KDSWHU 7KUHH'LPHQVLRQDO&RQVWUXFWRIWKH+XPDQ&RUQHDO(SLWKHOLXP IRU,Q9LWUR7R[LFRORJ\ '+1JX\HQ5RJHU:%HXHUPDQ%DUW'H:HYHUDQG0DUWLQ5RVG\ &KDSWHU 7KH+XPDQ&RUQHDO(SLWKHOLDO+&(77(3$VVD\IRU(\H,UULWDWLRQ 6FLHQWLÀF5HOHYDQFHDQG6XPPDU\RI3UHYDOLGDWLRQ6WXG\5HVXOWV 6KHUU\/:DUG0D[LPR*DFXOD-UDQG+HQU\)(GHOKDXVHU
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
3DUW,9 $&DVH6WXG\LQWKH8VHRI$OWHUQDWLYHVWR'HWHUPLQH WKH0HFKDQLVPRI6XOIXU0XVWDUG$FWLRQ :LOOLDP-6PLWK &KDSWHU &HOOXODU5HVLVWDQFHRI7HWUDK\PHQDWR6XOIXU0XVWDUG 3HWHU/3ODWWHERU]H-DPHV(6LVWUXQNDQG:LOOLDP-6PLWK &KDSWHU 6WXGLHVRI&HOOXODU%LRFKHPLFDO&KDQJHV,QGXFHGLQ+XPDQ&HOOV E\6XOIXU0XVWDUG :LOOLDP-6PLWK2IÀH(&ODUN,,,)UHG0&RZDQ0DXUD('H-RVHSK &KDULVVH'DYHQSRUWDQG&ODUN/*URVV
&KDSWHU +XPDQ.HUDWLQRF\WH,QÁ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ÀH(&ODUN,,,-DQHW0RVHU (ULF:1HDOOH\-XDQLWD-*X]PDQDQG&ODUN/*URVV &KDSWHU ,PDJLQJ6XOIXU0XVWDUG/HVLRQVLQ%DVDO&HOOVDQG+XPDQ(SLGHUPDO 7LVVXHVE\&RQIRFDODQG0XOWLSKRWRQ/DVHU6FDQQLQJ0LFURVFRS\ 5REHUW-:HUUOHLQDQG-DQQD60DGUHQ:KDOOH\ &KDSWHU 6XSSUHVVLRQRI6XOIXU0XVWDUG,QFUHDVHG,/LQ+XPDQ.HUDWLQRF\WH &HOO&XOWXUHVE\6HULQH3URWHDVH,QKLELWRUV,PSOLFDWLRQVIRU7R[LFLW\ DQG0HGLFDO&RXQWHUPHDVXUHV )UHG0&RZDQ&ODUHQFH$%URRPÀHOGDQG:LOOLDP-6PLWK &KDSWHU 'HYHORSPHQWRI0HGLFDO&RXQWHUPHDVXUHVWR6XOIXU0XVWDUG9HVLFDWLRQ :LOOLDP-6PLWK0LFKDHO&%DELQ5RE\Q&.LVHUDQG5REHUW3&DVLOODV
3DUW9 1HXURWR[LFRORJ\0ROHFXODU%LRPDUNHUV7UDQVJHQLFV DQG,PDJLQJ7HFKQRORJLHV :LOOLDP-6OLNNHU-UDQG7KRPDV-6RERWND
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
3DUW9, 5ROHRI7UDQVJHQLFVDQG7R[LFRJHQRPLFVLQWKH'HYHORSPHQW RI$OWHUQDWLYH7R[LFLW\7HVWV -HUU\+HLQGHO &KDSWHU 7KH$SSOLFDWLRQRI*HQRPLFVDQG3URWHRPLFVWR7R[LFRORJLFDO6FLHQFHV 6WHSKDQ&KHYDOLHU:LOOLDP'3HQQLHDQG,DQ.LPEHU &KDSWHU 8VHRI7UDQVJHQLF$QLPDOVLQ5HJXODWRU\&DUFLQRJHQLFLW\(YDOXDWLRQV )UDQN'6LVWDUHDQG$ELJDLO&-DFREV &KDSWHU &KDQJHVLQ*HQH([SUHVVLRQDIWHU([SRVXUHWR2UJDQRSKRVSKRUXV 23 $JHQWV -HQQLIHU:6HNRZVNL.HYLQ32·&RQQHOO$NEDU6.KDQ-DPHV-9DOGHV 0DU\DQQH9DKH\0DUWLQ1DX0DKD.KDOLODQG0RK\HH((OGHIUDZL
3DUW9,, 5HFHQW,QQRYDWLRQVLQ$OWHUQDWLYHV +DUU\6DOHPDQG6LGQH\$.DW]
&KDSWHU $UFKLYDO'DWDLQ7R[LFRORJ\0LQLPL]LQJ1HHGIRU$QLPDO([SHULPHQWV 0LOODUG00HUVKRQ &KDSWHU ,QIRUPDWLRQ0DQDJHPHQWDWWKH/LEUDU\RI&RQJUHVV$Q2YHUYLHZ ZLWK6SHFLDO5HIHUHQFHWR%LRPHGLFLQH 5RPDQ%:RUREHF &KDSWHU :RUOG:LGH:HE%LRPHGLFDO&KHPLFDODQG7R[LFRORJLFDO,QIRUPDWLRQ 5HVRXUFHVIURPWKH1DWLRQDO/LEUDU\RI0HGLFLQH *HRUJH&)RQJHU-DPHV.QREHQ6WHSKDQLH3XEOLFNHU3KLOLS:H[OHU DQG*HRUJHWWH:KLWLQJ &KDSWHU ,Q6LOLFR$SSURDFKHVIRU3K\VLRORJLFDOO\%DVHG3KDUPDFRNLQHWLF0RGHOLQJ 0DUWLQ%p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
PART I Progress in the Validation and Regulatory Acceptance of Alternatives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À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
2
ALTERNATIVE TOXICOLOGICAL METHODS
&KDSWHU ´,QWHJUDWHG ,Q9LWUR$SSURDFKHV IRU$VVHVVLQJ 6\VWHPLF7R[LFLW\µ ,Q DGGLWLRQ 'U (UURO =HLJHU 1DWLRQDO ,QVWLWXWH RI (QYLURQPHQWDO +HDOWK 6FLHQFHV 1,(+6 SURYLGHV &KDSWHU D VXPPDU\ RI WKH 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQDQG'HYHORSPHQWGRFXPHQWRQWKHUHFRJQLWLRQDVVHVVPHQWDQGXVH RI FOLQLFDO VLJQV DV KXPDQH HQGSRLQWV IRU H[SHULPHQWDO DQLPDOV XVHG LQ VDIHW\ HYDOXDWLRQ7KLVSDUWLVFRPSOHWHGE\'U0DUWLQ6WHSKHQVDQGKLVFROOHDJXHVIURP WKH +XPDQH 6RFLHW\ RI WKH 8QLWHG 6WDWHV ZLWK &KDSWHU ´3DLQ DQG 'LVWUHVV 0DQDJHPHQWLQ$QLPDO5HVHDUFKDQG7HVWLQJµ 7KHFROOHFWLYHH[SHUWLVHRIWKHDXWKRUVLQWKLVSDUWUHSUHVHQWVVRPHRIWKHEHVW LQQRYDWLYHDQGSURJUHVVLYHWKLQNLQJLQWKHZRUOG
CHAPTER
1
Historical Developments in the Humane Care and Use of Research Animals: The First 4000 Years +DUU\6DOHPDQG6LGQH\$.DW]
CONTENTS %LEOLFDO2ULJLQV &RORQLDO$PHULFD 9LFWRULDQ(QJODQG 5XVVHOODQG%XUFK 7KH7KUHH5V 5HIHUHQFHV
BIBLICAL ORIGINS &RQFHUQVIRUWKHKXPDQHWUHDWPHQWRIDQLPDOVKDYHELEOLFDORULJLQV$FFRUGLQJ WR *HQHVLV KXPDQNLQG ZDV JLYHQ ´HYHU\ VHHGEHDULQJ SODQW WKDW LV XSRQ WKH HDUWKDQGHYHU\WUHHWKDWKDVVHHGEHDULQJIUXLWµIRUIRRG3HUPLVVLRQWRHDWPHDW ZDVQ·WJLYHQXQWLODIWHUWKH)ORRG(YHQWKHQWKHVODXJKWHURIDQDQLPDOZDVPDGH DQDFWWKDWGHPDQGHGWKRXJKWFDUHDQGUHVSRQVLELOLW\,Q/HYLWLFXVDQG WKH&KLOGUHQRI,VUDHOZHUHJLYHQODZVRQZKLFKDQLPDOVFRXOGEHHDWHQDQGRQKRZ WKHVHDQLPDOVPXVWEHVODXJKWHUHG ,QFOXGHG LQ WKH -HZLVK GLHWDU\ ODZV LV WKH VHSDUDWLRQ RI PHDW DQG PLON 7KH SURKLELWLRQ RQ PL[LQJ DQLPDO ÁHVK DQG GDLU\ SURGXFWV LV DWWULEXWHG WR WKH YHUVH ´
3
4
ALTERNATIVE TOXICOLOGICAL METHODS
Table 1.1 Chronology for the Enactment of Animal Welfare Legislation Year
State
Year
State
Year
State
1828 1835 1838 1938 1842 1845 1848 1851 1851 1852 1854 1856 1857 1858 1859 1859 1860 1861
New York Massachusetts Connneticut Wisconsin New Hampshire Missouri Virginia Iowa Minnesota Kentucky Vermont Texas Rhode Island Tennessee Kansas Washington Pennsylvania Nevada
1864 1864 1867 1868 1868 1869 1871 1871 1871 1872 1873 1873 1873 1875 1879 1879 1880
Idaho Oregon New Jersey California West Virginia Illinois District of Columbia Michigan Montana Colorado Delaware Indiana Nebraska Georgia Arkansas Louisiana Mississippi
1880 1881 1881 1883 1883 1884 1887 1887 1889 1890 1891 1893 1895 1898 1913 1913 1921
Ohio North Carolina South Carolina Alabama Maine Hawaii New Mexico South Dakota Florida Maryland North Dakota Oklahoma Wyoming Utah Alaska Arizona Virgin Islands
UHÁHFWHGLQWKHYHUVH·VUHSHWLWLRQWZLFHLQ([RGXVDQGDQGDJDLQLQ 'HXWHURQRP\ %LEOLFDO H[SUHVVLRQV RI DQLPDO ZHOIDUH DUH IRXQG LQ WKH 7HQ &RPPDQGPHQWV ([RGXV² 5HPHPEHUWKH6DEEDWKGD\WRNHHSLWKRO\6L[GD\VVKDOO\RXODERUDQGGRDOO\RXU ZRUNEXWWKHVHYHQWKGD\LVD6DEEDWKXQWRWKH/RUG\RXU*RGLQLW\RXVKDOOQRW GRDQ\PDQQHURIZRUN\RXQRU\RXUVRQQRU\RXUGDXJKWHUQRU\RXUPDQVHUYDQW QRU\RXUPDLGVHUYDQWQRU\RXUFDWWOHQRUWKHVWUDQJHUWKDWLVZLWKLQ\RXUJDWHV
COLONIAL AMERICA 7KH3XULWDQ·V´%RG\RI/LEHUWLHVµEURXJKWDQLPDOZHOIDUHWR&RORQLDO$PHULFDLQ 7KHFKURQRORJ\IRUWKHHQDFWPHQWRIVXEVHTXHQWDQLPDOZHOIDUHOHJLVODWLRQLQ WKH8QLWHG6WDWHVLVWDEXODWHGDERYH$QLPDO:HOIDUH,QVWLWXWH VHH7DEOH $QLPDOV KDYH EHHQ XVHG IRU ODERUDWRU\ H[SHULPHQWV IRU PRUH WKDQ WZR FHQWXULHV 7KHLU LQFUHDVHG XVH LQ WKH WK FHQWXU\ EURXJKW QXPHURXV FKDOOHQJHV DOOHJLQJ WKH XVHRIDQLPDOVLQUHVHDUFKFUXHOLQKXPDQHXQHWKLFDOPHGLFDOO\XQSUHGLFWLYHXQQHF HVVDU\DQGHYHQPLVOHDGLQJ
VICTORIAN ENGLAND 'XULQJ WKH ÀUVW KDOI RI WKH WK FHQWXU\ 0DUVKDOO +DOO D %ULWLVK SK\VLFLDQ SURSRVHGÀYHSULQFLSOHVIRUHOLPLQDWLQJXQQHFHVVDU\DQGUHSHWLWLYHSURFHGXUHVDQG IRUPLQLPL]LQJVXIIHULQJLQDQLPDOH[SHULPHQWDWLRQ$OWKRXJKKHHDUQHGKLVOLYLQJ
THE FIRST 4000 YEARS
5
DVDPHGLFDOSUDFWLWLRQHUKHZDVDFWLYHLQUHVHDUFK+LVPRVWLPSRUWDQWFRQWULEXWLRQV ZHUHLQWKHDUHDRIFLUFXODWRU\SK\VLRORJ\+DOOIHOWFRPSHOOHGWRGHIHQGKLVH[SHU LPHQWV ZLWK DQLPDOV ZKLFK ZHUH FRPLQJ XQGHU LQFUHDVHG VFUXWLQ\ DQG FULWLFLVP IURPWKHDQWLYLYLVHFWLRQLVWPRYHPHQW+HDUJXHG´7KHZKROHVFLHQFHRIPHGLFLQH DQGVXUJHU\LQGHHGLVGHSHQGHQWXSRQSK\VLRORJ\7RH[FOXGHSK\VLRORJLFDOLQYHV WLJDWLRQZRXOGEHWRHUHFWDQXWWHUEDUULHUWRWKHSUDFWLFHRIRXUDUWµ,QKLV$&ULWLFDO DQG([SHULPHQWDO(VVD\RQWKH&LUFXODWLRQRIWKH%ORRGKHSURSRVHGÀYHSULQFLSOHV IRUH[SHULPHQWDOSK\VLRORJ\)\H :HVKRXOGQHYHUKDYHUHFRXUVHWRH[SHULPHQWLQFDVHVLQZKLFKREVHUYDWLRQVFDQ DIIRUGXVWKHLQIRUPDWLRQUHTXLUHG 1RH[SHULPHQWVVKRXOGEHSHUIRUPHGZLWKRXWDGLVWLQFWDQGGHÀQLWHREMHFWLYH :H VKRXOG QRW QHHGOHVVO\ UHSHDW H[SHULPHQWV ZKLFK KDYH EHHQ SHUIRUPHG E\ SK\VLRORJLVWVRIUHSXWDWLRQ ([SHULPHQWVVKRXOGEHSHUIRUPHGZLWKWKHOHDVWSRVVLEOHLQÁLFWLRQRIVXIIHULQJ (YHU\ SK\VLRORJLFDO H[SHULPHQW VKRXOG EH SHUIRUPHG XQGHU VXFK FLUFXPVWDQFHV DVZLOOVHFXUHDGXHREVHUYDWLRQDQGDWWHVWDWLRQRILWVUHVXOWVDQGWRREYLDWHDV PXFKDVSRVVLEOHWKHQHFHVVLW\IRULWVUHSHWLWLRQ
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
7KH ÀUVW WKUHH SURYLVLRQV RI WKH DFW DUH ELQGLQJ WKH ODVW VL[ FDQ EH GLVSHQVHG ZLWKE\PHDQVRIFHUWLÀFDWHV&RQYLFWLRQRIXQODZIXOH[SHULPHQWVLVVXEMHFWWRÀQHV DQGXSWRWKUHHPRQWKVLPSULVRQPHQW 7RZDUGWKHHQGRIWKHWKFHQWXU\WKH$PHULFDQ+XPDQH$VVRFLDWLRQLQFUHDVHG SUHVVXUHVIRUODZVSURKLELWLQJWKHUHSHWLWLRQRISDLQIXOH[SHULPHQWVIRUWKHSXUSRVH RI WHDFKLQJ RU GHPRQVWUDWLQJ DOUHDG\ NQRZQ RU DFFHSWHG IDFWV /HJLVODWLRQ ZDV SURSRVHGLQWKH86&RQJUHVVWRUHVWULFWYLYLVHFWLRQLQWKH'LVWULFWRI&ROXPELDE\ ZD\RIDV\VWHPRIUHJXODWLRQDQGSHULRGLFLQVSHFWLRQRIODERUDWRULHV7KHELOOZDV GHIHDWHG RQ WKH ÁRRU RI WKH 6HQDWH ODUJHO\ WKURXJK WKH WHVWLPRQLHV RIIHUHG E\ PHPEHUVRIWKHPHGLFDOFRPPXQLW\LQFOXGLQJ:LOOLDP+HQU\:HOFK'HDQRIWKH
6
ALTERNATIVE TOXICOLOGICAL METHODS
-RKQV+RSNLQV0HGLFDO6FKRRO7KHOHJLVODWLRQZDVUHLQWURGXFHGLQDV6HQDWH %LOODQGZDVRQFHDJDLQGHIHDWHG
RUSSELL AND BURCH $QLPDODFWLYLVPZDQHGDIWHU:RUOG:DU,UHPDLQHGDWDORZOHYHOXQWLOWKHHDUO\ VDQGWKHQLQFUHDVHGDJDLQ,WZDVDWWKLVWLPHWKDW:LOOLDP5XVVHOODQG5H[ %XUFK XQGHUWRRN D V\VWHPDWLF VWXG\ RI ODERUDWRU\ WHFKQLTXHV DQG WKHLU HWKLFDO DVSHFWV,QWKH\SUHSDUHGDJHQHUDOUHSRUWZKLFKOHGWRWKHSXEOLFDWLRQRIWKH 3ULQFLSOHVRI+XPDQH([SHULPHQWDO7HFKQLTXHV5XVVHOODQG%XUFK $WWKH HQGRIWKLVERRNWKH\FRQFOXGH ,QWKHFRXUVHRIWKLVERRNPDQ\SUREOHPVKDYHEHHQUDLVHGDQGPDQ\ÀHOGVUHYLHZHG ,WLVSURSHUWRFORVHZLWKWKHFRPPHQWWKDWUHVHDUFKLQWKLVZKROHVXEMHFWKDVEDUHO\ VWDUWHGDVDV\VWHPDWLFGLVFLSOLQH7KHNH\EUDQFKHVRIIXQGDPHQWDOVFLHQFHIRUWKH ZKROH HQWHUSULVH DUH WKRVH RI DQLPDO EHKDYLRU DQG SV\FKRVRPDWLFV WKRXJK PDQ\ RWKHUVVXFKDVVWDWLVWLFDOPHWKRGVDQGEODFNER[WKHRU\PXVWEHSUHVVHGLQWRVHUYLFH ,QWKLVERRNZHKDYHVRXJKWRQO\WROLPQWKHEDUHVWRXWOLQHVLWZLOOUHPDLQIRURWKHUV WRÀOOWKHLQWHULRU:HKRSHWKHERRNPD\VWLPXODWHVRPHH[SHULPHQWDOLVWVWRGHYRWH VSHFLDO DWWHQWLRQ WR WKH VXEMHFW DQG PDQ\ RWKHUV WR ZRUN LQ IXOO DZDUHQHVV RI LWV H[LVWHQFH DQG SRVVLELOLWLHV $ERYH DOO ZH KRSH LW ZLOO VHUYH WR SUHVHQW WR WKRVH EHJLQQLQJZRUNDXQLÀHGLPDJHRIVRPHRIWKHPRVWLPSRUWDQWDVSHFWVRIWKHLUVWXGLHV ,ILWGRHVDQ\RIWKHVHWKLQJVWKLVERRNZLOOKDYHDPSO\VHUYHGLWVSXUSRVH
THE THREE Rs 7KHERRNKDVLQGHHGVHUYHGLWVSXUSRVH7KHLUWKUHH5VUHSODFHPHQWUHGXF WLRQDQGUHÀQHPHQW KDYHEHFRPHIXQGDPHQWDOJXLGHOLQHVIRUFRQGXFWLQJEDVLF DQGDSSOLHGUHVHDUFKLPSOHPHQWLQJTXDOLW\FRQWURODQGTXDOLW\DVVXUDQFHSURFH GXUHV DQG SHUIRUPLQJ FOLQLFDO DQG HQYLURQPHQWDO DVVHVVPHQWV )HGHUDO UHJXOD WLRQVVXEVHTXHQWO\HQGRUVHGWKHSULQFLSOHVRIWKHWKUHH5V6RPHRIWKHUHOHYDQW OHJLVODWLRQLQFOXGH $QLPDO:HOIDUH$FWRISXEOLFODZ3/ $QLPDO:HOIDUH$FWRI3/ $QLPDO:HOIDUH$FWRI3/ )RRG6HFXULW\$FWRI3/ )RRG$JULFXOWXUH&RQVHUYDWLRQDQG7UDGH$FWRI3/
2I DW OHDVW HTXDO LPSRUWDQFH DUH WKH RQJRLQJ HIIRUWV WR SURPRWH WKH SULQFLSOHV RIWKHWKUHH5VRQDZRUOGZLGHEDVLV7KHVHDUHGHVFULEHGLQWKHVXEVHTXHQWFKDSWHUV RIWKLVVHFWLRQ
THE FIRST 4000 YEARS
7
REFERENCES $QLPDO:HOIDUH,QVWLWXWH $QLPDOVDQG7KHLU/HJDO5LJKWV$6XUYH\RI$PHULFDQ/DZV IURPWR$QLPDO:HOIDUH,QVWLWXWH:DVKLQJWRQ'&S )\H:% 3URÀOHVLQFDUGLRORJ\0DUVKDOO+DOO&OLQ&DUGLRO ² 5XVVHOO:06DQG%XUFK5/ 7KH3ULQFLSOHVRI+XPDQH([SHULPHQWDO7HFKQLTXHV 0HWKXHQ/RQGRQ
CHAPTER
2
A History of Interagency Approaches to Alternatives and Establishment of the Interagency Regulatory Alternatives Group 6LGQH\*UHHQ
CONTENTS ,QWURGXFWLRQ (VWDEOLVKPHQWRI,5$* ,5$*:RUNVKRSV (YROXWLRQRI,&&9$0 5HIHUHQFHV
INTRODUCTION 7KLV KLVWRU\ ZLOO GHVFULEH DFWLYLW\ SDUWLFXODUO\ LQ WKH LQLWLDO VWDJHV DVVRFLDWHG ZLWKWKH)RRGDQG'UXJ$GPLQLVWUDWLRQ)'$ 7KLVIRFXVLVDFRQVHTXHQFHRIWKH DWWHQWLRQDQLPDOULJKWVDFWLYLVWVKDYHJLYHQWRWKH'UDL]HH\HWHVWXVHGWRWHVWSHUVRQDO FDUHSURGXFWVZKLFKIDOOXQGHUWKHMXULVGLFWLRQRIWKH)'$7KLVDWWHQWLRQOHGWRWKH UHFRJQLWLRQHDUO\RQRIWKHQHHGIRULQWHUDJHQF\DSSURDFKHVWRGHYHORSPHQWVUHODWLYH WRWKHH\HWHVWLQSDUWLFXODUDQGDOWHUQDWLYHVLQJHQHUDO ,W PD\ VXUSULVH VRPH WR OHDUQ WKDW WKH ÀUVW WHVW PHWKRG LQ WR[LFRORJ\ WR GUDZ DWWHQWLRQRIWKHDQLPDOULJKWVDFWLYLVWVZDVQRWWKH'UDL]HWHVW7KH/'EHFDPHWKH IRFXV RI )'$ HIIRUWV LQ ,Q WKDW \HDU DQ )'$ZLGH VWHHULQJ FRPPLWWHH RQ DQLPDOZHOIDUHLVVXHVZDVRUJDQL]HG(DFKEXUHDXIRRGVGUXJVPHGLFDOGHYLFHV HWF ZDV UHSUHVHQWHG RQ WKLV FRPPLWWHH DQG ZDV UHTXHVWHG WR SURYLGH D OLVW RI SURFHGXUHVRUWHVWVWKDWUHTXLUHXVHRIDQLPDOVDQGWKDWZHUHUHTXHVWHGRIUHJXODWHG LQGXVWU\ HLWKHU URXWLQHO\ RU RFFDVLRQDOO\7KH QXPEHU RI DQLPDOV XVHG SHU GRVDJH
; E\&5&3UHVV//&
9
10
ALTERNATIVE TOXICOLOGICAL METHODS
RUSHUWHVWZDVDOVRUHTXHVWHG5HVSRQGHUVZHUHDVNHG´ZKHWKHUWKHUHZDVDQLPSOLHG UHTXLUHPHQWIRU/'GDWDµDQG´ZKHWKHUDOOLQGLYLGXDOVDVVRFLDWHGZLWKUHJXODWRU\ UHVHDUFK DFWLYLWLHV RI WKHLU GLYLVLRQRIÀFH ZHUH DZDUH WKDW WKH /' WHVW ZDV QRW UHTXLUHGE\WKH)'$µ,IWKHUHZHUHDQ\GRFXPHQWVJXLGHOLQHVUHFRPPHQGDWLRQV HWF VXJJHVWLQJ D UHTXLUHPHQW IRU WKH FODVVLFDO /' FRSLHV ZHUH WR EH SURYLGHG 7KLVDFWLYLW\FXOPLQDWHGLQDSROLF\VWDWHPHQWEHLQJLVVXHGLQWKH)HGHUDO5HJLVWHU LQFODULI\LQJWKH)'$·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ÀFLDO WR OHDUQ RI WKRVH UHTXLUHPHQWV HDUO\ LQ WKH SURFHVV RI GHYHORSPHQW ,QYHVWLJDWRUV ZHUH HQFRXUDJHG WR PHHW ZLWK )'$SHUVRQQHOWRGLVFXVVWKHLUSODQV 6HYHUDOFRVPHWLFFRPSDQLHVPHWZLWK)'$SHUVRQQHO7KHVHGLVFXVVLRQVUHVXOWHG LQ DQ XQGHUVWDQGLQJ EHWZHHQ )'$ SHUVRQQHO DQG LQGXVWU\ WKDW LQ JHQHUDO WKH SURFHGXUHVXQGHUGHYHORSPHQWFRXOGEHXVHGDVVFUHHQVEXWFRXOGQRWUHSODFHWKH 'UDL]HWHVW,WZDVDOVRXQGHUVWRRGWKDWWKHPHWKRGVZHUHSURGXFWVSHFLÀFDQGPD\ QRWEHXVHIXOIRUFRVPHWLFVLQJHQHUDO$IWHUVHYHUDOVXFKPHHWLQJV)'$SHUVRQQHO UHDOL]HG WKDW LW ZRXOG EH XVHIXO WR H[SDQG GLVFXVVLRQV WR LQFOXGH RWKHU UHJXODWRU\ DQG JRYHUQPHQW RUJDQL]DWLRQV7KLV ZRXOG DOORZ WKH DJHQFLHV WR FRPPHQW MRLQWO\ DQGSURYLGHIHHGEDFNWRLQGXVWU\RQDQDSSURDFKRUDVSHFLÀFWHVW7KLVZRXOGDOVR UHTXLUH UHJXODWRU\ DJHQFLHV WR EURDGHQ WKHLU YLHZ RI WKH DSSOLFDWLRQ RI D WHVW DQG SHUKDSVIRUJHDFRPPRQDSSURDFKWRLWVIXUWKHUGHYHORSPHQW$GGLWLRQDOO\LWZRXOG SURYLGH LQGXVWU\ D EHWWHU XQGHUVWDQGLQJ RI WKH SKLORVRSKLHV DQG SRVLWLRQV RI WKH DJHQFLHVZLWKRXWKDYLQJWRRUJDQL]HVHSDUDWHPHHWLQJVZLWKHDFK*UHHQ
ESTABLISHMENT OF IRAG $IWHUPXFKGLVFXVVLRQZLWKLQWKH&HQWHUIRU)RRG6DIHW\DQG$SSOLHG1XWULWLRQ ZKLFKKDGUHVSRQVLELOLW\IRUFRVPHWLFVDQGEHIRUHFRQWDFWLQJRWKHUIHGHUDOHQWLWLHV FOHDUDQFH DQG RSLQLRQV UHJDUGLQJ VXFK DQ DSSURDFK ZHUH REWDLQHG IURP WKH &RP PLVVLRQHU RI WKH )'$ DQG RWKHU FHQWHUV UHVSHFWLYHO\ &RPPHQWV IURP DOO FHQWHUV ZHUH VXSSRUWLYH RI WKH HIIRUW 5HVSRQVHV ZHUH UHFHLYHG IURP WKH &HQWHU IRU 'UXJ (YDOXDWLRQ DQG 5HVHDUFK WKH &HQWHU IRU %LRORJLF (YDOXDWLRQ DQG 5HVHDUFK 7KH 1DWLRQDO&HQWHUIRU7R[LFRORJLFDO5HVHDUFKWKH&HQWHUIRU9HWHULQDU\0HGLFLQHDQG WKH &HQWHU IRU 'HYLFHV DQG 5DGLRORJLF +HDOWK$IWHU FRQFXUUHQFH ZLWKLQ WKH )'$ ZDVUHDFKHGWKH(QYLURQPHQWDO3URWHFWLRQ$JHQF\(3$ DQGWKH&RQVXPHU3URGXFW 6DIHW\ &RPPLVVLRQ &36& ZHUH FRQWDFWHG$W WKH ÀUVW PHHWLQJ RI DJHQF\ UHSUH VHQWDWLYHVLQLWZDVGHFLGHGWRQDPHWKHRUJDQL]DWLRQWKH,QWHUDJHQF\5HJXOD WRU\$OWHUQDWLYHV*URXS,5$* 5LFKDUG+LOO0'RIWKH(QYLURQPHQWDO3URWHFWLRQ
A HISTORY OF INTERAGENCY APPROACHES TO ALTERNATIVES
11
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ÀFFRPPXQLW\LQERWKWKHSULYDWHDQGSXEOLFVHFWRUV SDUWLFLSDWHLQWKHFROOHFWLRQDQGH[FKDQJHRILQIRUPDWLRQDVVLVWLQVHWWLQJSULRULWLHV IRU WKH HYDOXDWLRQ RI LQ YLYR DQG LQ YLWUR PHWKRGV GHYHORSPHQW YDOLGDWLRQ DQG DFFHSWDQFHDQDO\]HLQIRUPDWLRQDQGPDNHUHFRPPHQGDWLRQVFRQVLVWHQWZLWKJRRG VFLHQFH DQG IXQFWLRQ DV D OLDLVRQ ZLWK LQWHUQDWLRQDO UHJXODWRU\ ERGLHV LQGXVWU\ DFDGHPLDDQGSXEOLFLQWHUHVWJURXSVWRIDFLOLWDWHLQLWLDWLYHVWKDWOHDGWRLQWHUQDWLRQDO KDUPRQL]DWLRQ%UDGODZDQG:LOFR[
IRAG WORKSHOPS 7KHÀUVWZRUNVKRSZDVKHOGLQ6HSWHPEHURILQ$UOLQJWRQ9$DQGIRFXVHG RQWKH'UDL]HWHVW7KHVWDWHRIDOWHUQDWLYHVZDVGLVFXVVHGLQWKHFRQWH[WRIWKDWWLPH IUDPH 7KLV ZRUNVKRS UHSUHVHQWHG DQ LQLWLDO HIIRUW LQWHQGHG WR VHW WKH VWDJH IRUDGGLWLRQDOSODQQLQJDQGIRFXV5HSUHVHQWDWLYHRIWKHSUHVHQWDWLRQVDWWKLVPHHWLQJ ZDVDGLVFXVVLRQRI´UHJXODWRU\FRQVLGHUDWLRQVIRUDOWHUQDWLYHVWRWKH'UDL]HH\HWHVWµ *UHHQ 7KHVHFRQGZRUNVKRSZDVWLWOHG´:RUNVKRSRQ8SGDWLQJ(\H,UULWDWLRQ7HVW 0HWKRGV 3URSRVDOV IRU 5HJXODWRU\ &RQVHQVXVµ DQG ZDV KHOG RQ 6HSWHPEHU ²LQ:DVKLQJWRQ'&7KHRULJLQDOLQWHQWZDVWRGLVFXVVLQYLWURDQG LQYLYRWHVWPHWKRGV,WEHFDPHFOHDUWKDWVSHFLÀFLQYLWURPHWKRGVZHUHQRWDWD VWDJHRIGHYHORSPHQWWREHFRQVLGHUHGDWWKDWWLPH7KXVDVHFRQGZRUNVKRSZDV SODQQHGIRUWKHLQYLWURPHWKRGV7KHSXUSRVHRIWKHÀUVWZRUNVKRSZDVWRLGHQWLI\ GLIIHUHQW WHVWLQJ DQG HYDOXDWLRQ SUDFWLFHV GHYHORS SURSRVDOV IRU FKDQJH WKDW PLQLPL]HGGLIIHUHQFHVLQWKRVHPHWKRGVDQGGHWHUPLQHDUHDVRIFRQVHQVXVLQWKH VFLHQWLÀFFRPPXQLW\7KXVWKHHPSKDVLVZDVE\GHIDXOWRQUHGXFWLRQDQGUHÀQH PHQWSURFHGXUHV $WWKLVZRUNVKRSVHYHQSDSHUVZHUHSUHVHQWHG´&ULWHULDIRU,Q9LWUR$OWHUQDWLYHV IRUWKH(\H,UULWDWLRQ7HVWµE\6LGQH\*UHHQ´6FUHHQLQJ3URFHGXUHVIRU(\H,UULWD WLRQµE\3DPHOD+XUOH\´8VHRI2SKWKDOPLF7RSLFDO$QHVWKHWLFVµE\9DQ6HDEDXJK ´7KH 8VH RI /RZ9ROXPH 'RVLQJ LQ WKH (\H ,UULWDWLRQ 7HVWµ E\ /DUN /DPEHUW ´1XPEHU RI$QLPDOV IRU 6HTXHQWLDO7HVWLQJµ E\ -DQHW 6SULQJHU ´6FRULQJ IRU (\H ,UULWDWLRQ7HVWVµ E\:LOH\ &KDPEHUV DQG ´$Q (\H ,UULWDWLRQ7HVW 3URWRFRO DQG DQ (YDOXDWLRQDQG&ODVVLÀFDWLRQ6\VWHPµE\.DLODVK*XSWD7KHZRUNVKRSFRQFOXGHG WKDW´ZLWKUHVSHFWWRUHGXFWLRQDQGUHÀQHPHQWWKHVWURQJHVWFRQVHQVXVZDVUHODWHG
12
ALTERNATIVE TOXICOLOGICAL METHODS
WRXVHRIWKHWZRVWDJHWHVWLQJLQZKLFKRQO\RQHRUWZRDQLPDOVZHUHVWXGLHGLQLWLDOO\ DQGWKHQDWXUHDQGFRQVLVWHQF\RIWKHÀQGLQJVGLFWDWHGIXUWKHUWHVWLQJWKHORZYROXPH WHVWSURYRNHGWKHVKDUSHVWGHEDWHDQGSDUWLFLSDQWFRQVHQVXVZDVQRWHYLGHQWPXFK LQIRUPDWLRQLVORVWZKHQWKHQXPEHURIJUDGHVRUFODVVHVRILUULWDQWVLVUHGXFHGWKXV HOLPLQDWLRQRID¶FRUURVLYHFODVV·ZRXOGUHTXLUHPRUHGLVFXVVLRQLQWHUQDWLRQDOSUDF WLFHV DQG FRQYHQWLRQV SUHYHQWHG D FRQVHQVXV UHJDUGLQJ WKH GHÀQLWLRQ RI D SRVLWLYH WHVWHLWKHUDVQXPEHURIDQLPDOVUHVSRQGLQJRUDVWKHPHDQVFRUHDQGWKHXVHRI WRWDODFLGLW\RUDONDOLQLW\DVDVXEVWLWXWHIRUS+UHTXLUHGIXUWKHUVWXG\µ7KHHQWLUH SURFHHGLQJVRIWKHZRUNVKRSZHUHSXEOLVKHGLQRQHYROXPHRI)RRGDQG&KHPLFDO 7R[LFRORJ\9ROXPHDQGWKHUHDGHULVUHIHUUHGWRWKDWSXEOLFDWLRQIRUDIXOO GLVFXVVLRQRIWKHZRUNVKRS 7KHWKLUGZRUNVKRSZDVKHOGLQ1RYHPEHULQ:DVKLQJWRQ'&DQGZDV WLWOHG ´:RUNVKRS RQ (\H ,UULWDWLRQ 7HVWLQJ 3UDFWLFDO$SSOLFDWLRQV RI 1RQ:KROH $QLPDO$OWHUQDWLYHVµ7KHJRDORIWKHZRUNVKRSZDVWRVHWDFRXUVHIRUWKHVFLHQWLÀF DSSURYDODQGDFFHSWDQFHRIQRQ²ZKROHDQLPDODOWHUQDWLYHVWRWKH'UDL]HH\HWHVW$ UHWURVSHFWLYH UHYLHZ RI WKHQ H[LVWLQJ LQ YLWUR DQG LQ YLYR GDWD E\ H[SHUW ZRUNLQJ JURXSVZDVFRQGXFWHGZLWKWKHLQWHQWWRH[DPLQHWKHVWDWXVRIDSUDFWLFDODSSOLFDWLRQ RILQYLWURDOWHUQDWLYHVXVHGWRSUHGLFWH\HLUULWDWLRQ%UDGODZDQG:LOFR[ ,W ZDVFRQFOXGHGWKDW´GDWDZDVLQVXIÀFLHQWWRVXSSRUWWKHWRWDOUHSODFHPHQWRILQYLYR RFXODU LUULWDQF\ WHVWLQJ ZLWK LQ YLWUR PHWKRGV DOWHUQDWLYH PHWKRGV WR WKH LQ YLYR 'UDL]H ZHUH EHLQJ XVHG H[WHQVLYHO\ E\ LQGXVWU\ DV VFUHHQV EDVHG RQ WKHQ FXUUHQW SUDFWLFH VRPH PRGHOV PD\ KDYH WKH SRWHQWLDO WR UHGXFH WKH QHHG IRU QHZ DQLPDO WHVWLQJ SURYLGHG WKH\ DUH YDOLGDWHG DQG FRQGXFWHG XQGHU ZHOO GHÀQHG FRQGLWLRQVµ ,W ZDV DOVR FRQFOXGHG WKDW ´EDVLF UHVHDUFK QHHGHG WR EH HQFRXUDJHG WR LGHQWLI\ PHFKDQLVWLFHQGSRLQWVIRUKXPDQRFXODULQMXU\WHVWEDWWHULHVLGHQWLÀHGWRWHVWQRYHO VXEVWDQFHVDWKLUGSDUW\WDNHWKHOHDGWRLGHQWLI\SURPLVLQJPHWKRGVDQGWRIDFLOLWDWH YDOLGDWLRQDQGLQWHUQDWLRQDOKDUPRQL]DWLRQRIPHWKRGGHYHORSPHQWYDOLGDWLRQDQG DFFHSWDQFH EH JLYHQ KLJK SULRULW\µ 7KH HQWLUH SURFHHGLQJV RI WKH ZRUNVKRS ZHUH SXEOLVKHGLQRQHYROXPHRI)RRGDQG&KHPLFDO7R[LFRORJ\9ROXPHDQG WKHUHDGHULVUHIHUUHGWRWKLVSXEOLFDWLRQIRUDIXOOGLVFXVVLRQRIWKHZRUNVKRS
EVOLUTION OF ICCVAM 7KHIHGHUDOHPSOR\HHVSDUWLFLSDWLQJLQYDULRXV,5$*DFWLYLWLHVVXFKDVPHHWLQJV RUJDQL]LQJV\PSRVLDDQGSDUWLFLSDWLQJLQH[SHUWZRUNJURXSVDOOKDGRWKHUSULPDU\ UHVSRQVLELOLWLHV6XSSRUWRIWKHVHLQGLYLGXDOVZDVFUXFLDOWRWKHVXFFHVVRIWKHJURXS 6LQFHLWVLQFHSWLRQWKHUHKDGEHHQQRIRUPDOEXGJHWWRVXSSRUWWKHJURXS·VDFWLYLWLHV $VFRPSHWLWLRQIRUVFDUFHUHVRXUFHVPDWHULDOL]HGLWEHFDPHLQFUHDVLQJO\PRUHGLI ÀFXOWIRUWKLVFRKRUWWRGHYRWHWKHWLPHDQGHIIRUWQHHGHGWRFRQWLQXHWKHZRUNRI WKHJURXSDQGWRVHHNDJHQF\DQGRWKHUIXQGLQJVRXUFHV 7KHHVWDEOLVKPHQWRIWKH,QWHUDJHQF\&RRUGLQDWLQJ&RPPLWWHHIRUWKH9DOLGDWLRQ RI$OWHUQDWLYH0HWKRGV,&&9$0 LQZDVYLHZHGDVDFRPSOHPHQWWRWKHZRUN RI WKH ,5$* ,WV PLVVLRQ ZDV WR GHYHORS DQG YDOLGDWH QHZ WHVW PHWKRGV DQG WR HVWDEOLVK FULWHULD DQG SURFHVVHV IRU WKH YDOLGDWLRQ DQG UHJXODWRU\ DFFHSWDQFH RI WR[LFRORJLFDOWHVWLQJPHWKRGV$OWKRXJKQHYHUIRUPDOO\VWDWHG ,EHOLHYHWKH,5$*
A HISTORY OF INTERAGENCY APPROACHES TO ALTERNATIVES
13
YLHZHGLWVHOIDVFRQFHQWUDWLQJRQZKDWZHUHFRQVLGHUHGPDMRUUHJXODWRU\DOWHUQDWLYH LVVXHVVXFKDVH\HDQGVNLQWHVWLQJ7KHUHKDGQRWEHHQPXFKWKRXJKWJLYHQWRRWKHU WR[LFRORJLFDOPHWKRGV7KH,&&9$0·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ÀWHG WUHPHQGRXVO\ IURP WKH H[SHULHQFH RI WKRVH ZKR RUJDQL]HG DQG H[HFXWHGWKHSURJUDPVRI,5$*
REFERENCES %UDGODZ-$DQG:LOFR[1/ :RUNVKRSRQH\HLUULWDWLRQWHVWLQJSUDFWLFDODSSOLFD WLRQVRIQRQZKROHDQLPDODOWHUQDWLYHV)RRG&KHP7R[LFRO² *UHHQ6 5HJXODWRU\FRQVLGHUDWLRQVIRUDOWHUQDWLYHVWRWKH'UDL]HH\HWHVW-7R[LFRO &XWDQHRXV2FXODU7R[LFRO ² *UHHQ 6 3URJUHVV RI YDULRXV 86 UHJXODWRU\ DJHQFLHV LQ UHYLHZLQJ DOWHUQDWLYH WHVW PHWKRGV-7R[LFRO&XWDQHRXV2FXODU7R[LFRO ² 1DWLRQDO,QVWLWXWHRI(QYLURQPHQWDO+HDOWK6FLHQFHV 9DOLGDWLRQDQG5HJXODWRU\$FFHS WDQFHRI7R[LFRORJLFDO7HVW0HWKRGV$5HSRUWRIWKHDGKRF,QWHUDJHQF\&RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV 1,+ SXEOLFDWLRQ 1,(+65HVHDUFK7ULDQJOH3DUN1&
CHAPTER
3
The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): Recent Progress in the Evaluation of Alternative Toxicity Testing Methods :LOOLDP66WRNHV
CONTENTS ,QWURGXFWLRQ %DFNJURXQGDQG+LVWRU\RIWKH,&&9$0 (VWDEOLVKPHQWRIWKH,&&9$0 ,&&9$0$XWKRUL]DWLRQ$FWRI 7KH1DWLRQDO7R[LFRORJ\3URJUDP,QWHUDJHQF\&HQWHUIRUWKH(YDOXDWLRQ RI$OWHUQDWLYH7R[LFRORJLFDO0HWKRGV1,&($70 7KH,&&9$06FLHQWLÀF$GYLVRU\&RPPLWWHH 7KH,&&9$07HVW0HWKRG(YDOXDWLRQ3URFHVV 7HVW0HWKRG9DOLGDWLRQ 7HVW0HWKRG6XEPLVVLRQV ,&&9$0,QWHUDJHQF\:RUNLQJ*URXSV ,QGHSHQGHQW6FLHQWLÀF3HHU5HYLHZ3DQHOV ([SHUW3DQHOVDQG:RUNVKRSV ,&&9$07HVW5HFRPPHQGDWLRQV 5HJXODWRU\$JHQF\&RQVLGHUDWLRQRI,&&9$05HFRPPHQGDWLRQV ,&&9$07HVW0HWKRG(YDOXDWLRQV 7KH/RFDO/\PSK1RGH$VVD\ 6NLQ&RUURVLYLW\ )URJ(PEU\R7HUDWRJHQHVLV$VVD\LQ;HQRSXV)(7$;
15
16
ALTERNATIVE TOXICOLOGICAL METHODS
8SDQG'RZQ3URFHGXUHIRU$FXWH2UDO7R[LFLW\ ,Q9LWUR0HWKRGVIRU$VVHVVLQJ$FXWH6\VWHPLF7R[LFLW\ 6XPPDU\ $FNQRZOHGJPHQWV 5HIHUHQFHV
INTRODUCTION 7R[LFRORJLFDO WHVW PHWKRGV DUH XVHG WR DVVHVV WKH VDIHW\ RU SRWHQWLDO DGYHUVH KHDOWK HIIHFWV RI FKHPLFDOV DQG SURGXFWV ,Q UHFHQW \HDUV WKHUH KDV EHHQ JURZLQJ LQWHUHVWLQGHYHORSPHQWRIQHZWHVWPHWKRGVWKDWSURYLGHPRUHDFFXUDWHDVVHVVPHQWV RIWR[LFLW\DQGWKDWFDQEHXVHGWRHYDOXDWHQHZWR[LFLW\HQGSRLQWVRILQWHUHVW1HZ PHWKRGV DUH DOVR VRXJKW WKDW SURYLGH LPSURYHG HIÀFLHQF\ LQ WHUPV RI WLPH DQG H[SHQVHDQGWKDWZLOOUHSODFHUHGXFHDQGUHÀQHDQLPDOXVH6WRNHV6WRNHV DQG0DUDIDQWH+LOODQG6WRNHV +RZHYHUEHIRUHDQHZPHWKRGLVXVHG WR JHQHUDWH LQIRUPDWLRQ IRU UHJXODWRU\ SXUSRVHV LW PXVW EH IRXQG WR EH YDOLG DQG DFFHSWDEOH IRU LWV SURSRVHG XVH 1,(+6 'HPRQVWUDWLQJ YDOLGLW\ UHTXLUHV VFLHQWLÀFHYLGHQFHRIWKHPHWKRG·VDFFXUDF\DQGUHSURGXFLELOLW\$FFHSWDQFHUHTXLUHV DGHWHUPLQDWLRQWKDWWKHPHWKRGZLOOIXOÀOODVSHFLÀFUHJXODWRU\QHHG ,QFUHDVLQJVRFLHWDOFRQFHUQVDERXWDQLPDOZHOIDUHDQGGLIÀFXOWLHVLQDFKLHYLQJ UHJXODWRU\DFFHSWDQFHRIDOWHUQDWLYHWHVWPHWKRGVFRQWULEXWHGWRQHZODZVWKDWOHG WR HVWDEOLVKPHQW RI WKH ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI $OWHUQDWLYH0HWKRGV,&&9$0 86&RGH3XUFKDVHHWDO86&RGH 6WRNHVDQG+LOO $QDGKRF,&&9$0HVWDEOLVKHGFULWHULDIRUWHVWPHWKRG YDOLGDWLRQDQGDFFHSWDQFHDQGDSURFHVVIRUIHGHUDODJHQFLHVWRFRRUGLQDWHWKHUHYLHZ RISURSRVHGWHVWPHWKRGVWKDWDUHRILQWHUHVWWRRWKHUIHGHUDO DJHQFLHV7DEOH $VWDQGLQJ,&&9$0HVWDEOLVKHGLQWRHYDOXDWHQHZDQGDOWHUQDWLYHWHVWPHWKRGV EHFDPHDSHUPDQHQWFRPPLWWHHLQ86&RGH 7KLVFKDSWHUZLOOSURYLGH DQRYHUYLHZRIWKH,&&9$0WHVWPHWKRGHYDOXDWLRQSURFHVVDQGGHVFULEHDOWHUQDWLYH WHVWPHWKRGVWKDWKDYHEHHQHYDOXDWHGE\WKH,&&9$0
BACKGROUND AND HISTORY OF THE ICCVAM 7KH1DWLRQDO,QVWLWXWHVRI+HDOWK1,+ 5HYLWDOL]DWLRQ$FWRI3XEOLF/DZ GLUHFWHGWKH1DWLRQDO,QVWLWXWHRI(QYLURQPHQWDO+HDOWK6FLHQFHV1,(+6 WRHVWDEOLVKFULWHULDIRUWKHYDOLGDWLRQDQGUHJXODWRU\DFFHSWDQFHRIDOWHUQDWLYHWHVWLQJ PHWKRGVDQGWRGHYHORSDSURFHVVE\ZKLFKVFLHQWLÀ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
ICCVAM EVALUATION OF ALTERNATIVE METHODS
17
,&&9$0 ,QGHYHORSLQJLWVUHSRUWWKHFRPPLWWHHVRXJKWEURDGLQSXW DQGSDUWLFLSDWLRQIURPLQWHUHVWHGVWDNHKROGHUVLQFOXGLQJLQGXVWU\DFDGHPLDDQLPDO ZHOIDUH RUJDQL]DWLRQV DQG WKH LQWHUQDWLRQDO FRPPXQLW\ 7KH DG KRF ,&&9$0 Table 3.1 Member Agencies Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Consumer Product Safety Commission Department of Defense Department of Energy Department of Health and Human Services Agency for Toxic Substances and Disease Registry Food and Drug Administration National Institute for Occupational Safety and Health National Institutes of Health, Office of the Director National Cancer Institute National Institute of Environmental Health Sciences National Library of Medicine Department of the Interior Department of Labor Occupational Safety and Health Administration Department of Transportation Research and Special Programs Administration Department of Agriculture Environmental Protection Agency Table 3.2 Test Method Validation and Acceptance Criteriaa Validation Criteria Clear statement of proposed use Biological basis/relationship to effect of interest provided Formal detailed protocol Reliability assessed Relevance assessed Limitations described All data available for review Data quality: Ideally good laboratory practices (GLPs) Independent scientific peer review Acceptance Criteria Fits into the regulatory testing structure Adequately predicts the toxic endpoint of interest Generates data useful for risk assessment Adequate data available for specified uses Robust and transferable Time and cost effective Adequate animal welfare consideration (3 Rs) a
These are shortened versions of the adopted criteria. For the full text see: National Institute of Environmental Health Sciences (NIEHS), Validation and Regulatory Acceptance of Toxicological Test Methods: A Report of the ad hoc Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), NIH publication 97-3981, Research Triangle Park, NC, 1997.
18
ALTERNATIVE TOXICOLOGICAL METHODS
SXEOLVKHG LWV ÀQDO UHSRUW 9DOLGDWLRQ DQG 5HJXODWRU\ $FFHSWDQFH RI 7R[LFRORJLFDO 7HVW0HWKRGVLQ,&&9$0 7KHUHSRUWGHVFULEHVYDOLGDWLRQDQGDFFHS WDQFH FULWHULD DQG SURFHVVHV IRU QHZ DQG UHYLVHG WHVW PHWKRGV 7DEOH 7KH SULQFLSOHV HPERGLHG LQ WKHVH FULWHULD DUH EDVHG RQ JRRG VFLHQFH DQG WKH QHHG WR HQVXUHWKDWWKHXVHRIQHZWHVWPHWKRGVZLOOSURYLGHIRUHTXLYDOHQWRUEHWWHUSURWHFWLRQ RIKXPDQKHDOWKDQGWKHHQYLURQPHQWWKDQSUHYLRXVWHVWLQJPHWKRGVRUVWUDWHJLHV Establishment of the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ÀFWHVWPHWKRGZRUNJURXSV ICCVAM Authorization Act of 2000 7KH,&&9$0ZDVGHVLJQDWHGDVDSHUPDQHQWFRPPLWWHHZLWKWKHHQDFWPHQWRI WKH,&&9$0$XWKRUL]DWLRQ$FWRI3XEOLF/DZ86 &RGH 7KHODZZDVHQDFWHG´WRHVWDEOLVKZKHUHYHUIHDVLEOHJXLGHOLQHVUHFRPPHQGDWLRQV DQGUHJXODWLRQVWKDWSURPRWHWKHUHJXODWRU\DFFHSWDQFHRIQHZRUUHYLVHGVFLHQWLÀ FDOO\ YDOLG WR[LFRORJLFDO WHVWV WKDW SURWHFW KXPDQ DQG DQLPDO KHDOWK DQG WKH HQYL URQPHQW ZKLOH UHGXFLQJ UHÀQLQJ RU UHSODFLQJ DQLPDO WHVWV DQG HQVXULQJ KXPDQ VDIHW\DQGSURGXFWHIIHFWLYHQHVVµ7KH$FWHVWDEOLVKHGWKH,&&9$0DVDSHUPDQHQW LQWHUDJHQF\FRPPLWWHHFRPSRVHGRIWKHKHDGVRUWKHLUGHVLJQHHVIURPWKHIHGHUDO DJHQFLHV WKDW RULJLQDOO\ DJUHHG WR SDUWLFLSDWH RQ WKH DG KRF ,&&9$0 7DEOH 7KH$FWPDQGDWHVVSHFLÀFSXUSRVHVDQGGXWLHVRIWKH,&&9$07DEOHVDQG 7KH,&&9$0DOVRFRQWLQXHVWRFRRUGLQDWHLQWHUDJHQF\LVVXHVRQWHVWPHWKRGGHYHO RSPHQWYDOLGDWLRQUHJXODWRU\DFFHSWDQFHDQGQDWLRQDODQGLQWHUQDWLRQDOKDUPRQL ]DWLRQ,&&9$0D Table 3.3 The Purposes of the ICCVAMa Increase the efficiency and effectiveness of federal agency test method review Eliminate unnecessary duplicative efforts and share experiences between federal regulatory agencies Optimize use of scientific expertise outside the federal government Ensure that new and revised test methods are validated to meet the needs of federal agencies Reduce, refine, or replace the use of animals in testing where feasible a
ICCVAM Authorization Act (U.S. Code, 2000).
ICCVAM EVALUATION OF ALTERNATIVE METHODS
19
Table 3.4 The Duties of the ICCVAMa Consider petitions from the public for review and evaluation of new and revised test methods for which there is evidence of scientific validity Coordinate the technical review and evaluation of new and revised test methods of interagency interest Submit ICCVAM test recommendations to each appropriate federal agency Facilitate and provide guidance on validation criteria and processes Facilitate: Interagency and international harmonization of test protocols that encourage the reduction, refinement, and replacement of animal test methods Acceptance of scientifically valid test methods and awareness of accepted methods Make ICCVAM final test recommendations and agency responses available to the public Prepare reports on the progress of this act and make these available to the public a
ICCVAM Authorization Act (U.S. Code, 2000).
THE NATIONAL TOXICOLOGY PROGRAM INTERAGENCY CENTER FOR THE EVALUATION OF ALTERNATIVE TOXICOLOGICAL METHODS (NICEATM) $1DWLRQDO7R[LFRORJ\3URJUDP,QWHUDJHQF\&HQWHUIRUWKH(YDOXDWLRQRI$OWHU QDWLYH7R[LFRORJLFDO 0HWKRGV 1,&($70 ZDV HVWDEOLVKHG E\ 1,(+6 LQ WR SURYLGH RSHUDWLRQDO VXSSRUW IRU WKH ,&&9$0 DQG LWV DFWLYLWLHV ,&&9$0 D6WRNHVDQG+LOO 1,&($70LVDSDUWRIWKH(QYLURQPHQWDO7R[LFRORJ\ 3URJUDP'LYLVLRQRI,QWUDPXUDO5HVHDUFK1,(+6ZLWKRIÀFHVLQ5HVHDUFK7ULDQJOH 3DUN 1RUWK &DUROLQD 7KH FRPSRQHQWV RI 1,&($70 DUH D FHQWHU RIÀFH WKH ,&&9$0SHHUUHYLHZDQGH[SHUWSDQHOVDQGDVFLHQWLÀFDGYLVRU\FRPPLWWHH7KH 1,&($70RIÀFHSURYLGHVFRPPLWWHHPDQDJHPHQWDQGRSHUDWLRQDOVXSSRUWIRUWKH ,&&9$0,&&9$0ZRUNLQJJURXSVSHHUUHYLHZDQGH[SHUWSDQHOVDQGWKHVFLHQ WLÀFDGYLVRU\FRPPLWWHH 1,&($70 FROODERUDWHV ZLWK WKH ,&&9$0 WR FDUU\ RXW VFLHQWLÀF SHHU UHYLHZ DQG LQWHUDJHQF\ FRQVLGHUDWLRQ RI QHZ WHVW PHWKRGV RI PXOWLDJHQF\ LQWHUHVW 7KH FHQWHUDOVRSHUIRUPVRWKHUIXQFWLRQVQHFHVVDU\WRHQVXUHFRPSOLDQFHZLWKSURYLVLRQV RI WKH ,&&9$0$XWKRUL]DWLRQ$FW RI 86 &RGH 7KH SXEOLF KHDOWK JRDORIWKH1,&($70DQGWKH,&&9$0LVWRSURPRWHWKHVFLHQWLÀFYDOLGDWLRQDQG UHJXODWRU\ DFFHSWDQFH RI QHZ WR[LFLW\ WHVWLQJ PHWKRGV WKDW DUH PRUH SUHGLFWLYH RI KXPDQKHDOWKDQGHFRORJLFDOHIIHFWVWKDQFXUUHQWO\DYDLODEOHPHWKRGV0HWKRGVDUH HPSKDVL]HGWKDWSURYLGHIRULPSURYHGWR[LFLW\FKDUDFWHUL]DWLRQVDYLQJVLQWLPHDQG FRVWVDQGUHÀQHPHQWUHGXFWLRQDQGUHSODFHPHQWRIDQLPDOXVHZKHQHYHUIHDVLEOH The ICCVAM Scientific Advisory Committee ,QRUGHUIRUWKH,&&9$0DQGWKH1,&($70WRREWDLQFRQVWUXFWLYHDGYLFHIURP NQRZOHGJHDEOHVFLHQWLVWVRXWVLGHRIJRYHUQPHQWDQ$GYLVRU\&RPPLWWHHRQ$OWHU QDWLYH7R[LFRORJLFDO 0HWKRGV $&$70 ZDV HVWDEOLVKHG LQ 1,(+6 7KH DGYLVRU\ FRPPLWWHH ZDV FRPSRVHG RI SURIHVVLRQDOV IURP DFDGHPLD LQGXVWU\ DQLPDOZHOIDUHJURXSVDQGRWKHURUJDQL]DWLRQV7KHFRPPLWWHHSURYLGHGDGYLFHRQ
20
ALTERNATIVE TOXICOLOGICAL METHODS
WKH DFWLYLWLHV DQG SULRULWLHV RI 1,&($70 DQG ,&&9$0 DQG RQ ZD\V WR IRVWHU SDUWQHUVKLS DFWLYLWLHV DQG LQWHUDFWLRQV DPRQJ LQWHUHVWHG SDUWLHV 7R FRPSO\ ZLWK SURYLVLRQVRIWKH,&&9$0$XWKRUL]DWLRQ$FWRIWKH$&$70ZDVUHFKDUWHUHG LQDVDQ1,+DGYLVRU\FRPPLWWHHDQGUHQDPHGWKH6FLHQWLÀ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ÀHGE\ODZDQGWKH6$&$70FKDUWHU86 &RGH 1,(+6 7KH FKDUWHU FDOOV IRU YRWLQJ PHPEHUV RI WKH 6$&$70 DQG WKH DFW VSHFLÀHV WKDW ,&&9$0 DJHQF\ UHSUHVHQWDWLYHV VHUYH DV H[ RIÀFLRQRQYRWLQJPHPEHUV
THE ICCVAM TEST METHOD EVALUATION PROCESS Test Method Validation $ PDMRU IXQFWLRQ RI WKH ,&&9$0 LV WR HYDOXDWH WKH YDOLGDWLRQ VWDWXV RI SURSRVHG QHZ UHYLVHG DQG DOWHUQDWLYH WHVW PHWKRGV DQG WR SURYLGH WHVW UHFRP PHQGDWLRQVWRIHGHUDODJHQFLHV9DOLGDWLRQLVGHÀQHGDVWKHSURFHVVE\ZKLFKWKH UHOLDELOLW\ DQG UHOHYDQFH RI D WHVW PHWKRG DUH HVWDEOLVKHG IRU D VSHFLÀF SXUSRVH ,&&9$0 5HOLDELOLW\ LV D PHDVXUH RI WKH H[WHQW WR ZKLFK D WHVW FDQ EH SHUIRUPHGUHSURGXFLEO\ZLWKLQDQGDPRQJODERUDWRULHVRYHUWLPHZKLOHUHOHYDQFH LVWKHH[WHQWWRZKLFKDWHVWPHWKRGZLOOFRUUHFWO\SUHGLFWRUPHDVXUHWKHELRORJLFDO HIIHFWRILQWHUHVW,&&9$0 $GHTXDWHYDOLGDWLRQLVFRQVLGHUHGDSUHUHTXL VLWH IRU UHJXODWRU\ DFFHSWDQFH FRQVLGHUDWLRQ $ WHVW PHWKRG W\SLFDOO\ HYROYHV WKURXJKDSURFHVVLQYROYLQJUHVHDUFKGHYHORSPHQWSUHYDOLGDWLRQDQGYDOLGDWLRQ EHIRUH JDLQLQJ DFFHSWDQFH DV DQ DSSURYHG WHVW PHWKRG ,&&9$0 7HVW PHWKRGVIRUZKLFKWKHUHDUHFRPSOHWHGYDOLGDWLRQVWXGLHVFDQEHVXEPLWWHGWRWKH ,&&9$0IRUFRQVLGHUDWLRQ Test Method Submissions )ROORZLQJFRPSOHWLRQRIDSSURSULDWHYDOLGDWLRQVWXGLHVWKHVSRQVRUVXEPLWVDOO DYDLODEOHLQIRUPDWLRQDQGVXSSRUWLQJGRFXPHQWDWLRQIRUDWHVWPHWKRGWR,&&9$0 LQ DFFRUGDQFH ZLWK WKH ,&&9$0 VXEPLVVLRQ JXLGHOLQHV )LJXUH ,&&9$0 D 7KHH[WHQWWRZKLFKHDFKRIWKHHVWDEOLVKHGYDOLGDWLRQDQGDFFHSWDQFHFULWHULD KDYHEHHQDGGUHVVHGPXVWEHGHVFULEHGLQWKHVXEPLVVLRQ,&&9$0 6XE PLVVLRQVPXVWFRQWDLQVXIÀFLHQWLQIRUPDWLRQIRU DQLQGHSHQGHQWVFLHQWLÀFSHHU UHYLHZSDQHOWRDVVHVVWKHYDOLGDWLRQVWDWXVRIWKHSURSRVHGWHVWPHWKRGDQG IRU DJHQFLHVWRDVVHVVWKHDFFHSWDELOLW\RIWKHSURSRVHGWHVWPHWKRGIRUSURYLGLQJXVHIXO LQIRUPDWLRQIRUKD]DUGRUULVNDVVHVVPHQW6XEPLVVLRQVVKRXOGLQFOXGHDOOUHOHYDQW
ICCVAM EVALUATION OF ALTERNATIVE METHODS
21
Test Sponsor Submission of Test Method
Peer Review Panels Expert Workshops Report
ICCVAM Interagency Working Groups
NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
Test Recommendations to Agencies
Figure 3.1
Advisory Committee on Alternative Toxicological Methods
Agency Decisions/Actions
ICCVAM test method evaluation process.
GDWDGHWDLOHGSURWRFROVVWDWLVWLFDODQDO\VHVSXEOLFDWLRQVDQGRWKHULQIRUPDWLRQDV GHVFULEHGLQWKHVXEPLVVLRQJXLGHOLQHV ICCVAM Interagency Working Groups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ndependent Scientific Peer-Review Panels :KHQDGHTXDWHLQIRUPDWLRQLVDYDLODEOHIRUDWHVWPHWKRGDQGLWKDVEHHQDFFHSWHG IRU,&&9$0HYDOXDWLRQDQLQGHSHQGHQWVFLHQWLÀFSHHUUHYLHZSDQHOLVXVXDOO\FRQ YHQHG7KHSDQHOLVFKDUJHGZLWKGHYHORSLQJDVFLHQWLÀFFRQVHQVXVRQWKHYDOLGDWLRQ VWDWXVRIWKHSURSRVHGWHVWPHWKRGLQFOXGLQJLWVXVHIXOQHVVIRUJHQHUDWLQJLQIRUPDWLRQ IRU VSHFLÀF KXPDQ KHDOWK DQGRU HFRORJLFDO ULVN DVVHVVPHQW SXUSRVHV )LJXUH 7KHSDQHOFRQVLVWVRIH[SHUWVIURPDURXQGWKHZRUOGZKRDUHNQRZOHGJHDEOHLQWKH
22
ALTERNATIVE TOXICOLOGICAL METHODS
ÀHOGDQGZKRGRQRWKDYHDFRQÁLFWRILQWHUHVWZLWKWKHRXWFRPHRIWKHHYDOXDWLRQ ,QDVVHVVLQJWKHYDOLGDWLRQVWDWXVRIDPHWKRGSHHUUHYLHZSDQHOVDUHDVNHGWRFRQVLGHU DOODYDLODEOHLQIRUPDWLRQDQGWRHYDOXDWHWKHH[WHQWWRZKLFKWKH,&&9$0YDOLGDWLRQ DQGDFFHSWDQFHFULWHULDKDYHEHHQDGGUHVVHG7KHSDQHOFRPSDUHVWKHWHVWPHWKRG·V SHUIRUPDQFH WR WKDW RI WKH FXUUHQW UHIHUHQFH PHWKRG DQG GHYHORSV FRQFOXVLRQV DQG UHFRPPHQGDWLRQVUHJDUGLQJWKHWHVWPHWKRG·VXVHIXOQHVVDGYDQWDJHVDQGOLPLWDWLRQV :KHUH DYDLODEOH DQG DSSURSULDWH WKH SDQHO FRQVLGHUV LQIRUPDWLRQ DYDLODEOH DERXW KXPDQ WR[LFLW\ IRU WKH UHIHUHQFH FKHPLFDOV XVHG WR HYDOXDWH WKH SUHGLFWLYH SHUIRU PDQFHRIWKHWHVWPHWKRG6XFKGDWDDOORZIRUDVVHVVPHQWRIWKHPHWKRG·VXVHIXOQHVV LQ SUHGLFWLQJ SRWHQWLDO DGYHUVH KXPDQ KHDOWK HIIHFWV )URP D VFLHQWLÀF SHUVSHFWLYH WKHSDQHODGGUHVVHVKRZDQGZKHQWKHQHZWHVWPHWKRGPLJKWSDUWLDOO\RUIXOO\UHSODFH H[LVWLQJPHWKRGVRUDSSURDFKHV 3HHUUHYLHZSDQHOVDUHDOVRDVNHGWRHYDOXDWHWKHH[WHQWWRZKLFKWKHWHVWPHWKRG SURYLGHVIRUWKHUHSODFHPHQWUHGXFWLRQRUUHÀQHPHQWRIDQLPDOXVH7KLVLQIRUPD WLRQ LV KHOSIXO EHFDXVH 86 ODZV UHJXODWLRQV DQG SROLFLHV UHTXLUH VFLHQWLVWV WR FRQVLGHUVFLHQWLÀ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xpert Panels and Workshops ,&&9$0PD\EHDVNHGWRUHYLHZWKHFXUUHQWYDOLGDWLRQVWDWXVRI WHVWPHWKRGV ZKHUHDGHTXDWHYDOLGDWLRQVWXGLHVDUHQRWDYDLODEOH,QWKHVHVLWXDWLRQVH[SHUWZRUN VKRSVRUH[SHUWSDQHOPHHWLQJVDUHFRQYHQHG,&&9$0D 7KHVHZRUNVKRSV DQGPHHWLQJVPD\ (YDOXDWHWKHLQWHULPYDOLGDWLRQVWDWXVRIPHWKRGV (YDOXDWHSURSRVHGYDOLGDWLRQVWXGLHV 'HYHORS UHFRPPHQGDWLRQV IRU UHVHDUFK GHYHORSPHQW DQG YDOLGDWLRQ VWXGLHV QHHGHGWRIXUWKHUFKDUDFWHUL]HRULPSURYHWKHXVHIXOQHVVRIWHVWPHWKRGV (YDOXDWHWKHDGHTXDF\RIFXUUHQWPHWKRGVIRUDVVHVVLQJVSHFLÀFWR[LFLWLHV ,GHQWLI\WHVWLQJDUHDVLQQHHGRIQHZRULPSURYHGPHWKRGV
)HGHUDO DJHQFLHV DQG RWKHU IXQGLQJ VRXUFHV FDQ WKHQ XVH WKLV LQIRUPDWLRQ WR HVWDEOLVKSULRULWLHVIRUDSSURSULDWHUHVHDUFKGHYHORSPHQWDQGYDOLGDWLRQHIIRUWV
ICCVAM EVALUATION OF ALTERNATIVE METHODS
23
ICCVAM Test Recommendations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
REGULATORY AGENCY CONSIDERATION OF ICCVAM RECOMMENDATIONS ,&&9$0WHVWUHFRPPHQGDWLRQVDQGWHVWPHWKRGHYDOXDWLRQUHSRUWVDUHIRUZDUGHG WRIHGHUDODJHQFLHVIRUWKHLUFRQVLGHUDWLRQWKURXJKWKH6HFUHWDU\RI+HDOWKDQG+XPDQ 6HUYLFHVRUKLVKHUGHVLJQHH86&RGH ,QDFFRUGDQFHZLWK3XEOLF/DZ DJHQFLHV PXVW UHYLHZ WKH ,&&9$0 WHVW UHFRPPHQGDWLRQV DQG QRWLI\ WKH ,&&9$0ZLWKLQGD\VRIWKHLUÀQGLQJV86&RGH (DFKIHGHUDODJHQF\ PDNHV D GHFLVLRQ UHJDUGLQJ WKH DSSOLFDELOLW\ DQG DFFHSWDELOLW\ RI WKH WHVW PHWKRG EDVHGRQWKHLUVSHFLÀFVWDWXWRU\PDQGDWHVDQGGHWHUPLQHVZKHQ DQGKRZWKH\FDQ EHXVHGWRPHHWDJHQF\WHVWLQJUHTXLUHPHQWV,IWKHWHVWPHWKRGLVDFFHSWHGDSSUR SULDWHDFWLRQLVWDNHQE\DQDJHQF\VXFKDVWKHUHYLVLRQRULVVXDQFHRIUHJXODWLRQV JXLGHOLQHVRUJXLGDQFHGRFXPHQWV7KH,&&9$0LVUHTXLUHGWRPDNHERWKLWVUHF RPPHQGDWLRQVDQGIHGHUDODJHQF\UHVSRQVHVDYDLODEOHWRWKHSXEOLF86&RGH
ICCVAM TEST METHOD EVALUATIONS The Local Lymph Node Assay 7KH ÀUVW WHVW PHWKRG HYDOXDWHG E\ WKH ,&&9$0 ZDV WKH PXULQH ORFDO O\PSK QRGH DVVD\ //1$ D QHZ DOWHUQDWLYH PHWKRG IRU DVVHVVLQJ WKH DOOHUJLF FRQWDFW GHUPDWLWLVSRWHQWLDORIFKHPLFDOV,&&9$0E6DLOVWDGHWDO'HDQHW DO+DQHNHHWDO 7KH//1$LVDPHFKDQLVPEDVHGWHVWPHWKRGWKDW SURYLGHV GRVHUHVSRQVH LQIRUPDWLRQ XVHV IHZHU DQLPDOV DQG HOLPLQDWHV SDLQ DQG GLVWUHVV FRPSDUHG WR WKH VWDQGDUG WHVWLQJ PHWKRG IRU ZKLFK LW FDQ EH VXEVWLWXWHG 'HDQ HW DO $ VFLHQWLÀF SHHUUHYLHZ SDQHO FRQFOXGHG WKDW WKH //1$ LV D YDOLGVXEVWLWXWHWRWKHFXUUHQWO\DFFHSWHGWHVWPHWKRGVWKDWXVHJXLQHDSLJV,&&9$0 E 'HDQ HW DO 7KH SDQHO DOVR FRQFOXGHG WKDW WKH //1$ SURYLGHV IRU WKH UHÀQHPHQW DQG UHGXFWLRQ RI DQLPDO XVH7KH ,&&9$0 IRUZDUGHG WHVW UHFRP PHQGDWLRQV WR DJHQFLHV IRU WKHLU FRQVLGHUDWLRQ DQG WKH //1$ ZDV VXEVHTXHQWO\ DFFHSWHG E\ WKH 86 (QYLURQPHQWDO 3URWHFWLRQ $JHQF\ (3$ )RRG DQG 'UXJ $GPLQLVWUDWLRQ)'$ DQG2FFXSDWLRQDO6DIHW\DQG+HDOWK$GPLQLVWUDWLRQ26+$ 6DLOVWDGHWDO $QHZLQWHUQDWLRQDOO\KDUPRQL]HGWHVWJXLGHOLQHWHVWJXLGHOLQH
24
ALTERNATIVE TOXICOLOGICAL METHODS
IRUWKH//1$KDVEHHQDGRSWHGE\WKH2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQ DQG'HYHORSPHQW2(&' ,&&9$0 RUJDQL]HG D WUDLQLQJ ZRUNVKRS RQ WKH //1$ LQ -DQXDU\ LQ FROODERUDWLRQZLWKWKH,QWHUQDWLRQDO/LIH6FLHQFHV,QVWLWXWH,/6, DQGRWKHUIHGHUDO DJHQFLHV7KHSXUSRVHRIWKHZRUNVKRSZDVWRWUDLQUHJXODWRU\VFLHQWLVWVDQGLQGXVWU\ WR[LFRORJLVWVRQKRZWRFRUUHFWO\SHUIRUPWKH//1$DQGLQWHUSUHWGDWDLQDFFRUGDQFH ZLWKUHJXODWRU\WHVWLQJUHTXLUHPHQWV6XFKWUDLQLQJLVH[SHFWHGWRIDFLOLWDWHHIIHFWLYH XVHRIWKH//1$ Skin Corrosivity &RUURVLWH[¤,Q9LWUR,QWHUQDWLRQDO,QF,UYLQH&DOLIRUQLD LVDQLQYLWURPHWKRG IRU DVVHVVLQJ WKH GHUPDO FRUURVLYLW\ SRWHQWLDO RI FKHPLFDOV7KH PHWKRG ZDV VXE PLWWHGWR,&&9$0IRUHYDOXDWLRQDQGVXEVHTXHQWO\XQGHUZHQWUHYLHZE\DQLQGH SHQGHQWVFLHQWLÀFSHHUUHYLHZSDQHOLQ-DQXDU\,&&9$0F 7KHSDQHO FRQFOXGHGWKDW&RUURVLWH[FRXOGEHXVHGWRDVVHVVWKHFRUURVLYLW\SRWHQWLDORIFHUWDLQ FKHPLFDOFODVVHVIRUVSHFLÀFUHJXODWRU\WHVWLQJSXUSRVHVVXFKDVIRUWUDQVSRUWDWLRQ KD]DUGFODVVLÀFDWLRQ,&&9$0F 7KHSDQHODOVRFRQFOXGHGWKDWWKHPHWKRG ZDV XVHIXO IRU VFUHHQLQJ WKH FRUURVLYLW\ SRWHQWLDO RI VRPH FKHPLFDO FODVVHV LQ D VWHSZLVH WLHUHG WHVWLQJ DSSURDFK VXFK DV WKDW HQGRUVHG E\ WKH 2(&' ,&&9$0 F ,&&9$0 :KHQ XVHG LQ WKLV PDQQHU WKH PHWKRG SURYLGHV IRU WKH UHÀ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ÀQHGH[SRVXUHSHULRG 7KHVHPHWKRGVKDYHEHHQDFFHSWHGE\WKH(XURSHDQ&RPPLVVLRQ(& (YDO XDWLRQ E\ ,&&9$0 XVLQJ DQ H[SHGLWHG UHYLHZ SURFHVV ZDV FRPSOHWHG LQ ,&&9$0 Frog Embryo Teratogenesis Assay in Xenopus (FETAX) ,&&9$0 DQG 1,&($70 FRQYHQHG DQ H[SHUW SDQHO PHHWLQJ LQ 0D\ WR HYDOXDWH WKH IURJ HPEU\R WHUDWRJHQHVLV DVVD\³;HQRSXV )(7$; D VFUHHQLQJ PHWKRGSURSRVHGIRUHYDOXDWLQJWKHGHYHORSPHQWDOWR[LFLW\SRWHQWLDORIFKHPLFDOV 7KHSDQHORIH[SHUWVFLHQWLVWVGHYHORSHGDFRQVHQVXVRQWKHFXUUHQWYDOLGDWLRQVWDWXV RI)(7$;DQGGHYHORSHGUHFRPPHQGDWLRQVRQFXUUHQWDQGSRWHQWLDOXVHVRI)(7$; $OWKRXJKWKHSDQHOFRQFOXGHGWKDW)(7$;ZDVQRWDGHTXDWHO\YDOLGDWHGIRUUHJX ODWRU\WHVWLQJDSSOLFDWLRQVWKHSDQHOUHFRPPHQGHGZD\VWKDWWKH)(7$;SURWRFRO PLJKWEHIXUWKHURSWLPL]HGWRLPSURYHUHSURGXFLELOLW\DQGSHUIRUPDQFH7KHSDQHO DOVR UHFRPPHQGHG DGGLWLRQDO UHVHDUFK DQG WHVW PHWKRG GHYHORSPHQW WKDW PLJKW
ICCVAM EVALUATION OF ALTERNATIVE METHODS
25
LPSURYH WKH DFFXUDF\ RI )(7$; IRU SUHGLFWLQJ GHYHORSPHQWDO WR[LFLW\ WR KXPDQV DQG HQYLURQPHQWDO VSHFLHV ,&&9$0 0LQXWHV RI WKH PHHWLQJ DUH RQ WKH ,&&9$01,&($70ZHEVLWHDWKWWSLFFYDPQLHKVQLKJRY Up-and-Down Procedure for Acute Oral Toxicity ,&&9$0DQG1,&($70FRPSOHWHGHYDOXDWLRQRIDUHYLVHGXSDQGGRZQSUR FHGXUH8'3 IRUGHWHUPLQLQJWKHDFXWHRUDOWR[LFLW\RIFKHPLFDOVLQ,&&9$0 E 5HYLVLRQ RI WKH 8'3 ZDV SURPSWHG E\ WKH 2(&'·V SURSRVHG GHOHWLRQ RI WKH FRQYHQWLRQDO DFXWH RUDO WR[LFLW\ WHVW JXLGHOLQH ,&&9$0 E 7KH (3$ UHYLVHGWKH8'3VRWKDWLWFRXOGSURYLGHHTXLYDOHQWKD]DUGLGHQWLÀFDWLRQDQGGRVH UHVSRQVHLQIRUPDWLRQDVWKHFRQYHQWLRQDOWHVWJXLGHOLQH2(&'(3$ 7KHLQGHSHQGHQWSHHUUHYLHZSDQHOFRQFOXGHGWKDWWKH8'3FRXOGUHSODFHWKHFRQ YHQWLRQDO DFXWH RUDO WR[LFLW\ WHVW WR HVWLPDWH DQ /' IRU KD]DUG FODVVLÀFDWLRQ DQG ODEHOLQJ SXUSRVHV +RZHYHU WKH 8'3 GRHV QRW SURYLGH GRVHUHVSRQVH DQG VORSH LQIRUPDWLRQVRRWKHUWHVWLQJZRXOGEHQHFHVVDU\LIWKLVLQIRUPDWLRQZDVUHTXLUHG 7KH8'3VLJQLÀFDQWO\UHGXFHVWKHQXPEHURIDQLPDOVQHFHVVDU\IRUGHWHUPLQLQJ DFXWHWR[LFLW\XVLQJDQDYHUDJHRIVHYHQWRQLQHDQLPDOVFRPSDUHGWRWKHRUPRUH XVHG LQ WKH FRQYHQWLRQDO WHVW PHWKRG ,&&9$0 E 7KH SURFHGXUH LQYROYHV VHTXHQWLDOWHVWLQJLQVLQJOHDQLPDOVZLWKWKHGRVHDGMXVWHGXSRUGRZQEDVHGRQWKH RXWFRPHRIWKHSUHYLRXVO\GRVHGDQLPDO7KH8'3OLPLWWHVWXVHVRQO\WKUHHWRÀYH DQLPDOVDQGFDQEHXVHGWRHYDOXDWHUHODWLYHO\QRQWR[LFVXEVWDQFHVWKDWKDYHD/' RIPRUHPJNJRUPJNJGHSHQGLQJRQWKHUHJXODWRU\UHTXLUHPHQW $VRIWZDUHSURJUDPLVDYDLODEOHWR IDFLOLWDWHFDOFXODWLRQRIGRVHV GHWHUPLQH ZKHQ WHVWLQJ LV FRPSOHWHG DQG FDOFXODWH DQ HVWLPDWHG /' DQG FRQÀGHQFH LQWHUYDO ,&&9$0 E 7KH UHYLVHG 8'3 ZDV VXEVHTXHQWO\ DGRSWHG E\ WKH 2(&'DVDQLQWHUQDWLRQDOO\KDUPRQL]HGWHVWJXLGHOLQH2(&'D )ROORZLQJ HYDOXDWLRQ RI WKH 8'3 WKH ,&&9$0 LQ SDUWQHUVKLS ZLWK WKH 86 (3$DQGWKH,QWHUQDWLRQDO/LIH6FLHQFHV,QVWLWXWH,/6, RUJDQL]HGDWUDLQLQJZRUN VKRSRQDFXWHWR[LFLW\WHVWLQJPHWKRGVLQ)HEUXDU\7KHZRUNVKRSSURYLGHG SUDFWLFDOLQIRUPDWLRQDQGFDVHVWXGLHVWRIDFLOLWDWHXQGHUVWDQGLQJDQGWKHLPSOHPHQ WDWLRQRIWKH8'3DQGWZRRWKHULQYLYRDOWHUQDWLYHPHWKRGVWKHDFXWHWR[LFFODVV SURFHGXUH DQG WKH À[HG GRVH SURFHGXUH 2(&' EF 7KH ZRUNVKRS DOVR GLVFXVVHGKRZWRXVHLQYLWURPHWKRGVWRHVWLPDWHVWDUWLQJGRVHVIRUDQLPDOVWXGLHV 6SLHOPDQQ ,&&9$0 E DQG WKH DSSOLFDWLRQ RI KXPDQH HQGSRLQWV WR DFXWHWR[LFLW\VWXGLHV2(&' In Vitro Methods for Assessing Acute Systemic Toxicity ,&&9$0DQG1,&($70RUJDQL]HGDQLQWHUQDWLRQDOZRUNVKRSRQLQYLWURPHWK RGVIRUDVVHVVLQJDFXWHV\VWHPLFWR[LFLW\LQ2FWREHU1,(+6,&&9$0 D 7KHZRUNVKRSH[SHUWVGHYHORSHGUHFRPPHQGDWLRQVRQWKHH[WHQWWKDWFXUUHQW LQYLWURWHVWPHWKRGVPLJKWEHXVHGWRHYDOXDWHDFXWHV\VWHPLFWR[LFLW\SRWHQWLDORI FKHPLFDOV 7KH H[SHUWV DOVR UHFRPPHQGHG UHVHDUFK GHYHORSPHQW DQG YDOLGDWLRQ HIIRUWVQHHGHGWRIXUWKHULPSURYHWKHXVHIXOQHVVRILQYLWURPHWKRGVIRUDFXWHWR[LFLW\ )RXUEUHDNRXWJURXSVDGGUHVVHGHDFKRIWKHIROORZLQJWRSLFV
26
ALTERNATIVE TOXICOLOGICAL METHODS
,QYLWURVFUHHQLQJPHWKRGVIRUDVVHVVLQJDFXWHWR[LFLW\ ,QYLWURPHWKRGVIRUWR[LFRNLQHWLFGHWHUPLQDWLRQV ,QYLWURPHWKRGVIRUSUHGLFWLQJRUJDQVSHFLÀFWR[LFLW\ &KHPLFDOGDWDVHWVIRUYDOLGDWLRQRILQYLWURDFXWHWR[LFLW\WHVWPHWKRGV
7KH À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²
SUMMARY 7KH ,&&9$0 SURYLGHV DQ HIÀFLHQW SURFHVV IRU WKH LQWHUDJHQF\ HYDOXDWLRQ RI QHZ UHYLVHG DQG DOWHUQDWLYH PHWKRGV RI PXOWLDJHQF\ LQWHUHVW 7KH ,&&9$0 DQG WKH 1,&($70 KDYH QRZ HYDOXDWHG VHYHUDO WHVW PHWKRGV WKDW UHGXFH UHÀQH DQG SDUWLDOO\UHSODFHDQLPDOXVHIRUUHJXODWRU\WHVWLQJ&RQWLQXHGGHYHORSPHQWYDOLGD WLRQDQGDGRSWLRQRILPSURYHGWHVWLQJPHWKRGVFDQEHH[SHFWHGWRVXSSRUWHQKDQFHG SURWHFWLRQ RI SXEOLF KHDOWK DQG WKH HQYLURQPHQW $GRSWLRQ RI VFLHQWLÀFDOO\ YDOLG DOWHUQDWLYHPHWKRGVZLOODOVREHQHÀWDQLPDOZHOIDUHE\WKHUHGXFWLRQUHSODFHPHQW DQGPRUHKXPDQHXVHRIODERUDWRU\DQLPDOV
ACKNOWLEDGMENTS 7KH DXWKRU DFNQRZOHGJHV 'HEELH 0F&DUOH\ IRU KHU H[SHUW HGLWRULDO DVVLVWDQFH LQ SUHSDULQJ WKLV PDQXVFULSW DQG WKH FRQWULEXWLRQV DQG VXSSRUW RI 'U 5LFKDUG 1 +LOO86(3$ZKRVHUYHGDVFRFKDLURIWKH,&&9$0IURPLWVLQFHSWLRQLQ XQWLO
REFERENCES %DOOV0%ODDXERHU%-)HQWHP-+%UXQHU/&RPEHV5'(NZDOO%)LHOGHU5- *XLOORX]R$ /HZLV 5: /RYHOO '3 5HLQKDUGW &$ 5HSHWWR * 6ODGRZVNL '6SLHOPDQQ+DQG=XFFR) 3UDFWLFDODVSHFWVRIWKHYDOLGDWLRQRIWR[LFLW\ WHVWSURFHGXUHV7KHUHSRUWDQGUHFRPPHQGDWLRQVRI(&9$0:RUNVKRS$OW/DE $QLP² %DUUDWW0'%UDQWRP3*)HQWHP-+*HUQHU,:DONHU$3DQG:RUWK$3 7KH (&9$0 LQWHUQDWLRQDO YDOLGDWLRQ VWXG\ RQ LQYLWUR WHVWV IRU VNLQ FRUURVLYLW\ 6HOHFWLRQDQGGLVWULEXWLRQRIWHVWFKHPLFDOV7R[LFRO,Q9LWUR²
ICCVAM EVALUATION OF ALTERNATIVE METHODS
27
'HDQ -7ZHUGRN /7LFH 5 6DLOVWDG ' +DWWDQ 'DQG 6WRNHV: (YDOXDWLRQ RIWKHPXULQHORFDOO\PSKQRGHDVVD\//1$ ,,FRQFOXVLRQVDQGUHFRPPHQGDWLRQV RI DQ LQGHSHQGHQW VFLHQWLÀF SHHU UHYLHZ SDQHO 5HJXO 7R[LFRO 3KDUPDFRO ² (&(XURSHDQ&RPPLVVLRQ (8&RPPLVVLRQ'LUHFWLYH(&RI$SULO 2IÀFLDO-RXUQDORIWKH(XURSHDQ&RPPXQLWLHV 6NLQ&RUURVLRQ5DW6NLQ7(5DQG +XPDQ6NLQ0RGHO$VVD\2II-(XU&RPPXQLWLHV-XQH (3$ (QYLURQPHQWDO 3URWHFWLRQ $JHQF\ +HDOWK (IIHFWV 7HVW *XLGHOLQHV 23376 $FXWH 2UDO 7R[LFLW\ :DVKLQJWRQ '& 2IÀFH RI 3HVWLFLGHV 3UHYHQWLRQ DQG 7R[LF 6XEVWDQFHV XUO KWWSZZZHSDJRY23376 +DUPRQL]HG +HDOWK (IIHFWV7HVW*XLGHOLQHV6HULHVSGI )HQWHP-+$UFKHU*(%%DOOV0%RWKDP3$&XUUHQ5'(DUO/.(VGDLOH'- +RO]KXWWHU+*DQG/LHEVFK0 7KH(&9$0LQWHUQDWLRQDOYDOLGDWLRQVWXG\ RQ LQYLWUR WHVWV IRU VNLQ FRUURVLYLW\ ,, 5HVXOWV DQG HYDOXDWLRQ E\ WKH PDQDJHPHQW WHDP7R[LFRO,Q9LWUR² +DQHNH .7LFH 5 &DUVRQ % 0DUJROLQ % DQG 6WRNHV:6 (YDOXDWLRQ RI WKH PXULQHORFDOO\PSKQRGHDVVD\//1$ ,,,'DWDDQDO\VHVFRPSOHWHGE\WKHQDWLRQDO WR[LFRORJ\SURJUDP173 LQWHUDJHQF\FHQWHUIRUWKHHYDOXDWLRQRIDOWHUQDWLYHWR[L FRORJLFDOPHWKRGV5HJXO7R[LFRO3KDUPDFRO ² +LOO5DQG6WRNHV:6 9DOLGDWLRQDQGUHJXODWRU\DFFHSWDQFHRIDOWHUQDWLYHV&DP EULGJH4XDUW+HDOWKFDUH(WKLFV²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¤DQLQYLWURWHVWPHWKRGIRUDVVHVVLQJGHUPDOFRUURVLYLW\SRWHQWLDO RIFKHPLFDOV1,+3XEOLFDWLRQ5HVHDUFK7ULDQJOH3DUN1&,&&9$0XUO KWWSLFFYDPQLHKVQLKJRYGRFVUHSRUWVFRUSUUHSKWP ,&&9$0 ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI$OWHUQDWLYH 0HWKRGV 0LQXWHV RI WKH H[SHUW SDQHO PHHWLQJ RQ WKH IURJ HPEU\R WHUDWRJHQHVLV DVVD\³[HQRSXV)(7$; DSURSRVHGVFUHHQLQJPHWKRGIRULGHQWLI\LQJWKHGHYHORS PHQWDOWR[LFLW\SRWHQWLDORIFKHPLFDOVDQGHQYLURQPHQWDOVDPSOHV5HVHDUFK7ULDQJOH 3DUN1&,&&9$0XUOKWWSLFFYDPQLHKVQLKJRYGRFVPLQXWHVIHWD[0LQSGI ,&&9$0 ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI$OWHUQDWLYH 0HWKRGV D $QQXDO SURJUHVV UHSRUW RI WKH ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQRI$OWHUQDWLYH0HWKRGV1,(+65HVHDUFK7ULDQJOH3DUN1&,&&9$0 XUOKWWSLFFYDPQLHKVQLKJRYDERXWDQQUSWDQQUSWKWP
28
ALTERNATIVE TOXICOLOGICAL METHODS
,&&9$0 ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI$OWHUQDWLYH 0HWKRGV E 7KHUHYLVHGXSDQGGRZQSURFHGXUHDWHVWPHWKRGIRUGHWHUPLQLQJWKHDFXWH RUDO WR[LFLW\ RI FKHPLFDOV 1,+ SXEOLFDWLRQ 5HVHDUFK 7ULDQJOH 3DUN 1& ,&&9$0XUOKWWSLFFYDPQLHKVQLKJRYPHWKRGVXGSGRFVXGSÀ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À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ÀQDOFZJÀQDOSGI /LHEVFK07UDXH'%DUUDEDV&6SLHOPDQQ+8SKLOO3:LONLQV60F3KHUVRQ-3 :LHPDQQ&.DXIPDQQ75HPPHOH0DQG+RO]KXWWHU+* 7KH(&9$0 SUHYDOLGDWLRQVWXG\RQWKHXVHRI(SL'HUPIRUVNLQFRUURVLYLW\WHVWLQJ$OW/DE $QLP²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ÀF$GYLVRU\&RPPLWWHHRQ$OWHUQDWLYH7R[LFRORJLFDO0HWKRGV)5 XUOKWWSLFFYDPQLHKVQLKJRYGRFV)5SGI 2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&'7HVW*XLGH OLQHDFXWHRUDOWR[LFLW\3DULV)UDQFH2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQ DQG'HYHORSPHQW
ICCVAM EVALUATION OF ALTERNATIVE METHODS
29
2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW *XLGDQFHGRFX PHQWRQWKHUHFRJQLWLRQDVVHVVPHQWDQGXVHRIFOLQLFDOVLJQVDVKXPDQHHQGSRLQWV IRU H[SHULPHQWDO DQLPDOV XVHG LQ VDIHW\ HYDOXDWLRQ 3DULV )UDQFH 2UJDQL]DWLRQ IRU (FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW D +DUPRQL]HG LQWHJUDWHGFODVVLÀFDWLRQV\VWHPIRUKXPDQKHDOWKDQGHQYLURQPHQWDOKD]DUGVRIFKHP LFDOVXEVWDQFHVDQGPL[WXUHV3DULV)UDQFH2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQ DQG'HYHORSPHQW 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW E 2(&' 7HVW *XLGHOLQHDFXWHRUDOWR[LFLW\XSDQGGRZQSURFHGXUH3DULV)UDQFH2UJDQL]D WLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW F 2(&' 7HVW *XLGHOLQHDFXWHRUDOWR[LFLW\DFXWHWR[LFFODVVPHWKRG3DULV)UDQFH2UJDQL]D WLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW G 2(&' 7HVW *XLGHOLQHDFXWHRUDOWR[LFLW\³À[HGGRVHPHWKRG3DULV)UDQFH2UJDQL]DWLRQ IRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&'7HVW*XLGH OLQHVHQVLWL]DWLRQORFDOO\PSKQRGHDVVD\3DULV)UDQFH2UJDQL]DWLRQIRU(FR QRPLF&RRSHUDWLRQDQG'HYHORSPHQW 3XEOLF+HDOWK6HUYLFH 3XEOLFKHDOWKVHUYLFHSROLF\RQKXPDQHFDUHDQGXVHRIODER UDWRU\DQLPDOV86'HSDUWPHQWRI+HDOWKDQG+XPDQ6HUYLFHV:DVKLQJWRQ'& 3XUFKDVH ,)+ %RWKDP 3$ %UXQHU /+ )OLQW 23 )UD]LHU -0 DQG 6WRNHV :6 6FLHQWLÀFDQGUHJXODWRU\FKDOOHQJHVIRUWKHUHGXFWLRQUHÀQHPHQWDQGUHSODFH PHQWRIDQLPDOVLQWR[LFLW\WHVWLQJ7R[LFRO6FL²OO 6DLOVWDG ' +DWWDQ ' +LOO 5 DQG 6WRNHV :6 (YDOXDWLRQ RI WKH PXULQH ORFDO O\PSK QRGH DVVD\ //1$ ,7KH ,&&9$0 UHYLHZ SURFHVV 5HJXO7R[LFRO 3KDU PDFRO ² 6SLHOPDQQ + %DOOV 0 /LHEVFK 0 DQG +DOOH: 'HWHUPLQDWLRQ RI WKH VWDUWLQJ GRVHIRUDFXWHRUDOWR[LFLW\/' WHVWLQJLQWKHXSDQGGRZQSURFHGXUH8'3 IURP F\WRWR[LFLW\GDWD$OW/DE$QLP² 6WRNHV:6 $QLPDOXVHDOWHUQDWLYHVLQUHVHDUFKDQGWHVWLQJREOLJDWLRQDQGRSSRUWX QLW\/DE$QLP² 6WRNHV:6DQG+LOO5 7KHUROHRIWKHLQWHUDJHQF\FRRUGLQDWLQJFRPPLWWHHRQWKH YDOLGDWLRQRIDOWHUQDWLYHPHWKRGVLQWKHHYDOXDWLRQRIQHZWR[LFRORJLFDOWHVWLQJPHWK RGVLQ3URJUHVVLQWKH5HGXFWLRQ5HÀQHPHQWDQG5HSODFHPHQWRI$QLPDO([SHUL PHQWDWLRQ %DOOV 0 YDQ =HOOHU $0 DQG +DOGHU 0 (GV (OVHYLHU 6FLHQFH $PVWHUGDPSS² 6WRNHV:6DQG-HQVHQ'- *XLGHOLQHVIRULQVWLWXWLRQDODQLPDOFDUHDQGXVHFRP PLWWHHV FRQVLGHUDWLRQ RI DOWHUQDWLYHV &RQWHPSRUDU\ 7RS /DE $QLP 6FL ² 6WRNHV:6DQG0DUDIDQWH( $OWHUQDWLYHWHVWLQJPHWKRGRORJLHVWKHWKPHHWLQJ RI WKH VFLHQWLÀF JURXS RQ PHWKRGRORJLHV IRU WKH VDIHW\ HYDOXDWLRQ RI FKHPLFDOV LQWURGXFWLRQDQGVXPPDU\(QYLURQ+HDOWK3HUVSHFW² 86 &RGH )HGHUDO$GYLVRU\ &RPPLWWHH$FW 3XEOLF /DZ 86 *RYHUQPHQW 3ULQWLQJ2IÀFH:DVKLQJWRQ'& 86&RGHD $QLPDO:HOIDUH$FW$PHQGPHQW3XEOLF/DZ86*RYHUQPHQW 3ULQWLQJ2IÀFH:DVKLQJWRQ'&
30
ALTERNATIVE TOXICOLOGICAL METHODS
86&RGHE +HDOWK5HVHDUFK([WHQVLRQ$FWRI3XEOLF/DZ86*RY HUQPHQW3ULQWLQJ2IÀFH:DVKLQJWRQ'& 86&RGH 1DWLRQDO,QVWLWXWHVRI+HDOWK5HYLWDOL]DWLRQ$FWRI3XEOLF/DZ 86*RYHUQPHQW3ULQWLQJ2IÀFH:DVKLQJWRQ'& 86&RGH ,&&9$0$XWKRUL]DWLRQ$FWRI3XEOLF/DZ86*RYHUQPHQW 3ULQWLQJ2IÀFH:DVKLQJWRQ'&XUOKWWSLFFYDPQLHKVQLKJRYDERXW3/SGI 86'HSDUWPHQWRI$JULFXOWXUH $QLPDO:HOIDUH)LQDO5XOHV&RGHRI)HGHUDO5HJX ODWLRQV3DUWVODQG)5
CHAPTER
4
Validation and Regulatory Acceptance of Alternative Test Methods: Current Situation in the European Union -XOLD+)HQWHPDQG0LFKDHO%DOOV
CONTENTS ,QWURGXFWLRQ 9DOLGDWLRQDQG5HJXODWRU\$FFHSWDQFH 6NLQ&RUURVLRQ 6NLQ,UULWDWLRQ 'LVFXVVLRQ $FNQRZOHGJPHQWV 5HIHUHQFHV
INTRODUCTION &RQVLGHUDEOHSURJUHVVKDVEHHQPDGHLQUHFHQW\HDUVLQYDOLGDWLQJLQYLWURDOWHU QDWLYHVWRDQLPDOWHVWV,Q)HEUXDU\WKH(XURSHDQ8QLRQ(8 0HPEHU6WDWHV DSSURYHGWKHÀ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
; E\&5&3UHVV//&
31
32
ALTERNATIVE TOXICOLOGICAL METHODS
ZLWKSDUWLFXODUUHIHUHQFHWRWKHYDULRXVVWDJHVLQYROYHGLQWKHSUHYDOLGDWLRQYDOLGD WLRQ DQG UHJXODWRU\ DFFHSWDQFH RI LQ YLWUR WHVWV IRU VNLQ FRUURVLRQ %RWKDP HW DO (&9$0E)HQWHPHWDO/LHEVFKHWDO
VALIDATION AND REGULATORY ACCEPTANCE ,WKDVEHHQDJUHHGLQWHUQDWLRQDOO\WKDWYDOLGDWLRQLHWKHSURFHVVE\ZKLFKWKH UHOLDELOLW\DQGUHOHYDQFHRIDSURFHGXUHDUHHVWDEOLVKHGIRUD VSHFLÀFSXUSRVH LVD SUHUHTXLVLWHIRUWKHUHJXODWRU\DFFHSWDQFHRIQHZWHVWPHWKRGV %DOOVHWDO D*ROGEHUJHWDO%DOOVDQG.DUFKHU%UXQHUHWDO2(&' )HQWHP DQG %DOOV ,&&9$0 7KH YDOLGDWLRQ SURFHVV KDV EHHQ ZHOOGRFXPHQWHGLQYDULRXVUHSRUWVHJ%DOOVHWDOD2(&',&&9$0 7\SLFDOO\LWLQYROYHVFRQGXFWLQJDQLQWHUODERUDWRU\EOLQGWULDODVDEDVLVIRU DVVHVVLQJZKHWKHUDWHVWFDQEHVKRZQWREHXVHIXODQGUHOLDEOHIRUDVSHFLÀFSXUSRVH DFFRUGLQJWRSUHGHÀQHGSHUIRUPDQFHFULWHULD9DOLGDWLRQVWXGLHVDUHFRQGXFWHGSULQ FLSDOO\WRSURYLGHREMHFWLYHLQIRUPDWLRQRQQHZWHVWVWRVKRZ WKDWWKH\DUHUREXVW DQG WUDQVIHUDEOH EHWZHHQ ODERUDWRULHV DQG WR VKRZ WKDW WKH GDWD JHQHUDWHG FDQ EH UHOLHG XSRQ IRU GHFLVLRQPDNLQJ SXUSRVHV HJ IRU WKH LGHQWLÀFDWLRQ DQG ODEHOLQJ RIDSRWHQWLDOVNLQFRUURVLYHVHYHUHH\HLUULWDQWWHUDWRJHQHWF ,IDQHZWHVWLVWR EHHQGRUVHGDVEHLQJVFLHQWLÀFDOO\YDOLGWKHRXWFRPHRIWKHYDOLGDWLRQVWXG\PXVW SURYLGHVXIÀFLHQWFRQÀ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
ACCEPTANCE OF ALTERNATIVE TESTS IN THE EUROPEAN UNION
33
7KH(&9$0DSSURDFKWRYDOLGDWLRQKDVEHHQGHVFULEHGSUHYLRXVO\%DOOVHWDO D %DOOV DQG .DUFKHU )HQWHP DQG %DOOV ,W FRYHUV ERWK D WKH FRQGXFWRISUDFWLFDOYDOLGDWLRQVWXGLHVDQGFULWLFDOUHYLHZRIWKHLURXWFRPHDQGE WKHSHHUUHYLHZRILQIRUPDWLRQDQGGDWDVXSSRUWLQJWKHYDOLGLW\RIDQ\QHZDOWHUQDWLYH WHVWWKDWPD\EHVXEPLWWHGGLUHFWO\WR(&9$0IRULWVFRQVLGHUDWLRQDQGRSLQLRQ :LWKUHVSHFWWRD IROORZLQJWKHFRPSOHWLRQRIDYDOLGDWLRQVWXG\WKHPDQDJH PHQW WHDP 07 SUHSDUHV D UHSRUW IRU SXEOLFDWLRQ LQ WKH SHHUUHYLHZHG VFLHQWLÀF OLWHUDWXUHHJ%DOOVHWDOE/RYHOHVVHWDO%UDQWRPHWDO)HQWHP HW DO 6SLHOPDQQ HW DO D ,Q WKH FDVH RI WKRVH PHWKRGV FRQVLGHUHG WR EHVFLHQWLÀFDOO\YDOLGE\WKH07DQLQGHSHQGHQWUHYLHZDVVHVVPHQWLVWKHQXQGHU WDNHQ%DOOVHWDOD,&&9$0 ,QWKH(8WKHSURFHVVIRUWKLVLQGHSHQ GHQW UHYLHZ LQLWLDOO\ LQYROYHV WKH (&9$0 VFLHQWLÀF DGYLVRU\ FRPPLWWHH (6$& ZKLFKFDQDJUHHXSRQDVWDWHPHQWHQGRUVLQJWKHYDOLGLW\RIDQHZWHVWPHWKRGHJ (&9$0 D 2WKHU VHUYLFHV RI WKH (XURSHDQ &RPPLVVLRQ (& DQG YDULRXVLQGHSHQGHQWH[SHUWFRPPLWWHHVDUHWKHQDVNHGWRUHYLHZWKHRXWFRPHRIWKH YDOLGDWLRQ VWXG\ IURP WKH SHUVSHFWLYH RI WKHLU VSHFLÀF UROHV LQWHUHVWV DQG OHJDO UHVSRQVLELOLWLHV)RUH[DPSOHWKHVFLHQWLÀFYDOLGLWLHVRIWKHLQYLWURWHVWVIRUSKRWR WR[LFLW\ DQG VNLQ FRUURVLRQ ZHUH VXEVHTXHQWO\ DOVR HQGRUVHG E\ '* (QYLURQPHQW UHVSRQVLEOH IRU (8 FKHPLFDOV WHVWLQJ OHJLVODWLRQ DQG '* (QWHUSULVH UHVSRQVLEOH IRU FRVPHWLFV PHGLFLQHV DQG YDFFLQHV WHVWLQJ OHJLVODWLRQ RI WKH (& DQG E\ WKH 6FLHQWLÀF &RPPLWWHH RQ &RVPHWLF 3URGXFWV DQG 1RQ)RRG 3URGXFWV LQWHQGHG IRU FRQVXPHUV6&&1)3WKH(&·VH[SHUWDGYLVRU\FRPPLWWHHRQFRVPHWLFV IROORZLQJ UHYLHZRIDOOUHOHYDQWGRFXPHQWDWLRQ 7KH VFLHQWLÀF YDOLGLW\ RI WKH //1$ IRU VNLQ VHQVLWL]DWLRQ 1,+ D DV ZHOO DV RI &RUURVLWH[ IRU VNLQ FRUURVLRQ 1,+ E KDV EHHQ HQGRUVHG E\ SHHUUHYLHZ SDQHOV FRQYHQHG LQ WKH 86 E\ ,&&9$0 EDVHG RQ HYDOXDWLRQV RI GDWD VXEPLWWHG E\ LQGXVWU\ ,Q DFFRUGDQFH ZLWK SRLQW E DERYH WKH (6$& KDV UHYLHZHG WKH VXEPLVVLRQ RQ WKH //1$ PDGH WR ,&&9$0 DQG KDV HQGRUVHG WKH YDOLGLW\RIWKH//1$DVDUHGXFWLRQDQGUHÀQHPHQWDOWHUQDWLYHIRUVNLQVHQVLWL]DWLRQ WHVWLQJ(&9$0 ,Q'HFHPEHUWKH(6$&DOVRUHYLHZHGWKHVXEPLV VLRQRQ&RUURVLWH[PDGHWR,&&9$0DQGWKHÀQGLQJVRIWKH,&&9$0SHHUUHYLHZ SDQHO(&9$0D 7KXVWKH(8KDVLQSODFHSURFHVVHVIRUFULWLFDOO\UHYLHZ LQJ DQG HQGRUVLQJ WKH YDOLGLWLHV RI DOWHUQDWLYH PHWKRGV HYDOXDWHG ERWK ZLWK DQG ZLWKRXWGLUHFW(&9$0LQYROYHPHQW )ROORZLQJ LQGHSHQGHQW HQGRUVHPHQW RI WKH YDOLGLW\ RI D QHZ WHVW PHWKRG WKH QH[WVWHSLIDSSURSULDWH PD\EHWRGUDIWDQHZWHVWJXLGHOLQHRUWRGUDIWDUHYLVLRQ WR DQ H[LVWLQJ JXLGHOLQH IRU VXEVHTXHQW FRQVLGHUDWLRQ E\ WKH UHOHYDQW UHJXODWRU\ DXWKRULWLHV)RUH[DPSOHGUDIWJXLGHOLQHVRQWKHLQYLWURWHVWVIRUSKRWRWR[LFLW\DQG VNLQFRUURVLRQZHUHSUHSDUHGE\WKH07VIRUWKHUHVSHFWLYHYDOLGDWLRQVWXGLHVDQG ZHUHVXEPLWWHGWRWKH2(&'6HFUHWDULDWLQ'HFHPEHU6LPLODUO\DGUDIWWHVW JXLGHOLQH RQ WKH XVH RI WKH //1$ IRU SUHGLFWLQJ VNLQ VHQVLWL]DWLRQ ZDV VXEPLWWHG WRWKH2(&'GXULQJIROORZLQJWKHVXFFHVVIXO,&&9$0UHYLHZ$VLVWKHFDVH IRUWKHLQGHSHQGHQWDVVHVVPHQWRIWKHYDOLGLW\RIQHZWHVWVWKHSURFHVVRIUHJXODWRU\ DFFHSWDQFHLQYROYHVYDULRXVVWDJHVRIFULWLFDOUHYLHZRIWKHQHZWHVWPHWKRGDQGDOO VXSSRUWLQJ GDWD )RU H[DPSOH GUDIWV RI SRWHQWLDO QHZ 2(&' WHVW JXLGHOLQHV DUH UHYLHZHGE\QDWLRQDOH[SHUWVLQDOORIWKH2(&'0HPEHU&RXQWULHVDVLPLODUSURFHVV
34
ALTERNATIVE TOXICOLOGICAL METHODS
LVIROORZHGLQWKH(8IRU$QQH[97HVW0HWKRGV'LUHFWLYH((&³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²WKHRXWFRPHRIWKLVVWXG\LVDOVRRXWOLQHGEULHÁ\ODWHULQWKLVFKDSWHU
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ÀFDQWDFKLHYHPHQWLQUHODWLRQWRWKHUHSODFHPHQWRI WR[LFLW\ WHVWV NQRZQ WR FDXVH FRQVLGHUDEOH DQLPDO SDLQ GXH WR WKH QDWXUH RI WKH HQGSRLQWXQGHUHYDOXDWLRQ $SUHYDOLGDWLRQVWXG\RQLQYLWURVNLQFRUURVLYLW\WHVWLQJZDVFRQGXFWHGGXULQJ DQG%RWKDPHWDO DVDÀUVWVWHSWRZDUGGHÀQLQJWKRVHDOWHUQDWLYH WHVWVWKDWFRXOGEHXVHGZLWKLQWKHFRQWH[WRI2(&'WHVWLQJJXLGHOLQH2(&' 7KUHHWHVWVZHUHLQFOXGHGLQWKHSUHYDOLGDWLRQVWXG\D WKHUDWVNLQWUDQVFX WDQHRXV HOHFWULFDO UHVLVWDQFH 7(5 DVVD\ E &RUURVLWH[ ,Q9LWUR ,QWHUQDWLRQDO ,UYLQH&$ DQGF WKH6NLQ=.FRUURVLYLW\WHVW$GYDQFHG7LVVXH6FLHQFHV /D-ROOD&$ )LIW\FRGHGFKHPLFDOV>FRUURVLYHV& QRQFRUURVLYHV1& @ ZHUHWHVWHG7KHUHSRUWRQWKHRXWFRPHRIWKHSUHYDOLGDWLRQVWXG\UHFRPPHQGHGWKDW DIRUPDOYDOLGDWLRQVWXG\RQDOWHUQDWLYHPHWKRGVIRUVNLQFRUURVLYLW\WHVWLQJVKRXOG EHFRQGXFWHG%RWKDPHWDO $QLQWHUQDWLRQDOYDOLGDWLRQVWXG\RQLQYLWURWHVWVIRUUHSODFLQJWKHLQYLYRUDEELW WHVWIRUVNLQFRUURVLYLW\ZDVFRQGXFWHGGXULQJDQGXQGHUWKHDXVSLFHVRI (&9$0)HQWHPHWDO 7KHPDLQREMHFWLYHVRIWKHVWXG\ZHUHWRD LGHQWLI\
ACCEPTANCE OF ALTERNATIVE TESTS IN THE EUROPEAN UNION
35
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ÀFDOO\ YDOLG UHSODFHPHQWV IRU WKHUDEELWWHVWIRUGLVWLQJXLVKLQJEHWZHHQ&DQG1&FKHPLFDOVIRUDOORIWKHFKHPLFDO W\SHV VWXGLHG >REMHFWLYH D @ (SLVNLQ ZDV DOVR DEOH WR GLVWLQJXLVK EHWZHHQ NQRZQ 581SDFNLQJJURXSDQG581SDFNLQJJURXSV,,DQG,,,FKHPLFDOVIRUDOO RIWKHFKHPLFDOW\SHVLQFOXGHGLQWKHVWXG\RQDQDFFHSWDEOHQXPEHURIRFFDVLRQV >REMHFWLYHE @)HQWHPHWDO )ROORZLQJIRUPDOSUHVHQWDWLRQRIWKHÀQGLQJV RIWKHYDOLGDWLRQVWXG\WRWKH(6$&DQGLWVFULWLFDOUHYLHZRIWKHGDWDWKHVFLHQWLÀF YDOLGLW\RIWKHUDWVNLQ7(5DQG(SLVNLQWHVWVZDVHQGRUVHGE\WKH(6$&LQ0DUFK DQGDVLJQHGVWDWHPHQWWRWKLVHIIHFWZDVLVVXHGMRLQWO\E\(&9$0'*-RLQW 5HVHDUFK &HQWHU DQG '* (QYLURQPHQW RI WKH (&7KLV ZDV GLVVHPLQDWHG ZLGHO\ DQGZDVDOVRSXEOLVKHGLQWKHVFLHQWLÀ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ÀFDWLRQV GHULYHG IURPWKHLQYLWURGDWDDQGIURPWKH LQYLYRGDWDZHUHYHU\JRRGDQGWKHWHVWZDV DEOHWRGLVWLQJXLVKEHWZHHQ&DQG1&FKHPLFDOVIRUDOORIWKHFKHPLFDOW\SHVVWXGLHG /LHEVFKHWDO )ROORZLQJFULWLFDOUHYLHZRIWKHWHVWSURWRFRODQGDOOGDWDVXSSRUWLQJWKHYDOLGLW\ RIWKH(SL'HUPWHVWIRUVNLQFRUURVLRQLWZDVHQGRUVHGDVVFLHQWLÀFDOO\YDOLGE\WKH (6$& LQ 0DUFK (&9$0 WKH FRPPLWWHH VWDWHG WKDW ´WKH (SL'HUP KXPDQ VNLQ PRGHO FDQ EH XVHG IRU GLVWLQJXLVKLQJ EHWZHHQ FRUURVLYH DQG QRQ FRUURVLYH FKHPLFDOV ZLWKLQ WKH FRQWH[W RI WKH GUDIW (8 DQG 2(&' WHVW JXLGHOLQHV RQVNLQFRUURVLRQµ$JDLQDVLJQHGVWDWHPHQWWRWKLVHIIHFWZDVLVVXHGDQGFLUFXODWHG E\WKH(&DQGWKLVZDVSXEOLVKHG(&9$0
36
ALTERNATIVE TOXICOLOGICAL METHODS
)XUWKHULQJ WKH HQGRUVHPHQW RI WKH VFLHQWLÀ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´%6NLQ&RUURVLRQµZDVLQFRUSRUDWHGLQWRWKH'6'YLD&RPPLVVLRQ'LUHFWLYH (&RI$SULOWKHWKDGDSWDWLRQWRWHFKQLFDOSURJUHVVRI&RXQFLO 'LUHFWLYH ((& (& 0HDQZKLOH WKH 2(&' QDWLRQDO FRRUGLQDWRUV VXEPLWWHGWKHLUFRPPHQWVRQWKHLQLWLDOGUDIWWHVWJXLGHOLQHSUHSDUHGLQDQG WKHVH ZHUH GLVFXVVHG DW WKHLU PHHWLQJ LQ )ROORZLQJ DQ 2(&' QRPLQDWHG H[SHUWV PHHWLQJ LQ 1RYHPEHU 2(&' WHVW JXLGHOLQHV RQ WKH UDW VNLQ 7(5 DVVD\7* DQGWKHKXPDQVNLQPRGHODVVD\V7* ZHUHÀQDOO\DFFHSWHG LQ0D\ &RUURVLWH[RQHRIWKHLQYLWURPHWKRGVLQFOXGHGLQWKH(&9$0YDOLGDWLRQVWXG\ )HQWHPHWDO ZDVVXEVHTXHQWO\HYDOXDWHGE\DSHHUUHYLHZSDQHOFRQYHQHG LQWKH86E\,&&9$01,+E 7KH07IRUWKH(&9$0YDOLGDWLRQVWXG\ KDGFRQFOXGHGWKDW&RUURVLWH[PD\EHYDOLGIRUWHVWLQJVSHFLÀFFODVVHVRIFKHPLFDOV VXFKDVRUJDQLFEDVHVDQGLQRUJDQLFDFLGV7KHGDWDEDVHUHYLHZHGLQWKH,&&9$0 HYDOXDWLRQZDVFRQVLGHUDEO\ODUJHUWKDQWKDWJHQHUDWHGLQWKH(&9$0SUHYDOLGDWLRQ %RWKDP HW DO DQG YDOLGDWLRQ )HQWHP HW DO VWXGLHV DQG WKH SHHU UHYLHZSDQHOZDVDEOHWREHPRUHVSHFLÀFLQLWVFRQFOXVLRQVVWDWLQJWKDW´LQOLPLWHG WHVWLQJVLWXDWLRQVWKHDVVD\LVYDOLGIRUHYDOXDWLQJWKHFRUURVLYLW\SRWHQWLDORIDFLGV DFLGGHULYDWLYHVDQGEDVHVµ7KHSHHUUHYLHZSDQHOFRQFOXGHGWKDWLQRWKHUWHVWLQJ VLWXDWLRQV DQG IRU RWKHU FKHPLFDO DQG SURGXFW FODVVHV WKH DVVD\ LV DSSURSULDWH DV SDUWRIDWLHUHGWHVWLQJVWUDWHJ\1,+E ,Q$SULODQ(6$&ZRUNLQJJURXSUHYLHZHGWKHVXEPLVVLRQRQ&RUURVLWH[ PDGH WR ,&&9$0 DQG WKH ÀQGLQJV RI WKH SHHUUHYLHZ SDQHO DQG D VWDWHPHQW RQ &RUURVLWH[HQGRUVLQJWKH,&&9$0ÀQGLQJVZDVDJUHHGXSRQDWWKH(6$&PHHWLQJ LQ 'HFHPEHU (&9$0 D 7KH (6$& FRQFOXGHG WKDW ´WKH &RUURVLWH[ DVVD\ LV D VFLHQWLÀFDOO\ YDOLGDWHG WHVW EXW RQO\ IRU WKRVH DFLGV EDVHV DQG WKHLU GHULYDWLYHVZKLFKPHHWWKHWHFKQLFDOUHTXLUHPHQWVRIWKHDVVD\µ
SKIN IRRITATION $ SUHYDOLGDWLRQ VWXG\ RQ LQ YLWUR WHVWV IRU DFXWH VNLQ LUULWDWLRQ ZDV FRQGXFWHG GXULQJDQGDVDIROORZXSWRWKHVXFFHVVIXOYDOLGDWLRQRILQYLWURWHVWV IRU VNLQ FRUURVLRQ %RWKDP HW DO )HQWHP HW DO 7KH RYHUDOO REMHFWLYHRIYDOLGDWLRQLQWKLVDUHDRIZKLFKWKHSUHYDOLGDWLRQVWXG\ZDVDQLQLWLDO
ACCEPTANCE OF ALTERNATIVE TESTS IN THE EUROPEAN UNION
37
VWDJH LV WR LGHQWLI\ WHVWV FDSDEOH RI GLVFULPLQDWLQJ LUULWDQWV , IURP QRQLUULWDQWV 1, DV GHÀQHG DFFRUGLQJ WR (8 ULVN SKUDVHV ´5µ QR FODVVLÀFDWLRQ DQG WKH KDUPRQL]HG2(&'FULWHULD´LUULWDQWµQRODEHO 7KHSUHYDOLGDWLRQVWXG\VSHFLÀFDOO\ DGGUHVVHGDVSHFWVRISURWRFROUHÀQHPHQWSKDVH, SURWRFROWUDQVIHUSKDVH,, DQG SURWRFRO SHUIRUPDQFH SKDVH ,,, LQ DFFRUGDQFH ZLWK WKH SUHYDOLGDWLRQ VFKHPH GHÀQHG E\ (&9$0 &XUUHQ HW DO 7KH WHVWV HYDOXDWHG ZHUH (SL'HUP SKDVHV,,,DQG,,, (SLVNLQSKDVHV,,,DQG,,, 3UHGLVNLQ%,235(',& 5HQQHV )UDQFH SKDVHV , DQG ,, DQG DGGLWLRQDO SURWRFRO UHÀQHPHQW WKH QRQ SHUIXVHGSLJHDUPHWKRGSKDVHV,DQG,,DQGDGGLWLRQDOSURWRFROUHÀQHPHQW DQG WKHPRXVHVNLQLQWHJULW\IXQFWLRQWHVW6,)7SKDVHV,DQG,, )HQWHPHWDO 0RGLÀHGVWDQGDUGL]HGWHVWSURWRFROVDQGZHOOGHÀQHGSUHGLFWLRQPRGHOVZHUH DYDLODEOHIRUHDFKRIWKHWHVWVDWWKHHQGRISKDVH,7KHUHVXOWVRISKDVH,LQWUDO DERUDWRU\UHSURGXFLELOLW\ ZHUHVXIÀFLHQWO\SURPLVLQJIRUDOORIWKHWHVWVWRSURJUHVV WR SKDVH ,, 3URWRFRO WUDQVIHU EHWZHHQ WKH OHDG ODERUDWRU\ DQG ODERUDWRU\ ZDV XQGHUWDNHQIRUDOOÀYHWHVWVGXULQJSKDVH,,DQGDGGLWLRQDOUHÀQHPHQWVZHUHPDGH WRWKHWHVWSURWRFROV)RU(SL'HUP(SLVNLQDQGWKH6,)7WKH LQWUDODERUDWRU\DQG LQWHUODERUDWRU\UHSURGXFLELOLWLHVZHUHDFFHSWDEOHKRZHYHUEHWWHUVWDQGDUGL]DWLRQRI FHUWDLQ DVSHFWV RI WKH WHVW SURWRFROV ZDV QHHGHG SULRU WR FRPPHQFLQJ SKDVH ,,, 1HLWKHU 3UHGLVNLQ QRU WKH SLJ HDU WHVW SHUIRUPHG VXIÀFLHQWO\ ZHOO LQ SKDVH ,, WR SURJUHVVWRSKDVH,,,7KH3UHGLVNLQSURWRFROZDVRYHUO\VHQVLWLYHUHVXOWLQJLQWKH SUHGLFWLRQRIDOOWKH1,FKHPLFDOVDV,7KHYDULDELOLW\LQWKHSLJHDUWHVWUHVXOWVZDV WRRJUHDWLQGLFDWLQJWKDWWKHWHVWZRXOGVKRZOLPLWHGSUHGLFWLYHDELOLW\,QDGGLWLRQDO VWXGLHV D UHSHDW RI SKDVH , IXUWKHU PRGLÀ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ÀQDOUHÀQHGWHVWSURWRFROV7KHLQWUDODERUDWRU\UHSURGXFLELOLW\ ZDVDFFHSWDEOHIRUERWK(SL'HUPDQG(SLVNLQ7KHLQWHUODERUDWRU\UHSURGXFLELOLW\ ZDV FRQVLGHUHG WR EH DFFHSWDEOH IRU (SLVNLQ KRZHYHU IRU (SL'HUP DQDO\VLV RI YDULDQFH$129$ LQGLFDWHGWKDWWKHUHZDVDVWDWLVWLFDOO\VLJQLÀ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
38
ALTERNATIVE TOXICOLOGICAL METHODS
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ÀF YDOLGLW\RIWKHPRXVH//1$IRUVNLQVHQVLWL]DWLRQ(&9$0 EDVHGRQFULWLFDO UHYLHZ RI WKH ,&&9$0 SHHUUHYLHZ GRFXPHQWDWLRQ DQG RWKHU SXEOLVKHG VWXGLHV 6LPLODUO\LWKDVHQGRUVHGWKHÀQGLQJVRIWKH,&&9$0SHHUUHYLHZSDQHORQ&RU URVLWH[(&9$0D 7KXV WKH (8 QRZ KDV LQ SODFH SURFHVVHV IRU FULWLFDOO\ UHYLHZLQJ DQG ZKHUH DSSURSULDWHHQGRUVLQJWKHYDOLGLWLHVRIDOWHUQDWLYHPHWKRGVHYDOXDWHGERWKZLWKDQG ZLWKRXW GLUHFW (&9$0 LQYROYHPHQW DQ\ZKHUH LQ WKH ZRUOG 2QFH VXFK SURFHVVHV IRUPXWXDOUHFRJQLWLRQRIYDOLGDWHGPHWKRGVKDYHDOVREHHQDJUHHGXSRQZLWKLQRWKHU NH\FRXQWULHVUHJLRQVLWLVKRSHGWKDWZHVKRXOGEHJLQWRVHHPRUHWLPHO\DQGPRUH HIÀFLHQWSURJUHVVLQLPSOHPHQWLQJYDOLGDWHGDOWHUQDWLYHPHWKRGVLQWRUHJXODWRU\WHVW LQJUHTXLUHPHQWVDWDQLQWHUQDWLRQDOOHYHOLQDGGLWLRQWRWKDWDWDQDWLRQDOUHJLRQDOOHYHO
ACKNOWLEDGMENTS 7KHNH\LQYROYHPHQWRIWKHIROORZLQJLQGLYLGXDOVLQWKHVWXGLHVRXWOLQHGLQWKLV SDSHU LV DFNQRZOHGJHG *UDHPH$UFKHU 3KLOLS %RWKDP 'DYLG %ULJJV &KULVWRSK &KHVQp5RGJHU&XUUHQ/HVOH\(DUO*UDKDP(OOLRWW'DYLG(VGDLOH-RKQ+DUEHOO -RQ+H\OLQJV0DQIUHG/LHEVFK5RODQG5RJXHW+DQYDQGH6DQGW+RUVW6SLHOPDQQ DQG$QGUHZ:RUWK
REFERENCES %DOOV0 'HÀQHGVWUXFWXUDODQGSHUIRUPDQFHFULWHULDZRXOGIDFLOLWDWHWKHYDOLGDWLRQ DQGDFFHSWDQFHRIDOWHUQDWLYHWHVWSURFHGXUHV$OW/DE$QLP² %DOOV0DQG.DUFKHU: 7KHYDOLGDWLRQRIDOWHUQDWLYHWHVWPHWKRGV$OW/DE$QLP ² %DOOV0%ODDXERHU%%UXVLFN')UD]LHU-/DPE'3HPEHUWRQ05HLQKDUGW & 5REHUIURLG 0 5RVHQNUDQ] + 6FKPLG % 6SLHOPDQQ + 6WDPPDWL$ / DQG:DOXP ( 5HSRUW DQG UHFRPPHQGDWLRQV RI WKH &$$7(5*$77 ZRUNVKRS RQ WKH YDOLGDWLRQ RI WR[LFLW\ WHVW SURFHGXUHV $OW /DE $QLP ² %DOOV0%ODDXERHU%-)HQWHP-+%UXQHU/&RPEHV5'(NZDOO%)LHOGHU5- *XLOORX]R$/HZLV5:/RYHOO'5HLQKDUGW&$5HSHWWR*6ODGRZVNL' 6SLHOPDQQ+DQG=XFFR)D 3UDFWLFDODVSHFWVRIWKHYDOLGDWLRQRIWR[LFLW\ WHVWSURFHGXUHV7KHUHSRUWDQGUHFRPPHQGDWLRQVRI(&9$0ZRUNVKRS$OW/DE $QLP²
ACCEPTANCE OF ALTERNATIVE TESTS IN THE EUROPEAN UNION
39
%DOOV0%RWKDP3$%UXQHU/+DQG6SLHOPDQQ+E 7KH(&+2LQWHUQDWLRQDO YDOLGDWLRQVWXG\RQDOWHUQDWLYHVWRWKH'UDL]HH\HLUULWDWLRQWHVW7R[LFRO,Q9LWUR ² %DUUDWW0'%UDQWRP3*)HQWHP-+*HUQHU,:DONHU$3DQG:RUWK$3 7KH (&9$0 LQWHUQDWLRQDO YDOLGDWLRQ VWXG\ RQ LQYLWUR WHVWV IRU VNLQ FRUURVLYLW\ , 6HOHFWLRQDQGGLVWULEXWLRQRIWKHWHVWFKHPLFDOV7R[LFRO,Q9LWUR² %DVNHWWHU ' *HUEHULFN ) DQG .LPEHU , 9DOLGDWLRQ LQ 3UDFWLFH³WKH 5HDOLW\ IRU 6NLQ 6HQVLWL]DWLRQ SDSHU SUHVHQWHG LQ 3URJUHVV LQ WKH 5HGXFWLRQ 5HÀQHPHQW DQG 5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ3URFHHGLQJVRIWKH7KLUG:RUOG&RQJUHVV RQ$OWHUQDWLYHVDQG$QLPDO8VHLQWKH/LIH6FLHQFHV%RORJQD³'HYHORSPHQWV LQ$QLPDODQG9HWHULQDU\6FLHQFHV9RO$%DOOV0YDQ=HOOHU$0DQG+DOGHU 0(GV(OVHYLHU$PVWHUGDPSS² %RWKDP 3$ &KDPEHUODLQ 0 %DUUDWW 0' &XUUHQ 5' (VGDLOH '- *DUGLQHU -5 *RUGRQ9&+LOGHEUDQG%/HZLV5:/LHEVFK0/RJHPDQQ32VERUQH5 3RQHF05pJQLHU-)6WHLOLQJ::DONHU$3DQG%DOOV0 $SUHYDO LGDWLRQVWXG\RQLQYLWURVNLQFRUURVLYLW\WHVWLQJ7KHUHSRUWDQGUHFRPPHQGDWLRQVRI (&9$0ZRUNVKRS$OW/DE$QLP² %RWKDP3$(DUO/.)HQWHP-+5RJXHW5DQGYDQGH6DQGW--0 $OWHUQDWLYH PHWKRGV IRU VNLQ LUULWDWLRQ WHVWLQJ WKH FXUUHQW VWDWXV (&9$0 6NLQ ,UULWDWLRQ7DVN )RUFHUHSRUW$OW/DE$QLP² %UDQWRP3*HWDO $VXPPDU\UHSRUWRIWKH&2/,3$LQWHUQDWLRQDOYDOLGDWLRQVWXG\ RQDOWHUQDWLYHVWRWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW7R[LFROLQ9LWUR² %UXQHU/+&DUU*-&KDPEHUODLQ0DQG&XUUHQ5' 9DOLGDWLRQRIDOWHUQDWLYH PHWKRGVIRUWR[LFLW\WHVWLQJ7R[LFRO,Q9LWUR² &XUUHQ5'6RXWKHH-$6SLHOPDQQ+/LHEVFK0)HQWHP-+DQG%DOOV0 7KHUROHRISUHYDOLGDWLRQLQWKHGHYHORSPHQWYDOLGDWLRQDQGDFFHSWDQFHRIDOWHUQDWLYH PHWKRGV$OW/DE$QLP² (& $QQH[,WR&RPPLVVLRQ'LUHFWLYH(&DGDSWLQJWRWHFKQLFDOSURJUHVVIRU WKHWKWLPH&RXQFLO'LUHFWLYH((&RQWKHDSSUR[LPDWLRQRIODZVUHJXOD WLRQVDQGDGPLQLVWUDWLYHSURYLVLRQVUHODWLQJWRWKHFODVVLÀFDWLRQSDFNDJLQJDQGODEHO LQJRIGDQJHURXVVXEVWDQFHV2II-(XU&RPPXQLWLHV/² (&9$0D (&9$01HZVDQG9LHZV$OW/DE$QLP² (&9$0E (&9$01HZVDQG9LHZV$OW/DE$QLP² (&9$0 (&9$01HZVDQG9LHZV$OW/DE$QLP² (&9$0D (&9$01HZVDQG9LHZV$OW/DE$QLP² (&9$0E (&9$01HZVDQG9LHZV$OW/DE$QLP² )HQWHP-+ 9DOLGDWLRQLQ3UDFWLFH³IURP7KHRU\WR5HDOLW\SDSHUSUHVHQWHGLQ3URJUHVV LQWKH5HGXFWLRQ5HÀQHPHQWDQG5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ3URFHHG LQJVRIWKH7KLUG:RUOG&RQJUHVVRQ$OWHUQDWLYHVDQG$QLPDO8VHLQWKH/LIH6FLHQFHV %RORJQD ³'HYHORSPHQWV LQ$QLPDO DQG9HWHULQDU\ 6FLHQFHV9RO $ %DOOV 0YDQ=HOOHU$0DQG+DOGHU0(GV(OVHYLHU$PVWHUGDP² )HQWHP-+DQG%DOOV0 7KH(&9$0$SSURDFKWR9DOLGDWLRQSDSHUSUHVHQWHGLQ $QLPDO$OWHUQDWLYHV:HOIDUHDQG(WKLFV3URFHHGLQJVRIWKH6HFRQG:RUOG&RQJUHVV RQ$OWHUQDWLYHVDQG$QLPDO8VHLQWKH/LIH6FLHQFHV8WUHFKW³'HYHORSPHQWV LQ$QLPDODQG9HWHULQDU\6FLHQFHV9ROYDQ=XWSKHQ/)0DQG%DOOV0(GV (OVHYLHU$PVWHUGDPSS² )HQWHP-+$UFKHU*(%%DOOV0%RWKDP3$&XUUHQ5'(DUO/.(VGDLOH'- +RO]KWWHU+*DQG/LHEVFK0 7KH(&9$0LQWHUQDWLRQDOYDOLGDWLRQVWXG\ RQLQYLWURWHVWVIRUVNLQFRUURVLYLW\,,5HVXOWVDQGHYDOXDWLRQE\WKH 0DQDJHPHQW 7HDP7R[LFRO,Q9LWUR²
40
ALTERNATIVE TOXICOLOGICAL METHODS
)HQWHP-%RWKDP3(DUO/5RJXHW5DQGYDQGH6DQGW- 3UHYDOLGDWLRQRILQYLWUR WHVWVIRUDFXWHVNLQLUULWDWLRQLQ$OWHUQDWLYHVWR$QLPDO7HVWLQJ,,3URFQG,QW6FLHQWLÀF &RQIRUJDQLVHGE\WKH(XURSHDQ&RVPHWLF,QGXVWU\%UXVVHOV%HOJLXP&ODUN'* /LVDQVN\6*DQG0DFPLOODQ5(GV&3/3UHVV1HZEXU\SS² )HQWHP-+%ULJJV'&KHVQp&(OOLRWW*5+DUEHOO-:+H\OLQJV-53RUWHV3 5RJXHW5YDQGH6DQGW--0DQG%RWKDP3$ $SUHYDOLGDWLRQVWXG\RQ LQYLWURWHVWVIRUDFXWHVNLQLUULWDWLRQUHVXOWVDQGHYDOXDWLRQE\WKH0DQDJHPHQW7HDP 7R[LFRO,Q9LWUR² *ROGEHUJ$0 )UD]LHU -0 %UXVLFN ' 'LFNHQV 06 )OLQW 2 *HWWLQJV 6' +LOO 51/LSQLFN5/5HQVNHUV.-%UDGODZ-$6FDOD5$9HURQHVL%*UHHQ 6:LOFR[1/DQG&XUUHQ5' )UDPHZRUNIRUYDOLGDWLRQDQGLPSOHPHQ WDWLRQ RI LQYLWUR WR[LFLW\ WHVWV UHSRUW RI WKH 9DOLGDWLRQ DQG 7HFKQRORJ\ 7UDQVIHU &RPPLWWHH RI WKH -RKQV +RSNLQV &HQWHU IRU$OWHUQDWLYHVWR$QLPDO7HVWLQJ -$P &ROO7R[LFRO² +HQGULNVHQ&)0 5HSODFHPHQW5HGXFWLRQDQG5HÀQHPHQWDQG%LRORJLFDOVDERXW )DFWV)LFWLRQDQG)UXVWUDWLRQVSDSHUSUHVHQWHGLQ3URJUHVVLQWKH5HGXFWLRQ5HÀQH PHQWDQG5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ3URFHHGLQJVRIWKH7KLUG:RUOG &RQJUHVV RQ $OWHUQDWLYHV DQG $QLPDO 8VH LQ WKH /LIH 6FLHQFHV %RORJQD 'HYHORSPHQWV LQ $QLPDO DQG9HWHULQDU\ 6FLHQFHV9RO $ %DOOV 0 YDQ =HOOHU $0DQG+DOGHU0(GV(OVHYLHU$PVWHUGDPSS² ,&&9$0 9DOLGDWLRQ DQG 5HJXODWRU\$FFHSWDQFH RI 7R[LFRORJLFDO 7HVW 0HWKRGV$ 5HSRUW RI WKH DG KRF ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQ RI $OWHUQDWLYH0HWKRGV1,(+65HVHDUFK7ULDQJOH3DUN1& /LHEVFK07UDXH'%DUUDEDV&6SLHOPDQQ+8SKLOO3:LONLQV60F3KHUVRQ-3 :LHPDQQ & .DXIPDQQ 7 5HPPHOH 0 DQG +RO]KWWHU +* 7KH (&9$0SUHYDOLGDWLRQVWXG\RQWKHXVHRI(SL'HUPIRUVNLQFRUURVLYLW\WHVWLQJ$OW /DE$QLP² /RYHOHVV 6( /DGLFV *6 *HUEHULFN *) 5\DQ &$ %DVNHWWHU '$ 6FKROHV (: +RXVH59+LOWRQ-'HDUPDQ5-DQG.LPEHU, )XUWKHUHYDOXDWLRQRI WKHORFDOO\PSKQRGHDVVD\LQWKHÀQDOSKDVHRIDQLQWHUQDWLRQDOFROODERUDWLYHWULDO 7R[LFRORJ\²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ÀQHPHQWDQG 5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ3URFHHGLQJVRIWKH7KLUG:RUOG&RQJUHVV RQ$OWHUQDWLYHVDQG$QLPDO8VHLQWKH/LIH6FLHQFHV%RORJQD$XJXVW²6HS WHPEHU'HYHORSPHQWVLQ$QLPDODQG9HWHULQDU\6FLHQFHV9RO$%DOOV0 YDQ=HOOHU$0DQG+DOGHU0(GV(OVHYLHU$PVWHUGDPSS²
ACCEPTANCE OF ALTERNATIVE TESTS IN THE EUROPEAN UNION
41
6FKRO]**HQVFKRZ(%URZQ13LHUVPD$%UDG\0&OHPDQQ1+XXVNRQHQ+ 3DLOODUG)%UHPHU6DQG6SLHOPDQQ+ )LUVWUHVXOWVRIDYDOLGDWLRQVWXG\ RIWKUHHLQYLWURHPEU\RWR[LFLW\WHVWV$OW/DE$QLP 6SLHOPDQQ+%DOOV0'XSXLV-3DSH:-:3HFKRYLWFK*GH6LOYD2+RO]KWWHU +*&ORWKLHU5'HVROOH3*HUEHULFN)/LHEVFK0/RYHOO::0DXUHU7 3IDQQHQEHFNHU83RWWKDVW-0&VDWR06ODGRZVNL'6WHLOLQJ:DQG%UDQ WRP3D (8&2/,3$´LQYLWURSKRWRWR[LFLW\µYDOLGDWLRQVWXG\UHVXOWVRISKDVH ,,EOLQGWULDO ,7KH7158SKRWRWR[LFLW\WHVW7R[LFRO,Q9LWUR² 6SLHOPDQQ+%DOOV0'XSXLV-3DSH:-:GH6LOYD2+RO]KWWHU+**HUEHULFN )/LHEVFK0/RYHOO::DQG3IDQQHQEHFNHU8E $VWXG\RQ89ÀOWHU FKHPLFDOVIURP$QQH[9,,RI(XURSHDQ8QLRQ'LUHFWLYH((&LQWKHLQYLWUR 7158SKRWRWR[LFLW\WHVW$OW/DE$QLP²
CHAPTER
5
Integrated In Vitro Approaches for Assessing Systemic Toxicity $QQD)RUVE\DQG%DV%ODDXERHU
CONTENTS ,QWURGXFWLRQ 7KH6WHSZLVH$SSURDFKIRU,QWHJUDWHG7HVWLQJ 7KH(&,7763URMHFW &RPSRXQGVDQG7HVW%DWWHU\ 5HVXOWV &RQFOXVLRQVDQG)XWXUH3HUVSHFWLYHV 5HÀQHPHQWRIWKH1HXURWR[LFLW\7HVW%DWWHU\ 'LIIHUHQW([SRVXUH7LPHV $FNQRZOHGJPHQWV 5HIHUHQFHV
INTRODUCTION &ODVVLFDOWR[LFRORJLFDOULVNDVVHVVPHQWLVEDVHGRQTXDQWLÀ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
43
44
ALTERNATIVE TOXICOLOGICAL METHODS
PDWLRQDQGNLQHWLFFRQVLGHUDWLRQV)XUWKHUPRUHLQYLWURDVVD\VKDYHEHHQGHYHORSHG WRPHDVXUHJHQHUDOF\WRWR[LFLW\UDWKHUWKDQRQPHFKDQLVPVRILPSRUWDQFHLQYLYR,W LVWKHUHIRUHQHFHVVDU\WRÀQGDVWUDWHJ\E\ZKLFKFHOOXODUWR[LFFRQFHQWUDWLRQVGHWHU PLQHGLQYLWURFDQEH´FRQYHUWHGµWRGRVHVWKDWDUHUHOHYDQWIRUULVNDVVHVVPHQW2QH DSSURDFKLVWRLQWHJUDWHWKHLQYLWURGDWDZLWKFRPSXWHUEDVHGELRNLQHWLFPRGHOV THE STEPWISE APPROACH FOR INTEGRATED TESTING 7REHDEOHWRFRQVWUXFWDELRNLQHWLFPRGHOLWLVQHFHVVDU\WRGHWHUPLQHUHOHYDQW SDUDPHWHUV RQ SK\VLRORJLFDO FKDUDFWHULVWLFV RI DQ RUJDQLVP DQG SK\VLFRFKHPLFDO FKDUDFWHULVWLFVRIWKHFRPSRXQGV7KHLQWHJUDWHGDSSURDFKIRUDVVHVVLQJWR[LFLW\FDQ EHSHUIRUPHGLQDVWHSZLVHSURFHGXUH 0RGHOEXLOGLQJRQWKHEDVLVRIQRQDQLPDOGDWDE\GHWHUPLQDWLRQRI 3K\VLFRFKHPLFDOSURSHUWLHVHJOLSRSKLOLFLW\DQGSURWHLQELQGLQJIURPZKLFK EORRG²WLVVXHSDUWLWLRQDLU²EORRGSDUWLWLRQFDQEHHVWLPDWHG 3DUDPHWHUVLQFHOOFXOWXUHV\VWHPVHJELRWUDQVIRUPDWLRQSDVVDJHRYHUFHOO OD\HUVZLWKEDUULHUIXQFWLRQV 9DOLGDWLRQRIWKHELRNLQHWLFPRGHOE\FRPSDULVRQZLWKNQRZQLQYLYRGDWD ,IQHFHVVDU\LPSURYHRUFRQVWUXFWWKHELRNLQHWLFPRGHOE\XVLQJLQYLYRGDWD7KLV VKRXOGEHGRQHE\H[WUDSRODWLRQRIGDWDIURPQRQWR[LFGRVHV 8VHLQYLWURDVVD\VWRGHWHUPLQHG\QDPLFGDWDIRU $VSHFLÀF F\WRWR[LFLW\ 7LVVXHVSHFLÀFWR[LFLW\ 5HOHYDQWFRQFHQWUDWLRQVIRUIXQFWLRQDOFHOOXODUGLVRUGHUVHJWKHFRQFHQWUD WLRQVJLYLQJHIIHFW(& 7KHVHFRQFHQWUDWLRQVDUHWKHQXVHGDVUHVSRQVH VXUURJDWHVWDUJHWWLVVXHOHYHOV DWJLYHQGRVHVLH/2('V ,QWHJUDWH NLQHWLF DQG G\QDPLF GDWD WR ÀQG UHOHYDQW FULWLFDO WLVVXH FRQFHQWUD WLRQ²HIIHFWUHODWLRQVKLSV 3UHGLFWVXUURJDWHGRVHVUHVXOWLQJLQLQYLYRHIIHFWV (YDOXDWHUHVXOWVE\FRPSDULQJZLWKNQRZQLQYLYRGDWD
THE ECITTS PROJECT ,Q WKH (XURSHDQ 5HVHDUFK *URXS IRU $OWHUQDWLYHV LQ 7R[LFLW\ 7HVWLQJ (5*$77 LQLWLDWHGDQLQWHUODERUDWRU\SURMHFWLQDVVRFLDWLRQZLWKWKH6ZHGLVK%RDUG IRU /DERUDWRU\ $QLPDOV &HQWUDOD )|UV|NVGMXUVQl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
INTEGRATED IN VITRO APPROACHES FOR ASSESSING SYSTEMIC TOXICITY
1. Experimental
2. Modeling
3. Validation (literature data)
in vitro data on kinetics
kinetic modeling
kinetics in vivo
in vitro data on dynamics
prediction of target tissue
(e.g., CNC, EC20, EC50)
45
concentrations (e.g., NOEL, LOEL) prediction of dynamics
in vivo systemic
prediction of systemic
Figure 5.1
toxic doses
toxic doses
(e.g., NOED, LOED,
(e.g., NOED, LOED,
LD50)
LD50)
Building blocks of the ECITTS scheme.
Compounds and Test Battery (LJKW ZHOOFKDUDFWHUL]HG WHVW FRPSRXQGV ZKLFK SRVVHVV DFWLYLW\ LQ WKH FHQWUDO RU SHULSKHUDO QHUYRXV V\VWHPV ZHUH VHOHFWHG 7KHVH ZHUH DFU\ODPLGH FDIIHLQH GLD]HSDP QKH[DQHKH[DQHGLRQH OLQGDQH SDUDWKLRQSDUDR[RQ SKHQ\WRLQ DQG WROXHQH $Q LQ YLWUR WHVW EDWWHU\ ZLWK JHQHUDO DQG QHXURVSHFLÀF HQGSRLQWV ZDV GHVLJQHGLQRUGHUWRFRYHUHQGSRLQWVIRUEDVDOF\WRWR[LFLW\PRUSKRORJ\SK\VLRORJ\ DQGQHXURFKHPLVWU\:DOXPHWDO)RUVE\HWDO 7KH KXPDQ QHXUREODVWRPD FHOO OLQH 6+6<< KDV EHHQ XVHG H[WHQVLYHO\ DV D PRGHOIRUV\PSDWKHWLFJDQJOLRQFHOOV5RVVHWDO DQGZDVFKRVHQIRUWKHVH VWXGLHV7KHFHOOVFDQEHIXUWKHUGLIIHUHQWLDWHGZKHQFXOWXUHGLQVHUXPIUHHPHGLXP ZLWKUHWLQRLFDFLG15$ ZKLFKLQGXFHVWKHFHOOVWRGHYHORSDQH[WHQVLYHQHWZRUN RI QHXULWHV 3nKOPDQ HW DO )LJXUH )XUWKHUPRUH WKH H[FLWDELOLW\ DQG
a Figure 5.2
b
(a) Native and (b) retinoic acid-differentiated SH-SY5Y cells.
46
ALTERNATIVE TOXICOLOGICAL METHODS
Table 5.1 Endpoints Studied in the in Vitro Neurotoxicity Test Battery for the ECITTS Project Endpoint Cytotoxicity/Inhibition of cell growth Neurite degeneration (ND) Protein synthesis rate (PSR) Basal intracellular free Ca2+ concentration (basal Ca2+) Voltage operated Ca2+ channels (VOCC) Phospholipase C-coupled acetylcholine receptor signal transduction (mAChR peak) Acetylcholine-induced capacitive Ca2+ entry (mAChR plateau)
Assay
Toxicity level
Total cellular protein content Number of neurites per cell [3H] leucine incorporation in proteins during 2 hr Fura-2/Ca2+, fluorescence
Basal cytotoxicity Morphology Physiology
High potassium-induced Ca2+ flux, fluorescence Carbachol-activated, immediate transient Ca2+ peak, fluorescence Carbachol-activated, secondary Ca2+ plateau, fluorescence
Neurochemistry
Physiology
Neurochemistry
Neurochemistry
UHFHSWRUIXQFWLRQVDUHHQKDQFHG+HQFHWKHFHOOVZHUHFXOWXUHGLQ15$IRUKU EHIRUH WKH KU RI H[SRVXUH ZLWK WKH WHVW FRPSRXQGV$IWHU H[SRVXUH WKH HIIHFWV RQ VHYHUDO HQGSRLQWV ZHUH LQYHVWLJDWHG DQG (& YDOXHV ZHUH HVWLPDWHG7KH HQG SRLQWVDQGWKHDVVD\VXVHGIRUWKHVWXG\DUHOLVWHGLQ7DEOH &ULWLFDOQHXURWR[LFFRQFHQWUDWLRQV&1&V ZHUHGHÀQHGDVWKH(&YDOXHGHWHU PLQHGLQWKHPRVWVHQVLWLYHHQGSRLQWIRUHDFKFRPSRXQG7KH&1&VZHUHK\SRWK HVL]HGWRPLPLFWKHWR[LFWDUJHWWLVVXHFRQFHQWUDWLRQVDWWKHORZHVWREVHUYHGHIIHFW OHYHOV/2(/V 7KH&1&VIRUHDFKFRPSRXQGZHUHLQWHJUDWHGZLWKFRPSXWHUEDVHG ELRNLQHWLF PRGHOV IRU UDWV DQG DFXWH DQG VXEFKURQLF /2('V ZHUH HVWLPDWHG )RU DFU\ODPLGHWKHVWXG\ZDVH[WHQGHGE\LQWHJUDWLQJWKH(&YDOXHUHÁ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À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esults 7KHFHOOXODUQHXURWR[LFDFWLYLWLHVIRUVL[RIWKHHLJKWWHVWFRPSRXQGVZHUHGHWHU PLQHGDIWHUKURIH[SRVXUH7KH&1&VDQGWKHDGGLWLRQDO(&DQG(&YDOXHV
INTEGRATED IN VITRO APPROACHES FOR ASSESSING SYSTEMIC TOXICITY
47
Table 5.2 Effects of the Test Compounds, Determined in Differentiated Human Neuroblastoma SH-SY5Y Cells, on in Vitro Endpoints as Presented in Table 5.1 Compound Acrylamide Acrylamide Caffeine Diazepam Lindane Lindane Lindane Parathion/paraoxon Phenytoin
In vitro effect
Concentration QM or QM/hr) (Q
20% cytotoxicity CNC; neurite degeneration/time CNC; inhibition of VOCC CNC; inhibition of VOCC CNC; inhibition of VOCC 20% increased basal [Ca2+]i 50% cytotoxicity CNC; neurite degeneration/time CNC; inhibition of protein synthesis
920 11 10 49 3.4 35 150 0.5 87
CNC, critical cellular neurotoxic concentration; VOCC, voltage operated calcium channels.
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
CONCLUSIONS AND FUTURE PERSPECTIVES 7KHSUHYDOLGDWLRQVWXG\VKRZHGWKDWLWLVSRVVLEOHWRHVWLPDWH/2('VDQG/'V E\LQWHJUDWLQJLQYLWURGHULYHGWR[LFLW\GDWDZLWKFRPSXWHUEDVHGELRNLQHWLFPRGHO LQJ+RZHYHUWKHUHDUHVRPHUHPDUNVWKDWKDYHWREHFRQVLGHUHG Refinement of the Neurotoxicity Test Battery 7KH UHVXOWV RI GLD]HSDP LQGLFDWHG WKDW WKH LQ YLYR HQGSRLQWV DUH GHSHQGHQW RQ UHOHYDQWLQYLWURHQGSRLQWVZKLFKGHVFULEHWKHPROHFXODUPHFKDQLVPVRIWKHFRP SRXQGV 7KXV WKH QHXURWR[LFLW\ WHVW EDWWHU\ ZKLFK FDQ EH GHVLJQHG DV D WLHUHG VWHSZLVH WHVW VWUDWHJ\ VKRXOG FRQVLVW RI D À[HG SDUW IRU HVWLPDWLRQ RI D VSHFLÀF V\VWHPLFWR[LFLW\EDVDOF\WRWR[LFLW\ SK\VLRORJ\IRULQVWDQFHHQHUJ\PHWDEROLVP DQGEDVDOLQWUDFHOOXODU&DFRQFHQWUDWLRQV DQGSRVVLEO\D[RQRSDWK\QHXULWHGHJHQ HUDWLRQ 7KH VHFRQG SDUW QHXURFKHPLVWU\ VKRXOG EH ÁH[LEOH DQG LQGLYLGXDOO\
48
ALTERNATIVE TOXICOLOGICAL METHODS
Estimated doses (mg/kg) or (mg/kg/day)
100.0
10.0
10
1
0.1
0.01
0.001 0.001
0.01
0.1
1
10
100
1000
Experimental doses (mg/kg) or (mg/kg/day) Lindane (CNC: inhibition of VOCC vs. LOED: learning; s.c.) Lindane (EC20: increased basal Ca2+ vs. LOED: convulsions; s.c.) Lindane (50% cytotoxicity vs. lowest LD50; a.) Lindane (50% cytotoxicity vs. highest LD50; a.) Acrylamide (20% cytotoxicity vs. LOED: gait; a.) Acrylamide (CNC: ND vs. LOED: startle response; 10 days) Acrylamide (CNC: ND vs. LOED: startle response; 30 days) Acrylamide (CNC: ND vs. LOED: startle response; 90 days) Caffeine (CNC: inhibited VOCC vs. LOED: anti-nociception; a.) Diazepam (CNC: inhibited VOCC vs. LOED: time to emerge; a.) Phenytoin (CNC: inhibition of PSR vs. operant learning; a.) Parathion/paraoxon (CNC of paraoxon: ND vs. LOED: tail-pinch response of parathion; a.)
Figure 5.3
Estimated versus experimental doses after (a) acute and/or (s.c.) subchronic exposure. See Table 5.1 for endpoint definitions. The line represents the identity.
GHVLJQHGIRUGLIIHUHQWFODVVHVRIFRPSRXQGV7KHVSHFLÀFHQGSRLQWVVKRXOGEHFKRVHQ EDVHGRQNQRZOHGJHDERXWWR[LFRORJLFDOPHFKDQLVPVRIUHODWHGFRPSRXQGV,QYLYR GDWDKXPDQGDWDDQGNQRZOHGJHDERXWVWUXFWXUHDFWLYLW\UHODWLRQVKLSVZLOOEHXVHIXO Different Exposure Times 7KHQHXURWR[LFDFWLYLWLHVVKRXOGEHGHWHUPLQHGDIWHUYDULRXVH[SRVXUHWLPHVLQ YLWUR'HWHUPLQDWLRQRIDFU\ODPLGHLQGXFHGGHJHQHUDWLRQRIQHXULWHVRYHUWLPHPDUN HGO\LPSURYHGWKHHVWLPDWLRQRIQHXURWR[LFLW\DIWHUVXEFKURQLFH[SRVXUH'H-RQJK HW DO )XUWKHUPRUH QHXURFKHPLFDO SURSHUWLHV PD\ EH GLIIHUHQW DIWHU VKRUW WHUPPLQXWHV DVFRPSDUHGWRORQJWHUPGD\V H[SRVXUH
INTEGRATED IN VITRO APPROACHES FOR ASSESSING SYSTEMIC TOXICITY
49
,Q FRQFOXVLRQ WKH (&,776 SUHYDOLGDWLRQ VWXG\ LQGLFDWHG WKDW WKH VWUDWHJ\ RI XVLQJFHOOXODULQYLWURPHWKRGVLQWHJUDWHGZLWKFRPSXWHUEDVHGELRNLQHWLFPRGHOLQJ FDQ EH D SRZHUIXO WRRO IRU ULVN DVVHVVPHQW +RZHYHU JHQHUDO DV ZHOO DV VSHFLÀF WR[LFRORJLFDOPHFKDQLVPVPXVWEHFRQVLGHUHGIRUWKHGHVLJQRIWHVWEDWWHULHV7KH UHVXOWVRIWKHSURMHFWDOVRUHYHDOHGWKDWLWLVSRVVLEOHWREXLOGFRPSXWHUEDVHGELR NLQHWLFPRGHOVRQLQYLWURGDWDIRUWKHUDW,QH[WHQVLRQFRPSXWHUEDVHGELRNLQHWLF PRGHOVRIKXPDQVFDQEHFRQVWUXFWHGZKHQ LQYLWURPHWKRGVIRUGHWHUPLQDWLRQRI KXPDQPHWDEROLVPEORRG²EUDLQEDUULHUSDUWLWLRQFRHIÀFLHQWVHWFDUHDYDLODEOH2QH JHQHUDOSUREOHPRIYDOLGDWLRQLVWKHOLPLWHGDPRXQWRIUHOLDEOHKXPDQWR[LFLW\GDWD ZKLFKPDNHVLWGLIÀFXOWWRYDOLGDWHDOWHUQDWLYHWHVWVIRUDODUJHUVHWRIWHVWFRPSRXQGV 1HYHUWKHOHVVRXUVWXGLHVKDYHVKRZQWKDWDOWHUQDWLYHVFDQHVWLPDWHWR[LFGRVHVZLWK WKHVDPHTXDOLW\DVWUDGLWLRQDODQLPDOWHVWV
ACKNOWLEDGMENTS 7KLVLQYHVWLJDWLRQZDVÀQDQFHGE\JUDQWVIURPWKH(XURSHDQ&HQWHUIRU9DOLGD WLRQRI$OWHUQDWLYH0HWKRGV(&9$0 DQGWKH6ZHGLVK%RDUGIRU/DERUDWRU\$QL PDOV&)1 :HWKDQNDOOSDUWLFLSDQWVLQWKH(&,776SURMHFWIRUYDOXDEOHFRQWULEX WLRQWRWKHELRNLQHWLFPRGHODQGVFLHQWLÀFGLVFXVVLRQV
REFERENCES %ODDXERHU%-)RUVE\$+RXVWRQ%-%HFNPDQ0&RPEHV5DQG'H-RQJK- $QLQWHJUDWHGDSSURDFKWRWKHSUHGLFWLRQRIV\VWHPLFWR[LFLW\XVLQJFRPSXWHUEDVHG ELRNLQHWLFPRGHOVDQGELRORJLFDOLQYLWURWHVWPHWKRGVLQ3URJUHVVLQWKH5HGXFWLRQ 5HÀQHPHQWDQG5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ%DOOV0YDQ=HOOHU$0 DQG+DOGHU0((GV(OVHYLHU$PVWHUGDP 'H-RQJK-DQG%ODDXERHU%- 6LPXODWLRQRIWROXHQHNLQHWLFVLQWKHUDWE\DSK\VL RORJLFDOO\EDVHGSKDUPDFRNLQHWLFPRGHOZLWKDSSOLFDWLRQRIELRWUDQIRUPDWLRQSDUDP HWHUVGHULYHGLQGHSHQGHQWO\LQYLWURDQGLQYLYR)XQG$SSO7R[LFRO² 'H-RQJK - 1RUGLQ$QGHUVVRQ 0 3ORHJHU %$ DQG )RUVE\ $ (VWLPDWLRQ RI V\VWHPLFWR[LFLW\RIDFU\ODPLGHE\LQWHJUDWLRQRI LQYLWURWR[LFLW\GDWDZLWKNLQHWLF VLPXODWLRQV7R[LFRO$SSO3KDUPDFRO² 'HVL, 1HXURWR[LFRORJLFDOHIIHFWRIVPDOOTXDQWLWLHVRIOLQGDQH,QW$UFK$UEHLWVPHG ² (NZDOO%%DULOH)&DVWDQR$&OHPHGVRQ&&ORWKLHU5'LHULFN[3(NZDOO%$ )HUUR0)LVNHVM|**DU]D2FDxDV/*yPH]/HFKyQ0-*OGHQ0+DOO 7,VRPDD%.DKUX$.HU]PDQ*.ULVWHQ8.XQLPRWR0.lUHQODPSL6 /HZDQ//RXNLDQRY$2KQR73HUVRRQH*5RPHUW/6DZ\HU7:6KULYDV WDYD56HJQHU+6WDPPDWL$7DQDND19DOHQWLQR0:DOXP(DQG=XFFR ) 0(,&(YDOXDWLRQRIDFXWHV\VWHPLFWR[LFLW\9,7KHSUHGLFWLRQRIKXPDQ WR[LFLW\E\URGHQW/'YDOXHVDQGUHVXOWVIURPLQYLWURPHWKRGV$OW/DE$QLP ² )RUVE\$ 3LOOL ) %LDQFKL9 DQG :DOXP ( 'HWHUPLQDWLRQV RI FULWLFDO FHOOXODU QHXURWR[LF FRQFHQWUDWLRQV LQ KXPDQ QHXUREODVWRPD 6+6<< FHOO FXOWXUHV $OW /DE$QLP²
50
ALTERNATIVE TOXICOLOGICAL METHODS
3nKOPDQ 6 5XXVDOD $, $EUDKDPVVRQ / 0DWWVVRQ 0(. DQG (VVFKHU 7 5HWLQRLFDFLGLQGXFHGGLIIHUHQWLDWLRQRIFXOWXUHGKXPDQQHXUREODVWRPDFHOOVDFRP SDULVRQZLWKSKRUEROHVWHULQGXFHGGLIIHUHQWLDWLRQ&HOO'LIIHUHQWLDWLRQ² 5RVV5$+\XE-RK75HLV'-6SHQJOHU%DQG%LHGOHU- 1HXURWUDQVPLWWHU V\QWKHVL]LQJHQ]\PHVLQKXPDQQHXUREODVWRPDFHOOVUHODWLRQVKLSWRPRUSKRORJLFDO GLYHUVLW\ LQ $GYDQFHV LQ 1HXUREODVWRPD 5HVHDUFK (YDQV$( (G 5DYHQ 3UHVV 1HZ
CHAPTER
6
Summary of the OECD’s New Guidance Document on the Recognition, Assessment, and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation (UURO=HLJHU
CONTENTS ,QWURGXFWLRQ 'HYHORSPHQWRIWKH*XLGDQFH'RFXPHQW 'HÀQLWLRQV *XLGLQJ3ULQFLSOHV ,QLWLDO&RQVLGHUDWLRQVLQWKH'HVLJQRI$QLPDO([SHULPHQWV 5HFRJQLWLRQDQG$VVHVVPHQWRI3DLQ'LVWUHVVDQG6XIIHULQJDV DQ$SSURDFKWR'HWHFWLQJ&OLQLFDO6LJQVDQG$EQRUPDO&RQGLWLRQV 0DNLQJDQ,QIRUPHG'HFLVLRQWR+XPDQHO\.LOO$QLPDOV 6HYHUH3DLQDQG'LVWUHVVDV&ULWHULDIRU+XPDQH.LOOLQJ *XLGDQFHRQWKH+XPDQH&RQGXFWRI6SHFLÀF7\SHVRI7R[LFLW\7HVWLQJ 5HIHUHQFH
INTRODUCTION ,Q1RYHPEHUWKH2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORS PHQW2(&' UHOHDVHGLWVQHZJXLGDQFHGRFXPHQW´5HFRJQLWLRQ$VVHVVPHQWDQG 8VH RI &OLQLFDO 6LJQV DV +XPDQH (QGSRLQWV IRU ([SHULPHQWDO $QLPDOV 8VHG LQ 51
52
ALTERNATIVE TOXICOLOGICAL METHODS
6DIHW\(YDOXDWLRQµ2(&' 7KLVFRQVHQVXVGRFXPHQWZDVGHYHORSHGIRUXVH ZLWKWKH2(&'·VH[LVWLQJDQGIXWXUHKHDOWKHIIHFWVWHVWJXLGHOLQHVDQGDVJXLGDQFH WR ODERUDWRU\ UHVHDUFKHUV LQ JHQHUDO ,W LV DOVR LQWHQGHG WR SURYLGH LQWHUQDWLRQDO KDUPRQL]DWLRQRQWKHXVHRIKXPDQHHQGSRLQWVLQWHVWLQJDQGUHVHDUFK +XPDQHHQGSRLQWVDUHGHÀQHGDVWKHHDUOLHVWLQGLFDWRUVLQDQDQLPDORIVHYHUH SDLQGLVWUHVVVXIIHULQJRULPSHQGLQJGHDWK7KHJXLGDQFHGRFXPHQWGHÀQHVWKHVH WHUPVDQGDGGUHVVHVWKHFRQFHSWRIUHÀQHPHQWRIDQLPDOWHVWLQJLHWKHPLQLPL]LQJ RISDLQGLVWUHVVDQGVXIIHULQJ WKURXJKWKHXVHRIKXPDQHHQGSRLQWV7KHQHHGIRU FDUHIXO GHVLJQ DQG PRQLWRULQJ RI H[SHULPHQWV DV ZHOO DV H[SHUW MXGJPHQW LQ WKH DSSOLFDWLRQRIKXPDQHHQGSRLQWVLVHPSKDVL]HG7KHJRDORIWKHH[SHULPHQWHUVKRXOG EH WR XVH KXPDQH HQGSRLQWV WR PLQLPL]H SDLQ GLVWUHVV RU VXIIHULQJ WR WKH H[WHQW SRVVLEOHZLWKRXWFRPSURPLVLQJWKHVFLHQWLÀFREMHFWLYHVRIWKHH[SHULPHQW 7KH GRFXPHQW SURYLGHV JXLGDQFH RQ WKH KXPDQH FRQGXFW RI VSHFLÀ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Á\VXPPDUL]HLWVSKLORVRSK\DQG FRQWHQW$VDUHVXOWWKLVDUWLFOHTXRWHVH[WHQVLYHO\IURPWKHJXLGDQFHGRFXPHQW
DEVELOPMENT OF THE GUIDANCE DOCUMENT &XUUHQW 2(&' KHDOWK HIIHFWV WHVW JXLGHOLQHV FRQWDLQ D JHQHUDO VWDWHPHQW WKDW DQLPDOV WKDW DUH PRULEXQG RU REYLRXVO\ LQ SDLQ DQG VKRZLQJ VLJQV RI VHYHUH DQG HQGXULQJGLVWUHVVVKRXOGEHKXPDQHO\NLOOHG,QDQDGKRFZRUNLQJJURXSZDV IRUPHGWRGHYHORSDQ2(&'JXLGDQFHGRFXPHQWWKDWZRXOGSURYLGHJXLGDQFHDQG FULWHULD IRU GHWHUPLQLQJ ZKHQ DQ DQLPDO LV LQ D PRULEXQG FRQGLWLRQ H[SHFWHG WR EHFRPHPRULEXQGRUH[SHULHQFLQJVLJQLÀFDQWSDLQDQGGLVWUHVVDQGVKRXOGWKHUHIRUH EHHXWKDQL]HGIRUKXPDQHUHDVRQV 7KLV JXLGDQFH GRFXPHQW DSSOLHV WKH SULQFLSOHV RI WKH WKUHH 5V UHSODFHPHQW UHGXFWLRQUHÀQHPHQW WRWKHXVHRIDQLPDOVLQUHJXODWRU\WR[LFLW\WHVWV,WVSHFLÀFDOO\ DGGUHVVHVUHÀ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
SUMMARY OF THE OECD’S NEW GUIDANCE DOCUMENT
53
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ÀFLHQWLQWKHPVHOYHVIRUKXPDQHNLOOLQJ$GGLWLRQDOIDFWRUVKDYHWREHFRQVLG HUHG,WLVDOVRUHFRJQL]HGWKDWPDQ\RIWKHVHVLJQVDUHKLJKO\REMHFWLYHDQGGLIIHUHQW GLDJQRVHVDQGFRQFOXVLRQVPD\EHUHDFKHGE\GLIIHUHQWLQYHVWLJDWRUV $QQH[ LV GHVLJQHG IRU GLVSOD\ LQ DQLPDO URRPV DQG IDFLOLWLHV ,W VXPPDUL]HV WKH FOLQLFDOVLJQVDQGFRQGLWLRQVRIDQLPDOVUHTXLULQJDFWLRQE\DQLPDOFDUHVWDIIDQG VWXG\GLUHFWRUVDQGSURYLGHVJXLGDQFHDVWRZKDWWKRVHDFWLRQVVKRXOGEH
7KLV JXLGDQFH GRFXPHQW LV LQWHQGHG WR EH ÁH[LEOH VR WKDW LW FDQ FKDQJH ZLWK LPSURYHG NQRZOHGJH LQ WKH IXWXUH ,W LV H[SHFWHG WKDW ZLWK LQFUHDVLQJ NQRZOHGJH DQGH[SHULHQFHLQYHVWLJDWRUVLQDQLPDOUHVHDUFKZLOOEHDEOHWRLGHQWLI\PRUHVSHFLÀF HDUO\KXPDQHHQGSRLQWVLQWKHIRUPRIFOLQLFDOVLJQVRILPSHQGLQJGHDWKRUVHYHUH SDLQDQGGLVWUHVV
DEFINITIONS $KXPDQHHQGSRLQWLVGHÀ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ÀFDWLRQRUUHGXFWLRQRIH[SRVXUH ,WLVUHFRJQL]HGKRZHYHUWKDWGLIIHUHQWDQLPDOVSHFLHVDQGDQLPDOVDWGLIIHUHQWVWDJHV RIGHYHORSPHQWPD\UHVSRQGGLIIHUHQWO\WRVLPLODUWHVWFRQGLWLRQVDQGH[KLELWGLI IHUHQWLQGLFDWLRQVRIGLVWUHVV 3DLQLVGHÀQHGDVDQXQSOHDVDQWVHQVRU\DQGHPRWLRQDOH[SHULHQFHDVVRFLDWHG ZLWK DFWXDO RU SRWHQWLDO WLVVXH GDPDJH RU GHVFULEHG LQ WHUPV RI VXFK GDPDJH 2EMHFWLYHVLJQVRISDLQFDQLQFOXGHYRFDOL]DWLRQHYLGHQFHRILQIHFWLRQDYHUVLRQ
54
ALTERNATIVE TOXICOLOGICAL METHODS
RUDYRLGDQFHE\DFWLYHZLWKGUDZDOIURPVWLPXOLJXDUGLQJDIIHFWHGERG\SDUWVVHOI PXWLODWLRQRUUHGXFHGIRRGLQWDNH 7KHUHDUHWKUHHJHQHUDOFDWHJRULHVRISDLQ $FXWHQRFLFHSWLYHSDLQWKHSDLQUHVSRQVHHYRNHGE\DEULHIQR[LRXVVWLPXOXVWKDW SURGXFHVQRWLVVXHGDPDJH7KLVIRUPRISDLQLVQRWUHJDUGHGDVVHYHUH 3HUVLVWHQW FKURQLF LQÁDPPDWRU\ SDLQ WKH SDLQ UHVXOWLQJ IURP WLVVXH GDPDJH ODVWLQJIRUWKHGXUDWLRQRIWKHGDPDJHRUWKHHQVXLQJLQÁDPPDWRU\SURFHVVZKLFK PD\SHUVLVWDIWHUWKHORFDOGDPDJHKDVKHDOHG7KLVW\SHRISDLQPD\EHVHYHUH RUGLVWUHVVLQJSDUWLFXODUO\LILWLVORQJODVWLQJRUSHUPDQHQW 1HXURSDWKLFSDLQSDLQDVDUHVXOWRIFRPSURPLVHGIXQFWLRQRUDEQRUPDODFWLYDWLRQ RIWKHSHULSKHUDORUFHQWUDOQHUYRXVV\VWHP1HXURSDWKLFSDLQLVDOZD\VFRQVLGHUHG WREHVHYHUHDQGGLVWUHVVLQJSDLQ
'LVWUHVVLVGHÀQHGDVDQDYHUVLYHVWDWHUHVXOWLQJIURPPDODGDSWLRQRULQDELOLW\WR DGDSWWRVWUHVVRUV3K\VLFDORUEHKDYLRUDODOWHUDWLRQVPD\EHVLJQVRIVWUHVV7KHPDMRU VWUHVVRUVDVVRFLDWHGZLWKGLVWUHVVDUHVLWXDWLRQVWKDWPD\JLYHULVHWRPDUNHGSDLQIHDU RUDQ[LHW\5HWUHDWWRWKHFRUQHURIWKHFDJHRUH[FHVVLYHVWUXJJOLQJRUYRFDOL]LQJRQ GRVLQJDUHH[DPSOHVRIGLVWUHVVLQDQWLFLSDWLRQRIDQH[SHULPHQWDOSURFHGXUH 6XIIHULQJLVGHÀ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
GUIDING PRINCIPLES %ULHÁ\ WKH JXLGLQJ SULQFLSOHV ZLWK UHVSHFW WR WKH XVH RI KXPDQH HQGSRLQWV LQFOXGHWKHIROORZLQJ 7KHUHLVVWURQJVFLHQWLÀFHYLGHQFHWKDWSDLQDQGGLVWUHVVDUHSUHVHQWLQDQLPDOVLQ FRPSDUDEOHVLWXDWLRQVDVWKH\RFFXULQKXPDQV 6HYHUHSDLQVXIIHULQJDQGGHDWKDUHWREHDYRLGHGDVWHVWHQGSRLQWV 6WXGLHVPXVWEHGHVLJQHGWRPLQLPL]HSDLQGLVWUHVVRUVXIIHULQJH[SHULHQFHGE\ WKHDQLPDOVFRQVLVWHQWZLWKWKHVFLHQWLÀFREMHFWLYHRIWKHVWXG\ 7KH HDUOLHVW SRVVLEOH HQGSRLQWV WKDW DUH LQGLFDWRUV RI GLVWUHVV VHYHUH SDLQ RU LPSHQGLQJGHDWKWKDWFRXOGEHXVHGDVLQGLFDWLRQVIRUKXPDQHO\NLOOLQJWKHDQLPDOV VKRXOGEHGHWHUPLQHGSULRUWRWKHDQLPDOV·UHDFKLQJDPRULEXQGVWDWH
SUMMARY OF THE OECD’S NEW GUIDANCE DOCUMENT
55
6WXGLHVVKRXOGEHWHUPLQDWHGSULRUWRWKHLUDQWLFLSDWHGWHUPLQDWLRQWLPHLIWKHREMHF WLYHVRIWKHVWXG\KDYHEHHQVDWLVÀ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ÀQHG $OODVSHFWVRIDQLPDOVWXGLHVVKRXOGEHVXEMHFWWRDQHWKLFDOUHYLHZSURFHVV
$OOGHFLVLRQVUHODWHGWRWKHDSSOLFDWLRQRIKXPDQHHQGSRLQWVVKRXOGEHPDGHE\ WKHVWXG\GLUHFWRURUGHVLJQDWHGUHVSRQVLEOHSHUVRQDIWHUFRQVXOWDWLRQZLWKWKHWHDP RIH[SHUWVZKLFKLQFOXGHVWKHSULQFLSDOLQYHVWLJDWRUWKHYHWHULQDULDQDQGDQH[SH ULHQFHGDQLPDOWHFKQLFLDQ7KHVWXG\SURWRFROVKRXOGFOHDUO\GHÀQHWKHFRQGLWLRQV XQGHUZKLFKLWLVQHFHVVDU\WRLPPHGLDWHO\DQGKXPDQHO\NLOODQDQLPDO7KHJRDO RIWKHH[SHULPHQWHUVKRXOGEHWRXVHKXPDQHHQGSRLQWVWRPLQLPL]HSDLQGLVWUHVV RUVXIIHULQJWRWKHH[WHQWSRVVLEOHZLWKRXWFRPSURPLVLQJWKHVFLHQWLÀFREMHFWLYHV RIWKHH[SHULPHQW
INITIAL CONSIDERATIONS IN THE DESIGN OF ANIMAL EXPERIMENTS ,Q RUGHU WR PHHW WKH LQWHQGHG REMHFWLYHV RI WKH H[SHULPHQW ZKLOH PLQLPL]LQJ SDLQGLVWUHVVDQGVXIIHULQJLWLVHVVHQWLDOWRFROOHFWDVPXFKLQIRUPDWLRQDVSRVVLEOH DERXWWKHVXEVWDQFHWREHWHVWHGSULRUWRGHVLJQLQJWKHH[SHULPHQW6XFKLQIRUPDWLRQ FDQLQFOXGHWKHIROORZLQJ
/LWHUDWXUHVHDUFKHVIRUVWXGLHVXVLQJWKHWHVWVXEVWDQFHRUUHODWHGVXEVWDQFHV 3K\VLFRFKHPLFDOSDUDPHWHUV 0ROHFXODUPRGHOLQJ 5HVXOWVIURPLQYLWURRUSULRULQYLYRWHVWV 6WDWLVWLFDOGHWHUPLQDWLRQVWRLGHQWLI\WKHIHZHVWQXPEHURIDQLPDOVDQGGRVHVWKDW FDQEHXVHGZLWKRXWFRPSURPLVLQJWKHREMHFWLYHVRIWKHVWXG\
7KLVSUHOLPLQDU\LQIRUPDWLRQFDQVHUYHPDQ\SXUSRVHV,WFDQKHOSWRGHÀQHWKH REMHFWLYHVRIWKHWHVWGHWHUPLQHZKHWKHUWKHUHVXOWVZRXOGGXSOLFDWHSUHYLRXVZRUN VHOHFW WKH PRVW DSSURSULDWH VSHFLHV GHWHUPLQH KRZ EHVW WR GHVLJQ WKH SURWRFRO WR VDWLVI\WKHREMHFWLYHVLGHQWLI\SRWHQWLDOFOLQLFDOVLJQVDQGHVWLPDWHWKHWLPLQJDQG GXUDWLRQRIWKHLURFFXUUHQFHVDQGGHWHUPLQHDQ\VSHFLDOWUDLQLQJQHHGHGE\SHUVRQQHO LQYROYHGLQWKHFRQGXFWRIWKHVWXG\
56
ALTERNATIVE TOXICOLOGICAL METHODS
3UHOLPLQDU\ UDQJHÀQGLQJ VWXGLHV DUH RIWHQ XVHG WR GHWHUPLQH WKH DSSURSULDWH GRVHUDQJHRUOLPLWGRVHWRXVHLQDQH[SHULPHQW7KHGRVHUDQJHVWXG\VKRXOGDOVR EH XVHG WR REWDLQ GDWD WKDW FDQ SURYLGH LQIRUPDWLRQ XVHIXO WR WKH LGHQWLÀFDWLRQ RI HDUO\ HQGSRLQWV DV LQGLFDWRUV RI VHYHUH SDLQ RU GLVWUHVV WKDW FRXOG WKHQ EH XVHG LQ WKHGHFLVLRQWRHLWKHUFRPSOHWHWKHVWXG\WRWHUPLQDWHWKHVWXG\EHIRUHWKHDQLPDOV H[SHULHQFHVHYHUHSDLQRUVXIIHULQJRUWRGHWHUPLQHZKHWKHUDQDOJHVLDRUDQHVWKHVLD ZLOOEHQHHGHGDQGFDQEHXVHG:KHQWKHVWXG\LVSHUIRUPHGLWVKRXOGXVHRQO\ WKHPLQLPXPQXPEHURIDQLPDOVFRQVLVWHQWZLWKWKHREMHFWLYHVRIWKHVWXG\ RECOGNITION AND ASSESSMENT OF PAIN, DISTRESS, AND SUFFERING AS AN APPROACH TO DETECTING CLINICAL SIGNS AND ABNORMAL CONDITIONS 7KHSULQFLSDOLQYHVWLJDWRUDQGWKHUHVSRQVLEOHFRPPLWWHHVHJDQLPDOFDUHDQG XVHHWKLFV KDYHWKHREOLJDWLRQIRUDVVXULQJWKDWDOOLQGLYLGXDOVLQYROYHGLQDVWXG\ KDYHWKHQHFHVVDU\H[SHUWLVHDQGWUDLQLQJWREHDEOHWRDVVHVVWKHDQLPDO·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À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ÁH[ DSSHDUDQFHSRVWXUHJURRPLQJSDWWHUQVDQGDFWLYLW\OHYHOV
SUMMARY OF THE OECD’S NEW GUIDANCE DOCUMENT
57
Table 6.1 Common Conditions and Clinical Signs Abdominal rigidity Abortion Agalactia Anemia Analgesia Anuria Apathy Ataxia/incoordination Bleeding Blepharospasm Blood in feces or urine Blood around nose, eyes Boarded abdomen Body temperature, abnormal Body weight loss or emaciation Breathing difficulties (Dyspnea) Cachexia Chewing, persistent Chromodachryorrhea Circling Comatose Compulsive behavior Constipation Convulsions Corneal ulceration Coughing/sneezing Cyanosis Dehydration Diarrhea
Discharge, abnormal Dyspnea (difficult breathing) Epistaxis (nasal bleeding) Excitable Eyelid closure Eyes fixed/sunken Fractured bone Gasping Grooming—failure to do Hunched/stiff posture Hyperreflexia Immobile/inactive Jaundice (icterus) Joints swollen Kyphosis Lateral position Limping/lameness Locomotory behavior Lordosis Loss of condition, body muscle Mammary gland abnormalities Moribund Motor excitation Not eating/drinking Oedema Pale mucous membranes Paralysis Paresis Piloerection
Pinna reflex Prostrate Pruritis Pupillary constriction/dilation Rales, pulmonary Rectal prolapse Recumbency, prolonged Red eye(s)/nose Reflexes Retention of feces Righting reflex Salivation, excessive or abnormal Seizures Self-mutilation Skin bruising/color/crepitus Spasm Staggering Sunken flanks Suppuration Swellings Tenesmus Tetany Tremor Urine retention Vaginal prolapse Vocalization Vomiting
&KDQJHV LQ ERG\ ZHLJKW VSHFLÀFDOO\ ZHLJKW ORVV DQG UHODWHG FKDQJHV LQ IRRG DQGZDWHUFRQVXPSWLRQ &KDQJHVLQFOLQLFDOSDUDPHWHUVHJERG\WHPSHUDWXUHKHDUWDQGUHVSLUDWLRQUDWH FOLQLFDOFKHPLVWU\DQGKHPDWRORJ\
7KHVHSDUDPHWHUVFDQVHUYHDVLQGLFDWRUVRIDGHWHULRUDWLQJFOLQLFDOFRQGLWLRQRIDQDQLPDO
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
58
ALTERNATIVE TOXICOLOGICAL METHODS
6LJQLÀFDQWEORRGORVV (YLGHQFHWRVXJJHVWLUUHYHUVLEOHRUJDQIDLOXUH 3URORQJHGDEVHQFHRIYROXQWDU\UHVSRQVHVWRH[WHUQDOVWLPXOL 3HUVLVWHQWGLIÀFXOWODERUHGEUHDWKLQJ 3URORQJHGLQDELOLW\WRUHPDLQXSULJKW 3HUVLVWHQWFRQYXOVLRQV 6HOIPXWLODWLRQ 3URORQJHGGLDUUKHD 6LJQLÀFDQWDQGVXVWDLQHGGHFUHDVHLQERG\WHPSHUDWXUH 6XEVWDQWLDOWXPRUV
$QLPDOFDUHVWDIIPXVWEHDGHTXDWHO\WUDLQHGIRUHDFKW\SHRIWR[LFLW\VWXG\VR WKDWWKH\FDQGLIIHUHQWLDWHEHWZHHQFOLQLFDOVLJQVLQGLFDWLYHRIDPRULEXQGFRQGLWLRQ DQGVLPLODUFOLQLFDOVLJQVWKDWPD\EHWUDQVLHQWHIIHFWVIURPDFXWHGRVLQJSURFHGXUHV
SEVERE PAIN AND DISTRESS AS CRITERIA FOR HUMANE KILLING 7KHIROORZLQJFOLQLFDOVLJQVPD\LQGLFDWHWKDWDQDQLPDOLVH[SHULHQFLQJVLJQLI LFDQW SDLQ DQG GLVWUHVV 3DLQ DQG GLVWUHVV VKRXOG EH DOOHYLDWHG ZLWK DSSURSULDWH WUHDWPHQW LI LW GRHV QRW LQWHUIHUH ZLWK WKH FRQGXFW RU WKH REMHFWLYHV RI WKH VWXG\ &RQVLGHUDWLRQVKRXOGEHJLYHQWRKXPDQHNLOOLQJRIWKHDQLPDOLIDQ\RIWKHIROORZLQJ DUHSUHVHQW
$EQRUPDOYRFDOL]DWLRQ $EQRUPDODJJUHVVLYHQHVV $EQRUPDOSRVWXUH $EQRUPDOUHDFWLRQWRKDQGOLQJ $EQRUPDOPRYHPHQWVRUUHOXFWDQFHWRPRYH 6HOILQGXFHGWUDXPD 'LIÀFXOWLHVLQUHVSLUDWLRQ %RQHIUDFWXUHVRSHQZRXQGVVLJQLÀFDQWEOHHGLQJFRUQHDORUVNLQXOFHUDWLRQ $EQRUPDOH[WHUQDODSSHDUDQFH 5DSLGZHLJKWORVVHPDFLDWLRQRUVHYHUHGHK\GUDWLRQ $Q\RWKHUIDFWRUV WKDWVXJJHVWVWKDWWKHDQLPDOPD\EHLQSDLQRUGLVWUHVV
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
SUMMARY OF THE OECD’S NEW GUIDANCE DOCUMENT
59
WR EH PDGH DQG 623V IRU LGHQWLI\LQJ GRFXPHQWLQJ DQG UHSRUWLQJ RI FOLQLFDO VLJQV7KHDQLPDOFDUHWHFKQLFLDQZLOOJHQHUDOO\EHWKHÀUVWWRREVHUYHWKHFOLQLFDO VLJQV DQG VKRXOG EULQJ WKLV LQIRUPDWLRQ WR WKH DWWHQWLRQ RI WKH DWWHQGLQJ YHWHUL QDULDQDQGWKHGHVLJQDWHGUHVSRQVLEOHSHUVRQXVXDOO\WKHVWXG\GLUHFWRU([SHU LPHQWVVKRXOGQRWEHDOORZHGWRSURFHHGORQJHUWKDQLVQHFHVVDU\WRDFKLHYHWKH SXUSRVHRIWKHVWXG\
GUIDANCE ON THE HUMANE CONDUCT OF SPECIFIC TYPES OF TOXICITY TESTING 7KLV VHFWLRQ RI WKH JXLGDQFH GRFXPHQW EULHÁ\ GHVFULEHV WKH SURWRFROV IRU D QXPEHURIVKRUWDQGORQJWHUPWR[LFRORJ\VWXGLHVDQGLGHQWLÀHVSRWHQWLDODUHDVRI SDLQDQGGLVWUHVVDQGDSSURDFKHVWRUHOLHYLQJWKLVGLVWUHVVZLWKRXWFRPSURPLVLQJWKH SXUSRVH RI WKH WHVWLQJ7KH DVVD\V DGGUHVVHG DUH DFXWH VLQJOH GRVH VWXGLHV RFXODU LUULWDWLRQVWXGLHVV\VWHPLFUHSHDWHGGRVHVWXGLHVUHSURGXFWLYHWR[LFLW\VWXGLHVVHQ VLWL]DWLRQVWXGLHVDQGFKURQLFWR[LFLW\DQGFDUFLQRJHQLFLW\VWXGLHV
REFERENCE 2(&' *XLGDQFH 'RFXPHQW *XLGDQFH 'RFXPHQW RQ WKH 5HFRJQLWLRQ$VVHVVPHQW DQG 8VHRI&OLQLFDO6LJQVDV+XPDQH(QGSRLQWVIRU([SHULPHQWDO$QLPDOV8VHGLQ6DIHW\ (YDOXDWLRQ3DULV1RYHPEHUXUOKWWSZZZRHFGRUJHKVWHVWPRQRVKWP
CHAPTER
7
Pain and Distress Management in Animal Research and Testing: The Humane Society of the United States Pain and Distress Initiative* 0DUWLQ/6WHSKHQV)UDQFLQH'ROLQV/RUL'RQOH\$GULHQQH01DYDUUR .DWKOHHQ0&RQOHHDQG$QGUHZ15RZDQ
CONTENTS ,QWURGXFWLRQ 3XEOLF&RQFHUQDERXW3DLQDQG'LVWUHVVLQ5HVHDUFK 7KH&KDOOHQJH ([SHULPHQWDO3URFHGXUHV7KDW&DXVH3DLQDQG'LVWUHVVLQ5HVHDUFK 7KH+6863DLQDQG'LVWUHVV,QLWLDWLYH 2XWUHDFKWR,$&8&V 5HJXODWRU\$VSHFWV )LQDQFLDO6XSSRUWIRU5HVHDUFKRQ3DLQDQG'LVWUHVV 'HYHORSPHQWRID7HFKQLFDO5HSRUWRQ$QLPDO3DLQDQG'LVWUHVV %HVW3UDFWLFHVDQG3ROLFLHV &RQFOXVLRQV $FNQRZOHGJPHQWV 5HIHUHQFHV
7KLVFKDSWHULVDGDSWHGIURP$QLPDO:HOIDUH3HUVSHFWLYHVRQ3DLQDQG'LVWUHVV0DQDJHPHQWLQ5HVHDUFK DQG7HVWLQJ06051HZV6SULQJ0DVVDFKXVHWWV6RFLHW\IRU0HGLFDO5HVHDUFK1RUWK&KHOPVIRUG 0$
61
62
ALTERNATIVE TOXICOLOGICAL METHODS
INTRODUCTION 7KHSXEOLF·VSHUFHSWLRQWKDWDQLPDOVVXIIHULQELRPHGLFDOUHVHDUFKDQGWHVWLQJ LVDNH\IDFWRUIXHOLQJWKHFRQWURYHUV\RYHUDQLPDOH[SHULPHQWDWLRQ7KLVSXEOLF FRQFHUQKDVEURXJKWDERXWODZVDQGUHJXODWLRQVWKDWVSHFLÀFDOO\DGGUHVVODERUD WRU\DQLPDOSDLQDQGGLVWUHVVDQGFDOOIRUHIIRUWVWROLPLWRUDWOHDVWUHSRUWZKHQ DQLPDO SDLQ DQG GLVWUHVV RFFXU +RZHYHU WKH LGHQWLÀFDWLRQ DQG PDQDJHPHQW RI SDLQ DQG GLVWUHVV LQ UHVHDUFK DQLPDOV DUH FRPSOH[ LVVXHV WKDW KDYH UHFHLYHG LQVXIÀFLHQWDWWHQWLRQWRGDWH7RDGGUHVVWKHJDSVLQRXUNQRZOHGJHRISDLQDQG GLVWUHVVDQGWRSURPRWHODERUDWRU\DQLPDOZHOIDUH7KH+XPDQH 6RFLHW\RIWKH 8QLWHG6WDWHV+686 KDVODXQFKHGDQLQLWLDWLYHWRHOLPLQDWHVLJQLÀFDQWSDLQDQG GLVWUHVV LQ ODERUDWRU\ DQLPDOV E\ WKH \HDU E\ ZRUNLQJ ZLWK ,QVWLWXWLRQDO $QLPDO &DUH DQG 8VH &RPPLWWHHV ,$&8&V DQG VFLHQWLVWV :KLOH WKLV LV DQ DPELWLRXV JRDO LW LV DUJXDEO\ ZLWKLQ WKH LQJHQXLW\ DQG VNLOOV RI WKRVH ZKR XVH DQGFDUHIRUODERUDWRU\DQLPDOVDQGWKHVFRSHDQGUHVSRQVLELOLW\RIWKHVFLHQWLÀF FRPPXQLW\0RUHLPSRUWDQWO\ZKLOHQRWZLGHO\UHFRJQL]HGRXWVLGHWKHUHVHDUFK FRPPXQLW\PRVWVFLHQWLVWVDQGODERUDWRU\SHUVRQQHOVXSSRUWHIIRUWVWRPLQLPL]H SDLQDQGGLVWUHVVLQODERUDWRU\DQLPDOV
PUBLIC CONCERN ABOUT PAIN AND DISTRESS IN RESEARCH 3ROOV DQG VXUYH\V KDYH EHJXQ WR GRFXPHQW WKH LQÁXHQFH RI DQLPDO VXIIHULQJ RQ SHRSOH·VYLHZVWRZDUGDQLPDOUHVHDUFK7KHUHVXOWVRIDSROOFRPPLVVLRQHGE\ 7KH+686LQGLFDWHWKDWSXEOLFDSSURYDORIDQLPDOUHVHDUFKYDULHVGUDPDWLFDOO\DFFRUG LQJWRWKHDPRXQWRISDLQDQGGLVWUHVVWKDWWKHDQLPDOVH[SHULHQFH6L[W\WZRSHUFHQW RI $PHULFDQV DSSURYH RI DQLPDO UHVHDUFK ZKHQ OLWWOH RU QR SDLQ DQG GLVWUHVV DUH H[SHULHQFHGEXWWKLVDSSURYDOGURSVWRZKHQWKHSDLQDQGGLVWUHVVDUHVHYHUH$ SROOFRPPLVVLRQHGE\WKH1HZ6FLHQWLVW$OGRXVHWDO IRXQGWKDWWKH%ULWLVK SXEOLF·VVXSSRUWIRUUHVHDUFKRQPLFHRUPRQNH\VGHFOLQHVWRGHSHQGLQJ RQWKHVSHFLHVDQGÀHOGRIUHVHDUFK ZKHQWKHDQLPDOVDUHVXEMHFWHGWRSDLQLOOQHVV RU VXUJHU\ ,Q DQRWKHU VXUYH\ 3ORXV DE FDQYDVVHG SURIHVVLRQDO SV\FKRORJLVWV DQG SV\FKRORJ\ VWXGHQWV LQ WKH 86 DQG IRXQG WKDW VXSSRUW IRU UHVHDUFK LQYROYLQJ ´SDLQ RU GHDWKµ LV DSSUR[LPDWHO\ ORZHU WKDQ IRU VWXGLHV VLPSO\ LQYROYLQJ FRQ ÀQHPHQW WKH LQÁXHQFH RI SDLQ DQG GHDWK ZHUH QRW DQDO\]HG VHSDUDWHO\ )LQDOO\ D VXUYH\FDUULHGRXWLQWKH86LQWKHPLGV)RXQGDWLRQIRU%LRPHGLFDO5HVHDUFK DVNHGLISDUWLFLSDQWVDJUHHGRUGLVDJUHHGZLWKWKHVWDWHPHQWWKDW´PRVWDQLPDOV XVHG LQ UHVHDUFK VXIIHU PRUH SDLQ DQG GLVWUHVV WKDQ WKH\ VKRXOGµ 7KH UHVSRQGHQWV VXSSRUWHG WKLV VWDWHPHQW E\ D ÀYH WR RQH PDUJLQ 1RW VXUSULVLQJO\ ZKHQ WKH VDPH VXUYH\ DVNHG SDUWLFLSDQWV ZKHWKHU WKH JRYHUQPHQW VKRXOG LPSRVH UHJXODWLRQV ´WR UHGXFHRUHOLPLQDWHSDLQDQGVXIIHULQJµRIWKHSXEOLFDQGRIVWXGHQWVVDLG\HV ,QWKH86WKH,$&8&V\VWHPLVVSHFLÀFDOO\FKDUJHGZLWKUHGXFLQJWKHOLNHO\ SDLQDQGGLVWUHVVWKDWDQLPDOVPD\H[SHULHQFHZKHQXVHGLQUHVHDUFK7KXV,$&8&V DUHUHTXLUHGE\$QLPDO:HOIDUH$FW$:$ UHJXODWLRQVWRHQVXUHWKDWLQYHVWLJDWRUV KDYHVHDUFKHGIRUDOWHUQDWLYHVWRDQ\UHVHDUFKOLNHO\WRFDXVHDQLPDOSDLQDQGGLVWUHVV HYHQLIDQHVWKHWLFVDQGDQDOJHVLFVDUHXVHGWRSUHYHQWVXFKRXWFRPHV%\FRQWUDVW
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
63
LQYHVWLJDWRUV GR QRW KDYH WR GHPRQVWUDWH WKDW WKH\ KDYH FRQVLGHUHG DOWHUQDWLYHV LI WKHUHVHDUFKSURMHFWLVSODFHGLQWKHQRQSDLQIXOQRQGLVWUHVVIXOFDWHJRU\7KHLPSOLFLW PHVVDJHLVWKDWLQÁLFWLQJDQLPDOSDLQDQGGLVWUHVVLVRIJUHDWHUSXEOLFFRQFHUQWKDQ NLOOLQJWKHDQLPDOVHXWKDQDVLD 'HVSLWHWKLVUHJXODWRU\HPSKDVLVRQDOOHYLDWLQJSDLQ DQGGLVWUHVVWKH86'HSDUWPHQWRI$JULFXOWXUH86'$ ZKLFKHQIRUFHVWKH$:$ SURYLGHVOLWWOHH[SOLFLWJXLGDQFHRQWKHWRSLFRURQWKHSRWHQWLDOLPSDFWRIVSHFLÀF H[SHULPHQWDOSURFHGXUHVVXFKDVLQIHFWLQJDQLPDOVZLWKSDWKRJHQLFRUJDQLVPVRQ SDLQ GLVWUHVV RU DQLPDO ZHOOEHLQJ JHQHUDOO\ VHH 86'$ 3ROLF\ DYDLODEOH DW KWWSZZZDSKLVXVGDJRYDFSROLF\SROLF\SGI
THE CHALLENGE 7KHV\VWHPDWLFUHGXFWLRQRIDQLPDOSDLQDQGGLVWUHVVLQUHVHDUFKLVDIRUPLGDEOH WDVNIRUVHYHUDOUHDVRQV)LUVWWKHUHLVPXFKFRQFHSWXDOFRQIXVLRQRYHUVXFKWHUPVDV SDLQ GLVWUHVV DQG VXIIHULQJ 6HFRQG DQLPDO XVH LQ WKH ODERUDWRU\ LV TXLWH YDULHG UHÀQHPHQWVGHYHORSHGIRUDQ\RQHVSHFLÀFSURFHGXUHZLOOQRWQHFHVVDULO\WUDQVODWHWR RWKHUSURFHGXUHV7KLUGDQLPDOSDLQGLVWUHVVDQGVXIIHULQJDUHQRWHDV\WRUHFRJQL]H RUPHDVXUHXQDPELJXRXVO\HYHQLQWKHFRPPRQO\XVHGODERUDWRU\VSHFLHVDQGWKHUH LVFRQVLGHUDEOHRSSRUWXQLW\IRUOHJLWLPDWHGLVDJUHHPHQWRYHUDVVHVVPHQWDQGWUHDWPHQW +HOO\HUHWDO )RXUWKWKHUHLVOLPLWHGSXEOLVKHGLQIRUPDWLRQDERXWDQLPDOV· H[SHULHQFHRISDLQGLVWUHVVDQGVXIIHULQJFDXVHGE\W\SLFDOODERUDWRU\SURFHGXUHV 7KHXVHRIDQDOJHVLFVLQODERUDWRU\URGHQWVKDVEHFRPHJHQHUDOO\DFFHSWHGSUDF WLFHRQO\LQWKHSDVWGHFDGH%HIRUHWKDWDQLPDOVW\SLFDOO\ZHUHQRWJLYHQWKHEHQHÀW RI WKH GRXEW ZKHQ WUHDWLQJ SDLQ RU GLVWUHVV (YHQ LQIDQW KXPDQV GLG QRW URXWLQHO\ UHFHLYHDQHVWKHVLDIRUPDMRUVXUJHU\\HDUVDJR%RXZPHHVWHUHWDO :KLOHWKHVXEMHFWRIODERUDWRU\DQLPDOSDLQLVQRZUHFHLYLQJLQFUHDVHGDWWHQWLRQ DQLPDOGLVWUHVVWKDWLVQRWWKHUHVXOWRISDLQHJIHDUDQ[LHW\RUGHSUHVVLRQ LVVWLOO ODUJHO\RYHUORRNHGLQRXUH[SHULHQFH7KH$:$UHJXODWLRQVDQGSROLFLHVGRQRWHYHQ GHÀQH ´GLVWUHVVµ +RZHYHU LQ -XO\ WKH 86'$ SXEOLVKHG D )HGHUDO 5HJLVWHU QRWLFH VWDWLQJ WKDW WKH DJHQF\ LV FRQVLGHULQJ GHÀQLQJ ´GLVWUHVVµ DQG UHSODFLQJ RU PRGLI\LQJWKHFXUUHQWSDLQDQGGLVWUHVVFODVVLÀFDWLRQV\VWHP7KH86'$VROLFLWHG FRPPHQWVRQWKHVHLVVXHVZKLFKDUHFXUUHQWO\XQGHUUHYLHZZLWKLQWKHDJHQF\,Q LWVVXEPLWWHGFRPPHQWV7KH+XPDQH6RFLHW\RIWKH8QLWHG6WDWHV+686 DUJXHG WKDW´GLVWUHVVµLVSHUKDSVEHVWGHÀQHGDVDQDYHUVLYHVWDWHUHVXOWLQJIURPDQLQDELOLW\ WRDGDSWWRVWUHVVRUVRUIURPPDODGDSWLRQ2(&' 6WUHVVRUVFDQEHSK\VLR ORJLFDOHJGLVHDVH HQYLURQPHQWDOHJUHVWUDLQW RUSV\FKRORJLFDOHJDQ[LHW\ ,/$5 7KH+686IXUWKHUHPSKDVL]HGWKDWDGHÀQLWLRQVKRXOGLQFOXGHVHYHUDO RSHUDWLRQDOHQGSRLQWVDQGH[DPSOHVRISURFHGXUHVWKDWPLJKWFDXVHGLVWUHVV 6HQVLWLYHSUDFWLFDOPHDVXUHVWRJDXJHOHYHOVRIGLVWUHVVLQFRPPRQODERUDWRU\ DQLPDO VSHFLHV GR QRW SUHVHQWO\ H[LVW )RU WKH PRVW SDUW DQLPDOFDUH VWDII UHO\ RQ DGKRFREVHUYDWLRQVRURQUHODWLYHO\LQVHQVLWLYHPHDVXUHVVXFKDVDZHLJKWORVVWR DVFHUWDLQZKHWKHUDQLPDOVDUHH[SHULHQFLQJSDLQRUGLVWUHVV,ISULQFLSDOLQYHVWLJDWRUV ODE SHUVRQQHO DQG ,$&8&V GR QRW FXUUHQWO\ KDYH WKH WRROV WR GRFXPHQW GLVWUHVV REMHFWLYHO\RUGRQRWUHFRJQL]HGLVWUHVVFDXVHGE\GLVHDVHWR[LFDJHQWVRUSV\FKR ORJLFDOIDFWRUVWKHQLWLVXQOLNHO\WKDWWKH\ZLOOWDNHPHDQLQJIXODFWLRQWRDOOHYLDWH
64
ALTERNATIVE TOXICOLOGICAL METHODS
VXFK GLVWUHVV ZKHQ LW RFFXUV ,W LV WKHUHIRUH HVVHQWLDO WR SURPRWH D GLVFXVVLRQ RQ ZKHQGLVWUHVVRFFXUVDQGWRDFKLHYHVRPHFRQVHQVXVRQWKRVHSURFHGXUHVWKDWFDXVH HLWKHUSDLQRUGLVWUHVV
EXPERIMENTAL PROCEDURES THAT CAUSE PAIN AND DISTRESS IN RESEARCH 7KHDQLPDOSDLQDQGGLVWUHVVFDXVHGE\VSHFLÀFUHVHDUFKPRGHOVDQGWHFKQLTXHV UDLVH VHULRXV FRQFHUQV IURP ERWK D VFLHQWLÀ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ÀFWHFKQLTXHVLQGXFHGLVWUHVVLQODERUD WRU\ DQLPDOV 6RPH GR VR GLUHFWO\ RWKHUV LQGLUHFWO\ E\ ÀUVW LQGXFLQJ SDLQ IHDU DQ[LHW\RUVRPHRWKHUDGYHUVHVWDWH
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ÀFDQWSDLQ DQGGLVWUHVVLQDQLPDOUHVHDUFK2XULQLWLDWLYHKDVWKHIROORZLQJIRXUHOHPHQWV Outreach to IACUCs ,Q WKH SDVW WKH DQLPDO SURWHFWLRQ FRPPXQLW\·V FDPSDLJQV DLPHG DW DQLPDO UHVHDUFKKDYHW\SLFDOO\VHOHFWHGLQGLYLGXDOVFLHQWLVWVRUUHVHDUFKSURMHFWVDVWDUJHWV RISURWHVWV,QWKH3DLQDQG'LVWUHVV,QLWLDWLYHE\FRQWUDVWWKH+686KDVLQYLWHGWKH FROODERUDWLRQ RI WKH VFLHQWLÀF FRPPXQLW\³WKRVH ZKR ZLOO XOWLPDWHO\ GHYHORS WKH WHFKQLTXHVDQGLPSOHPHQWWKHDSSURDFKHVWKDWZLOOPDNHRXUJRDODWWDLQDEOH6SH FLÀFDOO\7KH+686KDVLQYLWHG,$&8&VWRMRLQLQWKHLQLWLDWLYH7KH\DOUHDG\KDYH DVWDWXWRU\PDQGDWHWRPLQLPL]HSDLQDQGGLVWUHVV 7KH +686 EHJDQ IDFLOLWDWLQJ DQ H[FKDQJH RI LQIRUPDWLRQ DQG SROLFLHV DPRQJ ,$&8&V VR WKDW QHZ LGHDV DQG LQLWLDWLYHV LQFOXGLQJ ´EHVW SUDFWLFHVµ FRXOG EH GLVVHPLQDWHGTXLFNO\,QLWLDOO\7KH+686VHQWDVHULHVRIÀYHOHWWHUVDQGDWWDFKPHQWV WRWKHFKDLUVRIDOO,$&8&VQDWLRQZLGH7KHVHPDLOLQJVZHUHSULPDULO\LQIRUPDWLRQDO
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
65
Table 7.1 Models and Areas of Research and Specific Techniques That Cause Distress Research Models or Areas Non-Pain-Induced Distress Aggression Anxiety Cancer Depression Diabetes Drug addiction and withdrawal Environmental stress Fear Immunological research Infectious disease Motion sickness Nutrition research Panic Pharmacology (some) Psychopathology Radiation research Stress (psychological) Toxicology (induced effects) Transgenic research
(e.g., Vogel conflict-drinking model) (tumor burden, cachexia, carcinogenicity testing) (e.g., learned helplessness, forced swimming, maternal deprivation)
(e.g., hot, cold) (e.g., vaccine potency testing)
(e.g., nutrient deprivation) (e.g., tumor necrosis factor, capsaicin research) (other than anxiety, depression, fear, etc., mentioned above)
Pain-Induced Distress Arthritis Burn research Cancer research Chronic pain studies1 Dental studies Inflammation studies Experimental surgery Muricide Orthopedic studies Trauma research
(tumor pain)
(e.g., organ transplantation/rejection) (as a model of aggression, neophobia, etc.)
Specific Techniques Non-Pain-Induced and Pain-Induced Distress Anesthesia aftereffects Antibody production Aversive stimuli Bleeding techniques Complete Freund’s Adjuvant Control group Deprivation Dosing techniques Granuloma techniques Gut loop studies
(polyclonal and monoclonal) (e.g., electric shock) (including retro-orbital bleeding) (animals denied experimental treatments) (e.g., water, food, sleep, or social partners/experiences) (e.g., gavage)
(continued)
66
ALTERNATIVE TOXICOLOGICAL METHODS
Table 7.1 (continued) Models and Areas of Research and Specific Techniques That Cause Distress Knockout technology Restraint Surgery sequelae 1
Acute pain should not be a problem if the guidelines of the International Association for the Study of Pain (IASP, 1979) are followed.
LQ QDWXUH DOHUWLQJ ,$&8& FKDLUV WR XSFRPLQJ PHHWLQJV DQG QHZ SXEOLFDWLRQV DV ZHOODVLQIRUPLQJWKHPDERXWWKH3DLQDQG'LVWUHVV,QLWLDWLYH)HHGEDFNIURP,$&8& FKDLUV RQ WKH ÀUVW WZR PDLOLQJV ZDV PLQLPDO VR ZH LQFOXGHG D VWDPSHG VHOI DGGUHVVHG UHVSRQVH FDUG LQ WKH WKLUG7KRXJK ZH KHDUG IURP OHVV WKDQ RXW RI WKHDSSUR[LPDWHO\,$&8&VRYHURIWKHUHVSRQGHQWVLQGLFDWHGWKDWWKH\ IRXQG WKH PDLOLQJV KHOSIXO DQG ZDQWHG WR FRQWLQXH UHFHLYLQJ WKHP DQG RYHU WRRNWKHDGGLWLRQDOVWHSRIMRLQLQJLQWKHLQLWLDWLYH 7KH+686HYHQWXDOO\GLVFRQWLQXHGVHQGLQJOHWWHUVWR,$&8&FKDLUVDQGLQVWHDG FUHDWHGDQHZVOHWWHUVSHFLÀFDOO\DLPHGDW,$&8&VDQGRWKHUVLQWKHÀ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ÀOHRISDLQDQGGLVWUHVVLVVXHVZLWK,$&8&V 7KH+686KDVEHJXQWRIRFXVRQVSHFLÀFUHVHDUFKDUHDVSUDFWLFHVDQGWHFKQLTXHV VXFKDVLQIHFWLRXVGLVHDVHUHVHDUFK ZKHUHUHODWLYHO\OLWWOHDWWHQWLRQKDVEHHQJLYHQ WRDQLPDOVXIIHULQJ2XUDLPLVWRVHHNRXWQHZDSSURDFKHVWRUHFRJQL]LQJPHDVXU LQJ DQG DOOHYLDWLQJ DQLPDO GLVWUHVV ,Q RXU ÀUVW VXFK HIIRUW LQ ZH KHOG D ZRUNVKRSIRFXVHGRQWR[LFRORJ\UHVHDUFK$JURXSRILQWHUQDWLRQDOH[SHUWVDGGUHVVHG WRSLFVVXFKDVKXPDQHHQGSRLQWVWROHWKDOLW\QRQLQYDVLYHUHVHDUFKWHFKQLTXHVDQG GRVH²YROXPH JXLGHOLQHV ,QIRUPDWLRQ DERXW WKLV ZRUNVKRS LV DYDLODEOH DW KWWSZZZKVXVRUJDFH:HZHUHSDUWLFXODUO\LQWHUHVWHGLQWKHQHZWHFKQRO RJ\GHVFULEHGE\WKH;HQRJHQ&RUSRUDWLRQDVDSRVVLEOHUHÀQHPHQWDQGUHGXFWLRQ LQ LQIHFWLRXV GLVHDVH VWXGLHV$QRWKHU ZRUNVKRS ZDV KHOG LQ$XJXVW ZKLFK DGGUHVVHGLVVXHVLQLPPXQRORJ\UHVHDUFKLQFOXGLQJSRO\FORQDODQWLERG\SURGXFWLRQ DGMXYDQWXVHZHOIDUHFRQFHUQVDQGSRVVLEOHDOWHUQDWLYHV Regulatory Aspects 7KH86'$HQIRUFHVWKH$QLPDO:HOIDUH$FWZKLFKUHJXODWHVDQLPDOSDLQDQG GLVWUHVV ZKLOH WKH 1DWLRQDO ,QVWLWXWHV RI +HDOWK·V 2IÀFH RI /DERUDWRU\ $QLPDO :HOIDUH 2/$: HQIRUFHV 3XEOLF +HDOWK 6HUYLFH 3+6 JXLGHOLQHV RQ DQLPDO UHVHDUFK ZKLFK LQFOXGH SURYLVLRQV DJDLQVW FDXVLQJ XQQHFHVVDU\ DQLPDO SDLQ DQG GLVWUHVV $V SDUW RI LWV UHVSRQVLELOLWLHV XQGHU WKH $:$ WKH 86'$ LVVXHV DQQXDO DQLPDOZHOIDUHHQIRUFHPHQWUHSRUWVWKDWVXPPDUL]HGDWDRQWKHQXPEHURIDQLPDOV
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
67
RIUHJXODWHGVSHFLHVXVHGLQUHVHDUFKWHVWLQJDQGHGXFDWLRQJURXSHGXQGHUFROXPQ KHDGLQJVWKDWFRUUHVSRQGWRWKH86'$·VSDLQDQGGLVWUHVVFDWHJRULHV$QLPDOVXVHG LQSDLQIXORUGLVWUHVVIXOH[SHULPHQWVIRUZKLFKSDLQRUGLVWUHVVUHOLHYLQJGUXJVZHUH ZLWKKHOG DUH OLVWHG XQGHU FROXPQ ( )DFLOLWLHV OLVWLQJ DQLPDO XVH LQ FROXPQ ( DUH UHTXLUHGWRGHVFULEHWKHVHH[SHULPHQWVDQGH[SODLQZK\GUXJVIRUSDLQDQGGLVWUHVV UHOLHIZHUHZLWKKHOGVHH6WHSKHQVHWDOIRUDQDQDO\VLVRIWKHVHGHVFULSWLRQV 8QIRUWXQDWHO\WKH86'$·VSDLQDQGGLVWUHVVFODVVLÀFDWLRQV\VWHPLVRXWRIGDWH DQG LQ QHHG RI UHIRUP 2UODQV 6WHSKHQV :KHQ WKH FXUUHQW SDLQ FDWHJRULHVFROXPQ& QRSDLQFROXPQ' SDLQUHOLHYHGE\GUXJVDQGFROXPQ( SDLQ ZLWKRXW UHOLHI ZHUH ÀUVW LQWURGXFHG QHDUO\ \HDUV DJR WKH\ PD\ KDYH VHUYHG D XVHIXO SXUSRVH +RZHYHU WKH FDWHJRULHV DUH DPELJXRXV DQG LQFRPSOHWH DQGWKH\GRQRWDGHTXDWHO\DGGUHVVWKHLVVXHRIOHYHOVRISDLQDQGGLVWUHVVWKHFXUUHQW FDWHJRULHV ERLO GRZQ WR D \HVQR GLFKRWRP\ QRU GR WKH\ VSHFLÀFDOO\ DGGUHVV WKH LVVXHRIGLVWUHVV,QDGGLWLRQWRWKHVHLQKHUHQWSUREOHPVZLWKWKHV\VWHPWKHVLWXDWLRQ LVIXUWKHUFRPSOLFDWHGE\WKHSDXFLW\RI86'$JXLGDQFHWRLQVWLWXWLRQVRQDVVLJQLQJ SURWRFROV WR FDWHJRULHV DV ZHOO DV WKH ODFN RI 86'$ RYHUVLJKW RI LQVWLWXWLRQDO GHFLVLRQV RQ FDWHJRUL]DWLRQ RI DFWXDO H[SHULPHQWV +RZHYHU DV SUHYLRXVO\ PHQ WLRQHG WKH 86'$ LV FXUUHQWO\ FRQVLGHULQJ UHSODFLQJ RU PRGLI\LQJ LWV SDLQ DQG GLVWUHVVFODVVLÀ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ÀFDWLRQV WR LWV FXUUHQW VFKHPH 7KH SURSRVHG QHZ V\VWHP GLYLGHV SDLQDQGGLVWUHVVLQWRQRQHPLQRUPRGHUDWHDQGVHYHUHFDWHJRULHVZKHWKHURUQRW DQDOJHVLFV RU DQHVWKHWLFV DUH XVHG ,W KDV VRPH FRQWLQXLW\ ZLWK WKH H[LVWLQJ RQH ZLWKLWVKHDY\HPSKDVLVRQSDLQUHOLHIEXWLWWRRKDVJHQHUDWHGVRPHFULWLFLVP,Q D UHSRUW RQ ´UHJXODWRU\ EXUGHQµ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
68
ALTERNATIVE TOXICOLOGICAL METHODS
Table 7.2 The USDA’s Current Pain and Distress Categories and a Proposed Modification, as Well as Related Features of the Two Systems A. Current Scheme USDA Category C (63%)1 D (29%) E (8%)
Pain and/or Distress Little or None Yes or No2 Yes
Anesthesia/ Analgesia
Full ACUC Review
Alternative Literature Search
No Yes No
Yes Yes Yes
No Yes Yes
B. Proposed Scheme Category I II III IV 1 2
Pain and/or Distress
Anesthesia/ Analgesia
Full IACUC Review
Alternative Literature Search
Minor or None Minor or None Moderate Severe
No Yes Yes or No Yes or No
No Perhaps Yes Yes
No Perhaps Yes Yes
Numbers in parentheses are USDA figures for 2000. Animals listed in USDA category D were given pain- or distress-relieving drugs, but these drugs may not have been sufficient to relieve all pain and distress throughout the experiment.
QDPHO\WKHOHYHOVRISDLQDQGGLVWUHVVDFWXDOO\H[SHULHQFHGE\WKHDQLPDOV$VVXFK LWFRXOGEHXVHGWRPRQLWRUWUHQGVLQSDLQDQGGLVWUHVVDFURVV LQVWLWXWLRQVDQGRYHU WLPH DQG SURYLGH GDWD IRU FRPSDULVRQV ZLWK FRXQWULHV ZLWK VLPLODU V\VWHPV$OVR ,$&8&VPLJKWXVHWKHQHZV\VWHPWRJDXJHWKHLQWHQVLW\RIWKHLUSURWRFROUHYLHZ ZLWKSURWRFROVLQWKHVHYHUHFDWHJRU\EHLQJDVVLJQHGWKHPRVWLQWHQVHUHYLHZ 8QWLOWKHFXUUHQW86'$SDLQFODVVLÀFDWLRQV\VWHPLVUHYLVHG7KH+686ZLOO VHHNWRGHYHORSPRUHFRQVLVWHQF\LQKRZSDLQDQGGLVWUHVVDUHUHSRUWHG,QLWVDQQXDO UHSRUWVWKH86'$DJJUHJDWHVSDLQDQGGLVWUHVVGDWDDFURVVDOOIDFLOLWLHVZLWKLQHDFK VWDWH 7KHUH LV FRQVLGHUDEOH YDULDWLRQ DFURVV VWDWHV LQ WKH UHSRUWLQJ RI FROXPQ ( XVDJH 7DEOH 0DQ\ VWDWHV UHSHDWHGO\ UHSRUW IHZ RU QR DQLPDOV LQ FROXPQ ( 7DEOH ,WLVSRVVLEOHWKDWWKHQXPEHUVLQ7DEOHDFFXUDWHO\UHÁHFWWKHZD\ WKDW DQLPDOV ZHUH XVHG +RZHYHU RXU DQDO\VHV UHYHDO REYLRXV GLVFUHSDQFLHV EHWZHHQWKHW\SHVRIUHVHDUFKDQGSXEOLFDWLRQVHPHUJLQJIURPLQVWLWXWLRQVLQVRPH VWDWHVRQWKHRQHKDQGDQGWKHLUODFNRIUHSRUWLQJRIDQLPDOXVHLQFROXPQ(RQ WKHRWKHU7KH+686KDVGRQHDVLPLODUDQDO\VLVRIWKHWRSUHVHDUFKLQVWLWXWLRQV EDVHG RQ 1,+ IXQGLQJ LQ WKH 86 DQG KDV IRXQG WKDW WKHVH LQVWLWXWLRQV UHSRUWHG WKDW OHVV WKDQ RI WKHLU DQLPDOV H[SHULHQFHG XQUHOLHYHG SDLQ DQGRU GLVWUHVVIRUWKH\HDUV²WKHPRVWUHFHQW\HDUVIRUZKLFKLQGLYLGXDOIDFLOLW\ UHSRUWVDUHDYDLODEOH *LYHQWKHH[WHQWRIUHVHDUFKFRQGXFWHGDWWKHVHLQVWLWXWLRQV 7KH +686 EHOLHYHV WKDW WKLV SHUFHQWDJH UHSUHVHQWV VLJQLÀFDQW XQGHUUHSRUWLQJ RI SDLQ DQG GLVWUHVV DQG ZH KDYH VLQFH VHQW D OHWWHU WR HDFK RI WKRVH LQVWLWXWLRQV LQGLFDWLQJWKLVFRQFHUQ:HZLOOFRQWLQXHWRSUHVVXUHLQGLYLGXDOLQVWLWXWLRQVLQRUGHU WREULQJWKHVHLVVXHVWRWKHIRUHIURQW ,ILQVWLWXWLRQVGRQRWUHSRUWDQLPDOVH[SHULHQFLQJGLVWUHVVLQFROXPQ(WKHQ7KH +686IHDUVWKDWWKHQHHGVRIWKHVHDQLPDOVDUHEHLQJRYHUORRNHG,IWKH86'$GDWD
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
69
Table 7.3 State to State Variation in Reporting Animal Use in Column E (Unalleviated Pain or Distress) for States Using Greater Than 20,000 Animals
State Nationwide California Delaware Georgia Illinois Indiana Iowa Kansas Maryland Massachusetts Michigan Minnesota
Percentage of Animals in Column E 8 4 15 2 3 18 28 16 12 1 15 3
Percentage of Animals in Column E
State Missouri Nebraska New Jersey New York North Carolina Ohio Pennsylvania Texas Virginia Washington Wisconsin Federal Agencies
22 15 6 11 6 3 8 3 0 20 9 7
Note: USDA data from 2000. Table 7.4 States That Reported Less Than 1% of Animal Use in Column E between 1995 and 1997 Alaska Arizona Hawaii Kentucky Louisiana Maine
(300) (5,000) (500) (5,300) (16,800) (800)
Mississippi Nevada Oklahoma Oregon Rhode Island S. Carolina
(2,000) (3,000) (4,300) (4,700) (2,100) (6,100)
Tennessee Utah Vermont Virginia West Virginia Wyoming
(10,900) (4,600) (1,100) (19,200) (1,700) (300)
Data from the USDA. Figures in parentheses indicate the average number of animals used across all pain categories.
DUH WR EH DW DOO XVHIXO WKHQ EHWWHU UHSRUWLQJ JXLGHOLQHV VKRXOG EH GHYHORSHG 7KH WDVNZLOOQRWEHHDV\EXWWKLVLVQRH[FXVHIRUPDLQWDLQLQJWKHFXUUHQWXQLQIRUPDWLYH DQGLQFRQVLVWHQWV\VWHP ,QDGGLWLRQWRRXURXWUHDFKWRWKH86'$7KH+686ZLOOHQFRXUDJHWKH1,+·V 2/$:WRLVVXH´EHVWSUDFWLFHµJXLGHOLQHVFRYHULQJVSHFLÀFWHFKQLTXHV7KHUHJX ODWRU\EXUGHQUHSRUWPHQWLRQHGDERYHDOVRHQFRXUDJHVWKHDJHQF\WRGRWKHVDPH $Q H[DPSOH RI VXFK DQ LQLWLDWLYH LV WKH 1,+ 2IÀFH RI 3URWHFWLRQ IURP 5HVHDUFK 5LVNVQRZ2/$: OHWWHUVWDWLQJWKDWDVFLWHVSURGXFWLRQFDXVHVDQLPDOGLVWUHVVDQG VKRXOGEHXVHGRQO\LILQYLWURSURGXFWLRQRIPRQRFORQDODQWLERGLHVLVXQVXFFHVVIXO WKH WH[W RI WKH OHWWHU LV DYDLODEOH DW KWWSJUDQWVQLKJRYJUDQWVRODZUHIHU HQFHVGF²KWP Financial Support for Research on Pain and Distress 2QHRIWKHSUREOHPVLQDGYDQFLQJRXUNQRZOHGJHRIKRZWRDVVHVVDQGDOOHYLDWH DQLPDOSDLQDQGGLVWUHVVLVWKDWWKHUHLVYLUWXDOO\QRIXQGLQJWRVXSSRUWUHVHDUFKRQ WKLVWRSLF&OHDUO\WKHUHDUHLPSHGLPHQWVWRHQFRXUDJLQJDJHQFLHVWRSURYLGHIXQGV
70
ALTERNATIVE TOXICOLOGICAL METHODS
IRUSURMHFWVWKDWGHOLEHUDWHO\FDXVHDQLPDOGLVWUHVVEXWLWPD\EHSRVVLEOHWRSLJJ\ EDFNVXFKDVVHVVPHQWVRQWRRQJRLQJDQGDSSURYHG LQYHVWLJDWLRQVRIRWKHUWRSLFV 7KH+686SODQVWRXUJHERWKSULYDWHDQGJRYHUQPHQWHQWLWLHVWRIXQGVWXGLHVDLPHG DWGHYHORSLQJPRUHVHQVLWLYHDQGSUDFWLFDOPHDVXUHVRIDQLPDOGLVWUHVVDQGPHWKRGV E\ ZKLFK VXFK GLVWUHVV FDQ EH DOOHYLDWHG 7KH +686 KDV VXEPLWWHG WHVWLPRQ\ WR &RQJUHVVUHTXHVWLQJWKDWPLOOLRQRIWKH1,+·VUHVHDUFKDQGGHYHORSPHQW EXGJHWEHHDUPDUNHGWRLGHQWLI\DQGHOLPLQDWHSDLQDQGGLVWUHVVLQODERUDWRU\DQLPDOV ZLWKWKHFDYHDWWKDWWKHUHVHDUFKEHSLJJ\EDFNHGDVSUHYLRXVO\PHQWLRQHG Development of a Technical Report on Animal Pain and Distress 7KH+686ZLOOGUDIWDFRPSUHKHQVLYHGHWDLOHGDQGUHIHUHQFHGUHSRUWRQWKH VXEMHFW ZLWK WKH KHOS RI LQWHUQDWLRQDO H[SHUWV LQ YHWHULQDU\ PHGLFLQH DQLPDO EHKDYLRUSK\VLRORJ\QHXURORJ\DQHVWKHVLRORJ\SKLORVRSK\DQGRWKHUÀHOGV7KH WRSLFVFRYHUHGE\WKHUHSRUWZKLFKZLOOEHSXEOLVKHGE\7KH+686ZLOOLQFOXGH WKHIROORZLQJ 'HÀQLWLRQVRIDQLPDOSDLQGLVWUHVVGLVFRPIRUWDQ[LHW\IHDUDQGVXIIHULQJ %LRORJ\RISDLQGLVWUHVVDQGVXIIHULQJ 5HFRJQLWLRQ DQG DVVHVVPHQW RI DQLPDO SDLQ DQG GLVWUHVV FXUUHQW DQG SRWHQWLDO DSSURDFKHV $OOHYLDWLRQRIDQLPDOSDLQDQGGLVWUHVV +RXVLQJLVVXHVH[FOXGLQJJHQHUDOFDUHDQGIHHGLQJ 3DLQDQGGLVWUHVVFDXVHGE\VSHFLÀFWHFKQLTXHVDQGUHVHDUFKHQGSRLQWV
7KH+686LQYLWHVFROODERUDWLRQRQWKH3DLQDQG'LVWUHVV,QLWLDWLYHIURPDOOSDUWV RIWKHVFLHQWLÀFFRPPXQLW\LQFOXGLQJLQYHVWLJDWRUVDQLPDOFDUHWDNHUVYHWHULQDULDQV UHJXODWRU\ RIÀ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´EHVWSUDFWLFHVµ7KH+686 HQFRXUDJHVLQVWLWXWLRQVWRPDNHWKHLUJXLGHOLQHVDYDLODEOHWRRWKHULQVWLWXWLRQVVRWKDW EHVWSUDFWLFHVFDQHYROYHPRUHUDSLGO\ $SUHOLPLQDU\UHYLHZRIDYDLODEOHJXLGHOLQHVFRYHULQJVSHFLÀFWHFKQLTXHVVXJ JHVWVWKDWWKHUHLVFRQVLGHUDEOHYDULDWLRQLQVWDQGDUGSUDFWLFHDPRQJLQVWLWXWLRQV7KH +686KDVEHJXQVXPPDUL]LQJWKHDYDLODEOHLQIRUPDWLRQRQJXLGHOLQHVIRUVSHFLÀF WHFKQLTXHVDQGHQFRXUDJLQJDGLVFXVVLRQRIWKHGLIIHUHQWSUDFWLFHV:HLQLWLDWHGWKLV SURFHVV ZLWK DQ DQDO\VLV RI SROLFLHV RQ PRQRFORQDO DQWLERG\ SURGXFWLRQ JDWKHUHG
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
71
Table 7.5 Selected Elements of Institutional Policies on Monoclonal Antibody Production Available on the World Wide Web Penn State Monitoring subj. with solid tumors Priming Number of taps Monitoring postinoculation Replacement fluid after ascites harvest Anesthesia during tap
Stanford
U Iowa
U Minnesota
Not specified
3v/week
Not specified
3v/week
As low as 0.1 ml pristane Max 3 taps, last terminal Daily
Not specified
0.2 ml max pristane 2 taps, last after euthanasia Daily
0.5 ml max pristane Not specified
Not specified
Anesthesia can be used
Not specified 3v/week for first week, then daily Not specified
Anesthesia used for new personnel
Daily
1–2 ml of saline subcutaneous
Not specified
Not specified
Not specified
IURP WKH :RUOG :LGH :HE 7DEOH :H DVVXPH HDFK RI WKHVH JXLGHOLQHV LV HIIHFWLYHLQSURGXFLQJDQWLERGLHV7KHTXHVWLRQLVZKLFKRQHFDXVHVWKHOHDVWSDLQ DQG GLVWUHVV WR WKH DQLPDOV DQG ZKDW FDQ EH FRQVLGHUHG WR EH EHVW SUDFWLFH" ,W LV FOHDUWKDWPRUHLQWHULQVWLWXWLRQDOGLVFXVVLRQDQGHPSLULFDOVWXGLHVDUHQHHGHGWRDVVLVW VFLHQWLVWVDQG,$&8&VLQPDNLQJDGHWHUPLQDWLRQRQWKLVDQGRWKHUSUDFWLFHV7KH +686 KDV FRQGXFWHG VLPLODU DQDO\VHV IRU )UHXQG·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
CONCLUSIONS 7KHSXEOLF·VVXSSRUWIRUDQLPDOXVHLQELRPHGLFDOUHVHDUFKKDVGHFOLQHGLQUHFHQW \HDUV3ORXV SHUKDSVUHÁHFWLQJDQLQFUHDVLQJSHUFHSWLRQRUDSSUHFLDWLRQWKDW VXFK UHVHDUFK LQYROYHV DQLPDO VXIIHULQJ VHH DERYH DQG WKDW OLWWOH LV EHLQJ GRQH DERXWWKLVVXIIHULQJVHH3KLOOLSV *LYHQWKHSXEOLF·VLQWHUHVWLQWKHKXPDQH WUHDWPHQWRIDQLPDOVLQODERUDWRULHVJUHDWHUDWWHQWLRQVKRXOGEHSDLGWRPLQLPL]LQJ
72
ALTERNATIVE TOXICOLOGICAL METHODS
SDLQDQGGLVWUHVVLQUHVHDUFKDQLPDOV7KH+6863DLQDQG'LVWUHVV,QLWLDWLYHVHHNV WRHQFRXUDJHWKDWHIIRUW :H DUH DZDUH WKDW VRPH LQ WKH DQLPDO UHVHDUFK FRPPXQLW\ GLVWUXVW WKH +686 DQGWKHUHVWRIWKHDQLPDOSURWHFWLRQFRPPXQLW\DQGWKDWWKLVDWWLWXGHZLOOLPSHGH SURJUHVV RQ IRUJLQJ ZRUNLQJ UHODWLRQVKLSV RQ SDLQ DQG GLVWUHVV LVVXHV :H KDYH GHOLEHUDWHO\GHYHORSHGDQLQLWLDWLYHHOLPLQDWLRQRISDLQDQGGLVWUHVV ZKRVHSUHPLVHV DUH DOUHDG\ ZLGHO\ HPEUDFHG E\ WKH VFLHQWLÀF FRPPXQLW\:H WKHUHIRUH KRSH WKDW DQ\ VNHSWLFV ZLWKLQ WKH VFLHQWLÀF FRPPXQLW\ ZLOO DW OHDVW VXSSRUW WKH DLPV RI WKH LQLWLDWLYHLIQRW7KH+686·VHIIRUWVSHUVH )RUWKHPRPHQWRXUOLPLWHGNQRZOHGJHRISDLQDQGGLVWUHVVLQODERUDWRU\DQLPDOV OHDYHVXVZLWKIDUPRUHTXHVWLRQVWKDQDQVZHUV7KHQHHGIRULQFUHDVHGNQRZOHGJH RIWKHVHLVVXHVLVJDLQLQJIXUWKHUDWWHQWLRQLQWKHVFLHQWLÀ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
ACKNOWLEDGMENTS 7KHDXWKRUVZLVKWRWKDQNWKH.HQQHWK6FRWW7UXVWDQGWKH'RHUHQNDPS=ELQGHQ )XQGIRUKHOSLQJWRIXQGWKH+6863DLQDQG'LVWUHVV,QLWLDWLYH
References $OGRXV3&RJKODQ$DQG&RSOH\- /HWWKHSHRSOHVSHDN1HZ6FLHQWLVW0D\ %RXZPHHVWHU-YDQ'LMN0DQG7LEERHO' +XPDQQHRQDWHVDQGSDLQLQ+XPDQH (QGSRLQWVLQ$QLPDO([SHULPHQWVIRU%LRPHGLFDO5HVHDUFK+HQGULNVHQ&)0DQG 0RUWRQ'%(GV5R\DO6RFLHW\RI0HGLFLQH/RQGRQSS² (GLWRULDO 5LJKWZURQJVDQGLJQRUDQFH1DWXUH )OHFNQHOO 3$ $VVHVVPHQW DQG DOOHYLDWLRQ RI SRVWRSHUDWLYH SDLQ$:,& 1HZVOHWWHU ² )RXQGDWLRQIRU%LRPHGLFDO5HVHDUFK 0HPEHUVRIWKH$PHULFDQSXEOLFFRPPHQWRQ WKH XVH RI DQLPDOV LQ PHGLFDO UHVHDUFK DQG WHVWLQJ )RXQGDWLRQ IRU %LRPHGLFDO 5HVHDUFK:DVKLQJWRQ'& )R[0: /DERUDWRU\$QLPDO+XVEDQGU\(WKRORJ\:HOIDUHDQG([SHULPHQWDO9DUL DEOHV6WDWH8QLYHUVLW\RI1HZ
PAIN AND DISTRESS MANAGEMENT IN ANIMAL RESEARCH AND TESTING
73
,/$5 ,QVWLWXWH IRU /DERUDWRU\ $QLPDO 5HVRXUFHV 5HFRJQLWLRQ DQG $OOHYLDWLRQ RI 3DLQDQG'LVWUHVVLQ/DERUDWRU\$QLPDOV1DWLRQDO$FDGHP\RI6FLHQFHV:DVKLQJWRQ '& 2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW *XLGDQFH'RFX PHQW RQ WKH 5HFRJQLWLRQ$VVHVVPHQW DQG 8VH RI &OLQLFDO 6LJQV DV +XPDQH (QG SRLQWVIRU([SHULPHQWDO$QLPDOV8VHGLQ6DIHW\(YDOXDWLRQ2(&'(QYLURQPHQWDO +HDOWKDQG6DIHW\3XEOLFDWLRQV6HULHVRQ7HVWLQJDQG$VVHVVPHQW2(&'3DULV 2UODQV% $QLPDOSDLQVFDOHVDQGSXEOLFSROLF\$OW/DE$QLP² 3KLOOLSV07 6DYDJHVGUXQNVDQGODEDQLPDOVWKHUHVHDUFKHU·VSHUFHSWLRQRISDLQ 6RFLHW\DQG$QLPDOV² 3ORXV6D $WWLWXGHVWRZDUGWKHXVHRIDQLPDOVLQSV\FKRORJLFDOUHVHDUFKDQGHGXFDWLRQ UHVXOWVIURPDQDWLRQDOVXUYH\RISV\FKRORJLVWV$P3V\FKRO² 3ORXV6E $WWLWXGHVWRZDUGWKHXVHRIDQLPDOVLQSV\FKRORJLFDOUHVHDUFKDQGHGXFDWLRQ UHVXOWVIURPDQDWLRQDOVXUYH\RISV\FKRORJ\PDMRUV3V\FKRO6FL²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² 6WHSKHQV0/0HQGR]D3:HDYHU$DQG+DPLOWRQ7 8QUHOLHYHGSDLQDQGGLVWUHVV LQDQLPDOVDQDQDO\VLVRI86'$GDWDRQH[SHULPHQWDOSURFHGXUHV-$SSO$QLP :HOIDUH6FL ²
PART II Development of Predictive Methods Based on Mechanisms of Eye Irritation at the Ocular Surface: Meeting Industry and Regulatory Needs 6+(55</:$5' $1':,/(<$&+$0%(56 7KHUDWLRQDOHIRUWKLVVHFWLRQLVWRSURYLGHWKHUHDGHUZLWKDQXSGDWHRQWKHPRVW FXUUHQWGHYHORSPHQWVLQDOWHUQDWLYHPHWKRGVIRUWKHHYDOXDWLRQRIH\HLUULWDWLRQ 7KLV VHFWLRQ LV KLJKOLJKWHG E\ WKH FRQWULEXWLRQ IURP 'U 0DUWLQ 5HLP RQ WKH SDWKRORJ\ DQG FOLQLFDO IHDWXUHV RI WKHUPDO DQG FKHPLFDO H\H LQMXULHV 'U 5HLP·V &KDSWHU SURYLGHV LQVLJKW LQWR WKH EDVLF PHFKDQLVPV RI FKHPLFDO LQMXU\ WR WKH KXPDQH\HDQGGHVFULEHVXVHIXOPHWKRGVIRUFROOHFWLQJKXPDQFOLQLFDOGDWDIROORZLQJ RFXODUH[SRVXUHWRQR[LRXVPDWHULDOV 2YHUYLHZVRIWKHLQGXVWU\DQGUHJXODWRU\SHUVSHFWLYHVUHODWHGWRWKHGHYHORSPHQW YDOLGDWLRQDQGDSSOLFDWLRQRI'UDL]HH\HWHVWDOWHUQDWLYHPHWKRGVDUHSUHVHQWHGLQ &KDSWHU $QXPEHURIVFLHQWLVWVSUHVHQWWKHLUUHVHDUFKÀ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ÀFDOO\ DQG LQ SUHGLFWLYH FDSDELOLW\ RYHU WKH SDVW GHFDGH GXH WR WKH LQFUHDVHG VRSKLVWLFDWLRQ RI WKH ELRORJLFDO PRGHOV DQG WKH WHFKQRORJ\ DSSOLHG ([SORULQJ WKH SHUIRUPDQFHRIWKHVHDOWHUQDWLYHVWRWKH'UDL]HWHVWSURYLGHVWKHIUDPHZRUNQHHGHG WRPRYHIRUZDUGLQWRWKHQHZGHFDGHZKHUHZHH[SHFWWRKDYHRQHRUPRUHYDOLGDWHG QRQDQLPDOWHVWPHWKRGV IRUWKHHYDOXDWLRQRIKXPDQH\HLUULWDQWV
CHAPTER
8
Meeting Industry and Regulatory Needs for Alternative Test Methods to the Draize Rabbit Eye Irritation Test 6KHUU\/:DUG
CONTENTS ,QWURGXFWLRQ ,QGXVWU\3HUVSHFWLYH 5HJXODWRU\3HUVSHFWLYH 'LVFXVVLRQDQG&RQFOXVLRQV 5HIHUHQFHV
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ÀFDWLRQVRIWKHWHVWUHTXLUHGLIIHUHQW QXPEHUVRIDQLPDOV DQGWKHRFXODUUHVSRQVHRIWKHDQLPDOVLVPRQLWRUHGXVLQJ
77
78
ALTERNATIVE TOXICOLOGICAL METHODS
D VWDQGDUGL]HG VFRULQJ V\VWHP IRU WKH FRUQHD WKH FRQMXQFWLYD DQG WKH LULV IRU XSWRG $QLPDO ZHOIDUH FRQFHUQV RYHU WKH XVH RI DQLPDOV IRU DOO W\SHV RI WHVWLQJ DQG UHVHDUFKSXUSRVHVDURVHLQWKHHDUO\V$WWKDWWLPH&KDUOHV+XPHIRXQGHURI WKH 8QLYHUVLWLHV )HGHUDWLRQ IRU $QLPDO :HOIDUH SURSRVHG ´D VFLHQWLÀF VWXG\ RI KXPDQHWHFKQLTXHLQODERUDWRU\DQLPDOH[SHULPHQWVµ%DOOV 7KLVVWXG\OHG WRWKHSXEOLFDWLRQRI5XVVHOODQG%XUFK 7KH3ULQFLSOHVRI+XPDQH([SHUL PHQWDO7HFKQLTXHLQZKLFKWKHFRQFHSWVRIUHGXFWLRQUHÀQHPHQWDQGUHSODFHPHQW WKHWKUHH5V UHJDUGLQJWKHXVHRIDQLPDOVLQH[SHULPHQWDWLRQZHUHGHÀQHG 7KHPDQGDWHIRUERWKLQGXVWU\DQGJRYHUQPHQWUHJXODWRU\DJHQF\ VFLHQWLVWVLV WR HQVXUH WKH VDIHW\ RI SURGXFWV WKDW DUH PDGH DYDLODEOH IRU FRQVXPHU XVH %RWK JURXSVKDYHFRQÀ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
INDUSTRY PERSPECTIVE 7KHGHYHORSPHQWDQGXVHRIDQLPDODOWHUQDWLYHPHWKRGVE\LQGXVWU\DUHGULYHQ E\FXUUHQWVFLHQWLÀFVRFLDOHFRQRPLFDQGSROLWLFDOFRQVLGHUDWLRQV%RWKJRYHUQPHQW DJHQF\ DQG LQGXVWU\ VFLHQWLVWV DUH HQFRXUDJLQJ GHYHORSPHQW DQG XVH RI YDOLGDWHG QRQDQLPDOWR[LFRORJLFDOWHVWPHWKRGVVLQFHWKH\KDYHWKHSRWHQWLDOWRSURYLGHEHWWHU VFLHQWLÀFDQGPHFKDQLVWLFGDWDDQGWKHUHIRUHEHWWHUKXPDQULVNDVVHVVPHQW $Q LQGXVWU\ZLGH SUREOHP KDV EHHQ WKH ODFN RI DYDLODEOH QRQZKROH DQLPDO YDOLGDWHGDQGUHJXODWRU\DFFHSWHGWR[LFRORJLFDOWHVWPHWKRGVIRUSURGXFWVDIHW\HYDO XDWLRQV7KHFRPSHWLWLYHQHVVRIPDQ\PDQXIDFWXUHUVKLQJHVRQWKHLUDELOLW\WRGHYHORS DQGPDUNHWQHZSURGXFWV$OOJOREDOFRPSDQLHVDUHIDFHGZLWKSRWHQWLDOOHJLVODWLRQ UHJDUGLQJ WKH VDOH RI DQLPDOWHVWHG SURGXFWV 2UJDQL]DWLRQV WKDW KDYH WR HQJDJH LQ SURGXFWVDIHW\WHVWLQJDUHIDFHGZLWKDQXQXVXDOW\SHRIWHFKQRORJLFDOGLVFRQWLQXLW\
INDUSTRY AND REGULATORY PERSPECTIVES
79
8WWHUEDFN ³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·V QHHGV IRU QRQ DQLPDO WR[LFLW\ WHVWLQJ$V DQ H[DPSOH WKH *LOOHWWH ,Q9LWUR7HVWLQJ DQG 5HVHDUFK /DERUDWRU\,975/ ZDVHVWDEOLVKHGLQDVSDUWRIWKHFRPSDQ\·VUHVSRQVHWR WKHQHHGIRUQRQFOLQLFDOLQYLWURRUDOWHUQDWLYH WR[LFRORJLFDOWHVWPHWKRGVIRUSURGXFW VDIHW\HYDOXDWLRQV2QHRIWKHPDMRUREMHFWLYHVRIWKH,975/ZDVWRGHYHORSQHZ LQ YLWUR WHVW PHWKRGV ZLWK WKH JRDO EHLQJ WKHLU HYHQWXDO YDOLGDWLRQ DQG UHJXODWRU\ DFFHSWDQFH7KHÀUVWJRDOZDVWKHGHYHORSPHQWRIQRQFOLQLFDOWHVWPHWKRGVIRUWKH DVVHVVPHQWRIWKHKXPDQH\HLUULWDWLRQSRWHQWLDORIFKHPLFDOVDQGSURGXFWIRUPXOD WLRQV &RPSDQ\ VFLHQWLVWV GHYHORSHG D QHZ KXPDQ FRUQHDO HSLWKHOLDO FHOO OLQH WKH +&(7FHOOOLQHDQGXVHGWKHVHFHOOVWRGHYHORSDQLQYLWURFRUQHDOPRGHOWKH+&( 7 PRGHO 7KH +&(7 PRGHO ZDV XVHG WR GHYHORS VHYHUDO GLIIHUHQW LQ YLWUR WHVW PHWKRGVIRUWKHDVVHVVPHQWRIWKHH\HLUULWDWLRQSRWHQWLDORIFKHPLFDOVDQGSURGXFWV .DKQDQG:DONHU:DUGHWDO.UXV]HZVNLHWDO&ORWKLHU HWDO 2QHRIWKHPHWKRGVWKH+&(77(3DVVD\KDVEHHQXVHGWRSURYLGH GDWDRQWKHH\HLUULWDWLRQSRWHQWLDORISURGXFWVWRVWDIIWR[LFRORJLVWVDQGKDVXQGHUJRQH IRUPDOLQWHUODERUDWRU\SUHYDOLGDWLRQDQGYDOLGDWLRQVWXGLHV:DUGHWDO 7KLV WHVWPHWKRGDQGWKHUHVXOWVRIWKHSUHYDOLGDWLRQVWXG\IRUWKH+&(77(3DVVD\DUH WKHWRSLFRI&KDSWHULQWKLVYROXPH 7KH YDOLGDWLRQ DQG UHJXODWRU\ DFFHSWDQFH RI WKH +&(77(3 WHVW PHWKRG ZLOO SURYLGHLQGXVWU\VFLHQWLVWVZLWKDQDOWHUQDWLYHWRWKH'UDL]HUDEELWH\HWHVW9DOLGDWLRQ ZLOO IDFLOLWDWH WKH ZLGHU DFFHSWDQFH DQG XVH RI WKH WHVW PHWKRG9DOLGDWLRQ RI WKH +&(77(3DVVD\ZLOOFRQIHULQGXVWU\ZLGHUHFRJQLWLRQDQGZLOO GHPRQVWUDWHWKH JRRGZLOO HIIRUW RI WKH FRPSDQ\ LQ SURPRWLQJ WKH WKUHH 5V7KHVH VDPH SULQFLSOHV DUHWUXHIRUFRPSDQLHVWKDWDUHVXSSRUWLQJWKHGHYHORSPHQWDQGYDOLGDWLRQRIRWKHU 'UDL]HDOWHUQDWLYHPHWKRGVVXFKDV0DW7HN·V(SL2FXODUWHVWPHWKRG6WHUQHWDO .ODXVQHUHWDO 5HSODFLQJ WKH 'UDL]H UDEELW WHVW ZLWK D QRQ²DQLPDOEDVHG WHVW VFKHPH ZLOO SURPRWHWKHFRPSHWLWLYHDGYDQWDJHRIDQRUJDQL]DWLRQE\SURYLGLQJVRPHRUDOORI WKHIROORZLQJDGYDQWDJHV VFLHQWLÀFDOO\VXSHULRUSURGXFWVDIHW\HYDOXDWLRQV³WKH
80
ALTERNATIVE TOXICOLOGICAL METHODS
SRWHQWLDOWRSURYLGHEHWWHUVFLHQWLÀFDQGPHFKDQLVWLFGDWDDQGWKHUHIRUHEHWWHUKXPDQ ULVNDVVHVVPHQWV SURGXFWGLIIHUHQWLDWLRQ³VFLHQWLÀFDOO\VXSHULRUSURGXFWGHYHO RSPHQWDQGUHIRUPXODWLRQGXHWRPRUHVHQVLWLYHDQGVSHFLÀFPHDVXUHVRIUHOHYDQW ELRORJLFDOUHVSRQVHV FRVWVDYLQJV³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·VQHHGVIRUQRQFOLQLFDORFXODUWHVWPHWKRGV PHHWLQJVZLWKSDQHOVRIRSKWKDOPRORJ\H[SHUWVWRLGHQWLI\PHFKDQLVPVRIKXPDQH\H LUULWDWLRQWKDWPLJKWEHPRGHOHGE\LQYLWURV\VWHPVWKHGHYHORSPHQWRIDFKHPLFDO LQGXFHG KXPDQ H\H LQMXU\ FODVVLÀFDWLRQ VFKHPH DQG D SLORW VWXG\ WR HYDOXDWH WKH DYDLODELOLW\DQGXWLOLW\RIUHWURVSHFWLYHKXPDQFKHPLFDOLQGXFHGH\HLQMXU\GDWD,/6, $$7%OD]NDHWDO1XVVHQEODWWHWDO 7RDOOHYLDWHWKHFRQFHUQVLQ FRQGXFWLQJKXPDQWHVWLQJWKH,/6,$$7KDVZRUNHGZLWKDSDQHORIRSKWKDOPRORJ\ H[SHUWVWRGHYHORSDKXPDQH\HLQMXU\FODVVLÀFDWLRQVFKHPHWKDWFDQEHXVHGWRFROOHFW GDWDSURVSHFWLYHO\RUUHWURVSHFWLYHO\IURPDFFLGHQWDOKXPDQH\HH[SRVXUHVWRFKHPL FDOV DQG SURGXFWV %OD]ND HW DO 6LQFH WKH FRQVXPHUSURGXFW LQGXVWU\ KDV UHFHQWO\FXUWDLOHGPXFKRILWVIRUPHUVXSSRUWIRUDOWHUQDWLYHPHWKRGVGHYHORSPHQWWKH ,/6,$$7KDVGLVEDQGHG)XWXUHZRUNLQWKLVDUHDLVXQFHUWDLQ
REGULATORY PERSPECTIVE 7KHDFFHSWHGPHWKRGIRUGHWHUPLQLQJWKHH\HLUULWDWLRQSRWHQWLDORIDVXEVWDQFH LVWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW'UDL]HHWDO $QXPEHURIUHJXODWRU\ DJHQFLHVLQGLIIHUHQWFRXQWULHVUHTXLUH'UDL]HWHVWGDWDDVDSDUWRIWKHLUWHVWLQJ JXLGHOLQHVIRUULVNDVVHVVPHQW:LOOLDPV,/6,$$7 ,QWKHRULJLQDO WHVW QLQH UDEELWV ZHUH XVHG 7KH WHVW KDV EHHQ PRGLÀHG WR XVH IHZHU DQLPDOV DQG YDULRXV PRGLÀHG YHUVLRQV KDYH EHHQ VSHFLÀHG E\ WKH )HGHUDO +D]DUGRXV 6XEVWDQFHV$FW)+6$ WKH(QYLURQPHQWDO3URWHFWLRQ$JHQF\(3$ XQGHUWKH )HGHUDO ,QVHFWLFLGH )XQJLFLGH DQG 5RGHQWLFLGH $FW ),)5$ DQG WKH 7R[LF
INDUSTRY AND REGULATORY PERSPECTIVES
81
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´IRUHYDOXDWLQJWKHVDIHW\RIDVXEVWDQFHLQWURGXFHGLQWRRUDURXQGWKHH\Hµ)'$ ,Q WKHLU SRVLWLRQ SDSHU RQ DQLPDO XVH WKH )'$ VDLG WKH\ HQFRXUDJH HIIRUWVWRGHYHORSDQGLPSOHPHQWQRQZKROHDQLPDOWHFKQLTXHV)'$ 7KH )'$·V&HQWHUIRU'UXJ(YDOXDWLRQDQG5HVHDUFK&'(5 UHJXODWHVRYHUWKHFRXQWHU GUXJV DQG WKH\ GR QRW XVH WKH 'UDL]H WHVW DQG DFWLYHO\ GLVFRXUDJH LWV XVH 7KH )'$·V&HQWHUIRU%LRORJLFV(YDOXDWLRQDQG5HVHDUFK&%(5 IROORZV&'(5·VOHDG LQWKLVDUHD 7KH(3$2IÀ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´UHVXOWV IURP ZHOO YDOLGDWHG DQG DFFHSWHG LQ YLWUR WHVW V\VWHPV PD\ VHUYH WR LGHQWLI\ FRUURVLYHV RU LUULWDQWVVXFKWKDWWKHWHVWPDWHULDOQHHGQRWEHWHVWHGLQYLYRµ(3$ +RZHYHU LQYLWURWHVWV\VWHPVWKDWDUHZHOOYDOLGDWHGDQGDFFHSWHGGRQRW\HWH[LVWWRPHHW WKLVFULWHULRQ 3ULRUWRUHJXODWRU\DJHQF\DFFHSWDQFHDQHZ'UDL]HDOWHUQDWLYHPHWKRGZLOOKDYH WR EHFRPH D YDOLGDWHG PHWKRG 1HZ WR[LFRORJLFDO WHVW PHWKRGV GHYHORSHG LQ WKH 8QLWHG6WDWHVDUHHYDOXDWHGDQGUHFRPPHQGHGWRDSHHUUHYLHZSDQHOIRUYDOLGDWLRQ E\ WKH ,&&9$0 7KH ,&&9$0 KDV GHÀQHG WKH FULWHULD DQG SURFHVVHV IRU WKH YDOLGDWLRQDQGUHJXODWRU\DFFHSWDQFHRIQHZDQGUHYLVHGWR[LFRORJLFDOWHVWPHWKRGV 7KHVHJXLGHOLQHVDUHGHVFULEHGLQWKHUHSRUWWLWOHG9DOLGDWLRQDQG5HJXODWRU\$FFHS WDQFHRI7R[LFRORJLFDO7HVW0HWKRGV1,(+6 9DOLGDWLRQKDVEHHQGHÀQHGDV ´WKHSURFHVVZKHUHE\WKHUHOLDELOLW\DQGUHOHYDQFHRIDSURFHGXUHDUHHVWDEOLVKHGIRU DSDUWLFXODUSXUSRVHµ%DOOVHWDO 9DOLGDWLRQLVGHÀQHGE\WKH,&&9$0DV ´D VFLHQWLÀF SURFHVV GHVLJQHG WR FKDUDFWHUL]H WKH RSHUDWLRQDO FKDUDFWHULVWLFV
82
ALTERNATIVE TOXICOLOGICAL METHODS
DGYDQWDJHVDQGOLPLWDWLRQVRIDWHVWPHWKRGDQGWRGHPRQVWUDWHLWVUHOLDELOLW\DQG UHOHYDQFHµ1,(+6 7KHUHOHYDQFHRIDWHVWPHWKRGGHVFULEHVWKHH[WHQWWR ZKLFKDWHVWPHWKRGZLOOFRUUHFWO\SUHGLFWRUPHDVXUHWKHELRORJLFDOHIIHFWRILQWHUHVW DQG GHVFULEHV ZKHWKHU WKH WHVW LV PHDQLQJIXO DQG XVHIXO IRU D SDUWLFXODU SXUSRVH 1,(+6 5HOLDELOLW\ LV D PHDVXUH RI WKH GHJUHH WR ZKLFK D WHVW FDQ EH SHUIRUPHGUHSURGXFLEO\ERWKZLWKLQDQGEHWZHHQODERUDWRULHV1,(+6 5HJXODWRU\ DJHQF\ DFFHSWDQFH LV WKH DFFHSWDQFH RI D YDOLGDWHG WHVW PHWKRG IRU UHJXODWRU\XVH5HJXODWRU\DFFHSWDQFHFULWHULDKDYHEHHQGHÀQHGE\WKH,&&9$0 DQG ,&&9$0 ZLOO SURYLGH UHFRPPHQGDWLRQV UHJDUGLQJ D UHYLHZHG WHVW PHWKRG WR WKH DSSURSULDWH DJHQFLHV KRZHYHU WKH SURFHVV IRU WKH DFFHSWDQFH RI D QHZ WHVW PHWKRGLVOHIWXSWRWKHLQGLYLGXDODJHQF\1,(+6 7KH,&&9$0VXEPLVVLRQ JXLGHOLQHV UHTXLUH WKDW WKH ´LQWHQGHG UHJXODWRU\ XVHV DQG UDWLRQDOH HJ VFUHHQ VXEVWLWXWH UHSODFHPHQW RU DGMXQFW µ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´SUHSRQGHUDQFHRIHYLGHQFHµDSSURDFKRU QHZWHVWPHWKRGGDWDWKDWLVVXEPLWWHG DVDVXSSOHPHQWWR'UDL]HWHVWGDWDWKDWZLOOVHUYHWRUHGXFHWKHQXPEHURIDQLPDOV $QLVVXHRIVSHFLDOFRQFHUQWRPDQ\UHJXODWRU\DJHQF\VFLHQWLVWVLVWKHXVHRI 'UDL]H UDEELW H\H GDWD WR HYDOXDWH WKH SHUIRUPDQFH RI QHZ WHVW PHWKRGV WKDW DUH GHYHORSHGWRSUHGLFWWKHKXPDQUHVSRQVHWRH\HLUULWDQWV1XVVHQEODWWHWDO &KDPEHUV 7KH,&&9$0UHJXODWRU\DFFHSWDQFHFULWHULDUHODWHGWRWKLVLVVXH VWDWHVWKDW´GDWDJHQHUDWHGE\WKHPHWKRGVKRXOGDGHTXDWHO\PHDVXUHRUSUHGLFWWKH HQGSRLQWRILQWHUHVWDQGGHPRQVWUDWHDOLQNDJHEHWZHHQHLWKHUWKHQHZWHVWDQGDQ H[LVWLQJWHVWRUWKHQHZWHVWDQGHIIHFWVLQWKHWDUJHWVSHFLHVµ1,(+6 7KH UHIHUHQFHPHWKRGGDWDXVHGWRHYDOXDWHWKHSHUIRUPDQFHRIQHZ'UDL]HDOWHUQDWLYH PHWKRGVKDVEHHQWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW7KHFRQWLQXHGXVHRIWKHUDEELW DVWKHWHVWVSHFLHVLVGXHLQSDUWWRWKHODUJHGDWDEDVHRIRFXODUUHVSRQVHGDWDWKDW LVDYDLODEOHIRUWKHUDEELWWKXVWR[LFRORJLVWVIHHOFRPIRUWDEOHLQWKHXVHRIWKHPHWKRG +RZHYHUWKH'UDL]HWHVWKDVEHHQFLWHGDVDSRRUWHVWIRUPDQ\UHDVRQVLQFOXGLQJ WKH VSHFLHVELRORJLFDO GLIIHUHQFHV DQG WKH ODUJH FRHIÀ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´JROGVWDQGDUGµ1XVVHQEODWWHWDO&KDPEHUV%OD]NDHWDO
INDUSTRY AND REGULATORY PERSPECTIVES
83
+RZHYHUVXIÀFLHQWKXPDQH\HLUULWDWLRQGDWDLQWKHTXDQWLWDWLYHIRUPQHHGHG IRU QHZ WHVW PHWKRG HYDOXDWLRQ GRHV QRW H[LVW 7KHUH LV WKH SRWHQWLDO IRU XVLQJ UHWURVSHFWLYH RU SURVSHFWLYH DFFLGHQWDO KXPDQ H\H LQMXU\ GDWD EXW WKHUH LV DOVR D FRQFHUQDERXWLWVSUREDEOHODFNRIVXIÀFLHQWLQIRUPDWLRQ6RPHVFLHQWLVWVWKLQNWKDW KXPDQH\HWHVWLQJLVDGHTXDWHO\UHJXODWHGXQGHUFXUUHQWJXLGHOLQHVDQGWKDWDGGL WLRQDO WHVWLQJ FDQ EH FRQGXFWHG WR GHYHORS WKH GDWD QHHGHG &KDPEHUV KDV GHVFULEHG D SODQ IRU SURVSHFWLYHO\ FROOHFWLQJ KXPDQ H\H GDWD IRU SURGXFWV QRW H[SHFWHG WR FDXVH LQMXU\ DQG IRU FROOHFWLQJ DFFLGHQWDO H[SRVXUH LQIRUPDWLRQ IRU SURGXFWV WKDW FRXOG EH H[SHFWHG WR UHVXOW LQ H\H LQMXU\ 2WKHU VFLHQWLVWV DUH RI WKH RSLQLRQWKDWVXIÀFLHQWKXPDQH\HWHVWLQJFRXOGQRWEHSHUIRUPHGWRREWDLQWKHUDQJH RIGDWDQHHGHGWRYDOLGDWHDQHZPHWKRG7KHUHDUHGLFKRWRPLHVLQERWKWKHVFLHQWLÀF DQGWKHHWKLFDOLVVXHVDVVRFLDWHGZLWKWKHFROOHFWLRQDQGXVHRIKXPDQGDWDWKDWQHHG WREHDGGUHVVHGEHIRUHWKLVW\SHRIGDWDZLOOEHDYDLODEOH
DISCUSSION AND CONCLUSIONS 7KHPDLQJRDORIWKHV\PSRVLXPHQWLWOHG´'HYHORSPHQWRI3UHGLFWLYH0HWKRGV %DVHGRQ0HFKDQLVPVRI(\H,UULWDWLRQDWWKH2FXODU6XUIDFH0HHWLQJ,QGXVWU\5HJ XODWRU\ 1HHGVµ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À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ÀQLQJ WHVW PHWKRGYDOLGDWLRQFULWHULD+RZHYHUDWWKLVWLPHQRQHRIWKHVHRUJDQL]DWLRQVKDYH YDOLGDWHGDQDOWHUQDWLYHPHWKRGWRWKH'UDL]HUDEELWH\HWHVW$QXPEHURIUHDVRQV KDYHEHHQSURSRVHGWRH[SODLQWKHIDLOXUHRISUHYLRXVVWXGLHVWRYDOLGDWHDQDOWHUQDWLYH PHWKRGWRWKH'UDL]HWHVW3XUFKDVHHWDO 7KHHDUO\YDOLGDWLRQVWXGLHVZHUH FRQGXFWHG EHIRUH WKH FXUUHQW FRQFHSWV RI YDOLGDWLRQ FULWHULD ZHUH HVWDEOLVKHG ,Q PDQ\FDVHVWKHPHFKDQLVWLFEDVLVRIWKHWHVWPHWKRGVWKDWZHUHHYDOXDWHGZHUHQRW NQRZQ RU ZHUH QRW GHÀQHG 3UHYLRXV YDOLGDWLRQ VWXGLHV ZHUH VHW XS WR YDOLGDWH D
84
ALTERNATIVE TOXICOLOGICAL METHODS
UHSODFHPHQWWHVWIRUWKH'UDL]HH\HWHVWDQGDUHFRQVLGHUHGWREHUDWKHUULJLGLQWKH FULWHULDDQGSURFHVVHVWKDWZHUHXVHG 'UDL]HDOWHUQDWLYHPHWKRGVKDYHWKHLURZQXQLTXHFKDOOHQJHVZKHQLWFRPHVWR WHVW PHWKRG YDOLGDWLRQ 2QO\ D IHZ RI WKHVH LVVXHV ZLOO EH GLVFXVVHG KHUH 0DQ\ VFLHQWLVWV WKLQN WKDW WHVW EDWWHULHV UDWKHU WKDQ RQH WHVW PHWKRG ZLOO EH QHHGHG WR UHSODFHWKH'UDL]HWHVW7KHHVVHQWLDOFRPSRQHQWVIRUDUHSODFHPHQWVFKHPHIRUWKH 'UDL]HWHVWDUHQRWZHOOGHÀQHGDWWKLVWLPH2QHDSSURDFKLVWRYDOLGDWHLQGLYLGXDO WHVWV DV VFUHHQV XQWLO WKH\ FDQ EH DVVHPEOHG LQWR PRUH SUHGLFWLYH WHVW EDWWHULHV $QRWKHUDSSURDFKLVWRYDOLGDWHLQGLYLGXDOPHWKRGVWKDWDUHH[SHFWHGWREHSDUWRI DEDWWHU\ZLWKWKHOLPLWDWLRQVFOHDUO\GHÀQHGDQGWKHPHWKRGYDOLGDWHGIRURQO\WKH VSHFLÀFSXUSRVHIRUZKLFKLWLVGHÀ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ÀFSDUWRIWKH'UDL]HWHVWGDWDIUHTXHQWO\WKHFRUQHDORSDFLW\VFRUHLQPDNLQJ WKHLU ULVN DVVHVVPHQWV %RWK VWDWLVWLFDO DQG HPSLULFDOO\ GHULYHG GDWD VXSSRUW WKH FRQFOXVLRQ WKDW WKH UHVXOWV IURP D UHOHYDQW FRUQHDO WHVW PHWKRG DORQH VKRXOG EH VXIÀ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Á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
INDUSTRY AND REGULATORY PERSPECTIVES
85
REFERENCES %DJOH\'0:DWHUV'DQG.RQJ%0 'HYHORSPHQWRIDGD\FKRULRDOODQWRLF PHPEUDQHDVVD\DVDQDOWHUQDWLYHWRWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW)XQG&KHP 7R[LFRO² %DOOV0 7KHWKUHH5VFRQFHSWRIDOWHUQDWLYHVWRDQLPDOH[SHULPHQWDWLRQLQ$QLPDO $OWHUQDWLYHV:HOIDUHDQG(WKLFVYDQ=XWSKHQ/)0DQG%DOOV0(GV(OVHYLHU $PVWHUGDPSS² %DOOV0%ODDXERHU%-)HQWHP-+%UXQHU,&RPEHV5'(NZDOO%)LHOGHU5- *XLOORX]R$ /HZLV 5: /RYHOO '3 5HLQKDUGW &$ 5HSHWWR * 6ODGRZVNL '6SLHOPDQQ+DQG=XFFR) 3UDFWLFDODVSHFWVRIWKHYDOLGDWLRQRIWR[LFLW\ WHVWSURFHGXUHV7KHUHSRUWDQGUHFRPPHQGDWLRQVRIWKH(&9$0:RUNVKRS$OW /DE$QLP² %HFNOH\-+ &RPSDUDWLYHH\HWHVWLQJPDQYHUVXVDQLPDO7R[LFRO$SSO3KDUPDFRO ² %HFNOH\-+5XVVHOO7-DQG5XELQ/) 8VHRIWKHUKHVXVPRQNH\IRUSUHGLFWLQJ KXPDQUHVSRQVHWRH\HLUULWDQWV7R[LFRO$SSO3KDUPDFRO² %OD]ND0(&DVWHUWRQ3/'UHVVOHU:((GHOKDXVHU+).UXV]HZVNL)+0F&XOOH\ -31XVVHQEODWW5%2VERUQH55RWKHQVWHLQ$6WLW]HO.$7KRPDV.DQG :DUG 6/ 3URSRVHG QHZ FODVVLÀFDWLRQ VFKHPH IRU FKHPLFDO LQMXU\ WR WKH KXPDQH\HLQSUHSDUDWLRQ &KDPEHUV: 5HJXODWRU\SHUVSHFWLYH³0HHWLQJUHJXODWRU\DJHQF\QHHGVIRU'UDL]H DOWHUQDWLYHV $OWHUQDWLYH 7R[LFRORJLFDO 0HWKRGV IRU WKH 1HZ 0LOOHQQLXP 3URJUDP *XLGH86$UP\'R' %HWKHVGD0' &ORWKLHU 5 2UPH$ :DONHU 7/ :DUG 6/ .UXV]HZVNL )+ 'L3DVTXDOH /& DQG %URDGKHDG&/ $FRPSDULVRQRIWKUHHF\WRWR[LFLW\DVVD\VXVLQJWKHFRUQHDO +&(7PRGHO$OW/DE$QLP² 'L3DVTXDOH/&DQG+D\HV$: $FXWHWR[LFLW\DQGH\HLUULWDQF\LQ3ULQFLSOHVDQG 0HWKRGVRI7R[LFRORJ\WKHG+D\HV$:(G7D\ORUDQG)UDQFLV3KLODGHOSKLD ² 'UDL]H-+:RRGDUG*DQG&DOYHU\+2 0HWKRGIRUWKHVWXG\RILUULWDWLRQDQG WR[LFLW\RIVXEVWDQFHVDSSOLHGWRSLFDOO\WRWKHVNLQDQGPXFRXVPHPEUDQHV-3KDU PDFRO([S7KHU² (3$(QYLURQPHQWDO3URWHFWLRQ$JHQF\ +HDOWKHIIHFWVWHVWJXLGHOLQHV$FXWH H\HLUULWDWLRQXUOZZZHSDJRY )'$)RRGDQG'UXJ$GPLQLVWUDWLRQ $QLPDOXVHLQWHVWLQJ)'$UHJXODWHGSURGXFWV XUOKWWSYPFIVDQIGDJRY )ULHGHQZDOG-6+XJKHV:)DQG+HUUPDQQ+ $FLGEDVHWROHUDQFHRIWKHFRUQHD $UFK2SKWKDOPRO² *DXWKHURQ3'XNLF0$OL['DQG6LQD-) %RYLQHFRUQHDORSDFLW\DQGSHUPH DELOLW\WHVWDQLQYLWURDVVD\RIRFXODULUULWDQF\)XQGDP$SSO7R[LFRO *HUVKEHLQ//DQG0F'RQDOG-( (YDOXDWLRQRIWKHFRUQHDOLUULWDQF\RIWHVWVKDP SRRVDQGGHWHUJHQWVLQYDULRXVDQLPDOVSHFLHV)RRG&RVPHW7R[LFRO² *UHHQ :5 6XOOLYDQ -% +HKLU 50 6FKDUSI /* DQG 'LFNLQVRQ $: $ 6\VWHPDWLF&RPSDULVRQRI&KHPLFDOO\,QGXFHG(\H,QMXU\LQWKH$OELQR5DEELWDQG 5KHVXV0RQNH\7KH6RDSDQG'HWHUJHQW$VVRFLDWLRQ1HZ
86
ALTERNATIVE TOXICOLOGICAL METHODS
,&&9$01,&($70 7HVW PHWKRGV XQGHU UHYLHZ XUO KWWSLFFYDPQLHKVQLKJRY PHWKRGVUHYLHZKWP ,/6, $$7 ,QWHUQDWLRQDO /LIH 6FLHQFHV ,QVWLWXWH 7HFKQLFDO &RPPLWWHH RQ $OWHUQDWLYHV WR $QLPDO7HVWLQJ 5HSODFLQJWKH'UDL]HH\HLUULWDWLRQWHVWVFLHQWLÀFEDFNJURXQG DQGUHVHDUFKQHHGV-7R[LFRO&XWDQHRXV2FXODU7R[LFRO² .DKQ&5DQG:DONHU7/ +XPDQFRUQHDOHSLWKHOLDOFHOOOLQHVZLWKH[WHQGHGOLIHVSDQ WUDQVHSLWKHOLDOSHUPHDELOLW\DFURVVPHPEUDQHVIRUPHG LQYLWUR,QYHVW2SKWKDOPRO 9LV6FL .ODXVQHU06KHDVJUHHQ-%UH\IRJOH%6HQQRWW+/LHEVFK0.XELOXV- 7KH (SL2FXODU SUHGLFWLRQ PRGHO D UHSURGXFLEOH LQ YLWUR PHDQV RI DVVHVVLQJ RFXODU LUULWDQF\SRWHQWLDO$OW/DE$QLP .UXV]HZVNL)+:DONHU7/DQG'L3DVTXDOH/& (YDOXDWLRQRIDKXPDQFRUQHDO HSLWKHOLDOFHOOOLQHDVDQLQYLWURPRGHOIRUDVVHVVLQJRFXODULUULWDWLRQ)XQGDP$SSO 7R[LFRO² /RYHOO'3 3ULQFLSDOFRPSRQHQWDQDO\VLVRI'UDL]HH\HLUULWDWLRQWLVVXHVFRUHVIURP VDPSOHVRIFKHPLFDOVLQWKH(&(72&GDWDEDQN7R[LFRO,Q9LWUR²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² 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW )LQDO UHSRUW RI WKH 2(&' :RUNVKRS RQ KDUPRQL]DWLRQ RI YDOLGDWLRQ DQG DFFHSWDQFH FULWHULD IRU DOWHUQDWLYHWR[LFRORJLFDOWHVWPHWKRGV(190&&+(07* 2(&'3DULV 3XUFKDVH,)%RWKDP3$%UXQHU/+)OLQW23)UD]LHU-0DQG6WRNHV:6 :RUNVKRS RYHUYLHZ VFLHQWLÀF DQG UHJXODWRU\ FKDOOHQJHV IRU WKH UHGXFWLRQ UHÀQH PHQWDQGUHSODFHPHQWRIDQLPDOVLQWR[LFLW\WHVWLQJ7R[LFRO6FL² 5XVVHOO:06DQG%XUFK5/UHSULQWHG 7KH3ULQFLSOHVRI+XPDQH([SHUL PHQWDO7HFKQLTXH8QLYHUVLWLHV)HGHUDWLRQIRU$QLPDO:HOIDUH+HUWV8. 6SLHOPDQQ + 2FXODU LUULWDWLRQ LQ ,Q 9LWUR 0HWKRGV LQ 3KDUPDFHXWLFDO 5HVHDUFK $FDGHPLF3UHVV1HZ
INDUSTRY AND REGULATORY PERSPECTIVES
87
:DUG6/*DFXOD0-U&DR&'L3DVTXDOH/(GHOKDXVHU+.UXV]HZVNL)9DOGHV - :DONHU 7 DQG +D\HV $: 3UHYDOLGDWLRQ VWXG\ UHVXOWV IRU WKH KXPDQ FRUQHDOHSLWKHOLDOÁXRUHVFHLQWUDQVHSLWKHOLDOSHUPHDELOLW\DVVD\IRUH\HLUULWDWLRQWKH +&(77(3DVVD\-7R[LFRO&XWDQHRXV2FXODU7R[LFROVXEPLWWHG :HLO&6DQG6FDOD5$ 6WXG\RILQWUDDQGLQWHUODERUDWRU\YDULDELOLW\LQWKHUHVXOWV RIUDEELWH\HDQGVNLQLUULWDWLRQWHVW7R[LFRO$SSO3KDUPDFRO² :LOKHOPXV.5 7KH'UDL]HH\HWHVW6XUY2SKWKDOPRO² :LOOLDPV3' $OWHUQDWLYHVWRRFXODUWHVWLQJLQYLYRVFLHQWLÀFDQGUHJXODWRU\FRQVLG HUDWLRQV7R[LFRO0HWKRGV²
CHAPTER
9
The Ocular Surface: Barrier Function and Mechanisms of Injury and Repair 0DUWLQ5HLP
CONTENTS 7KH2FXODU6XUIDFH (OHFWURO\WHVDQG0HWDEROLWHVLQ&RUQHDO6WURPDDQG(SLWKHOLXP 7UDXPDWR2FXODU6XUIDFH &KHPLFDODQG7KHUPDO,QMXULHVWRWKH2FXODU6XUIDFH 3DWKRSK\VLRORJ\RI&KHPLFDO(\H,QMXULHV ,VFKHPLDDQG1HFURVLV ,QÁDPPDWRU\5HVSRQVH &\WRNLQHVDQG*URZWK)DFWRUVLQ&RUQHDDQG7HDUV &KHPLFDO$OWHUDWLRQRI([WUDFHOOXODU0DWUL[ 6WHP&HOO,QVXIÀFLHQF\ (Q]\PH$FWLYLWLHVDQG0HWDEROLWHVRQWKH2FXODU6XUIDFH &KDQJHVRIWKH&RQWHQWVRI1D.&O²DQG62² &DOFLÀFDWLRQDQG&RQWDPLQDWLRQ 6FDUULQJ $VSHFWVRI5HSDLU 5HIHUHQFHV
THE OCULAR SURFACE 7KHRSWLFDOTXDOLW\RIWKHH\HLVODUJHO\GHSHQGHQWRQWKHLQWHJULW\RIWKHFRUQHD DQGWKHRYHUO\LQJWHDUÀOP7KHLQWHUDFWLRQRIWKHRFXODUVXUIDFHÁXLGZLWKFRUQHDO HSLWKHOLXPDQGVWURPDKDVEHHQLQYHVWLJDWHGUHSHDWHGO\XVLQJYDULRXVPHWKRGV7KRIW DQG )ULHQG 5HLP HW DO 7R XQGHUVWDQG WKH SDWKRORJ\ RI WKH FRUQHD ; E\&5&3UHVV//&
89
90
ALTERNATIVE TOXICOLOGICAL METHODS
WKHVSHFLDOVWUXFWXUHRIWKHHSLWKHOLXPDQGVWURPDPXVWEHFRQVLGHUHG7KHFRUQHDO HSLWKHOLXP VKRZV GLVWLQFW OD\HUV FRQVLVWLQJ RI EDVDO LQWHUPHGLDWH DQG VXSHUÀFLDO FHOOV=RQXODHRFFOXGHQWVIRUPGLIIXVLRQEDUULHUVSUHYHQWLQJGLIIXVLRQRIHYHQUDWKHU VPDOOPROHFXOHVDQGSHQHWUDWLRQRIPLFURRUJDQLVPV7KHHSLWKHOLDOFHOOVDUHDWWDFKHG WRWKHEDVHPHQWPHPEUDQHE\KHPLGHVPRVRPHV5RKHQ ,QDGGLWLRQVSHFLDO DQFKRULQJ FRPSOH[HV SURWUXGH IURP WKH HSLWKHOLXP LQWR WKH VWURPD *LSVRQ HW DO )URP LWV DQDWRPLFDO VWUXFWXUH WKH HSLWKHOLXP FRQVLVWV PDLQO\ RI FHOOXODU PDWHULDOLWVH[WUDFHOOXODUVSDFHLVYHU\VPDOO 7KH VWURPD IRUPV WKH PDMRU SDUW RI WKH FRUQHD ,Q FRQWUDVW WR WKH HSLWKHOLXP DERXWRIWKHVWURPDOYROXPHLVPDGHXSE\WKHH[WUDFHOOXODUVSDFH,WLVÀOOHG ZLWK WKH GHOLFDWH VWUXFWXUH RI FROODJHQV DQG JO\FRVDPLQRJO\FDQV 1RUPDOO\ WKH VWURPD FRQWDLQV ZDWHU 5HLP D 7KH H[WUDFHOOXODU ZDWHU RI WKH FRUQHD UHSUHVHQWVDODUJHYROXPHIRUVROXWHVVXFKDVHOHFWURO\WHVPHWDEROLWHVOLNHJOXFRVH DQG ODFWDWH DQG ORZ PROHFXODU ZHLJKW SURWHLQV LQFOXGLQJ F\WRNLQHV 7KH FHOOV RI WKH VWURPD WKH NHUDWRF\WHV IRUP D V\QF\WLXP ZKLFK ZDV SHUFHLYHG PRUH FOHDUO\ ZKHQFRQIRFDOPLFURVFRS\ZDVLQWURGXFHG7KDHUDQG*H\HU
ELECTROLYTES AND METABOLITES IN CORNEAL STROMA AND EPITHELIUM (OHFWURO\WHV IRU H[DPSOH VRGLXP 1D SRWDVVLXP . FKORULGH &O FDO FLXP&D DQGVXOIDWH62 IRUPLPSRUWDQWSDUWVRIWKHLRQLFPLOLHXIRUOLYLQJ FHOOV6FKUDJHHWDO *OXFRVHLVNQRZQWREHDPDMRUQXWULHQWPHWDEROLWH RIWKHFRUQHDOWLVVXHV5HLPE /DFWDWHLVWKHSURGXFWRIWKHDQDHURELFHQHUJ\ SURGXFLQJ PHWDEROLVP 7DEOH ,Q WKH FRUQHD OLNH LQ PDQ\ RWKHU WLVVXHV DGH QRVLQHWULSKRVSKDWH$73 DQGDGHQRVLQHGLSKRVSKDWH$'3 DUHPDMRUFDUULHUVRI FHOOXODUHQHUJ\7KHUHIRUH$73OHYHOVDUHFRQVLGHUHGWRLQGLFDWHWKHYLWDOLW\RIWLVVXHV DQG FHOOV 5HLP HW DO +HQQLJKDXVHQ HW DO 6LQFH$73 OHYHOV Table 9.1 Stroma of rabbit cornea, mean ± SD, hydration = 3.2 ± 0.4 QMol/g H2O (n = 20) Na 125 ± 42 Cl 123 ± 25 K 24 ± 4 S 105 ± 21 P 12 ± 4
QMol/g net weight (n = 15) Lactate 9.66 ± 1.2 Glucose 3.63 ± 0.8 ATP 0.20 ± 0.05 ADP 0.07 ± 0.03 ASC 4.72 ± 1.44
Note: ASC = ascorbate. Levels of some metabolites and electrolytes in the corneal stroma. Adenosine triphosphate (ATP) and adenosine diphosphate (ADP) are strictly intracellular metabolites. Since the corneal stroma contains keratocytes only in about 10% of its volume, their levels are much lower than in the epithelium (see Table 9.2). Lactate is present in the extracellular as well as in the intracellular space and consequently shows levels close to those of the epithelium (Reim et al., 1970, 1978; Fischern, 1996).
THE OCULAR SURFACE: BARRIER AND INJURY
91
Table 9.2 Metabolite levels of rabbit corneal epithelium QMol/g wet weight, m ± SEM ATP ADP ATP/ADP AMP Glucose Lactate GSH GSSG ASC
3.03 ± 0.10 (n = 14) 0.26 ± 0.02 (n = 14) 12.23 ± 0.89 (n = 14) 0.93 ± 0.08 (n = 14) 2.02 ± 0.22 (n = 14) 9.89 ± 1.02 (n = 14) 3.03 ± 0.43 (n = 21) 0.28 ± 0.05 (n = 21) 11.55 ± 1.05 (n = 24)
*6+ UHGXFHG JOXWDWKLRQH *66* R[LGL]HG JOXWDWKLRQH$6& DVFRUEDWH Note: Levels of some metabolites in the corneal epithelium, which may be significant to estimate vitality, to indicate microtrauma, and to show levels of radical scavengers (Hennighausen et al., 1972; Reim et al., 1966, 1967, 1970, 1976, 1982).
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Á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
92
ALTERNATIVE TOXICOLOGICAL METHODS
DVFRUELFDFLGVHUYHVIRUVFDYHQJLQJR[\JHQDQGK\GUR[\OUDGLFDOVZKLFKDUHJHQ HUDWHG WR D ODUJH H[WHQW LQ WKH OLJKW H[SRVHG WLVVXHV RI WKH H\H 5HLP DQG %HFNHU 5LQJYROGHWDO
TRAUMA TO OCULAR SURFACE 7UDXPD GHÀQHG DV DQ DGYHUVH LQÁXHQFH LQFOXGLQJ PHFKDQLFDO FKHPLFDO RU SK\VLFDOLPSDFWLVFRQVLGHUHGWREHDTXDQWLWDWLYHSURFHVV,QWKLVFRQWH[WTXDQWLW\ LVXQGHUVWRRGDVDIXQFWLRQRIDGYHUVHLPSDFWDQGWLPH6HYHUH WUDXPDOLNHDONDOL EXUQVLPPHGLDWHO\FDXVHVVHYHUHGDPDJH>5HLPHWDO@2QWKHRWKHUKDQG PLOGLUULWDWLRQVXFKDVJHQWO\WRXFKLQJWKHVXUIDFHULQVLQJZLWKLQGLIIHUHQWÁXLGV RUOLWWOHDOWHUDWLRQRIS+LQGXFHGRQO\OLWWOHDOWHUDWLRQWRWKHWLVVXHZKLFKGLVDSSHDUHG TXLWHVRRQ0LQXWHOHVLRQVRIWKHHSLWKHOLXPPD\SURGXFHWLVVXHUHVSRQVHVZKLFK FDQEHGHWHFWHGZLWKYDULRXVPHWKRGVRIH[DPLQDWLRQVXFKDVFRQIRFDOPLFURVFRS\ ELRFKHPLFDODQDO\VHVRIWKHFRUQHDRUWKHWHDUÁ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ÁXLG LV QRW RQO\ FRPSRVHG RI WHDUV EXW LV LQÁXHQFHG E\ YDULRXVH\HGURSVDQGULQVLQJVROXWLRQV$VORQJDVWKHFRUQHDOHSLWKHOLXPLVLQWDFW LQWHUDFWLRQEHWZHHQFRUQHDDQGRFXODUVXUIDFHÁXLGLVVOLJKWDQGRIOLWWOHLPSRUWDQFH +RZHYHUVXUIDFHWUDXPDPD\GDPDJHWKHHSLWKHOLDOEDUULHUDQGLQGXFHLQWHUDFWLRQV EHWZHHQ VXUIDFH ÁXLG DQG FRUQHDO WLVVXHV (URVLRQV RU FRPSOHWH GHIHFWV RI WKH HSLWKHOLXPLQYROYHWKHVWURPD%\LWVVSHFLDODQDWRPLFDOVWUXFWXUHDQGLWVVZHOOLQJ SUHVVXUHWKHGHQXGHGVWURPDVRDNVÁXLGIURPWKHVXUIDFHOLNHDVSRQJH'RKOPDQ 5HLP &OLQLFDOO\ WKLV FRQGLWLRQ DSSHDUV ZLWK HGHPD +RZHYHU DV UHYHDOHGE\(';$DQGRWKHUDQDO\VHVFRUQHDOHGHPDIURPVXUIDFHOHVLRQVEULQJV DERXW GUDPDWLF FKDQJHV RI WKH FKHPLFDO FRPSRVLWLRQ RI WKH VWURPD 5HLP HW DO 6FKUDJHHWDO
CHEMICAL AND THERMAL INJURIES TO THE OCULAR SURFACE 6LQFHWKHSURJQRVLVRIFKHPLFDORUWKHUPDOLQMXULHVRIWKHH\HVGHSHQGVRQWKH VHYHULW\RIWKHGDPDJHDFODVVLÀFDWLRQLVQHFHVVDU\,Q7DEOHVLJQVRIFKHPLFDO LQMXULHVWRWKHH\HZHUHFRPSLOHGDQGJUDGHGLQRUGHUWRGHÀQHVWDJHVRIGDPDJH ,Q PLOG EXUQV VWDJH , VXUIDFH HSLWKHOLD EHFDPH GHIHFWLYH DQG WKH FRQMXQFWLYD ZDVK\SHUHPLF)LJXUH 6WDJH,,RIH\HEXUQLQMXULHVVKRZHGFKHPRVLVDQGVRPHLVFKHPLDRIFRQMXQFWLYD LQDGGLWLRQWRHSLWKHOLDOGHIHFWVDQGK\SHUDHPLD)LJXUH 6RPHSDUWVRIWKHOLPEDO
THE OCULAR SURFACE: BARRIER AND INJURY
93
Table 9.3 Grading of Eye Burns I
II
III
IV
Immediate signs Erosion Hyperemia
Large erosion Ischemia 1/3 Chemosis
Surface defect Ischemia >1/2 Rose chemosis Corneal opacity
Epithelia destroyed Deep ischemia >3/4 Dense corneal opacity Conjunctival necroses Sclera porcelain white Discoloration and atrophy of iris Fibrin exudate
Later signs Regeneration
Recirculation Regeneration
Persistent erosion Ulceration Vascularization Scars
Proliferation Large ulcerations Melting of cataract Glaucoma Scarification
Note: Grading of eye burns according to clinical signs. The upper part lists immediate damage visible, the lower one later secondary events. The classification of signs was developed from various authors and by clinical experiences (Hughes, 1946; Roper-Hall, 1965; Thoft, 1978; Reim and Kuckelkorn, 1995)
Figure 9.1
Eye with a mild alkali burn stage I (Table 9.3). The corneal epithelium was completely lost, but the stroma remained undamaged and clear. The conjunctiva showed hyperemia, but no swelling or ischemia. The damage healed within a few days.
]RQHPLJKWKDYHEHHQLQFOXGHGEXWGHHSHUWLVVXHVUHPDLQHGXQDIIHFWHG6XUURXQGLQJ FRQMXQFWLYDZDVPRUHRUOHVVLQÀOWUDWHGZLWKOHXNRF\WHV5HLPHWDO +RZHYHU VXUIDFHHSLWKHOLDUHJHQHUDWHGZLWKLQWZRRUWKUHHZHHNV5HLPHWDO 0RUHVHYHUHLQMXULHVZHUHVHHQLQVWDJH,,,EXUQV$OOVLJQVOLVWHGLQ7DEOH ZHUH IRXQG 7KH KHDOLQJ SHULRG ZDV H[WHQGHG DQG FRPSOLFDWHG E\ ORQJVWDQGLQJ HSLWKHOLDOGHIHFWVXOFHUDWLRQVFDUIRUPDWLRQDQGSHUPDQHQWFRUQHDOWXUELGLWLHV0RVW
94
Figure 9.2
ALTERNATIVE TOXICOLOGICAL METHODS
Lime burn stage II (Table 9.3). The whole corneal and some conjunctival epithelium was destroyed. The corneal stroma exhibited little superficial turbidities. The lower conjunctiva is demonstrated by upgaze. It was swollen (chemosis). Superficially in the conjunctiva, ischemia is recognized by the interrupted blood columns. With the lit lamp microscope, bloodstream could not be detected. Underneath the otherwise pale conjunctiva, intact sclera appeared with a faint rose background.
VHYHUH EXUQV H[KLELWHG GLVDVWURXV VWDJH ,9 GDPDJH )LJXUHV DQG DQG ODWH FRPSOLFDWLRQV LQGXFHG E\ WKH VHYHUH DQG ORQJVWDQGLQJ VHFRQGDU\ LQÁDPPDWLRQ 6XUIDFHHSLWKHOLDGLGQRWKHDODIWHU\HDUV6HFRQGDU\FRUQHDOVFDULÀFDWLRQQHRYDV FXODUL]DWLRQDQGVKULQNLQJRIFRQMXQFWLYDUHVXOWHGRIWHQLQEOLQGQHVV
Figure 9.3
Clinical appearance of a severe chemical injury grade IV. The inner margin of the upper lid showed a white line of necrosis. The conjunctiva appeared flat and white, also from necrosis, which presumably included visible parts of the sclera. In the upper left region, some hemorrhages were deposited in necrotic conjunctiva. Ischemia was evident. The cornea was completely turbid. The outlines of iris and pupil could be hardly identified.
THE OCULAR SURFACE: BARRIER AND INJURY
Figure 9.4
95
Melting of the anterior eye segment, nine days after most severe burn from liquid metal. There were extended necroses of all conjunctival, subconjunctival, and scleral tissues, appearing homogeneously white and slippery. Only in the right upper region, some hemorrhages in necrotic tissues showed red color. The cornea was opaque in the upper marginal parts. The lower and central cornea was melted away and the iris and lens exposed. Since at that time (1977) corneal donor material was not available, the eye was lost and had to be removed. In the melting tissues of the anterior eye segment, high activities of N-acetylglucose aminidase (NAcGA, E.C.3.2.1.50) and cathepsin-D (E.C.3.4.23.5) were found (Reim, 1982a).
PATHOPHYSIOLOGY OF CHEMICAL EYE INJURIES Ischemia and Necrosis 7KHGDPDJHE\FKHPLFDOLQMXULHVLVTXDQWLWDWLYHDQGGHSHQGVXSRQWKHTXDQWLW\ RIFRUURVLYHDJHQWLWVFRQFHQWUDWLRQDQGWKHSUHVVXUHRIDVSODVKKLWWLQJWKHH\HV 6XUIDFHHSLWKHOLDDUHGHVWUR\HGE\FKHPLFDODJHQWVZKLFKWKHQ PD\SHQHWUDWHWKH FRUQHDOVWURPDDQGWKHVXEFRQMXQFWLYDOWLVVXHVLQFOXGLQJ7HQRQ·VFDSVXOHDQGHYHQ VFOHUD 7KHUH NHUDWRF\WHV FRQMXQFWLYDO À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nflammatory Response 0HGLDWRUVRILQÁDPPDWLRQDUHUHOHDVHGLQQHFURWLFFHOOVDQGLQFHOOVERUGHULQJ RQ QHFURVLV 0DQ\ FRPSRXQGV DV VKRZQ LQ )LJXUH ZHUH DVVD\HG LQ FRUQHDO DQG FRQMXQFWLYDO VDPSOHV IURP ERWK PRGHO H[SHULPHQWV DQG FOLQLFDO SDWLHQWV
96
ALTERNATIVE TOXICOLOGICAL METHODS
Cornea and conjunctiva Severe lesion, severe response PGE2α, Interleukins, LT 4, Subst-P, VIP, CGRP Mild lesion weak response
IL-1, IL-6 IL-8, TNF
PMNs
PMNs, macrophages
T-lymphocytes B-lymphocytes Plasma cells
_
+
O2 OH -radicals lysosomal enzymes
Cellular and humoral antibodies Restitution
Inflammation Figure 9.5
Scars
Ulceration
Flow diagram of inflammatory cascade following chemical and thermal injuries of the eye. The inflammatory response is a quantitative process produced by the affected tissues and the leucocytes involved (Ghattacherjee et al., 1979; Reim et al., 1980, 1993, 1997; Reim, 1982a; Rochels et al., 1982; Kulkarni and Srinivasan, 1983; Becker et al., 1991, 1995; Reim and Leber, 1992; Reim and Becker, 1995).
%KDWWDFKHUMHHHWDO5RFKHOVHWDO.XONDUQLDQG6ULQLYDVDQ 5RFKHOV5HLPDQG/HEHU%HFNHUHWDO5HLPHWDO ,Q WKHFRUQHDOVWURPDDONDOLK\GURO\]HGPDWUL[SURWHLQV:KLNHKDUWHWDO LQWR VPDOOHUSHSWLGHVZKLFKVKRZHGOHXFRWD[LVDQGDQWLJHQLFLW\3ÀVWHUHWDO 7KH\FROOHFWLYHO\LQGXFHGDQLQÁDPPDWRU\UHVSRQVHIROORZLQJFKHPLFDOLQMXULHV +DVHEDHWDO7KLHOHWDO Cytokines and Growth Factors in Cornea and Tears &\WRNLQHVDQGJURZWKIDFWRUVSOD\DQLPSRUWDQWSDUWLQKHDOWKDQGGLVHDVH0DQ\ UHSRUWVDSSHDUHGRQF\WRNLQHVLQRFXODUFHOOVDQGWLVVXHV1RUPDOWHDUVFRQWDLQUDWKHU KLJK DPRXQWV RI WZR LPSRUWDQW JURZWK IDFWRUV HSLGHUPDO JURZWK IDFWRU (*) HQKDQFHV WKH UHJHQHUDWLRQ RI WKH FRUQHDO HSLWKHOLXP ,W VWLPXODWHV SUROLIHUDWLRQ RI HSLWKHOLDOFHOOVDQGÀEUREODVWV7UDQVIRUPLQJJURZWKIDFWRUF7*)F LVDNLQGRI DQWDJRQLVWWR(*),WLQKLELWVSUROLIHUDWLRQRIFRUQHDOHSLWKHOLXP3UHVXPDEO\ERWK JURZWKIDFWRUVDUHUHVSRQVLEOHIRUKRPHRVWDVLVRIWKHVXUIDFHHSLWKHOLXP7DEOH 0LVKLPDHWDO.UXVHDQG7VHQJ ,QH[SHULPHQWDODONDOLEXUQVZLWKRU11D2+LQWHUOHXNLQ,/EDSSHDUHG LQWKHFRUQHDRQWKHÀUVWGD\DIWHUWKHLQMXU\DQGUHDFKHVPD[LPXPOHYHOVRQGD\V WR,/FRPHVODWHUDQGSHDNVRQGD\7KHOHYHOVRI,/DQG,/ZHUHGHSHQGHQW RQWKHFRQFHQWUDWLRQRIWKH1D2+XVHGLQWKHVHH[SHULPHQWV6RWR]RQRHWDO 6RWR]RQRDQG.LQRVKLWD ,QWHUHVWLQJO\LQVHYHUHEXUQVE\11D2+,/ZDV IRXQGLQWKHFRUQHDVDSSHDULQJDIWHUGDQGUHPDLQLQJRQUDWKHUKLJKOHYHOVIRUVHYHUDO
THE OCULAR SURFACE: BARRIER AND INJURY
97
Table 9.4 Cytokines in Tears EGF p regeneration of epithelium TGFbeta 2 p inhibits proliferation TNFalpha, in inflammation Many others, but presumably released from damaged surface epithelia Note: Cytokines and growth factors in tears influencing the corneal epithelium (Mishima et al., 1991; Kruse and Tseng, 1994; Sotozono and Kinshita, 1998).
ZHHNV LQGXFLQJ LQÀOWUDWLRQ RI SRO\PRUSKRQXFOHDU OHXNRF\WHV DQG FRUQHDO YDVFXODU L]DWLRQ5HFHQWO\,/DQG,/ZHUHDQDO\]HGLQKXPDQFRUQHDOEXWWRQVREWDLQHGDW FRUQHDOJUDIWVIRUYDULRXVGLVHDVHV%HFNHUHWDO ,QWKHLQÁDPPDWRU\FRUQHDV KLJKOHYHOVRI,/DQG,/ZHUHIRXQG)LJXUH ,QUHODWLRQWRFOLQLFDOGLDJQRVHV LQFOXGLQJVRPHVHYHUHFKHPLFDOLQMXULHVF\WRNLQHOHYHOVLQWKHKXPDQFRUQHDOEXWWRQV VKRZHGFOHDUO\WKDWKLJKHULQWHUOHXNLQOHYHOVZHUHDVVRFLDWHGZLWKLQÁDPPDWRU\GLV HDVH,QEHJLQQLQJGLVHDVH,/ZDVLQFUHDVHGODWHU,/UHDFKHGKLJKHVWOHYHOV 7KHUHVXOWVRIF\WRNLQHOHYHOVLQKXPDQFRUQHDVDUHLQDJUHHPHQWZLWKFOLQLFDO REVHUYDWLRQVNQRZQIRUPDQ\\HDUV,PPHGLDWHO\DIWHUDFKHPLFDORUWKHUPDOLQMXU\ WKHDIIHFWHGWLVVXHVEHLQJQHFURWLFZHUHIUHHRIFHOOV+RZHYHUUDWKHUHDUO\SRO\ PRUSKRQXFOHDUOHXNRF\WHV301V ZHUHDFWLYDWHGDQGLQYDGHGWKHGDPDJHGWLVVXHV /DWHUPDFURSKDJHVSODVPDFHOOVDQGVXEVHTXHQWO\O\PSKRF\WHVIROORZHG5HLPHW DO ZKLFK HQKDQFHG DQG PDLQWDLQHG LQÁDPPDWLRQ WR D ODUJH H[WHQW E\ FRQWLQXRXVUHOHDVHRIF\WRNLQHVDQGVXSHUR[LGHUDGLFDOV%HFNHUHWDO ZKLFK LQGXFHGDOORIWKHSUREOHPVOLVWHGLQ7DEOH Levels of IL-1 and IL-6 (n=127) pg/mg protein — human corneal buttons 1000
100
10
1 Keratitis Inflammat.Cone Ulceration
Figure 9.6
Decompensation Dystrophy, Scars Keratoconus
Interleukin-1F (IL-1) and Interleukin-6 (IL-6) in human corneal buttons from keratoplasty. Total number of cases: 127. The logarithmic ordinate shows the concentrations found in pg/mg extractable protein. The symbols represent the median, squares stand for IL-1, rhombs for IL-6. The error bars demonstrate the 75% percentiles. In the abscissa, the diagnoses of the cases were indicated corresponding to the position of the symbols (Becker et al., 1995). Inflamed corneas revealed very high levels of IL-1 and IL-6. The levels in the uninflamed, quiete corneas were lower by an order of magnitude.
98
ALTERNATIVE TOXICOLOGICAL METHODS
Chemical Alteration of Extracellular Matrix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ÀVWHUHWDO )RXU WR VL[ ZHHNV DIWHU WKH EXUQ SURWHRO\WLF HQ]\PHV EHFDPH DFWLYDWHG DQG GHJUDGHGFRUQHDOFROODJHQDQGSURWHRJO\FDQV*QlGLQJHUHWDO 7KHVHDFWLY LWLHVLQGXFHGFRUQHDOXOFHUDWLRQDQGDQWHULRUVHJPHQWPHOWLQJ)LJXUH'RKOPDQ 5HLP5HLPDQG/HEHU5HLPHWDO Stem Cell Insufficiency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nzyme Activities and Metabolites on the Ocular Surface :KHQVXUIDFHHSLWKHOLDRIWKHH\HZHUHPLOGO\DQGPRGHUDWHO\GDPDJHGJOXFRVH DQG ODFWDWH ZHUH UHOHDVHG DQG LQFUHDVHG LQ WHDUV /DFWDWH OHYHOV ZHUH HOHYDWHG WR WZLFHWKHQRUPDOYDOXHVDQGJOXFRVHZDVHOHYDWHGXSWRÀYHWLPHVWKHQRUPDOYDOXHV 5HLPHWDO $OVRDIWHURFXODUVXUIDFHWUDXPDHQ]\PHVZHUHIRXQGLQWKH RFXODUVXUIDFHÁXLGLQLWLDOO\FHOOXODUHQ]\PHVDIWHUVRPHGD\VO\VRVRPDOHQ]\PHV 7KH1DFHW\OJOXFRVHDPLQLGDVHZDVDVVD\HGDVDPDUNHUHQ]\PH5HLPDQG/HEHU ,WDSSHDUHGWRJHWKHUZLWKPHWDOORSURWHLQDVHV*QlGLQJHUHWDO (YHQ LQFDVHVRIPLOGDQGPRGHUDWHH\HEXUQVDQGLQDWRSLFFRQMXQFWLYLWLVWKHUHOHDVHRI WKLVHQ]\PHWRWKHVXUIDFHÁXLGUHDFKHGÀYHWRWHQWLPHVWKHQRUPDODFWLYLWLHV)LJXUH 5HLPHWDO ,QVHYHUHFKHPLFDOLQMXULHVZKHQGHHSSRUFHODLQZKLWHLVFKHPLDKDGRFFXUUHG VWHPFHOOVRIWKHFRUQHDOHSLWKHOLXPZHUHGHVWUR\HG,QWKHVHUHJLRQVRIWKHOLPEDO FLUFXPIHUHQFH WKH FRUQHDO HSLWKHOLXP EHFDPH LQVXIÀFLHQW WR UHJHQHUDWH 7KLV
THE OCULAR SURFACE: BARRIER AND INJURY
99
N-Acetylglucose aminidase in human tears wmol/min/ml 10
Atopic conjunctivitis
1
Range of 8 samples from human burns Normal 0.24 s 0.09 (9)
0.1 Figure 9.7
Activity of N-acetylglucose aminidase (NAcGA, E.C.3.2.1.50) in human tears collected from nine human cases with eye burns stage I and II and an atopic patient. Please note that the ordinate is in logarithmic scale! The enzyme activity (QMol/min/ml) increased considerably in surface diseases.
FRQGLWLRQLQGXFHGSHUVLVWHQWHSLWKHOLDOGHIHFWV7KRIW5HLPDQG.XFNHONRUQ $IWHU WR ZHHNV YDU\LQJ VXSHUÀFLDO FRUQHDO XOFHUV DSSHDUHG 5HLP HW DO5HLP 'XULQJWKLVWLPHWKHLVFKHPLFFRQMXQFWLYDEHFDPHQHFURWLF DQG PHOWHG ,VFKHPLF VFOHUD ZDV H[SRVHG :LWK WKH LQÁDPPDWRU\ UHVSRQVH WKH DGMDFHQW KHDOWK\ FRQMXQFWLYD ZDV KHDYLO\ LQÀOWUDWHG E\ OHXNRF\WHV DQG IRUPHG SUROLIHUDWLRQWLVVXHZKLFKUHOHDVHGKLJKDFWLYLWLHVRIO\VRVRPDOHQ]\PHVVXFKDV PDWUL[PHWDOOR SURWHLQDVHV 003V DQG WKH PDUNHU HQ]\PH 1DFHW\OJOXFRVH DPLQLGDVH1$F*$ 5HLP5HLPDQG/HEHU5HLPHWDO 7KLV FRQGLWLRQ ZDV FOLQLFDOO\ PDUNHG ZLWK FRUQHRVFOHUDO XOFHUDWLRQ ² ZHHNV SRVW WUDXPD5HLPDE ,IWKHSUROLIHUDWLRQWLVVXHSURFHHGHGWRRVORZO\WRFRYHUWKHLVFKHPLFVFOHUDDQG WKHGHQXGHGFRUQHDOVWURPDWKHWLVVXHVZHUHPHOWHGE\WKH003V)LJXUH ,I SUROLIHUDWLRQWLVVXHSURFHHGHGIDVWHUWKHLVFKHPLFUHJLRQDQGWKHFRUQHDZHUHFRYHUHG ZLWKKLJKO\YDVFXODUL]HGSUROLIHUDWLRQDQGVFDUWLVVXH (DUO\ VXUJLFDO LQWHUYHQWLRQ ZLWK 7HQRQ SODVW\ DQG SURWHFWLRQ RI WKH FRUQHDO VXUIDFH SURKLELWHG RU KHDOHG FRUQHRVFOHUDO XOFHUDWLRQ DQG WKHUHE\ VDYHG WKH H\HV 5HLPDQG7HSLQJ5HLPHWDO.XFNHONRUQHWDO Changes of the Contents of Na1+, K1+, Cl1–, and SO42– &KDQJHVRIHOHFWURO\WHOHYHOVZHUHDQRWKHUDVSHFWRISDWKRSK\VLRORJ\6FKUDJH HWDO)LVFKHUQHWDO ,QWKHFRUQHDOVWURPDDIWHUH[SHULPHQWDODONDOL EXUQVVRGLXP1D FKORULGH&O DQGVXOIDWH62 ZHUHGHFUHDVHGZKHQWKH GHQXGHGVWURPDZDVULQVHGIRXUWLPHVGDLO\ZLWKVDOLQH7DEOH6FKUDJHHWDO /DQJHIHOG HW DO )LVFKHUQ HW DO :KHQ EDODQFHG VDOW VROXWLRQ %66 ZDVXVHGWKHGHFUHDVHRIHOHFWURO\WHVZDVOHVVVHYHUH+RZHYHUWKHVHYHUH ORVVRIVXOIDWHDIWHUWKHEXUQFRXOGQRWEHUHVWLWXWHGE\ULQVLQJ
100
ALTERNATIVE TOXICOLOGICAL METHODS
Table 9.5 Stroma of Rabbit Cornea, QMol/g H2O, mean ± SD
EDXA Na Cl S P Ca
Normal (n = 20) 125 123 105 12 3
± ± ± ± ±
Alkali Burn, Denuded, Rinsed for 16 Days, 4v daily with 0.9% NaCl (n = 8)
42 25 21 4 3
90 65 24 22 1
± ± ± ± ±
11 15 4 22 3
Note: Changes of the levels of some electrolytes in the corneal stroma after alkali burn. The denuded stroma was rinsed with saline, four times daily for 16 days. Na, Cl, and especially S were decreased, P increased (Fischern et al., 1998).
Calcification and Contamination 0RUHRYHU ZKHQ H\HV GHQXGHG IURP HSLWKHOLXP ZHUH ULQVHG ZLWK SKRVSKDWH EXIIHURULIWKH\ZHUHWUHDWHGZLWKH\HGURSVFRQWDLQLQJSKRVSKDWHEXIIHUDVVROYHQW RUSKRVSKDWHVDOWVRIGUXJVVXFKDVSUHGQLVRORQHSKRVSKDWHUDSLGFRUQHDOFDOFLÀ FDWLRQZDVREVHUYHGLQFOLQLFDOSDWLHQWVDQGLQPRGHOH[SHULPHQWV7DEOH)LJXUHV ²5HLPHWDO6FKUDJHHWDO ,QDGGLWLRQKXPDQFRUQHDOEXWWRQV REWDLQHGIURPEXUQWH\HVRQNHUDWRSODVW\DVZHOODVFRQMXQFWLYDOVDPSOHVUHYHDOHG D UHPDUNDEO\ KLJK FRQWDPLQDWLRQ E\ YDULRXV PHWDOV DQG PLQHUDOV 6FKUDJH DW HO 6FKLUQHU HW DO 7KHVH FRQWDPLQDWLRQV ZHUH H[SODLQHG RQ RQH KDQGE\LPSXULWLHVLQWKHWHVWPDWHULDOVDQGRQWKHRWKHUKDQG E\VHFRQGDU\LQWUR GXFWLRQRISDUWLFOHVZLWKRSKWKDOPLFVROXWLRQVXVHGLQWRSLFDOWKHUDS\RQWKHGHQXGHG VWURPDVXUIDFH5HLPHWDO Scarring ,QPDQ\FDVHVWKHXOFHUDWLRQVGLGQRWSHUIRUDWH7KHQSUROLIHUDWLRQWLVVXHFRY HUHG WKH ZKROH DQWHULRU H\H VHJPHQW DQG WUDQVIRUPHG LW LQWR VKULQNLQJ VFDUV7KLV LQGXFHGV\PEOHSKDUDWKDWWKHPRWLOLW\RIWKHJOREHZDVUHVWULFWHG5HLPDQG6DULF 5HLPD RUWKHJOREHZDVWRWDOO\LPPRELOL]HG+HDOLQJRIWKHVHFDVHV Table 9.6 Stroma of Rabbit Cornea, QMol/g H2O, Mean ± SD
EDXA Na Cl S P Ca
Normal (n = 20) 125 123 105 12 3
± ± ± ± ±
42 25 21 4 3
Alkali Burn, Denuded, Rinsed for 16 Days, 4v Daily with Phosphate Buffer (n = 8) 105 88 28 623 435
± ± ± ± ±
22 33 4 307 198
Note: Changes of the levels of some electrolytes in the corneal stroma after alkali burn and rinsing with isotonic phosphate buffer, four times daily for 16 days. Na, Cl, and especially S were decreased, but P and Ca were largely increased. Clinically, calcification of the cornea was observed (Schrage, 1997; Fischern et al., 1998; Haller, 2001).
THE OCULAR SURFACE: BARRIER AND INJURY
Figure 9.8
101
Left eye of a 16-year-old boy six months after a most severe chemical injury. In this accident, a highly alkaline etching fluid used to work on electronic parts spilled into both eyes of the patient. In this case, a severe inflammatory response had developed and remained for years. The conjunctiva-like proliferation tissue surrounding the cornea was swollen and very hyperemic. The cornea was devoid of epithelium. It showed extended ulceration especially in its marginal parts and was generally thinned. The upper right cornea showed white calcification. To save the eye from melting, a keratoplasty was performed. The excised cornea was examined with electron dispersive x-ray analysis method (EDXA) (see Figures 9.9 and 9.10).
ZDVVHYHUHO\FRPSOLFDWHGE\WKHLQÁDPPDWRU\UHDFWLRQZKLFKRIWHQUHFXUUHGZKHQ VXUJLFDO UHKDELOLWDWLRQ ZDV DWWHPSWHG$V WKLV FRQGLWLRQ ZDV H[WUHPHO\ GLIÀFXOW WR EHUHVWRUHGWKHSULPDU\JRDORIWKHUDS\PXVWEHWRDFKLHYHDWUDQVSDUHQWFRUQHDDQG WRDYRLGLWVQHRYDVFXODUL]DWLRQDVZHOODVHSLEXOEDUDQGSDOSHEUDOVFDUVDVPXFKDV SRVVLEOH)LJXUH
Figure 9.9
Scanning electron microscopy (SEM) on a cross section of the cornea seen in Figure 9.8. Magnification v200. The upper part shows calcification, the lower one parallel corneal lamellae (Schrage et al., 1988, 1993, 1996).
102
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 9.10 Electron dispersive x-ray analysis (EDXA) of the calcified cornea as demonstrated in Figures 9.8 and 9.9. The spectra of the x-rays backscattered at scanning electron microscopy (SEM) showed as expected high peaks for calcium (Ca) and phosphorus (P). But the most prominent peak from this sample was emitted from silicon (Si). Thus, EDXA revealed an unexpected high contamination of the cornea by silicone, which might have explained the severe and longstanding inflammatory response in this case (Schrage et al., 1988, 1993, 1996).
ASPECTS OF REPAIR +HDOWK\FRUQHDOHSLWKHOLXPLVZHOOHTXLSSHGIRUGHIHQVH0LQRUWUDXPDPD\EH YLVLEOHZLWKWKHFRQIRFDOUDWKHUWKDQZLWKWKHVOLWODPSPLFURVFRSH+RZHYHULQYLV LEOHWUDXPDLVDSWWRFDXVHDOWHUDWLRQRIFRUQHDOPHWDEROLVPDQGF\WRNLQHDFWLYLWLHV 0LFURWHFKQLTXHRIDQDO\VHVDOORZVH[DPLQDWLRQRIVLQJOHFRUQHDVDQGVDPSOHVFRQ WDLQLQJRQO\DIHZFHOOV7KHUHIRUHDQDO\VHVRIPHWDEROLWHVVXFKDV$73DQGODFWDWH VKRZHGLPSDLUHGFHOOYLWDOLW\&\WRNLQHVDQGHQ]\PHDFWLYLWLHVLQWKHFRUQHDDQGRQ WKHRFXODUVXUIDFHLQIRUPRQFHOOUHVSRQVHVWRWUDXPDDQGGLVHDVH
THE OCULAR SURFACE: BARRIER AND INJURY
103
Figure 9.11 Eye of a 42-year-old male 2 years after severe lime burn. Heavy scar formation could not be prohibited. The cornea was covered with thick highly vascularized proliferation tissue. The conjunctiva developed strong scars between the globe and the lids, reducing eye motility. The conjunctival scars also deformed the lid margins. The hyperemic, red scar tissue showed that the inflammatory response had not subsided after 2 years. The eye was practically blind and had bad prognoses for surgical rehabilitation.
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ÀFDQFHRINHUDWRF\WHVZDVMXVWUHDOL]HG5HGEUDNH HWDO6DOODHWDO0¡OOHU3HGHUVHQHWDO 7KHXVHRIFRUWLFRV WHURLGV WR LQKLELW WKH LQÁDPPDWRU\ UHDFWLRQ LV VWLOO FRQWURYHUVLDO &KXQJ DQG )DJHUKROP 7KH H[SHULHQFH ZLWK F\WRVWDWLF GUXJV WR UHGXFH FRQMXQFWLYDO DQG 7HQRQ·V WLVVXH SUROLIHUDWLRQ LV OLPLWHG 1HZ FRPSRXQGV WR PRGXODWH FHOO ELRORJLFDOIDFWRUVDUHXQGHULQYHVWLJDWLRQ 7KHÀQGLQJVWKDWULQVLQJÁXLGVDQGH\HGURSVROYHQWVLQÁXHQFHGFRQFHQWUDWLRQV RIVWURPDOHOHFWURO\WHVVXJJHVWHGDVHDUFKIRUÁXLGFRPSRVLWLRQVWKDWZLOOEHDEOH WR PDLQWDLQ D SK\VLRORJLFDO HQYLURQPHQW IRU WKH RFXODU VXUIDFH DQG WKH GHQXGHG VWURPDZKLFKLVDSWWRDYRLGFRUQHDOFDOFLÀFDWLRQDQGWKHORVVRIVXOIDWHIURPWKH VWURPDOPDWUL[6FKUDJHHWDO $WSUHVHQWIRUÀUVWDLGLQFKHPLFDOLQMXULHVWKHEXIIHUHGK\SHURVPRODU'LSKR WHULQHIURP3UHYRU3DULV VHHPHGWREHXVHIXO$VLGHIURPDQRQSKRVSKDWHEXIIHU LWFRQWDLQVDQDPSKRWKHULFPROHFXOHZLWKWKHFDSDFLW\WRELQGDQLRQVDQGFDWLRQV )ROORZLQJ ÀUVW DLG IRU IXUWKHU ULQVLQJ VWHULOH ZDWHU RU VDOLQH PD\ EH DV JRRG DV
104
ALTERNATIVE TOXICOLOGICAL METHODS
EDODQFHGVDOWVROXWLRQIRURSKWKDOPRORJLFDODSSOLFDWLRQV%66 RU5LQJHU·VODFWDWH VROXWLRQ.RPSDHWDO ,QFRQWLQXHGULQVLQJK\SRRVPRODUVROXWLRQVUHPRYHG VROXEOHFDXVWLFPDWHULDODQGFRQWDPLQDWLRQVIURPWKHVWURPD6FKUDJHHWDO ,Q DGGLWLRQ PHGLFDO WKHUDS\ LV LPSHUDWLYH WR VXSSUHVV LQÁDPPDWRU\ UHVSRQVHV DQG WKHUHE\ SUHYHQW VHTXHOV RI FKHPLFDO DQG WKHUPDO LQMXULHV +RZHYHU VXUJLFDO WUHDWPHQWVOLNHSHULGHFWRP\QHFURVHFWRP\7HQRQSODVW\FRUQHDODQGFRQMXQFWLYDO JUDIWV OLPEDO DQG DPQLRWLF PHPEUDQH WUDQVSODQWDWLRQ DUWLÀFLDO HSLWKHOLXP DQG NHUDWRSURWKHVHVDUHLQGLVSHQVDEOHDQGGHÀQLWHO\LPSURYHUHVXOWV5HWURVSHFWLYHHYDO XDWLRQ RI UHVXOWV JDYH LQVLJKW LQWR SUREOHPV DQG FRPSOLFDWLRQV DQG JDYH HYLGHQFH RIFKDQFHVIRUPDQ\SDWLHQWVZLWKVHYHUHO\EXUQHGH\HVWKDWZRXOGKDYHEHHQORVW \HDUVDJRDQGHDUOLHU.XFNHONRUQHWDO5HLPDQG.XFNHONRUQ
References %HFNHU-6DOOD6'RKPHQ85HGEUDNH&DQG5HLP0 ([SORUDWLYHVWXG\RI LQWHUOHXNLQOHYHOVLQWKHKXPDQFRUQHD*UDHIHV$UFK&OLQ([S2SKWKDOPRO ² %HFNHU-6DOOD65HGEUDNH&.XFNHONRUQ5DQG5HLP0 7KHUROHRIVXSHU R[LGH UDGLFDOV LQ WKH LQÁDPPDWLRQ RI WKH DQWHULRU H\H VHJPHQW 'RF 2SKWKDOPRO ² %HFNHU-6DOOD65HGEUDNH&6FKUDJH1)DQG5HLP0 6XUYLYDORIFRUQHDO JUDIWVDIWHUVHYHUHEXUQVRIWKHH\H2FXODU,PPXQRO,QÁDPPDWLRQ² %KDWWDFKHUMHH3.XONDUQL36DQG(DNLQV.( 0HWDEROLVPRIDUDFKLGRQLFDFLGLQ WKHUDEELWRFXODUWLVVXHV,QYHVW2SKWKDOPRO9LV6FL² &KXQJ-DQG)DJHUKROP3 6WURPDOUHDFWLRQDQGUHSDLU DIWHUFRUQHDODONDOLZRXQG LQUDEELWDTXDQWLWDWLYHPLFURUDGLRJUDSKLFVWXG\([S(\H5HV² &RWVDUHOLV*&KHQJ6'RQJ*6XQ7DQG/DYNHU5 ([LVWHQFHRIVORZF\FOLQJ OLPEDOHSLWKHOLDOEDVDOFHOOVWKDWFDQEHSUHIHUHQWLDOO\VWLPXODWHGWRSUROLIHUDWH,PSOL FDWLRQVRQHSLWKHOLDOVWHPFHOOV&HOO 'RKOPDQ & 7KH IXQFWLRQ RI WKH FRUQHDO HSLWKHOLXP LQ KHDOWK DQG GLVHDVH ,QYHVW 2SKWKDOPRO9LV6FL² )LVFKHUQ7 /RUHQ] 8 %XUFKDUG:* 5HLP 0 DQG 6FKUDJH 1) &KDQJHV LQ WKHPLQHUDOFRPSRVLWLRQRIWKHUDEELWFRUQHDDIWHUDONDOLEXUQV*UDHIHV$UFK.OLQ ([S2SKWKDOPRO² )UDQW] $ 6DOOD 6 DQG 5HGEUDNH & $ VHQVLWLYH DVVD\ IRU WKH TXDQWLÀFDWLRQ RI JOXFRVHDQGODFWDWHLQWKHKXPDQFRUQHDXVLQJDPRGLÀHGELROXPLQVFHQFHWHFKQLTXH *UDHIHV$UFK&OLQ([S2SKWKDOPRO² *LSVRQ,.6SXUU0LFKDXG67LVGDOH$DQG.HRXJK0 5HDVVHPEO\RIDQFKRULQJ VWUXFWXUHVRIFRUQHDOHSLWKHOLXPGXULQJZRXQGUHSDLULQWKHUDEELW,QYHVW2SKWKDOPRO 9LV6FL² *QlGLQJHU0,WRL06ODQVN\++DQG'RKOPDQ& 7KHUROHRIFROODJHQDVHLQ WKHDONDOLEXUQHGFRUQHD$P-2SKWKDOPRO² +DOOHU: 7KHUDSHXWLVFKH%HHLQÁXVVXQJGHU+RUQKDXWHOHPHQWHQDFK9HUlW]XQJGRF WRUDOWKHVLV)DFXOW\RI0HGLFLQH7HFKQLFDO8QLYHUVLW\5:7+ $DFKHQS +DVHED 7 1DND]DZD 0 .DR & 0XUWK\ 5 DQG .DR : ,VRODWLRQ RI ZRXQG VSHFLÀF F'1$ FORQHV IURP D F'1$ OLEUDU\ SUHSDUHG ZLWK P51$V RI DONDOL EXUQW UDEELWFRUQHDV&RUQHD²
THE OCULAR SURFACE: BARRIER AND INJURY
105
+HQQLJKDXVHQ86FKPLGW0DUWHQV):DQG5HLP0 0HWDEROLWVSLHJHOXQG(Q]\ PDNWLYLWlWHQGHV(QHUJLHOLHIHUQGHQ6WRIIZHFKVHOVLPUHJHQHULHUHQGHQ&RUQHDHSLWKHO %HU'WVFK2SKWKDOPRO*HV² +RJDQ0-$OYDUDGR-$DQG:HGHOO-( +LVWRORJ\RIWKH+XPDQ(\H$Q$WODV DQG7H[WERRN6DXQGHUV3KLODGHOSKLD/RQGRQ7RURQWR +XJKHV :- $ONDOL EXUQV RI WKH H\H ,, &OLQLFDO DQG SDWKRORJLFDO FRXUVH $UFK 2SKWKDOPRO² .LOS+ (LQÁXYRQ.RQWDNWOLQVHQDXI0HWDEROLWHXQG+\GUDWDWLRQGHU.DQLQFKHQ KRUQKDXW*UDHIHV$UFK.OLQ([S2SKWKDOPRO² .LOS + DQG +HLVLJ % 9HUlQGHUXQJHQ GHU *OXNRVH XQG /DNWDWNRQ]HQWUDWLRQHQ LQ 7UlQHQÁVVLJNHLWHQ GHV .DQLQFKHQ DXI PHFKDQLVFKH 5HL]XQJ XQG .RQWDNWOLQVHQ WUDJHQ*UDHIHV$UFK.OLQ([S2SKWKDOPRO² .RPSD 6:VWHPH\HU + 1HLW]HO 1 DQG 6FKUDJH 1 6SOXQJ EHL9HUlW]XQJ :LUNXQJXQWHUVFKLHGOLFKHU2VPRODULWlWHQDXILQWUDNDPHUDOHQS++RUQKDXWTXHOOXQJ XQG2VPRODULWlW2SKWKDOPRORJH6XSSO .UXVH) 'LH6WDPP]HOOHQGHV/LPEXVXQGLKUH%HGHXWXQJIUGLH5HJHQHUDWLRQGHU +RUQKDXWREHUÁlFKH2SKWKDOPRORJH² .UXVH ) DQG7VHQJ 6 7UDQVIRUPLHUHQGHU:DFKVWXPVIDNWRU EHWD XQG KHPPHQ GLH3UROLIHUDWLRQYRQ/LPEXVXQG+RUQKDXWHSLWKHO2SKWKDOPRORJH² .XFNHONRUQ5.RWWHN$6FKUDJH15HGEUDNH&DQG5HLP0 /DQJ]HLWHUJHE QLVVH PLW 7HQRQSODVWLN EHKDQGHOWHU VFKZHUYHUlW]WHU $XJHQ 2SKWKDOPRORJH ² .XFNHONRUQ55HGEUDNH&DQG5HLP0 7HQRQSODVW\$QHZVXUJLFDODSSURDFK IRUWKHWUHDWPHQWRIVHYHUHH\HEXUQV2SKWKDOPLF6XUJ/DVHUV² .XONDUQL36DQG6ULQLYDVDQ%' 6\QWKHVLVRIVORZUHDFWLQJVXEVWDQFHOLNHDFWLYLW\ LQUDEELWFRQMXQFWLYDDQGDQWHULRUXYHD,QYHVW2SKWKDOPRO9LV6FL² /DQJHIHOG 6 5HLP 0 5HGEUDNH & DQG 6FKUDJH 1) 7KH FRUQHDO VWURPD DQ LQKRPRJHQHRXVVWUXFWXUH*UDHIHV$UFK&OLQ([S2SKWKDOPRO² /DXZHU\QV%9DQGHQ2RUG--'H9RV5DQG0LVVRWWHQ / $QHZHSLWKHOLDO FHOOW\SHLQWKHKXPDQFRUQHD,QYHVW2SKWKDPRO9LV6FL² 0LVKLPD + 1DNDPXUD 0 0XUDNDPL - 1LVKLGD 7 DQG 2WRUL 7 7*)EHWD UHJXODWHV DFWLRQV RI (*) ,QWHUOHXNLQ DQG ÀEURQHFWLQ RQ WKH IXQFWLRQV RI FRUQHDO HSLWKHOLDOFHOOV,QYHVW2SKWKDOPRO9LV6FLVXSSO 0¡OOHU3HGHUVHQ7/L+)3HWUROO:0&DYDQDJK+'DQG-HVWHU-9 &RQIRFDO PLFURVFRSLFFKDUDFWHUL]DWLRQRIZRXQGUHSDLUIROORZLQJSKRWRUHIUDFWLYHNHUDWHFWRP\ ,QYHVW2SKWKDOPRO9LV6FL² 0RUOH\1DQG0F&XOORFK& &RUQHDOODFWDWHDQGS\ULGLQHQXFOHRWLGHVZLWKFRQWDFW OHQVHV$UFK2SKWKDOPRO² 3ÀVWHU 5 +DGGR[ - DQG 6RPPHUV & $ONDOLGHJUDGHG FRUQHD JHQHUDWHV D ORZ PROHFXODU ZHLJKW FKHPRDWWUDFWDQW IRU SRO\PRUSKRQXFOHDU OHXNR]\WHV ,QYHVW 2SK WKDOPRO9LV6FL² 5HGEUDNH&6DOOD69RQGHUKHFNHQ06LHEHQ3DQG5HLP0 *HZHEH]XVWDQG KXPDQHU+RUQKlXWHYRUXQGQDFK2UJDQNXOWXU³(LQÁXGHU7RGHVXUVDFKHGHV6SHQG HUV2SKWKDOPRORJH² 5HLP 0 :DUXP LVW GLH &RUQHD GXUFKVLFKWLJ"³hEHU 3K\VLRORJLH %LRFKHPLH XQG 6WRIIZHFKVHOGHU&RUQHD%HU'WVFK2SKWKDOPRO*HV² 5HLP0D 7KHFOLQLFDOVLJQLÀFDQFHRISURWHRO\WLFHQ]\PHVDQGJO\FRVLGDVHVLQFRUQHDO GLVHDVHLQ$VLDQ3DFLÀF$FDG2SKWKDOPRO%DQJNRN/DHWLDQJWRQJ7DQG&KRWLEXWU 6(GV3KLFNDQHV3UHVV%DQJNRNSS²
106
ALTERNATIVE TOXICOLOGICAL METHODS
5HLP0E 'LH%HGHXWXQJGHV/LPEXVIUGLH(UQlKUXQJGHU&RUQHDLQ/LPEXVSURE OHPH'RGHQ:(GV)(QNH6WXWWJDUWSS² 5HLP0D =XU%HKDQGOXQJVFKZHUVWHU9HUlW]XQJHQXQG9HUEUHQQXQJHQGHU%LQGHKDXW )RUWVFKU2SKWKDOPRO² 5HLP0E =XU3DWKRSK\VLRORJLHXQG7KHUDSLHYRQ9HUlW]XQJHQ)RUWVFKU2SKWKDO PRO² 5HLP0D &KLUXUJLVFKH$QDWRPLH3K\VLRORJLH%LRFKHPLH VRZLH)UDJHQGHU,QOD\ 7HFKQLN2SKWKDOPRORJH² 5HLP0E 7KHUHVXOWVRILVFKHPLDLQFKHPLFDOLQMXULHV(\H² 5HLP 0 %DKUNH & .XZHUW 7 DQG .XFNHONRUQ 5 ,QYHVWLJDWLRQ RI HQ]\PH DFWLYLWLHV LQ VHYHUH EXUQV RI WKH DQWHULRU H\H VHJPHQW *UDHIHV $UFK &OLQ ([S 2SKWKDOPRO² 5HLP 0 DQG %HFNHU - &HOO SURWHFWLRQ LQ WKH DQWHULRU VHJPHQW RI WKH DONDOL EXUQW H\HLQ&HOODQG7LVVXH3URWHFWLRQLQ2SKWKDOPRORJ\6FKPLGW.+(G+LSSRNUDWHV 9HUODJ6WXWWJDUWSS² 5HLP0HWDO 7KHUHGR[VWDWHRIWKHJOXWDWKLRQHLQWKHERYLQHFRUQHDOHSLWKHOLXP *UDHIHV$UFK.OLQ([S2SKWKDOPRO² 5HLP0%HLO.+.DPPHUHU*DQG.UHKZLQNHO6 ,QÁXHQFHRIV\VWHPLFDVFRUELF DFLG WUHDWPHQW RQ PHWDEROLWH OHYHOV DIWHU UHJHQHUDWLRQ RI WKH FRUQHDO HSLWKHOLXP IROORZLQJPLOGDONDOLEXUQV*UDHIHV$UFK.OLQ([S2SKWKDOPRO² 5HLP0%RHFN+.UXJ$DQG9HQVNH* $TXHRXVKXPRXUDQGFRUQHDVWURPD PHWDEROLWHOHYHOVXQGHUYDULRXVFRQGLWLRQV2SKWKDOPLF5HV² 5HLP0&DWWHSRHO+%LWWPDQQ.DQG.LOS+ 0HWKRGLVFKHXQGSK\VLRORJLVFKH $VSHNWH EHL GHU VWDWLVWLVFKHQ $XVZHUWXQJ YRQ 0HWDEROLWVSLHJHOQ LQ YHUVFKLHGHQHQ .RPSDUWLPHQWHQ GHU YRUGHUHQ$XJHQDEVFKQLWWH *UDHIHV$UFK .OLQ ([S 2SKWKDO PRO² 5HLP0)RHUVWHU.+DQG&DWWHSRHO+ 6RPHFULWHULDRIWKHPHWDEROLVPLQWKH GRQRU FRUQHD SDSHU SUHVHQWHG LQ WKH ;;, &RQFLO 2SKWKDOPRO ,QW 0H[LFR &LW\ 6RODQHV03(GV([FHUSWD0HGLFD$PVWHUGDPSS² 5HLP0.DXIKROG)0.HKUHU7.XFNHONRUQ5.XZHUW7DQG/HEHU0 =XU 'LIIHUHQ]LHUXQJGHU7KHUDSLHEHL9HUlW]XQJHQ)RUWVFKU2SKWKDOPRO² 5HLP0.RWWHN$DQG6FKUDJH1 7KHFRUQHDVXUIDFHDQGZRXQGKHDOLQJ3URJ 5HWLQDO(\H5HV² 5HLP0DQG.XFNHONRUQ5 9HUlW]XQJHQXQG9HUEUHQQXQJHQGHU$XJHQ$NW$XJHQ KHLON² 5HLP0DQG/HEHU0 1DFHW\OJOXFRVHDPLQLGDVHDFWLYLW\LQFRUQHDVFOHUDOXOFHUDWLRQ IROORZLQJVHYHUHH\HEXUQVUHODWHGWRLQGLYLGXDOSDWLHQWV&RUQHD² 5HLP 0 /HEHU 0 DQG .DXIKROG )0 1RUPDOH XQG SDWKRORJLVFKH %HVWDQGWHLOH GHU7UlQHQGHV%LQGHKDXWVHNUHWHV1HXHV2SW-² 5HLP00H\HU'DQG&DWWHSRHO+ hEHUGLH%HGHXWXQJGHV)ULHUVWRSYHUIDKUHQV IU GHQ LQ YLYR 6WDWXV GHU 0HWDEROLWH LP &RUQHDHSLWKHO *UDHIHV $UFK &OLQ ([S 2SKWKDOPRO² 5HLP 0 2YHUNlPSLQJ % DQG .XFNHONRUQ 5 =ZHLMlKULJH (UIDKUXQJHQ PLW GHU 7HQRQSODVWLN2SKWKDOPRORJH² 5HLP0DQG6DULF' 7UHDWPHQWRIFKHPLFDOEXUQVRIWKHDQWHULRUH\HVHJPHQWZLWK PDFURPROHFXODUVRGLXPK\DOXURQDWH+HDORQ LQ9LVFRHODVWLF0DWHULDOV%DVLF6FL HQFHDQG&OLQLFDO$SSOLFDWLRQ5RVHQ(6(G3HUJDPRQ3UHVV/RQGRQSS² 5HLP06FKPLGW)DQG0H\HU' 'LH0HWDEROLWHGHV (QHUJLHOLHIHUQGHQ6WRII ZHFKVHOV LQ GHU +RUQKDXW YHUVFKLHGHQHU 6lXJHWLHUH %HU 'WVFK 2SKWKDO *HV ²
THE OCULAR SURFACE: BARRIER AND INJURY
107
5HLP0DQG6FKPLGW0DUWHQV): 7UHDWPHQWRIEXUQVRIWKHDQWHULRUH\HVHJPHQW SDSHUSUHVHQWHGLQWKH;;,9&RQFLO2SKWKDOPRO,QW6DQ)UDQFLVFR0DXPHQHH( (G-3/LSSLQFRWW3KLODGHOSKLDSS² 5HLP06FKPLGW0DUWHQV):+|UVWHU%DQG6FKHLGKDXHU( 0RUSKRORJLVFKH XQGELRFKHPLVFKH%HIXQGHEHLH[SHULPHQWHOOHQ9HUlW]XQJHQPLW$ONDOL%HU'WVFK 2SKWKDOPRO*HV² 5HLP 0 6HLGO 0 DQG %UXFNHU . $FFXPXODWLRQ RI DVFRUELF DFLG LQ WKH FRUQHDO HSLWKHOLXP2SKWKDOPLF5HV² 5HLP 0 DQG 7HSLQJ & 6XUJLFDO SURFHGXUHV LQ WKH WUHDWPHQW RI PRVW VHYHUH H\H EXUQV$FWD2SWKDOPRO6XSSO² 5LQJYROG$$QGHUVVHQ(DQG.M¡QQLNVHQ, $VFRUEDWHLQWKHFRUQHDOHSLWKHOLXP RIGLXUQDODQGQRFWXUQDOVSHFLHV,QYHVW2SKWKDOPRO9LV6FL² 5RFKHOV5 $QLPDOH[SHULPHQWVWXGLHVRQWKHUROHRILQÁDPPDWLRQPHGLDWRUVLQFRUQHDO QHRYDVFXODULVDWLRQ'RF2SKWKDOPRO² 5RFKHOV 5 %XVVH: +DFNHOEXVFK 5 DQG .QLHSHU 3 3URVWDJODQGLQ.RQ]HQWUD WLRQVEHVWLPPXQJLP.DPPHUZDVVHUQDFKGHU%LQGHKDXW+RUQKDXWYHUlW]XQJ.RUUH ODWLRQ ELRFKHPLVFKHU IXQNWLRQHOOHU XQG PRUSKRORJLVFKHU %HIXQGH )RUWVFKU 2SKWKDOPRO² 5RKHQ -: 'LH +RUQKDXW 'HU SUlFRUQHDOH )LOP LQ $XJHQKHLONXQGH LQ .OLQLN XQG 3UD[LV)UDQFRLV-DQG+ROOZLFK)(GV*7KLHPH6WXWWJDUWSS² 5RSHU+DOO0- 7KHUPDODQGFKHPLFDOEXUQV7UDQV2SKWKDOPRO6RF8. 6DOOD65HGEUDNH&%HFNHU-DQG5HLP0 5HPDUNVRQWKHYLWDOLW\RIWKHKXPDQ FRUQHDDIWHURUJDQFXOWXUH&RUQHD² 6DOOD 6 5HGEUDNH & DQG )UDQW] $ (PSOR\PHQW RI ELROXPLQHVFHQFH IRU WKH TXDQWLÀFDWLRQRIDGHQRVLQHSKRVSKDWHVLQWKHKXPDQFRUQHD*UDHIHV$UFK&OLQ([S 2SKWKDOPRO² 6FKLUQHU*6FKUDJH16DOOD6DQG5HLP0 &RQMXQFWLYDOWLVVXHH[DPLQDWLRQLQ VHYHUHH\HEXUQVDVWXG\ZLWKVFDQQLQJHOHFWURQPLFURVFRS\DQGHQHUJ\GLVSHUVLYH [UD\DQDO\VLV*UDHIHV$UFK&OLQ([S2SKWKDOPRO² 6FKLUQHU*6FKUDJH1)6DOOD67HSLQJ&5HLP0%XUFKDUG:*DQG6FKZDE % 6LOEHUQLWUDWYHUlW]XQJ QDFK &UHGH·VFKHU 3URSK\OD[H (LQH U|QWJHQDQD O\WLVFKHXQGUDVWHUHOHNWURQHQPLNURVNRSLVFKH8QWHUVXFKXQJ.OLQ0EO$XJHQKHLON ² 6FKUDJH1 (OHPHQWHLQGHU&RUQHD+DELOLWDWLRQVVFKULIWIDFXOW\RIPHGLFLQH7HFK QLFDO8QLYHUVLW\5:7+ $DFKHQS 6FKUDJH 1) %HQ] . %HDXMHDQ 3 %XUFKDUG :* DQG 5HLP 0 $ VLPSOH HPSLULFDO FDOLEUDWLRQ RI HQHUJ\ GLVSHUVLYH [UD\ DQDO\VHV (';$ RQ WKH FRUQHD 6FDQQLQJ0LFURVFRS\² 6FKUDJH 1) )OLFN 6 5HGEUDNH & DQG 5HLP 0 (OHFWURO\WHV LQ WKH FRUQHD D WKHUDSHXWLFFKDOOHQJH*UDHIHV$UFK&OLQ([S2SKWKDOPRO² 6FKUDJH1)/RUHQ]8YRQ)LVFKHUQ7DQG5HLP0 7KHPLFURWUHSKLQH³DQHZ GLDJQRVWLFWRROIRUREWDLQLQJFRUQHDOELRSVLHV$FWD2SKWKDOPRORJLFD² 6FKUDJH 1) DQG 5HLP 0 'HU 0LNURWUHSDQ H[SHULPHQWHOOH (UIDKUXQJHQ HUVWH NOLQLVFKH$QZHQGXQJ.OLQ0EO$XJHQKHLON² 6FKUDJH1)5HLP0DQG%XUFKDUG:* 8QWHUVXFKXQJHQDQVFKZHUVWYHUlW]WHQ &RUQHDHQDFK/DQJ]HLWWKHUDSLHXQWHUEHVRQGHUHU%HDFKWXQJYRQSDUWLNXOlUHQ5FN VWlQGHQ DXV 7UDXPD XQG 7KHUDSHXWLND %HLWU (OHNWURQHQPLNURVNRS 'LUHNWDEE 2EHUÁ² 6RWR]RQR&+H-0DWVXPRWR<.LWD0,PDQLVKL-DQG.LQRVKLWD6 &\WRNLQH H[SUHVVLRQLQWKHDONDOLEXUQHGFRUQHD&XUU(\H5HV²
108
ALTERNATIVE TOXICOLOGICAL METHODS
6RWR]RQR&DQG.LQRVKLWD6 *URZWKIDFWRUVDQGF\WRNLQHVLQFRUQHDOZRXQGKHDOLQJ LQ&RUQHDO+HDOLQJ5HVSRQVHVWR,QMXULHVDQG5HIUDFWLYH6XUJHULHV1LVKLGD7(G .XJOHU3XEOLFDWLRQVWKH+DJXHSS² 7KDHU$$ DQG *H\HU 2& 'LH$QZHQGXQJ GHU NRQIRNDOHQ 6SDOW6FDQQLQJ0LN URVNRSLHDXIGLHLQYLYR8QWHUVXFKXQJGHU.RUQHD0LNURVWUXNWXULP=XVDPPHQKDQJ PLWGHP7UDJHQYRQ.RQWDNWOLQVHQ&RQWDFWRORJLFD² 7KLHO + 5LFKWHU 8 =LHUKXW 0 DQG 0OOHU & ,PPXQUHDNWLRQHQ GHU %LQGHKDXW XQG+RUQKDXWQDFKVFKZHUHQ9HUlW]XQJHQGHVlXHUHQ$XJHV.OLQ0EO$XJHQKHLON ² 7KRIW5 &KHPLFDODQGWKHUPDOLQMXU\,QW2SKWKDOPRO&OLQ² 7KRIW5 ,QGLFDWLRQVIRUFRQMXQFWLYDOWUDQVSODQWDWLRQ2SKWKDOPRORJ\² 7KRIW 5 DQG )ULHQG - )XQFWLRQDO FRPSHWHQFH RI WKH UHJHQHUDWLQJ RFXODU VXUIDFH HSLWKHOLXP,QYHVW2SKWKDOPRO9LV6FL² 7KRIW5$DQG)ULHQG- %LRFKHPLFDODVSHFWRIFRQWDFWOHQVZHDU$P-2SKWKDOPRO ² 7XUVV5DQG6FKHELW]+ 'LH%HGHXWXQJGHV.DPPHUZDVVHUVXQGGHU5DQGVFKOLQ JHQJHIlHIUGLH(UQlKUXQJGHU+RUQKDXW%HU'WVFK2SKWKDOPRO*HV² :KLNHKDUW'5(GZDUGV:&DQG535 6RUSWLRQRIVRGLXPK\GUR[LGHE\W\SH, FROODJHQDQGERYLQHFRUQHDV&RUQHD² =LHVNH -' %XNXVRJOX 0 DQG
CHAPTER
10
Evaluation and Refinement of the Bovine Cornea Opacity and Permeability Assay -RKQ/8EHOV-DPHV'3DDXZDQG3KLOOLS/&DVWHUWRQ
CONTENTS ,QWURGXFWLRQ 0HWKRGV 5HVXOWV 'LVFXVVLRQ $FNQRZOHGJPHQWV 5HIHUHQFHV
INTRODUCTION %HFDXVHRIOLPLWDWLRQVRIWKHVWDQGDUG'UDL]HUDEELWH\HLUULWDWLRQWHVWDVZHOO DVDQLQFUHDVLQJGHPDQGWRUHGXFHDQLPDOXVHLQWR[LFRORJ\DQ DOWHUQDWLYHRFXODU WR[LFRORJLFDOPHWKRGNQRZQDVWKHERYLQHFRUQHDRSDFLW\DQGSHUPHDELOLW\%&23 DVVD\KDVEHHQGHYHORSHG7KHWHVWRULJLQDOO\GHYHORSHGE\0XLU QHDUO\WZR GHFDGHVDJRLQYROYHVFODPSLQJDERYLQHFRUQHDEHWZHHQWZRVDOLQHÀOOHGFKDPEHUV DQGPHDVXULQJWUDQVPLWWDQFHRIZKLWHOLJKWWKURXJKWKHFRUQHDXVLQJPHDVXUHPHQWV RI YROWDJH IURP D SKRWRFHOO EHIRUH DQG DIWHU FKHPLFDO H[SRVXUH *DXWKHURQ HW DO UHÀQHGWKHDVVD\DQGGHPRQVWUDWHGWKDWWKHWHVWUHVXOWVZHUHFRQVLVWHQWZLWK WKH KLVWRULFDO GDWD RI WKH 'UDL]H WHVW &DVWHUWRQ HW DO ODWHU LQWURGXFHG WKH GHWHUPLQDWLRQRIRSDFLW\XVLQJVSHFWURSKRWRPHWHUDEVRUEDQFHPHDVXUHPHQWVDW QP DQG D FRUQHDO KROGHU PRGLÀFDWLRQ ZLWK UHPRYDEOH HQG ZLQGRZV WKDW DOORZHG GLUHFWDSSOLFDWLRQRIWHVWPDWHULDOVWRWKHFRUQHDOVXUIDFH $OWKRXJKLPSURYHPHQWVKDYHEHHQPDGHWRWKH%&23SURWRFROWRJDLQUHJXOD WRU\DFFHSWDQFHWKHDVVD\PXVWEHDEOHWRGLVWLQJXLVKEHWZHHQLUUHYHUVLEOHGDPDJH ; E\&5&3UHVV//&
109
110
ALTERNATIVE TOXICOLOGICAL METHODS
DQG WHPSRUDU\ ORVV RI WUDQVSDUHQF\ FDXVHG E\ LQFUHDVHG FRUQHDO K\GUDWLRQ GXH WR FKHPLFDOH[SRVXUH2QHRIWKHJRDOVRIRXUH[SHULPHQWVZDVWRH[DPLQHWKHUROHRI FKDQJHV LQ FRUQHDO K\GUDWLRQ LQ LQFUHDVLQJ RSDFLW\ %\ FRPSDULQJ RSDFLW\ GDWD JHQHUDWHG E\ PD[LPXP K\GUDWLRQ RI WKH FRUQHD WR RSDFLW\ GDWD DIWHU H[SRVXUH WR FKHPLFDOVWLVVXHGDPDJHLQGXFHGE\FKHPLFDOH[SRVXUHFDQEHGHWHUPLQHG ,QDGGLWLRQWRWKHQHFHVVLW\RIPHFKDQLVWLFGHWHUPLQDWLRQRIFRUQHDOGDPDJHWKH %&23 VKRXOG EH IXUWKHU UHÀ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
METHODS 7KH SURWRFRO IRU WKH K\GUDWLRQ VWXG\ KDV EHHQ SUHYLRXVO\ GHVFULEHG LQ GHWDLO 8EHOVHWDO &RUQHDVZHUHPRXQWHGHLWKHULQWDFWZLWKHSLWKHOLXPUHPRYHG RU ZLWK ERWK HSLWKHOLXP DQG HQGRWKHOLXP UHPRYHG LQ PLQLPXP HVVHQWLDO PHGLXP 0(0 6LJPD &KHPLFDO &RPSDQ\ 6W /RXLV 0LVVRXUL RU GHLRQL]HG ', ZDWHU DQGLQFXEDWHGIRUKDWHLWKHU&RU&$IWHULQFXEDWLRQDQPPFRUQHDOEXWWRQ ZDVUHPRYHGDQGZHLJKHG7KHWLVVXHZDVGULHGDQGUHZHLJKHGWRGHWHUPLQHK\GUD WLRQDVPJ+2PJGU\ZHLJKW$EVRUEDQFHUHDGLQJVZHUHPDGHDWQP 7RGHWHUPLQHHIIHFWVRIYDULRXVWHVWVXEVWDQFHVRQK\GUDWLRQDVZHOODVWKHHIIHFW RIK\GUDWLRQRQRSDFLW\VHYHUDOFRPSRXQGVZHUHDSSOLHGWRWKHFRUQHDOHSLWKHOLXP IRUPLQDVSHUWKH%&23SURWRFRO$IWHUKLQFXEDWLRQLQ0(0DW&K\GUDWLRQ DQG$DEVRUEDQFHDWDZDYHOHQJWKRIQPZHUHPHDVXUHG &RUQHDVZHUHPRXQWHGDFFRUGLQJWRWKH%&23SURWRFRODQGLQFXEDWHGLQ0(0 IRUPLQ7KHHSLWKHOLDOOD\HUVRIWKHFRUQHDVZHUHWKHQH[SRVHGWRWHVWVXEVWDQFHV IRUHLWKHUVHFRUPLQDQGZHUHLQFXEDWHGIRUK8EHOVHWDO 7KH$ ZDVPHDVXUHGIRUHDFKFRUQHDDQGWKHVHYDOXHVZHUHFRPSDUHGWRWKRVHREWDLQHG SUHYLRXVO\ IRU PLQ H[SRVXUHV &DVWHUWRQ HW DO &RUQHDO K\GUDWLRQ ZDV PHDVXUHGDVSUHYLRXVO\GHVFULEHG$IWHUKLQFXEDWLRQWKHHQGRWKHOLDOOD\HUVZHUH VWDLQHGZLWKWU\SDQEOXH6LJPD DQG$OL]DULQ5HG66LJPD DVGHVFULEHGE\8EHOV
THE BCOP ASSAY
111
Stainless Steel Ring
Quartz Window
O-Ring Top Holder Cornea
Epithelial Chamber
Sclera Vents Endothelial Chamber
O - Ring Bottom Holder O-Ring
Stainless Steel Ring
Quartz Window
Figure 10.1 Cross-section of the new cornea holder. In contrast to the old holder, the new holder clamps onto sclera rather than cornea. Also, the shape of the chamber fits the normal curvature of the cornea in contrast to the flat chamber of the current BCOP holder.
HWDO $QPPEXWWRQZDVUHPRYHGIURPWKHFHQWHURIWKHFRUQHDDQGSODFHG HQGRWKHOLDOVLGH XS LQ WKH GHSUHVVLRQ RI D KDQJLQJ GURS VOLGH 7KH FRUQHDV ZHUH H[DPLQHGE\OLJKWPLFURVFRS\DQGSKRWRJUDSKHG %HFDXVHWKHFXUUHQWO\XVHGFRUQHDOKROGHULQYROYHVFODPSLQJDQRYDOVKDSHGFRUQHD EHWZHHQWKHÁDWVXUIDFHVRIWZRFKDPEHUVZHGHVLJQHGDQHZKROGHUWRDFFRPPRGDWH WKHVKDSHRIWKHERYLQHFRUQHD8EHOVHWDO 0HDVXUHPHQWVZHUHPDGHRIWKH GLPHQVLRQVRIWKHERYLQHFRUQHDDQGDQLPSURYHGKROGHUZDVGHYHORSHGE\FRPSXWHU DLGHGGHVLJQXVLQJWKH3UR(QJLQHHUSURJUDP3DUDPHWULF7HFKQRORJLHV&RUSRUDWLRQ :DOWKDP0DVVDFKXVHWWV $SURWRW\SHZDVEXLOWXVLQJD6HOHFWLYH/DVHU6LQWHUVWDWLRQ )LJXUH '70 &RUSRUDWLRQ$XVWLQ 7H[DV 7KH SURWRW\SH ZDV WHVWHG E\ SHU IRUPLQJWKH%&23SURWRFROZLWKFRQWUROFRUQHDV&RUQHDVZHUHUHPRYHGIURPERYLQH H\HVDQGPRXQWHGLQWKHKROGHU0(0ZDVDGGHGWRWKHWZRFKDPEHUVDQG$UHDGLQJV ZHUH PDGH DW PLQ DQG K7KH HQGRWKHOLDO FHOO OD\HUV ZHUH VWDLQHG ZLWK WU\SDQ EOXHDQG$OL]DULQ5HG6DQGSKRWRJUDSKHGXVLQJOLJKWPLFURVFRS\
RESULTS 7KHK\GUDWLRQOHYHORIWKHLQWDFWXQWUHDWHGFRUQHDDIWHUKLQFXEDWLRQZDV sPJ+2PJGU\ZHLJKWZLWKDQDYHUDJH$RIs5HPRYDORIWKH HSLWKHOLXPFDXVHGDQLQFUHDVHLQK\GUDWLRQWR sPJ+2PJGU\ZHLJKW ZLWK RQO\ D PLQLPDO LQFUHDVH LQ DEVRUEDQFH WR s 5HPRYDO RI ERWK HSLWKHOLXPDQGHQGRWKHOLXPDQGLQFXEDWLRQLQZDWHUDW&ZDVGHVLJQHGWRFDXVH
112
ALTERNATIVE TOXICOLOGICAL METHODS
Table 10.1 Absorbance at 570 nm (A570) of Bovine Corneas Exposed to Various Treatments and Incubated in MEM for 3 h Treatment
None
Intact, 35ºC, MEM w/o Epi, 35ºC, MEM w/o Epi/Endo, 4ºC, H2O Isopropanol Acetone 30% TCA 1% NaOH 30% SLS
0.05 ± 0.03 0.11 ± 0.03 0.67 ± 0.13 — — — — —
Exposure 10 min 1 min — — — 0.59 ± 1.38 ± 1.43 ± 1.69 ± 0.095 ±
30 sec
— — — 0.23 ± 0.04 1.07 ± 0.21 2.28 ± 0.20 1.28 ± 0.29 0.48 ± 0.28
0.08 0.22 0.08 0.22 0.03
— — — 0.24 ± 0.07 0.87 ± 0.25 1.96 ± 0.06 0.36 ± 0.19 0.21 ± 0.11
Note: Intact is untreated cornea incubated in MEM. w/o Epi is cornea with epithelium removed, not exposed to chemical, and incubated in MEM for 3 h. w/o Epi/Endo is cornea with both epithelium and endothelium removed, not exposed to chemical, and incubated in H2O at 4ºC. Values are mean ±SD, n = 5–10. (Data cited from Ubels et al. [2000]. With permission of Elsevier Science.)
PD[LPDOK\GUDWLRQDQGJHQHUDWHGDK\GUDWLRQRIsPJ+2PJZLWKDQ DEVRUEDQFHRIsZKLFKLVVWLOOLQWKHUDQJHFRQVLGHUHGWRUHSUHVHQWRQO\ PRGHUDWHLUULWDWLRQE\WKH%&237DEOHDQG)LJXUH 18 16
30 sec 1 min
mg H20 / mg cornea
14
10 min 12 10 #
8 #
6
*
#
*
#
4 2
A TC % 30
% 30
N 1%
SL S
aO H
A IP
to ne ce A
w
In /o w/o tac Ep E t i-E pi nd o
0
Figure 10.2 Corneal hydration (mg H2O/mg cornea) following exposure to test substances for 30 sec, 1 min, or 10 min and incubation in MEM for 3 h. Intact is untreated cornea incubated in MEM. w/o Epi is cornea with epithelium removed, not exposed to chemical, and incubated in MEM for 3 h. w/o Epi-Endo is cornea with both epithelium and endothelium removed, not exposed to chemical, incubated in H2O at 4rC. Mean ±SD, n = 5. Values for intact, without Epi, and without Epi-Endo were all significantly different from each other. 30-sec values and unmarked 1min values are not different than intact value. # Significantly different than 30-sec and 1-min values within group. * Significantly different than 30-sec and 10-min values within group. (ANOVA and Dunnett’s test, P e0.05). (Data cited from Ubels et al. [2000]. With permission of Elsevier Science.)
THE BCOP ASSAY
113
&RUQHDVH[SRVHGWRIRXURXWRIÀ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
DISCUSSION 6HYHUDOFRQFOXVLRQVFDQEHGUDZQIURPWKHK\GUDWLRQVWXG\8EHOVHWDO )LUVWZKHQWKHFRUQHDOK\GUDWLRQLQFUHDVHVWRDOHYHORIPJ+2PJGU\ZHLJKW LQ WKH DEVHQFH RI HSLWKHOLXP )LJXUH WKH$ LQFUHDVHV WR RQO\ 7DEOH $QDEVRUEDQFHRILVJHQHUDOO\LQWHUSUHWHGLQWKH%&23DVVD\DVLQGLFDWLYH RI D FRUQHD WKDW LV RQO\ VOLJKWO\ GDPDJHG %HFDXVH ORVV RI HSLWKHOLXP JHQHUDWHV VXEVWDQWLDO HGHPD DQG WKH DEVRUEDQFH UHDGLQJ LQGLFDWHV RQO\ PLQRU GDPDJH WKH DEVRUEDQFH DORQH LV LQVXIÀ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
114
ALTERNATIVE TOXICOLOGICAL METHODS
a
b
Figure 10.3 Corneal endothelial cell layers stained with Alizarin Red S and trypan blue. Twenty percent of the endothelial layer is damaged after mounting in the old corneal holder (left), and none of the endothelial layer is damaged after mounting in the new holder (right). The streaks of damaged cells exhibited after mounting in the old holder are characteristic of wrinkling caused by the holder. Magnification 35v. (Reproduced from Ubels et al. [2002]. With permission of Elsevier Science.)
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
THE BCOP ASSAY
115
WKH FRUQHDO ZULQNOLQJ FRPPRQO\ H[KLELWHG E\ WKH VWDQGDUG %&23 KROGHUV )LJXUH LQGLFDWHVWKDWWKHQHZGHVLJQGRHVSUHYHQWHQGRWKHOLDOGDPDJH:LWKWKLVQHZ KROGHUHQGRWKHOLDOGDPDJHLQGXFHGE\FKHPLFDOH[SRVXUHFDQEHGHWHUPLQHG6LQFH HQGRWKHOLDO FHOOV DUH HVVHQWLDO WR SURSHU FRUQHDO IXQFWLRQ ORVV RI HQGRWKHOLDO FHOOV FRXOGUHVXOWLQLUUHYHUVLEOHGDPDJH:HSURSRVHWKDWHQGRWKHOLDOVWDLQLQJXVLQJWKH QHZ KROGHU GHVLJQ EH DGGHG WR WKH %&23 SURWRFRO WR VWUHQJWKHQ WKH FRQFOXVLRQV WKDWFDQEHPDGHIURPWKHWHVW
ACKNOWLEDGMENTS 7KH DXWKRUV WKDQN$LOHHQ (ULFNVRQ &KULVWRSKHU .UHXOHQ 5RVDQQH 3UXLV -XVWLQ 6\EHVPDDQG'HQQLV.RROIRUWKHLUFRQWULEXWLRQVWRWKHUHVHDUFKUHYLHZHGLQWKLVSDSHU
REFERENCES &DVWHUWRQ3/3RWWV/)DQG.OHLQ%' $QRYHODSSURDFKWRDVVHVVLQJH\HLUULWDWLRQ XVLQJWKHERYLQHFRUQHDORSDFLW\DQGSHUPHDELOLW\WHVW-7R[LFRO&XW2FXODU7R[ LFRO² *DXWKHURQ3'XNLF0$OL['DQG6LQD-) %RYLQHFRUQHDORSDFLW\DQGSHUPH DELOLW\WHVWDQLQYLWURDVVD\RIRFXODULUULWDQF\)XQGDP$SSO7R[LFRO² 0XLU &. $ VLPSOH PHWKRG WR DVVHVV VXUIDFWDQWLQGXFHG ERYLQH FRUQHDO RSDFLW\ LQ YLWURSUHOLPLQDU\ÀQGLQJV7R[LFRO/HWW² 8EHOV-/(ULFNVRQ$0=\OVWUD8.UHXOHQ&'DQG&DVWHUWRQ3/ (IIHFWRI K\GUDWLRQRQRSDFLW\LQWKHERYLQHFRUQHDORSDFLW\DQGSHUPHDELOLW\%&23 DVVD\ -7R[LFRO&XW2FXODU7R[LFRO² 8EHOV-/3DDXZ-'&DVWHUWRQ3/DQG.RRO'- $UHGHVLJQHGFRUQHDOKROGHU IRUWKHERYLQHFRUQHDRSDFLW\DQGSHUPHDELOLW\DVVD\WKDWPDLQWDLQVQRUPDOFRUQHDO PRUSKRORJ\7R[LFROLQ9LWUR² 8EHOV-/3UXLV506\EHVPD-7DQG&DVWHUWRQ3/ &RUQHDORSDFLW\K\GUDWLRQ DQG HQGRWKHOLDO PRUSKRORJ\ LQ WKH ERYLQH FRUQHD RSDFLW\ DQG SHUPHDELOLW\ DVVD\ XVLQJUHGXFHGWUHDWPHQWWLPHV7R[LFRO,Q9LWUR²
CHAPTER
11
Corneal Organ Culture for Ocular Toxicity Test of Commercial Hair Care Products )X6KLQ;<XDQG.H3LQJ;X
CONTENTS ,QWURGXFWLRQ 0HWKRGV &RUQHDO2UJDQ&XOWXUH &XOWXUH7UHDWPHQW 6XUIDFH%LRWLQ\ODWLRQ7LJKW-XQFWLRQ3HUPHDELOLW\$VVD\ (OHFWURSKRUHWLF0RELOLW\6KLIW$VVD\(06$ 5HVXOWVDQG'LVFXVVLRQ 5HIHUHQFHV INTRODUCTION &RPPHUFLDOSURGXFWVZKHWKHUGUXJVFRVPHWLFVRUEXONFKHPLFDOVDUHVXEMHFW WRDYDULHW\RIWHVWVWKDWDUHXVXDOO\SHUIRUPHGRQDQLPDOVWRGHWHUPLQHDQ\SRWHQWLDO DGYHUVHHIIHFWV$PRQJWKHURXWLQHO\SHUIRUPHGWHVWVLVRQHGHVLJQHGWRHYDOXDWHWKH WHVWVXEVWDQFH·VSRWHQWLDOWRFDXVHH\HLUULWDWLRQRULQMXU\WKH'UDL]HWHVW'UDL]HHW DO 7KH 'UDL]H WHVW DQG LWV QXPHURXV PRGLÀFDWLRQV KDYH UHPDLQHG WKH DFFHSWHGPHWKRGIRUHYDOXDWLQJRFXODUWR[LFLW\IRUPRUHWKDQÀYHGHFDGHV6\PSR VLXP 3URFHHGLQJV ,W KDV KRZHYHU EHHQ VXEMHFW WR PXFK FULWLFLVP IRU LWV LQKXPDQH WUHDWPHQW WR DQLPDOV DV ZHOO DV WKH LUUHSURGXFLELOLW\ RI WKH VXEMHFWLYH VFRULQJSURFHGXUH7KHUHIRUHWKHUHLVDJUHDWQHHGIRUPLQLPL]LQJWKHXVHRIDQLPDOV LQ FKHPLFDO WR[LFLW\ WHVWV DQG GHYHORSLQJ D PHFKDQLVWLFDOO\ EDVHG LQ YLWUR WHVWLQJ V\VWHP6\PSRVLXP3URFHHGLQJV ; E\&5&3UHVV//&
117
118
ALTERNATIVE TOXICOLOGICAL METHODS
6HYHUDO SURPLVLQJ V\VWHPV IRU RFXODU WR[LFLW\ WHVW DUH XVHG *DXWKHURQ HW DO RUDUHFXUUHQWO\XQGHUGHYHORSPHQWLQFOXGLQJXVLQJLPPRUWDOL]HGFHOOOLQHV .UXV]HZVNLHWDO:DUGHWDO KXPDQFRUQHDOHTXLYDOHQWVFRQVWUXFWHG IURPFHOOOLQHV*ULIÀ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ÀUPWKHXVHIXOQHVVRIWKLVPRGHOZHHYDOXDWHGWKUHHKDLUFDUHSURGXFWV LQDGRXEOHEOLQGPDQQHU:HIRXQGWKDWVKDPSRRVWKDWDUHPRGHUDWHO\LUULWDWLQJ FDXVHG EUHDNGRZQ RI WKH HSLWKHOLDO EDUULHU DQG DOWHUDWLRQ RI $3 DQG 1)O% '1$ELQGLQJ DFWLYLWLHV ZKLOH D PLQLPDOO\ LUULWDWLQJ KDLU FDUH SURGXFW KDG QR HIIHFWVRQFXOWXUHGFRUQHDV7KHVHUHVXOWVLQGLFDWHWKHYDOXHRIWKHV\VWHPDVDQ DOWHUQDWLYHIRUWKHLQYLYR'UDL]HWHVW
METHODS Corneal Organ Culture %RYLQHH\HVZHUHREWDLQHGIURPDORFDODEDWWRLUDQGWUDQVSRUWHGWRWKHODERUDWRU\ RQ LFH LQ D PRLVWXUH FKDPEHU &RUQHDOVFOHUDO ULPV ZLWK DSSUR[LPDWHO\ PP RI WKH OLPEDO FRQMXQFWLYD SUHVHQW ZHUH H[FLVHG DQG ULQVHG LQ VWHULOL]HG SKRVSKDWH EXIIHUHGVDOLQH3%6 7KHH[FLVHGFRUQHDVZHUHSODFHGHSLWKHOLDOVLGHGRZQLQWRD VWHULOH ´FXSµ 7KH HQGRWKHOLDO FRUQHDO FRQFDYLW\ ZDV WKHQ ÀOOHG ZLWK PLQLPXP HVVHQWLDOPHGLXP0(0 FRQWDLQLQJDJDURVHDQGPJPOUDWWDLOWHQGRQFRO ODJHQPDLQWDLQHGDWr&7KLVPL[WXUHZDVDOORZHGWRJHO&RUQHDDORQJZLWKLWV VXSSRUWLQJ JHO ZDV LQYHUWHG DQG WKHQ WUDQVIHUUHG WR D PP GLDPHWHU GLVK 7KH FXOWXUHPHGLXPDERXWPO ZDVDGGHGGURSZLVHWRWKHVXUIDFHRIFHQWUDOFRUQHD XQWLOWKHOLPEDOFRQMXQFWLYDZDVFRYHUHGOHDYLQJWKHHSLWKHOLXPH[SRVHGWRWKHDLU )RUHPDQHWDO;XHWDO
CORNEAL ORGAN CULTURE FOR OCULAR TOXICITY TEST
119
Culture Treatment 7KUHH KDLU FDUH SURGXFWV WHUPHG *$ *% DQG *& ZHUH DSSOLHG GLUHFWO\ RU GLOXWHG ZLWK 0(0 ÀUVW DQG WKHQ DSSOLHG GURSZLVH RQWR WKH FHQWHU VXUIDFH RI WKH FRUQHD$IWHUGLVFUHWHWLPHLQWHUYDOVWKHWUHDWHGFRUQHDVZHUHZDVKHG²WLPHVE\ GLSSLQJLQWR3%6VROXWLRQDQGWKHQSURFHVVHGIRUHLWKHUFHOOVXUIDFHELRWLQODEHOLQJ RUHSLWKHOLDOQXFOHDUH[WUDFWLRQ Surface Biotinylation-Tight Junction Permeability Assay &XOWXUHGFRUQHDVZHUHZHWWHGZLWKIUHVKO\PDGHPJPOVXOIR1+6/&ELRWLQ 3LHUFH&KHPLFDOV5RFNIRUG,/ LQ+DQN·VEDODQFHGVDOWVROXWLRQFRQWDLQLQJP0 &D&ODQGP00J&O&KHQHWDO $IWHUDPLQLQFXEDWLRQWKHVXUIDFH ODEHOHGFRUQHDVZHUHULQVHGZLWK3%6HPEHGGHGLQ2&7IUR]HQLQOLTXLGQLWURJHQ DQGVHFWLRQHGRQDFU\RVWDWDWDWKLFNQHVVRIQP7KHVHFWLRQVZHUHÀ[HGZLWKLFH FROG DFHWRQH DQG ODEHOHG ZLWK UKRGDPLQHDYLGLQ ' LQ 3%6 FRQWDLQLQJ ERYLQH VHUXPDOEXPLQ%6$ IRUK7KHVOLGHVZHUHPRXQWHGDQGH[DPLQHGXQGHUD1LNRQ (FOLSVH(ÁXRUHVFHQFHPLFURVFRSHHTXLSSHGZLWKD6SRWGLJLWDOFDPHUD Electrophoretic Mobility Shift Assay (EMSA) 7R SUHSDUHG FHOO H[WUDFWV IRU (06$ WKH HSLWKHOLDO FHOOV ZHUH UHPRYHG IURP FXOWXUHGERYLQHFRUQHDVH[SRVHGWRKDLUFDUHSURGXFWVXQGHUDGLVVHFWLRQPLFURVFRSH ZLWKDVFDOSHOEODGH&HOOVIURPHDFKFRUQHDZHUHUHVXVSHQGHGLQQORIH[WUDFWLQJ EXIIHUP0+HSHV.2+DWS+P0GLWKLRWKUHLWRO>'77@P0HWK\OHQH GLDPLQHWHWUDDFHWLFDFLG>('7$@P0.&OJO\FHUROP0SKHQ\OPH WK\OVXOIRQ\OÁXRULGH>306)@13 DQGLQFXEDWHGZLWKSHULRGLFDJLWDWLRQDW r&IRUK3URWHLQFRQFHQWUDWLRQZDVGHWHUPLQHGXVLQJPLFUR%&$SURWHLQDVVD\ UHDJHQWNLW3LHUFH&KHPLFDO&R 7KHROLJRQXFOHRWLGH&*&77*$7*$*7&$*& &**$$IRU$3ELQGLQJDQGWKHROLJRQXFOHRWLGH$*&77&$*$****$777& &*$*$**IRU1)O%ELQGLQJZHUHODEHOHGXVLQJ7SRO\QXFOHRWLGHNLQDVHDQG >K3@$73)RUGHWHFWLRQRI$3DQG1)O%'1$ELQGLQJDFWLYLWLHV 3ODEHOHG ROLJRQXFOHRWLGHVZHUHLQFXEDWHGZLWKDQJRIHSLWKHOLDOH[WUDFWHGSURWHLQVDQGWKH UHDFWLRQPL[WXUHZDVVXEMHFWHGWR(06$DVVD\DVGHVFULEHGE\;XHWDO
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
120
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 11.1 Biotin surface labeling to visualize epithelial barrier. Cultured bovine cornea was incubated with sulfo-NHS-LC-biotin for 30 min and then embedded in OCT, snapfrozen, and sectioned (6 Qm). Cryostat sections (8 Qm) were (A) stained directly with hematoxylin to reveal corneal morphology (B) or incubated with rhodamineavidin D to visualize the bound biotin. The rhodamine staining represents biotinylation of accessible surface of normal bovine cornea and linear staining at the corneal surface indicates functional epithelial TJ barrier in cultured corneas. Ep, epithelium; BM, basement membrane; St, stroma that consists of fibroblasts. A and B are mirror orientations of the same corneal sections.
:H ÀUVW DVVHVVHG GLVUXSWLRQ RI HSLWKHOLDO WLJKW MXQFWLRQ LQGXFHG E\ WKHVH KDLU FDUH SURGXFWV LQ FXOWXUHG ERYLQH FRUQHDV 0DPPDOLDQ FRUQHDO HSLWKHOLD FRQVLVW RI VHYHUDO OD\HUV RI FHOOV )LJXUH $ *LSVRQ DQG 6XJUXH $ EDVHPHQW PHPEUDQHOLHVLPPHGLDWHO\EHQHDWKWKHEDVDOODPLQDRIWKHFRUQHDOHSLWKHOLXPDQG WKHXQGHUO\LQJVWURPDLVFRPSRVHGRIPDQ\ODPHOODHRIFROODJHQÀEHUVZLWKÁDWWHQHG ÀEUREODVWV O\LQJ EHWZHHQ DGMDFHQW ODPHOODH 8VLQJ VXOIR1+6/&ELRWLQ WKDW FRYDOHQWO\FURVVOLQNVWRSURWHLQVZHGHPRQVWUDWHGWKHLPSHUPHDEOHQDWXUHRIWKH FRUQHD)LJXUH% ,QQRUPDOFRUQHDRQO\WKHRXWHUPRVWVXUIDFHRIHSLWKHOLXP ZDVFRQWLQXDOO\ODEHOHGZLWKELRWLQDVLQGLFDWHGE\DÁ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À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
CORNEAL ORGAN CULTURE FOR OCULAR TOXICITY TEST
121
Figure 11.2 Tight junction permeability assay of cultured bovine corneas in response to challenge of three hair care products. Corneas in culture were treated with 100%, 50% (not shown), and 25% chemicals, and TJ permeability of corneal epithelium was assessed by surface biotinylation as described in Figure 11.1. Inserts: corneal sections stained directly with hematoxylin to reveal corneal morphology. Note: extended biotinylation of the corneal surface caused by GA and GB exposure in a concentration dependent manner. However, no disruption of TJ was observed in GC treated cornea.
YLVLEOHGLVUXSWLRQRIVXUIDFHODEHOLQJDQGODEHOLQJRIPXOWLSOHHSLWKHOLDOOD\HUVDQG WKHVWURPD8QOLNH*$DQG*%FRUQHDVH[SRVHGWR*&'UDL]HVFRUHPLQLPDOO\ LUULWDWLQJ H[KLELWHGPLQLPDOGLVUXSWLRQRIVXUIDFHELRWLQ\ODWLRQZKHQXQGLOXWHG*& ZDVXVHGDQGQRDSSDUHQWHIIHFWVZKHQGLOXWLRQZDVXVHG)LJXUH 7DNHQ WRJHWKHU RXU UHVXOWV VXJJHVW WKDW KDLU FDUH SURGXFW²LQGXFHG DOWHUDWLRQ RI VXUIDFH ODEHOLQJZDVFRQVLVWHQWZLWKLUULWDQF\SRWHQWLDORIWKHVHFRQVXPHUSURGXFWVDVGHWHU PLQHG E\ WKH LQ YLYR 'UDL]H WHVW )XUWKHUPRUH VXUIDFH ELRWLQ\ODWLRQ RI FXOWXUHG FRUQHDLVDQHIIHFWLYHZD\WRHYDOXDWH7-SHUPHDELOLW\DQGDIWHUDODUJHQXPEHURI
122
ALTERNATIVE TOXICOLOGICAL METHODS
FKHPLFDOV ZLWK NQRZQ RFXODU WR[LFLW\ DUH WHVWHG WR JUDGH WKH RFXODU WR[LFLW\ RI VXUIDFWDQWEDVHGFRQVXPHUSURGXFWVDQGRWKHUFKHPLFDOV :HDOVRDVVHVVWKHDOWHUDWLRQRI1)O%'1$ELQGLQJDFWLYLW\FDXVHGE\WKHKDLU FDUHSURGXFWVLQWKHFRUQHDOHSLWKHOLDOFHOOV'LVUXSWLRQRI7-VZRXOGDOORZFKHPLFDOV WRGLIIXVHLQWRGHHSHUHSLWKHOLDOOD\HUVZKHUHVHQVHQHXURQVUHVLGHFDXVLQJ´LUULWD WLRQµDQGHSLWKHOLDOFHOOVWUHVVUHVSRQVHV,WLVJHQHUDOO\EHOLHYHGWKDWPRVWWR[LFR ORJLFDOO\ UHOHYDQW RXWFRPHV UHTXLUH QRW RQO\ GLIIHUHQWLDO JHQH H[SUHVVLRQ EXW DOVR GLIIHUHQWLDOH[SUHVVLRQRIPXOWLSOHJHQHV)DUUDQG'XQQ $FWLYDWHGWUDQVFULS WLRQIDFWRUVFRRUGLQDWHO\PRGXODWHWDUJHWJHQHH[SUHVVLRQYLDELQGLQJWRWKHVSHFLÀF '1$VHTXHQFHVORFDWHGLQWKHSURPRWHURUHQKDQFHU$3.DULQHWDO DQG 1)O% -DQVVHQ HW DO 3LQNXV HW DO DUH ZHOOFKDUDFWHUL]HG VWUHVV UHVSRQVH WUDQVFULSWLRQ IDFWRUV NQRZQ WR WUDQVDFWLYDWH D ODUJH QXPEHU RI VWUHVV UHVSRQVH JHQHV DQG WKHUHIRUH ÀW WKH SURÀOH RI LQGLFDWRUV RI VWUHVVLQGXFHG JHQH H[SUHVVLRQ ,Q WKLV VWXG\ 1)O% '1$ELQGLQJ DFWLYLW\ LQ UHVSRQVH WR FKHPLFDO FKDOOHQJH RI FXOWXUHG FRUQHDV ZDV PHDVXUHG XVLQJ HOHFWURSKRUHWLF PRELOLW\ VKLIW DVVD\(06$ ZLWKH[WUDFWVIURPHSLWKHOLDOFHOOV)LJXUHVKRZHGDOWHUDWLRQRI 1)O% '1$ELQGLQJ DFWLYLW\ IROORZLQJ KDLU FDUH SURGXFW FKDOOHQJHV WR FXOWXUHG FRUQHDV7KHUHZDVRQHPDMRUVKLIWHGEDQGREVHUYHGLQXQWUHDWHGFRUQHDOHSLWKHOLDO FHOOV,QFUHDVHLQ*$FRQFHQWUDWLRQOHGWRDGHFUHDVHLQ$3'1$ELQGLQJDFWLYLW\
Figure 11.3 EMSA analysis of NF-OB DNA-binding activity in bovine corneal epithelial cells in response to consumer product challenge. Panels showed cultured corneas were treated with different concentrations of three hair care products for 5 min, untreated cells were used as control (C). The corneas were then cultured for 10 min without the presence of the chemicals. Cell extracts from corneal epithelial cells treatment were probed with 32P-labeled AP-1 (upper panel) or NF-OB (lower panel) consensus oligonucleotide. EMSA experiments were repeated two times, and gels presented in the figure are from a representative set.
CORNEAL ORGAN CULTURE FOR OCULAR TOXICITY TEST
123
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ÁXHQFH GLUHFWO\ RU VHFRQGDU\WRGHFUHDVHGQXPEHURIYLDEOHFHOOV1HYHUWKHOHVVRXUUHVXOWVGHPRQVWUDWH D FDXVDO UHODWLRQVKLS EHWZHHQ DOWHUDWLRQ RI 1)O% DFWLYLWLHV DQG RFXODU WR[LFLW\ ZKLFKVXJJHVWVWKDW1)O%ELQGLQJDFWLYLW\PD\VHUYHDVDVSHFLÀFDQGTXDQWLÀ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
REFERENCES &KHQ<0HU]GRUI&3DXO'/DQG*RRGHQRXJK'$ &22+WHUPLQXVRIRFFOXGLQ LVUHTXLUHGIRUWLJKWMXQFWLRQEDUULHUIXQFWLRQLQHDUO\;HQRSXVHPEU\RV-&HOO%LRO ² 'UDL]H-+DQG:RRGDUG*+2& 0HWKRGIRUWKHVWXG\ RILUULWDWLRQDQGWR[LFLW\ RI VXEVWDQFHV DSSOLHG WRSLFDOO\ WR WKH VNLQ DQG PXFRXV PHPEUDQH - 3KDUPDFRO ([S7KHU² )DUU6DQG'XQQ57 &RQFLVHUHYLHZJHQHH[SUHVVLRQDSSOLHGWRWR[LFRORJ\7R[LFRO 6FL² )RUHPDQ'03DQFKROL6-DUYLV(-0F/HRG'DQG%RXOWRQ0( $VLPSOH RUJDQFXOWXUHPRGHOIRUDVVHVVLQJWKHHIIHFWVRIJURZWKIDFWRUVRQFRUQHDOUHHSLWKH OLDOL]DWLRQ([S(\H5HV²
124
ALTERNATIVE TOXICOLOGICAL METHODS
*DXWKHURQ3'XNLF0$OL['DQG6LQD- %RYLQH FRUQHDORSDFLW\DQGSHUPH DELOLW\WHVWDQLQYLWURDVVD\RIRFXODULUULWDQF\)XQGDP$SSO7R[LFRO² *LSVRQ , DQG 6XJUXH 6 &HOO ELRORJ\ RI WKH FRUQHDO HSLWKHOLXP LQ 3ULQFLSOHV DQG 3UDFWLFH RI 2SKWKDOPRORJ\ $OEHUW ' DQG -DNRELHF ) (GV 3KLODGHOSKLD :% 6DXQGHUVSS² *RRGHQRXJK'$ 3OXJJLQJWKHOHDNV3URF1DWO$FDG6FL86$² *UDQW5/VHHFRPPHQWV@6FLHQFH² -DQVVHQ<0 %DUFKRZVN\$ 7UHDGZHOO 0 'ULVFROO .( DQG 0RVVPDQ %7 $VEHVWRV LQGXFHV QXFOHDU IDFWRU NDSSD % 1)NDSSD % '1$ELQGLQJ DFWLYLW\ DQG 1)NDSSD%GHSHQGHQWJHQHH[SUHVVLRQLQWUDFKHDOHSLWKHOLDOFHOOV3URF1DWO$FDG 6FL86$² -HVWHU-9/L+)3HWUROO:03DUNHU5'&DYDQDJK+'&DUU*-6PLWK%DQG 0DXUHU-.D $UHDDQGGHSWKRIVXUIDFWDQWLQGXFHGFRUQHDOLQMXU\FRUUHODWHV ZLWKFHOOGHDWK,QYHVW2SKWKDOPRO9LV6FL² -HVWHU-93HWUROO:0%HDQ-3DUNHU5'&DUU*-&DYDQDJK+'DQG0DXUHU -.E $UHDDQGGHSWKRIVXUIDFWDQWLQGXFHGFRUQHDOLQMXU\SUHGLFWVH[WHQWRI VXEVHTXHQWRFXODUUHVSRQVHV,QYHVW2SKWKDOPRO9LV6FL² .DULQ0/LX=DQG=DQGL( $3IXQFWLRQDQGUHJXODWLRQ&XUU2SLQ&HOO%LRO ² .UXV]HZVNL)+:DONHU7/DQG'L3DVTXDOH/& (YDOXDWLRQRIDKXPDQFRUQHDO HSLWKHOLDOFHOOOLQHDVDQLQYLWURPRGHOIRUDVVHVVLQJRFXODULUULWDWLRQ)XQGDP$SSO 7R[LFRO² 3LQNXV 5 :HLQHU /0 DQG 'DQLHO 9 5ROH RI R[LGDQWV DQG DQWLR[LGDQWV LQ WKH LQGXFWLRQRI$31)NDSSD%DQGJOXWDWKLRQH6WUDQVIHUDVHJHQHH[SUHVVLRQ-%LRO &KHP² 6\PSRVLXP3URFHHGLQJV 5HSODFLQJWKH'UDL]HH\HLUULWDWLRQWHVWVFLHQWLÀFEDFNJURXQG DQGUHVHDUFKQHHGV-7R[LFRO&XW2FXODU7R[LFRO² :DUG 6/:DONHU7/ DQG 'LPLWULMHYLFK 6' (YDOXDWLRQ RI FKHPLFDOO\ LQGXFHG WR[LFLW\ XVLQJ LQ YLWUR PRGHO RI KXPDQ FRUQHDO HSLWKHOLXP 7R[LFRO LQ YLWUR ² ;X.3/L;)DQG<X)6 &RUQHDORUJDQFXOWXUHPRGHOIRUDVVHVVLQJHSLWKHOLDO UHVSRQVHVWRVXUIDFWDQWV7R[LFRO6FL²
CHAPTER
12
Human Corneal Equivalents for In Vitro Testing 0D\*ULIÀWKDQG(ULN6XXURQHQ
CONTENTS ,QWURGXFWLRQ 'HYHORSPHQWRI&HOO/LQHVDQG&RQVWUXFWLRQRI&RUQHDV &KDQJHVLQ&RUQHDO7UDQVSDUHQF\LQ5HVSRQVHWR&KHPLFDOV &KDQJHVLQ*HQH([SUHVVLRQLQ5HVSRQVHWR&KHPLFDO([SRVXUH 'HYHORSPHQWRI5HODWHG7LVVXHV 5HIHUHQFHV
INTRODUCTION ,QWKLVFKDSWHUZHUHYLHZWKHGHYHORSPHQWRIWLVVXHHQJLQHHUHGKXPDQFRUQHDV DQGDVVRFLDWHGVWUXFWXUHVIRUXVHDVSRVVLEOHLQYLWURDOWHUQDWLYHVWRRFXODULUULWDQF\ WHVWLQJLQDQLPDOV$WSUHVHQWWHVWVRISRWHQWLDORFXODUWR[LFLW\DUHPHDVXUHGXVLQJ WKH'UDL]HRU/9(7ORZYROXPHH\HWHVW UDEELWRFXODULUULWDQF\WHVWV 'DVWRQDQG )UHHEHUJ 7KHUHOLDELOLW\DQGSHUWLQHQFHRIUHVXOWVREWDLQHGIURPQRQ²KXPDQ VSHFLÀF WLVVXHV UHPDLQ TXHVWLRQDEOH 7KLV DQG WKH SXVK IRU D EDQ RQ OLYH DQLPDO WHVWLQJ KDV QHFHVVLWDWHG WKH GHYHORSPHQW RI DOWHUQDWLYHV IRU VDIHW\ HIÀFDF\ DQG WR[LFRORJ\WHVWLQJRIGUXJVDQGFRQVXPHUSURGXFWV 2XU WHDP *ULIÀWK :DWVN\ 2VERUQH DQG RWKHUV KDG SUHYLRXVO\ GHYHORSHG D FROODJHQJO\FRVDPLQRJO\FDQV EDVHG VWDELOL]HG PDWUL[ WKDW VHUYHG DV D VFDIIROG IRU WKHFRQVWUXFWLRQRIDQLQYLWURWLVVXHHTXLYDOHQWRIWKHKXPDQFRUQHD*ULIÀWKHWDO 7KHVH KXPDQ FRUQHDO HTXLYDOHQWV FRPSULVHG DOO WKUHH PDLQ OD\HUV RI WKH FRUQHD VWUDWLÀHG HSLWKHOLXP VWURPD ZLWK NHUDWRF\WHV DQG HQGRWKHOLDO PRQROD\HU DQGPLPLFNHGKXPDQFRUQHDVLQNH\SK\VLFDODQGSK\VLRORJLFDOIXQFWLRQV&HOOVIRU ; E\&5&3UHVV//&
125
126
ALTERNATIVE TOXICOLOGICAL METHODS
HDFKRIWKHWLVVXHOD\HUVZHUHLVRODWHGIURPWKHLQGLYLGXDOFHOOXODUOD\HUVRIKXPDQ H\H EDQN FRUQHDV ,Q RUGHU WR PDLQWDLQ D FRQWLQXRXV VXSSO\ RI FHOOV IRU UHVHDUFK SXUSRVHV DQG DOVR IRU KRPRJHQHLW\ IRU UHSHDWDELOLW\ LQ WHVWLQJ FRUQHDO FHOO OLQHV ZHUH GHYHORSHG E\ H[WHQGLQJ WKHLU OLIH VSDQV XVLQJ YLUDO JHQHV WKDW UHWDUGHG RU LQKLELWHGQRUPDOVHQHVFHQFH
DEVELOPMENT OF CELL LINES AND CONSTRUCTION OF CORNEAS &RUQHDO FHOO OLQHV ZLWK H[WHQGHG OLIH VSDQV ZHUH GHYHORSHG E\ WUDQVIHFWLRQ .LQJVWRQHWDO RIJHQHVIURP69ODUJH7DQWLJHQFRGLQJUHJLRQV %U\DQ DQG 5HGGHO DGHQRYLUXV ($ 4XLQODQ DQG KXPDQ SDSLOORPD YLUXV +39 (( UHJLRQ +DOEHUW HW DO 5KLP HW DO LQWR ORZ SDVVDJHSULPDU\FHOOVIURPHDFKRIWKHWKUHHPDLQOD\HUVRIWKHFRUQHD3ULRUWRXVH LQWKHFRUQHDOHTXLYDOHQWVFHOOOLQHVZHUHVFUHHQHGIRUPRUSKRORJLFDOELRFKHPLFDO SURWHLQDQGP51$PDUNHUV DQGHOHFWURSK\VLRORJLFDOVLPLODULWLHVWRIUHVKO\GLVVR FLDWHG RU ORZ SDVVDJH FXOWXUHG FRUQHDO FHOOV REWDLQHG IURP SRVW PRUWHP KXPDQ FRUQHDV7KHJRDOZDVWRLGHQWLI\OLQHVZLWKIXQFWLRQDOSURSHUWLHVVLPLODUWRQRUPDO FHOOVIRUXVHLQWKHFRUQHDOHTXLYDOHQWV&RQVWUXFWLRQVXVLQJFHOOOLQHVZLWKDSSUR SULDWHLRQFKDQQHODFWLYLWLHV\LHOGHGWKHPRVWVXFFHVVIXOFRUQHDOHTXLYDOHQWV &RUQHDO HTXLYDOHQWV ZHUH FRQVWUXFWHG LQ LQVHUWV DV GHVFULEHG E\ *ULIÀWK HW DO %ULHÁ\DFROODJHQFKRQGURLWLQVXOIDWHVXEVWUDWHZDVFURVVOLQNHGZLWK WRJOXWHUDOGHK\GHDQGWKHQWUHDWHGZLWKJO\FLQHWRUHPRYHH[FHVVJOXWHUDOGH K\GH7KLVV\QWKHVL]HGWLVVXHPDWUL[SURYLGHGWKHVFDIIROGWRZKLFKFHOOVZHUHDGGHG 6WURPDOFHOOVZHUHPL[HGLQWRWKHPDWUL[DQGHSLWKHOLXPRUHQGRWKHOLXPFHOOVZHUH OD\HUHGRQWRSRUEHORZ6XFFHVVIXOFRQVWUXFWVZHUHDFKLHYHGZLWKHLWKHUHSLWKHOLXP RUHQGRWKHOLXPEHLQJVHHGHGRQWRWKHLQVHUWÀUVW2QFHWKHHSLWKHOLXPZDVFRQÁXHQW WKHFRUQHDOHTXLYDOHQWZDVPDLQWDLQHGDWDQDLU²OLTXLGLQWHUSKDVHWRDOORZGLIIHUHQ WLDWLRQLQWRPXOWLOD\HUV7KHFRUQHDOHTXLYDOHQWVZHUHDOORZHGWRGLIIHUHQWLDWHIRU ZHHNV DQG ZHUH WKHQ WHVWHG IRU NH\ SK\VLFDO DQG SK\VLRORJLFDO IXQFWLRQV 7KH HTXLYDOHQW FRUQHDO WLVVXH ZDV IRXQG WR EH VXLWDEOH IRU RFXODU WHVWLQJ EHFDXVH LW PLPLFNHG WKH KXPDQ FRUQHD LQ LPSRUWDQW IXQFWLRQDO FKDUDFWHULVWLFV VXFK DV PRU SKRORJ\ELRFKHPLFDOPDUNHUH[SUHVVLRQWUDQVSDUHQF\LRQDQGÁXLGWUDQVSRUWDQG JHQHH[SUHVVLRQ
CHANGES IN CORNEAL TRANSPARENCY IN RESPONSE TO CHEMICALS 7R HYDOXDWH WKH SRWHQWLDO RI WKH FRUQHDO HTXLYDOHQW DV D PRGHO IRU WHVWLQJ RI FKHPLFDOV IRU RFXODU LUULWDQF\ SRWHQWLDO ZH KDG H[SRVHG H[FLVHG UDEELW FRUQHDV KXPDQH\HEDQNFRUQHDVDQGFRUQHDOHTXLYDOHQWVWRFKHPLFDODJHQWV:HGHPRQ VWUDWHG RSDFLÀFDWLRQ ZLWKLQ WKH WUHDWPHQW ]RQH RI DOO WKUHH W\SHV RI FRUQHDV LQ UHVSRQVH WR SRWHQWLDOO\ LUULWDWLQJ FKHPLFDOV WKDW FRXOG EH TXDQWLÀHG RQ D FXVWRP LQVWUXPHQW3ULHVWDQG0XQJHU &KDQJHVLQWUDQVSDUHQF\OLJKWWUDQVPLVVLRQ RIWKHFRUQHDOHTXLYDOHQWVLQUHVSRQVHWRDSDQHORIVL[FKHPLFDOVWKDWUDQJHGIURP
HUMAN CORNEAL EQUIVALENTS FOR IN VITRO TESTING
127
PLOGWRKDUVKZHUHFRPSDUDEOHWRWKRVHREVHUYHGLQH[YLYRKXPDQDQGUDEELWFRUQHDV *ULIÀWKHWDO 7KHFRUQHDOHTXLYDOHQWVGHPRQVWUDWHGDQDFWLYHUHVSRQVHWR GLIIHUHQWJUDGHVRILQMXU\DQLPSRUWDQWIXQFWLRQDOFKDUDFWHULVWLFRIKXPDQFRUQHDV 7KHUHVSRQVHVDQGWUHQGVREVHUYHGZHUHFRPSDUDEOHWRWKRVHVHHQLQUDEELWFRUQHDV DQGKXPDQFRUQHDV
CHANGES IN GENE EXPRESSION IN RESPONSE TO CHEMICAL EXPOSURE :HXVHGUHYHUVHWUDQVFULSWLRQ²SRO\PHUDVHFKDLQUHDFWLRQ573&5 WRH[DPLQH UHODWLYHFKDQJHVLQJHQHH[SUHVVLRQLQFRUQHDOHTXLYDOHQWVLQUHVSRQVHWRLQMXU\DQG FRPSDUHGWKHVHZLWKFKDQJHVREVHUYHGLQH[FLVHGKXPDQH\HEDQNFRUQHDV&RUQHDV DQGFRUQHDOHTXLYDOHQWVZHUHH[SRVHGWRDQDTXHRXVVROXWLRQRIVRGLXPGRGHF\O VXOIDWH6'6 DVXUIDFWDQWWKDWFDXVHVPLOGWRPRGHUDWHLQMXU\WRWKHFRUQHD'UDL]H HWDO*ULIÀWKHWDO ([SRVXUHRIFRUQHDVWR6'6UHVXOWHGLQGLIIHUHQWLDO LQFUHDVHV LQ P51$ OHYHOV LQ WKH GLIIHUHQW JHQHV H[DPLQHG FIRV F\WRNLQHV ,/ ,/E)*)DQG9(*)DQGW\SH,FROODJHQ ZKRVHSURGXFWVKDYHUROHVLQFRUQHDO ZRXQGKHDOLQJ*ULIÀWKHWDO $OWKRXJKVLPLODUWUHQGVZHUHREVHUYHGLQERWK IDEULFDWHG FRUQHDV DQG H\H EDQN FRUQHDV WKH IRUPHU VKRZHG JUHDWHU VHQVLWLYLW\ LQGLFDWHG E\ PRUH PDUNHG LQFUHDVHV LQ P51$ H[SUHVVLRQ 2QH SRVVLELOLW\ LV WKDW WKH H\H EDQN FRUQHDV KDG XQGHUJRQH VWRUDJH IRU XS WR K ,Q DGGLWLRQ DOO WKH KHDOWKLHVW H\H EDQN FRUQHDV DUH XVHG IRU WUDQVSODQWDWLRQ DQG ZHUH WKHUHIRUH QRW DYDLODEOHIRURXUVWXG\
DEVELOPMENT OF RELATED TISSUES 7KH SUHVHQW FRUQHD JLYHV TXDQWLÀDEOH FKDQJHV LQ WUDQVSDUHQF\ DQG JHQH H[SUHVVLRQ LQGLFDWLQJ GLIIHUHQW GHJUHHV RI FHOOXODU GDPDJH LQ UHVSRQVH WR WR[LF VWLPXOL +RZHYHU LW SURYLGHV QR LQGLFDWLRQV RI VHQVLWLYLW\ SDLQ RU SRWHQWLDO QHXURWR[LFLW\)RUIXWXUHWHVWLQJRISRWHQWLDOGUXJDQGFKHPLFDOVHQVLWLYLW\LQQHU YDWHGFRUQHDOHTXLYDOHQWVDUHEHLQJGHYHORSHG0RGLÀ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
128
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 12.1 Confocal image of a corneal equivalent with surrounding sclera containing chick embryonic dorsal root ganglion (not shown). Neurites, labeled with nerve-specific antineurofilament antibody are seen traveling through the sclera (S) parallel to the corneal periphery and branching into the cornea (C). White dashed line, corneal periphery; arrows, parallel neurites; arrowheads, branching neurites.
IRU WKH GHYHORSPHQW RI ORZ UHMHFWLRQ UDWH LPSODQWDEOH WHPSRUDU\ RU SHUPDQHQW FRUQHDUHSODFHPHQWV
REFERENCES %U\DQ 70 DQG 5HGGHO 55 69LQGXFHG LPPRUWDOL]DWLRQ RI KXPDQ FHOOV &ULW 5HY2QFRJ² 'DVWRQ *3 DQG )UHHEHUJ )( 2FXODU LUULWDWLRQ WHVWLQJ LQ 'HUPDO DQG 2FXODU 7R[LFRORJ\+REVRQ':(G&5&3UHVV%RFD5DWRQ² 'UDL]H-+:RRGDUG*DQG&DOYHU\+2 0HWKRGVIRUWKHVWXG\RILUULWDWLRQDQG WR[LFLW\RIVXEVWDQFHVDSSOLHGWRSLFDOO\WRWKHVNLQDQGPXFRXVPHPEUDQHV-3KDU PDFRO([S7KHU² *ULIÀWK-)1L[RQ*$%UXFH5'5HHU3-DQG%DQQDQ($ 'RVHUHVSRQVH VWXGLHVZLWKFKHPLFDOLUULWDQWVLQWKHDOELQRUDEELWH\HDVDEDVLVIRUVHOHFWLQJRSWLPXP WHVWLQJFRQGLWLRQVIRUSUHGLFWLQJKD]DUGWRWKHKXPDQH\H7R[LFRO$SSO3KDUPDFRO ² *ULIÀWK02VERUQH50XQJHU5;LRQJ;'RLOORQ&-/D\FRFN1/&+DNLP0 6RQJ<DQG:DWVN\0$ )XQFWLRQDOKXPDQFRUQHDOHTXLYDOHQWVFRQVWUXFWHG IURPFHOOOLQHV6FLHQFH²
HUMAN CORNEAL EQUIVALENTS FOR IN VITRO TESTING
129
+DOEHUW&/'HPHUV*:DQG*DOORZD\'$ 7KH(JHQHRIKXPDQSDSLOORPD YLUXVW\SHLVVXIÀFLHQWIRULPPRUWDOL]DWLRQRIKXPDQHSLWKHOLDOFHOOV-9LURO ² +DOEHUW &/ 'HPHUV *: DQG *DOORZD\ '$ 7KH ( DQG ( JHQHV RI KXPDQ SDSLOORPDYLUXVW\SHKDYHZHDNLPPRUWDOL]LQJDFWLYLW\LQKXPDQHSLWKHOLDOFHOOV- 9LURO² .LQJVWRQ5(&KHQ&$2ND\DPD+DQG5RVH-. ,QWURGXFWLRQRI'1$LQWR PDPPDOLDQFHOOVLQ&XUUHQW3URWRFROV0ROHFXODU%LRORJ\$XVXEHO)0HWDO(GV :LOH\1HZ
CHAPTER
13
The EpiOcular Prediction Model: A Reproducible In Vitro Means of Assessing Ocular Irritancy 0LWFKHOO.ODXVQHU3DWULFN-+D\GHQ%ULGJHW$%UH\IRJOH .ULVWHQ/%HOODYDQFH0HOLVVD02VERUQ'DQLHO5&HUYHQ *HRUJH/'H*HRUJHDQG-RVHSK.XELOXV
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV (SL2FXODU2&/ 7LVVXH6RXUFH +LVWRORJ\ 7LVVXH9LDELOLW\$VVD\³077(70HWKRG 3UHHTXLOLEUDWLRQRI7LVVXH 3UHSDUDWLRQRI7HVW$UWLFOHV $SSOLFDWLRQRI7HVW$UWLFOHWR(SL2FXODU7LVVXH ([SRVXUH7LPHV ([SRVXUH&RQGLWLRQV 5HPRYDORI7HVW$UWLFOHIURP(SL2FXODU7LVVXH 7LVVXH9LDELOLW\077$VVD\ &DOFXODWLRQRI(IIHFWLYH7LPH(7 'HWHUPLQDWLRQRI3UHGLFWLRQ0RGHO 7HVWLQJRI3UHGLFWLRQ0RGHO 4XDOLW\&RQWURO7HVWLQJ ,QWHUODERUDWRU\7HVWLQJ 7HVWLQJRI8OWUDPLOG0DWHULDOV 5HVXOWV +LVWRORJLFDO&KDUDFWHUL]DWLRQRIWKH(SL2FXODU7LVVXH0RGHO 'HWHUPLQDWLRQRI3UHGLFWLRQ0RGHO ; E\&5&3UHVV//&
131
132
ALTERNATIVE TOXICOLOGICAL METHODS
7HVWLQJRI3UHGLFWLRQ0RGHO 4XDOLW\&RQWURO5HVXOWV² ,QWHUODERUDWRU\5HSURGXFLELOLW\ 7HVWLQJRI8OWUDPLOG0DWHULDOV 'LVFXVVLRQ $FNQRZOHGJPHQWV 5HIHUHQFHV INTRODUCTION $QDFFXUDWHUHSURGXFLEOHLQYLWURPHDQVRIUHSODFLQJWKH'UDL]HUDEELWH\HWHVW 'UDL]HHWDO KDVUHPDLQHGHOXVLYHGHVSLWHH[WHQVLYHYDOLGDWLRQVWXGLHVWRWHVW SRVVLEOHLQYLWURDOWHUQDWLYHV7KH&RPLWHGHV$VVRFLDWLRQV(XURSHHQHVGHO·,QGXVWULH GH DO 3DUIXPHULH GHV 3URGXLWV &RVPHWLTXHV HW GH 7RLOHWWH &2/,3$ LQWHUQDWLRQDO YDOLGDWLRQVWXG\LQYHVWLJDWHGWHQDOWHUQDWLYHPHWKRGVDQGFRQFOXGHGWKDWQRQHRIWKH PHWKRGV FRXOG EH GHHPHG D YDOLG UHSODFHPHQW IRU WKH 'UDL]H H\H LUULWDWLRQ VWXG\ DOWKRXJKWKUHHPHWKRGVWKHÁXRUHVFHLQOHDNDJHWHVWUHGEORRGFHOODVVD\FODVVLÀFDWLRQ PRGHODQGWKHWLVVXHHTXLYDOHQWDVVD\ ZHUHIRXQGWREHHLWKHUUHOLDEOHRUUHOHYDQW %UDQWRP HW DO 6LPLODUO\ WKH (XURSHDQ &RPPLVVLRQ%ULWLVK +RPH 2IÀ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ÀUVWGHPRQVWUDWLQJ WKDW D PHWKRG LV SUHGLFWLYH IRU D VSHFLÀF FODVV RI PDWHULDOV 7KH FXUUHQW VWXG\ LQYHVWLJDWHV WKH XVH RI DQ RUJDQRW\SLF WLVVXH PRGHO WR SUHGLFW WKH RFXODU LUULWDQF\ SRWHQWLDORIZDWHUVROXEOHQRQDOFRKROPDWHULDOV :LWKWKHORQJWHUPJRDORIGHYHORSLQJDYDOLGDWHGLQYLWURDVVD\V\VWHPWRUHSODFH 'UDL]HRFXODUWHVWLQJDSUHGLFWLRQHTXDWLRQKDVEHHQGHYHORSHGVRWKDWD´SUHGLFWHGµ 'UDL]HVFRUHFRXOGEHFRPSXWHGEDVHGRQDQ(SL2FXODU077DVVD\UHVXOWV,QRUGHU WRHYDOXDWHWKHUHOLDELOLW\DQGUHOHYDQFHRIWKHSUHGLFWLRQPRGHOWKHSUHGLFWLRQ LQWHUYDOV 3, ZHUH GHWHUPLQHG %UDQWRP HW DO 7KH SUHGLFWLRQ PRGHO ZDV XVHGWRFRPSDUHLQYLWURDQGLQYLYRUHVXOWVIRUDYDULHW\RIFRQVXPHUSURGXFWV MATERIALS AND METHODS EpiOcular (OCL-200) Tissue Source 7KH(SL2FXODUWLVVXHPRGHOLVSUHSDUHGXVLQJSURSULHWDU\PDQXIDFWXULQJWHFKQLTXHV LQZKLFKQRUPDOKXPDQQHRQDWDOIRUHVNLQNHUDWLQRF\WHVGHULYHGIURPDVLQJOHGRQRU
THE EPIOCULAR PREDICTION MODEL
133
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²OLTXLGLQWHUIDFHLHRQO\WKHEDVDOVLGHRIWKHFHOOFXOWXUHLQVHUWVLVH[SRVHGWR WKHPHGLXP7KHFXOWXUHPHGLXPLV'XOEHFFR·VPRGLÀHGHDJOH·VPHGLXP'0(0 WR ZKLFK D SURSULHWDU\ PL[WXUH RI QXWULHQWV JURZWK IDFWRUV DQG KRUPRQHV KDV EHHQ DGGHGDOOPHGLDDUHVHUXPIUHH$IWHUDSSUR[LPDWHO\ZHHNRIFXOWXUHWKHFHOOFXOWXUH LQVHUWVFRQWDLQLQJWKHVWUDWLÀHGWLVVXHDUHSODFHGDWRSDJDURVHJHOVLQDZHOOSODWH 7KLVZHOOSODWHLVKHUPHWLFDOO\VHDOHG´SDFNDJHGµ DQGVKLSSHGIRUFRPPHUFLDOVDOH RUVWRUHGDWr&IRUWRKUSULRUWRWHVWLQJ)RUFRPPHUFLDOSXUSRVHVWKHVHSDFNDJHG WLVVXHVDUHVKLSSHGHYHU\0RQGD\RQZHWLFHFD& YLDRYHUQLJKWH[SUHVVGHOLYHU\ $OO(SL2FXODUWLVVXHVXVHGWKURXJKRXWWKHVWXGLHVGHVFULEHGKHUHLQZHUHWDNHQIURP VWDQGDUGORWVRI(SL2FXODUWLVVXHWKDWRWKHUZLVHZRXOGKDYHEHHQXVHGIRUFRPPHUFLDO VDOH7KHWLVVXHZDVSDFNDJHGDVLIIRUVKLSPHQWDQGWKHQVWRUHGIRUDWOHDVWKUDW& WRVLPXODWHWKHZHWLFHVKLSSLQJDQGVWRUDJHSURFHGXUHVXVHGIRUFRPPHUFLDOSURGXFW Histology (SL2FXODUWLVVXHVDPSOHVZHUHÀ[HGLQIRUPDOLQURRPWHPSHUDWXUHRYHU QLJKW DQGFXWIURPFHOOFXOWXUHLQVHUWVXVLQJDQPPGLDPHWHUGHUPDOSXQFKDQG FXWLFOHVFLVVRUV)ROORZLQJGHK\GUDWLRQLQDJUDGHGVHULHVRIHWKDQROWLVVXHVDPSOHV ZHUHSDUDIÀQHPEHGGHGVHFWLRQHGDQGVWDLQHGZLWKKHPDWR[\OLQDQGHRVLQ+ ( /LJKWPLFURVFRS\ZDVSHUIRUPHGXVLQJD1LNRQ'LDSKRWÀWWHGZLWK+RIIPDQPRG XODWLRQRSWLFV$FRUQHDIURPDZKLWH1HZ=HDODQGUDEELWZKLFKZDVWKHXQQHHGHG E\SURGXFWRIRSKWKDOPLFH\HUHVHDUFKDWWKH(\H5HVHDUFK,QVWLWXWH%RVWRQ0$ ZDVSURFHVVHGLQDQLGHQWLFDOPDQQHUIRUFRPSDULVRQSXUSRVHV
TISSUE VIABILITY ASSAY—MTT ET-50 METHOD Preequilibration of Tissue $IWHUVWRUDJHDW&FXOWXUHVZHUHUHPRYHGIURPWKHSDFNDJHVDQGUHHTXLOLEUDWHG WR&E\SODFLQJWKHPLQVL[ZHOOSODWHVFRQWDLQLQJPOSHUZHOORIDVVD\PHGLD VXSSOLHGZLWK2&/(SL2FXODUWLVVXHPRGHONLW IRUKU$IWHUKUWKHPHGLXP ZDVUHSODFHGZLWKIUHVKDVVD\PHGLXPDQGWLVVXHVZHUHGRVHGZLWKWHVWPDWHULDO Preparation of Test Articles ,QRUGHUWRKDQGOHPDWHULDOVIRUZKLFKWKHFKHPLFDOQDWXUHDQGSRWHQWLDORFXODU LUULWDQF\LVXQNQRZQWKHVSHFLÀFJUDYLW\6* RIOLTXLGWHVWPDWHULDOVLVGHWHUPLQHG
134
ALTERNATIVE TOXICOLOGICAL METHODS
0DWHULDOVWKDWKDYHD6*JUHDWHUWKDQZHUHGLOXWHGWRZLWKXOWUDSXUHZDWHU DQGWKHQDSSOLHGQRQ²ZDWHUVROXEOHPDWHULDOVZHUHDSSOLHGDVDSDVWHZKLFKZDV PDGH E\ PL[LQJ HTXDO PDVVHV RI WKH PDWHULDO DQG XOWUDSXUH ZDWHU 0DWHULDOV WKDW KDYHD6*OHVVWKDQIRUH[DPSOHDOFRKROVDOFRKROFRQWDLQLQJIRUPXODWLRQV RU PDQ\ RUJDQLF FKHPLFDOV DUH QRW GLVFXVVHG LQ WKLV SDSHU 7KH PHWKRG XVHG WR GHWHUPLQH6*ZDVWRSLSHWWHQORIPDWHULDOLQWRDWDUHGFRQWDLQHURQDQDQDO\WLFDO EDODQFH GHWHUPLQH WKH PDVV DQG UHSHDW WKH SURFHGXUH XVLQJ QO RI XOWUDSXUH ZDWHU %RWK WHVW PDWHULDO DQG XOWUDSXUH ZDWHU ZHUH DOORZHG WR HTXLOLEUDWH WR URRP WHPSHUDWXUHIRUKU$UDWLRRIWKHPDVVHVPDVVRIWHVWDUWLFOHGLYLGHGE\WKHPDVV RIXOWUDSXUHZDWHU JLYHVWKH6*RIWKHWHVWDUWLFOH Application of Test Article to EpiOcular Tissue ,I WKH 6* ZDV GHWHUPLQHG WR EH ! WKH WHVW DUWLFOH ZDV GLOXWHG WR PDWHULDOVRI6*ZHUHQRWLQFOXGHGLQWKHVHVWXGLHV$IWHUGLOXWLRQQORI WKHWHVWPDWHULDOZHUHDSSOLHGHYHQO\WRWKHVXUIDFHRIWKH(SL2FXODUWLVVXH)UHH ÁRZLQJOLTXLGVZHUHSLSHWWHGRQWRWKHVXUIDFHRIWKH(SL2FXODUWLVVXHDQGYLVFRXV PDWHULDOV ZHUH DSSOLHG ZLWK D SRVLWLYH GLVSODFHPHQW SLSHWWH 6ROLGV ZHUH SUHSDUHG E\ PDNLQJ D ZWZW VOXUU\ VROLGXOWUDSXUH +2 PJ RI WKH VOXUU\ ZDV VSUHDGHYHQO\RYHUDÁDWHQGRIDQDSSOLFDWRUSLQZLWKDFLUFXODUDUHDRIFP DQG WKH DSSOLFDWRU SLQ ZDV WKHQ LQYHUWHG DQG SODFHG JHQWO\ LQ FRQWDFW ZLWK WKH (SL2FXODUDSLFDOVXUIDFHWKHDSSOLFDWRUSLQZDVOHIWLQSODFHIRUWKHGXUDWLRQRIWKH H[SRVXUH Exposure Times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able 13.1 Choice of Additional Exposure Times Based on the Viability of the Initial 20-Min Exposure Viability after 20-min exposure
Additional exposure times (min)
90% <90% but > 30% <30%
60, 240 5, 60 1, 5
THE EPIOCULAR PREDICTION MODEL
135
FRPSDULQJ WKH FRORU RI WKH WLVVXH WR WKDW RI FRQFXUUHQW QHJDWLYH FRQWUROV ,Q VRPH LQVWDQFHVWHVWLQJZDVSHUIRUPHGRQVXEVHTXHQWGD\VE\FKRRVLQJWLPHSRLQWVEDVHG RQ DFWXDO YLDELOLWLHV UHVXOWLQJ IURP WKH PLQ H[SRVXUH %\ XVLQJ WKH PLQ H[SRVXUHWLPHUHVXOWVWRFKRRVHDGGLWLRQDOWLPHSRLQWVWKHH[SRVXUHWLPHQHHGHGWR UHGXFHWKHYLDELOLW\WRLHWKHHIIHFWLYHWLPH>(7@ FDQEHLQWHUSRODWHG ZKLOHXVLQJDPLQLPXPQXPEHURIWLVVXHVDPSOHV,QDOOFDVHVWKHYLDELOLW\UHVXOWLQJ IURPWKHRULJLQDOPLQWLPHSRLQWZDVLQFOXGHGLQWKHFDOFXODWLRQRIWKH(7 Exposure Conditions )RUDOOH[SRVXUHVRIPLQRUORQJHUWLVVXHVZHUHLQFXEDWHGZLWKWKHWHVWDUWLFOH DW & DQG &2 H[SRVXUHV RI OHVV WKDQ PLQ ZHUH SHUIRUPHG LQ WKH ODE DW URRPWHPSHUDWXUHDQGDPELHQWDWPRVSKHULFFRQGLWLRQV Removal of Test Article from EpiOcular Tissue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issue Viability: MTT Assay 7KH YLDELOLW\ RI WKH (SL2FXODU WLVVXH ZDV GHWHUPLQHG XVLQJ WKH 077 WLVVXH YLDELOLW\DVVD\7KH077DVVD\ZDVSHUIRUPHGDVIROORZVDIWHUUHPRYDORIWKHWHVW PDWHULDOE\ULQVLQJZLWK3%6FXOWXUHVZHUHSODFHGLQQ/RI'0(0FRQWDLQLQJ PJPOVROXWLRQRI077G\HGLPHWK\OWKLD]R\O GLSKHQ\OWHWUD]ROLXP EURPLGH IRUKUDWr&&2077LVWDNHQXSE\YLDEOHFHOOVDQGUHGXFHG E\PLWRFKRQGULDOGHK\GURJHQDVHVWRIRUPDSXUSOHIRUPD]DQ6LQFHRQO\YLDEOHFHOOV ZLWK IXQFWLRQLQJ PLWRFKRQGULD ZLOO SHUIRUP WKLV UHDFWLRQ WKH DPRXQW RI FRORUHG IRUPD]DQSURGXFHGKDVEHHQVKRZQWREHSURSRUWLRQDOWRWKHQXPEHURIYLDEOHFHOOV 0RVPDQQ $IWHUKUWKHSXUSOHIRUPD]DQG\HZDVH[WUDFWHGRYHUQLJKWRU IRU D PLQLPXP RI KU ZLWK VKDNLQJ XVLQJ PO RI LVRSURS\O DOFRKRO DQG WKH IRUPD]DQH[WUDFWZDVTXDQWLÀHGE\PHDVXULQJWKHDEVRUEDQFH$ DWQPXVLQJ DQ(0$;ZHOOSODWHUHDGHU0ROHFXODU'HYLFHV0HQOR3DUN&$ 7KHQXPEHU RIYLDEOHFHOOVZDVQRUPDOL]HGDVDSHUFHQWRIWKHQHJDWLYHFRQWUROFXOWXUHVVROYHQW YHKLFOHRQO\ WKDWKDYHEHHQORDGHGZLWK077DQGH[WUDFWHGLQDQLGHQWLFDOPDQQHU 7KHSHUFHQWDJHRIYLDEOHFHOOVUHPDLQLQJZDVGHWHUPLQHGXVLQJWKHHTXDWLRQ YLDELOLW\ 2'WUHDWHGFXOWXUH 2'FRQWURO 7KHSHUFHQWDJHYLDELOLW\ZDVFDOFXODWHGXVLQJWKHDYHUDJHRSWLFDOGHQVLW\UHDGLQJ IURPGXSOLFDWHFXOWXUHVWUHDWHGLQDQLGHQWLFDOPDQQHU
136
ALTERNATIVE TOXICOLOGICAL METHODS
Calculation of Effective Time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etermination of Prediction Model 'UDL]H GDWD ZHUH DYDLODEOH IRU ZDWHUVROXEOH PDWHULDOV LQ WKH (&(72& GDWDEDVH%DJOH\HWDO $OVR'UDL]HGDWDIRUDQDGGLWLRQDOFRVPHWLFRU SHUVRQDOFDUHSURGXFWVLQJUHGLHQWVZHUHPDGHDYDLODEOHWR0DW7HNE\FRPPHUFLDO FRPSDQLHV LQWHUHVWHG LQ WKH GHYHORSPHQW RI D GDWDVHW IRU (SL2FXODU $OO PDWHULDOVDUHOLVWHGLQ7DEOH$Q(7IRUWKHPDWHULDOVZDVGHWHUPLQHG XVLQJ WKH SURFHGXUHV GHVFULEHG DERYH )RU PDWHULDOV ZLWK 'UDL]H VFRUHV DW D VSHFLÀHG FRQFHQWUDWLRQ D VROXWLRQ RI WKH VSHFLÀHG FRQFHQWUDWLRQ ZDV PDGH XS SULRUWRGHWHUPLQDWLRQRIWKH6*DQGWKHVROXWLRQZDVXVHGQHDWRUGLOXWHGWR GHSHQGLQJRQWKH6*$OOPDWHULDOVZHUHWHVWHGDWOHDVWWZLFHXVLQJWZRGLIIHUHQW ORWVRI(SL2FXODUWLVVXH $QDYHUDJH(7IRUWKHYDULRXVPDWHULDOVZDVGHWHUPLQHGDQGWKH'UDL]HVFRUH ZDVSORWWHGYHUVXVORJ(7 /LQHDUUHJUHVVLRQURXWLQHVLQWKHJUDSKLFVSURJUDP 6OLGHZULWH9HUVLRQ $GYDQFH *UDSKLFV 6RIWZDUH (QFLQLWDV &$ ZHUH XVHG WR ÀQGWKHEHVWÀWWRWKHVHGDWDWRGHWHUPLQHDSUHGLFWLRQHTXDWLRQ Testing of Prediction Model 'UDL]H VFRUHV IRU YDULRXV FRQVXPHU DQG SHUVRQDO FDUH SURGXFWV LQFOXGLQJ ÀYH VKDPSRRVVL[KDQGIDFHERG\VRDSVÀYHODXQGU\GHWHUJHQWVIRXUGLVKZDVKLQJOLT XLGV DQG IRXU VNLQ ORWLRQV ZHUH PDGH DYDLODEOH WR 0DW7HN &RUSRUDWLRQ E\ 0% 5HVHDUFK/DERUDWRULHV6SLQQHUVWRZQ3$ $OOPDWHULDOVZHUHRIIWKHVKHOISURGXFWV DYDLODEOHDWUHWDLOVWRUHV(DFK(7ZDVGHWHUPLQHGDVRXWOLQHGDERYHLQDWOHDVW WZR VHSDUDWH ORWV RI (SL2FXODU 8VLQJ HDFK (7 SUHGLFWHG 'UDL]H VFRUHV ZHUH FDOFXODWHGDQGDQDYHUDJHSUHGLFWHG'UDL]HVFRUHZDVFRPSXWHGIRUHDFKPDWHULDO 6XEVHTXHQWO\WKHLQYLWURSUHGLFWHG'UDL]HVFRUHZDVSORWWHGYHUVXVWKHDFWXDO'UDL]H VFRUHVWKHGDWDZHUHÀWWHGWRWKHOLQHSUHGLFWHG'UDL]H DFWXDO'UDL]H\ [ DQG DFRUUHODWLRQFRHIÀFLHQWUZDVGHWHUPLQHG
THE EPIOCULAR PREDICTION MODEL
137
Table 13.2 In Vitro and In Vivo Data Used to Generate the Prediction Model; In Vitro Data from EpiOcular ET-50 Determinations; In vivo Data from ECETOC Database or Commercial Sources Conc. tested
# 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47
Benzalkonium chloride (10%) Benzalkonium chloride (5%) Benzalkonium chloride (1%) Cetyl pyridinium bromide (10%) Cetyl pyridinium bromide (1%) Cetyl pyridinium bromide (0.1%) Glycerol Sodium hydroxide (10%) Sodium hydroxide (1%) Propylene glycol Sodium dodecyl sulfate (30%) Sodium dodecyl sulfate (15%) Sodium dodecyl sulfate (3%) Trichloro acetic acid (30%) Trichloro acetic acid (3%) Triton X-100 (10%) Triton X-100 (5%) Triton X-100 (1%) Tween 20 (100%) Body/hand wash Body/hand wash Eye gel/colorant Eye gel/colorant Face/body wash Face/body wash Face/body wash Hand/body lotion Hand/body lotion Hand/body lotion Shampoo—baby Shampoo—baby Conditioner Shampoo—regular Shampoo—regular Na2-ricinoleadmido MEA sulfosuccinate Sodium trideceth sulfate Cetrimonium chloride Stearalkonium chloride Cocamide DEA Disodium cocoamphodipropionate Surfactant blend Surfactant blend Final formulation shampoo Final formulation shampoo Final formulation shampoo Final formulation shampoo Final formulation shampoo
2.0% 1.0% 0.2% 2.0% 0.2% 0.02% 20.0% 2.0% 0.2% 20.0% 6.0% 3.0% 0.6% 6.0% 0.6% 2.0% 1.0% 0.2% 20.0% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
ET-50 (min)
Draize (MMAS)
1.07 1.0 5.9 9.0 30.1 240.0 240.0 1.0 2.3 240.0 2.1 5.1 9.0 1.0 155.1 2.5 5.3 36.7 240.0 9.1 14.8 240 240 240 6.5 10.2 240 240 240 30.8 25.7 240 6.0 8.7 108.9
108.0 83.8 45.3 89.7 36.0 2.7 1.7 108.0 25.8 1.3 60.5 59.2 16.0 106.0 6.7 68.7 33.1 1.7 4.0 32 35 0 2 2 25 40 2 2 3 10 18 2 30 35 0
2.5 116.9 240 240 11.2 19.2 40.4 26.1 29.1 4.2 9.3 9.0
33 6.67 14 0 15.3 6.0 2.67 4.0 12.5 32.7 31.6 34.4 (continued)
138
ALTERNATIVE TOXICOLOGICAL METHODS
Table 13.2 (continued) In Vitro and In Vivo Data Used to Generate the Prediction Model; In Vitro Data from EpiOcular ET-50 Determinations; In vivo Data from ECETOC Database or Commercial Sources Conc. tested
# 48 49 50 51 52 53 54 55 56 57 58 59
Final formulation shampoo Final formulation shampoo Final formulation shampoo Final formulation shampoo Final formulation shampoo Hydro-alcohol (hair spray) solution 10% fatty alcohol ethoxylate Eye makeup remover (surfactant sol.) Lactic acid (3% solution) Oleic acid Skin care emulsion Body spray
20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20% 20%
ET-50 (min)
Draize (MMAS)
31.0 63.1 47.1 29.4 42.1 84.1 189 240 240 240 240 240
3.9 3.5 8.3 6.57 4.8 6.0 3.5 0 0 2 0 0
Quality Control Testing (DFKZHHNO\ORWRI(SL2FXODUWLVVXHLVWHVWHGXVLQJWKHFRPPRQVXUIDFWDQW7ULWRQ ; 6LJPD &KHPLFDO &RPSDQ\ 6W /RXLV 02 2QH KXQGUHG PLFUROLWHUV RI D VROXWLRQRI7ULWRQ;LQXOWUDSXUHZDWHUWR02KP DUHDSSOLHGWR GXSOLFDWH(SL2FXODUWLVVXHV1 IRUDQGPLQLQDGGLWLRQ Q/RI XOWUDSXUHZDWHUDUHDSSOLHGWRWULSOLFDWHWLVVXHVIRUPLQWRVHUYHDVWKHQHJDWLYH FRQWURO7KHLQWUDORWYDULDELOLW\RIWKHWLVVXHZDVDVVHVVHGE\GHWHUPLQLQJDQDYHUDJH VWDQGDUGGHYLDWLRQDQGFRHIÀFLHQWRIYDULDWLRQ&9 vVWDQGDUGGHYLDWLRQDYHU DJH IRU HDFK RI WKHVH WLPHG DSSOLFDWLRQV LQ DGGLWLRQ WKH &9V ZHUH DYHUDJHG WR FRPSXWHDQDYHUDJH&9IRUWKHHQWLUHORW7KHLQWHUORWYDULDELOLW\ZDVDVVHVVHGE\ FRPSXWLQJ WKH (7 IRU HDFK WLVVXH ORW DQG WKHQ E\ FRPSDULQJ HDFK (7 IRU 7ULWRQ ; IURP DOO (SL2FXODU WLVVXH ORWV SURGXFHG GXULQJ WKH FDOHQGDU \HDUV ²)LQDOO\WKHDYHUDJH0772'IRUWKHQHJDWLYHFRQWUROWLVVXHVDQGWKH UHVXOWDQW&9ZHUHGHWHUPLQHG Interlaboratory Testing 7LVVXHVIURPDVLQJOHSURGXFWLRQORWZHUHSDFNDJHGDQGVKLSSHGWRWKH3URFWHU DQG *DPEOH &RPSDQ\ &LQFLQQDWL 2+ DQG WKH ,QVWLWXWH IRU ,Q 9LWUR 6FLHQFHV *DLWKHUVEXUJ0' ,QDGGLWLRQWLVVXHIURPWKHVDPH(SL2FXODUORWZDVUHWDLQHG DW 0DW7HN DQG VWRUHG DW r& IRU KU SULRU WR WHVWLQJ 5HVXOWV IURP WKH WZR ODERUDWRULHVDQGIURP0DW7HN·VODERUDWRU\ZHUHFRPSDUHGIRUWKHSRVLWLYHFRQWURO 7ULWRQ ; DQG IRU WZR DGGLWLRQDO PDWHULDOV IURP WKH (&(72& GDWDEDVH %DJOH\HWDO D VRGLXPGRGHF\OVXOIDWH6'6 DQGE EHQ]DO NRQLXPFKORULGH%$. 1RWH$VSHUWKHSURFHGXUHVGHVFULEHGDERYH6'6DQG %$. ZHUH WKH DFWXDO FRQFHQWUDWLRQV WHVWHG LQ WKH WKUHH ODEV 'RVH UHVSRQVH FXUYHVZHUHFRQVWUXFWHGXVLQJ1 WLVVXHVDQGDQ(7ZDVGHWHUPLQHGLQHDFK ODEIRUHDFKRIWKHWKUHHPDWHULDOV$VZLWKWKHGDWDEDVHWHVWLQJUHSURGXFLELOLW\RI
THE EPIOCULAR PREDICTION MODEL
139
WKH WHVWLQJ UHVXOWV ZDV DVVHVVHG E\ FDOFXODWLQJ DYHUDJHV VWDQGDUG GHYLDWLRQV DQG FRHIÀFLHQWVRIYDULDWLRQIRUHDFKRIWKHPDWHULDOVWHVWHG,QDGGLWLRQDFRHIÀFLHQWRI YDULDWLRQZDVGHWHUPLQHGIRUHDFKRIWKHWLPHSRLQWVWHVWHGLQHDFKODERUDWRU\DQG DQDYHUDJH&9ZDVFDOFXODWHGIRUWKHODERUDWRU\)LQDOO\WKH(7IRUHDFKPDWHULDO IURPWKHWKUHHODEVZDVFRPSDUHG Testing of Ultramild Materials 7KHPHWKRGXVHGWRWHVWYHU\PLOGPDWHULDOVLHWKRVHWRZKLFKWKH'UDL]HWHVW ZDVLQVHQVLWLYH00$6 GLIIHUHGIURPWKHPHWKRGGHVFULEHGDERYHLQWZRNH\ DVSHFWVD WKHPDWHULDOVZHUHDSSOLHGQHDWUHJDUGOHVVRIWKH 6*DQGE H[SRVXUH WLPHVZHUHH[WHQGHGXSWRKU7KH(7ZDVGHWHUPLQHGDVSUHYLRXVO\GHVFULEHG XVLQJWKH077WLVVXHYLDELOLW\DVVD\
RESULTS Histological Characterization of the EpiOcular Tissue Model &URVVVHFWLRQVRI+ (VWDLQHG(SL2FXODUWLVVXHDQGDUDEELWFRUQHDDUHVKRZQ LQ)LJXUH7KHVWUXFWXUHVDUHRIHTXDOWKLFNQHVVDQGFRQVLVWRIDFXERLGDOOD\HU RI EDVDO FHOOV ZLWK DGGLWLRQDO OD\HUV RI ÁDWWHQHG FHOOV 7KHUH LV QR HYLGHQFH RI D JUDQXODURUFRUQLÀHGOD\HUDVZRXOGEHVHHQZLWKIXOO\GLIIHUHQWLDWHGNHUDWLQRF\WHV FXOWXUHGDWWKHDLU²OLTXLGLQWHUIDFH5HJQLHUHWDO0DNHWDO%RHOVPD HW DO &HOOV RQ WKH DSLFDO VXUIDFH RI ERWK WLVVXHV DUH VTXDPRXV DQG VKRZ HORQJDWHGQXFOHL
A
B
Figure 13.1 Hematoxylin and Eosin (H&E) stained histological cross sections of (A) EpiOcular tissue model and (B) rabbit cornea epithelium and underlying stroma. Tissues were fixed in 10% formalin, embedded in paraffin, and stained with H&E. Final magnification 360v.
140
ALTERNATIVE TOXICOLOGICAL METHODS
OCL-200 Prediction Equation Draize Score (MMAS)
150 r = 0.90
125
59 materials
100 75 50 25 0 1
10
100
300
ET-50 (min) Prediction Equation: Draize (MMAS) = –4.74 + 101.7/
(ET-50) 95% Prediction Intervals: Draize (MMAS) = –30.54 + 100.4/
(ET-50) Draize (MMAS) = 21.07 + 102.9/
(ET-50) Figure 13.2 Graphical depiction of in vivo and in vitro data used to derive the prediction equation. All materials tested that had specific gravity >0.95 were diluted to 20% in ultrapure water. If actual ET-50 exceeded 240 min, ET-50 was set equal to 240 min. If ET was less than 1 min, ET-50 was set to 1 min.
Determination of Prediction Model 7KH FKHPLFDO QDPH RU SURGXFW FDWHJRU\ WKH UHVSHFWLYH (7 DQG WKH 'UDL]H VFRUHIRUWKHPDWHULDOVXVHGWRFRQVWUXFWWKHSUHGLFWLRQHTXDWLRQDUHJLYHQLQ7DEOH (7 DQG 'UDL]H VFRUHV DUH SORWWHG LQ )LJXUH 7KH RSWLPDO ÀW IRU WKH SUHGLFWLRQHTXDWLRQZDVGHWHUPLQHGWREH 'UDL]H00$6 ²(7 ZKHUHWKH(7LVH[SUHVVHGDVe(7ePLQ 7KHFRQÀGHQFHLQWHUYDOVIRUWKHSUHGLFWLRQHTXDWLRQSUHGLFWLRQLQWHU YDO DUH 8SSHUOLPLW'UDL]H00$6 (7 /RZHUOLPLW'UDL]H00$6 ²(7 Testing of Prediction Model 7DEOH VKRZV SUHGLFWHG DQG DFWXDO 'UDL]H VFRUHV IRU WKH ÀQDO IRUPXODWLRQ FRVPHWLFSHUVRQDOFDUHSURGXFWVXVHGWRWHVWWKHXWLOLW\RIWKHSUHGLFWLRQPRGHO$ JUDSKLFDOFRPSDULVRQRIWKHDFWXDO'UDL]HDQGSUHGLFWHG'UDL]HVFRUHVLVVKRZQLQ )LJXUH7KHDELOLW\WRFRUUHFWO\SUHGLFWWKHLQYLYR'UDL]HVFRUHVZDVDVVHVVHG
THE EPIOCULAR PREDICTION MODEL
141
Table 13.3 EpiOcular Prediction Model Testing: Comparison between In Vivo and In Vitro Predicted Draize Code 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Predicted Draize
Product
10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599 10599
A B C D E F G H I J K L M N O P Q R S T U V W X
Body wash Body wash Dishwashing liquid Hand soap liquid Dishwashing liquid Facial soap Dishwashing liquid Dishwashing liquid Laundry detergent Laundry detergent Laundry detergent Dishwashing liquid Shampoo Shampoo Shampoo Hand soap liquid Skin lotion Shampoo Skin lotion Shampoo Body wash Laundry detergent Laundry detergent Skin lotion
Actual Draize (MMAS)
14.6 31.3 51.3 28.0 25.2 15.6 50.8 60.5 37.3 1.8 33.4 96.9 6.5 32.9 8.4 18.1 1.8 46.9 1.8 39.3 41.2 1.8 39.9 1.8
16.7 44.7 38.3 24.7 39.3 9.3 39.0 50.3 37.3 0.7 37.7 37.7 4.0 41.7 3.3 13.3 0.7 33.7 0.0 37.7 33.0 0.7 44.0 0.7
7HVWLQJRI2&/3UHGLFWLRQ0RGHO ,Q9LYR00$6 YV3UHGLFWHG'UDL]H
3UHGLFWHG'UDL]H
FRQVXPHUSURGXFWVWHVWHG U PDWHULDOV U PDWHULDOV
,Q9LYR'UDL]H00$6 Figure 13.3 Comparison of predicted and actual Draize scores for consumer products including: shampoos (5), face/body soap (6), dishwashing liquids (4), laundry detergents (5), and skin lotions (4). The predicted Draize scores were calculated based on the ET-50 using the prediction equation shown in Figure 13.2.
142
ALTERNATIVE TOXICOLOGICAL METHODS
Table 13.4 EpiOcular QC Testing Results for Positive (0.3% Triton X-100) and Negative (ultrapure water) Controls Calendar Year
Tissue Lots
Triton ET-50 (min)
Neg. Control (OD)
Avg. Lot CV (%)
2000 1999 1998 1997 1996
60 84 85 81 47
23.1s6.0 22.6s5.0 25.2s5.6 22.9s4.7 24.9s6.3
1.441 1.433 1.354 1.343 1.274
5.5 5.6 5.5 5.4 5.2
E\ FDOFXODWLQJ WKH FRUUHODWLRQ FRHIÀFLHQW U IRU WKH OLQH DFWXDO 'UDL]H SUHGLFWHG 'UDL]H \ [ 7KH YDOXH RI U ZDV GHWHUPLQHG WR EH KRZHYHU LI RQH RI WKH ODXQGU\ GHWHUJHQWV ZKRVH 'UDL]H VFRUH ZDV RYHUSUHGLFWHG E\ (SL2FXODU ZDV H[FOXGHGIURPWKHUHJUHVVLRQOLQHWKHFRUUHODWLRQFRHIÀFLHQWULVHVWRU Quality Control Results: 1996–2000 $ VXPPDU\ RI TXDOLW\ FRQWURO GDWD IRU FDOHQGDU \HDUV WKURXJK LV SUHVHQWHGLQ7DEOH7KH\HDUO\DYHUDJHIRUWKHSRVLWLYHFRQWURO7ULWRQ; KDVUHPDLQHGVWDEOHUDQJLQJIURPWRPLQDQGUHVSHF WLYHO\ 7KHQHJDWLYHFRQWUROKDVYDULHGEHWZHHQDQRSWLFDOGHQVLW\RIWR DQGUHVSHFWLYHO\ 7KHYDULDELOLW\ZLWKLQWLVVXHORWVKDVEHHQH[WUHPHO\ ORZ,QDOO\HDUVWKHDYHUDJHORW&9ZDVOHVVWKDQ Interlaboratory Reproducibility 7KH(7IRUHDFKRIWKHWKUHHPDWHULDOVWHVWHGLQWKHWKUHHODERUDWRULHVLVVKRZQ LQ7DEOH)RUDOOWKUHHPDWHULDOVLQWHUODERUDWRU\UHSURGXFLELOLW\ZDVJRRG³FRHI ÀFLHQWV RI YDULDWLRQ IRU WKH (7 ZHUH OHVV WKDQ ,Q DGGLWLRQ WLVVXHV ZLWKLQ JLYHQORWVRIWLVVXHZHUHKLJKO\UHSURGXFLEOHDVHYLGHQFHGE\WKHDYHUDJHFRHIÀFLHQW RIWKHYDULDWLRQLQHDFKODEZKLFKZDVOHVVWKDQ Testing of Ultramild Materials 7KH(7IRUDEURDGUDQJHRIFRQFHQWUDWLRQVRIEHQ]DONRQLXPFKORULGH%$. DQG VRGLXP GRGHF\O VXOIDWH 6'6 DUH VKRZQ LQ 7DEOH DQG )LJXUH $W Table 13.5 Results of Interlaboratory Testing Laboratory: P&G: IIVS: MatTek: Average: Std. Dev.: CV:
ET-50 (mins): BAK SDS 5.75 6.39 5.97 6.04 0.32 5.36
3.12 3.30 3.72 3.38 0.31 9.19
Triton 25.40 26.59 29.75 27.24 2.25 8.26
Intralaboratory Reproducibility Avg. CV (%) 7.75 7.14 9.56
THE EPIOCULAR PREDICTION MODEL
143
Table 13.6 ET-50 for Ultramild Materials for Which the Draize Test Is Insensitive In Vivo Concentration
Draize (MMAS)
ET-50 (min)
Benzalkonium chloride (BAK) 10.00% 5.00% 1.00% 0.30% 0.10% 0.03%
108.0 83.8 45.3 8.67 0 0
1.1 1.0 5.9 28.9 212.7 2053.0
Sodium dodecyl sulfate (SDS) 30.00% 15.00% 3.00% 1.00% 0.30% 0.10%
60.5 59.2 16.0 0.67 0 0
2.1 5.1 9.0 29.5 740.1 1938.3
&RPSDULVRQRI(7'UDL]H6FRUHDQG 3UHGLFWLRQ(TXDWLRQIRU6'6DQG%$. 6'6
%$.
3UHG(TXDW
'UDL]H6FRUH00$6
%$.UDQJH 6'6UDQJH
(7PLQ Figure 13.4 Use of EpiOcular to differentiate between very mild materials that cannot be distinguished by the in vivo Draize test (MMAS < 1.0).
FRQFHQWUDWLRQVRI%$.DQG6'6WKH'UDL]HVFRUHGURSVEHORZDQG KHQFH WKH 'UDL]H WHVW FDQQRW GLVWLQJXLVK EHWZHHQ ORZHU FRQFHQWUDWLRQV RI WKHVH VXUIDFWDQWV +RZHYHU DV VKRZQ LQ 7DEOH (SL2FXODU WHVWV UHYHDO D GUDPDWLF GLIIHUHQFHLQ(7EHORZWKHVHFRQFHQWUDWLRQV7KXVLQYLWUR(SL2FXODUWHVWLQJFDQ EHXVHGWRFKDUDFWHUL]HPDWHULDOVWKDWDUHWRRPLOGIRUWKH'UDL]HWHVWWRGLVWLQJXLVK 7KH(SL2FXODUWHVWLVVHQVLWLYHDWFRQFHQWUDWLRQVWKUHHIROGDQGWHQIROGIRU%$.DQG 6'6UHVSHFWLYHO\ EHORZWKHFRQFHQWUDWLRQDWZKLFKWKH'UDL]HVFRUHLVe
144
ALTERNATIVE TOXICOLOGICAL METHODS
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À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À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ÀHG7KXV WKUHH H[SRVXUHWLPHVXVLQJQ WLVVXHVDUHVXIÀFLHQWWRDFFXUDWHO\GHWHUPLQHDQ(7 DQGFDOFXODWHDSUHGLFWHG'UDL]HVFRUH ,Q UHODWLRQ WR WKH ORWWRORW UHSURGXFLELOLW\ RI WKH (SL2FXODU WHVW PHWKRG SDVVIDLOFULWHULDKDYHEHHQHVWDEOLVKHGVXFKWKDWWKHSRVLWLYHFRQWUROIRUHDFKWLVVXH ORW PXVW EH ZLWKLQ VWDQGDUG GHYLDWLRQV RI WKH DYHUDJH VHH7DEOH 4XDOLW\ FRQWURO 4& WHVWLQJ RI WKH (SL2FXODU WLVVXH LV SHUIRUPHG ERWK SULRU WR VKLSPHQWDQGDIWHUGD\RIVWRUDJHDWr&7KHSUHVKLSPHQW4&UHVXOWVGDWDQRW VKRZQ KDYHEHHQIRXQGWREHSUHGLFWLYHRIWKHSRVWVKLSPHQWSRVWVWRUDJHUHVXOWV VKRZQLQ7DEOH7KXVVFUHHQLQJRIWLVVXHSURSHUWLHVSULRUWRVKLSPHQWDYRLGV VKLSPHQW RI WLVVXH WKDW ZLOO QRW PHHW 4& SDUDPHWHUV 3UHWHVWLQJ KDV NHSW WKH SHUFHQWDJHRIIDLOHGORWVEHORZ
THE EPIOCULAR PREDICTION MODEL
145
5HJDUGLQJ WKH XVH RI WKH GLOXWLRQ SURWRFRO SUHVHQWHG KHUH LW LV XQGHUVWRRG WKDW VRPH GLOXWLRQ RI WKH WHVW PDWHULDOV ZLOO RFFXU LQ YLYR GXH WR WKH WHDU ÀOP SUHVHQW RQ WKH FRUQHD DQG DV D UHVXOW RI WHDULQJ RU RWKHU GLVFKDUJHV UHVXOWLQJ IURPLQVWLOODWLRQRIWKHWHVWPDWHULDOLQWRWKHFRQMXQFWLYDOVDFDVSHU'UDL]HWHVW PHWKRG ,QDGGLWLRQLQLWLDOWHVWUHVXOWVZLWKWKH(SL2FXODUWLVVXHPRGHOVKRZHG WKDWUHODWLYHO\PLOGPDWHULDOVVXFKDVEDE\VKDPSRRVZLWK'UDL]HVFRUHVRI RU EHORZ JDYH DQ (7 EHORZ PLQ 7KXV LQ RUGHU WR PRUH FORVHO\ PLPLF LQYLYR'UDL]HH[SRVXUHFRQGLWLRQVDQGWRLQFUHDVHWKHUDQJHRILQYLWURVFRUHV WKHGLOXWLRQSURWRFROZDVGHYHORSHG:KHWKHUGLOXWLRQRIWKHWHVWDUWLFOHGXHWR WKH WHDU ÀOP DQGRU WHDULQJ ZLOO UHVXOW LQ D GLOXWLRQ LV GLIÀFXOW WR DVVHVV 1RQHWKHOHVVWKHGLOXWLRQSURWRFRODSSHDUVWRVDWLVIDFWRULO\FRUUHODWHLQYLYRDQG LQYLWURUHVXOWVIRUDEURDGYDULHW\RIZDWHUVROXEOHPDWHULDOV 7KH VSHFLÀ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²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
ACKNOWLEDGMENTS 7KHDXWKRUVJUDWHIXOO\DFNQRZOHGJHWKHSDUWLFLSDQWVLQWKHLQWHUODERUDWRU\UHSUR GXFLELOLW\ VWXG\ 5RVHPDULH 2VERUQH DQG 'HH 5REHUWV RI WKH 3URFWRU DQG *DPEOH &RPSDQ\ &LQFLQQDWL 2+ DQG -RKQ +DUEHOO +DQV 5DDEH DQG *UHJ 0XQ RI WKH ,QVWLWXWHIRU,Q9LWUR6FLHQFHV*DLWKHUVEXUJ0'
146
ALTERNATIVE TOXICOLOGICAL METHODS
REFERENCES %DJOH\'0%RWKDP3$*DUGQHU-5+ROODQG*.UHLOLQJ5/HZLV5:6WULQJHU '$DQG:DONHU$3 (\HLUULWDWLRQUHIHUHQFHFKHPLFDOVGDWDEDQN7R[LFRO ,Q9LWUR² %DOOV0%RWKDP3$%UXQHU/+DQG6SLHOPDQQ+ 7KH(&+2LQWHUQDWLRQDO YDOLGDWLRQVWXG\RQDOWHUQDWLYHVWRWKH'UDL]HH\HLUULWDWLRQWHVW7R[LFRO,Q9LWUR ² %RHOVPD(*LEEV6)DOOHU&DQG3RQHF0 &KDUDFWHUL]DWLRQDQGFRPSDULVRQRI UHFRQVWUXFWHGVNLQPRGHOVPRUSKRORJLFDODQGLPPXQRKLVWRFKHPLFDOHYDOXDWLRQ$FWD 'HUP9HQHUHRO² %UDQWRP3*%UXQHU/+&KDPEHUODLQ0'H6LOYD2'XSXLV-(DUO/./RYHOO '33DSH:-:8WWOH\0%DJOH\'0%DNHU):%UDFKHU0&RXUWHOOHP RQW 3 'HFOHUFT / )UHHPDQ 6 6WHLOLQJ::DONHU$3 &DUU *- 'DPL 1 7KRPDV*+DUEHOO--RQHV$-3IDQQHQEHFNHU86RXWKHH-$7FKHQJ0 $UJHPEHDXV+&DVWHOOL'&ORWKLHU5(VGDLOH'-,WLJDNH+.DVDL<.RMLPD +.ULVWHQ8/DUQLFRO0/HZLV5:0DUHQXV.0RUHQR23HWHUVRQ$ 5DVPXVVHQ(65RELHV&DQG6WHUQ0 $VXPPDU\UHSRUWRIWKH&2/,3$ LQWHUQDWLRQDOYDOLGDWLRQVWXG\RQDOWHUQDWLYHVWRWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW 7R[LFRO,Q9LWUR² &KDPEHUODLQ 0 *DG 6& *DXWKHURQ 3 DQG 3ULQVHQ 0. ,5$* ZRUNLQJ JURXS³2UJDQRW\SLFPRGHOVIRUWKHDVVHVVPHQWSUHGLFWLRQRIRFXODULUULWDWLRQ,QWHU DJHQF\5HJXODWRU\$OWHUQDWLYHV*URXS)RRG&KHP7R[LFRO² 'UDL]H -+ :RRGDUG * DQG &DOYHU\ +2 0HWKRGV IRU VWXG\ RI LUULWDWLRQ DQG WR[LFLW\RIVXEVWDQFHVDSSOLHGWRSLFDOO\WRWKHVNLQDQGPXFRXVPHPEUDQHV-3KDU PDFRO([S7KHUDSHXWLFV² 0DN +: &XPSVWRQH 0% .HQQHG\$+ +DUPRQ &6 *X\ 5+ DQG 3RWWV 52 %DUULHUIXQFWLRQRIKXPDQNHUDWLQRF\WHVJURZQDWWKHDLUOLTXLGLQWHUIDFH- ,QYHVWLJDWLYH'HUPDWRO² 0RVPDQQ7 5DSLG FRORULPHWULF DVVD\ IRU FHOOXODU JURZWK DQG VXUYLYDO DSSOLFDWLRQ WRSUROLIHUDWLRQDQGF\WRWR[LFLW\DVVD\V-,PPXQRO0HWKRGV² 5HJQLHU 0 $VVHOLQHDX ' DQG /HQRLU 0& +XPDQ HSLGHUPLV UHFRQVWUXFWHG RQ GHUPDO VXEVWUDWHV LQ YLWUR DQ DOWHUQDWLYH WR DQLPDOV LQ VNLQ SKDUPDFRORJ\ 6NLQ 3KDUPDFRO² 6SLHOPDQQ + 2FXODU LUULWDWLRQ LQ ,Q 9LWUR 0HWKRGV LQ 3KDUPDFHXWLFDO 5HVHDUFK &DVWHOO-9DQG*RPH]/HFKRQ0-(GV$FDGHPLF/RQGRQSS² 6WHUQ0.ODXVQHU0$OYDUDGR55HQVNHUV.DQG'LFNHQV0 (YDOXDWLRQRI WKH(SL2FXODU70WLVVXHPRGHODVDQDOWHUQDWLYHWRWKH'UDL]HH\HLUULWDWLRQWHVW7R[LFRO ,Q9LWUR²
CHAPTER
14
Three-Dimensional Construct of the Human Corneal Epithelium for In Vitro Toxicology '+1JX\HQ5RJHU:%HXHUPDQ%DUW'H:HYHUDQG0DUWLQ5RVG\
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV 7KUHH'LPHQVLRQDO&RUQHDO(SLWKHOLDO&HOO&RQVWUXFWV +LVWRORJ\ ,Q9LWUR7R[LFRORJ\$VVD\ :HVWHUQ%ORW$QDO\VLV 5HVXOWV +LVWRORJLF&KDUDFWHULVWLFVRIWKH7KUHH'LPHQVLRQDO&RUQHDO (SLWKHOLDO&RQVWUXFWV %LRFKHPLFDO&KDUDFWHULVWLFVRIWKH7KUHH'LPHQVLRQDO&RUQHDO (SLWKHOLDO&RQVWUXFWV 5HVSRQVHWR%HQ]DONRQLXP&KORULGH 'LVFXVVLRQ $FNQRZOHGJPHQWV 5HIHUHQFHV INTRODUCTION 7KHFRUQHDOHSLWKHOLXPFRPSULVLQJÀYHRUVL[OD\HUVRIGLIIHUHQWLDWHGHFWRGHUPDO FHOOV SURWHFWV WKH FRUQHD DQG FRQWULEXWHV WR LWV RSWLFDO SURSHUWLHV /HPS %HXHUPDQDQG3HGUR]D6FKPLGW ,QMXU\WRWKHFRUQHDSUHVHQWVDVXEVWDQWLDO WKUHDWWRYLVLRQ*DVVHWHWDO&OD\WRQHWDO2VJRRGHWDO 7KXV GHWHUPLQLQJWKHULVNRIFRUQHDOLQMXU\IURPH[SRVXUHWRFKHPLFDOV³ERWKDWKRPH DQGLQWKHZRUNSODFH³LVRIFULWLFDOLPSRUWDQFH 147
148
ALTERNATIVE TOXICOLOGICAL METHODS
7KH 'UDL]H WHVW KDV EHHQ XVHG DV D VWDQGDUG PHWKRG WR HYDOXDWH WKH SRWHQWLDO RFXODUWR[LFLW\RILQGXVWULDODQGKRXVHKROGFKHPLFDOVVXFKDVWKRVHXVHGLQFRVPHWLFV DQGVRDSVIRUPDQ\\HDUV+RZHYHUSUREOHPVZLWKWKH'UDL]HWHVWVXFKDVLQDF FXUDF\DQGQRQVSHFLÀ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
MATERIALS AND METHODS Three-Dimensional Corneal Epithelial Cell Constructs ,PPRUWDOL]HGKXPDQFRUQHDOHSLWKHOLDOFHOOV,+&(& ZHUHSODFHGLQDQLQHUW SHUPHDEOH SRO\FDUERQDWH LQVHUW 1XQF$6 5RVNLOGH 'HQPDUN DQG FXOWLYDWHG DW WKH DLUOLTXLG LQWHUIDFH LQ D FKHPLFDOO\ GHÀQHG PHGLXP IRU G7KH WKUHHGLPHQ VLRQDOFRQVWUXFWVZHUHVKLSSHGRYHUQLJKWWRWKH/68(\H&HQWHU LQ1HZ2UOHDQV /RXLVLDQDIURPWKH6NLQ(WKLF/DERUDWRULHVLQ1LFH)UDQFH8SRQDUULYDOWKHFRQ VWUXFWV ZHUH DVHSWLFDOO\ UHPRYHG DQG SODFHG LQ VL[ZHOO FXOWXUH SODWHV FRQWDLQLQJ QORIPDLQWHQDQFHPHGLXPVXSSOLHGE\6NLQ(WKLF7KHFXOWXUHVZHUHDOORZHG WRHTXLOLEUDWHLQDKXPLGLÀHGLQFXEDWRUDW&IRUKUDIWHUZKLFKWKHPHGLXP ZDVUHPRYHGDQGUHSODFHGZLWKIUHVKPHGLXP Histology &RQVWUXFWVZHUHWUDQVIHUUHGWRVL[ZHOOSODWHVÀOOHGZLWKDVROXWLRQFRQWDLQLQJ JOXWDUDOGHK\GHDQGSDUDIRUPDOGHK\GHLQD0VRGLXPFDFRG\ODWHEXIIHU
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
149
S+ FRQWDLQLQJ SLFULF DFLG DW & %HXHUPDQ DQG 3HGUR]D6FKPLGW 7KHÀ[DWLYHVROXWLRQZDVDOVRSLSHWWHGLQWRWKHLQWHULRURIWKHFRQVWUXFWV 6SHFLPHQV ZHUH ZDVKHG LQ 0 VRGLXP FDFRG\ODWH RYHUQLJKW SRVWÀ[HG LQ RVPLXPWHWUR[LGHGHK\GUDWHGLQDJUDGHGHWKDQROVHULHVDQGHPEHGGHGLQSODVWLF UHVLQ (SRQDWH 7HG 3HOOD 5HGGLQJ &$ 8OWUDWKLQ VHFWLRQV QP ZHUH VWDLQHG IRU FRQWUDVW ZLWK XUDQ\O DFHWDWH DQG OHDG FLWUDWH 8OWUDVWDLQHU /.% %URPPD6ZHGHQ DQGYLHZHGXVLQJDWUDQVPLVVLRQHOHFWURQPLFURVFRSH(0 &$ =HLVV 7KLFN SODVWLF VHFWLRQV QP ZHUH VWDLQHG ZLWK WROXLGLQH EOXH IRU OLJKWPLFURVFRS\DQGSKRWRJUDSK\ IN VITRO Toxicology Assay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À[HGIRUOLJKWDQGWUDQVPLVVLRQHOHFWURQPLFURVFRS\RUSURFHVVHGIRU :HVWHUQEORWDQDO\VLV Western Blot Analysis 7KH WKUHHGLPHQVLRQDO FRQVWUXFWV ZHUH O\VHG ZLWK QO RI LFHFROG EXIIHUHG 3%6 FRQWDLQLQJ7ULWRQ ; VRGLXP GHR[\FKRODWH VRGLXP GRGHF\O VXOIDWH OHXSHSWLQQJPO ('7$P0 SHSVWDWLQ$QJPO DSURWLQLQ QJPO DQG SKHQ\OPHWK\OVXOIRQ\O Á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v/DHPPOLEXIIHUv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³$(DQG$(
150
ALTERNATIVE TOXICOLOGICAL METHODS
%RHKULQJHU0DQQKHLP*URXS5RFKH%DVHO6ZLW]HUODQG FRUQHDVSHFLÀFN'D $( 5HVHDUFK'LDJQRVWLFV,QF)ODQGHUV1- DQGODPLQLQ &DO ELRFKHP 6DQ 'LHJR &$ WR[LFRORJ\ DQDO\VLVSKRVSKRVSHFLÀF PLWRJHQDFWLYDWHG SURWHLQNLQDVH0$3. 6DQWD&UX]%LRWHFKQRORJ\,QF6DQWD&UX]&$ 7KH PHPEUDQHV ZHUH WKHQ LQFXEDWHG ZLWK D KRUVHUDGLVK SHUR[LGDVH +53 FRQMX JDWHG VHFRQGDU\ DQWLERG\ DQWLPRXVH +53 6DQWD &UX] %LRWHFKQRORJ\ 'HWHUPLQDWLRQ RI UHDFWLYLW\ ZDV FDUULHG RXW XVLQJ HOHFWURFKHPLFDO OXPLQHVFHQFH (&/ GHWHFWLRQUHDJHQWVDQGYLVXDOL]HGRQ[UD\ÀOP+\SHUÀOP$PHUVKDP
RESULTS Histologic Characteristics of the Three-Dimensional Corneal Epithelial Constructs +LVWRORJLFDOO\WKHWKUHHGLPHQVLRQDOFRQVWUXFWVRI,+&(&UHVHPEOHGWKHVWUDWLÀHG FHOOXODURUJDQL]DWLRQRIKXPDQFRUQHDOHSLWKHOLXP)LJXUH 7KHQRQNHUDWLQL]HG VXSHUÀFLDOFHOOVZHUHÁDWWHQHGLQWKHSODQHRIWKHFRQVWUXFW7KHRXWHUPHPEUDQHVRI WKHVH FHOOV ZHUH WKURZQ LQWR PLFURYLOOL D IHZ PLFURQV LQ OHQJWK &HOOV LQ DOO OD\HUV H[KLELWHGDZHOOGHYHORSHGF\WRVNHOHWDOQHWZRUNDQGZHUHDWWDFKHGWRDGMDFHQWFHOOV E\ GHVPRVRPHV )LJXUHV DQG &HOOV RI WKH LQWHUPHGLDWH OD\HU GLVSOD\HG PRUHODWHUDOF\WRSODVPLFH[WHQVLRQVWKDQWKRVHLQWKHEDVDOOD\HUVLPLODUWRZLQJFHOOV LQKXPDQFRUQHDOHSLWKHOLXP0HDQWKLFNQHVVRIWKHFRQVWUXFWVZDVQP QP 6(Q VLPLODUWRWKDWRIQRUPDOKXPDQFRUQHDOHSLWKHOLXP
Figure 14.1 Light micrograph of a plastic section from a construct after 24 hr equilibration at 37°C. The tissue organization reveals a stratified appearance with columnar basal cells, defined wing cells, and flattened superficial cells. Toluidine blue and basic fuchsin, original magnification 160v.
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
151
Figure 14.2 Transmission electron micrograph of the construct after 24 hr equilibration at 37°C. The superficial cells give rise to numerous villus processes. The nucleus is oriented parallel to the surface. Some small, spot-like junction arrangements are seen between cells at the surface. Desmosomes are present between adjacent cells. Original magnification 12,600v.
Figure 14.3 Transmission electron micrograph of basal cells of the three-dimensional construct. The nucleus of the basal cell is upright. Within the cell, there is an extensive cytoskeletal network. Mitochondria surround the nucleus and desmosomes join adjacent cells. Original magnification 10,000v.
152
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 14.4 High-power transmission electron micrograph of the basal membrane of a basal cell revealing numerous mature hemidesmosomes. Also visible are the components of the hemidesmosomes: the intracellular membrane placode, filaments radiating through the membrane, and the typical band in what would be the lamina lucida. The amorphous band at the bottom is the polycarbonate support membrane of the construct. Original magnification 75,000v.
7KH EDVDO FHOO OD\HU FRQVLVWHG RI D VLQJOH OD\HU RI FROXPQDU FHOOV ZKRVH EDVDO PHPEUDQHVUHVWHGRQWKHLQVHUW)LJXUHVDQG $WWKHXOWUDVWUXFWXUDOOHYHO WKHEDVDOPHPEUDQHVUHYHDOHGPDWXUHKHPLGHVPRVRPHVZLWKLQWHUQDOSODFRGHVDQG ÀODPHQWVUDGLDWLQJWKURXJKWKHFHOOPHPEUDQH)LJXUH 7KHF\WRSODVPRIWKH FROXPQDU FHOOV ZDV ÀOOHG ZLWK PDWV RI ÀODPHQWV DQG VSDUVH PLWRFKRQGULD ZHUH ORFDWHGDURXQGWKHQXFOHXV Biochemical Characteristics of the Three-Dimensional Corneal Epithelial Constructs 7KH WKUHHGLPHQVLRQDO FRQVWUXFWV ZHUH DVVHVVHG IRU LPPXQRUHDFWLYLW\ WR WKH HSLWKHOLDO FHOOVSHFLÀF NHUDWLQV D JURXS RI ZDWHULQVROXEOH SURWHLQV WKDW IRUP WKH PDMRUFRPSRQHQWVRIWKHF\WRVNHOHWDOFRPSOH[.HUDWLQVDUHGLYLGHGLQWRDFLGLFDQG EDVLF VXEIDPLOLHV DQG DUH IRXQG WRJHWKHU LQ SDLUV7KH FKDUDFWHUL]DWLRQ RI VSHFLÀF NHUDWLQVSUHVHQWLQWKHKXPDQFRUQHDOHSLWKHOLXPE\LPPXQREORWWLQJXVLQJWKH$( DQG$(PRQFORQDODQWLERGLHVKDVEHHQUHSRUWHG7VHQJHWDO $VVKRZQLQ WKH:HVWHUQEORWVWKHH[SUHVVLRQSDWWHUQRI$(IRUWKHFRQVWUXFWVZDVVLPLODUWR WKDW IRU ,+&(& FXOWXUHG IRU ZHHNV )LJXUH $ ([SUHVVLRQ RI$( IRU WKH WKUHHGLPHQVLRQDOFRQVWUXFWVZDVVLPLODUWRWKHH[SUHVVLRQSDWWHUQVVHHQLQFXOWXUHG ,+&(&DQGIUHVKO\REWDLQHGKXPDQGRQRUFRUQHDOHSLWKHOLDOFHOOV)LJXUH% :HVWHUQEORWVXVLQJWKH$(DQWLERG\DPDUNHURIFRUQHDOGLIIHUHQWLDWLRQVKRZHG SRVLWLYHLPPXQRUHDFWLYLW\WRDN'DSURWHLQLQGLFDWLQJWKDWWKHHSLWKHOLDOFHOOVRI WKHWKUHHGLPHQVLRQDOFRQVWUXFWH[SUHVVHGFRUQHDVSHFLÀFNHUDWLQ)LJXUH
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
153
Figure 14.5 Western blots of the acidic (AE1) and the basic (AE3) keratin family in the threedimensional construct: A. The reactivity pattern for AE1 in the three-dimensional construct (Lane 1) is similar to that of immortalized human corneal epithelial cells (IHCEC) cultured for 4 weeks (Lane 2). B. The reactivity pattern for AE3 (Lane 1) is similar to that of cultured IHCEC at 1 week (Lane 2) and 2 weeks (Lane 3) and human donor corneal epithelial cells obtained within 24 hr after death (Lane 4). The molecular weights of several cytokeratin isoforms recognized by the respective antibodies are indicated below under AE1 and AE3, respectively.
Figure 14.6 Western blot of the 64 kDa cornea-specific keratin AE5 in the three-dimensional construct. Lanes show the construct on Day 0 (immediately upon arrival), Day 1 (24 hr equilibration at 37°C), and Day 2 (48 hr at 37°C), as well as the fresh human donor corneal epithelial cell positive control (+) and the rabbit lacrimal gland negative control (–).
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esponse to Benzalkonium Chloride %HQ]DONRQLXP FKORULGH ZKLFK LV FRPPRQO\ XVHG DV D SUHVHUYDWLYH LQ RSK WKDOPLF VROXWLRQV LQ FRQFHQWUDWLRQV IURP WR PD\ LQFUHDVH HSLWKHOLDO
154
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 14.7 Western blot of laminin in the three-dimensional construct. One band is seen at 220 kDa and another at 440 kDa. Lane 1, three-dimensional construct; Lane 2, fresh human corneal donor epithelial cells from cadaver eyes; Lane 3, immortalized human corneal epithelial cells cultured for 4 weeks.
SHUPHDELOLW\7KHHIIHFWVRIEHQ]DONRQLXPFKORULGHDWVHYHUDOFRQFHQWUDWLRQVZHUH GHWHUPLQHGDIWHUKUH[SRVXUH/LJKWPLFURVFRS\VKRZHGQRGLIIHUHQFHVLQWKH YHKLFOH3%6 FRQWURODQGWKHQRUPDOFRQWUROFRQVWUXFWVQRWVKRZQ :LWK EHQ]DONRQLXP FKORULGH FHOOXODU RUJDQL]DWLRQ ZDV VLPLODU WR WKDW RI WKH FRQWUROV DOWKRXJKVRPHPLQRUVORXJKLQJRIWKHVXSHUÀFLDOFHOOVZDVVHHQ)LJXUH$
Figure 14.8 /LJKWPLFURJUDSKVRIWKHWKUHHGLPHQVLRQDOFRQVWUXFWVKRZLQJFHOOXODUGDPDJHDIWHUWUHDW PHQWZLWKEHQ]DONRQLXPFKORULGHIRUKU$ % & 2ULJLQDO PDJQLÀFDWLRQv FRQWLQXHG
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
155
Figure 14.8 (continued) /LJKWPLFURJUDSKVRIWKHWKUHHGLPHQVLRQDOFRQVWUXFWVKRZLQJFHOOXODUGDP DJH DIWHU WUHDWPHQW ZLWK EHQ]DONRQLXP FKORULGH IRU KU $ % & 2ULJLQDOPDJQLÀFDWLRQv
:LWKEHQ]DONRQLXPFKORULGHWKHRUJDQL]DWLRQRIWKHFRQVWUXFWVZDVVLPLODU WRWKDWRIWKHFRQVWUXFWVWUHDWHGZLWKEHQ]DONRQLXPFKORULGHDOWKRXJKWKH DPRXQW RI FHOOXODU GHEULV ZDV JUHDWHU )LJXUH % 7UDQVPLVVLRQ HOHFWURQ PLFURVFRS\VKRZHGUHPQDQWVRIVXSHUÀFLDOFHOOVDQGLQFUHDVHGYHVLFXODWLRQQRW VKRZQ :LWKEHQ]DONRQLXPFKORULGHWKHHIIHFWZDVVHYHUH)LJXUH& &HOOXODUGDPDJHZDVFOHDUO\HYLGHQWDQGWKHFRQVWUXFWVZHUHFRPSOHWHO\VHSDUDWHG IURP WKH EDVDO PHPEUDQH WKHUH ZDV PXFK PRUH YDFXRODWLRQ DQG WKH QXFOHL DSSHDUHGS\NQRWLF
156
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 14.9 Top: Western blot analysis for phosphorylated (active) p42/p44 mitogen-activated protein kinase (MAPK) after treatment with benzalkonium chloride. Positive control (Ctrl +), epidermal growth factor-stimulated A431 cells. Negative control (Ctrl –), unstimulated A431 cells. Bottom: The histogram shows the increase in intensity level (activity) of p42/p44 with increasing concentrations of benzalkonium chloride (BAK). The absence of activity with 0.1% benzalkonium chloride is likely due to cell death resulting from toxic insult.
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
DISCUSSION ,QWKLVVWXG\ZHGHPRQVWUDWHGVLPLODULWLHVEHWZHHQWKHWKUHHGLPHQVLRQDO,+&(& FRQVWUXFWDQGQRUPDOKXPDQFRUQHDOHSLWKHOLXPLQWHUPVRIWKHRYHUDOOPRUSKRORJ\
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
157
DQGWKLFNQHVVDERXWQP 7KHVWUDWLÀHGDSSHDUDQFHRIWKHFROXPQDUEDVDOFHOOV DQGWKHZLQJFHOOVRYHUKDQJLQJWKHURXQGHGVXUIDFHVRIWKHEDVDOFHOOVZDVVLPLODU WR WKH RUJDQL]DWLRQ RI HSLWKHOLDO WLVVXH LQ YLYR 5HPDUNDEO\ WKH FXOWXUHG FRQVWUXFW FHOOVSURGXFHGPDWXUHKHPLGHVPRVRPHVDORQJWKHEDVDOPHPEUDQHRIWKHEDVDOFHOOV DQG ÀODPHQWV ZHUH VHHQ WR UDGLDWH IURP WKH LQWHUQDO PHPEUDQH SODFRGHV RI WKH KHPLGHVPRVRPHV 7KHVH PHFKDQLFDO DWWDFKPHQWV ZHUH IXQFWLRQDO WR VRPH H[WHQW EHFDXVHEHQ]DONRQLXPFKORULGHDIIHFWHGWKHLULQWHJULW\DOORZLQJWKHVXSSRUW PHPEUDQHWRIDOODZD\7KLVVXJJHVWVDQDGGLWLRQDOHIIHFWRIWKLVSUHVHUYDWLYHWKDW KDVQRWEHHQSUHYLRXVO\QRWHG ,PPXQRUHDFWLYLW\ WR N'D NHUDWLQ LQGLFDWHV WKDW WKH FHOOV RI WKH FRQVWUXFW UHWDLQWKLVFRUQHDVSHFLÀ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À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À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ÀQGLQJ WKH SDUDPHWHUV WKDW GHVFULEH
158
ALTERNATIVE TOXICOLOGICAL METHODS
FRDUVHPHDVXUHVRIWKHUHVSRQVHLVQRWGLIÀFXOW+RZHYHUIXUWKHUZRUNLVUHTXLUHG WR GHYHORS DQG UHÀQH WKHVH PHDVXUHV DQG LPSURYH WKHLU DELOLW\ WR LQFUHDVH RXU XQGHUVWDQGLQJ RI WKH FDSDFLW\ IRU KHDOLQJ DQG WKH UHWXUQ WR WKH QRUPDO VWDWH DIWHU H[SRVXUHWRDWR[LFHYHQW
ACKNOWLEDGMENTS 7KLVVWXG\ZDVVXSSRUWHGLQSDUWE\863XEOLF+HDOWK6HUYLFHJUDQWV(< (<DQG(<GHSDUWPHQWDOFRUHJUDQW IURPWKH1DWLRQDO(\H,QVWLWXWH 1DWLRQDO,QVWLWXWHVRI+HDOWK%HWKHVGD0DU\ODQGDQGDQXQUHVWULFWHGGHSDUWPHQWDO JUDQWIURP5HVHDUFKWR3UHYHQW%OLQGQHVV,QF1HZ
REFERENCES $UDNL6DVDNL.2KDVKL<6DVDEH7+D\DVKL.:DWDQDEH+7DQR<DQG+DQGD+ $Q 69LPPRUWDOL]HG KXPDQ FRUQHDO HSLWKHOLDO FHOO OLQH DQG LWV FKDUDFWHU L]DWLRQ,QYHVW2SKWKDOPRO9LV6FL² %HXHUPDQ5:DQG3HGUR]D6FKPLGW/ 8OWUDVWUXFWXUHRIWKHKXPDQFRUQHD0LFURVF 5HV7HFK² %XUVWHLQ1/DQG.O\FH6' (OHFWURSK\VLRORJLFDQGPRUSKRORJLFHIIHFWVRIRSKWKDOPLF SUHSDUDWLRQVRQUDEELWFRUQHDHSLWKHOLXP,QYHVW2SKWKDOPRO9LV6FL² &OD\WRQ 50 *UHHQ . :LOVRQ 50 =HKLU $ -DFN - DQG 6HDUOH / 7KH SHQHWUDWLRQRIGHWHUJHQWVLQWRDGXOWDQGLQIDQWH\HVSRVVLEOHKD]DUGVRIDGGLWLYHVWR RSKWKDOPLFSUHSDUDWLRQV)RRG&KHP7R[LFRO² 'DZVRQ0DQG0XVWDID$) 8VHRIFXOWXUHGKXPDQFRQMXQFWLYDODQGRWKHUFHOOVWR DVVHVVWKHUHODWLYHWR[LFLW\RIVL[ORFDODQDHVWKHWLFV)RRG&KHP7R[LFRO² 'RXFHW2/DQYLQ0DQG=DVWURZ/ $QHZLQYLWURKXPDQHSLWKHOLDOPRGHOIRU DVVHVVLQJWKHH\HLUULWDWLRQSRWHQWLDORIIRUPXODWHGFRVPHWLFSURGXFWV,Q9LWUR0RO 7R[LFRO² 'RXFHW2/DQYLQ0DQG=DVWURZ/ &RPSDULVRQRIWKUHHLQYLWURPHWKRGVIRUWKH DVVHVVPHQW RI WKH H\HLUULWDWLQJ SRWHQWLDO RI IRUPXODWHG FRVPHWLF SURGXFWV ,Q9LWUR 0RO7R[LFRO² *DVVHW $5 ,VKLL< .DXIPDQ +( DQG 0LOOHU 7 &\WRWR[LFLW\ RI RSKWKDOPLF SUHVHUYDWLYHV$P-2SKWKDOPRO² *UDQW5/
CONSTRUCT OF THE HUMAN CORNEAL EPITHELIUM FOR TOXICOLOGY
159
.DKQ&5
CHAPTER
15
The Human Corneal Epithelial HCE-T TEP Assay for Eye Irritation: Scientific Relevance and Summary of Prevalidation Study Results 6KHUU\/:DUG0D[LPR*DFXOD-UDQG+HQU\)(GHOKDXVHU
CONTENTS ,QWURGXFWLRQ 6FLHQWLÀF5HOHYDQFH %DFNJURXQGDQG5DWLRQDOHIRUWKH'HYHORSPHQW RIWKH+&(77(3$VVD\ 6FLHQWLÀF%DVLVIRUWKH+&(77(3$VVD\ 7KH0HFKDQLVPRI$FWLRQRI)OXRUHVFHLQ7(3LQWKH7HVW6\VWHP &RPSDUHGWRWKH+XPDQ(\H 3UHYDOLGDWLRQ6WXG\5HVXOWV 3XUSRVHIRUWKH+&(77(3$VVD\ 6WXG\6WUXFWXUH 'DWD$QDO\VLV 5HVXOWV &RQFOXVLRQV 6XPPDU\ 5HIHUHQFHV
INTRODUCTION 1HZ DOWHUQDWLYH WHVW PHWKRGV WR WKH 'UDL]H UDEELW H\H LUULWDWLRQ WHVW PXVW EH DEOHWRPHHWWKHSHUIRUPDQFHH[SHFWDWLRQVRIDIRUPDOYDOLGDWLRQVWXG\,QWHUQD WLRQDO RUJDQL]DWLRQV KDYH SURYLGHG VSHFLÀF FULWHULD WKDW DUH WR EH PHW IRU WHVW
161
162
ALTERNATIVE TOXICOLOGICAL METHODS
PHWKRGYDOLGDWLRQLQWKHLUSXEOLVKHGJXLGHOLQHV%DOOVHWDOD2(&' 1,(+6 7KUHH FRQGLWLRQV PXVW EH VDWLVÀHG IRU D QHZ WR[LFRORJLFDO WHVW PHWKRG WR EH FRQVLGHUHGYDOLGWKHVFLHQWLÀFUHOHYDQFHWKHSUHGLFWLYHUHOHYDQFHDQGWKHUHOLDELOLW\ RIWKHQHZWHVWPHWKRG1,(+6:RUWKDQG%DOOV 7KHSUHIHUUHGGHYHO RSPHQW RI D QHZ WHVW PHWKRG ZRXOG LQFOXGH VWUDWHJLFDOO\ SODQQLQJ WKH WHVW PHWKRG GHYHORSPHQWSUHYDOLGDWLRQDQGYDOLGDWLRQVRWKDWDOOFRQGLWLRQVIRULWVYDOLGDWLRQDUH IXOÀOOHGE\WKHFRPSOHWLRQRIWKHLQWHUODERUDWRU\YDOLGDWLRQVWXG\+RZHYHUWHVWPHWK RGVLQWKHSURFHVVRIYDOLGDWLRQDWWKLVWLPHZHUHGHYHORSHGEHIRUHWKHIRUPDOYDOLGDWLRQ SURFHVVHVGHÀQHGE\WKH(XURSHDQ&HQWHUIRUWKH9DOLGDWLRQRI$OWHUQDWLYH0HWKRGV (&9$0 WKH2(&'DQGWKH,QWHUDJHQF\&RRUGLQDWLQJ&RPPLWWHHRQWKH9DOLGDWLRQ RI$OWHUQDWLYH0HWKRGV,&&9$0 ZHUHÀQDOL]HG7KHUHIRUHWKHÁH[LELOLW\WKDWKDV EHHQ SURSRVHG IRU WKH YDOLGDWLRQ SURFHVVHV 1,(+6 :RUWK DQG %DOOV IDYRUVWKHFRQWLQXHGHYDOXDWLRQRIVFLHQWLÀFDOO\UHOHYDQWPHWKRGVWKDWDUHOLNHO\WREH XVHIXOUHSODFHPHQWVRUDGMXQFWVWRFXUUHQWWR[LFLW\WHVWPHWKRGV 7KLVFKDSWHUGHVFULEHVWZRHVVHQWLDOVWHSVLQWKHYDOLGDWLRQSURFHVVHVWDEOLVKLQJ WKHVFLHQWLÀFUHOHYDQFHRIDQHZWHVWPHWKRGDQGWKHSUHYDOLGDWLRQRIWKHWHVWPHWKRG 7KHVHFRPSRQHQWVRIWKHYDOLGDWLRQSURFHVVDUHGHVFULEHGIRUWKH+&(77(3DVVD\ DKXPDQFRUQHDOHSLWKHOLDOFHOOEDVHGDVVD\WKDWZDVGHYHORSHGDVDQLQYLWURDOWHU QDWLYHPHWKRGWRWKH'UDL]HUDEELWH\HLUULWDWLRQWHVW.DKQDQG:DONHU.DKQ HWDO.UXV]HZVNLHWDO
SCIENTIFIC RELEVANCE Background and Rationale for the Development of the HCE-T TEP Assay 7KH+&(77(3WHVWPHWKRGZDVGHYHORSHGDWWKH*LOOHWWH0HGLFDO(YDOXDWLRQ /DERUDWRULHV*0(/ LQ²DVDQLQYLWURWHVWPHWKRGXVHGWRHYDOXDWHWKH RFXODU LUULWDWLRQ SRWHQWLDO RI ZDWHUVROXEOH FKHPLFDOV DQG IRUPXODWLRQV .DKQ DQG :DONHU.DKQHWDO.UXV]HZVNLHWDO 7KH+&(77(3 DVVD\ PHDVXUHV WKH GRVHGHSHQGHQW HIIHFW RI D WHVW PDWHULDO RQ WKH VXEVHTXHQW ÁXRUHVFHLQ WUDQVHSLWKHOLDO SHUPHDELOLW\ 7(3 DFURVV VWUDWLÀ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ÀFXOWWRREWDLQDQGGRQRWVXUYLYH ORQJ LQ FXOWXUH 2Q WKH RWKHU KDQG ZHOOFKDUDFWHUL]HG FHOO OLQHV SURYLGH D UHDGLO\ DYDLODEOH VRXUFH RI FHOOV WKDW FDQ EH XVHG IRU WKH GHYHORSPHQW RI UHSURGXFLEOH LQ YLWURWHVWPHWKRGV $QXPEHURIKXPDQFRUQHDOHSLWKHOLDOFHOOOLQHVZHUHGHYHORSHGDQGFKDUDFWHU L]HGE\*0(/VFLHQWLVWVEHWZHHQDQG7KH+&(7FHOOOLQHZDV
THE HUMAN CORNEAL HCE-T TEP ASSAY
163
GHYHORSHGE\WUDQVIHFWLRQWKHLQVHUWLRQRIYLUDOJHQHV RISULPDU\FXOWXUHVRIKXPDQ FRUQHDOHSLWKHOLDOFHOOV+&( ZLWKWKH69ODUJH7DQWLJHQSODVPLG5697.DKQ HWDO.DKQDQG5KLP-XO\:DONHUDQG.DKQ6HSWHPEHU 7KH UHVXOWLQJFHOOOLQHVZHUHFKDUDFWHUL]HGXVLQJDQXPEHURIFULWHULDWRGHWHUPLQHWKHLU FRPSDUDELOLW\WRSULPDU\+&(FHOOVLQFOXGLQJFHOOPRUSKRORJ\FDOFLXPPHGLDWHG PRGXODWLRQRIPRUSKRORJ\NHUDWLQH[SUHVVLRQF\WRNLQHUHOHDVHODFWDWHSURGXFWLRQ PHWDOORSURWHLQDVHH[SUHVVLRQDQGWKHDELOLW\WRIRUPVWUDWLÀHGFXOWXUHVWKDWGHYHORS DPHDVXUDEOHHSLWKHOLDOSHUPHDELOLW\EDUULHUDQGH[SUHVVWLJKWMXQFWLRQV.DKQHWDO .DKQDQG:DONHU.UXV]HZVNLHWDO:DUGHWDOD E D &ORWKLHU HW DO 5HVHDUFK ÀQGLQJV LQ RWKHU ODERUDWRULHV KDYH DOVRFRQÀ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ÀOP7KHVHLQYLWURFXOWXUHVRIVWUDWLÀHG+&( 7FHOOVDUHFDOOHGWKH+&(7PRGHO7KHERWWRPOD\HUVRI+&(7FHOOVDUHLPPHUVHG LQFHOOFXOWXUHPHGLXPDQGWKHWRSOD\HUIDFHVWKHDLUVRWKH\DUHGHVFULEHGDVJURZQ DWWKHDLU²OLTXLGLQWHUIDFH)LJXUH$ 7KLVW\SHRIFXOWXUHIRUPDWSURPRWHVWKH GHYHORSPHQW RI PXOWLSOH FHOO OD\HUV VWUDWLÀFDWLRQ DQG WKH IRUPDWLRQ RI MXQFWLRQV EHWZHHQWKHFHOOVZKLFKDUHQRUPDOSURFHVVHVWKDWFRUQHDOHSLWKHOLDOFHOOVXQGHUJR DVWKH\SUROLIHUDWHDQGGLIIHUHQWLDWH 2QHRIWKHPDMRUIXQFWLRQVRIDQHSLWKHOLDOWLVVXHLVWRIRUPDERUGHUEHWZHHQ GLIIHUHQWELRORJLFDOHQYLURQPHQWVWKXVSURYLGLQJERWKDSURWHFWLYHUROHDQGDVHOHF WLYH SHUPHDELOLW\ EDUULHU 0DFND\ HW DO $W WKH RFXODU VXUIDFH WKH FRUQHDO HSLWKHOLXP IRUPV D EDUULHU WR SURWHFW WKH H\H IURP WKH H[WHUQDO HQYLURQPHQW 7KH LQWDFW FRUQHDO HSLWKHOLXP IRUPV D WLJKW EDUULHU WKDW LV LPSHUPHDEOH WR WKH VPDOO PROHFXODUZHLJKWÁXRUHVFHQWG\HVRGLXPÁXRUHVFHLQ0DXULFH1RUQ 7KXV WKH WHFKQLTXH RI YLWDO VWDLQLQJ RI WKH FRUQHD E\ ÁXRUHVFHLQ FDQ EH XVHG E\ RSKWKDOPRORJLVWVWRLGHQWLI\RFXODUVXUIDFHHSLWKHOLDOGHIHFWV 7KHVWUDWLÀHGFXOWXUHVRIWKH+&(7PRGHOGHYHORSDQHSLWKHOLDOEDUULHUIXQFWLRQ ZKLFKLVUHODWLYHO\LPSHUPHDEOHWRÁXRUHVFHLQ'LVUXSWLRQRIWKHHSLWKHOLDOEDUULHU IXQFWLRQLQWKH+&(7PRGHOE\DFKHPLFDOLUULWDQWFDQEHPHDVXUHGE\LWVLQFUHDVHG SHUPHDELOLW\ WR VRGLXP ÁXRUHVFHLQ :DUG HW DO E .UXV]HZVNL HW DO &KHPLFDO LUULWDQWV KDYH OLNHZLVH EHHQ IRXQG WR GLVUXSW WKH LPSHUPHDELOLW\ RI WKH LQWDFWKXPDQFRUQHDWRÁXRUHVFHLQ0DUVKDQG0DXULFH 6LQFHGLVUXSWLRQRI
164
A.
ALTERNATIVE TOXICOLOGICAL METHODS
B.
C.
D. Determination of In Vitro Endpoint, FR85
E. Prediction Model
Figure 15.1 The three major steps in the execution of the HCE-T TEP assay (A–C), a typical dose-response curve (D), and the prediction model (E).
WKH FRUQHDO HSLWKHOLDO EDUULHU LV RQH RI WKH HDUOLHVW ELRORJLFDO HYHQWV WKDW RFFXUV LQ FKHPLFDOLQGXFHG H\H LUULWDWLRQ 0DXULFH LW KDV EHHQ LGHQWLÀHG DV D SDUDPHWHU WKDW VKRXOG EH SUHGLFWLYH RI WKH RFXODU LUULWDWLRQ SRWHQWLDO RI FKHPLFDOV DQGRWKHUH\HLUULWDQWV7FKDR:DUGHWDOE 7KH+&(77(3DVVD\SURYLGHVDPHDQVWRPHDVXUHWKHWUDQVHSLWKHOLDOSHUPH DELOLW\ 7(3 RI WKH PXOWLOD\HUHG FRUQHDO HSLWKHOLDO FXOWXUHV WR VRGLXP ÁXRUHVFHLQ DIWHU WKHLU H[SRVXUH WR LQFUHDVLQJ GRVHV RI D WHVW PDWHULDO7KH +&(77(3 DVVD\ FRQVLVWV RI WKUHH PDMRU VWHSV GHYHORSPHQW DQG JURZWK RI WKH +&(7 FXOWXUHV )LJXUH$ H[SRVXUHRIWKHFXOWXUHVIRUPLQWRGLIIHUHQWFRQFHQWUDWLRQVRI
THE HUMAN CORNEAL HCE-T TEP ASSAY
165
D WHVW PDWHULDO )LJXUH % DQG HYDOXDWLRQ RI WHVW PDWHULDO HIIHFWV RQ WKH SHUPHDELOLW\RIWKHFXOWXUHVWRVRGLXPÁXRUHVFHLQ)LJXUH& %\PHDVXULQJWKH DPRXQWRIÁXRUHVFHLQWKDWSDVVHVWKURXJKWKHFXOWXUHVLQWRWKHEDVDOPHGLDWKH+&( 77(3DVVD\SURYLGHVDTXDQWLWDWLYHPHDVXUHIRUWKHGRVHGHSHQGHQWHIIHFWRIDWHVW PDWHULDORQWKH+&(7FHOOFXOWXUHV7KHUHVXOWVFDQEHSORWWHGDVDGRVHUHVSRQVH FXUYH)LJXUH' 7KHHQGSRLQWIRUWKHLQYLWURDVVD\WKHORJ)5LVREWDLQHG IURPWKHGRVHUHVSRQVHFXUYH7KH)5LVWKHFRQFHQWUDWLRQRIWHVWPDWHULDODVVR FLDWHGZLWKÁXRUHVFHLQUHWHQWLRQ)5 UHODWLYHWRWKHFRQWUROFXOWXUHV7KH)5 ZDVHPSLULFDOO\GHWHUPLQHGWREHWKHHQGSRLQWWKDWSURYLGHGRSWLPDOFRUUHODWLRQWR 'UDL]HH\HLUULWDWLRQGDWD.UXV]HZVNLHWDO $SUHGLFWLRQPRGHOFRQWDLQVDQDOJRULWKPWKDWGHÀ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cientific Basis for the HCE-T TEP Assay 7KHVWDQGDUGPHWKRGDFFHSWHGE\UHJXODWRU\DJHQFLHVIRUGHWHUPLQLQJWKHH\H LUULWDWLRQ SRWHQWLDO RI D VXEVWDQFH KDV EHHQ WKH 'UDL]H UDEELW H\H LUULWDWLRQ WHVW 'UDL]HHWDO 7KHRULJLQDOWHVWKDVEHHQPRGLÀHGWRXVHWKUHHWRVL[DQLPDOV DQG YDULRXV PRGLÀHG YHUVLRQV DUH VSHFLÀHG E\ GLIIHUHQW UHJXODWRU\ DJHQFLHV UHYLHZHGLQ&KDQDQG+D\HVSS²'L3DVTXDOHDQG +D\HV S ,QJHQHUDODVPDOODPRXQWRIWHVWPDWHULDOPORUPJ LVSODFHG LQ WKH FRQMXQFWLYDO VDF RI RQH H\H RI D VSHFLÀHG QXPEHU RI DOELQR UDEELWV 7KH RFXODU UHDFWLRQ WR WKH WHVW PDWHULDO LV GHWHUPLQHG DQG JUDGHG DW YDULRXV VFRULQJ LQWHUYDOVDFFRUGLQJWRUHVSRQVHVLQWKHFRUQHDWKHFRQMXQFWLYDDQGWKHLULV,QD VWDQGDUGJUDGLQJVFKHPHWKHWRWDOLUULWDWLRQLVUDQNHGRQDVFDOHRIWRWKH FRUQHDO UHVSRQVHV FRPSULVH SRLQWV WKH FRQMXQFWLYDO UHVSRQVHV SRLQWVDQGWKHLULVUHVSRQVHVSRLQWV7R[LFRORJLVWVIHHOFRPIRUWDEOHZLWK WKH FRQWLQXHG XVH RI WKLV PHWKRG EHFDXVH RI LWV IDPLOLDULW\ DQG EHFDXVH RI WKH ODUJH GDWDEDVH RI LQIRUPDWLRQ DYDLODEOH +RZHYHU FRQVLGHUDEOH GLIIHUHQFHV H[LVW EHWZHHQWKHUDEELWDQGWKHKXPDQH\HZKLFKKDVOHGPDQ\WRTXHVWLRQWKHXVHRI WKH 'UDL]H WHVW IRU WKH SUHGLFWLRQ RI WKH KXPDQ RFXODU UHVSRQVH %HFNOH\ %HFNOH\HWDO*HUVKEHLQDQG0F'RQDOG*UHHQHWDO:DONHU ,/6,$$7 3UREOHPV ZLWK WKH UHSURGXFLELOLW\ RI 'UDL]H WHVW UHVXOWV
166
ALTERNATIVE TOXICOLOGICAL METHODS
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ÀFDQFHRIRIWKH WRWDO'UDL]HVFRUHPD[LPXPFRUQHDOVFRUHRXWRIPD[LPXPWRWDOVFRUH 7KHFRUQHDOHSLWKHOLXPDVWKHRXWHUPRVWOD\HURIWKHFRUQHDVHUYHVDVDIXQF WLRQDOEDUULHUWRWR[LFDQWHQWU\LQWRWKHH\H'DVWRQDQG)UHHEHUJ+DFNHWWDQG 0F'RQDOG 7KHFRUQHDOHSLWKHOLXPLVDVWUDWLÀHGWLVVXHFRPSRVHGRIÀYHWR VL[ FHOO OD\HUV 7KH VXUIDFH FHOOV DUH FRQQHFWHG E\ WLJKW MXQFWLRQV DQG DGGLWLRQDO GHVPRVRPDOLQWHUFHOOXODUMXQFWLRQVH[LVWWKURXJKRXWWKHUHPDLQLQJFHOOOD\HUV)LJXUH 7KHVHPXOWLSOHFHOOOD\HUVDQGLQWHUFHOOXODUDGKHVLRQVSURYLGHWKHSURWHFWLYH EDUULHU RI WKH RFXODU VXUIDFH7KH RXWHU WLJKW MXQFWLRQ RI WKH FRUQHDO HSLWKHOLXP LV WKHSULPDU\MXQFWLRQWRUHJXODWHHSLWKHOLDOSHUPHDELOLW\7KHLQWHUFHOOXODUDGKHVLRQV DQG WLJKW MXQFWLRQV DUH RUJDQL]HG LQ D WLVVXHVSHFLÀF PDQQHU SURYLGLQJ D XQLTXH W\SHDQGGHJUHHRIEDUULHUIXQFWLRQE\WKHFRUQHDOHSLWKHOLXP0DFND\HWDO +DPDODLQHQHWDO $QXQGHUVWDQGLQJRIWKHVWUXFWXUHDQGSK\VLRORJ\RIWKHFRUQHD LVHVVHQWLDOWR WKHGHYHORSPHQWRIDSSURSULDWHO\VWUXFWXUHGLQYLWURFRUQHDOPRGHOV7KHFRUQHDLV FRPSRVHG RI WKUHH FHOOXODU OD\HUV WKH RXWHUPRVW FRUQHDO HSLWKHOLXP WKH VWURPD ZKLFK LV LQWHUVSHUVHG ZLWK À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
Corneal epithelium
Ocular surface (cornea, conjunctiva and iris)
Rabbit (in vivo)
Test Tissue
Human (in vitro)
Test Species
Superficial to eye
Superficial to cell cultures
Exposure Route
Until washed out by blinking and tearing (<5 min)
5 min
Exposure Time 5 concentrations with highest equal to that evaluated in Draize test Concentration defined by toxicologist (neat or diluted)
Concentration Tested Concentration of test material causing 15% of fluorescein to penetrate through the corneal epithelium (FR85) Cornea: area of damage and opacity Conjunctiva: chemosis, redness and discharge Iris: degree of effect
Endpoint Measured
Area of corneal damage is related to epithelial cytotoxicity and junctional disruption; opacity is related to penetration of test material into stroma. Conjunctiva damage similar to cornea—epithelial toxicity and penetration. Iris—material has penetrated to cause more severe damage.
Cytotoxicity and junctional disruption in the corneal epithelium
Mechanism of Tissue Damage
Table 15.1 Similarities and Differences in the Endpoint Measured in the HCE-T TEP Assay and in the Draize Eye Irritation Test
THE HUMAN CORNEAL HCE-T TEP ASSAY 167
168
ALTERNATIVE TOXICOLOGICAL METHODS
tear film
tight junction
desmosomal junction stroma Figure 15.2 Cross-sectional diagram of the human corneal epithelium. A drawing illustrating the multiple cell layers, the apical tight junctions, and the intercellular desmosomal junctions of the corneal epithelium.
VXEVWDQFHVVXFKDVHWKDQRODQGDFHWRQHVKRZHGVSHFLHVVSHFLÀFFRUQHDOHIIHFWV 7KHVHUHVXOWVVXSSRUWWKHELRORJLFDOUHOHYDQFHRIXVLQJ'UDL]HUDEELWH\HWHVWGDWD DV WKH UHIHUHQFH PHWKRG IRU D KXPDQ FRUQHDO FHOOEDVHG LQ YLWUR WHVW PHWKRG IRU WKH HYDOXDWLRQ RI VXUIDFWDQWV DQG VXUIDFWDQWEDVHG WHVW PDWHULDOV 7KHVH À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ÀHG+&(7PRGHO 7KH +&(7 7(3 DVVD\ KDV DOVR EHHQ DEOH WR LGHQWLI\ VHYHUH H\H LUULWDQWV EXW DQ LQVXIÀFLHQWQXPEHUKDYHEHHQHYDOXDWHGWRGHWHUPLQHWKHDFFXUDF\DQGSUHFLVLRQRI WKHUHVXOWV 5HSURGXFWLRQRIWKHELRORJLFDOFKDUDFWHULVWLFVRIWKHFRUQHDOVXUIDFHZDVWDNHQ LQWRFRQVLGHUDWLRQGXULQJWKHGHYHORSPHQWRIWKH+&(7PRGHO7KH+&(7PRGHO FRQVLVWVRIDPXOWLOD\HUHGFXOWXUHRI+&(7KXPDQFRUQHDOHSLWKHOLDOFHOOVJURZQ RQDSHUPHDEOHFROODJHQPHPEUDQHDWWKHDLU²OLTXLGLQWHUIDFH&XOWXUHRIWKH+&( 7FHOOVRQSHUPHDEOHPHPEUDQHVDWWKHDLU²OLTXLGLQWHUIDFHLQPHGLXPFRQWDLQLQJ DQHOHYDWHGFRQFHQWUDWLRQRIFDOFLXPP0 LQGXFHVWKHFHOOVWRVWUDWLI\DQG GLIIHUHQWLDWH IRUPLQJ D WLVVXH ZLWK D ZHOOGHYHORSHG EDUULHU IXQFWLRQ %DUULHU
THE HUMAN CORNEAL HCE-T TEP ASSAY
A
169
B
Ap
Ap
M M KGM
0.01% BAC
Figure 15.3 Cross sections of stratified HCE-T cultures visualized by transmission electron microscopy following 5-min superficial exposures to (A) cell culture medium (KGM) (5000v); and (B) 0.01% benzalkonium chloride (BAC) (6000v). Ap = apical surface of the culture; M = collagen membrane. [Photos contributed by S.D. Dimitrijevich.]
IXQFWLRQ LQ WKH +&(7 PRGHO FDQ EH PHDVXUHG E\ WKH DELOLW\ RI WKH FXOWXUHV WR UHVWULFWWKHSHUPHDWLRQRIVRGLXPÁXRUHVFHLQPHDVXUHGDVWUDQVHSLWKHOLDOSHUPH DELOLW\WRÁXRUHVFHLQ7(3 DQGWRGHYHORSWLJKWMXQFWLRQVPHDVXUHGDVWUDQVHSL WKHOLDO HOHFWULFDO UHVLVWDQFH 7(5 .DKQ DQG :DONHU .UXV]HZVNL HW DO :DUGHWDOE 8OWUDVWUXFWXUDO DQDO\VLV RI WKH +&(7 PRGHO LOOXVWUDWHV LWV FRPSDUDELOLW\ WR WKH KXPDQFRUQHDOVXUIDFH:DUGHWDODE )LJXUHVDQG 7KH VXUIDFHFHOOOD\HUVLQWKHFRUQHD0DFND\HWDO DQGLQWKH+&(7PRGHODUH FRPSRVHGRIÁDWWHQHGVTXDPRXVHSLWKHOLDOFHOOVWKDWFRQWDLQWKHWLJKWMXQFWLRQVUHVSRQ VLEOHIRUUHJXODWLRQRISDUDFHOOXODUSHUPHDELOLW\LQWKLVWLVVXH7KHPLGGOHDQGEDVDO FHOOOD\HUVRIWKH+&(7PRGHOH[SUHVVQXPHURXVGHVPRVRPDOLQWHUFHOOXODUMXQFWLRQV 7KH FURVVVHFWLRQ SKRWRPLFURJUDSKV VKRZQ LQ )LJXUH LOOXVWUDWH WKH HIIHFW RI WKH FKHPLFDO WR[LFDQW EHQ]DONRQLXP FKORULGH %$& RQ WKH FHOOV RI DQ +&(7 FXOWXUH)LJXUH$VKRZVDFURVVVHFWLRQIURPDQXQWUHDWHGGD\+&(7FXOWXUH %$& ZDV F\WRWR[LF WR WKH VXSHUÀFLDO FHOOV LQ DQRWKHU +&(7 FXOWXUH DV VKRZQE\WKHODFNRILQWUDFHOOXODUFRQWHQWLQWKHVXUIDFHFHOORIWKHSKRWRPLFURJUDSK )LJXUH% 7KHHSLWKHOLDOFHOOVLQWKH%$&WUHDWHGFXOWXUHDOVRDSSHDUWRKDYH VRPHHGHPDLQGLFDWHGE\WKHLUSOXPSDSSHDUDQFHDQGE\WKHLQFUHDVHGLQWHUFHOOXODU VSDFHV 3K\VLRORJLFDO DVVHVVPHQW RI WKH FXOWXUHV VKRZHG WKDW %$& FDXVHG
170
A
ALTERNATIVE TOXICOLOGICAL METHODS
B
Figure 15.4 Cross sections of stratified HCE-T cultures, visualized by transmission electron microscopy, which were fixed in a special buffer to retain the mucin layer. The dark-stained surface material is the mucin produced by the corneal epithelial cells. (A) A continuous layer of mucin is found on the surface of a differentiated culture (maintained at the air–liquid interface in serum-free medium containing 1.15 mM calcium) in which the TER is high (tight junctions are intact); and (B) mucin is found between the cells in this non-differentiated culture (maintained submerged in serum-free medium containing 0.15 mM calcium) in which the TER is low (tight junctions not intact).
OHVVWKDQRYHUDOOF\WRWR[LFLW\077DVVD\ RQO\VOLJKWO\LQFUHDVHGWKHÁXRUHV FHLQ SHUPHDELOLW\ RI WKH FXOWXUHV GHFUHDVHG 7(3 EXW VLJQLÀFDQWO\ GDPDJHG WKH WLJKWMXQFWLRQVGHFUHDVHG7(5 :DUGHWDOE $QRWKHUVLPLODULW\EHWZHHQWKH+&(7FXOWXUHVDQGWKHLQYLYRFRUQHDOVXUIDFH LVWKHSURGXFWLRQRIPXFLQE\WKHFRUQHDOHSLWKHOLDOFHOOVDQGLWVORFDOL]DWLRQDWWKH VXUIDFHRIWKHLQWDFWFRUQHDDQGRQWKHVXUIDFHRIWKH+&(7FXOWXUHV:DUGHWDO D )LJXUH 0XFLQ LV D FRPSRQHQW RI WKH WHDU ÀOP WKDW LV SURGXFHG E\ FRUQHDODQGFRQMXQFWLYDOHSLWKHOLDOFHOOVDVZHOODVWKHJREOHWFHOOVRIWKHFRQMXQFWLYD ,QDWRPLHWDO 7KHIXQFWLRQVRIPXFLQDWWKHRFXODUVXUIDFHDUHWRIDFLOLWDWH VSUHDGLQJRIWKHDTXHRXVSRUWLRQRIWKHWHDUÀ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ÀQGLQJV VXSSRUW WKH ELRORJLFDO UHOHYDQFH RI XVLQJ D GLIIHUHQWLDWHG WKUHH GLPHQVLRQDO FRUQHDO HSLWKHOLDO FHOO PRGHO IRU WKH GHYHORSPHQW RI D 'UDL]H DOWHU QDWLYHWHVWPHWKRG
THE HUMAN CORNEAL HCE-T TEP ASSAY
171
)OXRUHVFHLQSHUPHDELOLW\DVDPHDVXUHRIEDUULHUGLVUXSWLRQLQHSLWKHOLDOFXO WXUHVZDVRULJLQDOO\SURSRVHGDVDPRGHOWRHYDOXDWHSRWHQWLDOFKHPLFDOWR[LFLW\ WRWKHH\HE\7FKDR 7KHRULJLQDOÁXRUHVFHLQOHDNDJHDVVD\XVHGPRQROD\HU FXOWXUHV RI 0DQGLQ'DUE\ FDQLQH NLGQH\ HSLWKHOLDO FHOOV 0'&. FHOOV 7KH 0'&.FHOOÁXRUHVFHLQOHDNDJHDVVD\LVDXVHIXOVFUHHQIRUH\HLUULWDQWV6KDZHW DO $OWKRXJK VWXGLHV DUH RQJRLQJ ÁXRUHVFHLQ SHUPHDELOLW\ DFURVV PRQROD\HU 0'&. FXOWXUHV KDV QRW GHPRQVWUDWHG VXIÀFLHQW FRUUHODWLRQ WR WKH 'UDL]H WHVW WR ZDUUDQW LWV UHFRPPHQGDWLRQ IRU YDOLGDWLRQ %DOOV HW DO E *HWWLQJV HW DO %UDGODZ HW DO %UDQWRP HW DO =DQYLW HW DO 7LJKW MXQFWLRQ GLVUXSWLRQ LQ 0'&. FXOWXUHV DSSHDUV WR RFFXU VLPXOWD QHRXVO\ ZLWK LQFUHDVHG ÁXRUHVFHLQ SHUPHDELOLW\ SHUVRQDO FRPPXQLFDWLRQ 5 &ORWKLHU 7LJKWMXQFWLRQGLVUXSWLRQKRZHYHULVRQO\SDUWRIWKHPHFKDQLVP RIEDUULHUIXQFWLRQGLVUXSWLRQZKHQLWRFFXUVDWWKHRFXODUVXUIDFH,QWKHVWUDWLÀHG KXPDQ FRUQHDO HSLWKHOLXP WKH PXOWLSOH FHOO OD\HUV WLJKW MXQFWLRQV DQG RWKHU LQWHUFHOOXODUMXQFWLRQVDFWWRUHWDUGÁXRUHVFHLQSHQHWUDWLRQLQWRWKHFRUQHDOVWURPD $UDLHDQG0DXULFH 7KHVDPHPHFKDQLVPVDUHUHVSRQVLEOHIRUÁXRUHVFHLQ UHWHQWLRQE\+&(7FXOWXUHV7KHGDWDVKRZQLQ)LJXUHLOOXVWUDWHWKLVSRLQW &KHPLFDOH[SRVXUHVGLVUXSWHGWKHWLJKWMXQFWLRQV7(5 EHIRUHÁXRUHVFHLQLPSHU PHDELOLW\7(3 ZDVSHUWXUEHGLQWKH+&(7PRGHO:DUGHWDOE )LJXUH ,Q WKH VDPH H[SHULPHQWV UHFRYHU\ LQ WKH DELOLW\ RI WKH FXOWXUHV WR UHWDLQ ÁXRUHVFHLQZDVIRXQGWREHLQGHSHQGHQWRIUHFRYHU\LQ7(57KXVDOWKRXJKWKH 0'&.ÁXRUHVFHLQOHDNDJHDVVD\LVXVHIXODVDVFUHHQLWGRHVQRWFRQWDLQDOORI WKH WLVVXHVSHFLÀF IHDWXUHV QHHGHG WR UHSURGXFH WKH LUULWDQW UHVSRQVH DW KXPDQ RFXODUVXUIDFH 7KH H[SHULPHQWDO GDWD DQG WKH VFLHQWLÀF OLWHUDWXUH UHSRUWHG KHUH VXSSRUW WKH FRQFOXVLRQ WKDW WKH +&(7 7(3 DVVD\ LV D WHVW PHWKRG WKDW LV ELRORJLFDOO\ DQG PHFKDQLVWLFDOO\EDVHGDQGWKXVVKRXOGSURYLGHDJRRGPRGHOIRUWKHKXPDQFRUQHDO UHVSRQVHWRH\HLUULWDQWV Day 1
Day 3
% of Control
100 80 60 40 20 0 0.00
TEP MTT TER
0.02
0.04
SDS(%)
0.06
0.00
0.02
0.04
0.06
SDS(%)
Figure 15.5 Three assays were used to evaluate the dose-dependent effects of sodium dodecyl sulfate (SDS) on HCE-T cultures on the day of treatment (day 1), and 48 hr later (day 3). TEP, transepithelial permeability to fluorescein; TER, transepithelial electrical resistance; MTT, cell viability assay using the MTT dye [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide]. Each dose is represented by triplicate cultures, and the error bars are the standard deviations.
172
ALTERNATIVE TOXICOLOGICAL METHODS
The Mechanism of Action of Fluorescein TEP in the Test System Compared to the Human Eye 2QHRIWKHSULPDU\UHVSRQVHVWKDWRFFXUXSRQVXSHUÀFLDORFXODUH[SRVXUHWRDQ LUULWDWLQJ PDWHULDO LV GLVUXSWLRQ RI WKH FRUQHDO HSLWKHOLDO EDUULHU IXQFWLRQ %DUULHU GLVUXSWLRQ FDQ EH PHDVXUHG E\ WKH ORVV RI ÁXRUHVFHLQ LPSHUPHDELOLW\ DFURVV WKH FRUQHDOHSLWKHOLXPERWKLQWKHKXPDQH\HDQGLQWKH+&(7PRGHO$VH[SODLQHG LQ WKH SUHYLRXV VHFWLRQ WKLV LV GXH WR WKH VLPLODULW\ LQ WKH FHOOXODU PHFKDQLVPV LQYROYHGLQWKHPDLQWHQDQFHRIEDUULHUIXQFWLRQLQWKHLQYLYRFRUQHDOHSLWKHOLXPDQG LQWKHVWUDWLÀHG+&(7FXOWXUHV 7UDQVHSLWKHOLDOÁXRUHVFHLQSHUPHDELOLW\KDVEHHQVKRZQWREHDXVHIXOLQGLFDWRU RIWKHLQWHJULW\RIWKHLQYLYRFRUQHDOHSLWKHOLDOEDUULHU0DXULFH0DXULFHDQG 6LQJK %XUVWHLQ 9LWDO VWDLQLQJ RI WKH KXPDQ FRUQHD XVLQJ VRGLXP ÁXRUHVFHLQLVDVWDQGDUGWHFKQLTXHXVHGE\RSKWKDOPRORJLVWVWRDVVHVVGDPDJHWR WKHFRUQHDOHSLWKHOLXP6RGLXPÁXRUHVFHLQLVDVPDOOPROHFXODUPDVV EULJKWO\ ÁXRUHVFHQWDQG\HOORZLVKJUHHQFRORUHGPROHFXOH7KHVRGLXPVDOWRIÁXRUHVFHLQ LVZDWHUVROXEOHVKRZVQHJOLJLEOHELQGLQJWRWKHLQWDFWRFXODUVXUIDFHDQGLVFRQ VLGHUHG WR EH QRQWR[LF 0DXULFH ZKLFK DUH SURSHUWLHV WKDW PDNH VRGLXP ÁXRUHVFHLQDXVHIXOPROHFXOHIRURSKWKDOPRORJLFXVH,QVROXWLRQWKHFRORUHGÁXR UHVFHLQ FDQ EH TXDQWLWDWHG E\ PHDVXULQJ HLWKHU DEVRUEDQFH RU ÁXRUHVFHQFH ZLWK SHDN DEVRUSWLRQ DW QP DQG SHDN HPLVVLRQ DW QP 0DXULFH 7KH SHUPHDELOLW\ RI ÁXRUHVFHLQ LQ WKH KXPDQ FRUQHDO HSLWKHOLXP LQ RQH VXEMHFW ZDV UHSRUWHGWREHv²FPKUZKLFKLVVLJQLÀFDQWO\OHVVWKDQWKDWPHDVXUHGIRU WKHFRUQHDOHQGRWKHOLXP v²FPKU 0DXULFH 7KRVHÀQGLQJVGHP RQVWUDWH WKH VLJQLÀFDQW UROH RI WKH FRUQHDO HSLWKHOLXP DV WKH PDMRU EDUULHU WR WKH SHQHWUDWLRQ RI ZDWHUVROXEOH GUXJV DQG FRPSRXQGV LQFOXGLQJ VRGLXP ÁXRUHVFHLQ LQWRWKHH\H 7KH LQ YLYR FRUQHDO HSLWKHOLDO EDUULHU WR ÁXRUHVFHLQ KDV EHHQ GHWHUPLQHG E\ PHDVXULQJWKHORVVRIÁXRUHVFHLQIURPWKHWHDUÀOPDQGLWVDSSHDUDQFHLQWKHDQWHULRU FKDPEHU 0DXULFH GH .UXLMI HW DO $Q LQVWUXPHQW FDOOHG D VFDQQLQJÁXRURSKRWRPHWHULVXVHGWRHYDOXDWHWKHSHUPHDWLRQRIÁXRUHVFHLQLQWRWKH DQWHULRUFKDPEHURIWKHH\H(GHOKDXVHUDQG*UHHQ $UHYLHZRIWKLVSURFHGXUH LVEH\RQGWKHVFRSHRIWKLVFKDSWHU,WLVZRUWK\WRQRWHKRZHYHUWKDWWKHSURFHGXUH LVOLPLWHGE\WKHUHVROXWLRQRIWKHLQVWUXPHQWDQGE\RWKHUPHWKRGRORJLFDOSUREOHPV VRWKDWDODUJHSRSXODWLRQQHHGVWREHHYDOXDWHGWRGHWHUPLQHHIIHFWVDPRQJWUHDWPHQW JURXSV-RVKLHWDO0F1DPDUDHWDO 7KHVHWHFKQLFDOGLIÀFXOWLHVZLWK ÁXRURSKRWRPHWU\PDNHLWXQOLNHO\WKDWWKHFRUUHODWLRQRILQYLYRÁXRURSKRWRPHWU\ GDWD WR WKH LQ YLWUR +&(7 7(3 DVVD\ ZRXOG EH IHDVLEOH +RZHYHU WKH SULQFLSOH XQGHUO\LQJWKHWZRWHFKQLTXHVLVWKHVDPH &RUQHDOSHUPHDELOLW\WRÁXRUHVFHLQLVDPHDVXUHRIFHOOXODUGDPDJHPDQLIHVWHG DVF\WRWR[LFLW\DQGMXQFWLRQDOGLVUXSWLRQWRWKHFRUQHDOHSLWKHOLXP$UDLHDQG0DX ULFH 0F&DUH\ DQG 5HDYHV (SLWKHOLDO FHOO GDPDJH DQG MXQFWLRQDO GLVUXSWLRQDUHHDUO\HYHQWVWKDWRFFXUGXULQJFKHPLFDOLQGXFHGKXPDQH\HLUULWDWLRQ 5DPVHODDU HW DO *REEHOV DQG 6SLW]QDV *UDQW DQG 6FKXPDQ 0F&DUH\ DQG 5HDYHV -HVWHU HW DO 0DXUHU HW DO E $ UHFHQWO\ SURSRVHG FODVVLÀFDWLRQ VFKHPH IRU KXPDQ FKHPLFDOLQGXFHG H\H LQMXU\ WKDW ZDV
THE HUMAN CORNEAL HCE-T TEP ASSAY
173
GHYHORSHG E\ D JURXS RI RSKWKDOPLF UHVHDUFKHUV KDV LGHQWLÀHG FRUQHDO HSLWKHOLXP DV RQH RI WKH ÀUVW RFXODU WLVVXHV WR EH DIIHFWHG E\ VXSHUÀFLDO FKHPLFDO H[SRVXUH 0DXUHUHWDOD%OD]NDHWDO 7KHFODVVLÀFDWLRQVFKHPHLQGLFDWHVWKDW WKHGHJUHHRIFRUQHDOHSLWKHOLDOLQMXU\LQFUHDVHVZLWKWKHRYHUDOOVHYHULW\RIFKHPLFDO LQMXU\WRWKHH\HXQWLOWKHHSLWKHOLXPLVWRWDOO\GHVWUR\HG/LNHZLVHLQWKH+&(7 PRGHORFXODUVXUIDFHHSLWKHOLDOEDUULHUGLVUXSWLRQDVPHDVXUHGE\DOWHUHGÁXRUHVFHLQ SHUPHDELOLW\RFFXUVTXLFNO\XSRQVXSHUÀFLDOWR[LFDQWH[SRVXUH)OXRUHVFHLQSHUPH DELOLW\HSLWKHOLDOFHOOF\WRWR[LFLW\DQGGLVUXSWLRQRILQWHUFHOOXODUDGKHVLRQVMXQFWLRQV LQFUHDVHLQDGRVHGHSHQGHQWPDQQHUZLWKFKHPLFDOH[SRVXUH:DUGHWDOE )LJXUH 6LQFHWKH7(3DVVD\SURYLGHVDPHDVXUHRIWKHLQWHJULW\RIWKH+&( 7HSLWKHOLDOEDUULHULWLVDQDORJRXVWRWKHLQYLYRHYHQWRIHSLWKHOLDOEDUULHUGLVUXSWLRQ WKDWFDQEHPHDVXUHGE\LQFUHDVHGHSLWKHOLDOSHUPHDELOLW\WRÁXRUHVFHLQIROORZLQJ FKHPLFDOH[SRVXUH $ UHWURVSHFWLYH HYDOXDWLRQ RI WKH ÁXRUHVFHLQ VWDLQLQJ GDWD IRU UDEELW H\HV IROORZLQJ H[SRVXUH WR VXUIDFWDQWFRQWDLQLQJ IRUPXODWLRQV ZKLFK ZDV FROOHFWHG GXULQJWKH&RVPHWLF7RLOHWULHVDQG)UDJUDQFH$VVRFLDWLRQ&7)$ 3KDVH,,,6WXG\ *HWWLQJV HW DO GHPRQVWUDWHV WKDW FRUQHDO ÁXRUHVFHLQ VWDLQLQJ FRUUHODWHV ZHOO ZLWK WKH 'UDL]H VFRUH GDWD FROOHFWHG IURP WKH VDPH DQLPDOV )LJXUH 7KHVDPHIRUPXODWLRQVZHUHHYDOXDWHGXVLQJWKH+&(77(3DVVD\7KHUHODWLRQ VKLSEHWZHHQWKHLQYLYRÁXRUHVFHLQVWDLQLQJGDWDDWKUYHUVXVWKHLQYLWURORJ 50.0 MMAS R2 = 0.9435 45.0 MMCS R2 = 0.9711 40.0 35.0
Draize Data
30.0 25.0 20.0 15.0 10.0 5.0
–20.000
0.0 0.000
20.000
40.000
60.000
80.000
100.000
120.000
24 Hr Fluorescein Figure 15.6 Fluorescein staining data from rabbit eyes following surfactant-containing formulation exposure correlates well with Draize tissue score data (modified maximum average score, MMAS and modified maximum average corneal score, MMCS) from the same animals. The error bars are the standard deviations; n = 5–6 rabbits evaluated per Draize test; and n = 2–4 rabbits evaluated for fluorescein staining at 24 hr. [Data from Gettings et al., 1996.]
174
ALTERNATIVE TOXICOLOGICAL METHODS
120
MMAS R2 = 0.632 MMCS R2 = 0.7057
100
24 Hr R2 = 0.7361 Fluorescein
Draize Data
80
60
40
20
-0.8
-0.6
-0.4
-0.2
0 0
0.2
0.4
0.6
-20
logFR85 Figure 15.7 The relationship between the in vivo 24-hour fluorescein staining data and the in vitro log FR85 values for the subset of the CTFA formulations that are represented in the HCE-T TEP assay Prediction Model. The error bars are the standard deviations; n = 2 TEP assays; n = 5–6 rabbits per Draize test; and n = 2–4 rabbits per fluorescein data.
)5YDOXHVIRUWKH&7)$IRUPXODWLRQVZKLFKDUHSDUWRIWKH+&(77(3DVVD\ SUHGLFWLRQ PRGHO LV VKRZQ LQ )LJXUH 7KHVH UHVXOWV GHPRQVWUDWH WKH UHODWLRQVKLSEHWZHHQÁXRUHVFHLQVWDLQLQJRIWKHUDEELWFRUQHDDQGWKH'UDL]HVFRUHV )LJXUH DQG WKHUHODWLRQVKLSEHWZHHQWKHLQYLYRÁXRUHVFHLQVWDLQLQJDQG WKH LQ YLWUR +&(7 7(3 DVVD\ )LJXUH 7KH ÁXRUHVFHLQ VWDLQLQJ GDWD DUH DYDLODEOHDORQJZLWKWKHVWDQGDUG'UDL]HVFRUHGDWDIRUWKHVXUIDFWDQWFRQWDLQLQJ IRUPXODWLRQV HYDOXDWHG LQ WKH &7)$ 3KDVH ,,, 6WXG\ *HWWLQJV HW DO 8QIRUWXQDWHO\ÁXRUHVFHLQGDWDDUHQRWDYDLODEOHIRUPDQ\RIWKHPDWHULDOVHYDOX DWHGZLWKWKH'UDL]HWHVWDQGVXIÀFLHQWPDWHULDOVZLWKÁXRUHVFHLQGDWDZHUHQRW DYDLODEOHIRUXVHLQWHVWPHWKRGYDOLGDWLRQ 7KH UHVXOWV UHSRUWHG LQ WKH RSKWKDOPRORJ\ DQG WR[LFRORJ\ OLWHUDWXUH IRU VXU IDFWDQW H[SRVXUHV RI WKH KXPDQ DQG UDEELW H\H VXSSRUW WKH XVH RI ÁXRUHVFHLQ SHUPHDELOLW\ DV DQ DSSURSULDWH PHDVXUH IRU VXUIDFWDQWLQGXFHG H\H LUULWDWLRQ 0DUVK DQG 0DXULFH REVHUYHG WKDW KXPDQ H\HV WUHDWHG ZLWK QRQLRQLF GHWHUJHQWVVKRZHGSHUWXUEDWLRQRIHSLWKHOLDOÁXRUHVFHLQSHUPHDELOLW\DWFRQFHQ WUDWLRQVMXVWVOLJKWO\OHVVWKDQWKRVHWKDWSURGXFHGPDUNHGH\HLUULWDWLRQ2QWKH RWKHUKDQGLQWZRGLIIHUHQWH[SHULPHQWVWKDWFRPSDUHGWKHUHVSRQVHVRIKXPDQ DQGUDEELWH\HVWRVXSHUÀFLDODSSOLFDWLRQVRIEHQ]DONRQLXPFKORULGH%$& WKH UDEELW H\HV ZHUH IRXQG WR EH PRUH VHQVLWLYH WKDQ KXPDQ H\HV WUHDWHG ZLWK WKH VDPH VXUIDFWDQW FRQFHQWUDWLRQV %XUVWHLQ %XHKOHU DQG 1HZPDQQ 7KHVHREVHUYDWLRQVOHG%XUVWHLQ WRFRQFOXGHWKDW´PHDVXUHPHQWVRIRFXODU SHUPHDELOLW\ DQG VXUIDFH GDPDJH DUH QRW GLUHFWO\ WUDQVIHUDEOH IURP UDEELWV WR KXPDQVµ+LVUHVXOWVKRZHYHURQO\LQGLFDWHWKDWWKHUDEELWH\HRYHUSUHGLFWHGWKH
THE HUMAN CORNEAL HCE-T TEP ASSAY
175
KXPDQRFXODUUHVSRQVHWRWKHFDWLRQLFVXUIDFWDQW%$&3UHOLPLQDU\+&(77(3 DVVD\ GDWD REWDLQHG DW *0(/ IRU VHYHUDO FDWLRQLF VXUIDFWDQWV LQFOXGLQJ %$& VKRZHG WKDW WKH\ DOVR ZHUH XQGHUSUHGLFWHG LQ WKH LQ YLWUR DVVD\ UHODWLYH WR WKH 'UDL]HWHVWXQSXEOLVKHGREVHUYDWLRQV 7KLVUHYLHZRIWKHVFLHQWLÀFOLWHUDWXUHDQGWKHUHVXOWVZLWKWKH+&(7PRGHO DQG WKH +&(7 7(3 DVVD\ OHG XV WR FRQFOXGH WKDW WKH PHFKDQLVWLF EDVLV RI ÁXRUHVFHLQLPSHUPHDELOLW\SHUPHDELOLW\LQWKH+&(7PRGHOLVDQDORJRXVWRWKH PHFKDQLVP RI ÁXRUHVFHLQ LPSHUPHDELOLW\SHUPHDELOLW\ LQ WKH LQ YLYR FRUQHDO HSLWKHOLXP )OXRUHVFHLQ LPSHUPHDELOLW\ LQ WKH +&(7 PRGHO LV GXH WR WKH ELR ORJLFDOUHOHYDQFHRIWKHVWUDWLÀHGFRUQHDOHSLWKHOLDOFXOWXUHVZLWKWKHLUDQDORJRXV PXOWLSOH FHOO OD\HUV WLJKW MXQFWLRQV DQG RWKHU LQWHUFHOOXODU DGKHVLRQV WKDW DUH UHVSRQVLEOH IRU WKH LPSHUPHDELOLW\ RI WKH HSLWKHOLXP WR ÁXRUHVFHLQ 6XUIDFWDQWV SHUWXUEWKHLPSHUPHDELOLW\RIWKHLQYLYRFRUQHDOHSLWKHOLXPDQGWKH+&(7PRGHO E\WKHVDPHPHFKDQLVP³F\WRWR[LFLW\DQGMXQFWLRQDOGLVUXSWLRQWRWKHVXSHUÀFLDO FHOOVWKDWLQFUHDVHVLQDGRVHGHSHQGHQWPDQQHU7KXVWKHWHVWV\VWHPWKH+&( 77(3DVVD\ DQGWKHKXPDQH\HWKHVSHFLHVRILQWHUHVW VKDUH DVLPLODUPHFK DQLVP IRU ÁXRUHVFHLQ LPSHUPHDELOLW\ LQ WKH XQGDPDJHG WLVVXHV DQG D VLPLODU PHFKDQLVPIRUWKHLQFUHDVHLQÁXRUHVFHLQSHUPHDELOLW\REVHUYHGDIWHUVXSHUÀFLDO H[SRVXUHWRVXUIDFWDQWV
PREVALIDATION STUDY RESULTS $VRQHRIWKHVWHSVLQWKHYDOLGDWLRQSURFHVVWKH+&(77(3DVVD\ZDVHYDOXDWHG LQDSUHYDOLGDWLRQVWXG\3UHYDOLGDWLRQKDVEHHQGHÀQHGDV´WKHSURFHVVGXULQJZKLFK DVWDQGDUGL]HGWHVWSURWRFROLVHYDOXDWHGIRUXVHLQYDOLGDWLRQVWXGLHV%DVHGRQWKH RXWFRPHRIWKRVHVWXGLHVWKHWHVWSURWRFROPD\EHPRGLÀHGRURSWLPL]HGIRUXVHLQ IXUWKHUYDOLGDWLRQVWXGLHVµ,&&9$0 7KHSUHYDOLGDWLRQVWXG\DQGLWVUHVXOWVDUHRQO\EULHÁ\VXPPDUL]HGKHUHDQGZLOO EHSXEOLVKHGLQJUHDWHUGHWDLOHOVHZKHUH:DUGHWDOE Purpose for the HCE-T TEP Assay )RUWKH3UHYDOLGDWLRQ6WXG\WKH+&(77(3DVVD\ZDVHYDOXDWHGIRULWVDELOLW\ WRSUHGLFWWKHH\HLUULWDWLRQSRWHQWLDORIZDWHUVROXEOHVXUIDFWDQWFRQWDLQLQJIRUPX ODWLRQV ZLWKLQ WKH UDQJH RI LUULWDWLRQ UHIHUHQFHG E\ D 'UDL]H 0$6 RI WR RU 'UDL]HWRWDOFRUQHDOVFRUHRIWR 7KHJRDOVRIWKHLQWHUODERUDWRU\SUHYDOLGDWLRQ VWXG\ ZHUH WR GHYHORS DQ RSWLPL]HG SURWRFRO IRU YDOLGDWLRQ RI WKH WHVW PHWKRG WR GHPRQVWUDWH WKH PHWKRG·V WUDQVIHUDELOLW\ WR RWKHU ODERUDWRULHV DQG WR SURYLGH D SUHOLPLQDU\DVVHVVPHQWRIWKHUHOLDELOLW\DQGWKHUHOHYDQFHRIWKH+&(77(3DVVD\ IRULWVVWDWHGSXUSRVH Study Structure 7KH VWXG\ FRQVLVWHG RI WKH HYDOXDWLRQ RI ÀYH VXUIDFWDQWFRQWDLQLQJ IRUPXOD WLRQVE\WKUHHODERUDWRULHVZLWKHDFKPDWHULDOWHVWHGIRXUWLPHVLQHDFKODERUDWRU\
176
ALTERNATIVE TOXICOLOGICAL METHODS
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´WUDLQLQJµDVVD\VWRGHPRQVWUDWHWKHLUSURÀFLHQF\ZLWKWKHDVVD\ EHIRUHLQLWLDWLRQRIWKHVWXG\7HVWPDWHULDOVZHUHVHOHFWHGIRUWKHVWXG\WKDWKDG JRRGTXDOLW\KLVWRULFDOUHIHUHQFHPHWKRGGDWD7KHÀYHWHVWPDWHULDOVZHUHZDWHU VROXEOH VXUIDFWDQWEDVHG FRQVXPHU SURGXFW IRUPXODWLRQV ZKLFK VSDQQHG WKH UDQJHRIH\HLUULWDWLRQIURPQRQLUULWDWLQJWRVHYHUHVHH7DEOH 7ZRRIWKH IRUPXODWLRQVZHUH*LOOHWWHSURGXFWIRUPXODWLRQVDQGWKUHHZHUH&7)$3KDVH,,, IRUPXODWLRQV *HWWLQJV HW DO 7ZR RI WKH WHVW PDWHULDOV DUH FODVVLÀHG DV QHJDWLYHQRQLUULWDQWV WZRDVSRVLWLYHLUULWDQWV DQGRQHDVLQGHWHUPLQDWHXVLQJ WKH)HGHUDO+D]DUGRXV6XEVWDQFHV$FW)+6$ JXLGHOLQHV)+6$ Data Analysis %HIRUHWKHEHJLQQLQJRIWKHVWXG\DSUHGLFWLRQPRGHO30 ZDV GHYHORSHGE\ WKH VWDWLVWLFDO PRGHOLQJ RI WKH UHODWLRQVKLS EHWZHHQ WKH LQ YLWUR7(3 GDWD DQG WKH KLVWRULFDOLQYLYR'UDL]H0$6GDWDIRUZDWHUVROXEOHVXUIDFWDQWVDQGVXUIDFWDQW FRQWDLQLQJIRUPXODWLRQV)LJXUHV(DQG 7KLVPRGHOLVGHVFULEHGE\WKH HTXDWLRQ 'UDL]H 0$6 >D H[S EORJ )5 ² F @ G ZKLFK LV D IRXU SDUDPHWHU ORJLVWLF FXUYH ZLWK SDUDPHWHU HVWLPDWHV RI D E F ²DQGG 7KHJHQHUDOL]HGFRUUHODWLRQFRHIÀFLHQW5IRUWKH0$630 SORWLVDQGWKHRXWHUGDVKHGOLQHVUHSUHVHQWWKHFRQÀGHQFHLQWHUYDOV 7KHGRVHUHVSRQVHGDWDIURPHDFK7(3DVVD\DUHSORWWHGDVÁXRUHVFHLQUHWHQ WLRQ)5 SHUFHQWDJHRIFRQWURO YHUVXVWKHORJRIWKHFRQFHQWUDWLRQSHUFHQWDJH RILQLWLDOWHVWPDWHULDOFRQFHQWUDWLRQ )LJXUH' 7KHORJ)5LVWKHFRQFHQ WUDWLRQ RI WHVW PDWHULDO ZKHUH WKH +&(7 FXOWXUHV UHWDLQ RI WKH ÁXRUHVFHLQ UHODWLYHWRFRQWUROFXOWXUHVDQGLVWKHHQGSRLQWIURPWKHGRVHUHVSRQVHFXUYHWKDW LVXVHGIRUFRUUHODWLRQZLWKWKHUHIHUHQFHPHWKRGGDWD7KH7(3DVVD\HQGSRLQW WKHORJ)5ZDVXVHGWRGHÀQHWKHSUHGLFWHGLQYLYR'UDL]H0$6IRUWKHPDWHULDO HYDOXDWHG LQ HDFK DVVD\ E\ XVLQJ WKLV SUHGLFWLRQ PRGHO 3UHGLFWLRQ PRGHOV ZHUH DOVRGHYHORSHGXVLQJWKH'UDL]HFRUQHDOVFRUH&6 DQGWKHFRUQHDORSDFLW\VFRUH &26 ZKLFKZHUHXVHGWRREWDLQWKHSUHGLFWHG&6DQGSUHGLFWHG&26IRUHDFK WHVWPDWHULDO 7HVWPHWKRGSHUIRUPDQFHZDVHYDOXDWHGE\ HYDOXDWLQJWKHÀWRIWKH+&( 77(3DVVD\GDWDZLWKLQWKHFRQÀGHQFHLQWHUYDOVRIWKHHVWDEOLVKHGSUHGLFWLRQ PRGHO DQG E\ FRPSDULQJ WKH LUULWDWLRQ FODVVLÀFDWLRQ IRU HDFK WHVW PDWHULDO GHWHUPLQHGE\WKHLQYLYR'UDL]HWHVWWRWKDWGHWHUPLQHGE\WKH+&(77(3DVVD\ 7KH LUULWDWLRQ FODVVLÀFDWLRQV FDQ EH XVHG WR FDOFXODWH WKH SHUIRUPDQFH VWDWLVWLFV
100%
100%
100%
Cleansing gel
Shampoo 1
Shampoo 2
c
b
stearalkonium chloride ceteth-24 dimethyl stearamine glyceryl stearate cocoamphodiacetate sodium nonoxynol-6phosphate quaternium-26 PEG-120-methyl glucose dioleate sodium lauryl sulfate disodium laureth sulfosuccinate butylene gylcol lauramide DEA ammonium lauryl sulfate lauramide DEA ethoxydiglycol hydroxypropyl methylcellulose
sodium laureth sulfate cocamidopropyl betaine
Surfactant Ingredients
5.0 0.5 12.0 2.0 0.4 0.15
25.0 15.0
1.14 1.0 0.67 0.44 15.0 6.0 1.5 1.5
25.0 5.0
Percent Formula (w/w)
anionic nonionic — —
anionic anionic nonionic nonionic
cationic nonionic cationic nonionic amphoteric anionic cationic nonionic
anionic amphoteric
Surfactant Class
MAS 57.4 CS 38.0 COS 2.0
MAS 37.8 CS 20.0 COS 1.0
MAS 22.0 CS 10.0 COS 0.5
MAS 4.8 CS 0.0 COS 0.0 MAS 14.2 CS 0.0 COS 0.0
Draize Scoresb
Concentration used in Draize test, and initial concentration for dilution in TEP assay. MAS is the maximum average score; CS is the corneal score; COS is the corneal opacity score. Federal Hazardous Substances Act (FHSA) classifications: –, negative; +, positive; –/+ repeat test (FHSA, 1979).
100%
Hair conditioner
a
2.5%
Bubble bath
Product Type
Conc. Testeda
Table 15.2 Prevalidation Study Test Materials and Draize Data
+
+
–/+
–
–
FHSA Classc
THE HUMAN CORNEAL HCE-T TEP ASSAY 177
178
ALTERNATIVE TOXICOLOGICAL METHODS
LQFOXGLQJWHVWPHWKRGVHQVLWLYLW\DQGVSHFLÀFLW\ IRUDWHVWPHWKRGXVLQJDv FRQWLQJHQF\WDEOHDQDO\VLV&RRSHUHWDO,&&9$0 +RZHYHUDGDWD VHWRIRQO\ÀYHWHVWPDWHULDOVGLGQRWSURYLGHDVXIÀFLHQWVDPSOHVL]HIRUWKLVW\SH RIDQDO\VLV 6HYHUDOPHWKRGVZHUHXVHGWRDVVHVVWKHUHSHDWDELOLW\RUZLWKLQLQWUD ODERUD WRU\ YDULDELOLW\ DQG WKH UHSURGXFLELOLW\ RU EHWZHHQ LQWHU ODERUDWRU\ YDULDELOLW\ $OOPHWKRGVUHVXOWHGLQWKHVDPHFRQFOXVLRQVDQGRQO\WKHUHVXOWVIURPWKHFRHIÀ FLHQWRIYDULDWLRQ&9 DQDO\VLVZLOOEHVKRZQKHUH Results 2QHPHWKRGIRUHYDOXDWLQJWKHSHUIRUPDQFHRIDQHZWR[LFLW\WHVWPHWKRGLVWR GHWHUPLQHZKHWKHUWKHQHZWHVWUHVXOWVIROORZWKHDOJRULWKPRIWKHH[LVWLQJSUHGLFWLRQ PRGHO7KHODEDYHUDJHDVVD\UHVXOWVIRUDOOÀYHWHVWPDWHULDOVIHOOZLWKLQWKH FRQÀGHQFH LQWHUYDOV &, RI WKH 0$6 30 RI WKH LQGLYLGXDO DVVD\V )LJXUH 7KHODEDYHUDJHUHVXOWVIRUIRXURXWRIÀYHPDWHULDOVIHOOZLWKLQWKH&, RIWKHFRUQHDOVFRUH&6 30DQGÀYHRXWRIÀYHPDWHULDOVIHOOZLWKLQWKH&, RI WKH FRUQHDO RSDFLW\ VFRUH &26 30 QRW VKRZQ $QRWKHU W\SH RI VWDWLVWLFDO DQDO\VLVXVHGWRGHWHUPLQHGDWDUHODWLRQVKLSVDFKLVTXDUHDQDO\VLVVKRZHGVLJQLI LFDQW UHODWLRQVKLS EHWZHHQ LUULWDWLRQ FODVVLÀFDWLRQ REWDLQHG E\ WKH 0$6 30 DQG FODVVLÀFDWLRQREWDLQHGE\WKH'UDL]HWHVWS $ VHFRQG ZD\ WR HYDOXDWH WHVW PHWKRG SHUIRUPDQFH LV E\ FRPSDULQJ WKH LUULWDWLRQFODVVLÀFDWLRQIRUHDFKWHVWPDWHULDOGHWHUPLQHGE\WKHUHIHUHQFHPHWKRG 'UDL]H WHVW WR WKDW GHWHUPLQHG E\ WKH QHZ WHVW PHWKRG 7(3 DVVD\ $OO ÀYH PDWHULDOV ZHUH FRUUHFWO\ FODVVLÀHG DV LUULWDQW RU QRQLUULWDQW E\ WKH 7(3 DVVD\ UHODWLYH WR WKHLU FODVVLÀFDWLRQ E\ WKH 'UDL]H WHVW 7DEOH 7KH LUULWDWLRQ FODVVLÀFDWLRQVIRUHDFKWHVWPDWHULDOEDVHGRQWKHIRXUFODVVHVDVVLJQHGE\.D\ DQG &DODQGUD DUH VKRZQ LQ 7DEOH 7KHVH LUULWDWLRQ FODVVLÀFDWLRQV ZHUHLQDJUHHPHQWIRUIRXURIWKHÀYHWHVWPDWHULDOV7KHPRVWLUULWDWLQJPDWHULDO VKDPSRR ZDV XQGHUSUHGLFWHG E\ WKH7(3 DVVD\ E\ RQH FODVVLÀFDWLRQ OHYHO LQ DOOWKUHHODERUDWRULHV 7KHVWDWLVWLFDODQDO\VHVVKRZHGQRVLJQLÀFDQWGLIIHUHQFHVLQERWKEHWZHHQODE RUDWRU\DQGZLWKLQODERUDWRU\YDULDELOLW\IRUWKHÀYHWHVWPDWHULDOVQRWVKRZQ 7KH FRHIÀFLHQWRIYDULDWLRQ&9 IRUWKHEHWZHHQODERUDWRU\SUHGLFWHG0$6UHVXOWVZHUH WR 7DEOH $ GLVFXVVLRQ RI WKH VWDWLVWLFDO DQDO\VLV IRU WHVW PHWKRG UHOLDELOLW\ZLOOEHSUHVHQWHGLQJUHDWHUGHWDLOHOVHZKHUH:DUGHWDOE Conclusions 7KHSUHYDOLGDWLRQVWXG\UHVXOWVSURYLGHDSUHOLPLQDU\DVVHVVPHQWRIWHVWPHWKRG SHUIRUPDQFHDQGLQWUDODERUDWRU\DQGLQWHUODERUDWRU\DVVD\YDULDELOLW\ 7KH UHVXOWV LQGLFDWH WKDW WKH +&(7 7(3 DVVD\ LV WUDQVIHUDEOH WR RWKHU ODERUDWRULHV KDVDFFHSWDEOHLQWUDODERUDWRU\DQGLQWHUODERUDWRU\YDULDELOLW\ZKHQ SHUIRUPHG E\ WUDLQHG VWDII IROORZLQJ WKH GHVLJQDWHG SURWRFRO GHPRQVWUDWHG JRRGSHUIRUPDQFHLQSUHGLFWLQJWKH'UDL]HVFRUHVIRUÀYHVXUIDFWDQWFRQWDLQLQJ
Draize MAS
THE HUMAN CORNEAL HCE-T TEP ASSAY
70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 –0.8
179
A
–0.4
0.0
0.4
0.8
1.2
1.6
2.0
2.4
2.8
3.2
Draize MAS
LogFR85 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 –0.8
B
–0.4
0.0
0.4
0.8
1.2
1.6
2.0
2.4
2.8
3.2
LogFR85 Figure 15.8 Overlay of the prevalidation study test results for five test materials in the MAS Prediction Model (PM). The solid line represents the nonlinear regression curve of the MAS PM, and the dashed lines are the 95% confidence intervals. (A) Overlay of the 60 log FR85 values in the MAS PM. There are 12 values for each of the five test materials on the plot, but, due to overlap in the data, all 12 points may not be distinct. (B) Fit of the average log FR85 value for each of the five test materials in the MAS PM. The result for each test material is the average of 12 assays.
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
180
ALTERNATIVE TOXICOLOGICAL METHODS
Table 15.3 The Nonirritant/Irritant Classification of the Five Test Materials as Determined by the Draize Test and by the HCE-T TEP Assay Test Material
Draize Score Classificationa
TEP Assay MAS PMb
TEP Assay CS PMb
TEP Assay COS PMb
Bubble bath Hair conditioner Cleansing gel Shampoo 1 Shampoo 2
1 1 2 2 2
1 1 2 2 2
1 1 2 2 2
1 1 1 2 2
a
Draize classification was the same across the MAS, CS, and COS scores, except for the cleansing gel which was an irritant by the MAS and CS, but a nonirritant by the COS. b Draize scores for the classifications: nonirritant MAS e 15; nonirritant CS < 5; nonirritant COS < 0.667. Note: Draize maximum average score, MAS; corneal score, CS; corneal opacity score, COS. Table 15.4 Average HCE-T TEP Assay Results for Five Test Materials in Three Laboratories; The Predicted MAS and Class from the TEP assay Are Compared to the Draize MAS and Class for Each Test Result Test Material Bubble bath Hair conditionerc Cleansing gel Shampoo 1 Shampoo 2 a b
c
Draize MASa
Draize Classb
Predicted MASa
Predicted Classb
4.8 14.2 22.0 37.8 57.4
1 1 2 3 4
4.20 1.82 16.15 34.62 41.18
1 1 2 3 3
MAS, maximum average score. The four classification cutoffs for MAS are based on the scheme proposed by Kay and Calandra (1962): MAS 0–15, minimal (class 1); MAS 15.1–25, mild (class 2); MAS 25.1–55, moderate (class 3); MAS > 55, severe (class 4). Hair conditioner was less water soluble than other test materials, which may account for its underprediction when it was diluted.
SUMMARY 7KLV FKDSWHU GHVFULEHV IRU WKH +&(7 7(3 DVVD\ WKH UHVXOWV IRU WZR RI WKH HVVHQWLDOVWHSVLQWKHYDOLGDWLRQSURFHVVHVWDEOLVKLQJWKHVFLHQWLÀFUHOHYDQFHRIWKH QHZWHVWPHWKRGDQGWKHSUHYDOLGDWLRQRIWKHPHWKRG $QHZWR[LFLW\WHVWPHWKRGWRHYDOXDWHKXPDQH\HLUULWDWLRQSRWHQWLDOPXVWEH UHOHYDQWWRWKHELRORJLFDODQGWR[LFRORJLFDOSURFHVVHVWKDWRFFXUZKHQDFKHPLFDO RUFKHPLFDOPL[WXUHPDNHVFRQWDFWZLWKWKHKXPDQRFXODUVXUIDFH7KHVFLHQWLÀF UHOHYDQFH RI WKH +&(7 7(3 DVVD\ ZDV GHÀQHG XVLQJ UHVXOWV REWDLQHG IURP D QXPEHURIGLIIHUHQWH[SHULPHQWVFRQGXFWHGXVLQJWKHWHVWV\VWHPDQGZLWKUHOHYDQW VXSSRUWLQJ LQIRUPDWLRQ IURP WKH RSKWKDOPRORJLF UHVHDUFK OLWHUDWXUH7KH +&(7 7(3 DVVD\ DFKLHYHV ELRORJLFDO UHOHYDQFH E\ FRPELQLQJ D PRGHO RI WKH KXPDQ FRUQHDO VXUIDFH ZLWK D WHVW PHWKRG WKDW KDV D PHFKDQLVWLF UHODWLRQVKLS WR KXPDQ H\H LUULWDWLRQ 7KH H[SHULPHQWDO GDWD DQG WKH VFLHQWLÀF OLWHUDWXUH UHSRUWHG KHUH VXSSRUWWKHFRQFOXVLRQWKDWWKH+&(77(3DVVD\LVDWHVWPHWKRGWKDWLVELRORJ LFDOO\ DQG PHFKDQLVWLFDOO\ EDVHG DQG WKXV VKRXOG SURYLGH D JRRG PRGHO IRU WKH KXPDQFRUQHDOUHVSRQVHWRH\HLUULWDQWV
THE HUMAN CORNEAL HCE-T TEP ASSAY
181
Table 15.5 Variability in the Draize MAS Compared to the Predicted MAS for the HCE-T TEP Assay Prevalidation Study Data Test Material
Intralab CV (%) for Draize MASa
Bubble bath
22.82
Hair conditionerd
19.67
Cleansing gel
53.24
Shampoo 1
10.31
Shampoo 2
8.32
Intralab CV (%) for Predicted MASb 9.94 10.06 4.94 33.19 15.80 54.09 17.50 3.01 25.90 12.54 21.21 20.42 14.60 14.62 29.49
Interlab CV (%) for Predicted MASc 6.03
15.59
15.10
12.49
2.83
a
Evaluated using five to six animals from one lab. Evaluated using four replicates per lab for three labs. c Results from three testing labs. d Hair conditioner was less water soluble, which may account for its greater variability when it was diluted. Notes: Intralab is the within lab variability (repeatability); interlab is the between lab variability (reproducibility). Coefficient of variation, CV; maximum average score, MAS. b
$SUHYDOLGDWLRQVWXG\ZDVFRQGXFWHGWRHYDOXDWHWKHSHUIRUPDQFHRIWKH+&( 77(3DVVD\IRUWKHSUHGLFWLRQRIWKHRFXODULUULWDWLRQSRWHQWLDORIVXUIDFWDQWEDVHG IRUPXODWLRQV7KHWHVWPHWKRGZDVWUDQVIHUUHGWRRWKHUODERUDWRULHVDQGWKHUHVXOWV RI WKH LQWHUODERUDWRU\ DVVHVVPHQW VXJJHVW WKDW WKH +&(7 7(3 DVVD\ LV D UHOLDEOH DQGUHOHYDQWPHWKRGIRUWKHSUHGLFWLRQRIWKHH\HLUULWDWLRQSRWHQWLDORIVXUIDFWDQW FRQWDLQLQJIRUPXODWLRQV
REFERENCES $OEHUW '0 DQG -DNRELHF )$ 3ULQFLSOHV DQG 3UDFWLFH RI 2SKWKDOPRORJ\9RO :%6DXGHUV&RPSDQ\3KLODGHOSKLD $UDLH0DQG0DXULFH' 7KHUDWHRIGLIIXVLRQRIÁXRURSKRUHVWKURXJKWKHFRUQHDO HSLWKHOLXPDQGVWURPD([S(\H5HV² $UFKHU*%DOOV0%UXQHU/+&XUUHQ5')HQWHP-++RO]KXWWHU+*/LHEVFK 0/RYHOO'3DQG6RXWKHH-$ 7KHYDOLGDWLRQRIWR[LFRORJLFDOSUHGLFWLRQ PRGHOV$OW/DE$QLP² %DOOV 0 %ODDXERHU %- )HQWHP -+ %UXQHU / DQG &RPEHV 5' D 3UDFWLFDO DVSHFWVRIWKHYDOLGDWLRQRIWR[LFLW\WHVWSURFHGXUHV7KHUHSRUWDQGUHFRPPHQGDWLRQV RIWKH(&9$0ZRUNVKRS$OW/DE$QLP² %DOOV0%RWKDP3$%UXQHU/+DQG6SLHOPDQQ+E 7KH(&+2LQWHUQDWLRQDO YDOLGDWLRQVWXG\RQDOWHUQDWLYHVWRWKH'UDL]HH\HLUULWDWLRQWHVW7R[LFRO,Q9LWUR ²
182
ALTERNATIVE TOXICOLOGICAL METHODS
%HFNOH\-+ &RPSDUDWLYHH\HWHVWLQJPDQYHUVXVDQLPDO7R[LFRO$SSO3KDUPDFRO ² %HFNOH\-+5XVVHOO7-DQG5XELQ/) 8VHRIWKHUKHVXVPRQNH\IRUSUHGLFWLQJ KXPDQUHVSRQVHWRH\HLUULWDQWV7R[LFRO$SSO3KDUPDFRO² %HUU\0DQG(DVW\'/ ,VRODWHGKXPDQDQGUDEELWH\H0RGHOVRIFRUQHDOWR[LFLW\ 7R[LF,Q9LWUR² %OD]ND0(&DVWHUWRQ3/'UHVVOHU:((GHOKDXVHU+).UXV]HZVNL)+0F&XOOH\ -31XVVHQEODWW5%2VERUQH55RWKHQVWHLQ$6WLW]HO.$7KRPDV.DQG :DUG 6/ 3URSRVHG QHZ FODVVLÀFDWLRQ VFKHPH IRU FKHPLFDO LQMXU\ WR WKH KXPDQH\HLQSUHSDUDWLRQ %UDGODZ - *XSWD . *UHHQ 6 +LOO 5 DQG:LOFR[ 1 3UDFWLFDO DSSOLFDWLRQ RI QRQZKROHDQLPDODOWHUQDWLYHVVXPPDU\RI,5$*:RUNVKRSRQH\HLUULWDWLRQWHVWLQJ )RRGDQG&KHP7R[LFRO² %UDQWRP 3* %UXQHU /+ &KDPEHUODLQ 0 'H6LOYD 2 'XSXLV - (DUO /. /RYHOO '33DSH:-:DQG8WWOH\0 $VXPPDU\RIWKH&2/,3$LQWHUQDWLRQDO YDOLGDWLRQ VWXG\ RQ DOWHUQDWLYHV WR WKH 'UDL]H UDEELW H\H LUULWDWLRQ WHVW 7R[LFRO ,Q 9LWUR² %UDXQVWHLQ6*'HUDPDXGW7*5RVHQEOXP'*'XQQ0*DQG$EUDKDP1* +HPHR[\JHQDVHJHQHH[SUHVVLRQDVDVWUHVVLQGH[WRRFXODULUULWDWLRQ&XUU(\H 5HV² %UXQHU/+&DUU*-&KDPEHUODLQ0DQG&XUUHQ5' 9DOLGDWLRQRIDOWHUQDWLYH PHWKRGVIRUWR[LFLW\WHVWLQJ7R[LFRO,Q9LWUR² %XHKOHU (9 DQG 1HZPDQQ ($ $ FRPSDULVRQ RI H\H LUULWDWLRQ LQ PRQNH\V DQG UDEELWV7R[LFRO$SSO3KDUPDFRO %XUEDFK*-1DLN60+DUWHQ%-/LX/'LWKPDU6*URVVQLNODXV+:DUG6/ $UPVWURQJ&$&DXJKPDQ6:DQG$QVHO-& ,QWHUOHXNLQH[SUHVVLRQ DQGPRGXODWLRQLQKXPDQFRUQHDOHSLWKHOLDOFHOOV&XUU(\H5HV² %XUVWHLQ1/ 3UHVHUYDWLYHDOWHUDWLRQRIFRUQHDOSHUPHDELOLW\LQKXPDQVDQGUDEELWV ,QYHVW2SKWKDOPRO9LV6FL² &KDQ3.DQG+D\HV$: $FXWHWR[LFLW\DQGH\HLUULWDQF\LQ3ULQFLSOHVDQG0HWKRGV RI7R[LFRORJ\UGHG+D\HV$:(G5DYHQ3UHVV/WG1HZ
THE HUMAN CORNEAL HCE-T TEP ASSAY
183
'UDL]H-+:RRGZDUG*DQG&DOYHU\+2 0HWKRGVIRUWKHVWXG\RILUULWDWLRQDQG WR[LFLW\RIVXEVWDQFHVDSSOLHGWRSLFDOO\WRWKHVNLQDQGPXFRXVPHPEUDQHV-3KDU PDFRO([S7KHU² (GHOKDXVHU+)DQG*UHHQ. :RUNVKRSRQLQYLWURYHUVXVLQYLYRPRGHOVIRURFXODU WR[LFLW\ WHVWLQJ LQ $GYDQFHV LQ 2FXODU7R[LFRORJ\ *UHHQ . HW DO (GV 3OHQXP 3UHVV1HZ
184
ALTERNATIVE TOXICOLOGICAL METHODS
-RVKL$0DXULFH'DQG3DXJK-5 $QHZPHWKRGIRUGHWHUPLQLQJFRUQHDOHSLWKHOLDO EDUULHUWRÁXRUHVFHLQLQKXPDQV,QYHVW2SKWKDOPRO9LV6FL² .DKQ&5DQG5KLP-6-XO\ 86SDWHQW .DKQ&5DQG:DONHU7/ +XPDQFRUQHDOHSLWKHOLDOFHOOOLQHVZLWKH[WHQGHGOLIHVSDQ WUDQVHSLWKHOLDOSHUPHDELOLW\DFURVVPHPEUDQHVIRUPHG LQYLWUR,QYHVW2SKWKDOPRO 9LV6FL .DKQ &5
THE HUMAN CORNEAL HCE-T TEP ASSAY
185
1RUQ06 0LFURSXQFWDWHÁXRUHVFHLQYLWDOVWDLQLQJRIWKHFRUQHD$FWD2SKWKDOPRO ² 2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW (QYLURQPHQW'LUHFWRUDWH &KHPLFDOV *URXS DQG 0DQDJHPHQW &RPPLWWHH )LQDO 5HSRUW RI WKH 2(&' :RUNVKRS RQ +DUPRQL]DWLRQ RI9DOLGDWLRQ DQG$FFHSWDQFH &ULWHULD IRU$OWHUQDWLYH 7R[LFRORJLFDO7HVW0HWKRGV(190&&+(07* 2(&'3DULV)UDQFH 5DPVHODDU-$0%RRW-3YDQ+DHULQJHU1-YDQ%HVW-$DQG2RVWHUKXLV-$ &RUQHDOHSLWKHOLDOSHUPHDELOLW\DIWHULQVWLOODWLRQRIRSKWKDOPLFVROXWLRQVFRQWDLQLQJ ORFDODQDHVWKHWLFVDQGSUHVHUYDWLYHV&XUU(\H5HV² 6KDZ$-&ORWKLHU5+DQG%DOOV0 /RVVRIWUDQVHSLWKHOLDOLPSHUPHDELOLW\RID FRQÁXHQWPRQROD\HURI0DQGLQ'DUE\FDQLQHNLGQH\0'&. FHOOVDVDGHWHUPLQDQW RIRFXODULUULWDQF\SRWHQWLDO$OW/DE$QLP² 6KDZ$-%DOOV0&ORWKLHU5+DQG%DWHPDQ1' 3UHGLFWLQJRFXODULUULWDQF\ DQGUHFRYHU\IURPLQMXU\XVLQJ0DQGLQ'DUE\FDQLQHNLGQH\FHOOV7R[LFRO,Q9LWUR ² 6PROLQ*DQG7KRIW5$ 7KH&RUQHD6FLHQWLÀF)RXQGDWLRQVDQG&OLQLFDO3UDFWLFH QGHG/LWWOH%URZQDQG&RPSDQ\%RVWRQ 6RQJ 3, $EUDKDP 7 3DUN < =LYRQ\ $ +DUWHQ % (GHOKDXVHU +) :DUG 6/ $UPVWURQJ&$DQG$QVHO-& 7KHH[SUHVVLRQRIIXQFWLRQDO/36UHFHSWRU SURWHLQV &' DQG WROOOLNH UHFHSWRU LQ KXPDQ FRUQHDO FHOOV ,QYHVW 2SKWKDOPRO 9LV6FL² 7FKDR5 7UDQVHSLWKHOLDOSHUPHDELOLW\RIÁXRUHVFHLQLQYLWURDVDQDVVD\WRGHWHUPLQH H\HLUULWDQWVLQ$OWHUQDWLYH0HWKRGVLQ7R[LFRORJ\3URJUHVVLQ,Q9LWUR7R[LFRORJ\ 9RO*ROGEHUJ$0(G0DU\$QQ/LHEHUW,QF1HZ
186
ALTERNATIVE TOXICOLOGICAL METHODS
:RUWK$3DQG%DOOV0 7KHLPSRUWDQFHRIWKHSUHGLFWLRQPRGHOLQWKHYDOLGDWLRQ RIDOWHUQDWLYHWHVWV$OW/DE$QLP² =DQYLW $ 0HXQLHU 3$ &ORWKLHU 5 :DUG 5 DQG %XLDWWL7FKHQJ 0 2FXODU LUULWDQF\DVVHVVPHQWRIFRVPHWLFVIRUPXODWLRQVDQGLQJUHGLHQWVÁXRUHVFHLQOHDNDJH WHVW7R[LFRO,Q9LWUR²
PART III Dermal Testing Alternatives +$55<6$/(0 $1'6,'1(<$.$7= ,QWKLVVHFWLRQWKHÀ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ÀOHV3DWULFN+D\GHQ6H\RXP$\HKXQLH* 5REHUW-DFNVRQ6DUDK.XSIHU7KRPDV/DVW0LWFKHOO.ODXVQHUDQG-RVHSK.XELOXV SUHVHQWGDWDRQLQWUDORWDQGLQWHUORWUHSURGXFLELOLW\IRUDGLIIHUHQWLDWHGKXPDQGHUPDO HSLWKHOLDOWLVVXHPRGHOGHVFULEHDQHZPRGHOFRPSRVHGRIERWKNHUDWLQRF\WHVDQG PHODQRF\WHVDQGVXUYH\DSSOLFDWLRQVWRLUULWDWLRQSKRWRWR[LFLW\DQGFRUURVLYLW\
CHAPTER
16
Alternative Methods for Dermal Toxicity Testing 5REHUW/%URQDXJK
CONTENTS ,QWURGXFWLRQ 6NLQ&RUURVLRQ 6NLQ,UULWDWLRQ 6NLQ6HQVLWL]DWLRQ 6NLQ3KRWRWR[LFLW\ 3HUFXWDQHRXV$EVRUSWLRQ 5HIHUHQFHV
INTRODUCTION 3URJUHVVLVEHLQJPDGHLQWKHYDOLGDWLRQRIDOWHUQDWLYHWHVWVIRUGHUPDOWR[LFLW\ WHVWLQJ$ EULHI VXPPDU\ RI UHFHQW SURJUHVV LV SURYLGHG IRU WKH YDOLGDWLRQ RI WHVWV WRPHDVXUHVNLQFRUURVLRQLUULWDWLRQVHQVLWL]DWLRQDQGSKRWRWR[LFLW\&XUUHQWHIIRUWV WRYDOLGDWHDQLQYLWURSHUFXWDQHRXVDEVRUSWLRQPHWKRGDUHGLVFXVVHG
SKIN CORROSION 7ZRPHWKRGVKDYHUHFHQWO\EHHQYDOLGDWHGIRUWKHPHDVXUHPHQWRIVNLQFRUUR VLYLW\ E\ WKH (XURSHDQ &HQWUH IRU 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV (&9$0 )HQWHPHWDO %RWKWKHWUDQVFXWDQHRXVHOHFWULFDOUHVLVWDQFHDVVD\7(52OLYHU DQG3HPEHUWRQ DQGWKH(SLVNLQWHVWZHUHIRXQGWREHDFFHSWDEOHIRUDZLGH UDQJH RI FKHPLFDO FODVVHV 7KH\ PHW DOO RI WKH FULWHULD RI XQGHUSUHGLFWLRQ DQG 189
190
ALTERNATIVE TOXICOLOGICAL METHODS
RYHUSUHGLFWLRQDQGVKRZHGDFFHSWDEOHLQWUDODERUDWRU\DQGLQWHUODERUDWRU\UHSURGXF LELOLW\&RUURVLWH[ZDVDOVRHYDOXDWHGLQWKHVWXG\EXWZDVQRWXVDEOHIRUDERXW RIWKHWHVWFKHPLFDOV7KLVWHVWGLGQRWPHHWDOOWKHFULWHULDIRUDFFHSWDELOLW\ $ SURSRVHG 2(&' WHVWLQJ VWUDWHJ\ IRU FRUURVLYH FKHPLFDOV ZDV HYDOXDWHG E\ XVLQJWKHWHVWUHVXOWVIRUWKHFKHPLFDOVLQWKHDERYHYDOLGDWLRQVWXG\:RUWKHW DO 7KH DXWKRUV FRQFOXGHG WKDW FKHPLFDOV FDQ EH FODVVLÀHG DV FRUURVLYH RU QRQFRUURVLYH E\ WKH VHTXHQWLDO DSSOLFDWLRQ RI WKUHH DOWHUQDWLYH PHWKRGV VWUXFWXUH DFWLYLW\ UHODWLRQVKLSV ZKHUH DYDLODEOH S+ PHDVXUHPHQWV DQG HLWKHU RQH RI WKH DERYHYDOLGDWHGPHWKRGV7(5RU(SLVNLQ $ÀQGLQJRIQRQFRUURVLYLW\LQWKHWLHU WHVWQHHGVWREHFRQÀUPHGZLWKDUDEELWWHVW ,Q 9LWUR ,QWHUQDWLRQDO DVNHG WKH ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV ,&&9$0 WR HYDOXDWH WKH XVHIXOQHVV RI &RU URVLWH[ IRU VNLQ FRUURVLYLW\ PHDVXUHPHQWV7KH ,&&9$0 SHHUUHYLHZ SDQHO FRQ FOXGHG WKDW LQ FHUWDLQ FLUFXPVWDQFHV XVH IRU 86 'HSDUWPHQW RI 7UDQVSRUWDWLRQ &RUURVLWH[FRXOGEHXVHGDVDVWDQGDORQHDVVD\,QRWKHUFDVHVWKHDVVD\FRXOGEH XVHGDVSDUWRIDWLHUHGDVVHVVPHQWVWUDWHJ\
SKIN IRRITATION $OWKRXJKDQXPEHURIPHWKRGVIRUVNLQLUULWDWLRQKDYHEHHQHYDOXDWHGLQFHOOFXOWXUH DQGVNLQPHPEUDQHSUHSDUDWLRQVQRPHWKRGVKDYHDV\HWEHHQYDOLGDWHG6NLQLUULWDWLRQ DQG WKH UHVXOWLQJ LQÁDPPDWRU\ UHVSRQVH LV D FRPSOH[ SURFHVV 6LPXODWLRQ RI VNLQ LUULWDWLRQLVOLNHO\WREHPRUHGLIÀ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ÀYHWHVWPHWKRGV(SLGHUP (SLVNLQ3UHGLVNLQWKHQRQSHUIXVHGSLJHDUPRGHODQGWKHPRXVHVNLQLQWHJULW\ IXQFWLRQWHVW6,)7 1HLWKHU3UHGLVNLQQRUWKHQRQSHUIXVHGSLJHDUPRGHOSHUIRUPHG ZHOOHQRXJKWRDGYDQFHWRSKDVH,,,7KHSHUIRUPDQFHRI(SLGHUPDQG(SLVNLQLQ SKDVH,,,GLGQRWPHHWWKHFULWHULDVHWIRUDIRUPDOYDOLGDWLRQVWXG\7KH6,)7WHVW UHPDLQVWREHHYDOXDWHGLQSKDVH,,,)HQWHPHWDO
SKIN SENSITIZATION 7KH ORFDO O\PSK QRGH DVVD\ //1$ UHFHQWO\ EHFDPH WKH ÀUVW WHVW PHWKRG YDOLGDWHGE\,&&9$07KHSHHUUHYLHZSDQHOUHFRPPHQGHGWKH//1$DVDVWDQG DORQHDOWHUQDWLYHIRUFRQWDFWVHQVLWL]DWLRQSURYLGHGWKDWWKHSURWRFROFRQWDLQHGFHUWDLQ VSHFLÀFVWHSVDVRXWOLQHGLQWKHUHSRUW$QRQ $OWKRXJKWKH//1$UHTXLUHV WKHXVHRIPLFHIHZHUDQLPDOVDUHQHHGHGWKDQZLWKDQLQYLYRVWXG\)XUWKHUPRUH WKHPLFHKDYHOHVVGLVFRPIRUWVLQFHWKHDVVD\RQO\LQYROYHVLQGXFWLRQRIVHQVLWL]DWLRQ
ALTERNATIVE METHODS FOR DERMAL TOXICITY TESTING
191
SKIN PHOTOTOXICITY 7KH(XURSHDQ8QLRQ(8 DQG&ROLSDVSRQVRUHGDSUHYDOLGDWLRQVWXG\EHJLQQLQJ LQWKDWHYDOXDWHGWKHDFFXUDF\RIVHYHQPHWKRGVLQPHDVXULQJSKRWRWR[LFLW\ SKRWRKHPRO\VLV WHVW KLVWLGLQH R[LGDWLRQ WHVW &DQGLGD DOELFDQV WHVW 6RODWH[ 3, 6NLQ7HVWVNLQDQGWKH7PRXVHÀEUREODVWWHVWQHXWUDOUHGXSWDNH158 7KH 7158WHVWZDVIRXQGWRJLYHWKHEHVWFRUUHODWLRQZLWKLQYLYRGDWD7KHIRUPDO YDOLGDWLRQRIWKH7158WHVWZDVFRQGXFWHGLQ²E\(8&2/,3$XVLQJ FKHPLFDOVLQODERUDWRULHV7KHUHVXOWVZHUHUHSURGXFLEOHDQGFRUUHODWHGZHOO ZLWKLQYLYRGDWD6SLHOPDQQHWDO 7KH(&9$06FLHQWLÀF$GYLVRU\&RP PLWWHHDQGWKH(XURSHDQ&RPPLVVLRQ(& FRQFOXGHGWKDWWKH7158WHVWZDV YDOLGDWHG DQG UHDG\ WR EH FRQVLGHUHG IRU UHJXODWRU\ DFFHSWDQFH7KH (&6&&1)3 6FLHQWLÀF&RPPLWWHHIRU&RVPHWLFVDQG1RQ)RRG3URGXFWV KDVUHFHQWO\SURSRVHG WKDW WKH 7 158 PHWKRG EH WKH VWDQGDUG PHWKRG IRU WHVWLQJ 89 OLJKW DEVRUELQJ FRVPHWLFLQJUHGLHQWVIRUSKRWRWR[LFSRWHQWLDO
PERCUTANEOUS ABSORPTION ,Q YLWUR VNLQ DEVRUSWLRQ YDOXHV DUH XVHG LQ H[SRVXUH HVWLPDWHV RI SRWHQWLDOO\ KD]DUGRXVWRSLFDOO\DSSOLHGFKHPLFDOV/RFDODQGRUV\VWHPLFDEVRUSWLRQPD\EHRI FRQFHUQLQWKHH[SRVXUHHVWLPDWH$EVRUSWLRQGDWDIURPLQYLYRKXPDQVWXGLHVZRXOG EHPRVWUHOHYDQWEXWHWKLFDOFRQVLGHUDWLRQVRIWHQUHTXLUHWKHXVHRILQYLWURPHWKRGV WRREWDLQKXPDQVNLQDEVRUSWLRQGDWD,QYLYRDQLPDODEVRUSWLRQGDWDDUHVRPHWLPHV FROOHFWHG EXW WKH SUREOHP RI H[WUDSRODWLRQ WR KXPDQ DEVRUSWLRQ YDOXHV UHPDLQV $QLPDODEVRUSWLRQGDWDDUHXVXDOO\FRQVLGHUHGRYHUHVWLPDWHVRIDEVRUSWLRQWKURXJK KXPDQVNLQ,IPHWDEROLVPRIWKHWHVWFRPSRXQGLVRILQWHUHVW PHWDEROLVPYDOXHV IURPKXPDQVNLQZRXOGEHPRVWUHOHYDQWIRUH[SRVXUHDVVHVVPHQWV ,QYLWURVNLQDEVRUSWLRQVWXGLHVKDYHEHHQFRQGXFWHGIRURYHU\UZLWKPDQ\ VWXGLHV UHSRUWLQJ JRRG FRUUHODWLRQV EHWZHHQ LQ YLYR DQG LQ YLWUR UHVXOWV 7KH LQ YLWURVNLQPRGHOLVSUREDEO\PRUHDFFXUDWHO\UHIHUUHGWRDVDQH[YLYRV\VWHPVLQFH WKHVNLQVWUXFWXUHLVLQWDFWDQGIXQFWLRQVDVDGLIIXVLRQDOEDUULHUWRDEVRUSWLRQLQ D VLPLODU PDQQHU LQ HLWKHU WKH LQ YLYR RU LQ YLWUR VWXG\ 7KH XVH RI YLDEOH VNLQ PRUH FORVHO\ VLPXODWHV WKH LQ YLYR VLWXDWLRQ DQG FDQ SURYLGH XVHIXO LQIRUPDWLRQ RQ PHWDEROLVP GXULQJ WKH SHUFXWDQHRXV DEVRUSWLRQ SURFHVV:H SURSRVHG D SUR WRFROIRUFRQGXFWLQJDQLQYLWURVNLQDEVRUSWLRQVWXG\ZLWKYLDEOHKXPDQRUDQLPDO VNLQ %URQDXJK DQG &ROOLHU 1RQSK\VLRORJLFDO VROXELOL]LQJ DJHQWV FRXOG QRW EH DGGHG WR WKH UHFHSWRU ÁXLG WR SURPRWH SDUWLWLRQLQJ RI WKH WHVW FRPSRXQG LQWR WKH UHFHSWRU ÁXLG$EVRUSWLRQ ZDV GHÀQHG DV WKH VXP RI WKH UHFHSWRU ÁXLG DQGVNLQFRQWHQWVDWWKHHQGRIWKHVWXG\6SOLWWKLFNQHVVKXPDQVNLQJDYHSUHIHUUHG DEVRUSWLRQYDOXHVE\PLQLPL]LQJUHWHQWLRQRIDEVRUEHGPDWHULDOLQVNLQ$OWKRXJK WKH SURWRFRO VSHFLÀHV WKH XVH RI YLDEOH VNLQ QRQYLDEOH VNLQ VKRXOG EH VXIÀFLHQW ZKHQVNLQPHWDEROLVPLVQRWDQLVVXH+RZHYHUWKHEDUULHUSURSHUWLHVRIVNLQPXVW EH VKRZQ WR EH LQWDFW 3URWRFROV KDYH DOVR EHHQ SURSRVHG UHFHQWO\ LQ (XURSH E\ WKH(XURSHDQ&HQWHUIRU(FRWR[LFRORJ\DQG7R[LFRORJ\RI&KHPLFDOV(&(72& WKH (XURSHDQ &RVPHWLF 7RLOHWU\ DQG 3HUIXPHU\ $VVRFLDWLRQ &2/,3$
192
ALTERNATIVE TOXICOLOGICAL METHODS
0DFPLOODQ DQG WKH (XURSHDQ &HQWUH IRU WKH 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV(&9$0+RZHVHWDO 0DMRUDUHDVRIGLVDJUHHPHQWH[LVWEHWZHHQRXUSURWRFRODQGVRPHRUDOORIWKRVH SUHSDUHGE\WKHDERYH(XURSHDQRUJDQL]DWLRQV7KHLVVXHVDUHOLVWHGEHORZ 6KRXOGVNLQFRQWHQWVRIWHVWPDWHULDOEHVXPPHGZLWKUHFHSWRUÁXLGYDOXHVWRJHWWRWDO SHUFXWDQHRXVDEVRUSWLRQ" 6KRXOG VXUIDFWDQWV DQG RUJDQLF VROYHQWV EH DOORZHG LQ UHFHSWRU ÁXLG RU VKRXOG D SK\VLRORJLFDOEXIIHUEHXVHG" 6KRXOGWKHSURWRFROUHTXLUHKXPDQRUDQLPDOVNLQ" 6KRXOGYLDEOHRUQRQYLDEOHVNLQEHXVHG" 6KRXOG IXOOWKLFNQHVV VNLQ EH DOORZHG RU PXVW D VSOLWWKLFNQHVV SUHSDUDWLRQ GHU PDWRPHKHDWVHSDUDWLRQ EHSUHSDUHG"
$GUDIW2(&'SURWRFRODQGJXLGDQFHGRFXPHQWKDVDGGUHVVHGWKHVHLVVXHVDQG LVFXUUHQWO\LQWKHDSSURYDOSURFHVV
REFERENCES $QRQ 7KH PDULQH ORFDO O\PSK QRGH DVVD\ D WHVW PHWKRG IRU DVVD\LQJ WKH DOOHUJLF FRQWDFWGHUPDWLWLVSRWHQWLDORIFKHPLFDOVFRPSRXQGV1,+SXEOLFDWLRQ %RWKDP3$(DUO/.)HQWHP-+5DJHG5DQGYDQGH6DQGW--0 $OWHUQDWLYH PHWKRGVIRUVNLQLUULWDWLRQWHVWLQJWKHFXUUHQWVWDWXV$OW/DE$QLP² %URQDXJK5/DQG&ROOLHU6: 3URWRFROIRULQYLWURSHUFXWDQHRXVDEVRUSWLRQVWXGLHV LQ ,Q 9LWUR 3HUFXWDQHRXV $EVRUSWLRQ 3ULQFLSOHV )XQGDPHQWDOV DQG $SSOLFDWLRQV %URQDXJK5/DQG0DLEDFK+,(GV &5&3UHVV1HZ
CHAPTER
17
Allergic Contact Hypersensitivity: Mechanisms and Methods* 'HQLVH06DLOVWDG
CONTENTS ,QWURGXFWLRQ 3URFHVV ,&&9$0DQGWKH//1$5HYLHZ %DFNJURXQG &RQWDFW+\SHUVHQVLWLYLW\DQG$OOHUJLF&RQWDFW'HUPDWLWLV7HVW0HWKRGV %DFNJURXQG$Q([DPSOHRIWKH'LOHPPDRI*37HVWV 0HFKDQLVPV&RQWDFW+\SHUVHQVLWLYLW\$OOHUJLF&RQWDFW'HUPDWLWLV ,QGXFWLRQ3KDVH (OLFLWDWLRQ3KDVH 7HVW0HWKRGV 7UDGLWLRQDO&RQWDFW+\SHUVHQVLWLYLW\7HVWV³*XLQHD3LJ 7KH/RFDO/\PSK1RGH$VVD\//1$ ³0XULQH 2WKHU0XULQH6\VWHPV //1$³([9LYR 0RXVH(DU6ZHOOLQJ7HVW0(67 6XPPDU\RI$&'&+$QLPDO0RGHOV )XWXUH 5HIHUHQFHV
7KLV PDQXVFULSW KDV EHHQ UHYLHZHG E\ WKH 86 (QYLURQPHQWDO 3URWHFWLRQ$JHQF\ DQG DSSURYHG IRU SXEOLFDWLRQ$SSURYDOGRHVQRWVLJQLI\WKDWWKHFRQWHQWVQHFHVVDULO\UHÁHFWWKHYLHZDQGSROLFLHVRIWKH $JHQF\HQGRUVHPHQWRUUHFRPPHQGDWLRQIRUXVH
193
194
ALTERNATIVE TOXICOLOGICAL METHODS
INTRODUCTION 7KHPXULQHORFDOO\PSKQRGHDVVD\//1$ ZDVWKHÀUVWWHVWPHWKRGVXEPLWWHG WRWKH,QWHUDJHQF\&RRUGLQDWLQJ&RPPLWWHHRQWKH9DOLGDWLRQRI$OWHUQDWLYH0HWKRGV ,&&9$0 IRUFRQVLGHUDWLRQRILWVYDOLGDWLRQVWDWXV7KH//1$LVDQLQYLYRPRXVH WHVW GHYHORSHG IRU WKH GHWHFWLRQ RI FKHPLFDOV ZLWK SRWHQWLDO IRU LQGXFLQJ DOOHUJLF FRQWDFWGHUPDWLWLV$&' FRQWDFWK\SHUVHQVLWLYLW\&+ LQKXPDQVDQGZDVSURSRVHG DV DQ DOWHUQDWLYH WHVW PHWKRG WR WKH JXLQHD SLJ *3 VHQVLWL]DWLRQ WHVWV SUHYLRXVO\ DFFHSWHGE\UHJXODWRU\DJHQFLHVLQWKH8QLWHG6WDWHVDQGHOVHZKHUH 7KH ,&&9$0 SURFHVV DQG WKH YDOXH WKDW WKLV SURFHVV RIIHUV WR UHJXODWRU\ DJHQFLHVLQGXVWU\DQGDQLPDOZHOIDUHFRQFHUQVLVVLJQLÀFDQW,QDGGLWLRQWKHUROH RI UHVHDUFKHUV LQ WKH GHYHORSPHQW RI DOWHUQDWLYH WHVWLQJ PHWKRGV LV EURXJKW WR IUXLWLRQ ZLWK WKH HYDOXDWLRQ RI WKHVH WHVW PHWKRGV ,&&9$0 7KLV ÀUVW ,&&9$0HQGHDYRUZDVWKHHYDOXDWLRQRIDPHWKRGWRDVVHVVFRQWDFWVHQVLWL]DWLRQ SRWHQWLDORIFKHPLFDOV ,Q RUGHU WR DSSUHFLDWH WKH ,&&9$0 SURFHVV IRU WKLV ÀUVW PHWKRG WR XQGHUJR UHYLHZDFOHDUXQGHUVWDQGLQJRIFXUUHQWWHVWPHWKRGVDQGPHFKDQLVPVRIK\SHUVHQ VLWLYLW\LVHVVHQWLDO7KHSXUSRVHRIWKLVPDQXVFULSWLVWR SURYLGHEDFNJURXQGDQG PHFKDQLVWLF LQIRUPDWLRQ RQ &+ DQG FODULI\ WKH DQLPDO WHVWV PHWKRGV XVHG IRU WKHGHWHFWLRQRISRWHQWLDOFRQWDFWVHQVLWL]HUV
PROCESS ICCVAM and the LLNA Review 7KHIUDPHZRUNIRUWKH,&&9$0JRDOVDQGSURFHVVZDVUHÀQHGDQGWHVWHGZLWK WKHÀUVWPHWKRGHYDOXDWLRQWKH//1$)LJXUH6DLOVWDGHWDO 8VLQJWKH1DWLRQDO,QVWLWXWHVRI+HDOWKSXEOLFDWLRQ9DOLGDWLRQDQG5HJXODWRU\ $FFHSWDQFH RI 7R[LFRORJLFDO 7HVW 0HWKRGV $ 5HSRUW RI WKH DG KRF ,QWHUDJHQF\ &RRUGLQDWLQJ&RPPLWWHHRQWKH9DOLGDWLRQRI$OWHUQDWLYH0HWKRGV,&&9$0 DV D JXLGH * )UDQN *HUEHULFN 3URFWHU DQG *DPEOH 86 'DYLG $ %DVNHWWHU 8QLOHYHU 8. DQG ,DQ .LPEHU =HQHFD 8. VSRQVRUV SUHSDUHG D //1$ VXEPLVVLRQDQGUHTXHVWHGWKDW,&&9$0UHYLHZWKHPHWKRG7KHVSRQVRUVVSHFLÀ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ÀF,&&9$0FULWHULDZHUH DGGUHVVHGE\WKHPHWKRG7KHVHLQFOXGHDGGUHVVLQJDQLPDOXVHDQGZHOIDUHLVVXHV DQGHFRQRPLFLVVXHVDORQJZLWKWKHSURPLVHIRUEHWWHUDVVHVVPHQWRIKXPDQKHDOWK KD]DUGLGHQWLÀFDWLRQ
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
195
LLNA SPONSORS Data submission/ method support
Peer Review Panel Evaluation/ REPORT
NICEATM Support
Immunotoxicology Working Group Facilitation/ recommendation
ICCVAM
Advisory Committee on Alternative Toxicological Methods Guidance
Agency Response
Input/ guidance/ response
AGENCY LLNA Recommendation
REGULATORY ACTION Figure 17.1 ICCVAM review process: the local lymph node assay. (Modified from Sailstad, 2000.)
,&&9$0HVWDEOLVKHGDQH[SHUWZRUNLQJJURXSFRPSRVHGRI86JRYHUQPHQW DJHQF\UHSUHVHQWDWLYHVWRIXUWKHUHYDOXDWHWKHVXEPLWWHGPDWHULDOVDQGWRDLGLQWKH SHHUUHYLHZSURFHVV7KLVJURXSZDVUHIHUUHGWRDVWKH,PPXQRWR[LFRORJ\:RUNLQJ *URXSRU,:*7KHSXUSRVHRIWKH,:*ZDVWRSURYLGHOHDGHUVKLSDQGJXLGDQFHIRU WKH//1$SHHUUHYLHZDQGWRSURYLGHUHFRPPHQGDWLRQVWRVSHFLÀFDJHQFLHVIROORZLQJ SHHUUHYLHZ6SHFLÀFWDVNVXQGHUWDNHQE\WKH,:*LQFOXGHG WKHPRGLÀFDWLRQRI WKHJHQHUDO,&&9$0WHVWPHWKRGVXEPLVVLRQJXLGHOLQHVIRUUHOHYDQFHWRWKHPHWKRG IRU WKH VSRQVRU LGHQWLÀFDWLRQ RI SRWHQWLDO SHHU UHYLHZ SDQHO 353 FDQGLGDWHV WKHGHYHORSPHQWRIHYDOXDWLRQJXLGDQFHIRUWKHSDQHOWRXVHLQWKHLUDVVHVVPHQW RI WKH //1$ WR HQVXUH WKDW WKH ,&&9$0 YDOLGDWLRQ DQG DFFHSWDQFH FULWHULD ZHUH DGHTXDWHO\DGGUHVVHG LQSXWIRUWKHSDQHOPHHWLQJDQGUHSRUWIRUPDW SUHSD UDWLRQRIDUHYLVHG//1$SURWRFROWKDWUHÁHFWHGWKHSDQHOUHFRPPHQGDWLRQV LQSXW DQG JXLGDQFH WR ,&&9$0 DJHQFLHV RQ WKH VWUHQJWKV DQG OLPLWDWLRQV RI WKH //1$ DQG DVVLVWDQFHZLWKDVSHFWVRILPSOHPHQWDWLRQDWWKHDJHQF\OHYHO )ROORZLQJVHOHFWLRQRIWKHSDQHOH[SHUWVD353FKDLUZDVVHOHFWHGDQGJXLGDQFH PDWHULDOVZHUHSURYLGHGWRWKH353DORQJZLWKWKHVSRQVRUV·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ÀF FRPPXQLW\ RQH HDFK IURP 'HQPDUN 1RUZD\ DQG -DSDQ 7KH //1$UHYLHZWKURXJKWKH,&&9$0SURFHVVLVGLVFXVVHGHOVHZKHUH,&&9$0 6DLOVWDGHWDO'HDQHWDO
196
ALTERNATIVE TOXICOLOGICAL METHODS
BACKGROUND Contact Hypersensitivity and Allergic Contact Dermatitis Test Methods 7UDGLWLRQDOO\ *3 WHVWV KDYH EHHQ XVHG WR DVVHVV WKH $&'&+ SRWHQWLDO RI FKHPLFDOV 7KHVH WHVWV XVHG VLQFH KDYH EHHQ LPSRUWDQW WRROV IRU SKDUPD FHXWLFDODQGFKHPLFDOFRPSDQLHVDVZHOODVUHJXODWRU\DJHQFLHV.OHFDN +RZHYHU WKH VXEPLVVLRQ RI D //1$ SURWRFRO WR ,&&9$0 IRU FRQVLGHUDWLRQ DV DQ DOWHUQDWLYH WR *3 WHVWV DQG WKH VXJJHVWLRQ WR XVH D PXULQH V\VWHP LQWURGXFHG DQHZDSSURDFKWRWKHHYDOXDWLRQRI&+7KHVSRQVRUVRIWKH//1$UHTXHVWHGLWV HYDOXDWLRQ DV DQ DOWHUQDWLYH WR WKH FXUUHQWO\ DFFHSWHG *3 WHVWV WKXV SURYLGLQJ DQRWKHU PHWKRG IRU WKH LGHQWLÀFDWLRQ RI &+ SRWHQWLDO RI FKHPLFDOV7KH UHTXHVW DQG LQWHQGHG XVH RI D QHZ PHWKRG PXVW EH FOHDU DQG LQ WKLV FDVH WKH VSRQVRUV ZHUHQRWUHTXHVWLQJHOLPLQDWLRQRIH[LVWLQJWHVWVEXWDFFHSWDQFHRIWKH//1$DV DQDOWHUQDWLYHPHWKRGWKDWFRXOGEHXVHGLQOLHXRIWKHWUDGLWLRQDO*3WHVWLIGHVLUHG DQGDSSURSULDWH Background: An Example of the Dilemma of GP Tests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À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À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
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
197
Mechanisms: Contact Hypersensitivity/Allergic Contact Dermatitis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nduction Phase 7KH ÀUVW SKDVH VHQVLWL]DWLRQ LQGXFWLRQ SKDVH RULJLQDWHV XSRQ HSLFXWDQHRXV DSSOLFDWLRQ RI D KDSWHQ ,W LV EHOLHYHG WKDW KDSWHQV FRXSOH WR FDUULHU SURWHLQV RQ GHUPDODQGHSLGHUPDOFHOOVWREHFRPHIXOO\LPPXQRJHQLF7KHGHQGULWLFFHOOVZLWKLQ VNLQ/DQJHUKDQVFHOOV/& WDNHXSDQGSURFHVVWKHDQWLJHQKDSWHQ DQGPLJUDWH WRWKHUHJLRQDOGUDLQLQJO\PSKQRGHZKHUHWKH\SUHVHQWWKHDQWLJHQWRO\PSKRF\WHV
INDUCTION PHASE
ELICITATION PHASE
CHEMICAL ALLERGEN
EDEMA AND ERYTHEMA
LANGERHANS CELL (LC)
INITIAL NONSPECIFIC INFLAMMATORY MEDIATORS MIGRATION TO LOCAL LYMPH NODE
LC AND LYMPHOCYTE INTERACTION
“PRIMED” LYMPHOCYTES
CELLULAR INFLUX CYTOKINES, COSTIMULATORY, ADHESION MOLECULES INCREASE
SPECIFIC RESPONSE
LYMPHOCYTE PROLIFERATION
Figure 17.2 Illustration of contact hypersensitivity (CH) mechanisms: induction and elicitation phase. During the induction phase of CH, immature dendritic cells of the skin, called “Langerhans cells” (LC), effectively uptake and process the allergen. Simultaneously, epidermal keratinocytes and the LCs themselves release cytokine mediators which assist the LCs in the migration to the draining lymph node and maturation into effective antigen-presenting cells. In the lymph node, LC to T lymphocyte interactions occur, which is followed by lymphocyte proliferation. The proliferation results in “primed” effector lymphocytes which maintain a memory for the specific allergen. The elicitation phase of CH appears to involve two mechanisms of action. Initially, allergens cause direct cellular action releasing a series of nonspecific inflammatory mediators. These mediators are responsible for some of the cellular influx into the site of allergen challenge. Additionally, the “primed” lymphocytes are called into the area in a very specific response. These responses and the cytokines, costimulatory factors, and adhesion molecules act to produce the end results of erythema and edema. (Modified from Selgrade et al., 2001.)
198
ALTERNATIVE TOXICOLOGICAL METHODS
2QFH DQWLJHQ LV HIIHFWLYHO\ SUHVHQWHG WR O\PSKRF\WHV ZLWKLQ WKH O\PSK QRGH DFWLYDWLRQ DQG UDSLG SUROLIHUDWLRQ RI WKHVH FHOOV RFFXUV &HOOXODU SUROLIHUDWLRQ LV FRQVLGHUHGDKDOOPDUNRIWKHLQGXFWLRQSKDVHRI&+DQGLVWKHPHFKDQLVWLFEDVLV IRUWKH//1$ 7KHLQLWLDODSSOLFDWLRQRIDVHQVLWL]LQJDJHQWWRWKHVNLQLQGXFHVVROXEOHIDFWRUV VXFKDVF\WRNLQHVWKDWDFWLYDWHDFDVFDGHRIHYHQWVFULWLFDOIRUVHQVLWL]DWLRQ.LPEHU DQG'HDUPDQ (SLGHUPDONHUDWLQRF\WHVVHFUHWHLQÁ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licitation Phase *UDEEHDQG6FKZDU] SURYLGHDQH[FHOOHQWUHYLHZRIWKHHYHQWVLQYROYHG LQWKHHOLFLWDWLRQSKDVHRI&+)ROORZLQJSUROLIHUDWLRQ7O\PSKRF\WHVDUHFRQVLGHUHG ´SULPHGµ DQG KDYH D VSHFLÀF PHPRU\ IRU WKH VHQVLWL]LQJ DJHQW 8SRQ VXEVHTXHQW H[SRVXUH WR WKH DJHQW DQ DQWLJHQVSHFLÀF UHVSRQVH RFFXUV 7KLV VHFRQG SKDVH LV UHIHUUHG WR DV WKH HOLFLWDWLRQ SKDVH:KLOH HYHQWV DVVRFLDWHG ZLWK WKH HOLFLWDWLRQ RI &+ DUH QRW DV ZHOO FKDUDFWHUL]HG DV WKRVH DVVRFLDWHG ZLWK LQGXFWLRQ LW LV HYLGHQW IURP KLVWRSDWKRORJ\ WKDW PDVW FHOO GHJUDQXODWLRQ YDVRGLODWLRQ DQG WKH LQÁX[ RI QHXWURSKLOV DQG PRQRQXFOHDU DQG 7 O\PSKRF\WHV FHOOV RFFXU +RZHYHU FOLQLFDO PDQLIHVWDWLRQKLVWRSDWKRORJ\DQGLPPXQRKLVWRORJ\RIDOOHUJLFDQGLUULWDQWFRQWDFW GHUPDWLWLVDUHYLUWXDOO\LQGLVWLQJXLVKDEOH&+LVGLVWLQJXLVKHGIURPLUULWDWLRQEHFDXVH LW UHTXLUHV LPPXQRORJLF PHPRU\ RI D VSHFLÀ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ÀFSULPHGPHPRU\ 7FHOOVZKLFKFDUU\VNLQKRPLQJUHFHSWRUVDUHFRQVWDQWO\ SDWUROOLQJ WKURXJKRXW WKH VNLQ$V ZLWK LQGXFWLRQ /DQJHUKDQV FHOOV WDNH XS DQG SURFHVV DQWLJHQ +RZHYHU XQOLNH LQGXFWLRQ DQWLJHQ LV SUHVHQWHG WR WKHVH SULPHG 7 FHOOV LQ WKH VNLQ UDWKHU WKDQ WKH O\PSK QRGH WULJJHULQJ WKH ORFDO UHVSRQVHV
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
199
FODVVLFDOO\ DVVRFLDWHG ZLWK &+$ UHFHQW WKHRU\ VXJJHVWV WKDW WKH LQLWLDO UHVSRQVH WR HOLFLWDWLRQ LV D QRQVSHFLÀF LQÁDPPDWRU\ UHVSRQVH WULJJHUHG E\ WKH SURGXFWLRQ RISURLQÁ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
TEST METHODS Traditional Contact Hypersensitivity Tests—Guinea Pig 7KH *3 KDV EHHQ LGHQWLÀHG DV DQ DQLPDO PRGHO IRU &+ IRU PRUH WKDQ \U 7KHUHDUHVHYHUDOJXLQHDSLJWHVWVIRUWKHDVVHVVPHQWRI&+7KHVHLQFOXGHWKHJXLQHD SLJPD[LPL]DWLRQWHVW*307 WKH%XHKOHUDVVD\%$ )UHXQG·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·VFRPSOHWHDGMXYDQWYLDLQWUDGHUPDOLQMHFWLRQV 2Q GD\ WKHUH LV D FKDOOHQJH H[SRVXUH ZKLFK LV YLVXDOO\ DVVHVVHG IRU HU\WKHPD KU ODWHU7KH DVVHVVPHQW RI WKH FKDOOHQJH VLWH LV JUDGHG QR YLVXDO FKDQJH SDWFK\ HU\WKHPD FRQÁXHQW HU\WKHPD FRQÁ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
200
ALTERNATIVE TOXICOLOGICAL METHODS
Guinea Pig Maximization Test
Buehler Assay 20 animals/group
Topical antigen application: ID injection w/ or w/o FCA
Induction
Topical antigen application: closed patch
Days 5-8
Day 20–22 topical application
48, 72 h after challenge
Days 0, 6–8, and 13–15
Challenge
Day 27–28 topical application (untreated flank for 6 h)
Endpoint Analysis
21, 24, 48 h after removing patch
erythema
Figure 17.3 Guinea pig models. (Modified from Sailstad, 2002.)
YLVXDO DVVHVVPHQW RI HU\WKHPD PDNHV WKH HYDOXDWLRQ RI FRORUHG UHDJHQWV VXFK DV G\HVYHU\GLIÀFXOWDQGYXOQHUDEOHWRVXEMHFWLYLW\:KLOHWKH*307KDVEHHQFODV VLÀHGDVPRUH´VHQVLWLYHµWKDQWKH%$LWKDVDOVREHHQFULWLFL]HGIRUIDOVHSRVLWLYH UHVSRQVHVDQGWKHGHOHWHULRXVDIIHFWWKDWDGMXYDQWKDVRQWKHJXLQHDSLJV$GGLWLRQ DOO\VLQFHWKHWHVWVUHTXLUHERWKSKDVHVRI&+WKHUHLVDFHUWDLQDPRXQWRISDLQDQG GLVWUHVV FDXVHG E\ WKH HGHPD DQG HU\WKHPD WKDW LV DVVRFLDWHG ZLWK WKH HOLFLWDWLRQ SKDVH6DLOVWDG The Local Lymph Node Assay (LLNA)—Murine 7KH//1$DVVXEPLWWHGWR,&&9$0IRUUHYLHZ)LJXUH6DLOVWDG XVLQJWKHLQGXFWLRQSKDVHRI&+PHDVXUHVWKHLQFRUSRUDWLRQRI+PHWK\OWK\PLGLQH RU ,LRGRGHR[\XULGLQH LQWR SUROLIHUDWLQJ O\PSKRF\WHV LQ WKH GUDLQLQJ O\PSK QRGHVRIDQLPDOVWRSLFDOO\H[SRVHGWRWKHWHVWDJHQW7KHSURWRFROVSHFLÀHVWKDWWKH WHVWDJHQWEHDSSOLHGIRUWKUHHFRQVHFXWLYHGD\VWRWKHGRUVDOSRUWLRQRIWKHHDUVRI &%$PLFH2QGD\WKHUDGLRLVRWRSHLVLQMHFWHGLQWRWKHWDLOYHLQRIHDFKPRXVH )LYHKRXUVDIWHUWKHLQMHFWLRQWKHGUDLQLQJO\PSKQRGHRIHDFKHDULVH[FLVHGDQG SRROHGIRUHDFKDQLPDO'HSHQGLQJXSRQWKHLVRWRSHVHOHFWHGVSHFLÀ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
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
Days 1, 2, 3
201
Agent applied to ears
IV tail injection of isotope
Day 6
Day 6: 5 h post IV injection
Lymph nodes removed
Proliferation measured: Isotope incorporation expressed as disintegration per minute (dpm) Figure 17.4 The local lymph node assay. (Modified from Sailstad, 2002.)
WKH WHVW FKHPLFDO LV FRQVLGHUHG WR EH D VHQVLWL]HU $GGLWLRQDOO\ ZLWK WKH XVH RI LQGLYLGXDODQLPDOGDWDVWDWLVWLFDODQDO\VLVLVSRVVLEOH,&&9$06DLOVWDGHW DO'HDQHWDO6DLOVWDG 7KH //1$ VSRQVRUV SURSRVHG WKDW WKLV PHWKRG SURYLGHV VSHFLÀ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ÀFDWLRQ RI FKHPLFDOV ZLWK WKH SRWHQWLDO IRU FRQWDFW VHQVLWL]DWLRQ +RZHYHU WKH\ LQGLFDWHG WKDW WKH IROORZLQJ SURWRFRO PRGLÀFDWLRQV EH DFFHSWHG &%$ IHPDOH PLFH VKRXOG EH XVHG H[FOXVLYHO\ XQWLO PRXVH VWUDLQ DQG JHQGHU FRPSDULVRQVWXGLHVDUHSHUIRUPHG DQLPDOVVKRXOGEHLQGLYLGXDOO\LGHQWLÀHG ERG\ ZHLJKW GDWD VKRXOG EH FROOHFWHG DW WKH VWDUW DQG HQG RI WKH VWXG\ O\PSKRF\WHSUROLIHUDWLRQGDWDVKRXOGEHFROOHFWHGDWWKHOHYHORILQGLYLGXDODQLPDO VWDWLVWLFDO DQDO\VLV VKRXOG EH SHUIRUPHG D VLQJOH GRVH RI D VHQVLWL]HU LQGXFLQJDPRGHUDWHUHVSRQVHVKRXOGEHLQFOXGHGDVDFRQFXUUHQWSRVLWLYHFRQWURO LQHDFKVWXG\ +PHWK\OWK\PLGLQHRU ,LRGRGHR[\XULGLQHPD\EHXVHGLQ WKH//1$ HYDOXDWLRQRIUHVSRQVHVKRXOGLQFOXGHD6,!VWDWLVWLFDOVLJQLÀ FDQFHDQGGRVHUHVSRQVHLQIRUPDWLRQDQG DQLOOXVWUDWLRQVKRXOGEHDGGHGWR WKHSURWRFROLQGLFDWLQJWKHQRGHVGUDLQLQJWKHH[SRVXUHVLWHWKDWDUHWREHFROOHFWHG 7KH SDQHO DOVR UHFRPPHQGHG WKDW UHWURVSHFWLYH GDWD DXGLWV EH FRQGXFWHG RQ DW OHDVW WKUHH RI WKH LQWUDODERUDWRU\ DQG LQWHUODERUDWRU\ //1$ YDOLGDWLRQ VWXGLHV FRQGXFWHGE\WKHVSRQVRUV7KHUHZHUHVRPHOLPLWDWLRQVRUSRWHQWLDOOLPLWDWLRQV
202
ALTERNATIVE TOXICOLOGICAL METHODS
RIWKH//1$LGHQWLÀHGE\WKH3537KHVHDUHWKHHYDOXDWLRQRIPL[WXUHVPHWDOV DQGLUULWDQWV7KHSDQHOUHFRPPHQGHGWKDW*3WHVWVEHXVHGIRUWKHHYDOXDWLRQRI VXFK PDWHULDOV 7KH 353 FRQFOXGHG XQDQLPRXVO\ WKDW WKH //1$ LV D GHÀQLWH LPSURYHPHQWZLWKUHVSHFWWRDQLPDOZHOIDUHLHUHÀQHPHQWDQGUHGXFWLRQ RYHU WKHDFFHSWHG*307,&&9$0 Other Murine Systems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—Ex Vivo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ouse Ear Swelling Test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
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
203
PHASE Induction
Elicitation
LLNA
GPMT and BA
MEST
Figure 17.5 Contact hypersensitivity models and endpoint mechanisms.
SUMMARY OF ACD/CH ANIMAL MODELS &+FDQEHGLYLGHGLQWRWZRPHFKDQLVWLFSKDVHVLQGXFWLRQDQGHOLFLWDWLRQ0HWKRGV WKDWDUHDYDLODEOHUHO\RQWKHVHPHFKDQLVPV)LJXUH DQGWKHHQGSRLQWHYDOXDWLRQ RI WKH &+ SKDVH7KXV WKH //1$ PHDVXUHV SUROLIHUDWLRQ E\ WKH LQFRUSRUDWLRQ RI D UDGLRLVRWRSHDQGWKH*307RU%$PHDVXUHVHU\WKHPDE\YLVXDODVVHVVPHQW$GGL WLRQDOO\WKH0(67PHDVXUHVWKHHGHPDSURGXFHGE\WKHDQWLJHQFKDOOHQJH
FUTURE $GYDQWDJHV RI WKH PXULQH V\VWHP IRU WKH LGHQWLÀFDWLRQ RI SRWHQWLDO FRQWDFW VHQVLWL]LQJFKHPLFDOJREH\RQGWKHVSHFLÀF//1$HYDOXDWHGE\,&&9$07KHUH DUHPDQ\LPPXQRFKHPLFDOVDQGFRPPHUFLDOO\DYDLODEOHUHDJHQWVIRUWKHPRXVH ,PPXQRFKHPLFDOV VXFK DV F\WRNLQHV DQG RWKHU VROXEOH FRPSRQHQWV DUH UHDGLO\ DYDLODEOH DQG FRUUHODWH WR WKH KXPDQ IDFWRUV $GGLWLRQDOO\ WKH ELRORJ\ RI WKH PXULQHLPPXQHV\VWHPLVZHOOXQGHUVWRRGHVSHFLDOO\ZKHQFRPSDUHGWRWKDWRI WKHJXLQHDSLJ7KHVHDGYDQWDJHVVKRXOGOHDGWRDGGLWLRQDODGYDQFHVLQ&+DVVHVV PHQW2WKHUHQGSRLQWVRI&+XVLQJD//1$DSSURDFKPD\LQFOXGHDQRWKHUPDUNHU IRUSUROLIHUDWLRQQRQUDGLRLVRWRSH RULGHQWLÀ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ÀF HQGSRLQWV RI &+ FDQ EH GHÀQHG DQG PHDVXUHG 7KH ,&&9$0 HYDOXDWLRQ RI WKH //1$SURYLGHGWKHÀUVWVWHSLQWKHDFFHSWDQFHRIQHZWHVWPHWKRGVIRUWKHIXWXUH RI&+HYDOXDWLRQ
204
ALTERNATIVE TOXICOLOGICAL METHODS
7KH//1$UHYLHZE\DQ,&&9$0HVWDEOLVKHGLQGHSHQGHQWSHHUUHYLHZSDQHO DQGWKHLUFRQFOXVLRQVDQGÀQGLQJVFRQFHUQLQJWKLVQHZWHVWPHWKRGLQGLFDWHWKDW WKH//1$KDVPXOWLSOHDGYDQWDJHVRYHUWKH*3WHVWV6FLHQWLÀFDOO\WKH//1$XVHV DQ REMHFWLYH HQGSRLQW DQG SURYLGHV D GLVWLQFW DGYDQWDJH ZKHQ FRORUHG PDWHULDOV DUH WHVWHG $GGLWLRQDOO\ WKH UHGXFWLRQ RI WKH QXPEHUV RI DQLPDOV XVHG DQG WKH UHGXFWLRQLQGLVWUHVVWRWKHDQLPDOVLVDVLJQLÀFDQWDQLPDOZHOIDUHLPSURYHPHQW %DVHGRQWKHVHDGYDQWDJHVDORQJZLWKWKHUHFRPPHQGHGSURFHGXUHVWKH//1$ ZDV SURSRVHG DV DQ DOWHUQDWLYH IRU *3 WHVWV 7KLV OHYHO RI HQGRUVHPHQW DFFHSWV QHJDWLYH GDWD ZLWKRXW IXUWKHU DQLPDO WHVWLQJ 7KH ,&&9$0 HQGRUVHG WKH 353·V UHFRPPHQGDWLRQV DQG VHQW WKHLU UHSRUW WR 86 DJHQFLHV ,Q WXUQ 86 IHGHUDO DJHQFLHVDVVRFLDWHGZLWKDOOHUJLFFRQWDFWGHUPDWLWLVDFFHSWHGWKH,&&9$0//1$ DQGUHFRPPHQGDWLRQV,QGLYLGXDOO\DJHQFLHVKDYHZRUNHGZLWKWKHLUJXLGHOLQHVWR LQFRUSRUDWH WKHVH FKDQJHV WR DFFHSW WKH //1$ )ROORZLQJ WKH ,&&9$0 UHYLHZ WKH //1$ ZDV HQGRUVHG LQWHUQDWLRQDOO\ DV WKH 2(&' DOVR DFFHSWHG WKH //1$ ZLWK VOLJKW PRGLÀFDWLRQV WR WKH ,&&9$0 SURWRFRO DV D VWDQGDORQH DOWHUQDWLYH WRWKH*3WHVWPHWKRGV2(&' ,QVXPPDU\WKHUHDUHDQXPEHURIPHFKDQLVWLFDQLPDOPRGHOVWKDWKDYHEHHQ XVHGWRDVVHVVWKHSRWHQWLDOIRUFKHPLFDOVWRSURGXFHDOOHUJLF FRQWDFWGHUPDWLWLV 7KH JXLQHD SLJ WHVWV KDYH EHHQ XVHG IRU WKH ORQJHVW SHULRG RI WLPH ZKHUHDV WKH PXULQHPRGHOVDUHUHODWLYHO\QHZ7KHPRUHUHFHQWHYDOXDWLRQRIPXULQHPRGHOV DVDOWHUQDWLYHVWRWKHJXLQHDSLJWHVWOHGWRWKH//1$UHYLHZ7KH//1$KDVEHHQ H[WHQVLYHO\ HYDOXDWHG7KURXJK UHYLHZ DQG DFFHSWDQFH E\ WKH ,&&9$0 2(&' DQG 86 IHGHUDO DJHQFLHV WKH //1$ LV D VWDQGDORQH DOWHUQDWLYH WR *3 WHVW PHWKRGV7KH//1$RIIHUVDYDULHW\RIVFLHQWLÀFDQGDQLPDOZHOIDUHDGYDQWDJHV WKDWLQGLFDWHLWVXVHLQPRVWWHVWLQJVLWXDWLRQV
REFERENCES 'HDQ-+7ZHUGRN/(7LFH556DLOVWDG'0+DWWDQ'*DQG6WRNHV:6 ,&&9$0HYDOXDWLRQRIWKHPXULQHORFDOO\PSKQRGHDVVD\&RQFOXVLRQVDQGUHFRP PHQGDWLRQVRIDQLQGHSHQGHQWVFLHQWLÀFSHHUUHYLHZSDQHO5HJXO7R[LFRO3KDUPD FRO² (QN$+ DQG .DW] 6, (DUO\ PROHFXODU HYHQWV LQ WKH LQGXFWLRQ SKDVH RI FRQWDFW VHQVLWLYLW\3URF1DWO$FDG6FL86$² *HUEHULFN *) HW DO 6HOHFWLYH PRGXODWLRQ RI 7 FHOO PHPRU\ PDUNHUV &'/ DQG &'RQPXULQHGUDLQLQJO\PSKQRGHFHOOVIROORZLQJDOOHUJHQDQGLUULWDQWWUHDWPHQW 7R[LFRO$SSO3KDUPDFRO² *UDEEH6DQG6FKZDU]7-DQXDU\ ,PPXQRUHJXODWRU\PHFKDQLVPVLQYROYHGLQHOLF LWDWLRQRIDOOHUJLFFRQWDFWK\SHUVHQVLWLYLW\,PPXQRO7RGD\² ,&&9$0 ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI$OWHUQDWLYH 0HWKRGV 9DOLGDWLRQDQGUHJXODWRU\DFFHSWDQFHRIWR[LFRORJLFDOWHVWPHWKRGV$UHSRUW RIWKHDGKRF,QWHUDJHQF\&RRUGLQDWLQJ&RPPLWWHHRQWKH9DOLGDWLRQRI$OWHUQDWLYH 0HWKRGV1,+SXEOLFDWLRQ1DWLRQDO,QVWLWXWHRI(QYLURQPHQWDO+HDOWK6FL HQFHV5HVHDUFK7ULDQJOH3DUN1&
ALLERGIC CONTACT HYPERSENSITIVITY: MECHANISMS AND METHODS
205
,&&9$0 ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH9DOLGDWLRQ RI$OWHUQDWLYH 0HWKRGV 7KHPXULQHORFDOO\PSKQRGHDVVD\DWHVWPHWKRGIRUDVVHVVLQJWKHDOOHUJLF FRQWDFW GHUPDWLWLV SRWHQWLDO RI FKHPLFDOVFRPSRXQGV 1,+ SXEOLFDWLRQ 1DWLRQDO,QVWLWXWHRI(QYLURQPHQWDO+HDOWK6FLHQFHV5HVHDUFK7ULDQJOH3DUN1& .LPEHU,D 7KHORFDOO\PSKQRGHDVVD\LQ'HUPDWRWR[LFRORJ\WKHG0DU]XOOL)1 DQG0DLEDFK+,(GV7D\ORUDQG)UDQFLV:DVKLQJWRQ'&SS² .LPEHU,E 0RXVHSUHGLFWLYHWHVWVLQ7R[LFRORJ\RI&RQWDFW+\SHUVHQVLWLYLW\.LPEHU ,DQG0DXUHU7(GV7D\ORUDQG)UDQFLV/RQGRQ8.SS² .LPEHU,DQG'HDUPDQ5- &RQWDFWK\SHUVHQVLWLYLW\LPPXQRORJLFDOPHFKDQLVPV LQ 7R[LFRORJ\ RI &RQWDFW +\SHUVHQVLWLYLW\ .LPEHU , DQG 0DXUHU 7 (GV 7D\ORU DQG)UDQFLV/RQGRQSS² .OHFDN * 7HVW PHWKRGV IRU DOOHUJLF FRQWDFW GHUPDWLWLV LQ DQLPDOV LQ 'HUPDWRWR[L FRORJ\WKHG0DU]XOOL)1DQG0DLEDFK+,(GV7D\ORUDQG)UDQFLV:DVK LQJWRQ'&² 2(&'2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW 2(&'JXLGHOLQHV IRUWHVWLQJRIFKHPLFDOVVNLQVHQVLWL]DWLRQ2(&'3DULV 2(&' 2UJDQL]DWLRQ IRU (FRQRPLF &RRSHUDWLRQ DQG 'HYHORSPHQW 7HVW JXLGHOLQHV IRUWKHWHVWLQJRIFKHPLFDOV>VNLQVHQVLWLVDWLRQ/RFDO/\PSK1RGH$VVD\@*XLGHOLQH DFFHSWHG$SULO2(&'3DULV 6DLOVWDG '0 0XULQH ORFDO O\PSK QRGH DVVD\ DQ DOWHUQDWLYH WHVW PHWKRG IRU VNLQ K\SHUVHQVLWLYLW\WHVWLQJ/DE$QLP² 6DLOVWDG'07RSSHU-6'RHUÁHU'/4DVLP0DQG6HOJUDGH0-. (YDOX DWLRQRIDQ$]RDQG7ZR$QWKUDTXLQRQH'\HVIRU$OOHUJLF3RWHQWLDO)XQGDP$SSO 7R[LFRO² 6DLOVWDG'0+DWWDQ'+LOO5DQG6WRNHV: 7KHÀUVWPHWKRGHYDOXDWLRQE\WKH ,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV ,&&9$0 WKHPXULQHORFDOO\PSKQRGHDVVD\//1$ LQ3URJUHVVLQWKH5HGXFWLRQ 5HÀQHPHQWDQG5HSODFHPHQWRI$QLPDO([SHULPHQWDWLRQ%DOOV0YDQ=HOOHU$0 DQG+DOGHU0((GV(OVHYLHU6FLHQFH$PVWHUGDP 6DLOVWDG '0 +DWWDQ ' +LOO 51 DQG 6WRNHV:6 ,&&9$0HYDOXDWLRQRIWKH PXULQHORFDOO\PSKQRGHDVVD\7KH,&&9$0UHYLHZSURFHVV5HJXO7R[LFRO3KDU PDFRO² 6HOJUDGH0-.*HUPROHF'5/XHENH5:6PLDORZLF]5-:DUG0'DQG6DLOVWDG '0 ,PPXQRWR[LFLW\ LQ ,QWURGXFWLRQ WR %LRFKHPLFDO 7R[LFRORJ\ UG HG +RGJVRQ(DQG6PDUW5&(GV:LOH\1HZ
CHAPTER
18
Validating In Vitro Dermal Absorption Studies: An Introductory Case Study 5REHUW3=HQG]LDQDQG0LFKDHO'HOODUFR
CONTENTS ,QWURGXFWLRQ 0HWKRGVIRU(YDOXDWLRQRIWKH5HSRUWV 0DWHULDOVDQG0HWKRGVRIWKH,QGLYLGXDO6WXGLHV 5HVXOWVRIWKH6WXGLHV 'LVFXVVLRQ 5HIHUHQFHV
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ÀHG SXUSRVHV7KHVHWKUHHVWHSVVKRXOGEHIROORZHGZKHWKHUWKHWHVWLVDQHZSURFHGXUH RULWLVLQWHQGHGWRUHSODFHRUDXJPHQWDQHVWDEOLVKHGSURFHGXUH,QSUDFWLFHWKHVH VWHSV DUH IUHTXHQWO\ LQFRPSOHWHO\ SHUIRUPHG DQG UHFRUGHG MXPEOHG WRJHWKHU RU SHUIRUPHGRXWRIRUGHU%HFDXVHRIWKLVIDLOXUHWRDFKLHYHDGHÀQHGSURFHVVZHDUH IUHTXHQWO\ OHIW ZLWK DFFHSWHG WHVW SURFHGXUHV ZKHUH LQVWUXFWLRQV DUH LQFRPSOHWH RU ODFNLQJDQGZKHUHZHKDYHQRHYLGHQFHWKDWWKHUHVXOWVDUHFRQVLVWHQWRUDFFXUDWHO\ UHSUHVHQW WKH SURFHVV WKDW ZH DUH REVHUYLQJ 7KLV KDV EHFRPH SDUWLFXODUO\ WUXH LQ 207
208
ALTERNATIVE TOXICOLOGICAL METHODS
WKH JHQHUDO SURFHVV RI YDOLGDWLQJ LQ YLWUR GHUPDO DEVRUSWLRQ GHUPDO SHQHWUDWLRQ SURFHGXUHVDQGWKHGHYHORSPHQWRILQYLWURGHUPDODEVRUSWLRQWHVWJXLGHOLQHVE\WKH 2UJDQL]DWLRQIRU(FRQRPLF&RRSHUDWLRQDQG'HYHORSPHQW2(&' $QRQ 7KLVFKDSWHUIRFXVHVRQWKHÀUVWVWHSRIWKHSURFHVVWHVWGHYHORSPHQWDQGXVHVWKH UHSRUWVRQWKHGHUPDODEVRUSWLRQRIDFHWRFKORUVXEPLWWHGWRWKH2IÀFHRI3HVWLFLGH 3URJUDPV 233 86 (QYLURQPHQWDO 3URWHFWLRQ $JHQF\ (3$ WR LOOXVWUDWH WKH VWDQGDUGIRUH[SHULPHQWDOGHVLJQDQGUHSRUWLQJQHFHVVDU\WRPRYHIURPWHVWGHYHO RSPHQW WR WHVW YDOLGDWLRQ DQG XOWLPDWH DFFHSWDQFH7KH VWXGLHV ZHUH SHUIRUPHG LQ YLYR XVLQJ WKH UDW /\WKJRH DQG -RQHV LQ YLWUR XVLQJ WKH UDW HSLGHUPDO PHPEUDQHSUHSDUDWLRQ&ORZHVDQG6FRWWD DQGLQYLWURLQWKHKXPDQHSLGHU PDOPHPEUDQHSUHSDUDWLRQ&ORZHVDQG6FRWWE
METHODS FOR EVALUATION OF THE REPORTS 6WXG\UHSRUWVRQWKHGHUPDODEVRUSWLRQRIDFHWRFKORUZHUHVXEPLWWHGWR233E\ DSHVWLFLGHUHJLVWUDQWLQWKHSURFHVVRIUHUHJLVWUDWLRQRIWKHSHVWLFLGHDFHWRFKORU7KH UHSRUWVFRQIRUPWRWKH233UHTXLUHPHQWVIRUVWXG\WHVW UHSRUWLQJ233UHSRUWLQJ UHTXLUHPHQWVDUHLQWZRSDUWVUHJXODWRU\UHTXLUHPHQWVDQGVFLHQWLÀFUHTXLUHPHQWV 5HJXODWRU\ UHTXLUHPHQWV DSSO\ WR DOO VWXG\ UHSRUWV VXEPLWWHG WR 233 ,Q JHQHUDO WKH\ FRQVLVW RI UHTXLUHPHQWV IRU DQG GHWDLOHG FRPSRVLWLRQ RI WLWOH SDJH VWDWHPHQW RI QR GDWD FRQÀGHQWLDOLW\ FODLPV VLJQHG JRRG ODERUDWRU\ SUDFWLFH FRPSOLDQFH VWDWHPHQWVLJQHG TXDOLW\DVVXUDQFHVWDWHPHQWVLJQHG FHUWLÀFDWLRQRIGDWDDFFX UDF\VLJQHG WDEOHRIFRQWHQWVVXPPDU\DQGERG\RIUHSRUW7KHVLJQDWXUHVUHTXLUHG DUHWKRVHRIWKHLQGLYLGXDOVUHVSRQVLEOHIRUHDFKSDUWLFXODUDVSHFWRIWKHVWXG\7KHVH UHTXLUHPHQWV DUH VSHFLÀHG LQ WKH IHGHUDO UHJLVWHU &)5 SDUWV WR DQG KDYHWKHIRUFHRIODZ7KHVFLHQWLÀFUHTXLUHPHQWVIRUUHSRUWLQJYDU\WRVRPHH[WHQW ZLWKWKHW\SHRIVWXG\7KHUHTXLUHPHQWVIRUGHUPDODEVRUSWLRQVWXGLHVDUHVSHFLÀHG LQWKH*XLGHOLQHIRU'HUPDO$EVRUSWLRQRI3HVWLFLGHV=HQG]LDQ ,QJHQHUDO WKH\ FRQVLVW RI WKH IROORZLQJ LGHQWLÀFDWLRQ DQG SURSHUWLHV RI WKH WHVW FRPSRXQG YHKLFOHDQGH[SHULPHQWDODQLPDOWKHH[SHULPHQWDOGHVLJQDQLPDOKXVEDQGU\REVHU YDWLRQVDQGSUHSDUDWLRQIRUGRVLQJGRVHSUHSDUDWLRQGRVHDSSOLFDWLRQDQGSURWHF WLRQ RI WKH DSSOLFDWLRQ VLWH KDQGOLQJ GXULQJ H[SRVXUH DQG WHUPLQDWLRQ VDPSOH FROOHFWLRQDQGVDPSOHDQDO\VLV$OOGDWDJHQHUDWHGGXULQJWKHVWXG\PXVWEHUHSRUWHG XVXDOO\LQDSSHQGLFHVDQGWKHUHVXOWVGLVFXVVHGZLWKVXPPDU\WDEOHVRULOOXVWUDWLRQV 7KHUHSRUWVRIWKHDFHWRFKORUVWXGLHVVDWLVÀHGDOORIWKHVHGDWDUHSRUWLQJUHTXLUHPHQWV 7KH VWXGLHV ZHUH MXGJHG VFLHQWLÀFDOO\ DFFHSWDEOH ,Q HDFK VWXG\ WKH IROORZLQJ FULWHULDIRUDGHUPDODEVRUSWLRQVWXG\ZHUHPHW 7KHWHVWPDWHULDOZDVUDGLRODEHOHGZLWK & LQVXFKDPDQQHUDVWRSHUPLWWKH TXDQWLWDWLYHWUDFLQJRILWDQGRULWVPHWDEROLWHV 7KHWHVWPDWHULDOZDVGLVVROYHGVXVSHQGHGLQDYHKLFOHZKLFKPLPLFNHGWKDWRI ÀHOGH[SRVXUH 7KHWHVWPDWHULDOZDVDSSOLHGTXDQWLWDWLYHO\DVPDVVSHUXQLWDUHDRIDSSOLFDWLRQVLWH 7KHDSSOLFDWLRQVLWHZDVSUHSDUHGLQDVWDQGDUGPDQQHU 7KHDSSOLFDWLRQVLWHZDVSURWHFWHGDJDLQVWGLVWXUEDQFHRUORVVRIWKHWHVWPDWHULDO
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
209
$WWKHHQGRIWKHH[SRVXUHSHULRGWKHDSSOLFDWLRQVLWHZDVZDVKHGZLWKDZDWHU VROXWLRQRIVRDSGHWHUJHQWWRPLPLFKXPDQZDVKLQJ $OOFRPSRQHQWVRIWKHWHVWV\VWHPZHUHFROOHFWHGDQGDQDO\]HGVHSDUDWHO\VRDV WRREWDLQDFRPSOHWHPDWHULDOEDODQFHRIGRVHGLVWULEXWLRQ 7KHSRUWLRQRIWKHGRVHLQWKHVNLQHSLGHUPDOPHPEUDQHDQGWKHSRUWLRQWKDWKDG SDVVHGWKURXJKLWZDVGHWHUPLQHG $W OHDVW IRXU LQGLYLGXDO DQLPDOVPHPEUDQH VDPSOHV ZHUH XVHG IRU HDFK GRVH H[SRVXUHWHVWHG
,QHDFKVWXG\UDGLRODEHOHGDFHWRFKORU&SKHQ\O ZDVWKHWUDFHUGLOXWHGZLWK XQODEHOHGDFHWRFKORUZKHUHQHFHVVDU\WRPDNHXSWKHGRVH,WZDVDSSOLHGLQDXVH IRUPXODWLRQ'RVHVDSSOLHGZHUHDVIROORZVDQGQJFPLQYLYR UDWDQGDQGQJFPLQYLWURUDWDQGKXPDQ([SRVXUHGXUDWLRQV ZHUHDQGKUIRUWKHUDWLQYLYRDQGLQYLWURDQGDQGKU IRUWKHKXPDQLQYLWUR7KHGRVHVDQGGXUDWLRQVRIH[SRVXUHZHUHMXGJHGVXIÀFLHQWO\ VLPLODUWRDOORZFRPSDULVRQRIWKHH[SHULPHQWDOUHVXOWV ,Q SDUWLFXODU WKH HYDOXDWLRQ GHWHUPLQHG WKDW WKH WHVW PDWHULDO DSSOLHG LQ HDFK VWXG\ ZDV LGHQWLFDO WKH GRVHV ZHUH HVVHQWLDOO\ LGHQWLFDO DQG FRPPRQ H[SRVXUH GXUDWLRQVZHUHXVHG7KXVRQHFDQFRPSDUHDQGFRQWUDVWWKHHQWU\LQWRDQGSDVVDJH WKURXJKWKHVNLQPHPEUDQHLQWKHWKUHHWHVWV\VWHPV
MATERIALS AND METHODS OF THE INDIVIDUAL STUDIES 'RVH SUHSDUDWLRQ ZDV DV IROORZV 'RVH SUHSDUDWLRQ ZDV WKH VDPH LQ WKH WKUHH VWXGLHV/\WKJRHDQG-RQHV&ORZHVDQG6FRWWDE 7KH IRXU GRVH OHYHOV FRUUHVSRQGLQJ WR WKH IRUPXODWLRQ FRQFHQWUDWH PJ DFH WRFKORUPO DQGWKUHHDTXHRXVGLOXWLRQVWKHUHRIQRPLQDOO\DQG)RU HDFKSUHSDUDWLRQWKHUHTXLUHGDPRXQWRIDPHWKDQROVWRFNVROXWLRQRI>&@ODEHOHG DFHWRFKORUZDVWUDQVIHUUHGWRDJODVVYLDODQGWKHVROYHQWHYDSRUDWHGXQGHUDVWUHDP RI QLWURJHQ 7KH DPRXQW RI XQODEHOHG DFHWRFKORU UHTXLUHG WR JLYH WKH DSSURSULDWH VSHFLÀFDFWLYLW\ZDVDGGHGWRWKHYLDODQGPL[HGZLWKWKHUDGLRODEHOHGPDWHULDO7KH UHTXLUHGEODQNIRUPXODWLRQZDVWKHQDGGHGDQGDOORZHGWRPL[ZLWKWKHDFHWRFKORU )LQDOO\WKHUHTXLUHGDPRXQWRIGHLRQL]HGZDWHUZDVDGGHGDQGWKHVXVSHQVLRQPL[HG E\VWLUULQJ,QWKHFDVHRIWKHGLOXWLRQZKLFKFRQWDLQHGQRXQODEHOHGDFHWRFKORU WKLVSURFHGXUHZDVIROORZHGE\VRQLFDWLRQIRUPLQXWHVWRDVVLVWGLVSHUVLRQ
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¶2· ULQJV ZHUH JOXHG WR WKH VNLQ VXUIDFH RQH
210
ALTERNATIVE TOXICOLOGICAL METHODS
EHKLQGHDFKVKRXOGHUXVLQJF\DQRDFU\ODWHJOXH7KHLQWHUQDOVXUIDFHRIVNLQHQFRP SDVVHGE\HDFKULQJZDVDSSUR[LPDWHO\FP$4XHHQ$QQSODVWLFFROODUZDVVHFXUHG DURXQGWKHQHFNRIHDFKDQLPDODQGWKHUDWVWUDQVIHUUHGWRLQGLYLGXDOVWDLQOHVVVWHHO PHWDEROLVPFDJHV 8VLQJDQOFDSDFLW\SRVLWLYHGLVSODFHPHQWSLSHWWHDQGGLVSRVDEOHSRO\SURS\OHQH WLSV QO RI GRVH VXVSHQVLRQ ZDV DSSOLHG WR WKH VNLQ VXUIDFH ZLWKLQ RQH ¶2· ULQJ DQGZDVVSUHDGRYHUWKHFPDSSOLFDWLRQDUHDXVLQJWKHVLGHDQGHQGRIWKHSLSHWWH WLSZKLFKZDVUHWDLQHGIRUDQDO\VLV 7KHDSSOLHGVXVSHQVLRQZDVDOORZHGWRGU\7KHDSSOLFDWLRQVLWHZDVWKHQSURWHFWHG E\DSSO\LQJF\DQRDFU\ODWHJOXHDURXQGWKHVXUIDFHRIWKH¶2·ULQJDQGVXSHULPSRVLQJ DVHFRQGVLPLODUUXEEHU¶·ULQJFRYHUHGZLWKDÀQHSHUPHDEOHQ\ORQJDX]HQP EROWLQJ FORWK JOXHG WR WKH VXUIDFH RI WKH ULQJ ZLWK %RVWLN )RU WKH GLOXWLRQ H[SHULPHQW WKH Q\ORQ JDX]H ZDV UHSODFHG ZLWK DQ DFWLYH FKDUFRDO ÀOWHU SDG 7KLV GRVLQJ SURFHGXUH ZDV WKHQ UHSHDWHG IRU WKH VHFRQG DSSOLFDWLRQ VLWH 5DGLRDFWLYLW\ LQRQWKHSLSHWWHWLSVZDVGHWHUPLQHGIRUGRVHTXDQWL]DWLRQ$QLPDOVZHUHUHWXUQHG WRWKHPHWDEROLVPFDJHVDQGXULQHDQGIHFHVFROOHFWHGIRUWKHGXUDWLRQRIH[SRVXUH $W DQG KRXUV IRXU DFFHSWDEOH UDWV ZHUH VHOHFWHG DQG ZHUH DQDHVWKHWL]HGZLWK)/827+$1(YDSRU$QLPDOVZLWKGHWDFKHGRUEDGO\GDPDJHG SURWHFWLYHULQJVZHUHGHHPHGXQDFFHSWDEOHDQGZHUHH[FOXGHGIURPWKHVWXG\ )RUHDFKUDWWKHQ\ORQJDX]HRUFDUERQÀOWHUVFRYHULQJERWKDSSOLFDWLRQVLWHVZHUH GHWDFKHGDQGUHWDLQHGLQDVLQJOHYLDO7KHVNLQVXUIDFHZDVFDUHIXOO\ZDVKHGZLWKD DTXHRXV VROXWLRQ RI 7HHSRO/ XVLQJ FRWWRQ ZRRO VZDEV 7KH VNLQ VXUIDFH ZDV WKHQULQVHGZLWKZDWHUZKLFKZDVDOVRUHFRYHUHGRQFRWWRQZRROVZDEV$OOVZDEV XVHG WR ZDVK HDFK DQLPDO ZHUH UHWDLQHG LQ D VLQJOH YLDO DQG ZHUH UHWDLQHG IRU UDGLRDFWLYLW\DQDO\VLV
$EORRGVDPSOHZDVWDNHQE\FDUGLDFSXQFWXUHDQGWKHDQLPDOVDFULÀFHG5HVLG XDOXULQHZDVUHPRYHGIURPWKHEODGGHUDQGDGGHGWRWKHXULQHFROOHFWLRQ 7KHUXEEHU¶2·ULQJVZHUHGHWDFKHGIURPWKHVNLQVXUIDFHDQGZHUHUHWDLQHGLQWKH VDPH YLDO DV WKH Q\ORQ JDX]H FRYHUV IRU VXEVHTXHQW VROYHQW H[WUDFWLRQ7KH UXEEHU ¶2· ULQJV IURP WKH GLOXWLRQ H[SHULPHQW ZHUH UHWDLQHG DQG H[WUDFWHG LQ D VHSDUDWH YLDO7KH VNLQ HQFRPSDVVLQJ ERWK DSSOLFDWLRQ VLWHV ZDV WKHQ UHPRYHG DQG WUDQVIHUUHGWRDVLQJOHYLDOIRUHDFKDQLPDO
7KHUHVLGXDOFDUFDVVZDVUHWDLQHGIRUDQDO\VLV )RU HDFK UDW LQ WKH IRUPXODWLRQ FRQFHQWUDWH PJJ DTXHRXV GLOXWLRQ PJJ DQG DTXHRXV GLOXWLRQ PJJ WKH IROORZLQJ VDPSOHV ZHUH DQDO\]HGVNLQZDVKSURWHFWLYHFRYHUVNLQDSSOLFDWLRQVLWH XULQHIHFHVFDJHZDVK DQGFDUFDVV)RUWKHDTXHRXVGLOXWLRQPJJ WKHUXEEHU¶2·ULQJVDQG FDUERQÀOWHUZHUHDQDO\]HGVHSDUDWHO\ 7KHHSLGHUPDOPHPEUDQHXVHGLQWKHVHVWXGLHVZHUHSUHSDUHGDVIROORZV&ORZHV DQG6FRWWD
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
211
5DWV ZHUH NLOOHG ZKHQ WKH\ ZHUH RU GD\V RI DJH ZHLJKW ² J E\ )/827+$1( DQHVWKHVLD IROORZHG E\ FHUYLFDO GLVORFDWLRQ DQG IXU IURP WKH GRUVR OXPEDUUHJLRQUHPRYHGXVLQJDQLPDOFOLSSHUVHQVXULQJWKDWWKHVNLQZDVQRWGDPDJHG 7KHFOLSSHGDUHDRIVNLQZDVH[FLVHGDQGDQ\VXEFXWDQHRXVIDWUHPRYHG7KHVNLQV ZHUH VRDNHG IRU ² KRXUV LQ 0 VRGLXP EURPLGH WKHQ WKH HSLGHUPLV ZDV FDUHIXOO\SHHOHGIURPWKHGHUPLV
(DFK HSLGHUPDO PHPEUDQH ZDV JLYHQ DQ LGHQWLI\LQJ QXPEHU DQG VWRUHG RQ DOXPLQXP IRLO LQ D IUHH]HU DW ²r& XQWLO XVHG (SLGHUPDO VDPSOHV ZHUH XVHG ZLWKLQGD\VRISUHSDUDWLRQ 3HUFXWDQHRXVDEVRUSWLRQZDVVWXGLHGDVIROORZV&ORZHVDQG6FRWWD *ODVVGLIIXVLRQFHOOVLQZKLFKWKHHSLGHUPLVIRUPVDKRUL]RQWDOPHPEUDQHVHSDUDWLQJ GRQRURXWHU DQGUHFHSWRUFKDPEHUVZHUHXVHGIRUPHDVXULQJVNLQDEVRUSWLRQ FPRIHSLGHUPDOVXUIDFHZDVDYDLODEOHIRUDEVRUSWLRQDQGDOOH[SHULPHQWVZHUH FRQGXFWHGDWr&5HFHSWRUVROXWLRQVZHUHVWLUUHG
7KH YROXPH RI WKH FKDPEHU ZDV QRW VSHFLÀHG7KH LQWHJULW\ RI WKH PHPEUDQH ZDVDVVHVVHGDVIROORZV ,QLWLDOO\WKHLQWHJULW\RIDOOHSLGHUPDOPHPEUDQHVZDVHVWDEOLVKHGE\PHDVXUHPHQW RI WKHLU SHUPHDELOLW\ WR WULWLDWHG ZDWHU 0HPEUDQHV GLVSOD\LQJ SHUPHDELOLW\ FRHIÀ FLHQWV RI v ² FP KU² RU JUHDWHU ZHUH UHJDUGHG DV ¶GDPDJHG· DQG UHMHFWHG 7ULWLDWHGZDWHUZDVGHVRUEHGIURPWKHPHPEUDQHVE\FDUHIXOZDVKLQJRIWKHGRQRU UHFHSWRUFKDPEHUVZLWKVDOLQH7KHGRQRUFKDPEHUZDVOHIWRSHQWRWKHDWPRVSKHUH RYHUQLJKWDQGDSSUR[LPDWHO\POVDOLQHZDVOHIWLQWKHUHFHSWRUFKDPEHUWRPDLQWDLQ DKLJKUHODWLYHKXPLGLW\
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ÁXLGDQGWKHULQVLQJGLVFDUGHG7KHGRQRUFKDPEHUZDV SODFHGLQDPOEHDNHUDQGVRDNHGLQPOIUHVKUHFHSWRUÁXLGIRUDWOHDVWKU EHIRUHDVDPSOHQO ZDVWDNHQIRUDQDO\VLV5HVLGXDOGRQRUPDWHULDOZDVUHPRYHG IURPWKHH[SRVHGVXUIDFHRIWKHHSLGHUPLVE\ULQVLQJZLWKPO DOLTXRWRIZY 7((32//LQZDWHUXQWLOWKHUDGLRDFWLYLW\LQWKHULQVHZDVOHVVWKDQFSPLQD
212
ALTERNATIVE TOXICOLOGICAL METHODS
VDPSOHQO RIWKHPOULQVH7KHULQVLQJVZHUHFRPELQHGDQGWKHWRWDOYROXPH UHFRUGHG$VDPSOHQO ZDVDQDO\]HGE\OLTXLGVFLQWLOODWLRQFRXQWLQJ (DFKHSLGHUPLVPHPEUDQHZKLOVWVWLOODWWDFKHGWRWKHUHFHSWRUFKDPEHUZDVSODFHG LQ D PO JODVV EHDNHU DQG PO RI 6ROXHQH DGGHG WR FRYHU WKH HSLGHUPLV :KHQWKHHSLGHUPLVVDPSOHKDGGLVVROYHGDPOVDPSOHZDVDGGHGWR+LRQLF)ORXU LQDJODVVVFLQWLOODWLRQYLDODQGDQDO\]HGE\OLTXLGVFLQWLOODWLRQFRXQWLQJ
7KHIROORZLQJGHVFULEHWKHSUHSDUDWLRQRIVNLQVDPSOHVGRVHDGPLQLVWUDWLRQDQG VDPSOHFROOHFWLRQIRUWKHKXPDQLQYLWURVWXG\&ORZHVDQG6FRWWE $EGRPLQDO ZKROH VNLQ GHUPLV DQG HSLGHUPLV ZDV REWDLQHG SRVW PRUWHP IURP VXEMHFWVRIYDU\LQJDJHV)HPDOHVDPSOHVZHUHXVHGDVWKHPRUHGHQVHO\KDLUHGPDOH VDPSOHV ZHUH OHVV OLNHO\ WR JLYH LQWDFW HSLGHUPDO PHPEUDQHV DIWHU VHSDUDWLRQ 7KH HSLGHUPLVZDVUHPRYHGIURPWKHGHUPLVE\LPPHUVLRQRIWKHZKROHVNLQLQZDWHUDW r& IRU VHFRQGV IROORZHG E\ JHQWO\ WHDVLQJ WKH HSLGHUPLV IUHH7KH HSLGHUPDO PHPEUDQHVZHUHJLYHQXQLTXHLGHQWLI\LQJQXPEHUVDQGVWRUHGRQWLQIRLOLQDIUHH]HU XQWLOUHTXLUHG(SLGHUPLVVDPSOHVZHUHXVHGZLWKLQGD\VRISUHSDUDWLRQ *ODVVGLIIXVLRQFHOOVLQZKLFKWKHHSLGHUPLVIRUPVDKRUL]RQWDOPHPEUDQHVHSDUDWLQJ GRQRURXWHU DQGUHFHSWRUFKDPEHUVZHUHXVHGIRUPHDVXULQJVNLQDEVRUSWLRQ FP RI HSLGHUPDO VXUIDFH ZDV DYDLODEOH IRU DEVRUSWLRQ DQG DOO H[SHULPHQWV ZHUH FRQGXFWHGDWr&5HFHSWRUVROXWLRQVZHUHVWLUUHG
9ROXPHIRUWKHUHFHSWRUFKDPEHUZDVQRWVSHFLÀHG ,QLWLDOO\WKHLQWHJULW\RIDOOHSLGHUPDOPHPEUDQHVZDVHVWDEOLVKHGE\PHDVXUHPHQW RIWKHLUSHUPHDELOLW\WRWULWLDWHGZDWHU ,Q WKLV VWXG\ PHPEUDQHV GLVSOD\LQJ SHUPHDELOLW\ FRHIÀFLHQWV RI v ² FP KU² RUJUHDWHUZHUHUHJDUGHGDV¶GDPDJHG·DQGUHMHFWHG 7ULWLDWHGZDWHUZDVGHVRUEHGIURPWKHPHPEUDQHVE\FDUHIXOZDVKLQJRIWKHGRQRU UHFHSWRUFKDPEHUVZLWKVDOLQH7KHGRQRUFKDPEHUZDVOHIWRSHQWRWKHDWPRVSKHUH RYHUQLJKWDQGDSSUR[LPDWHO\POVDOLQHZDVOHIWLQWKHUHFHSWRUFKDPEHUWRPDLQWDLQ DKLJKUHODWLYHKXPLGLW\ $PHDVXUHGYROXPHRIYYHWKDQROZDWHUZDVSODFHGLQWRWKHUHFHSWRUFKDPEHUV RIWKHFHOOV7KH>&@DFHWRFKORUIRUPXODWLRQVZHUHDSSOLHGWRWKHPHPEUDQHVDWD UDWHRIQOFP² WRJLYHDFHWRFKORUGRVHUDWHVRI QJFP²QJFP² QJFP²DQGQJFP² 7KHDSSOLFDWLRQVZHUHVSUHDGRYHUWKHVNLQVXUIDFHXVLQJLQGLYLGXDOORRSVRIVLOLFRQH UXEEHUWXELQJPPLG ZKLFKZHUHDQDO\]HGIRUUDGLRDFWLYLW\DIWHUXVH $WWKHGHVLJQDWHGWLPHVDQGKRXUV WKHH[SRVXUHZDVWHUPLQDWHGE\UHPRYDO RIWKHGRQRUFKDPEHUDQGWKHUHFHSWRUVROXWLRQ7KHUHFHSWRUVROXWLRQZDVVDPSOHG DQGWKHUHPDLQGHUGLVFDUGHG7KHHPSW\UHFHSWRUFKDPEHUZDVULQVHGZLWKPORI
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
213
IUHVK UHFHSWRU ÁXLG DQG WKH ULQVLQJ GLVFDUGHG7KH GRQRU FKDPEHU ZDV SODFHG LQ D PO EHDNHU DQG VRDNHG LQ PO IUHVK UHFHSWRU Á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
RESULTS OF THE STUDIES 7KHVWXG\UHSRUWVZHUHUHYLHZHGE\WKHÀ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
34.1 32.3 34.9 31.1 22.1 15.1
212.0 204.9 216.9 218.5 190.4
2571.9 2175.7 2322.7 2260.1 2261.4 1788.9
0.5 1 2 4 10 24
0.5 1 2 4 10
0.5 1 2 4 10 24
285.9 405.4 355.2 502.7 435.5 627.2
24.2 21.7 23.7 21.0 28.2
3.0 3.2 4.1 4.9 5.6 8.1
0.2 0.2 0.2 0.2 0.3 0.4
Cover
— — — — — —
— — — — —
— — — — — —
0.1 0.1 0.2 0.3 0.4 0.7
Carbon Filter
74.2 95.2 98.9 93.3 88.3 86.0
9.2 8.7 13.3 8.7 10.8
1.4 1.3 1.2 1.2 1.2 0.9
0.1 0.2 0.2 0.2 0.3 0.4
0.3 0.3 0.1 0.1 0.2 47.9
0.01 0.01 0.01 0.01 0.1
270 Qg/cm2 3.40 0.01 3.21 0.02 4.91 0.02 3.21 0.7 3.99 3.5 2934 Qg/cm2 2.53 0.1 3.24 0.2 3.37 0.5 2.18 2.3 3.01 15.2 2.92 97.1
0.001 0.001 0.005 0.003 0.3 2.1
0.001 0.001 0.001 0.001 0.01 0.2
Feces
42 Qg/cm2 3.18 0.004 2.99 0.02 2.78 0.02 2.81 0.2 2.66 2.1 1.83 5.5
0.01 0.01 0.01 0.02 0.2 0.5
Urine
3 Qg/cm2 4.00 6.00 7.17 7.93 9.63 12.53
Skin Qg/cm2 %
Absorbed is sum of urine, feces, cage wash, and carcass. Source: Lythgoe, 1990a.
a
0.22 2.2 2.0 1.8 1.2 0.9
Wash
0.5 1 2 4 10 24
Exposure (hr)
0.4 0.2 0.6 1.1 1.6 8.4
0.04 0.05 0.05 0.06 0.56
0.01 0.01 0.3 0.01 0.4 0.6
0.001 0.001 0.001 0.01 0.01 0.02
Cage Wash
40.3 150.9 98.5 74.8 114.3 216.7
12.9 15.1 8.1 12.3 21.1
1.7 2.5 1.8 3.6 7.0 4.4
0.1 0.1 0.2 0.3 0.4 0.2
Carcass
40.9 153.04 99.6 78.3 131.3 369.9
12.9 15.2 8.2 13.0 25.2
1.7 2.5 1.9 3.9 9.8 12.6
0.1 0.1 0.2 0.3 0.6 0.9
1.39 5.22 3.39 2.67 4.47 12.61
4.79 5.63 3.03 4.83 17.52
3.95 5.98 4.38 9.24 23.06 29.64
3.79 4.28 7.32 9.93 19.55 31.37
Absorbed Qg/cm2 %
Table 18.1 Acetochlor In Vivo (Mean dose distribution as Qg equivalents of acetochlor per cm2. Mean of four male rats.)
214 ALTERNATIVE TOXICOLOGICAL METHODS
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
215
Table 18.2 Acetochlor In Vitro (Mean dose distribution in vitro dermal absorption in rat skin. Mean of four to seven skin samples. Results presented as Qg/cm2.) Exposure (hr)
Absorbed Qg/cm2 %
Wash
Skin Qg/cm2 %
Donor
Loop
3.60 3.77 3.84 2.98 2.52 2.75
0.08 0.04 0.03 0.05 0.01 0.02
0.55 0.44 0.50 0.43 0.59 0.41
2.30 2.47 3.09 2.28 2.11 1.73
1.41 0.97 0.57 0.58 0.78 0.14
1.03 1.02 1.25 1.38 0.98 1.21
4.06 5.22 8.84 5.09 7.11 4.53
10.5 14.3 19.4 4.41 5.59 5.52
13.4 16.7 8.25 11.6 11.6 13.3
Total Recovered
3.02 Qg/cm2 0.05 1 2 4 10 24
0.41 0.82 1.14 1.37 2.15 2.12
13.68 27.12 37.78 45.30 71.19 70.13
1.73 1.32 0.95 0.80 0.17 0.13
0.11 0.11 0.12 0.09 0.08 0.08
2.89 2.73 2.73 2.75 2.99 2.77
47.3 Qg/cm2 0.5 1 2 4 10 24
2.02 3.90 10.3 16.0 20.7 28.7
4.27 8.25 21.78 33.83 43.76 60.68
25.6 28.2 18.7 13.6 7.1 2.9
1.09 1.17 1.46 1.08 1.00 0.79
31.1 35.3 32.2 32.7 30.6 33.7
318 Qg/cm2 0.5 1 2 4 10 24
6.58 21.4 33.4 80.9 182 246
2.07 6.73 10.50 25.44 57.23 77.36
283 383 261 262 158 67
12.9 16.6 28.1 16.2 22.6 14.4
325 452 350 375 379 347
3095 Qg/cm2 1 2 4 10 24
17 104 137 264 757
0.55 3.36 4.43 8.53 24.46
2411 3146 2103 2344 1598
143 187 111 196 202
4.62 6.04 3.59 6.33 6.53
311 313 316 294 182
118 138 161 156 127
2999 3858 2828 3253 2866
Note: The 0.5-hr exposure was not performed at the high dose. Source: Clowes and Scott, 1990a.
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
216
ALTERNATIVE TOXICOLOGICAL METHODS
Table 18.3 Acetochlor In Vitro (Mean dose distribution in vitro dermal absorption in human skin. Mean of six skin samples. Results expressed as Qg/cm2.) Exposure (hr)
Absorbed Qg/cm2 %
Wash
Skin Qg/cm2 %
Donor
Loop
Total Recovered
3.02 Qg/cm2 2 10 24
0.015 0.074 0.261
0.486 2.44 8.63
2.36 2.61 1.54
0.273 0.271 0.092
9.04 9.98 3.03
0.035 0.136 0.098
0.359 0.194 0.244
3.12 3.86 2.80
2.61 2.31 3.09
3.04 3.28 2.24
47.3 Qg/cm2 2 10 24
0.140 1.70 3.63
0.296 3.59 7.68
34.2 30.4 26.2
1.89 4.43 1.63
3.99 9.37 3.45
41.9 42.7 37.4
318 Qg/cm2 2 10 24
0.816 5.69 43.6
0.256 1.79 13.7
239 221 245
18.9 12.1 18.2
5.94 3.82 5.72
70.4 91.8 62.3
22.4 15.8 15.8
352 347 384
3095 Qg/cm2 2 10 24
4.57 22.4 32.5
0.148 0.722 1.05
2796 2057 1669
51.5 80.5 38.4
1.67 2.60 1.24
772 896 671
260 259 217
3884 3314 2628
Source: Clowes and Scott, 1990b.
DISCUSSION 7KHVWXGLHVZHUHZHOOGHVLJQHGZHOOSHUIRUPHGDQGZHOOUHSRUWHG7KH\VDWLVÀ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
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
217
Table 18.4 Comparison of the Percent Absorbed In Vitro and In Vivo in Rat Skin; Data Are from Tables 18.1 and 18.2 Dose Qg/cm2) (Q
0.5
1.0
2.0
4.0
10.0
24.0
Exposure Duration (hr) 3.0 in vivo 3.02 in vitro 42.5 in vivo 47.3 in vitro 270 in vivo 318 in vitro 2934 in vivo 3095 in vitro
3.8 13.7 4.0 4.3 4.8 2.1 1.4 —
4.3 27.1 6.0 8.2 5.6 6.7 5.2 0.6
7.3 37.8 4.4 21.8 3.0 10.5 3.4 3.4
9.9 45.3 9.2 33.8 4.8 25.4 2.7 4.4
19.5 71.2 23.1 43.8 9.3 57.2 4.5 8.5
31.4 70.1 29.6 60.7 17.5 77.4 12.6 24.5
4.6 3.7 5.3 1.6
3.7 1.9 6.2 1.9
2.2 2.1 4.4 1.9
Ratio in Vitro/in Vivo 3.02/3.0 47.3/42.4 318/270 3095/2934
3.6 1.1 0.4 —
Dose 1 Dose 2
6.3 1.4 1.2 0.1
5.2 5.0 3.5 1.0
Dose 3 Dose 4
7 6
Ratio vitro/vivo
5 4 3 2 1 0 0
5
10
15
20
25
Exposure (h)
Figure 18.1 The ratio of the in vitro absorption to the in vivo absorption with exposure duration in the rat. Dose ratios 1, 2, 3, and 4 are in order of low dose ratio to high dose ratio. Data are from Table 18.4.
DV\VWHPDWLFHUURULQWKHLQYLWURSURFHGXUH7KLVLQGLFDWHVWKDWWKHSURFHGXUHPD\ QRWEHFRUUHFWDEOH7KHGDWDVWURQJO\VKRZWKDWWKHSURFHGXUHLVQRWUHDG\WRHQWHU WKHWHVWYDOLGDWLRQVWHS :HKDYHQRKXPDQLQYLYRGDWDWRFRPSDUHZLWKWKHKXPDQ LQYLWURGDWDDQGVR FDQQRW GLUHFWO\ DVVHVV LWV YDOLGLW\ +RZHYHU WKH SRLQW KDV EHHQ UDLVHG WKDW HYHQ LI LQ YLWURGDWDGRQRWPDWFKLQYLYRRQHPD\FRPSDUHUDWDQGKXPDQLQYLWURGDWDWRREWDLQ
218
ALTERNATIVE TOXICOLOGICAL METHODS
Table 18.5 Comparison of the Percent Absorbed In Vitro in Rat and Human Epidermal Membrane Preparations; Data Are from Tables 18.2 and 18.3 Dose Qg/cm2) (Q
2.0
10.0
24.0
Exposure Duration (hr) 3.03 rat human 47.3 rat human 318 rat human 3095 rat human
37.8 0.49 21.8 0.30 10.5 0.26 3.4 0.15
71.2 2.44 43.8 3.59 57.2 1.79 8.5 0.72
70.1 8.63 60.7 7.68 77.4 13.7 24.5 1.05
Ratio Rat/Human 3.03 47.3 318 3095
77.1 72.7 40.4 22.7
29.2 12.2 32.0 11.8
8.1 7.9 5.6 23.3
D UDW WR KXPDQ DEVRUSWLRQ FRQYHUVLRQ IDFWRU ,W LV JHQHUDOO\ DFFHSWHG WKDW UDW VNLQ LV PRUH SHUPHDEOH WR FKHPLFDOV WKDQ KXPDQ LQ WKH RUGHU RI WKUHH WR ÀYH WLPHV PRUH SHUPHDEOH$FRQYHUVLRQIDFWRUZRXOGHQDEOHRQHWRFRQYHUWUDWGHUPDOWR[LFLW\GDWDWR KXPDQGHUPDOWR[LFLW\7KHSHUFHQWRIGRVHDEVRUEHGLQYLWURLQWKHUDWDQGLQWKHKXPDQ HSLGHUPDOPHPEUDQHSUHSDUDWLRQDQGWKHLUUDWLRDUHSUHVHQWHGLQ7DEOH7KHUDWLRV RILQYLWURUDWWRLQYLWURKXPDQIRUHDFKGRVHDUHSORWWHGLQ)LJXUHDVUDWLRDJDLQVW vitro R/H 47.3 wg/cm2 vitro R/H 318 wg/cm2 vitro R/H 3095 wg/cm2
80 70
Ratio rat/human
60 50 40 30 20 10 0 0
5
10
15
20
25
Duration of Exposure (h)
Figure 18.2 The ratio of the rat in vitro absorption to the human in vitro absorption with exposure duration. Dose ratios 1, 2, 3, and 4 are in order of low dose ratio to high dose ratio. Data are from Table 18.5.
VALIDATING IN VITRO DERMAL ABSORPTION STUDIES
219
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
REFERENCES $QRQ0D\ 'UDIW2(&'*XLGHOLQHIRUWKH7HVWLQJRI&KHPLFDOV3URSRVDOIRUD1HZ *XLGHOLQH 'HUPDO 'HOLYHU\ DQG 3HUFXWDQHRXV$EVRUSWLRQ LQ YLWUR 0HWKRG 3DULV 2(&' %DOOV 0 %ODDLERHU % %UXVLFN ' HW DO 5HSRUW DQG UHFRPPHQGDWLRQV RI WKH &$$7(5*$77ZRUNVKRSRQWKHYDOLGDWLRQRIWR[LFRORJ\WHVWSURFHGXUHV$OW/DE $QLP² &ORZHV+0DQG6FRWW5&D $FHWRFKORULQYLWURSHUFXWDQHRXVDEVRUSWLRQWKURXJK 6SUDJXH 'DZOH\ UDW HSLGHUPLV IURP IRUPXODWLRQ :) ,&, &HQWUDO 7R[LFRORJ\ /DERUDWRU\ UHSRUW QXPEHU -9, &7/3 05,' DYDLODEOH IURP 3XEOLF'RFNHWDQG)UHHGRPRI,QIRUPDWLRQ2IÀFH)LHOG2SHUDWLRQV'LYLVLRQ& 2IÀFH RI 3HVWLFLGH 3URJUDPV 86 (QYLURQPHQWDO 3URWHFWLRQ $JHQF\ 0 6W :DVKLQJWRQ'& &ORZHV+0DQG6FRWW5&E $FHWRFKORULQYLWURSHUFXWDQHRXVDEVRUSWLRQWKURXJK KXPDQHSLGHUPLVIURPIRUPXODWLRQ:)UHSRUWQXPEHU&7/3-9, 05,'DYDLODEOHIURP3XEOLF'RFNHWDQG)UHHGRPRI,QIRUPDWLRQ2IÀFH )LHOG2SHUDWLRQV'LYLVLRQ& 2IÀFHRI3HVWLFLGH3URJUDPV86(QYLURQPHQWDO 3URWHFWLRQ$JHQF\06W:DVKLQJWRQ'& /\WKJRH5(DQG-RQHV%. $FHWRFKORULQYLYRSHUFXWDQHRXVDEVRUSWLRQVWXG\LQ WKH UDW ,&, &HQWUDO 7R[LFRORJ\ /DERUDWRU\ UHSRUW QXPEHU &7/3 85205,' DYDLODEOHIURP3XEOLF'RFNHWDQG)UHHGRPRI,QIRU PDWLRQ2IÀFH)LHOG2SHUDWLRQV'LYLVLRQ& 2IÀFHRI3HVWLFLGH3URJUDPV86 (QYLURQPHQWDO3URWHFWLRQ$JHQF\06W:DVKLQJWRQ'& =HQG]LDQ53 *XLGHOLQHIRU'HUPDO$EVRUSWLRQRI3HVWLFLGHV3%²1DWLRQDO 7HFKQLFDO,QIRUPDWLRQ6HUYLFH)URQW5R\DO5G6SULQJÀHOG9$
CHAPTER
19
A Molecular Diagnostic Approach to Irritant or Allergic Patch Testing Using the DermPatch 0HOLVVD0)LW]JHUDOG9HUD%0RUKHQQ6WDFH\%+XPSKUH\ 1LUPDOD-D\DNXPDUDQG/DZUHQFH$5KHLQV
CONTENTS %DFNJURXQG 0DWHULDOVDQG0HWKRGV 7DSH6WULSSLQJDQG([WUDFWLRQRI7RWDO51$ 5LERQXFOHDVH3URWHFWLRQ$VVD\ ,QGXFWLRQRI(U\WKHPDWRXV5HDFWLRQVRQWKH6NLQ 5HVXOWV 'LVFXVVLRQ 5HIHUHQFHV
BACKGROUND (OXFLGDWLRQRIWKHPROHFXODUHYHQWVWKDWOHDGWRLUULWDQWFRQWDFWGHUPDWLWLV,&' RU DOOHUJLF FRQWDFW GHUPDWLWLV $&' LQ KXPDQ VNLQ ZLOO EH KHOSIXO LQ GHYHORSLQJ PHFKDQLVWLFWR[LFRORJLFDODVVD\VWKDWSHUPLWWKHUHGXFWLRQUHÀQHPHQWRUUHSODFH PHQW RI DQLPDOV LQ SURGXFW VDIHW\ WHVWLQJ 7KH ÀUVW DOWHUQDWLYH WR[LFRORJLFDO WHVW DSSURYHGE\,&&9$0ZDVDPHFKDQLVWLFWHVWWKHPXULQHORFDOO\PSKQRGHDVVD\ 0//1$ ZKLFKUHSODFHGWKHJXLQHDSLJPD[LPL]DWLRQWHVWLQ7KH0//1$ PHDVXUHVO\PSKRF\WHSUROLIHUDWLRQWKURXJK+PHWK\OWK\PLGLQHXSWDNHLQWKHGUDLQ LQJ O\PSK QRGHV RI DQLPDOV WRSLFDOO\ H[SRVHG WR WKH WHVW DUWLFOH 6LQFH WKH WHVW LV EDVHGRQHYHQWVRFFXUULQJGXULQJWKHLQGXFWLRQSKDVHRIDOOHUJLFFRQWDFWGHUPDWLWLV
; E\&5&3UHVV//&
221
222
ALTERNATIVE TOXICOLOGICAL METHODS
Table 19.1 Skin Cytokins (adapted from Gerberick et al., 1998) Cytokines IL-1E IL-1F IL-3 IL-6 IL-7 IL-8 IL-10 IL-12 IL-15 G-CSF M-CSF GM-CSF TGF-E TGF-F TNF-E MIP-1E MIP-1F IP-10
Constitutive or inducible expression in Langerhans cells Keratinocytes Fibroblasts – + – + – – – –
+ – + + + + +
– – – – + – + + –
+ + + + + + – + +
+ + + – + – + + + – + – + – – – +
WKH DQLPDO GRHV QRW KDYH WR GHYHORS DQG VXIIHU IURP DQ DOOHUJLF VNLQ UHDFWLRQ &RPSDUHGZLWKWKHJXLQHDSLJPD[LPL]DWLRQDVVD\WKH0//1$UHGXFHVWKHQXPEHU RIDQLPDOVE\KDOIDQGWKHWHVWLQJWLPHIURPZHHNVWRZHHN$OLPLWDWLRQRIWKH 0//1$LVGLIÀFXOW\LQGHWHFWLQJVWURQJLUULWDQWVDQGGLIÀFXOW\LQGLVFHUQLQJFRQWDFW DOOHUJ\ LQGXFHG E\ PHWDOV7KH ,&&9$0 UHFRPPHQGHG WKDW IXWXUH LPSURYHPHQWV WR WKH 0//1$ VKRXOG LQFOXGH DOWHUQDWLYH HQGSRLQWV VXFK DV F\WRNLQH SURGXFWLRQ 1DWLRQDO7R[LFRORJ\3URJUDP &\WRNLQHVDUHJO\FRSURWHLQVWKDWLQGXFHDQGUHJXODWHFHOOJURZWKGLYLVLRQGLI IHUHQWLDWLRQDQGPRYHPHQW,QDGGLWLRQF\WRNLQHVKDYHEHHQVKRZQWREHLQYROYHG LQLQÁDPPDWRU\UHDFWLRQVDQGRWKHUGLVHDVHVWDWHV7KHUROHRIF\WRNLQHVLQGHUPD WRWR[LFRORJ\ KDV EHHQ UHYLHZHG E\ *HUEHULFN HW DO 7DEOH VKRZV WKH YDULRXVFHOOW\SHVWKDWDUHFDSDEOHRISURGXFLQJF\WRNLQHVLQWKHVNLQ 7DEOHFRPSDUHVF\WRNLQHSURÀOHVIRULUULWDQWYHUVXVDOOHUJLFFRQWDFWGHUPD WLWLVREWDLQHGIURPVWXGLHVXVLQJVNLQELRSVLHVRUFHOOFXOWXUHV$OWKRXJKDQXPEHU RI F\WRNLQHV DSSHDU WR EH XSUHJXODWHG LQ WKH WZR W\SHV RI FRQWDFW GHUPDWLWLV LW LV QRW\HWFOHDUZKDWPDUNHUVGLVWLQJXLVK,&'IURP$&'RUZKHWKHUGLIIHUHQWSURÀOHV ZLOO UHVXOW DFURVV FKHPLFDO FODVVHV RI LUULWDQWV RU DOOHUJHQV :KHQ XVLQJ UHYHUVH WUDQVFULSWDVHSRO\PHUDVHFKDLQUHDFWLRQ573&5 WRDPSOLI\P51$REWDLQHGIURP SXQFK ELRSVLHV WKH FHOOXODU VRXUFH RI WKH P51$ LV XQFOHDU VLQFH WKH VNLQ WLVVXH FRQWDLQVERWKGHUPDODQGHSLGHUPDOFHOOV7KHGRVHRIDQLUULWDQWFDQLQÁXHQFHWKH F\WRNLQHSURÀOHDGRVHGHSHQGHQWLQFUHDVHLQ,/DQG,/KDVEHHQREVHUYHGIRU WKHLUULWDQWVRGLXPODXU\OVXOIDWHXVLQJDKXPDQVNLQHTXLYDOHQWPRGHO3RQHFDQG .HPSHQDDU *HQH H[SUHVVLRQ SURÀOHV DUH OLNHO\ WR YDU\ GHSHQGLQJ RQ WKH GHOD\ EHWZHHQ WKH VDPSOLQJ WLPH DQG WKH WLPH RI LQLWLDO FRQWDFW ZLWK D VXEVWDQFH )LQDOO\ JHQHWLF YDULDWLRQ DFURVV LQGLYLGXDOV ZLOO DOVR LQÁXHQFH JHQH H[SUHVVLRQ SURÀOHVLQWKHVNLQLQKXPDQFOLQLFDOVWXGLHVRI,&'DQG$&'
IRRITANT OR ALLERGIC PATCH TESTING USING THE DERMPATCH
223
Table 19.2 mRNA Cytokine Profiles from Human Skin Biopsy or Human Cell Samples
TNF-E IFN-K IL-2 GM-CSF IL-1E (human cells) IL-1F (human cells) IL-4 IL-6 IL-10 IL-12 p35 (human cells) IL-12 p40 (human cells)
ACD
ICD
increased increased increased increased dependent on allergen increased increased increased increased no change increased
increased increased increased increased increased increased not determined not determined no change no change no change
Source: Adapted from Wakem and Gaspari, 2000.
$WKRURXJKUHYLHZRIWKHPHFKDQLVPVRI,&'DQG$&'ZDVZULWWHQE\:DNHP DQG *DVSDUL 7DEOH VXPPDUL]HV VDOLHQW IHDWXUHV RI ,&' DQG $&' $OWKRXJK WKHLU PHFKDQLVPV DSSHDU WR EH VLPLODU LW PD\ EH SRVVLEOH WR GLVFHUQ IXQGDPHQWDO GLIIHUHQFHV EHWZHHQ ,&' IURP$&' DW WKH PROHFXODU OHYHO E\ JHQH H[SUHVVLRQSURÀOLQJVWXGLHV 5HYLHZVRIPHWKRGVIRUWHVWLQJWKHLUULWDWLRQDQGVHQVLWL]DWLRQSRWHQWLDORIVXE VWDQFHV KDYH EHHQ SUHSDUHG E\ 0DLEDFK DQG FRZRUNHUV 0DU]XOLL DQG 0DLEDFK 3DWLOHWDO%DVKLUDQG0DLEDFK %RWKWKH'UDL]HWHVWIRUSUH GLFWLQJVNLQLUULWDWLRQDQGWKHPRGLÀHG'UDL]HWHVWIRUGHWHUPLQLQJVNLQVHQVLWL]DWLRQ SRWHQWLDO DUH EDVHG RQ YLVXDO JUDGLQJ VFDOHV +RZHYHU LW LV IUHTXHQWO\ GLIÀFXOW WR GLVWLQJXLVKLUULWDQWIURPLPPXQRORJLFDOUHDFWLRQVRIWKHVNLQHLWKHUFOLQLFDOO\RUE\ URXWLQHKLVWRORJLFDOH[DPLQDWLRQ7DEOH ,QKXPDQFOLQLFDOVWXGLHVXVLQJSDWFKWHVWVZLWKVHOHFWHGLUULWDQWVDQGDOOHUJHQV ZHKDYHREWDLQHGP51$HQFRGLQJF\WRNLQHVIURPHSLGHUPDOFHOOVLVRODWHGZLWKD QRQLQYDVLYHDGKHVLYHWDSHVWULSSLQJPHWKRGRORJ\WKH'HUP3DWFK 0RUKHQQHWDO *HQHH[SUHVVLRQSURÀOHVRIVNLQFHOOVREWDLQHGZLWKWKH 'HUP3DWFKFDQEH Table 19.3 Mechanisms of Irritant versus Allergic Contact Dermatitis Feature Chemical agents Concentration of the agent Genetic predisposition Sensitization and lag period Trigger Cytokine release T-cell activation Mast-cell activation Langerhans’ cells Eicosanoid production
Allergic
Irritant
low molecular weight, lipid soluble less critical ++++ necessary interaction of antigen with primed T cells ++++ early ++++ ++ increased ++
acids, alkalies, surfactants, solvents, oxidants, enzymes more critical ++ not necessary damage to keratinocytes
Source: Adapted from Marks and DeLeo.
+++ later ++++ ++ decreased ++
224
ALTERNATIVE TOXICOLOGICAL METHODS
Table 19.4 Clinical and Histological Aspects of Contact Dermatitis Feature
Allergic
Irritant
Itch Pain, burning Erythema Vesicles Pustules Hyperkeratosis Fissuring Sharp demarcation Reaction delay after contact Spongiosis Dermal edema Necrotic keratinocytes Ballooning degeneration Lymphocytic infiltrate Neurotrophilic infiltrate
++++ (early) ++ ++++ ++++ + ++ ++ yes days ++++ ++++ ++++ + ++++ +
+++ (late) ++++ (early) ++++ + +++ +++ ++++ yes minutes to hours ++++ ++++ ++++ +++ ++++ +++
Source: Adapted from Marks and DeLeo.
DQDO\]HGE\VWDQGDUGPROHFXODUELRORJ\WHFKQLTXHVVXFKDVWKHULERQXFOHDVHSURWHF WLRQDVVD\53$ TXDQWLWDWLYHUHYHUVHWUDQVFULSWDVHSRO\PHUDVHFKDLQUHDFWLRQ4 573&5 RUJHQHDUUD\WHFKQRORJ\
MATERIALS AND METHODS Tape Stripping and Extraction of Total RNA 7KH XVH RI WDSH VWULSSLQJ WR UHPRYH VPDOO TXDQWLWLHV RI HSLGHUPLV ZDV LQLWLDOO\ GHVFULEHGE\:ROI /DWHUWKHWHFKQLTXHZDVPRGLÀHGWRUHPRYHWKHXSSHUOD\HUV RIWKHHSLGHUPLVLQURGHQWVLQDQDWWHPSWWRLVRODWH/DQJHUKDQVFHOOV6WUHLOHLQHWDO :HKDYHXVHGWKHWDSHVWULSSLQJWHFKQLTXHWRLVRODWHHSLGHUPDOFHOOIUDJPHQWV 8VLQJWKLVPHWKRGRQHFDQLVRODWHVPDOODPRXQWVRI51$'1$SURWHLQRUOLSLGV IURPRQHDQGWKHVDPHVNLQKDUYHVWLQJSURFHGXUH6NLQFHOOVZHUHUHPRYHGXVLQJ' 6TXDPH¤ WDSH &X'HUP 'DOODV 7; WR VWULS WKH VNLQ·V FHOO OD\HUV 7KH VNLQ ZDV VWULSSHG PXOWLSOH WLPHV ZLWK WKH WDSH WR REWDLQ HSLGHUPDO IUDJPHQWV7KH ÀUVW WKUHH WDSHVWULSVZHUHGLVFDUGHGDQGWKHVXEVHTXHQWWDSHVWULSVZHUHH[WUDFWHG(DFKWDSH ZDVWKHQSODFHGLQDQ51DVHIUHH(SSHQGRUI¤WXEHFRQWDLQLQJPORI7UL5HDJHQW 0ROHFXODU5HVHDUFK&HQWHU,QF&LQFLQQDWL2+ 51$IURPWDSHVXVHGDWWKHVDPH VNLQVLWHZDVH[WUDFWHGZLWKDQGSRROHGLQWKHVDPHDOLTXRWRI7UL5HDJHQW7KH51$ WKHQZDVH[WUDFWHGE\YRUWH[LQJDQGFHQWULIXJLQJWKHWDSHV LQWKH(SSHQGRUI¤WXEH Ribonuclease Protection Assay 7KH53$KDVEHHQGHVFULEHGE\*LOPDQ 7KLVDVVD\PDNHVXVHRIWKH IDFWWKDWP51$DWRQHSRLQWLQLWVOLIHF\FOHH[LVWVDVDVLQJOHVWUDQGHGPROHFXOH $WWKLVVWDJHWKHP51$RILQWHUHVWFDQEH´SURWHFWHGµE\DOORZLQJLWWRELQGWR D ODEHOHG DQWLVHQVH PROHFXOH WKDW KDV EHHQ SUHSDUHG SUHYLRXVO\ $W WKLV VWDJH
IRRITANT OR ALLERGIC PATCH TESTING USING THE DERMPATCH
225
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ÀHG XVLQJ D VWDQGDUGSRO\DFU\ODPLGHVHTXHQFLQJJHO 7KH53$QRWRQO\LGHQWLÀHVVPDOOTXDQWLWLHVRIP51$EXWDWWKHVDPHWLPHLW TXDQWLWDWHV WKH DPRXQW RI WKH P51$ SUHVHQW LQ D JLYHQ FHOO VXVSHQVLRQ 7KLV LV DFFRPSOLVKHGE\DGGLQJODEHOHGDQWLVHQVHPROHFXOHVIRUWKHVRFDOOHG´KRXVHNHHS LQJµJHQHVHJWKHP51$IRUJO\FHUDOGHK\GHSKRVSKDWHGHK\GURJHQDVH*$3'+ *$3'+ LV YLWDO LQ SHUIRUPLQJ PDQ\ FHOOXODU IXQFWLRQV DQG WKXV UHODWLYHO\ ODUJH TXDQWLWLHVRIWKLVHQ]\PHDUHSURGXFHGLQWKHFHOODWDOOWLPHV7KHUHIRUHWKHWRWDO DPRXQWRI*$3'+SURGXFHGLQDFHOOGRHVQRWÁXFWXDWHJUHDWO\RYHUDJLYHQWLPH SHULRGDQGWKHDPRXQWRIP51$IRU*$3'+SHUFHOOUHPDLQVUHODWLYHO\FRQVWDQW 7KXVWKHTXDQWLW\RIP51$IRU*$3'+LQHDFKODQHFDQEHXVHGDVDPDUNHUIRU WKHWRWDODPRXQWRI51$LQWKHWLVVXHLVRODWHGLHWKHDPRXQWRIFHOOXODUPDWHULDO WKDWRULJLQDOO\ZDVSUHVHQWLQWKHWDSHVWULSSHGVDPSOH Induction of Erythematous Reactions on the Skin :H LQGXFHG ,&' RU $&' UHDFWLRQV XVLQJ VWDQGDUG SURJQRVWLF WHVWLQJ WHFK QLTXHV %ULHÁ\ GLEXW\O VTXDUDWH LQ DFHWRQH ZDV DSSOLHG IRU KU XQGHU RFFOXVLRQ WR WKH XSSHU DUP WR LQGXFH WKH$&' UHDFWLRQ 0DU]XOLL DQG 0DLEDFK $IWHU DERXW G WKH GLEXW\O VTXDUDWH ZDV UHDSSOLHG WR HOLFLW WKH LPPXQHPHGLDWHGUHDFWLRQ,QWKHVDPHLQGLYLGXDODSSOLFDWLRQRIPORIVRGLXP ODXU\OVXOIDWH6/6 )LVKHU6FLHQWLÀF6DQ'LHJR&$ LQGLVWLOOHGZDWHU WRWKHFRQWUDODWHUDOXSSHUDUPIRUKUXQGHURFFOXVLRQZDVXVHGWRJHQHUDWHWKH ,&'7KHWDSHVWULSSLQJZDVSHUIRUPHGKUDIWHUHOLFLWDWLRQRIWKH$&'DQG KUDIWHULQGXFWLRQRIWKH,&'7KHWRWDO51$LVRODWHGIURPHDFKVDPSOHZDVXVHG GLUHFWO\ IRU WKH 53$ XVLQJ WKH 5LER4XDQW¤ 0XOWL3UREH 51DVH SURWHFWLRQ DVVD\ V\VWHPZLWKRXWSULRUGHWHUPLQDWLRQRIWKHDPRXQWRIWRWDO51$E\HJPHDVXUH PHQWRIWKHRSWLFDOGHQVLW\8QGLJHVWHGSUREHVIRUWKHF\WRNLQHV ZHUHUXQSDUDOOHO ZLWKVDPSOHVRQVWDQGDUGDFU\ODPLGHVHTXHQFLQJJHOVDQGXVHGWRLGHQWLI\GLJHVWHG F\WRNLQHPHVVDJHV*HOVFRQWDLQLQJGLJHVWHG51$EDQGVZHUHH[SRVHGWRDSKRV SKRUVFUHHQ0ROHFXODU'\QDPLFV,QF6XQQ\YDOH&$
RESULTS :HUHFHQWO\KDYHXVHGSUREHVIRUWKHF\WRNLQHVLQWHUOHXNLQ,/ LQWHUOHX NLQ ,/ LQWHUOHXNLQ ,/ LQWHUOHXNLQ ,/ WKH SURWHLQV
226
ALTERNATIVE TOXICOLOGICAL METHODS
JDPPDLQWHUIHURQK,)1 DQGLQGXFLEOHQLWULFR[LGHV\QWKDVHL126 DVZHOODV WKHKRXVHNHHSLQJJHQHV/*$3'+IRUK\EULGL]DWLRQWR51$VDPSOHVREWDLQHG IURPVHYHUDOLQGLYLGXDOV6WUHLOHLQHWDO %\53$DQDO\VLVWKHP51$IRU WKHF\WRNLQHV,/DQG,OFRXOGEHFOHDUO\LGHQWLÀHGLQWKUHHRIWKHÀYHVXEMHFWV RQO\LQWKHVNLQVDPSOHVREWDLQHGE\WDSHVWULSSLQJRIWKHVLWHVGHPRQVWUDWLQJDQ $&'6LPLODUO\WKHP51$IRUK,)1ZDVREVHUYHGIRUWKH$&'VNLQVLWHLQWZR RI WKH ÀYH VXEMHFWV %RWK WKH ,&' DQG WKH$&' UHDFWLRQV FOHDUO\ GHPRQVWUDWHG EDQGVIRU,/,/DQGL126ZHUHREVHUYHGLQDOORIWKHVNLQVDPSOHVLQFOXGLQJ FRQWUROVLWHVWKDWZHUHQRWSDWFKHG
DISCUSSION :H KDYH VKRZQ WKDW VPDOO DPRXQWV RI P51$ FDQ EH H[WUDFWHG IURP WKH VNLQ IUDJPHQWVREWDLQHGE\WDSHVWULSSLQJKXPDQVNLQ:HKDYHHVWDEOLVKHGWKDWFHUWDLQ F\WRNLQHSDWWHUQVDSSHDUWREHVSHFLÀFIRU$&'YHUVXV,&'5HFHQWO\DJURXSRI LQYHVWLJDWRUVKDVGHPRQVWUDWHGGLIIHUHQFHVLQWKHP51$H[SUHVVLRQRISURWHLQVLQ VNLQELRSVLHVREWDLQHGIURP$&'DQG,&'XVLQJLQVLWXK\EULGL]DWLRQ)OLHUHWDO 7KHVHDXWKRUVGHPRQVWUDWHGFOHDUO\WKDWRQO\VNLQFHOOVWDNHQIURP$&'EXW QRWIURPQRUPDOVNLQRU,&'H[SUHVVHGWKHP51$IRU+/$'5DQWLJHQDVZHOODV ,&$0 7KHVH WZR SURWHLQV DUH NQRZQ WR EH LQGXFHG E\ K,)1 RQ NHUDWLQRF\WHV ERWKLQYLYRDQGLQYLWUR ,Q DGGLWLRQ WR EHLQJ QRQLQYDVLYH DQ DGYDQWDJH RI WKH 'HUP3DWFK DSSURDFK WR JHQH H[SUHVVLRQ SURÀOLQJ RI WKH VNLQ LV WKDW FHOOV LVRODWHG E\ WDSH VWULSSLQJ DUHWKRXJKWWREHSUHGRPLQDQWO\HSLGHUPDOFHOOV7KHHSLGHUPLVLVFRPSULVHGRI NHUDWLQRF\WHVLQYDULRXVVWDJHVRIGLIIHUHQWLDWLRQDORQJZLWKDVPDOOQXPEHURI RWKHUFHOOW\SHVVXFKDV/DQJHUKDQVFHOOV,Q,&'NHUDWLQRF\WHVDUHWKHÀUVWFHOO W\SHVWREHGDPDJHGE\WKHLUULWDWLQJVXEVWDQFHDIWHULWSDVVHVWKURXJKWKHVWUDWXP FRUQHXP.HUDWLQRF\WHVDUHLQYROYHGLQWKHVLJQDOLQJSDWKZD\VWKDWLQLWLDWHWKH LQÁDPPDWRU\FDVFDGHWKDWHYHQWXDOO\OHDGVWRLQÀOWUDWLRQRIPRQRQXFOHDUFHOOV VZHOOLQJDQGGDPDJHWRWKHXQGHUO\LQJGHUPLV,QWKHLQGXFWLRQSKDVHRI$&' DIWHU WKH DQWLJHQ HQFRXQWHUV WKH /DQJHUKDQV FHOOV WKH NHUDWLQRF\WHV VLJQDO WKH /DQJHUKDQVFHOOVWRPLJUDWHWRWKHORFDOO\PSKQRGHV7KHUROHRIWKHNHUDWLQRF\WH LQ FXWDQHRXV LUULWDWLRQ DQG VHQVLWL]DWLRQ KDV EHHQ UHFHQWO\ UHYLHZHG &RTXHWWH HW DO ,Q DWWHPSWLQJ WR GLIIHUHQWLDWH ,&' IURP$&' E\ JHQH H[SUHVVLRQ SURÀOHVVHOHFWLYHO\VDPSOLQJHSLGHUPDOFHOOVE\DGKHVLYHWDSHVWULSSLQJPD\EH DVLPSOHUDSSURDFKWKDQWDNLQJELRSV\VDPSOHVZKLFKFRQWDLQERWKGHUPLVDQG HSLGHUPLV 7KHWHFKQLTXHZHGHVFULEHKHUHFDQEHH[SDQGHGWRVDPSOHDODUJHUVHWRIJHQH SUREHV E\ SUHSDULQJ F'1$ IURP WKH P51$ VDPSOH XVLQJ D UHYHUVH WUDQVFULSWDVH UHDFWLRQDPSOLI\LQJWKHF'1$DQGDSSO\LQJWKHUHVXOWLQJF'1$SRROWRDJHQHDUUD\ VXFK DV WKH 6LJPD F\WRNLQH DUUD\ 3UHOLPLQDU\ UHVXOWV REWDLQHG E\ RXU ODERUDWRU\ XQSXEOLVKHGGDWD LQGLFDWHWKDWVXIÀFLHQWTXDQWLWLHVRIKLJKTXDOLW\P51$IRUJHQH DUUD\H[SHULPHQWVFDQEHREWDLQHGE\WKH'HUP3DWFKDGKHVLYHWDSHVWULSSLQJPHWKRG RORJ\ 7KH XVH RI JHQH DUUD\V LQ FDUHIXOO\ GHVLJQHG KXPDQ FOLQLFDO VWXGLHV ZLOO EH HVVHQWLDOIRUHVWDEOLVKLQJDFRQVLVWHQWVHWRIPDUNHUVWRGLVWLQJXLVK,&'IURP$&'
IRRITANT OR ALLERGIC PATCH TESTING USING THE DERMPATCH
227
REFERENCES %DVKLU 6 - DQG 0DLEDFK + , 0HWKRGV IRU WHVWLQJ WKH LUULWDWLRQ DQG VHQVLWL]DWLRQ SRWHQWLDO RI GUXJV DQG HQKDQFHUV LQ %LRFKHPLFDO 0RGXODWLRQ RI 6NLQ 5HDFWLRQV 7UDQVGHUPDOV7RSLFDOV&RVPHWLFV.\GRQLHXV$)DQG:LOOH--(GV&5&3UHVV %RFD5DWRQSS² &RTXHWWH$%HUQD13RXPD\<DQG3LWWHONRZ05 7KHNHUDWLQRF\WHLQFXWDQHRXV LUULWDWLRQDQGVHQVLWL]DWLRQLQ%LRFKHPLFDO0RGXODWLRQRI6NLQ5HDFWLRQV7UDQVGHU PDOV7RSLFDOV &RVPHWLFV .\GRQLHXV$) DQG:LOOH -- (GV &5& 3UHVV %RFD 5DWRQSS² *HUEHULFN *) 6LNRUVNL (( 5\DQ &$ DQG /LPDUGL /& 8VH RI F\WRNLQHV LQ GHUPDWRWR[LFRORJ\LQ'HUPDWRWR[LFRORJ\0HWKRGV0DU]XOOL)1DQG0DLEDFK+, (GV7D\ORUDQG)UDQFLV:DVKLQJWRQ'&SS² )OLHU-%RRUVPD'0%UX\Q]HHO'3YDQ%HHN3-6WRRI7-6FKHSHU5-:LOOHP]H 5DQG7HQVHQ&3 7KH&;&5DFWLYDWLQJFKHPRNLQHV,30LJDQG,3 DUHH[SUHVVHGLQDOOHUJLFEXWQRWLQLUULWDQWSDWFKWHVWUHDFWLRQV-,QYHVW'HUPDWRO ² *LOPDQ0 5LERQXFOHDVHSURWHFWLRQDVVD\LQ&XUUHQW3URWRFROVLQ0ROHFXODU%LRORJ\ $XVXEHO ) HW DO (GV 1HZ
CHAPTER
20
In Vitro Skin Equivalent Models for Toxicity Testing 3DWULFN-+D\GHQ6H\RXP$\HKXQLH*5REHUW-DFNVRQ 6DUDK.XSIHU/DPRUH7KRPDV-/DVW0LWFKHOO.ODXVQHU DQG-RVHSK.XELOXV
CONTENTS ,QWURGXFWLRQ $LU²/LTXLG,QWHUIDFH7LVVXH&XOWXUHV 6XUYH\RI8VHVDQG(QGSRLQWV &RUURVLYLW\ 3KRWRWR[LFLW\ ,UULWDWLRQ 0HODQRJHQHVLV 3HUFXWDQHRXV$EVRUSWLRQ 'UXJ0HWDEROLVP 0LVFHOODQHRXV6WXGLHV 4XDOLW\&RQWURODQG9DOLGDWLRQ,VVXHV +LVWRORJLFDO(YDOXDWLRQRI(DFK7LVVXH/RW 4XDQWLWDWLYH$VVHVVPHQWRI)XQFWLRQDO5HVSRQVH WR7RSLFDO7ULWRQ;7UHDWPHQW (PHUJLQJ$SSOLFDWLRQVRI$/,7LVVXHV *HQH0LFURDUUD\7HFKQRORJ\ +LJK7KURXJKSXW$/,7LVVXH)RUPDWV 6XPPDU\ $FNQRZOHGJPHQWV 5HIHUHQFHV
229
230
ALTERNATIVE TOXICOLOGICAL METHODS
INTRODUCTION 3ULRUWRKXPDQXVHRIQHZFRVPHWLFRUWKHUDSHXWLFSURGXFWVLQYLYRDQLPDOWHVWV DUH RIWHQ FRQGXFWHG LQ RUGHU WR VFUHHQ IRU VDIHW\ DQG HIÀFDF\ +RZHYHU PRGHUQ SURGXFWGHYHORSPHQWSURFHVVHVDUHUHQGHULQJDQLPDOWHVWLQJLQFUHDVLQJO\H[SHQVLYH DQG LPSUDFWLFDO )XUWKHUPRUH WKH WHQHWV RI HWKLFDO DQLPDO WHVWLQJ FDOO IRU SUDFWLFH RIWKHWKUHH5VRIUHÀQHPHQWUHGXFWLRQDQGUHSODFHPHQWRIDQLPDOWHVWV7KHUHIRUH DJURZLQJQHHGH[LVWVIRUUDSLGDQGUHOLDEOHLQYLWURPHWKRGVIRUVDIHW\VFUHHQLQJRI QHZFRVPHWLFIRUPXODWLRQVDQGOHDGFDQGLGDWHVIRUWRSLFDOWKHUDSHXWLFV7KLVQHHG LVHVSHFLDOO\DFXWHIRUFRVPHWLFSURGXFHUVZKRPXVWSURGXFHVDIHDQGHIÀ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ÀQLVKHG SURGXFWV LQWHQGHG IRU WRSLFDO DSSOLFDWLRQ )RU H[DPSOH VXEPHUJHG FXOWXUHV UHVWULFW WKH WHVWLQJ WR PDWHULDOV WKDW FDQ EH GLVVROYHG LQ DTXHRXV PHGLD 7KXV PDQ\ RLOVROXEOH LQJUHGLHQWV RU ÀQLVKHG SURGXFWV VXFK DV FUHDPV ORWLRQV RU SRZGHUVFDQQRWEHDGHTXDWHO\WHVWHGLQVXEPHUJHGFXOWXUHV\VWHPV)XUWKHUPRUH VXEPHUJHG FXOWXUH V\VWHPV RI VNLQ FHOOV GR QRW SRVVHVV GLIIHUHQWLDWHG IXQFWLRQV DQGEDUULHUSURSHUWLHVRIVWUDWLÀHGVNLQWLVVXHVDQGWKXVGRQRWDFFXUDWHO\UHÁHFW WKHLQYLYRSK\VLRORJ\RIWKHVNLQ 7KUHHGLPHQVLRQDORUJDQRW\SLFVNLQPRGHOVZKLFKRYHUFRPHPDQ\RIWKHVKRUW FRPLQJVRIVDIHW\WHVWLQJLQVXEPHUJHGPRQROD\HUVNLQFHOOFXOWXUHVDUHFRPPHU FLDOO\ DYDLODEOH 0DW7HN &RUS $VKODQG 0$ 7KHVH PRGHOV DUH FXOWXUHG DW WKH DLU²OLTXLG LQWHUIDFH $/, DQG DUH PRUH VXLWDEOH IRU VDIHW\ DQG HIÀFDF\ WHVWLQJ RI WRSLFDOSURGXFWV$PRQJWKHVDIHW\LVVXHVWKDWRUJDQRW\SLFVNLQPRGHOVFDQDGGUHVV DUH WLVVXH GDPDJH LH FHOO GHDWK E\ QHFURVLV RU DSRSWRVLV LUULWDWLRQ DQG '1$ GDPDJHFDXVHGE\WRSLFDOWUHDWPHQWRUXOWUDYLROHWUDGLDWLRQ7KLVSDSHUZLOOGHVFULEH DYDULHW\RIFRPPHUFLDOO\DYDLODEOH$/,FXOWXUHVDQGSUHVHQWDVXUYH\RIDSSOLFDWLRQV RIWKHVHPRGHOVIRUWRSLFDOSKDUPDFHXWLFDODQGFRVPHWLFSURGXFWVDIHW\DVVHVVPHQW
AIR–LIQUID INTERFACE TISSUE CULTURES $/,WLVVXHVDUHW\SLFDOO\SURGXFHGE\VHHGLQJHSLWKHOLDOFHOOVRQWRDPLFURSRURXV PHPEUDQHFRQWDLQHGLQDVSHFLDOO\GHVLJQHGWLVVXHFXOWXUHLQVHUW)LJXUHVKRZV D VFKHPDWLF UHSUHVHQWDWLRQ RI DQ $/, FXOWXUH V\VWHP &HOOV DUH LQLWLDOO\ IHG E\ H[SRVLQJ ERWK WKH XSSHU DQG ORZHU VXUIDFH RI WKH PHPEUDQH WR FXOWXUH PHGLXP )ROORZLQJ VHYHUDO GD\V RI FRPSOHWHO\ VXEPHUJHG FXOWXUH WR DOORZ D FRQÁXHQW FHOO OD\HU WR GHYHORS PHGLXP LV UHPRYHG IURP WKH WRS VXUIDFH RI WKH PHPEUDQH DQG VXEVHTXHQWIHHGLQJRIWKHFHOOVRFFXUVE\DGGLWLRQRIIUHVKPHGLXPWRWKHXQGHUVLGH RI WKH PHPEUDQH RQO\ 7KH WRS VXUIDFH RI WKH FHOO OD\HU LV WKXV H[SRVHG WR WKH
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
231
Tissue Culture Well Culture Insert ALI Tissue Membrane Medium
Figure 20.1 Schematic representation of the air–liquid interface (ALI) tissue culture technique. Table 20.1 Epithelial Tissues Successfully Cultured at the ALI Skin equivalentsa Keratinocytes only Keratinocytes plus fibroblastsb Keratinocytes plus melanocytes Keratinocytes plus Langerhans cells Ocular corneal epitheliuma Tracheal/bronchiala epithelium Tracheal/bronchial submucosal glands Vaginal epitheliuma,b Gingival epitheliuma,b a b
Cultured at MatTek Corp. In development.
DWPRVSKHUH&RQWLQXHG$/,FXOWXUHRIHSLWKHOLDOFHOOVHYHQWXDOO\UHVXOWVLQWKHIRU PDWLRQRIDGLIIHUHQWLDWHGLQYLYROLNHWLVVXH%HOOHWDO $YDULHW\RI$/,WLVVXHVLQFOXGLQJGHUPDORFXODUWUDFKHDOEURQFKLDOJLQJLYDO DQGYDJLQDOHSLWKHOLDWLVVXHVDUHSURGXFHGE\0DW7HN&RUS7DEOH $OORIWKHVH WLVVXHV DUH SURGXFHG IURP QRUPDO KXPDQ FHOOV DQG DUH FXOWXUHG LQ D FRPSOHWHO\ GHÀQHGVHUXPIUHHPHGLXP'HWDLOHGFKDUDFWHULVWLFVRIWKH(SL'HUPNHUDWLQRF\WH FXOWXUH 0HODQR'HUP NHUDWLQRF\WHPHODQRF\WH FRFXOWXUH ,PPXQR'HUP NHUDWL QRF\WH/DQJHUKDQVFHOOFRFXOWXUH DQG(SL'HUP)7NHUDWLQRF\WHÀEUREODVWFRFXO WXUH SURGXFWVDUHGHVFULEHGLQGHWDLOEHORZ (SL'HUPFXOWXUHVDUHFRPSRVHGRIQRUPDOKXPDQHSLGHUPDONHUDWLQRF\WHVFXO WXUHGRQDFROODJHQW\SH,JHOPDWUL[7KHVHWLVVXHVGLVSOD\DVWUDWLÀHGGLIIHUHQWLDWHG PRUSKRORJ\ZLWKEDVDOVSLQRXVJUDQXODUDQGVWUDWXPFRUQHXPOD\HUVHYLGHQW7KH ZHOOGHYHORSHG VWUDWXP FRUQHXP DQG QRUPDO FHUDPLGH DQG OLSLG SURÀOH FRQIHUV D EDUULHUIXQFWLRQWKDWDOWKRXJKQRWHTXDOWRLQYLYRVNLQLVVLJQLÀFDQWDQGUHSURGXF LEOH)LJXUH$VKRZVDKLVWRORJLFDOFURVVVHFWLRQRI(SL'HUPWLVVXH1RUPDOLQ YLYROLNH XOWUDVWUXFWXUH RI (SL'HUP·V LQWHUFHOOXODU ODPHOODU OLSLG VKHHWV LV GHPRQ VWUDWHGE\WUDQVPLVVLRQHOHFWURQPLFURVFRS\)LJXUH% .HUDWLQRF\WHV KDYH DOVR EHHQ FRFXOWXUHG ZLWK QRUPDO KXPDQ PHODQRF\WHV WR SURGXFHWKH0HODQR'HUPSURGXFW7KHVHFRFXOWXUHVFDQEHSURGXFHGZLWKPHODQR F\WHVIURPGRQRUVRIYDULRXVVNLQW\SHVWRDFKLHYHWLVVXHVZLWKYDULRXVGHJUHHVRI SLJPHQWDWLRQ)LJXUHVKRZVDWRSYLHZRI0HODQR'HUPWLVVXHSURGXFHGZLWK
232
ALTERNATIVE TOXICOLOGICAL METHODS
(A)
(B)
Figure 20.2 (A) Histological cross section of H&E stained EpiDerm-200. Magnification = 440v. (B) Transmission electron micrograph of ruthenium tetroxide stained intercellular lamellar lipid sheets (150,000v).
Figure 20.3 Top macroscopic view of MelanoDerm tissues containing normal human melanocytes derived from Black donor skin (400v magnification).
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
233
• Asian (A) • Black (B) • Caucasian (C) Figure 20.4 Development of pigmentation in MelanoDerm tissue produced with melanocytes derived from various skin phototypes. The figure shows the top macroscopic view of tissue inserts. Day 0 indicates the day of shipment of a fully differentiated tissue. Pigmentation develops during additional culture of the fully differentiated tissue by the end user.
PHODQRF\WHVIURP%ODFNGRQRUV0DFURVFRSLFSLJPHQWDWLRQRIFXOWXUHVLQFRUSRUDWLQJ PHODQRF\WHVIURPGRQRUVRIGLIIHUHQWVNLQSKRWRW\SHVGHPRQVWUDWLQJWKHH[SHFWHG OHYHOVRISLJPHQWDWLRQDUHVKRZQLQ)LJXUH0HODQR'HUPWLVVXHVDOVRH[KLELW PDFURVFRSLFGDUNHQLQJRUOLJKWHQLQJLQUHVSRQVHWRFKHPLFDORUELRFKHPLFDOWUHDW PHQWVDVZHOODVPHODQRVRPHWUDQVIHUWRNHUDWLQRF\WHV6HLEHUJD.ODXVQHU 6HLEHUJE )RUH[DPSOHWKHWLVVXHVFDQEHLQGXFHGWRGDUNHQE\WUHDWPHQW ZLWK JURZWK IDFWRUV VXFK DV EPHODQRF\WHVWLPXODWLQJ KRUPRQH E06+ DQG F ÀEUREODVWJURZWKIDFWRUF)*) )LJXUH $OWHUQDWLYHO\WRSLFDONRMLFDFLGWUHDW PHQWLQGXFHVDOLJKWHQLQJRI0HODQR'HUPWLVVXH)LJXUH $TXDQWLWDWLYHPHODQLQ DVVD\KDVDOVREHHQGHYHORSHGWRIDFLOLWDWHSLJPHQWDWLRQVWXGLHVZZZPDW7HNFRP 7KHOLJKWHQLQJHIIHFWRIWRSLFDONRMLFDFLGRQGHYHORSPHQWRISLJPHQWDWLRQLQ0HO DQR'HUPDVGHWHUPLQHGE\WKHPHODQLQDVVD\LVVKRZQLQ7DEOH $ PRGHO RI QRUPDO KXPDQ NHUDWLQRF\WHV FRFXOWXUHG ZLWK QRUPDO KXPDQ ÀEUR EODVWV WR SURGXFH D ´IXOO WKLFNQHVVµ GHUPDOHSLGHUPDO WLVVXH (SL'HUP)7 LV DOVR DYDLODEOH 7KLV WLVVXH PRGHO SRVVHVVHV D GHUPDO FRPSRQHQW FRPSRVHG RI YLDEOH ÀEUREODVWV HPEHGGHG LQ D FROODJHQ W\SH , JHO DV ZHOO DV D IXOO\ GLIIHUHQWLDWHG HSL GHUPLV)LJXUH 7KHIXOOWKLFNQHVVVNLQHTXLYDOHQWVZLOOIDFLOLWDWHLQYHVWLJDWLRQ
10-7M MSH, 3 ng/ml FGF 5x10-8 MSH, 1.5 ng/ml FGF 10-8 MSH, 0.3 ng/ml FGF No MSH or FGF added Figure 20.5 Pigmentation of MelanoDerm tissue (Black melanocytes) induced by E-MSH and F-FGF as shown by top macroscopic view of tissue inserts. Tissues were cultured in media containing the indicated concentrations of growth factors for up to 20 days following shipment of commercial MelanoDerm tissue.
234
ALTERNATIVE TOXICOLOGICAL METHODS
Day:
3
7
10
14
Kojic Acid—topical
Control
Figure 20.6 Lightening effect of topical kojic acid on MelanoDerm tissue. Tissues containing Black melanocytes were treated topically with 1% kojic acid for the indicated number of days (25 Ql applied topically every other day). The top macroscopic view of the tissues reveals the visually observable lightening effect.
Table 20.2 Lightening of MelanoDerm Tissue by Topical Treatment with 1% Kojic Acid Treatment H 2O 1% kojic acid
Qg/tissue) Melanin content (Q Day 10 Day 14 19.9 11.4
35.3 18.3
Figure 20.7 EpiDerm-FT tissue contains normal human fibroblasts cultured within a collagen type I dermal matrix. A fully differentiated epidermis derived from normal human keratinocytes is cultured on the top of the dermis.
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
235
Figure 20.8 Immunohistochemical staining of HLA-DR on human Langerhans cells within (A) ImmunoDerm tissue and (B) excised human skin.
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orrosivity 7KH (SL'HUP PRGHO KDV EHHQ IRUPDOO\ YDOLGDWHG E\ 7KH 1DWLRQDO &HQWHU IRU 'RFXPHQWDWLRQ DQG (YDOXDWLRQ RI $OWHUQDWLYH 0HWKRGV WR $QLPDO ([SHULPHQWV =(%(7 DV DQ DOWHUQDWLYH PHWKRG IRU WHVWLQJ FRUURVLYLW\ RI PDWHULDOV IROORZLQJ WRSLFDOH[SRVXUH/LHEVFKHWDOE 7KLVSURWRFROXVHVWKH077DVVD\0RV PDQQ WRGHWHUPLQHWLVVXHYLDELOLW\DIWHUWUHDWPHQWRI(SL'HUPZLWKWRSLFDOO\ DSSOLHG PDWHULDOV ,I WLVVXH YLDELOLW\ LV DIWHU PLQ H[SRVXUH FRPSDUHG WR XQWUHDWHGFRQWUROV RULIWLVVXHYLDELOLW\LVDIWHUPLQH[SRVXUHWKHPDWHULDO LVODEHOHGDVFRUURVLYH/LHEVFKHWDOE Phototoxicity (SL'HUP WLVVXHV KDYH EHHQ VXFFHVVIXOO\ XWLOL]HG IRU SKRWRWR[LFLW\ VFUHHQLQJ RI WRSLFDOO\ DSSOLHG SURGXFWV /LHEVFK HW DO D -RQHV HW DO ,Q
236
ALTERNATIVE TOXICOLOGICAL METHODS
MTT (% untreated control)
120
Chloropromazine
100 80
-UVA +UVA 42%
60 68% 40 87%
74%
20
-2%
0 0.001
0.003
0.010
0.032
0.100
[Concentration %] Figure 20.9 Phototoxicity of chlorpromazine. EpiDerm tissues were topically treated with the indicated concentrations of chlorpromazine and incubated overnight. On the following day tissues were either irradiated with 6 J/cm2 of UVA or kept in the dark. Tissues were then rinsed, fed with fresh medium, and incubated overnight. Finally, tissue viability was determined by the MTT assay. A decrease in tissue viability of 30% or greater between the irradiated and nonirradiated tissues indicates a phototoxic effect.
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rritation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elanogenesis 0HODQR'HUP WLVVXH ZKLFK FRQWDLQV QRUPDO KXPDQ PHODQRF\WHV FRFXOWXUHG ZLWKQRUPDOKXPDQNHUDWLQRF\WHVLVÀQGLQJLQFUHDVLQJXVHIRUVWXGLHVLQYROYLQJ
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
237
PHODQRJHQHVLVDQGSLJPHQWDWLRQVWXGLHV6HLEHUJHWDOD DQGVNLQOLJKWHQLQJ .ODXVQHUHWDO6HLEHUJHWDOE )LJXUHV²7DEOH Percutaneous Absorption 7KHEDUULHUGHYHORSHGE\(SL'HUPDQGRWKHULQYLWURVNLQHTXLYDOHQWWLVVXHVLV VLJQLÀFDQWEXWW\SLFDOO\OHVVWKDQWKDWRILQYLYRVNLQ5RJXHWHWDO +RZHYHU (SL'HUPWLVVXHVFDQEHVXFFHVVIXOO\XVHGIRUSHUFXWDQHRXVDEVRUSWLRQVWXGLHV)RU H[DPSOH (SL'HUP KDV EHHQ XVHG LQ VWXGLHV WR HYDOXDWH SHUPHDWLRQ RI EHQ]R\O FKORULGH LQ FRVPHWLF SURGXFWV )DUHV HW DO WR VWXG\ HOHFWURWUDQVSRUW GUXJ GHOLYHU\WHFKQRORJ\'DGGRQD DQGWRPHDVXUHSHUPHDWLRQRIFKHPLFDOVVXFK DVODXULFDFLGFDIIHLQHRUPDQQLWRO5RJXHWHWDO Drug Metabolism 6NLQ LV NQRZQ WR FRQWDLQ SKDVH , R[LGDWLYH DQG SKDVH ,, FRQMXJDWLYH GUXJ PHWDEROL]LQJHQ]\PHV0XNKWDUHWDO0HUNHWDO 7RGDWHUHODWLYHO\ IHZGUXJPHWDEROLVPVWXGLHVKDYHEHHQUHSRUWHGLQVNLQHTXLYDOHQWV&KDUDFWHUL]DWLRQ RIGUXJPHWDEROLVPFDSDELOLWLHVRILQYLWURVNLQHTXLYDOHQWVLVFXUUHQWO\LQFRPSOHWH +RZHYHU (SL'HUP KDV EHHQ XVHG WR VWXG\ PHWDEROLVP RI YLWDPLQ ( 1DEL HW DO DQG JOXWDWKLRQH 6WUDQVIHUDVH DFWLYLW\ 5RJXHW HW DO ,Q YLWUR VNLQ HTXLYDOHQWVZLOOXQGRXEWHGO\ÀQGH[SDQGHGXWLOLW\IRUFXWDQHRXVGUXJPHWDEROLVP DSSOLFDWLRQVLQWKHIXWXUH
MISCELLANEOUS STUDIES $V QRWHG DERYH VNLQ HTXLYDOHQW PRGHOV FDQ EH XVHG IRU D ZLGH YDULHW\ RI PHFKDQLVWLFVWXGLHVLQYROYLQJQXPHURXVHQGSRLQWV(SL'HUPDQGVLPLODUVNLQHTXLY DOHQWVKDYHEHHQXVHGWRVWXG\LQÁDPPDWRU\PHGLDWRUVLQFOXGLQJF\WRNLQHV,/E 71)E ,/ DQG SURVWDJODQGLQV 3*( DW WKH PHVVDJH RU SURWHLQ OHYHO 0RUH UHFHQWO\VWXGLHVUHODWHGWRPHGLDWRUVRIDSRSWRVLVSS*$''FDVSDVHV =KDR HW DO +D\GHQ HW DO DQJLRJHQVLV HJ YDVFXODU HQGRWKHOLDO JURZWK IDFWRUSODFHQWDJURZWKIDFWRU 5HQGOHWDO+D\GHQHWDO DQG SKRWRDJLQJ 0DUWLQ HW DO KDYH EHHQ UHSRUWHG (SL'HUP KDV DOVR EHHQ HPSOR\HG WR VWXG\ KHDW VKRFN %RZHUV HW DO DQG WKH HIIHFWV RI FKHPLFDO ZDUIDUHDJHQWV5KRDGVHWDO )XUWKHUUHÀQHPHQWRIVNLQHTXLYDOHQWPRGHOV DQGDSSOLFDWLRQRIDGYDQFHVLQJHQRPLFVDQGSURWHRPLFVVKRXOGOHDGWRH[SDQGHG XVH RI WKHVH PRGHOV IRU VWXG\ RI D ZLGH YDULHW\ RI FXWDQHRXV SKHQRPHQD VHH HPHUJLQJXVHVEHORZ
QUALITY CONTROL AND VALIDATION ISSUES ,QRUGHUIRULQYLWURHSLWKHOLDOWLVVXHVWREHVXFFHVVIXOO\XVHGIRUVDIHW\DVVHVVPHQW LQ WKH LQGXVWULDO SURGXFW GHYHORSPHQW SURFHVV WKH\ PXVW ÀUVW EH YDOLGDWHG 7KH
238
ALTERNATIVE TOXICOLOGICAL METHODS
,QWHUDJHQF\ &RRUGLQDWLQJ &RPPLWWHH RQ WKH 9DOLGDWLRQ RI $OWHUQDWLYH 0HWKRGV ,&&9$0 KDVGHÀQHGYDOLGDWLRQDVHVWDEOLVKPHQWRIUHOLDELOLW\ DQGUHOHYDQFHIRU DVSHFLÀ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ÀFDQWYDULDELOLW\ ZLOOOHDGWRGLIÀFXOWLHVLQDFKLHYLQJTXDQWLWDWLYHUHVXOWVDQG JHQHUDOO\SRRUSHUIRU PDQFHLQWKHWHVWLQJODERUDWRU\ 7KHUHIRUHWKHIROORZLQJTXDOLW\FRQWUROSURFHGXUHVDUHURXWLQHO\SHUIRUPHGWR HQVXUHORWWRORWUHSURGXFLELOLW\DQGVDWLVIDFWRU\SHUIRUPDQFHRI(SL'HUPWLVVXHVLQ LQGXVWULDOVDIHW\DVVHVVPHQWDSSOLFDWLRQV
HISTOLOGICAL EVALUATION OF EACH TISSUE LOT + (FURVVVHFWLRQVRIHDFKWLVVXHORWDUHHYDOXDWHGLQWHUPVRIQXPEHURIFHOO OD\HUV DQG SURSHU IRUPDWLRQ RI DSSURSULDWH WLVVXH DUFKLWHFWXUH 7KH WLVVXH VKRXOG FRQVLVW RI HLJKW WR WZHOYH FHOO OD\HUV LQ WKLFNQHVV DQG GLVSOD\ EDVDO VSLQRXV DQG JUDQXODUFHOOOD\HUVDQGDZHOOGHYHORSHGVWUDWXPFRUQHXP
QUANTITATIVE ASSESSMENT OF FUNCTIONAL RESPONSE TO TOPICAL TRITON X-100 TREATMENT $UHSURGXFLEOHTXDQWLÀ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
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
239
Table 20.3 EpiDerm-200 Triton X-100 ET50 Database Summary Year 2000 1999 1998 1997 1996 1995 a
a
EPI-200 Triton ET-50 6.76 6.75 7.24 6.78 6.74 6.65
EPI-200 Triton C.V.
Lots
Avg. C.V.
16.4 18.2 17.9 15.9 14.6 77.8
89 146 175 228 184 112
6.2 5.7 9.2 9.9 9.6 4.9
Through September 2000.
DO+DUEHOOHWDO 6LPLODUSURWRFROVZHUHUHFHQWO\XVHGE\5RJXHWHW DO DQG%RHOVPDHWDO WRHYDOXDWHDQXPEHURIFRPPHUFLDOO\DYDLODEOH LQYLWURHSLGHUPDOPRGHOVLQFOXGLQJ(SL'HUP7KH(SL'HUPPRGHOSHUIRUPHGIDYRU DEO\LQWKHVHVWXGLHVKLJKOLJKWLQJWKHUHVXOWRIFDUHIXODWWHQWLRQWRTXDOLW\FRQWURO 5RJXHWHWDO%RHOPVDHWDO
EMERGING APPLICATIONS OF ALI TISSUES Gene Microarray Technology 5HFHQWO\JHQHH[SUHVVLRQPLFURDUUD\WHFKQRORJLHVKDYHEHFRPHZLGHO\DYDLODEOH 7KHVHHPHUJLQJWHFKQRORJLHVKROGFRQVLGHUDEOHSURPLVHIRUHQDEOLQJJUHDWO\HQKDQFHG GLVFRYHU\DQGSUHGLFWLYHSRWHQWLDOIURPLQYLWURV\VWHPV*HQHH[SUHVVLRQPLFURDUUD\V FRQVLVWLQJRIJHQHVSHFLÀF'1$VHTXHQFHVERXQGWRDVROLGPDWUL[PDNHLWSRVVLEOH WR VLPXOWDQHRXVO\ DQDO\]H KXQGUHGV RU HYHQ WKRXVDQGV RI JHQH H[SUHVVLRQ FKDQJHV (LVHQDQG%URZQ+HJGHHWDO/RFNKDUWDQG:LQ]HOHU&HOLVHW DO *HQHDUUD\GDWDDQDO\VLVSURJUDPVHPSOR\LQJFOXVWHULQJWHFKQLTXHVKDYH EHHQ GHYHORSHG WR IDFLOLWDWH WKH LGHQWLÀFDWLRQ RI SUHGLFWLYH ´ÀQJHUSULQWµ SDWWHUQV RI JHQHH[SUHVVLRQFDXVHGE\H[SRVXUHWRYDULRXVFKHPLFDORUHQYLURQPHQWDOWUHDWPHQWV %UD]PDDQG9LOR6KHUORFN 7KHSRZHURIWKLVWHFKQRORJ\KDVDOUHDG\ EHHQGHPRQVWUDWHGIRUFODVVLÀFDWLRQVRIFDQFHURXVWXPRUVDQGLGHQWLÀFDWLRQRIQHZ WXPRU W\SHV (LVHQ HW DO *ROXE HW DO 3HURX HW DO $ORQ HW DO $OL]DGHKHWDO GLVHDVHVVXFKDVDWKHURVFOHURVLV +LOWXQHQHWDO 0F&DIIUH\HWDO DQGWR[LFRORJ\DQGGUXJVFUHHQLQJDSSOLFDWLRQV5RFNHWWDQG 'L[%DUWRVLHZLF]HWDO ,QWKHVHH[DPSOHVDQDO\VLVRIVHYHUDOWKRXVDQGV RIJHQHVUHYHDOHGDPXFKVPDOOHUVXEVHWRIJHQHVWKDWSURYLGHWKHUHTXLUHGSUHGLFWLYH LQIRUPDWLRQ2QFHGLVFRYHUHGWKHVHVPDOOVXEVHWVFDQEHXVHGIRUURXWLQHVFUHHQLQJ DSSOLFDWLRQV,QDGGLWLRQWRDOORZLQJSUHGLFWLYHFODVVLÀFDWLRQVWREHPDGHPLFURDUUD\ JHQHH[SUHVVLRQSURÀOLQJKROGVJUHDWSURPLVHIRULGHQWLI\LQJPHFKDQLVPVRIFDQFHU DQG RWKHU GLVHDVHV GUXJ HIIHFWV DQG WR[LFLW\ $IVKDUL HW DO /RFNKDUW DQG :LQ]HOHU&HOLVHWDO1XZD\VLUHWDO $/,FXOWXUHVRIKXPDQVNLQHTXLYDOHQWVDUHLGHDOV\VWHPVIRUXVHZLWKHPHUJLQJ PLFURDUUD\WHFKQRORJLHV7KHDELOLW\WRSURGXFHFRFXOWXUHVRINHUDWLQRF\WHVZLWKPHO DQRF\WHV/DQJHUKDQVFHOOVRUÀEUREODVWVDQGWKHIXOO\GLIIHUHQWLDWHGQDWXUHRIWKHVH
240
ALTERNATIVE TOXICOLOGICAL METHODS
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r&LQD&2 DWPRVSKHUHIRUYDULRXVWLPHVSULRUWRYLDELOLW\GHWHUPLQDWLRQRU51$LVRODWLRQ7RWDO 51$ZDVLVRODWHGE\XVHRIDFRPPHUFLDOO\DYDLODEOHNLW$WODV3XUH7RWDO51$ ,VRODWLRQNLW&ORQWHFK/DERUDWRULHV3DOR$OWR&$ 7RDQDO\]HFKDQJHVLQJHQHH[SUHVVLRQHDFK51$VDPSOHZDVFRQYHUWHGWR 3 ODEHOHGF'1$DVVSHFLÀHGLQWKH$WODVF'1$H[SUHVVLRQDUUD\XVHUPDQXDO&ORQ WHFK DQGK\EULGL]HGZLWK$WODVKXPDQFDQFHUF'1$H[SUHVVLRQDUUD\PHPEUDQHV FRQWDLQLQJFDQFHUUHODWHGF'1$V)ROORZLQJSUREHK\EULGL]DWLRQPHPEUDQHVZHUH ZDVKHGDQGH[SRVHGWR[UD\ÀOPIRUKU$XWRUDGLRJUDSKVZHUHGLJLWL]HGZLWKD VFDQQHUDQGDQDO\]HGZLWK$WODV,PDJHVRIWZDUH&ORQWHFK $WZRIROGGLIIHUHQFH LQVLJQDOLQWHQVLW\EHWZHHQWKHWHVWDQGFRQWUROPHPEUDQHVZDVFRQVLGHUHGWRUHSUHVHQW VLJQLÀ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ÀHGSODFHQWDJURZWKIDFWRU3O*) DJHQHPHVVDJH WKDW KDV QRW SUHYLRXVO\ EHHQ UHSRUWHG WR EH XSUHJXODWHG E\ 89% LUUDGLDWLRQ RI HSLGHUPLV3ODFHQWDJURZWKIDFWRULVDSRWHQWDQJLRJHQLFIDFWRURISRWHQWLDOO\JUHDW VLJQLÀFDQFHLQUHODWLRQWRVNLQUHODWHGSKHQRPHQDLQFOXGLQJZRXQGKHDOLQJDQGVNLQ FDQFHU /DFDO HW DO 7KHUHIRUH IXUWKHU H[SHULPHQWDWLRQ ZDV FRQGXFWHG WR FRQÀUPWKHXSUHJXODWLRQRI3O*)IROORZLQJ89%LUUDGLDWLRQRI(SL'HUP 3ODFHQWD JURZWK IDFWRU SULPHU VHTXHQFHV d**&&&7*&7$&&7*77&77 ***&&7&d DQG d&&$*7$&$$*&$$$7**&$$$*7**$***d ZHUH REWDLQHG IURP &ORQWHFK 5HYHUVH WUDQVFULSWLRQ SRO\PHUDVH FKDLQ UHDFWLRQ 573&5 ZDVSHUIRUPHGRQWRWDO51$LVRODWHGIURP89%LUUDGLDWHGKUSRVWLUUDGLDWLRQ RU QRQLUUDGLDWHG FRQWURO (SL'HUP VDPSOHV (SL'HUP 51$ LVRODWLRQ SURWRFRO DYDLODEOH IURP 0DW7HN &XVWRPHU 6HUYLFH VHH ZZZ0DW7HNFRP KWWSZZZ0DW7HNFRP 3&5FRQGLWLRQVZHUHDVIROORZVPHOWWHPSHUDWXUH r&DQQHDOLQJWHPSHUDWXUH r& H[WHQVLRQ WHPSHUDWXUH r& %\ WKH WK F\FOH WKH H[SHFWHG 3&5 SURGXFW ES ZDVREVHUYHGRQO\LQWKHLUUDGLDWHGVDPSOH)LJXUH $IWHURU F\FOHVWKHESSURGXFWZDVREVHUYDEOHLQERWKLUUDGLDWHGDQGFRQWUROVDPSOHVEXW ZDVVWURQJO\XSUHJXODWHGLQWKHLUUDGLDWHGVDPSOHV)LJXUH
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
241
Figure 20.10 Changes in cancer-related gene expression following UVB-irradiation of EpiDerm tissue. AtlasTM human cancer cDNA expression array analysis of gene expression changes induced in EpiDerm tissues 6 hr after irradiation with 175 mJ/cm2 UVB.
Table 20.4 UVB-Irradiation of EpiDerm Tissue WAF-1 (+) MAP Kinase p38 (+) Growth-arrest-specific protein (+) c-Myc binding protein MM-1 (+) TRAF-interacting protein (+) Caspases (+) Death-associated protein kinase (DAP kinase 1, +) p53-induced protein (+) GADD45 (+) DNA excision repair protein ERCC1 (+) DNA-repair protein XRCC1 (+) Placenta growth factors 1+2 (+) TIMP-1 (+) T-plasminogen activator (+) Rho GDP dissociation inhibitor 1 (+) Endothelin 2 (–) IL-6 (–) Leukocyte interferon-inducible peptide (–) 60S ribosomal protein (–)
7KH DERYH H[DPSOH LOOXVWUDWHV WKH SRZHU RI QHZ JHQH DUUD\ WHFKQRORJ\ IRU GLVFRYHU\ RI QRYHO LQIRUPDWLRQ 2QJRLQJ JHQH DUUD\ H[SHULPHQWDWLRQ E\ XV DQG RWKHUVZLOOFRQWLQXHWRSURYLGHLPSRUWDQWQHZLQIRUPDWLRQUHOHYDQWWRGHUPDOELRORJ\
242
ALTERNATIVE TOXICOLOGICAL METHODS
– +
– +
– +
– +
Markers
273 bp
20
25
30
35
Cycles Figure 20.11 Induction of PlGF expression following UVB-irradiation of EpiDerm tissue. Agarose gel electrophoresis of products obtained by RT-PCR of total RNA isolated from EpiDerm tissue 20 hours following UVB-irradiation. (–) no irradiation. (+) UVB-irradiated. The expected PlGF PCR product is 273 bp.
High-Throughput ALI Tissue Formats 7R HQKDQFH WKH XWLOLW\ RI$/, WLVVXHV ZLWK PRGHUQ KLJKWKURXJKSXW +73 DQG JHQRPLF WHFKQRORJLHV QHZ +73$/, WLVVXH IRUPDWV DQG 51$ LVRODWLRQ SURFHGXUHV KDYHEHHQGHYHORSHG(SL'HUPWLVVXHVFDQEHSURGXFHGLQHLWKHUZHOO(SL'HUP RUZHOO(SL'HUP IRUPDWV)LJXUH +D\GHQHWDOE 7KHVH QHZIRUPDWVZLOOIDFLOLWDWHURERWLFDVZHOODVPDQXDO+73PDQLSXODWLRQRI$/,WLVVXHV
Figure 20.12 EpiDerm tissues cultured in 24 well (EpiDerm-224) or 96 well (EpiDerm-296) high throughput ALI formats. Each tissue has its own individual media reservoir to avoid cross-contamination of samples.
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
243
Figure 20.13 Total RNA-96 isolation kit designed for high throughput total RNA isolation from EpiDerm-296.
Figure 20.14 Agarose gel electrophoresis of total RNA isolated from EpiDerm-296 with the Total RNA-96 isolation kit. Average yield is approximately 10 Qg DNA-free total RNA/EpiDerm-296 tissue.
$FRQYHQLHQWNLWKDVDOVREHHQGHYHORSHGWKDWDOORZVIRUWRWDO51$LVRODWLRQLQ DZHOOIRUPDW7KHNLWFRQVLVWVRIEXIIHUVIRUO\VLVELQGLQJZDVKLQJDQGHOXWLRQ '1$VHUHDJHQWVDZHOOJODVVÀEHUÀOWHUELQGLQJSODWHDQGZHOOSODVWLFZDUH IRUO\VLVZDVKLQJ'1$VHDQGHOXWLRQRSHUDWLRQV)LJXUH %ULHÁ\(SL'HUP WLVVXHV DUH O\VHG DQG WKH O\VDWH LV WUDQVIHUUHG WR WKH JODVV ÀEHU ÀOWHU ELQGLQJ SODWH&RQWDPLQDWHVDUHZDVKHGDZD\DQG'1$VHWUHDWPHQWLVSHUIRUPGLUHFWO\RQ WKHELQGLQJÀOWHUV)LQDOO\SXULÀHGWRWDO51$LVHOXWHGUHDG\IRU3&5JHQHH[SUHV VLRQPLFURDUUD\VRURWKHUXVHV7KHSURFHGXUH\LHOGVDSSUR[LPDWHO\QJRIKLJK TXDOLW\'1$IUHHWRWDO51$(SL'HUPWLVVXH)LJXUH
SUMMARY ,Q YLWUR VNLQ HTXLYDOHQW PRGHOV FXOWXUHG DW WKH DLU²OLTXLG LQWHUIDFH DUH QRZ URXWLQHO\DYDLODEOHIRUVDIHW\DVVHVVPHQWSURGXFWGHYHORSPHQWDQGEDVLFUHVHDUFK DSSOLFDWLRQV 6WULFW DWWHQWLRQ WR TXDOLW\ FRQWURO IDFLOLWDWHV VDWLVIDFWRU\ SHUIRUPDQFH RIWKHVHWLVVXHVDQGYDOLGDWLRQRISURWRFROVIRUYDULRXVLQGXVWU\DSSOLFDWLRQV(PHUJ LQJ JHQRPLF DQG KLJKWKURXJKSXW DSSOLFDWLRQV ZLOO DOORZ WKHVH PRGHOV WR PDNH
244
ALTERNATIVE TOXICOLOGICAL METHODS
LPSRUWDQW FRQWULEXWLRQV WR PRGHUQ VDIHW\ DVVHVVPHQW DQG SURGXFW GHYHORSPHQW HIIRUWVDQGUHGXFHDQLPDOWHVWLQJIRUWKHVHSXUSRVHV
ACKNOWLEDGMENTS 7KLVZRUNZDVVXSSRUWHGE\1,+JUDQWV5(6DQG5$5 DQG'2'JUDQW'$0'&
REFERENCES $IVKDUL&$1XZD\VLU()DQG%DUUHWW-& $SSOLFDWLRQRIFRPSOHPHQWDU\'1$ PLFURDUUD\WHFKQRORJ\WRFDUFLQRJHQLGHQWLÀFDWLRQWR[LFRORJ\DQGGUXJVDIHW\HYDO XDWLRQ&DQFHU5HV² $OL]DGHK$$(LVHQ0%'DYLV5(0D&/RVVRV,65RVHQZDOG$%ROGULFN-& 6DEHW+7UDQ7<X;3RZHOO-,
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
245
&RRSHU+DQQDQ5+DUEHOO-:&RHFNH6%DOOV0%RZH*&HUYLQND0&ORWKLHU 5 +HUPDQQ ) .ODKP ,. GH /DQJH - /LHEVFK 0 DQG9DQSDU\V 3 (&9$0ZRUNVKRSUHSRUW$OW/DE$QLP² 'DGGRQD3 1HZGUXJGHOLYHU\V\VWHPVYDOLGDWLRQRILQYLWURPRGHOV$OW/DE$QLP (DUO/.+DOO0DQQLQJ7-+ROODQG*+,UZLQ$0F3KHUVRQ-3DQG6RXWKHH-$ 6NLQLUULWDWLRQSRWHQWLDORIVXUIDFWDQWPL[WXUHVXVLQJUHOHYDQWGRVHVLQLQYLWUR V\VWHPV$OW/DE$QLP$EVWU (LVHQ 0% DQG %URZQ 32 '1$ DUUD\V IRU DQDO\VLV RI JHQH H[SUHVVLRQ 0HWK (Q]\PRO² (LVHQ0%6SHOOPDQ37%URZQ32DQG%RWVWHLQ' &OXVWHUDQDO\VLVDQGGLVSOD\ RIJHQRPHZLGHH[SUHVVLRQSDWWHUQV3URF1DWO$FDG6FL86$² )DUHV +0 &KDWWHUMHH 6 DQG +D\ZDUG 0 ,Q YLWUR SHUPHDWLRQ DQG LUULWDWLRQ RI EHQ]R\OSHUR[LGHFRQWDLQLQJSURGXFWVSDSHUSUHVHQWHGDWWKH$PHULFDQ$VVRFLDWLRQ RI3KDUPDFHXWLFDO6FLHQWLVWVWK$QQXDO0HHWLQJ1RYHPEHUSDSHU3'' *ROXE756ORQLP'.7DPD\R3+XDUG&*DDVHQEHHN00HVLURY-3&ROOHU+ /RK0/'RZQLQJ-5&DOLJLXUL0$%ORRPÀHOG&'DQG/DQGHU(6 0ROHFXODUFODVVLÀFDWLRQRIFDQFHUFODVVSUHGLFWLRQE\JHQHH[SUHVVLRQPRQLWRULQJ 6FLHQFH² +DUEHOO-6RXWKHH-DQG&XUUHQ5' 7KHSDWKWRUHJXODWRU\DFFHSWDQFHRILQYLWUR PHWKRGVLVSDYHGZLWKWKHVWULFWHVWVFLHQWLÀFVWDQGDUGVLQ$QLPDO$OWHUQDWLYHV:HOIDUH DQG (WKLFV YDQ =XWSKHQ /)0 DQG %DOOV 0 (GV (OVHYLHU 6FLHQFH 1HZ
246
ALTERNATIVE TOXICOLOGICAL METHODS
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² /RFNKDUW'-DQG:LQ]HOHU($ *HQRPLFVJHQHH[SUHVVLRQDQG'1$DUUD\V1DWXUH ² 0DUWLQ.0/\WH30D]XUXN.DQG6KDSLUR6 ,QKLELWLRQRI89LQGXFHG003 LQHSLGHUPDOHTXLYDOHQWVE\DQWLR[LGDQWV-,QYHVW'HUPDWRO$EVWU 0F&DIIUH\7$)X&'X%(NVLQDU6.HQW.&%XVK+.UHLJHU.5RVHQJDUW 7&\EXOVN\0,6LOYHUPDQ(6DQG&ROOLQV7 +LJKOHYHOH[SUHVVLRQRI (JUDQG(JULQGXFLEOHJHQHVLQPRXVHDQGKXPDQDWKHURVFOHURVLV-&OLQ,QYHVW ² 0HUN +) -XJHUW ). DQG )UDQNHQEHUJ 6 %LRWUDQVIRUPDWLRQV LQ WKH VNLQ LQ 'HUPDWRWR[LFRORJ\0DU]XOOL)1DQG0DLEDFK+,(GV7D\ORUDQG)UDQFLV:DVK LQJWRQ'&² 0RVPDQQ7 5DSLG FRORULPHWULF DVVD\ IRU FHOOXODU JURZWK DQG VXUYLYDO DSSOLFDWLRQ WRSUROLIHUDWLRQDQGF\WRWR[LFLW\DVVD\V-,PPXQRO0HWK 0XNKWDU+ &XWDQHRXVPHWDEROLVPRI[HQRELRWLFVDQGVWHURLGKRUPRQHVLQ3KDUPD FRORJ\RIWKH6NLQ+0XNKWDU(G&5&3UHVV%RFD5DWRQ)/S² 1DEL=7DYDNNRO$6ROLPDQ1DQG3ROHIND7* %LRFRQYHUVLRQRIWRFRSKHU\O DFHWDWH WR WRFRSKHURO LQ KXPDQ VNLQ RUJDQ FXOWXUH PRGHOV - ,QYHVW 'HUPDWRO $EVWU 1XZD\VLU()%LWWQHU07UHQW-%DUUHWW-&DQG$IVKDUL&$ 0LFURDUUD\VDQG WR[LFRORJ\WKHDGYHQWRIWR[LFRJHQRPLFV0RO&DUFLQRJHQV² 3HUNLQV0$2VERUQH55RELQVRQ0.5DQD)*KDVVHPL$DQG+DOO% &RPSDULVRQRILQYLWURDQGLQYLYRKXPDQVNLQUHVSRQVHVWRFRQVXPHUSURGXFWVDQG LQJUHGLHQWVZLWKDUDQJHRILUULWDQF\SRWHQWLDO7R[LFRO6FL² 3HUNLQV0$2VERUQH55DQD)5*KDVVHPL$DQG5RELQVRQ0. &RPSDU LVRQRILQYLWURDQGLQYLYRKXPDQVNLQUHVSRQVHVWRFRQVXPHUSURGXFWVDQGLQJUHGLHQWV ZLWKDUDQJHRILUULWDQF\SRWHQWLDO7KH7R[LFRORJLVW$EVWU 3HURX&0-HIIUH\66YDQGH5LMQ05HHV&$(LVHQ0%5RVV'73HUJDPHQ VFKLNRY$:LOOLDPV &) =KX 6; /HH -& /DVKNDUL ' 6KDORQ ' %URZQ 32DQG%RWVWHLQ' 'LVWLQFWLYHJHQHH[SUHVVLRQSDWWHUQVLQKXPDQPDPPDU\ HSLWKHOLDOFHOOVDQGEUHDVWFDQFHUV3URF1DWO$FDG6FL86$² 5HQGO 0 0D\HU & )LVFKHU + 3DPPHU -:HQLQJHU: DQG 7VFKDFKOHU ( :RXQGLQJXSUHJXODWHVYDVFXODUHQGRWKHOLDOJURZWKIDFWRUSURGXFWLRQE\NHUDWLQRF\WHV RILQYLWURUHFRQVWUXFWHGHSLGHUPLV-,QYHVW'HUPDWRO$EVWU 5HQGO 0 0D\HU & DQG 7VFKDFKOHU ( 7RSLFDOO\ DSSOLHG ODFWLF DFLG LQFUHDVHV VSRQWDQHRXV VHFUHWLRQ RI YDVFXODU HQGRWKHOLDO JURZWK IDFWRUYDVFXODU SHUPHDELOLW\ IDFWRU 9(*)93) E\ KXPDQ UHFRQVWUXFWHG HSLGHUPLV - ,QYHVW 'HUPDWRO $EVWU
IN VITRO SKIN EQUIVALENT MODELS FOR TOXICITY TESTING
247
5KRDGV/60HUVKRQ00DQG9DQ%XVNLUN5* $V\QWKHWLFKXPDQHSLGHUPDO PRGHO FDQ GLIIHUHQWLDWH DFXWH IURP ODWHQW HIIHFWV RI WKH PRQRIXQFWLRQDO PXVWDUG DQDORJXHFKORURHWK\OHWK\OVXOÀGH,Q9LWUR7R[LFRO 5RFNHWW-&DQG'L['- '1$DUUD\VWHFKQRORJ\RSWLRQVDQGWR[LFRORJLFDODSSOL FDWLRQV;HQRELRWLFD² 5RJXHW5%HFN+%RHOVPD(%UDFKHU0)DOOHU&+DUULV,/RWWH&'UHKHU) DQG3RQHF0 7HVWLQJDQGLPSURYHPHQWRIUHFRQVWUXFWHGVNLQNLWVLQRUGHU WRHODERUDWH(XURSHDQVWDQGDUGVÀUVWUHVXOWV$OW/DE$QLP 6HLEHUJ 0 3DLQH & 6KDUORZ ($QGUDGH*RUGRQ 3 &RVWDQ]R 0 (LVLQJHU 0 DQG 6KDSLUR66E ,QKLELWLRQRIPHODQRVRPHWUDQVIHUUHVXOWVLQVNLQOLJKWHQLQJ- ,QYHVW'HUPDWRO² 6HLEHUJ 0 3DLQH & 6KDUORZ ($QGUDGH*RUGRQ 3 &RVWDQ]R 0 (LVLQJHU 0 DQG 6KDSLUR 66 D 7KH SURWHDVHDFWLYDWHG UHFHSWRU UHJXODWHV SLJPHQWDWLRQ YLD NHUDWLQRF\WHPHODQRF\WHLQWHUDFWLRQV([S&HOO5HV² 6KHUORFN* $QDO\VLVRIODUJHVFDOHJHQHH[SUHVVLRQGDWD&XUU2SLQ,PPXQRO ² :DUUHQ 5 6DQGHUV /0 &XUWLV 6/:RQJ /) =KX & 7ROOHQV )5 DQG 2WWH 7( +XPDQLQYLWURDQGLQYLYRFXWDQHRXVUHVSRQVHVWRVRDSVXVSHQVLRQUROHRI VROXWLRQ EHKDYLRU LQ SUHGLFWLQJ SRWHQWLDO LUULWDQW FRQWDFW GHUPDWLWLV ,Q 9LWUR 0RO 7R[LFRO =KDR -) 7KDQJ<- .XELOXV - -LQ ;+ 6DQWHOOD 50$WKDU 0 :DQJ =< DQG %LFNHUV '5 5HFRQVWLWXWHG GLPHQVLRQDO KXPDQ VNLQ DV D QRYHO LQ YLWUR PRGHOIRUVWXGLHVRIFDUFLQRJHQHVLV%LRFKHP%LRSK\V5HV&RPPXP²
PART IV A Case Study in the Use of Alternatives to Determine the Mechanism of Sulfur Mustard Action :,//,$0-60,7+ 6XOIXU PXVWDUG LV DQ DON\ODWLQJ DJHQW WKDW FDXVHV GHELOLWDWLQJ LQMXULHV ZKHQ LW FRQWDFWVWLVVXH,WVSULPDU\WDUJHWWLVVXHVDUHVNLQUHVSLUDWRU\WUDFWDQGH\HV(YHQ WKRXJKVXOIXUPXVWDUGKDVEHHQUHFRJQL]HGDVDFKHPLFDOWKUHDWDJHQWIRUPRUHWKDQ \HDUVWKHUHLVQRDYDLODEOHWKHUDS\IRUWKHPXVWDUGLQMXU\7KHODFNRIWKHUDS\ LV LQ ODUJH PHDVXUH GXH WR WKH FRPSOH[ SDWKRORJ\ WKDW LV LQGXFHG E\ WKLV DJHQW 1XPHURXVFHOOXODUDQGWLVVXHDOWHUDWLRQVRFFXUDIWHUH[SRVXUHWRPXVWDUGDQGGHYHO RSPHQW RI WKHUDSHXWLF PHDVXUHV UHTXLUHV XQGHUVWDQGLQJ RI WKRVH SDWKRORJLFDO SUR FHVVHVPRVWUHOHYDQWWRWKHREVHUYHGWLVVXHLQMXULHV7KH86$UP\0HGLFDO5HVHDUFK ,QVWLWXWH RI &KHPLFDO 'HIHQVH 86$05,&' KDV EHHQ WDVNHG ZLWK GHÀQLQJ WKH PHFKDQLVPVRIPXVWDUGLQGXFHGSDWKRORJ\DQGZLWKXVLQJWKHXQGHUVWDQGLQJRIWKHVH WR[LFPHFKDQLVPVWRGHYHORSPHGLFDOFRXQWHUPHDVXUHVWRSURWHFW86FLWL]HQVERWK PLOLWDU\ DQG FLYLOLDQ IURP WKH GHYDVWDWLQJ HIIHFWV RI H[SRVXUH WR WKLV LQVLGLRXV FKHPLFDOWKUHDWDJHQW ,QWKLVVHFWLRQQLQHFKDSWHUVUHSRUWRQYDULRXVPRGHOVWKDWKDYHEHHQHPSOR\HG WRDQVZHUPHFKDQLVWLFTXHVWLRQVDERXWWKHWR[LFLW\RIVXOIXUPXVWDUGDQGWRHYDOXDWH FDQGLGDWHSURSK\ODFWLFDQGWKHUDSHXWLFFRPSRXQGVDJDLQVWPXVWDUGLQMXU\0RVWRI WKH UHVHDUFK KDV XVHG LQ YLWUR PRGHOV WR GHÀQH WR[LF PHFKDQLVPV EXW XOWLPDWHO\ HYDOXDWLRQRIWKHUDS\IRUVXFKDFRPSOH[SDWKRORJ\PXVWXVHDZKROHDQLPDOPRGHO WR UHSUHVHQW WKH IXOO UDQJH RI F\WRWR[LF KLVWRWR[LF DQG LQÁ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
250
ALTERNATIVE TOXICOLOGICAL METHODS
'1$&KDSWHU3ODWWHERU]HDQG6PLWK 7KHRWKHUVFUHHQLQJPRGHOVWXGLHGLVWKH KXPDQHSLGHUPDONHUDWLQRF\WH+(. +(.LVWKHLQYLWUR HTXLYDOHQWRIWKHEDVDO HSLGHUPDOFHOOOD\HUZKLFKLVEHOLHYHGWREHWKHSULQFLSDOWDUJHWFHOORIPXVWDUGLQ VNLQ6HYHUDOLQGLFDWRUVRIFHOOGHDWKZHUHHYDOXDWHGLQ&KDSWHU.HOO\HWDO IRU HDVHRIXVHLQF\WRWR[LFW\VFUHHQLQJ 7KH+(.PRGHOLVXVHGLQVL[RIWKHVHSDSHUVWRVWXG\JHQRPLFELRFKHPLFDO DQGF\WRVNHOHWDODOWHUDWLRQVLQGXFHGE\PXVWDUG6FKODJHUHWDO&KDSWHU HYDOXDWH WKHWR[LFRJHQRPLFFKDQJHVWKDWDUHLQGLFDWLYHRILQÁDPPDWRU\UHVSRQVHV6PLWKHW DO &KDSWHU ORRN DW D QXPEHU RI ELRFKHPLFDO DOWHUDWLRQV ZKLOH 6PLWK HW DO &KDSWHU GHPRQVWUDWH VSHFLÀF '1$ UHVSRQVHV WKDW FRXOG DIIHFW WKH DELOLW\ RI +(.WRXQGHUJRF\WRNLQHVLV6LQFHHSLGHUPDO²GHUPDOVHSDUDWLRQLVWKHKDOOPDUNRI WKHPXVWDUGOHVLRQLQVNLQ.HOO\HWDO&KDSWHU XVHVHYHUDODVVD\VRISURWHRO\VLV LQ +(. DQG LVRODWHG KXPDQ O\PSKRF\WHV WR VWXG\ WKH UROH RI SURWHDVH DFWLYLW\ IROORZLQJLQYLWURPXVWDUGH[SRVXUHDQGWRGHÀQHDPRGHOIRUHYDOXDWLQJDQWLSURWHDVH WKHUDSLHV .QRZLQJ WKDW LQÁDPPDWRU\ SURFHVVHV DUH FULWLFDO WR WKH IXOO H[SUHVVLRQ RI WKH PXVWDUG OHVLRQ &RZDQ HW DO &KDSWHU GHPRQVWUDWH PXVWDUGLQGXFHG H[SUHVVLRQRIWKHF\WRNLQH,/LQPXVWDUGH[SRVHG+(.DQGHVWDEOLVKWKLVPRGHO DV D XVHIXO VFUHHQ IRU DQWLLQÁ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
CHAPTER
21
Cellular Resistance of Tetrahymena to Sulfur Mustard 3HWHU/3ODWWHERU]H-DPHV(6LVWUXQNDQG:LOOLDP-6PLWK
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV &HOO&XOWXUHDQG60([SRVXUHV &RXOWHU&RXQWHU6WXGLHV 5HVXOWV 'LVFXVVLRQ $FNQRZOHGJPHQWV 5HIHUHQFHV
INTRODUCTION 6XOIXUPXVWDUG60ELVFKORURHWK\O VXOÀGH LVDSRWHQWDON\ODWLQJDJHQWWKDW FRQWLQXHVWREHDWKUHDWDVDFKHPLFDOZHDSRQ5HVHDUFKKDVVKRZQWKDW60LVKLJKO\ UHDFWLYHWRPDQ\FHOOXODUQXFOHRSKLOHVZLWK'1$DSSHDULQJWREHDFULWLFDOWDUJHW 7KHVH DON\ODWLRQ HYHQWV LQYROYH '1$ VWUDQG EUHDNV DV ZHOO DV WKH IRUPDWLRQ RI LQWUDVWUDQG RU LQWHUVWUDQG FURVVOLQNV 3DSLUPHLVWHU 7KH ODWWHU HYHQWV DUH ODUJHO\WKRXJKWWRFDXVHWKHREVHUYHG60LQGXFHGUHGXFWLRQLQ'1$V\QWKHVLVDQG VXEVHTXHQWLQWHUUXSWLRQRIWKHQRUPDOFHOOF\FOH(PLVVRQDQG6PLWK ,QKXPDQVH[SRVHGWR60WKHÀUVWWDUJHWRILQFDSDFLWDWLRQLVWKHH\HVIROORZHG E\DODWHQWSHULRGLQZKLFKYHVLFDWLRQRFFXUV'HVSLWHRFXODULQMXULHVKDYLQJEHHQ UHSRUWHG VLQFH :RUOG :DU , WKH FXUUHQW OHDG WKHUDSLHV SURYLGH DW EHVW WUDQVLHQW V\PSWRPDWLFUHOLHI$EDWWHU\RIFDQGLGDWHWKHUDSHXWLFFRPSRXQGVH[LVWVEXWKDVQRW EHHQDGHTXDWHO\WHVWHGDVWKHFXUUHQWWHVWPRGHOVWDQGDUG'UDL]HWHVW'UDL]HHWDO 251
252
ALTERNATIVE TOXICOLOGICAL METHODS
DQGLVFXPEHUVRPHODERULQWHQVLYHDQGH[SHQVLYH7KHVHGLIÀFXOWLHVFRXOG EHFLUFXPYHQWHGWKURXJKWKHXVHRIDOWHUQDWLYHLQYLWURPRGHOV ,QWKLVVWXG\WKHFRPPRQIUHVKZDWHUFLOLDWHGSURWR]RDQ7HWUDK\PHQDZDVH[DP LQHGDVDQDOWHUQDWLYHLQYLWURPRGHO6LOYHUPDQHWDOLOOXVWUDWHGWKDWWKLVXQLFHOOXODU HXNDU\RWHLVDVXLWDEOHDOWHUQDWLYHPRGHOWRRFXODUWHVWLQJLQUDEELWVE\FRQVLVWHQWO\ VKRZLQJWKDWLQYLWURWHVWLQJKDGHTXDORUJUHDWHU´LUULWDQF\µWKDQLQYLYRWHVWLQJIRU PRVW FKHPLFDOV 6LOYHUPDQ 6LOYHUPDQ DQG 3HQQLVL 7KHVH ELRDVVD\V ZHUH SURYHQ WR EH TXLFN UHOLDEOH VHQVLWLYH DQG LQH[SHQVLYH DVSHFWV WKDW PDGH 7HWUDK\PHQDDQLGHDOFDQGLGDWHRUJDQLVPWREHJLQDQDOWHUQDWLYHVVWXG\
MATERIALS AND METHODS Cell Culture and SM Exposures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ÀQDOFRQFHQWUDWLRQRIRUP07KLVZDVIROORZHG E\DGLOXWLRQDQGVXEVHTXHQWVHULDOGLOXWLRQVWRWKHGHVLUHGFRQFHQWUDWLRQ8SRQ GLOXWLRQ 60 ZDV LPPHGLDWHO\ DGGHG WR D KHDOWK\ 7HWUDK\PHQD FXOWXUH PL[HG IRU aVHFRQDYRUWH[DFWLRQPL[HUDQGSODFHGRQDURFNLQJSODWIRUP7KHQHJDWLYH FRQWURO ZDV WUHDWHG LGHQWLFDOO\ EXW 60 ZDV DEVHQW IURP WKH FXOWXUH PHGLXP DQG FHOOV$WVSHFLÀFWLPHSRLQWVDEDFWHULRORJLFORRSIXORIWKLVPL[WXUHaPO ZDV SODFHG RQ D PLFURVFRSH FRYHUJODVV DQG LQYHUWHG LQWR D GHSUHVVLRQ VOLGH DQG FHOOV ZHUH H[DPLQHG IRU PRWLOLW\ DW v PDJQLÀFDWLRQ7KH PRWLOLW\ SDWWHUQ RI WKH 7HW UDK\PHQDH[FOXGLQJVSHHGRIPRYHPHQW ZDVREVHUYHGHYDOXDWHGDQGTXDQWLÀHG (DFK ORZSRZHU PLFURVFRSLF ÀHOG FRQWDLQHG DSSUR[LPDWHO\ WR RUJDQLVPV 0RWLOLW\ZDVHVWLPDWHGE\PDNLQJDQDSSUR[LPDWHFRXQWRIWKHWRWDOQXPEHURIFHOOV LQWKHPLFURVFRSLFVDPSOHDQGWKHQXPEHURIFHOOVPRYLQJQRUPDOO\&HOOVPRYLQJ VORZHURUIDVWHUWKDQWKHFRQWUROVZHUHFRQVLGHUHGWREHPRYLQJQRUPDOO\ Coulter Counter Studies &HOOV ZHUH H[DPLQHG ZLWK D &RXOWHU +LDOHDK )/ =0 SDUWLFOH FRXQWHU$Q DOLTXRW PO RI FHOO VXVSHQVLRQ ZDV PL[HG ZLWK PO RI &RXOWHU ,VRWRQ LQ DQ $FFXYHWWHDQGUHDGRQWKHFRXQWHU&HOOQXPEHUDQGDYHUDJHVL]HZHUHUHFRUGHG
CELLULAR RESISTANCE OF TETRAHYMENA TO SULFUR MUSTARD
253
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aDWP0aDWP0DQGaDWP0$WP0 FHOOV KDG GHFUHDVHG LQ VL]H EXW WKLV FHOO SRSXODWLRQ ZDV GHWHUPLQHG WR QRW EH DOLYH %\KUSRVWH[SRVXUHYLDEOHFHOOVKDGQHDUO\UHJDLQHGWKHLULQLWLDOVL]H
100
Percentage Viable
80
60
40
CHO and HeLa PBL HEK Tetrahymena Yeast
20
0 10 -8
10 -7
10 -6
10 -5
10 -4
10 -3
10 -2
10 -1
SM Concentration [M] Figure 21.1 Cell viability vs. [SM]. Viability of six different cell lines was analyzed over a range of SM concentrations. Symbols are represented within the graph.
254
ALTERNATIVE TOXICOLOGICAL METHODS
60 8.0 mM 4.0 mM 2.0 mM
50
0.5 - 1.0 mM 0.3 mM & Positive Control
Cell Number
40
30
20
10
0 0
10
20
30
40
50
60
70
80
Time (h) Figure 21.2 Effects of SM on cell number over time. The number of Tetrahymena was determined after exposure to a range of SM concentrations and over a period of 72 hr. Symbols are represented within the graph.
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ÀHGUHODWLYHWRRWKHU LQYLWURV\VWHPVLQ)LJXUH7HWUDK\PHQDYLDELOLW\LVLQLWLDOO\DIIHFWHGE\60DWD FRQFHQWUDWLRQRYHUvWKDWRI+(.WKHFXUUHQWLQYLWURVNLQPRGHO60FRQFHQWUD WLRQV EHORZ P0 DSSHDUHG WR KDYH QR HIIHFW RQ FHOO YLDELOLW\ ZKLOH H[SRVXUH WR FRQFHQWUDWLRQVDWRUDERYHP0UHVXOWHGLQFHOOGHDWK7KHVHKLJKFRQFHQWUDWLRQV PD\EHVXIÀFLHQWWRGHVWUR\RXWHUPHPEUDQHLQWHJULW\DQGOHDGWRF\WRO\VLV 60FRQFHQWUDWLRQVEHORZP0GLGKDYHDVLJQLÀFDQWLPSDFWRQFHOOSUROLI HUDWLRQDVVKRZQLQ)LJXUH$OOFHOOVH[SRVHGWRFRQFHQWUDWLRQVDERYHP0 KDGFHOOGLYLVLRQDUUHVWHGIRUKUEXWFRQWLQXHGWRJURZLQVL]H7KLVXQEDODQFHG FHOOJURZWKLVDFKDUDFWHULVWLFRI60LQMXU\DQGKDVEHHQZHOOGRFXPHQWHGLQ+(. 6PLWKHWDO DOEHLWDWDPXFKORZHUFRQFHQWUDWLRQ7KLVFHOOXODUUHVSRQVHLV
CELLULAR RESISTANCE OF TETRAHYMENA TO SULFUR MUSTARD
255
WKRXJKW WR EH GXH WR H[WHQVLYH '1$ GDPDJH WKDW VHYHUHO\ LPSHGHV WKH QRUPDO UHSOLFDWLRQ 6XEVHTXHQWO\ FHOOXODU PDVV DFFXPXODWHV LQ WKH IRUP RI LQFUHDVHG FHOO YROXPH SURWHLQ DQG 51$ FRQWHQW EXW WKH FHOOV IDLO WR GLYLGH XQWLO WKH GDPDJHG '1$LVVXIÀFLHQWO\UHSDLUHG&HOOGLYLVLRQLQ60H[SRVHG7HWUDK\PHQDKDGUHVXPHG E\KU$W60FRQFHQWUDWLRQVIURPWRP0WKHVHJURZWKUDWHVZHUHQHDUO\ FRPSDUDEOHWRSRVLWLYHFRQWURO ,QWKHSUHVHQFHRIP060FHOOVDVVXPHGDVSKHULFDOVKDSHDQGF\WRO\VHG ZLWKLQWRPLQ7KHIDFWWKDWWKLVGHIRUPLW\LQERG\VKDSHZDVTXLFNO\IROORZHG E\F\WRO\VLVVXJJHVWVDVXGGHQFKDQJHLQWKHFRUWLFDOJHOVWUXFWXUH6LPLODUFKDQJHV RFFXULQ7HWUDK\PHQDH[SRVHGWRPHUFDSWRHWKDQRORUWKHDONO\ODWLQJDJHQWPHWHSD DQGERWKZHUHDWWULEXWHGWRDOWHUDWLRQVLQWKH²6+66EDODQFHZKLFKLVQHFHVVDU\ IRUWKHPDLQWHQDQFHRIWKHFRUWLFDOJHOVWUXFWXUH6KLYDMLHWDO=LPPHUPDQ 7KLV H[SODQDWLRQ ZRXOG DOVR VHHP ORJLFDO KHUH VLQFH 60 OLNH DOO NQRZQ DON\ODWLQJ DJHQWV KDV DQ DIÀQLW\ IRU WKLRO JURXSV 3DSLUPHLVWHU HW DO 7KH GHYLDWLRQLQFHOOYLDELOLW\EHWZHHQWKH&RXOWHUDQDO\VLV>FHOO GHDWKDWP060@ DQG DOO RWKHU VWXGLHV LV DWWULEXWHG WR WKH IRUPHU EHLQJ FRQGXFWHG LQ FHOO FXOWXUH PHGLXP7KH VDOWV SUHVHQW LQ NHUDWLQRF\WH JURZWK PHGLXP FRXOG QHJDWLYHO\ DIIHFW WKHYLDELOLW\RIWKLVIUHVKZDWHURUJDQLVP ,WLVZRUWKZKLOHWRVSHFXODWHRQWKHUHDVRQV EHKLQG7HWUDK\PHQDUHVLVWDQFH$V VWDWHGHDUOLHU60LVKLJKO\JHQRWR[LFDQGUHVLVWDQFHLVOLNHO\WREHFRXSOHGZLWKDQ RUJDQLVP·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ÀYH PLFURQXFOHXVFKURPRVRPHV0ES E\VLWHVSHFLÀFIUDJPHQWDWLRQLPPHGLDWHO\ DIWHU PHLRVLV 7XFNHG LQ D VPDOO SRFNHW DORQJVLGH WKH PDF LV WKH VPDOO GLSORLG PLFURQXFOHXV PLF ,W LV WUDQVFULSWLRQDOO\ LQHUW GLYLGHV PLWRWLFDOO\ DQG IXQFWLRQV DVWKHFHOO·VJHUPOLQHGXULQJPHLRWLFUHFRPELQDWLRQ 7KHREVHUYHGFHOOXODUUHVLVWDQFHWR60PD\LQSDUWEHDWWULEXWHGWRWKLVQXFOHDU GLPRUSKLFIHDWXUHVSHFLÀFDOO\WKDWWKHPDFPD\EHSUHIHUHQWLDOO\DON\ODWHGE\60 WKHUHE\ OHDYLQJ WKH PLF·V JHQHWLF LQWHJULW\ UHODWLYHO\ LQWDFW 7KLV LV SODXVLEOH VLQFH DON\ODWLQJDJHQWVKDYHEHHQVKRZQWRSUHIHUHQWLDOO\WDUJHW'1$WKDWLVEHLQJDFWLYHO\ WUDQVFULEHG3DSLUPHLVWHUHWDO 7KLVVLWHVSHFLÀFWDUJHWLQJLQWKH7HWUDK\PHQD·V PDFKDVSUHYLRXVO\EHHQREVHUYHGZLWKWKHDONO\ODWLQJDJHQWPHWK\OPHWKDQHVXOIRQDWH 006 &DPSEHOO DQG 5RPHUR (YHQ LQ WKH XQOLNHOLKRRG WKDW WKHUH ZDV D OLPLWHGSUHIHUHQFHLQ'1$DON\ODWLRQWKHPDFLVVWRLFKLRPHWULFDOO\SUHVHQWDWDWHQIROG JUHDWHUFRQFHQWUDWLRQWKDQWKHPLF3UHVFRWW0DUVKHWDO $VVXPLQJWKDW DON\ODWLRQVDFFXPXODWHLQWKHDXWRQRPRXVO\UHSOLFDWLQJVSHFLHVLHPDF WKHUHVXOWLQJ '1$GDPDJHPD\QRWVLJQLÀFDQWO\LPSDLUQRUPDOFHOOXODUKRPHRVWDVLVDVHDFKVSHFLHV H[LVWVRQWKHDYHUDJHDWFRSLHVSHUFHOO7KXV60FRQFHQWUDWLRQVWKDWDUHJHQRWR[LF WRGLSORLGPDPPDOLDQFHOOVPD\KDYHDOLPLWHGHIIHFWRQ7HWUDK\PHQD
256
ALTERNATIVE TOXICOLOGICAL METHODS
7KHOLPLWHGHIIHFWVREVHUYHGRQFHOOXODUSUROLIHUDWLRQPD\DOVRLQSDUWEHGXHWR WKHTXLHVFHQWPLF·VJHUPOLQHJHQHWLFLQWHJULW\UHPDLQLQJLQWDFWDIWHU60H[SRVXUHV ,IWKHVHFHOOVFDQXQGHUJRPHLRVLVWKHUHVXOWLQJGDXJKWHUFHOOVZRXOGRQO\FRQWDLQ WKH UHODWLYHO\ XQGDPDJHG PLF 7KLV ZRXOG QDWXUDOO\ OHDG WR WKH JHQHUDWLRQ RI DQ HQWLUHO\QHZPDFDQGWKHFHOOVJHQHWLFLQWHJULW\ZRXOGUHPDLQIXOO\LQWDFW $SDUWIURPWKLVXQXVXDOJHQRPHRUJDQL]DWLRQ7HWUDK\PHQDDOVRDSSHDUWRKDYH D PRUH HIÀFLHQW '1$ UHSDLU V\VWHP WKDQ PDPPDOLDQ FHOOV ([SRVXUH WR 89 OLJKW RUWR006UHVXOWHGLQRYHUDvLQFUHDVHLQWKHP51$IRU5DGWKHHXNDU\RWLF KRPRORJ RI WKH ( FROL UHF$ UHFRPELQDVH &DPSEHOO DQG 5RPHUR &HOOV UHVSRQGHGTXLFNO\WRWKHVHLQVXOWV5DGOHYHOVZHUHVLJQLÀFDQWO\LQFUHDVHGDW PLQSRVWH[SRVXUHWKHHDUOLHVWWLPHSRLQWH[DPLQHG7KLVVLJQLÀFDQWGHJUHHRILQGXF WLRQDSSHDUVWREHDXQLTXHUHVSRQVHRI7HWUDK\PHQDDVLQRWKHURUJDQLVPVRQO\D WZRWRWHQIROGLQGXFWLRQKDVEHHQREVHUYHG8QDUJXDEO\WKHLQGXFWLRQRIVLJQLÀFDQW DPRXQWV RI 5DG GLUHFWO\ FRQWULEXWHV WR WKH REVHUYHG 7HWUDK\PHQD·V KHLJKWHQHG UHVLVWDQFH WR 60 DON\ODWLRQ ,W VHHPV OLNHO\ WKDW VXIÀ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ÀF PHFKDQLVPV RI 60 WR[LFLW\ WKDW FRXOG EH KDUGHU WR REVHUYH LQ PRUHVHQVLWLYHPRGHOV
ACKNOWLEDGMENTS 7KHDXWKRUVZRXOGOLNHWRWKDQN&ODUHQFH%URRPÀHOGDQG6WHSKHQ%DVNLQIRUPDQ\ LQVLJKWIXOGLVFXVVLRQV
REFERENCES &DPSEHOO&DQG5RPHUR'3 ,GHQWLÀFDWLRQDQGFKDUDFWHUL]DWLRQRIWKH5$'JHQH IURPWKHFLOLDWH7HWUDK\PHQDWKHUPRSKLOD1XFOHLF$FLGV5HV² 'UDL]H-:RRGDUG*DQG&DOYHU\+ 0HWKRGVIRUWKHVWXG\RILUULWDWLRQDQGWR[LFLW\ RIVXEVWDQFHVDSSOLHGWRSLFDOO\WRWKHVNLQDQGPXFRXVPHPEUDQHV-3KDUP([S 7KHU²
CELLULAR RESISTANCE OF TETRAHYMENA TO SULFUR MUSTARD
257
(PLVVRQ(DQG6PLWK: &\WRPHWULFDQDO\VLVRI'1$GDPDJHLQFXOWXUHGKXPDQ HSLWKHOLDO FHOOV IROORZLQJ H[SRVXUH WR VXOIXU PXVWDUG - $P &ROO 7R[LFRO 6²6 .LUFKHU0DQG%UHQGHO0 '1$DON\ODWLRQE\PXVWDUGJDVLQ\HDVWVWUDLQVRIGLIIHUHQW UHSDLUFDSDFLW\&KHP%LRO,QWHUDFW² 0DUVK 7& &ROH (6 6WXDUW .5 &DPSEHOO & DQG 5RPHUR '3 5DG LV UHTXLUHGIRUSURSDJDWLRQRIWKHJHUPLQDOQXFOHXVLQ7HWUDK\PHQDWKHUPRSKLOD*HQHW LFV² 3DSLUPHLVWHU%)HLVWHU$-5RELQVRQ6,DQG)RUG5' 0HGLFDO'HIHQVHDJDLQVW 0XVWDUG*DV7R[LF0HFKDQLVPVDQG3KDUPDFRORJLFDO,PSOLFDWLRQV6FLHQFH$SSOL FDWLRQV,QWHUQDWLRQDO&RUSRUDWLRQ&5&3UHVV%RFD5DWRQ)/ 3UHVFRWW'0 7KH'1$RIFLOLDWHGSURWR]RD0LFURELRO5HY² 5REHUWV -- 3ODQW -( 6WXUURFN -( DQG &UDWKRUQ$5 4XDQWLWDWLYH DVSHFWV RI WKHUHSDLURIDON\ODWHG'1$LQFXOWXUHGPDPPDOLDQFHOOV &KHP%LRO,QWHUDFW ² 6KLYDML66D[HQD'0DQG3LOODL0. 0RGHRIDFWLRQRIDON\ODWLQJDJHQWVXVLQJ D FLOLDWH SURWR]RDQ DV D PRGHO V\VWHP ,,, (IIHFWV RI PHWHSD RQ FHOO GLYLVLRQ DQG '1$ V\QWKHVLV LQ WKH FLOLDWH %OHSKDULVP LQWHUPHGLXP ,QGLDQ - ([S %LRO ² 6LOYHUPDQ- 3UHOLPLQDU\ÀQGLQJRQWKHXVHRISURWR]RD7HWUDK\PHQDWKHUPRSKLOD DVDPRGHOIRURFXODULUULWDWLRQWHVWLQJLQUDEELWV/DE$QLP6FL² 6LOYHUPDQ - DQG 3HQQLVL 6 (YDOXDWLRQ RI7HWUDK\PHQD WKHUPRSKLOD DV DQ LQ YLWUR DOWHUQDWLYHWRRFXODULUULWDWLRQVWXGLHVLQUDEELWV-7R[LFRO&XWDQHRXV2FXODU7R[LFRO ² 6PLWK:-%ODQN-$6WDUQHU5$0HQWRQ5*DQG+DUULV- (IIHFWRIVXOIXU PXVWDUGH[SRVXUHRQKXPDQHSLGHUPDONHUDWLQRF\WHYLDELOLW\DQGSURWHLQFRQWHQWLQ 7R[LFLW\$VVHVVPHQW$OWHUQDWLYHV0HWKRGV,VVXHV2SSRUWXQLWLHV6DOHP+DQG.DW] 6$(GV+XPDQD3UHVV7RWRZD1-² 6PLWK:-6DQGHUV.0*DOHV<$DQG*URVV&/ )ORZF\WRPHWULFDQDO\VLV RIWR[LFLW\E\YHVLFDWLQJDJHQWVLQKXPDQFHOOVLQYLWUR-7R[LFRO&XWDQHRXV2FXODU 7R[LFRO² =LPPHUPDQ$0 (IIHFWV RI PHUFDSWRHWKDQRO RQ WKH IXUURZLQJ FDSDFLW\ RI DUEDFLD HJJV%LRO%XOO²
CHAPTER
22
Studies of Cellular Biochemical Changes Induced in Human Cells by Sulfur Mustard :LOOLDP-6PLWK2IÀH(&ODUN,,,)UHG0&RZDQ0DXUD('H-RVHSK &KDULVVH'DYHQSRUWDQG&ODUN/*URVV
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV &HOO&XOWXUHV +(. +H/D /\PSKRF\WHV '1$,VRODWLRQ 5HDJHQWV 3KHQRO&KORURIRUP([WUDFWLRQ &RPPHUFLDO.LWV 0RGLÀHG.LW8VDJH 3XOVH)LHOG*HO(OHFWURSKRUHVLV3)*( 3$53$VVD\ &DOFLXP0HDVXUHPHQW ,QWHUOHXNLQ(/,6$ 0HDVXUHPHQWRI)FDQG&T5HFHSWRUV 5HVXOWV 'LVFXVVLRQ 5HIHUHQFHV
259
260
ALTERNATIVE TOXICOLOGICAL METHODS
INTRODUCTION 7KH PLVVLRQ RI WKH 86 $UP\ 0HGLFDO 5HVHDUFK ,QVWLWXWH RI &KHPLFDO 'HIHQVH 05,&' LQFOXGHV EDVLF UHVHDUFK LQWR WKH PHFKDQLVPV RI DFWLRQ RI FKHPLFDOWKUHDWDJHQWV7KHUHVXOWVREWDLQHGIURPVXFKVWXGLHV DUHWKHQXVHGWR GHÀQHSKDUPDFRORJLFDOLQWHUYHQWLRQVWUDWHJLHVWRSURWHFWZDUÀJKWHUVDQGFLYLO LDQV DJDLQVW LQMXU\ E\ WKHVH DJHQWV 7KH FHOOXODU SKDUPDFRORJ\ WHDP DW WKH 05,&'IRFXVHVLWVUHVHDUFKRQWKHDFWLYHFHOOXODUDQGWLVVXHSDWKRJHQLFPHFK DQLVPV DFWLYH IROORZLQJ H[SRVXUH WR VXOIXU PXVWDUG dGLFKORURHWK\O VXOÀGH $UP\GHVLJQDWLRQ+' 7KLVUHSRUWSUHVHQWVVRPHRIWKHUHVXOWVRIWKRVHVWXGLHV DQGUDLVHVTXHVWLRQVSHUWDLQLQJWRPRGHOVDQGSURFHGXUHVHPSOR\HG
MATERIALS AND METHODS Cell Cultures HEK 3ULPDU\FXOWXUHVRIDGXOWQRUPDOKXPDQHSLGHUPDONHUDWLQRF\WHV+(.V ZHUH REWDLQHG IURP &ORQHWLFV &RUSRUDWLRQ 6DQ 'LHJR &$ 7KH FHOOV ZHUH SDVVDJHG LQWRRUFPWLVVXHFXOWXUHÁDVNVPDLQWDLQHGLQ.HUDWLQRF\WHJURZWKPHGLD .*0&ORQHWLFV DQGJURZQWRYDULRXVFRQÁXHQFLHV+(.VZHUHH[SRVHGWRHLWKHU RU Q0 +' DORQJ ZLWK XQWUHDWHG FRQWUROV 3RVWH[SRVXUH LQFXEDWLRQ WLPHV ZHUH IURP WR KU DIWHU ZKLFK FHOOV ZHUH KDUYHVWHG E\ 7U\SVLQ('7$ &ORQHWLFV&RUSRUDWLRQ HeLa +H/DFXOWXUHVZHUHPDLQWDLQHGLQFPFXOWXUHÁDVNV&RUQLQJ*ODVV:RUNV &RUQLQJ1< LQPLQLPDOHVVHQWLDOPHGLXP0(0 ZLWKIHWDOFDOIVHUXP)&6 DWr&DQG&2 :KHQ WKH FXOWXUHV ZHUH WR FRQÁXHQW WKH PHGLXP ZDV UHPRYHG DQG UHSODFHG ZLWK D PHGLXP FRQWDLQLQJ +' WR Q0 DQG WKH FHOOV ZHUH LQFXEDWHG IRU PLQ LQ DQ DSSURYHG IXPH KRRG DW URRP WHPSHUDWXUH WR UHPRYH DQ\ KD]DUGRXV YDSRUV $IWHU KU WKH PHGLXP ZDV UHPRYHG DQG UHSODFHG ZLWK IUHVK 0(0 ZLWKRXW +' WR LQFXEDWH DQ DGGLWLRQDO WR KU 7KH FHOOV ZHUH KDUYHVWHGE\UHPRYLQJWKHPHGLXPDQGDGGLQJSKRVSKDWHEXIIHUHGVDOLQHFRQWDLQ LQJWU\SVLQDQG('7$WRWKHÁDVN7KHGHWDFKHGFHOOVZHUHSLSHWWHGLQWRDFRQLFDO FHQWULIXJH WXEH FRQWDLQLQJ 0(0 ZLWK )&6 DQG 7U\SVLQ LQKLELWRU VROXWLRQ &ORQHWLFV6DQ'LHJR&$ 7KHFHOOVZHUHKDUYHVWHGYLDFHQWULIXJDWLRQDWvJ IRU PLQ7KH VXSHUQDWH ZDV UHPRYHG DQG WKH FHOOV VXVSHQGHG LQ PO RI P07ULVEXIIHUS+ DQGP00J&O7KHFXOWXUHVZHUHPDLQWDLQHGRQLFH XQWLOWKHDVVD\ZDVLQLWLDWHG
BIOCHEMICAL CHANGES INDUCED IN CELLS BY SULFUR MUSTARD
261
Lymphocytes %ORRGZDVREWDLQHGIURPDQRUPDOKXPDQYROXQWHHUXQGHUDQDSSURYHGKXPDQ XVHSURWRFRO7KHEORRGZDVGLOXWHGZLWKSKRVSKDWHEXIIHUHGVDOLQH3%6 DQG('7$ 6LJPD6W/RXLV02 OD\HUHGRQD3HUFROOG DQGFHQWULIXJHGDWv J IRU PLQ DW r& 7KH O\PSKRF\WH EDQG ZDV UHPRYHG FROOHFWHG SODFHG LQ D FHQWULIXJHWXEHDQGWKHQFHQWULIXJHGDWvJIRUPLQ3HOOHWVZHUHUHVXVSHQGHG DQGZDVKHGZLWK7\URGHVIUHHZLWKJOXFRVHUHFHQWULIXJHGDVDERYHDQGUHVXVSHQGHG LQ530,6LJPD6W/RXLV02 DNA Isolation Reagents 7KHIROORZLQJEXIIHUVDQGVROXWLRQVZHUHHPSOR\HG
/\VLVEXIIHU³P01D('7$P07ULV³+&O/DXUR\OVDUFRVLQH 7(EXIIHUFRQVLVWHGRIP07ULV7UL]PD%DVH P01D('7$S+ v7%(%XIIHU³v7%(LQP07ULVP0ERULFDFLGP0('7$S+ 6WRUDJHEXIIHU³0('7$S+ v5HDFW%XIIHU³SUHSDUHGDVSHUPDQXIDFWXUHU·VLQVWUXFWLRQVDOLTXRWHGLQPO YROXPHV 3URWHLQDVH.VWRFN XVHGWRPJPOLQ6'6 51DVHVWRFN PJPO 1RW,UHVWULFWLRQHQ]\PH³XQLWVDW8QO 3KHQ\OPHWK\OVXOIRQ\OÁXRULGH306) P0VWRFNVROXWLRQ,VRSURSDQRO 6RGLXPDFHWDWH³0VROXWLRQSUHSDUHGSHUPDQXIDFWXUHUVLQVWUXFWLRQVS+
Phenol-Chloroform Extraction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ommercial Kits .LWVIRULVRODWLRQRI'1$IURPPDPPDOLDQFHOOVDQGWLVVXHZHUHREWDLQHGIURP %RHKULQJHU0DQQKHLPDQGXVHGDFFRUGLQJWRWKHPDQXIDFWXUHU·VGLUHFWLRQV
262
ALTERNATIVE TOXICOLOGICAL METHODS
Modified Kit Usage 7KH IROORZLQJ PRGLÀFDWLRQV WR WKH %RHKULQJHU NLW ZHUH HPSOR\HG WKH O\VLV EXIIHUWHPSHUDWXUHZDVGHFUHDVHGIURPWRr&WKHDPRXQWRISURWHLQDVH.ZDV GRXEOHGWKHSURWHLQSUHFLSLWDWLRQVWHSZDVH[WHQGHGWRRYHUQLJKWDW²r& Pulse Field Gel Electrophoresis (PFGE) 3)*(ZDVUXQXVLQJORZPHOWDJDURVHDQGDUXQQLQJJHO7KHJHOV ZHUH VWDLQHG ZLWK QO RI 6<%5 JUHHQ QXFOHLF DFLG VWDLQ LQ PO RI v 7%(EXIIHU PARP Assay 7KHFHOOVXVSHQVLRQZDVVRQLFDWHGRQLFHZLWKDPLFURWLSVHWWLQJRI LQD %UDQZLOO%LRVRQLN,,,VRQLFDWRUE\SXOVLQJIRUVHFIROORZHGE\PLQRIFRROLQJ 7KLV VWHS ZDV UHSHDWHG WZLFH IRU PD[LPDO OLEHUDWLRQ RI SRO\$'3ULERVH SRO\ PHUDVH6XGKDNDUHWDO 7KHVWDQGDUGDVVD\LQYROYHGWKHDGGLWLRQRIVDPSOH QJ ZHW ZHLJKW RI FHOOV WR D UHDFWLRQ PL[WXUH P0 WULV >S+ @ DQG P0 0J&O ZLWK D ÀQDO YROXPH RI QO7KH UHDFWLRQ PL[WXUH ZDV LQFXEDWHG IRU VHF DW r& DQG WKH UHDFWLRQ LQLWLDWHG E\ WKH DGGLWLRQ RI QO RI >$GH QLQH²+@1$' VSHFLÀF DFWLYLW\ P&LP0RO DW D ÀQDO FRQFHQWUDWLRQ RI Q0 1$' 1$' LQ H[FHVV 7KH UHDFWLRQ SURFHHGHG IRU VHF DW r& DQG ZDV WHUPLQDWHG E\ WKH DGGLWLRQ RI PO RI WULFKORURDFHWLF DFLG 7&$ 7KH VDPSOHZDVSODFHGRQLFHIRUDWOHDVWPLQDQGWKHUHVXOWLQJSUHFLSLWDWHFROOHFWHG RQ Q0 SRUH VL]H ÀOWHUV :KDWPDQ +LOOVERUR 25 ZDVKHG ZLWK PO RI 7&$ ULQVHG ZLWK PO RI HWKDQRO DQG GULHG 5DGLRDFWLYLW\ ZDV GHWHUPLQHGE\OLTXLGVFLQWLOODWLRQVSHFWURPHWU\ Calcium Measurement 7ZRW\SHVRI+(.SUHSDUDWLRQVZHUHXVHGWU\SVLQL]HGVXVSHQGHGDQGFRYHUVOLS JURZQ7KHUPDQR[&RYHUVOLSV1XQF 7KHVXVSHQGHG+(.ZHUHDWDFRQFHQWUDWLRQ RI v PO LQ .*0 7KH FRYHUVOLS FHOO FRQFHQWUDWLRQ ZDV DVVXPHG WR EH DSSUR[LPDWHO\ WKH VDPH DV WKH VXVSHQGHG FHOOV %RWK FHOO SUHSDUDWLRQ W\SHV ZHUH ORDGHGZLWKQ0)XUD$0WKHDFHWR[\PHWK\OHVWHUIRUP0ROHFXODU3UREHV 7KHFHOOVZHUHLQFXEDWHGLQWKHGDUNIRUPLQDQGWKHQZDVKHG7KHFHOOVZHUH WUDQVIHUUHGWRDFXYHWWH³HLWKHUPOVXVSHQGHGFHOOVZLWKPO3%6RUFRYHUVOLS LQPO3%6GHSHQGLQJRQWKHH[SHULPHQW$ÁXRURPHWULFVFDQZDVSHUIRUPHGXVLQJ DQH[FLWDWLRQUDWLRRIQPDQGQPHPLVVLRQ$EDVHOLQHZDVHVWDEOLVKHG IRU WKH FHOOV DQG DV WKH VFDQ FRQWLQXHG WR UXQ +' ZDV DGGHG WR WKH FXYHWWH WR D ÀQDOFRQFHQWUDWLRQRIQ07KHVFDQZDVFDUULHGRXWRYHUWRPLQ Interleukin ELISA 4XDQWLNLQH(OLVDNLWVIRUKXPDQ,/E,/F,/DQG,/ZHUHREWDLQHGIURP 5 '6\VWHPV0LQQHDSROLV01 DQGXVHGDFFRUGLQJWRPDQXIDFWXUHU·VGLUHFWLRQV
BIOCHEMICAL CHANGES INDUCED IN CELLS BY SULFUR MUSTARD
263
Measurement of Fc and C1q Receptors $WDQGKUDIWHU+'H[SRVXUHDGKHUHQW+(.ZHUHVWDLQHGZLWKÁXRURFKURPH FRQMXJDWHGPRQRFORQDODQWLERGLHVDJDLQVWWKH)F5,,,&' )F5,,&' 3KDUP LQJHQ6DQ'LHJR&$ RUXQFRQMXJDWHGDQWLKXPDQ&T4XLGHO6DQ'LHJR&$ FRXQWHUVWDLQHGZLWKÁXRURFKURPHFRQMXJDWHGDQWLPRXVH,*3KDUPLQJHQ )OXRUHV FHQFHLQWHQVLW\ZDVMXGJHGPLFURVFRSLFDOO\RQD=HLVVÁXRUHVFHQWPLFURVFRSH
RESULTS 2XU LQLWLDO DWWHPSWV DW SXOVHGÀHOG JHO HOHFWURSKRUHVLV 3)*( RI +(. '1$ IROORZLQJH[SRVXUHWR+'XVHGWKHSURFHGXUHGHVFULEHGE\%HQWOH\HWDO LQ ZKLFKWUHDWHGFHOOVDUHSODFHGLQDJDURVHSOXJVH[SRVHGWRO\VLQJEXIIHUVDQGWKHQ WUDQVIHUUHG WR WKH JHOV 7KLV VWHS SUHVXPDEO\ ZRXOG VLJQLÀFDQWO\ UHGXFH WKH WLPH DQGKDQGOLQJIRURSWLPL]HGDQDO\VLVEXWZHFRXOGQRWGHWHFW'1$PLJUDWLRQWKURXJK WKH3)*(7RHQVXUHWKDW+(.'1$H[KLELWHGQRUPDOPLJUDWLRQSDWWHUQVWKURXJK RXU 3)*( ZH XVHG D FRPPHUFLDO '1$ LVRODWLRQ NLW IURP %RHKULQJHU0DQQKHLP GHVLJQHGIRUPDPPDOLDQFHOOVDQGWLVVXHV$OWKRXJKZHREWDLQHGORZ\LHOGVRI'1$ WKHSXULW\RIWKHLVRODWHVZDVLQVXIÀFLHQWDVMXGJHGE\WKHQPUDWLRPXVW EH! 7KHVHUHVXOWVDORQJZLWKWKRVHRIRXURWKHULVRODWLRQDWWHPSWVDUHOLVWHGLQ 7DEOH 7R YDOLGDWH WKH DELOLW\ RI WKH NLWV WR LVRODWH KXPDQ '1$ ZH XVHG KXPDQ SHULSKHUDOEORRGOHXNRF\WHV3%/ DQGREWDLQHGJRRG\LHOGUHFRYHULHVZLWKDGHTXDWH SXULW\8VLQJSKHQROFKORURIRUPH[WUDFWLRQRI'1$ZHDOVRIDLOHGWRJHQHUDWHGHFHQW \LHOGVRISXUH'1$IURPFRQWURO+(.:HPRGLÀHGWKHNLWSURFHGXUHDVGHVFULEHG LQWKHPHWKRGVDQGXOWLPDWHO\\LHOGHGVXIÀFLHQWTXDQWLWLHVRISXUH'1$IURPFRQWURO +(.7KLVPRGLÀHGH[WUDFWLRQSURFHGXUHZDVWKHQXVHGRQ+'H[SRVHGFHOOVDQG 7DEOHVKRZVWKHKLJK\LHOGVDQGSXULWLHVREWDLQHG Table 22.1 Problems Seen with DNA Isolation from HEK
Procedure
Date
Sample
Purity Level of DNA (260/280 Ratio)
Purification of HEK DNA using Boehringer Mannheim Kit for mammalian cells Purification of lymphocyte DNA using Boehringer Mannheim Kit for mammalian blood Phenol/chloroform extraction of HEK DNA
8/4/98 8/18/98 8/24/98 9/2/98 9/8/98 9/29/98 10/1/98 10/7/98 10/13/98 10/19/98 10/27/98 11/5/98
Control Control Control Control Control Control Control Control Control Control Control Control
1.35 1.65 1.35 1.82 1.81 1.93 1.22 1.35 1.47 1.90 1.86 1.86
Purification of HEK DNA using Boehringer Mannheim Kit for mammalian cells (modified procedure)
DNA Yield (mg/ml) 60 45 25 189 185 194 60 33 67 94 93 98
264
ALTERNATIVE TOXICOLOGICAL METHODS
Table 22.2 Purification of HEK DNA using Boehringer Mannheim Kit for Mammalian Cells Exposed to Sulfur Mustard (HD) Date 11/19/98
11/26/98
12/8/98
Sample Control 50 mM HD 100 mM HD 300 mM HD Control 50 mM HD 100 mM HD 300 mM HD Control 50 mM HD 100 mM HD 300 mM HD
Purity Level of DNA (260/280 Ratio)
DNA Yield
1.81 2.10 1.89 1.82 1.85 1.99 1.86 1.81 1.98 1.96 1.91 1.86
122 163 150 199 194 213 198 172 183 179 176 199
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ÁXHQFLHVIURPWR%DVHGRQGLVFXVVLRQVZLWK RXUFROOHDJXHVDW'5(6ZHXQGHUWRRNVWXGLHVXVLQJSDVVDJH+(.8VLQJDGKHUHQW FHOOVRQFRYHUVOLSVDWDQ\FRQÁXHQF\RUWU\SVLQL]HGFHOOVWKDWKDGEHHQDWFRQÁX HQF\ZHRQFHDJDLQIDLOHGWRGHWHFWDQ\FKDQJHLQLQWUDFHOOXODUFDOFLXPOHYHOVLQ+(. H[SRVHGWRQ0+'%XWZKHQZHXVHGSDVVDJH+(.JURZQWRIXOOFRQÁXHQF\ WU\SVLQL]HGWKHFHOOVDQGH[SRVHGWKHPDVVXVSHQVLRQVZHZHUHDEOHWRGHWHFWDVPDOO HOHYDWLRQRILQWUDFHOOXODUFDOFLXPZLWKLQPLQRIH[SRVXUH)LJXUH 6LQFHWKHWLVVXHUHVSRQVHWR+'LVNQRZQWRLQYROYHDQLQÁDPPDWRU\FRPSRQHQW ZHDWWHPSWHGWRGHÀQHWKHLQÁDPPDWRU\UHODWHGUHVSRQVHVRI+(. WRLQYLWUR+' H[SRVXUH8VLQJLPPXQRÁXRUHVFHQWDVVD\VZLWKFRPPHUFLDOPRQRFORQDODQWLERGLHV ZH ZHUH DEOH WR GHWHFW LQFUHDVHG H[SUHVVLRQ RI UHFHSWRUV IRU WKH )F UHJLRQ RI LPPXQRJOREXOLQDQGUHFHSWRUVIRUWKHLQLWLDWLQJVHTXHQFHRIWKHFRPSOHPHQWSDWK ZD\&T7DEOH ,QDGGLWLRQXVLQJ(OLVDDVVD\VIRUKXPDQLQWHUOHXNLQVZH GHPRQVWUDWHG VLJQLÀFDQWO\ LQFUHDVHG UHOHDVH RI ,/F ,/ DQG ,/ LQ FXOWXUH VXSHUQDWDQWÁXLGVDWKUDIWHUQ0+',/ZDVDOVRVLJQLÀFDQWO\HOHYDWHGDW DQGQ0)LJXUH
BIOCHEMICAL CHANGES INDUCED IN CELLS BY SULFUR MUSTARD
265
HeLa PARP enzyme activity
120
% of maximum response
100
80
60
40
20
0
1
2
4
6
9
24
Time post-HD (h) 100 µM HD 10 µM HD
HEK PARP enzyme activity
140
% of maximum response
120 100 80 60 40 20 0 1
2
4
6
24
Time post-HD (h) x-axis vs. 100 µM HD x-axis vs. 10 µM HD
Figure 22.1 Time-dependent response of PARP activity following HD exposure of (top) HeLa cells and (bottom) HEK cells. Two concentrations of HD were used, 10 and 100 QM, and PARP activities are presented as percent maximal response.
DISCUSSION :HHQFRXQWHUHGVLJQLÀFDQWGLIÀFXOWLHVLVRODWLQJSXUH'1$IURPERWKFRQWURODQG +' H[SRVHG FHOOV $OWKRXJK ZH KDYH QRW VHHQ VLPLODU GLIÀFXOWLHV UHSRUWHG LQ WKH OLWHUDWXUHVLPLODUREVHUYDWLRQVKDYHEHHQPDGHDW05,&'IRU\HDUV$IWHUPRGLÀFDWLRQ RI %RHKULQJHU·V NLW SURFHGXUH ZH ÀQDOO\ UHFRYHUHG JRRG TXDQWLWLHV RI SXUH '1$ +RZHYHU '1$ IURP +'WUHDWHG +(. IDLOHG WR PLJUDWH SDVW WKH RULJLQ E\ 3)*(
266
ALTERNATIVE TOXICOLOGICAL METHODS
2.6
Ratio (340:380 nm)
2.5 2.4 2.3 2.2 2.1 2.0 1.9 1.8 1.7 0
200
400
600
800
1000
1200
1400
Time (s) Figure 22.2 Increase in intracellular calcium in HEK (passage 2) exposed to 300 QM HD as measured by 340:380 nm ratio of Fura-2 AM. Table 22.3 Binding in HD-Exposed HEKa QM) Dose HD (Q 100 200
Hrs post HD C 1q
0
8 16 24
– – –
– – +
– NT +++
– ++ +++
CD32
0
50
100
200
8 24
– –
+ +
+ ++
+ +++
a
300
+ = weak; ++ = moderate; +++ = intense; NT = not tested. Grading of staining was judged visually by fluorescence microscope and HEK controls not exposed to HD were negative for fluorescence.
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ÁHFWWKHNLQHWLFVRI'1$ VWUDQGEUHDNDJHLQWKHGLIIHUHQWFHOOW\SHV%RWKFHOOW\SHVVKRZDUHERXQGLQ3$53 DFWLYLW\DWKUZKLFKPD\EHUHODWHGWRDVHFRQGDU\GHSOHWLRQLQFHOOXODU1$' RFFXUULQJDURXQGKUSRVWH[SRVXUHXQSXEOLVKHGREVHUYDWLRQ 7KH FDOFLXP UHVXOWV DUH LQWULJXLQJ DQG UDLVH VHULRXV TXHVWLRQV DERXW WKH LQ YLWUR PRGHOVEHLQJXVHG:KLOHRXUQRUPDOFXOWXUHFRQGLWLRQVSDVVDJHDQGOHVVWKDQ FRQÁXHQF\ KDYHQHYHUVKRZQDOWHUDWLRQVRILQWUDFHOOXODUFDOFLXPOHYHOVIROORZLQJ+' XVLQJSDVVDJHFXOWXUHVDWFRQÁXHQF\JDYHUHVXOWVQRWLQFRQVLVWHQWZLWKWKRVH
BIOCHEMICAL CHANGES INDUCED IN CELLS BY SULFUR MUSTARD
267
4000 3500
pg/ml IL-8
3000 2500 2000 1500 1000 500 0 -50
0
50
100
150
200
250
300
350
HD Concentration HD-exposed HEK
Figure 22.3 Concentration-dependent increase in the secretion of IL-8 from HEK exposed to HD.
UHSRUWHGE\+DPLOWRQHWDO :KDWDUHWKHRSWLPDOFRQGLWLRQVRI+(.JURZWK DVWRSDVVDJHQXPEHUDQGFRQÁXHQF\DWWLPHRIH[SRVXUH"'R+(.VLQYLWURPLPLF WKHLULQYLYRFRXQWHUSDUWVLQDOOELRFKHPLFDOUHVSRQVHVWRWR[LFDJHQWV"7KHVHTXHVWLRQV PXVWEHDGGUHVVHGLIWKH+(.PRGHOLVWRDGYDQFHRXUNQRZOHGJHRIWKH+'LQMXU\ 7KH LQFUHDVHG H[SUHVVLRQ RI )F DQG &T UHFHSWRUV DORQJ ZLWK ,/ LQ +(. H[SRVHGWR+' LQYLWURVXSSRUWVWKHFRQFHSWRIDSULPDU\UROHRIEDVDOHSLGHUPDO FHOOVLQJHQHUDWLRQRIDQLQÁDPPDWRU\UHVSRQVHLQWLVVXHH[SRVHGWR+'LQYLYR:H KDYHVHHQKLVWRSDWKRORJLFHYLGHQFHRIHGHPDDQGLQGXUDWLRQLQH[SRVHGWLVVXHORQJ EHIRUHLQÀOWUDWLQJLQÁDPPDWRU\FHOOVFDQEHGHWHFWHG7KHGDWDSUHVHQWHGKHUHDUJXH WKDW WKH SURJHQLWRU RI WKH +'LQGXFHG LQÁDPPDWRU\ UHVSRQVH PD\ EH VNLQ NHUDWL QRF\WHVZLWKIXOOSUHVHQWDWLRQRIWKHLQÁDPPDWRU\GDPDJHEHLQJDFRPELQDWLRQRI HDUO\DQGODWHHYHQWVLQYROYLQJDOOFRPSRQHQWVRIWKHLQÁDPPDWRU\UHVSRQVH 7KH KXPDQ HSLGHUPDO NHUDWLQRF\WH FHOO FXOWXUH PRGHO KDV EHHQ DORQJ ZLWK KXPDQ3%/DPDLQVWD\RIFHOOXODUUHVHDUFKLQWRWKHPHFKDQLVPVRIDFWLRQRI+' 7KHUHDUHKRZHYHUPDQ\TXHVWLRQVWKDWPXVWEHDGGUHVVHGDVZHDSSURDFKGHÀQLQJ DQWLYHVLFDQWFRXQWHUPHDVXUHV:HZLOOQHYHUEHSHUPLWWHGWRH[SRVHKXPDQVWR+' IRUUHVHDUFKSXUSRVHVEHFDXVHRILWVFDUFLQRJHQLFSRWHQWLDO7KHUHIRUHVHOHFWLRQDQG RSWLPL]DWLRQRILQYLWURDQGH[YLYRPRGHOVZLOOEHFUXFLDOWRDQ\ORQJWHUPVXFFHVV REFERENCES %HQWOH\./%LHEHULFK&-DQG5XGGOH)+ 3XOVHGÀHOGHOHFWURSKRUHVLVSURFH GXUHVSUREOHPVDQGSUDFWLFDOLWLHVLQ0HWKRGVLQ1XFOHLF$FLGV5HVHDUFK&5&3UHVV %RFD5DWRQ)/FK +DPLOWRQ0'RUDQGHX)0F&DIIHU\0DQG6DZ\HU7 0RGLÀFDWLRQRIF\WROVROLF IUHHFDOFLXPFRQFHQWUDWLRQVLQKXPDQNHUDWLQRF\WHVDIWHUVXOSKXUPXVWDUGH[SRVXUH 7R[LFRO,Q9LWUR² 6XGKDNDU 6 7HZ .' DQG 6PXOVRQ 0( (IIHFW RI PHWK\OQLWURVRXUHD RQ SRO\DGHQRVLQH GLSKRVSKDWHULERVH SRO\PHUDVH DFWLYLW\ DW WKH QXFOHRVRPDO OHYHO &DQFHU5HV²
CHAPTER
23
Human Keratinocyte Inflammatory Transcript Gene Activity Following Sulfur Mustard* -RKQ-6FKODJHU.DVKLI$OL+LOPD5%HQMDPLQ&ODLUH)/HYLQH 'RXJODV3$YHU\DQG-DPHV+&ODUN
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV 0DWHULDOV &HOO&XOWXUHDQG([SRVXUH 51$3UHSDUDWLRQ 3URELQJF'1$$UUD\%ORW 6XEWUDFWLRQ/LEUDU\&RQVWUXFWLRQ 6XEWUDFWLRQ/LEUDU\6HTXHQFHDQG$QDO\VLV 5HVXOWV 'LVFXVVLRQDQG&RQFOXVLRQV 5HIHUHQFHV
INTRODUCTION +XPDQVNLQH[SRVXUHWR60GLVUXSWVWLVVXHKRPHRVWDVLVWKURXJKFRYDOHQWDON\ ODWLRQ RI FHOOXODU QXFOHRSKLOHV ([SRVXUH WR 60 DW D VXIÀFLHQW GRVH SURGXFHV VNLQ EOLVWHUV DW WKH HSLGHUPDOGHUPDO MXQFWLRQ 3DSLUPHLVWHU HW DO 3HWUDOL DQG 2JHVE\0HJHH 7KH VSHFLÀF FHOOXODU SDWKZD\V DIIHFWHG E\ 60 DON\ODWLRQ
7KHRSLQLRQVRUDVVHUWLRQVFRQWDLQHGKHUHLQDUHWKHSULYDWHYLHZVRIWKHDXWKRUVDQGDUHQRWWREHFRQVWUXHG DVRIÀFLDORUDVUHÁHFWLQJWKHYLHZVRIWKH'HSDUWPHQWRIWKH$UP\RUWKH'HSDUWPHQWRI'HIHQVH
269
270
ALTERNATIVE TOXICOLOGICAL METHODS
OHDGLQJWRWKLVORVVRIHSLGHUPDO²GHUPDODGKHUHQFHDVZHOODVWKHDFWLYDWHGSDWKZD\V SURGXFLQJWKHODWHQWLQÁDPPDWLRQWKDWIRUPVODUJHÁXLGÀOOHGKXPDQVNLQEOLVWHUV KDYHEHHQGLIÀFXOWWRHOXFLGDWH:HZHUHLQWHUHVWHGLQXVLQJWUDQVFULSWLRQDODQDO\VLV WRLGHQWLI\WKHLQÁDPPDWRU\RULUULWDQWFRPSRQHQWVRI60H[SRVXUHLQFXOWXUHGDGXOW KXPDQHSLGHUPDONHUDWLQRF\WHV+(. 7ZR60H[SRVXUHFRQFHQWUDWLRQVZHUHVWXG LHG D KLJK GRVH DW Q0 60 LQ PO RI PHGLXP ZKLFK LV HVWLPDWHG WR EH HTXLYDOHQWWRDVNLQEOLVWHULQJH[SRVXUHDQGDORZGRVHDWQ060ZKLFKLVQRW VXIÀFLHQWWRSURGXFHVNLQYHVLFDWLRQEXWNQRZQWRSURGXFHVLJQLÀFDQW'1$GDPDJH 6PLWK HW DO +DUW DQG 6FKODJHU 7KH Q0 60 FRQFHQWUDWLRQ ZDV XVHGIRUFRPSDULVRQWRWKHQ060H[SRVXUHWRGLVWLQJXLVKWKHWUDQVFULSWLRQDO HYHQWVDVVRFLDWHGZLWKFHOOXODUGDPDJHSURGXFLQJLQÁDPPDWLRQRUEOLVWHULQJIURP WKRVH DVVRFLDWHG ZLWK '1$ GDPDJH DW D QRQEOLVWHULQJ H[SRVXUH *HQH H[SUHVVLRQ DVVD\VZHUHSHUIRUPHGZLWK51$LVRODWHGDWDQGKUDIWHU60H[SRVXUH7KLV WLPHIUDPHZDVFKRVHQVRWKDWDQDO\VHVZRXOGEHZLWKLQRUSUHFHGHWKHWLPHIUDPH NQRZQIRUKXPDQ60VNLQEOLVWHULQJDWWRKUSRVW60H[SRVXUH3DSLUPHLVWHU HWDO ,Q WKLV VWXG\ WZR SURFHGXUHV ZHUH XVHG WR LGHQWLI\ WKH 60LQGXFHG P51$ FKDQJHVLQ+(.EDVHGRQWKHDVVXPSWLRQWKDWDVLJQLÀFDQWHOLFLWDWLRQGLYHUVLW\RI WUDQVFULSWVRFFXUVIROORZLQJD60H[SRVXUH,QWKHÀUVWDSSURDFKP51$WUDQVFULSWV ZHUHLVRODWHGDWKUIURPXQWUHDWHG+(.DQGIURP+(.WUHDWHGZLWKHLWKHURU Q0607KHSXULÀHGSRO\$P51$ZDVUHYHUVHWUDQVFULEHGLQWRUDGLRODEHOHG F'1$WKDWZDVXVHGWRSUREHDEORWFRQWDLQLQJNQRZQWUDQVFULSWLRQDOO\UHJXODWHG KXPDQJHQHV7KHVHFRQGDSSURDFKXVHGDSRO\PHUDVHFKDLQUHDFWLRQ3&5 VXE WUDFWLRQ OLEUDU\ JHQHUDWLRQ WHFKQLTXH 'LDWFKHQNR HW DO WR FDSWXUH WKH SUH GRPLQDQWWUDQVFULSWVXSUHJXODWHGDWDQG Q060H[SRVXUHVDWDQGKU 7KHVXEWUDFWLRQOLEUDU\WHFKQLTXHZDVSHUIRUPHGWRHQVXUHLVRODWLRQRIDQ\GRPLQDQW LQÁDPPDWRU\WUDQVFULSWQRWFRQWDLQHGRQWKHF'1$DUUD\EORW$OWKRXJKPDQ\PRUH JHQH FKDQJHV ZHUH IRXQG XVLQJ ERWK SURFHGXUHV WKLV UHSRUW IRFXVHV RQ RQO\ WKH LQÁDPPDWLRQDVVRFLDWHGWUDQVFULSWVLGHQWLÀHGE\WKHVHWHFKQLTXHV
MATERIALS AND METHODS Materials 7KH KXPDQ $WODV¦ JHQH DUUD\ $WODV,PDJH VRIWZDUH 3&5VHOHFW¦ F'1$VXEWUDFWLRQNLWDQG$GYDQ7$JH¦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²r&$OORWKHUFKHPLFDOVDQGUHDJHQWVXVHGZHUHREWDLQHGIURP6LJPD&KHPLFDO 6W/RXLV02 XQOHVVRWKHUZLVHVWDWHG
HUMAN KERATINOCYTE SM INFLAMMATORY TRANSCRIPT GENE ACTIVITY
271
Cell Culture and Exposure +(.VIURPDGXOWEUHDVWWLVVXHORWGRQRUDJH ZHUHREWDLQHGDVF\UR SUHVHUYHGÀUVWSDVVDJH3 VWRFNVRIvFHOOVYLDOIURP&ORQHWLFV,QF6DQ 'LHJR&$ &HOOVZHUHWKDZHGDQGVHHGHGDWFPLQWRFPÁDVNV&RUQLQJ $FWRQ0$ +(.VZHUHJURZQLQNHUDWLQRF\WHJURZWKPHGLXP.*0'&ORQHWLFV WR WR GHQVLW\ SULRU WR WU\SVLQ GHWDFKPHQW DQG UHVHHGLQJ DW FP LQWR FPÁDVNV7KLUGSDVVDJHÁDVNVRI+(.DWFRQÁXHQFHZHUHUHPRYHGIURP WKHr&FXOWXUHLQFXEDWRUDQGDOORZHGWRFRROWRURRPWHPSHUDWXUHSULRUWRWUHDW PHQW$IUR]HQDOLTXRWV RI60.*0ZDVWKDZHGDQGZKHQWKHWZROLTXLGSKDVHV ZHUHDSSDUHQWE\QRWLQJWKHQO60GURSOHWDP060VROXWLRQZDVSUHSDUHG E\UDSLGOLTXLGYRUWH[LQJ7KLV60VROXWLRQZDVSODFHGLPPHGLDWHO\LQDQLFHEDWK WR VORZ WKH UDWH RI K\GURO\VLV GXULQJ 60 DGGLWLRQ WR FHOO PHGLXP 7KUHH WR ÀYH ÁDVNVSHUH[SRVXUHFRQGLWLRQZHUHHLWKHUOHIWXQWUHDWHGFRQWURO RUH[SRVHGWR RUQ060LQPOIRUERWKWLPHSRLQWVLQYHVWLJDWHG RNA Preparation $WDQGKUWKHPHGLXPZDVUHPRYHGDQGWKHFHOOVIURPERWKWUHDWHGDQGFRQWURO ÁDVNVZHUHO\VHGZLWKDEXIIHUFRQWDLQLQJ0JXDQLGLXPWKLRF\QDQDWHP0VRGLXP FLWUDWHVRGLXPVDUFRVLQHS+7RWDOFHOOXODU51$ZDVLVRODWHGXVLQJWKHDFLG JXDQLGLXP WKLRF\QDQDWH EXIIHUSKHQROFKORURIRUP H[WUDFWLRQ PHWKRG )DUUHOO $IWHUSKDVHVHSDUDWLRQDQGSUHFLSLWDWLRQWKH51$VDPSOHVZHUHVROXELOL]HGLQJXDQLG LXPEXIIHUDQGVWRUHGIUR]HQDW²r&XQWLOXVH-XVWSULRUWRF'1$SUHSDUDWLRQWKH 51$ZDVSXULÀHGE\SRO\$P51$VHOHFWLRQXVLQJDSRO\G7FROXPQ4LDJHQ9DOHQFLD &$ 7KHSXULÀHGP51$ZDVFRQFHQWUDWHGE\HWKDQROSUHFLSLWDWLRQLQWKHSUHVHQFHRI JO\FRJHQDQGGLVVROYHGLQZDWHUIRUGHWHUPLQLQJP51$FRQFHQWUDWLRQXVLQJDEVRUEDQFH DWQP7KHVHVDPSOHVZHUHXVHGWKHVDPHGD\IRUF'1$SUHSDUDWLRQ Probing cDNA Array Blot P51$QJ ZDVUDGLRODEHOHGZLWKE3G$73XVLQJ00/97KHUDGLRODEHOHG F'1$ZDVSXULÀHGDZD\IURPXQLQFRUSRUDWHGUDGLRQXFOHRWLGHVXVLQJJHOFROXPQV &ORQWHFK 7KHODEHOHGF'1$IURPHDFKWUHDWPHQWJURXSDQGFRQWUROZDVDGGHGWR DK\EULGL]DWLRQEXIIHUFRQWDLQLQJPJRIVDOPRQVSHUP'1$DQGWKHPL[WXUHVZHUH XVHGWRH[SRVHWKUHHVHSDUDWHF'1$EORWVZKLFKRULJLQDWHGIURPWKHVDPHSURGXFWLRQ ORW IRU KU DW r& 7KH EORWV ZHUH ULQVHG WKUHH WLPHV ZLWK v 66& 6'6 IROORZHGE\WZRWLPHVZLWKv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ÀFWUDQVFULSW7DEOHVDQG
272
ALTERNATIVE TOXICOLOGICAL METHODS
Table 23.1 HEK Housekeeping Gene Transcripts at 16 Hr Following Sulfur Mustard Gene Ratioa Gene Transcript 14-3-3 zeta protein 23 kDa Highly Basic Protein E-Tubulin F-Actin Glyceraldehyde 3-phosphate dehydrogenase HLA class I histocompatibility antigen C-4 alpha chain Hypoxanthine-guanine phosphoribosyltransferase Ribosomal Protein S9 Ubiquitin a
b
Control Intensityb
25 QM SM
200 QM SM
317 1689 307 236 612 487
0.7 2.0 0.57 1.2 0.44 0.94
0.44 2.3 1.4 1.2 1.1 1.0
59
0.9
3.7
978 2064
1.2 0.8
2.1 0.73
Induction ratio from phosphorimage densitometeric measurements of listed gene transcript normalized to the sum total of the detected transcript intensity/pixel density. Control intensity (grayscale pixel density) adjusted from background. Background was set at the median intensity of the blank space between the six array panels. The subtracted background intensity ranged from 19 to 43.
Table 23.2 HEK Inflammation-Associated Transcripts at 16 Hr Following Sulfur Mustard Gene Ratioa Gene Transcript CD40 Interleukin 1 E Interleukin 1 F Interleukin 2 receptor E subunit Interleukin 6 Interleukin 7 receptor E subunit Interleukin 8 Interleukin 13 Interleukin 15 Macrophage inflammatory protein 2E S19 ribosomal protein Tumor necrosis factor E a
b
c
Control Intensityb
25 QM SM
200 QM SM
86 67 101 148 494 131 16 349 215 11 886 50
4.9 0.1 0.6 0.3 0.7 0.4 —c 3.0 — — 0.9 —
0.3 1.4 3.5 0.4 0.6 0.7 20 0.7 0.03 13 2.1 1.4
Induction ratio from phosphorimage densitometeric measurements of listed gene transcript normalized to the sum total of the detected transcript density. Control intensity (grayscale pixel density) adjusted from background. Background was set at the median intensity of the blank space between the six array panels. The subtracted background intensity ranged from 19 to 43. Transcript not detected above background.
HUMAN KERATINOCYTE SM INFLAMMATORY TRANSCRIPT GENE ACTIVITY
273
1 2
Figure 23.1 Atlas cDNA array nylon blot image. HEK were exposed to 200 QM sulfur mustard for 16 h and mRNA isolated and 32P labeled as cDNA. The array contains doubledot blots of cDNA from 588 transcriptionally regulated genes and 9 housekeeping genes at the bottom of the array (see 3 housekeeping genes in rectangular box). Boxes 1 and 2 show expression of macrophage inflammatory protein 2E and interleukin 8, respectively. These inflammatory transcripts were at very low expression levels in control HEK.
Subtraction Library Construction P51$QJ ZDVUHYHUVHWUDQVFULEHGXVLQJ6XSHUVFULSW00/9/LIH7HFKQRO RJLHV*DLWKHUVEXUJ0' WRJHQHUDWHF'1$7KHF'1$IURPRQH60FRQFHQWUDWLRQ DQGLWVSDLUHGFRQWUROZHUHXVHGLQSURFHGXUHVVLPLODUWRWKRVHGHVFULEHGE\'LDWFK HQNRHWDO ZKLFKZHUHDFFRUGLQJWRWKH&ORQWHFK3&56HOHFWF'1$VXE WUDFWLRQNLWSURFHGXUHV7KHSUHSDUHGVXEWUDFWLRQOLEUDU\FRQVLVWHGRIWKHWUDQVFULSWV XSUHJXODWHGE\60 Subtraction Library Sequence and Analysis 7KHOLEUDULHVZHUHFORQHGLQWRWKHDGYDQWDJH3&5FORQLQJYHFWRU&ORQWHFK E\ 7$FORQLQJXVLQJWKH3&5SURGXFWVIURPWKHVXEWUDFWLRQOLEUDU\,QGLYLGXDOEDFWHULDO FRORQLHVZHUHFXOWXUHGRYHUQLJKWDQGSODVPLG'1$LVRODWHGZLWKD4LDJHQSODVPLG '1$PLQLSUHSFROXPQ'1$EDVHVHTXHQFHZDVGHWHUPLQHGE\F\FOH VHTXHQFLQJ XVLQJWKH3UL]P¦UHDFWLRQNLW3($SSOLHG%LRV\VWHPV)RVWHU&LW\&$ DQGUHDFWLRQ DQDO\]HG XVLQJ D '1$ VHTXHQFHU $SSOLHG %LRV\VWHPV PRGHO $ 6HTXHQFH LGHQWLÀFDWLRQZDVSHUIRUPHGE\FRPSDULQJWKHF'1$LQVHUWVHTXHQFHGDWDUHSUH VHQWLQJWKHVHQVHRUDQWLVHQVHVWUDQGRIWKHLVRODWHGP51$WUDQVFULSWZLWKDOONQRZQ
274
ALTERNATIVE TOXICOLOGICAL METHODS
VHTXHQFHVLQWKHQRQUHSHDWLQJ15 DQGWKHH[SUHVVLRQVHTXHQFHWDJ(67 GDWDEDVHV DWWKH1DWLRQDO&HQWHUIRU%LRWHFKQRORJ\,QIRUPDWLRQ1&%, XVLQJWKHEDVHDOLJQ PHQW SURJUDP %/$67 DYDLODEOH RQ WKH 1&%, ,QWHUQHW ZHE VLWH KWWSZZZQFELQOPQLKJRY $SSUR[LPDWHO\ EDFWHULDO FRORQLHV IURP HDFK OLEUDU\ZHUHVHOHFWHGIRUSODVPLGF'1$LQVHUWVHTXHQFHLGHQWLÀFDWLRQ
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ÁDPPDWRU\JHQHWUDQVFULSW FKDQJHV7DEOHOLVWVWKHLQÁDPPDWRU\WUDQVFULSWVH[SUHVVHGLQ+(.3ULPDU\ F\WRNLQHVIRXQGRQWKHDUUD\DWLQFUHDVHGOHYHOVDIWHUQ060H[SRVXUHZHUH LQWHUOHXNLQF,/F WXPRUQHFURVLVIDFWRUE71)E DQGLQWHUOHXNLQE,/ E 7DEOH 7KH ODUJHVW LQGXFWLRQV UHODWLYH WR FRQWURO OHYHOV RQ WKH F'1$ DUUD\ZHUHWKHVHFRQGDU\LQÁDPPDWRU\WUDQVFULSWVLQWHUOHXNLQ ,/ DQGPDF URSKDJHLQÁDPPDWRU\SURWHLQE0,3E +RZHYHUWKHLQGXFWLRQQXPEHUVIRU ,/ DQG 0,3E PLJKW QRW EH DQ DFFXUDWH FDOFXODWLRQ RI WKHLU WUDQVFULSW OHYHOV VLQFH WKH FRQWURO WUDQVFULSW H[SUHVVLRQ OHYHOV ZHUH YHU\ ORZ$QRWKHU VHFRQGDU\ LQÁDPPDWRU\ WUDQVFULSW FKDQJHG ZDV WKH 6 ULERVRPDO SURWHLQ ZLWK D PRGHVW LQFUHDVHDWQ060H[SRVXUH2WKHUSURLQÁDPPDWRU\WUDQVFULSWVVXFKDVWKH LQWHUOHXNLQWUDQVFULSWGLGQRWFKDQJHIURPFRQWUROH[SUHVVLRQRULQWHUOHXNLQ WUDQVFULSW H[SUHVVLRQ WKDW EHFDPH YLUWXDOO\ XQGHWHFWDEOH DIWHU 60 H[SRVXUH7KH LQWHUOHXNLQUHFHSWRUVXEXQLWV,/5EDQG,/5EZHUHGHWHFWHGLQ+(.EXWGLG QRWFKDQJHIURPFRQWUROOHYHOVDWHLWKHU60FRQFHQWUDWLRQ$WKUIROORZLQJWKH Q060H[SRVXUHWUDQVFULSWVIRU,/DQG0,3EZHUHQRWGHWHFWHGLQ+(. $OVRWKHSULPDU\F\WRNLQH71)EZDVQRWGHWHFWHGDQG,/EZDVWHQIROGORZHU WKDQ FRQWURO DW Q0 60 H[SRVXUH ,/F GLG QRW FKDQJH IURP FRQWURO 0DQ\ LQÁDPPDWRU\F\WRNLQHDQGF\WRNLQHUHFHSWRUWUDQVFULSWVRQWKHF'1$DUUD\EORW ZHUHQRWH[SUHVVHGE\+(.GDWDQRWVKRZQ ,QÁDPPDWLRQDVVRFLDWHGWUDQVFULSWVLVRODWHGE\VXEWUDFWLRQOLEUDU\GLIIHUHGIURP WKRVHFDWDORJXHGIURPWKHF'1$DUUD\H[FHSWIRU,/,/ZDVWKHSUHGRPLQDQW XSUHJXODWHGWUDQVFULSWUHSUHVHQWLQJRYHURIWKHLVRODWHGWUDQVFULSWVLQWKHKU OLEUDU\SURGXFHGIROORZLQJQ060H[SRVXUH,/ZDVDOVRLVRODWHGLQDQKU Q060OLEUDU\EXWWKHWUDQVFULSWZDVQRWIRXQGLQHLWKHURUKUVXEWUDFWLRQ OLEUDULHV JHQHUDWHG DIWHU Q0 60 H[SRVXUH $QRWKHU LQÁDPPDWLRQDVVRFLDWHG WUDQVFULSWLQWKHXSUHJXODWHGOLEUDU\LVRODWHGDWKUDIWHUQ060ZDVQXFOHDU
HUMAN KERATINOCYTE SM INFLAMMATORY TRANSCRIPT GENE ACTIVITY
275
IDFWRURIDFWLYDWHG7FHOOV1)$7 7KHKUXSUHJXODWHG Q060VXEWUDFWLRQ OLEUDU\DOVRFRQWDLQHGDQQH[LQ,8SUHJXODWHGWUDQVFULSWVLQOLEUDULHVSURGXFHGDWWKH Q060H[SRVXUHZHUHWLVVXHIDFWRUDWKUDQGLQWHUOHXNLQEDQGWLVVXHIDFWRU DWKU
DISCUSSION AND CONCLUSIONS 7KHLQYHVWLJDWLRQRI60JHQHFKDQJHVXVLQJ$WODVF'1$DUUD\VOHDGVWRDQ LQLWLDO FRQFHUQ DERXW QRUPDOL]LQJ GDWD WR D VSHFLÀ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ÀUVWZDV GXHWRLWVFRQVWLWXWLYHO\KLJKWUDQVFULSWH[SUHVVLRQOHYHOWKDWPDGHLWGLIÀFXOWWRXVH GXHWRRYHUH[SRVXUHSUREOHPVGXULQJH[WHQGHGH[SRVXUHH[SHULPHQWV7KHVHFRQG ZDVWKDWPXOWLSOHSURWHRVRPHWUDQVFULSWVZKLFKLQYROYHGLJHVWLRQRIXELTXLWLQDWHG SURWHLQVZHUHLVRODWHGLQXSUHJXODWHGVXEWUDFWLRQOLEUDULHVIURP60H[SRVHG+(. 7KLVUDLVHGFRQFHUQVDERXWSRWHQWLDOFKDQJHVLQXELTXLWLQSURWHLQOHYHOVDVZHOODV LWV WUDQVFULSW RYHU WLPH +\SR[DQWKLQHJXDQLQH SKRVSKRULERV\OWUDQVIHUDVH GLG QRW SURGXFHVXIÀ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ÁDPPDWLRQDVVRFLDWHGWUDQVFULSWVZHUH GHWHFWHGXVLQJERWKWHFKQLTXHV2QWKHF'1$DUUD\WKHSUHGRPLQDQWLQÁDPPDWRU\ WUDQVFULSWVH[SUHVVHGDWKUDIWHUQ060ZHUH,/DQG0,3E2XUODEKDV UHSRUWHGLQFUHDVHVLQ+(.,/WUDQVFULSWE\60SUHYLRXVO\6FKODJHU DQG UHFHQWO\ RWKHU LQYHVWLJDWRUV UHSRUWHG VLPLODU ÀQGLQJV /DUGRW HW DO .HUDWL QRF\WHV FDQ UHDGLO\ LQGXFH ,/ WKURXJK GLYHUVH QR[LRXV VWLPXOL 6XEFODVVHV RI FRPSRXQGVIRXQGWRLQFUHDVH+(.,/SURWHLQLQFOXGHQRWRQO\SURLQÁDPPDWRU\ F\WRNLQHV EXW DOVR HQGRWR[LQV WXPRU SURPRWHUV FHOO F\FOH PRGXODWRUV DQG FRP SRXQGVWKDWHQKDQFHUHDFWLYHR[\JHQVSHFLHV:LOPHUDQG/XVWHU *HQHUDOO\ WKHVH WUDQVFULSWV UHSUHVHQW D VHFRQGDU\ WUDQVFULSW UHVSRQVH SURGXFHG E\ UHFHSWRU
276
ALTERNATIVE TOXICOLOGICAL METHODS
VSHFLÀFVWLPXODWLRQWKURXJKELQGLQJRISULPDU\F\WRNLQHVVXFKDVE\71)ERQ71) UHFHSWRU IROORZLQJ GDPDJH HOLFLWDWLRQ 7KHUHIRUH VXOIXU PXVWDUG FRXOG HOLFLW WKH H[SUHVVLRQ RI ,/ WKURXJK PXOWLSOH LQÁXHQFHV SURGXFLQJ DQ DGGLWLYH VWLPXOXV RQ +(.LQFOXGLQJLQFUHDVLQJWKHSULPDU\F\WRNLQHLQÁXHQFLQJWKHFHOOF\FOHFKDQJLQJ FHOOXODU R[LGDWLRQ VWDWH RU GLUHFWO\ DON\ODWLQJ RU FURVVOLQNLQJ VSHFLÀF UHFHSWRUV WR SURGXFHDFWLYDWHGUHFHSWRUVWKDWPD\LQLWLDWHDVHFRQGDU\F\WRNLQHUHVSRQVH +(.SURGXFHDVWURQJ,/H[SUHVVLRQIROORZLQJ60RQO\DWDYHVLFDWLQJFRQ FHQWUDWLRQZKLFKVXJJHVWV,/SOD\VDQLPSRUWDQWUROHLQWKHWLVVXHSURLQÁDPPDWRU\ HYHQWV FRQWULEXWLQJWRVNLQSDWKRORJ\)URPWKHVHOLPLWHGGDWD,/DOVRDSSHDUV WR EH WKH PRVW LQGXFHG WUDQVFULSW ZKLFK VXJJHVWV LW FRXOG EH XVHG DV D VHQVLWLYH ELRPDUNHULQFRQWUROOHG60H[SHULPHQWVIRUGHWHUPLQLQJWUHDWPHQWDQGSUHWUHDWPHQW UHJLPHQV )RU LQ YLYR VFUHHQLQJ SXUSRVHV WKH EHVW PRGHOV ZRXOG EH WKRVH ZLWK D VWURQJ ,/ UHVSRQVH VXFK DV UDEELW VNLQ ZKLFK KDV EHHQ VKRZQ WR H[SUHVV ,/ DIWHU60H[SRVXUH7VXUXWDHWDO RUVZLQHDVWKHVNLQPRGHOZKLFKZRXOG DOVR EH FDSDEOH RI HOLFLWLQJ DQ ,/ UHVSRQVH +RZHYHU DQRWKHU &;& F\WRNLQH VXFKDVPRXVH0,3ZRXOGEHUHTXLUHGIRUPRQLWRULQJLQURGHQWVVLQFH0,3LV WKHFORVHVWKRPRORJRIKXPDQ,//HHHWDO 0,3EZDVWKHVHFRQGPRVWDPSOLÀHGLQÁDPPDWRU\SURWHLQWUDQVFULSWHOLFLWHG E\60H[SRVXUH0,3ELVD&;&FKHPRNLQHVLPLODUWR,/NQRZQWRVWLPXODWH PLJUDWLRQRIKXPDQEORRGPRQRF\WHV5RWKHWDO8JXFFLRQLHWDO DV ZHOO DV DFWLYDWHG PHPRU\W\SH7 FHOOV DQG QDLYHW\SH7 O\PSKRF\WHV WKURXJK WKH EORRGYHVVHOHQGRWKHOLXP5RWKHWDO 7KHPRXVHPDFURSKDJH0,3H[SUHV VLRQFDQEHLQGXFHGE\YDQDGLXPDQGWKLVLQGXFWLRQKDVEHHQLQÁXHQFHGE\DGGLWLRQ RI 1DFHW\OF\VWHLQH ZKLFK VXJJHVWV WKDW OLNH ,/ R[LGDWLYH GDPDJH FRXOG DOVR HOLFLW0,3E &KRQJHWDO 1RVSHFLÀFOLWHUDWXUHUHIHUHQFHZDVIRXQGDVVR FLDWLQJ 0,3E ZLWK HLWKHU +(.V RU KXPDQ VNLQ HSLGHUPLV H[SUHVVLRQ +RZHYHU WKHH[SUHVVLRQRI0,3EDQG,/WUDQVFULSWVKRZVWKDW+(.VDUHDFWLYHO\UHFUXLWLQJ LQÁDPPDWRU\FHOOV $QRWKHULQÁDPPDWLRQDVVRFLDWHGVHFRQGDU\FKHPRNLQHWUDQVFULSWXSUHJXODWHGDW KLJK60FRQFHQWUDWLRQZDVWKH6ULERVRPDOSURWHLQ6ULERVRPDOSURWHLQIRUPV GLPHUVWKDWZHUHLQLWLDOO\LVRODWHGLQWKHFKURQLFLQÁDPPDWRU\ GLVHDVHUKHXPDWRLG DUWKULWLV
HUMAN KERATINOCYTE SM INFLAMMATORY TRANSCRIPT GENE ACTIVITY
277
003DQGHQKDQFHWKHWLVVXHLQKLELWRURIPHWDOORSURWHLQDVH2ULHQWHHWDO 7KLVDQWLLQÁDPPDWRU\SURWHLQPD\DLGLQWKHPRGXODWLRQRIVNLQSURLQÁDPPDWRU\ WUDQVFULSWLQGXFWLRQDWVXEYHVLFDWLQJ60H[SRVXUH$OVR&'WXPRUQHFURVLVOLNH UHFHSWRUZDVXSUHJXODWHGDWORZFRQFHQWUDWLRQEXWQRWIRXQGDWKLJKFRQFHQWUDWLRQ &'OLJDWLRQRQNHUDWLQRF\WHVFDQHQKDQFH&'H[SUHVVLRQDQGVHFUHWLRQRI,/ 9DQ.RRWHQDQG%DQFKHUHDX ,QFUHDVHG,/H[SUHVVLRQGLGQRWRFFXULQ WKHVHFHOOVDWWKLVFRQFHQWUDWLRQRI607KHVHÀQGLQJVUHTXLUHIXUWKHULQYHVWLJDWLRQ WRGHWHUPLQHWKHUHFHSWRUIXQFWLRQDQGZKHWKHULWKDVLQYROYHPHQWLQSURLQÁDPPD WLRQRUDUROHLQFUHDWLQJDSURDSRSWRWLFVWDWHIRUWKHFHOO 8VLQJWKHVXEWUDFWLRQOLEUDU\SURFHGXUHWKHLQÁDPPDWLRQDVVRFLDWHGWUDQVFULSWV LVRODWHGGLIIHUHGFRQVLGHUDEO\IURPWKRVHFDWDORJHGIURPWKHF'1$DUUD\H[FHSWIRU WKH SUHGRPLQDQW WUDQVFULSW ,/ ,/ UHSUHVHQWHG RI WKH OLEUDU\ JHQHUDWHG DW KU IROORZLQJ KLJK 60 FRQFHQWUDWLRQ H[SRVXUH WR +(. 6LPLODU WR F'1$ DUUD\ GDWD,/ZDVQRWGHWHFWHGLQWKHORZGRVHVXEWUDFWLRQOLEUDULHV2WKHULQÁDPPDWLRQ DVVRFLDWHGWUDQVFULSWVZHUHLVRODWHGDVVLQJOHFRORQ\REVHUYDWLRQVLQERWKXSUHJXODWHG OLEUDULHV DW DQG KU VWXGLHV 0RVW WUDQVFULSWV ZHUH QRW SUHVHQW RQ WKH F'1$ DUUD\)XUWKHUDQDO\VLVXVLQJWUDQVFULSWDQGSURWHLQTXDQWLWDWLRQPHWKRGVLVUHTXLUHG WR HQVXUH WKDW WKHVH WUDQVFULSWV VLJQLÀFDQWO\ DUH FKDQJHG DQG WR PDNH FHUWDLQ WKH SURWHLQVIURPWKHVHWUDQVFULSWVVXEVHTXHQWO\SDUWLFLSDWHLQWKHLQÁDPPDWRU\SURWHLQ SURÀOHSURGXFHGE\60 ,QWKLVVWXG\WKH+(.FXOWXUHGLQGHÀQHGNHUDWLQRF\WHJURZWKPHGLXPH[SUHVVHG HQKDQFHGOHYHOVRIWKUHHSULPDU\F\WRNLQHVIROORZLQJH[SRVXUHWRKLJK60FRQFHQ WUDWLRQ 71)E ,/F DQG ,/E (DFK RI WKHVH WUDQVFULSWV SURGXFHV D SURWHLQ F\WRNLQH WKDW HLWKHU VLQJO\ RU LQ FRPELQDWLRQ FDQ SURGXFH D YDULHW\ RI UHVSRQVHV GHSHQGLQJRQWKHWLPHDQGOHYHORIH[SUHVVLRQWRVXEVHTXHQWO\LQGXFH,/'HWHU PLQLQJ KRZ WKHVH SULPDU\ F\WRNLQHV DUH WHPSRUDOO\ H[SUHVVHG HVSHFLDOO\ D VKRUW WLPHIROORZLQJ60H[SRVXUHZLOOEHRIVLJQLÀFDQWLQWHUHVWVLQFHHDFKF\WRNLQHFDQ LQFUHDVHRQHDQRWKHUDVZHOODVWKHPDMRUVHFRQGDU\F\WRNLQHVIRXQGLQWKLVVWXG\ %R[PDQHWDO ,QFRQFOXVLRQ,/WUDQVFULSWLVVWURQJO\H[SUHVVHGIURP60H[SRVHG+(.DQG FRXOGVHUYHDVDELRPDUNHUIRUVFUHHQLQJRIWKHUDSHXWLFSUHYHQWLRQRI60LQÁDPPD WLRQLQKXPDQFHOOVDQGWLVVXHVDQGLQDQLPDOPRGHOVWKDWHOLFLW,/UDEELWRUSLJ $OWKRXJKQRUPDOFXOWXUHG+(.FDQH[SUHVVDPXOWLWXGHRIVSHFLÀFSURLQÁDPPDWRU\ DQGDQWLLQÁDPPDWRU\WUDQVFULSWV6FKU|GHU WKHVHGDWDVKRZWKDW+(.VZKLFK DUHNQRZQWREHWKHFHQWHURI60WLVVXHGDPDJHE\KLVWRSDWKRORJ\HOLFLWDVSHFLÀF VHWRIWUDQVFULSWVWKDWZRXOGPHGLDWHSURLQÁDPPDWRU\HYHQWV7KHSURWHLQVSURGXFHG IURPWUDQVFULSWH[SUHVVLRQZRXOGSDUWLFLSDWHLQWKHH[DFHUEDWLRQRIDVNLQEOLVWHULQJ HYHQW 8VLQJ F'1$ DUUD\V DQG VXEWUDFWLRQ OLEUDU\ SURGXFWLRQ DV D EURDG HQGSRLQW DSSURDFK LQ D VLPSOH FHOO V\VWHP SHUPLWV WKH GHWHUPLQDWLRQ RI KRZ DQ LQGLYLGXDO KXPDQFHOOW\SHPD\SDUWLFLSDWHLQWKLVFRPSOH[WLVVXHUHVSRQVH)XUWKHULQYHVWLJDWLRQ XVLQJ WUDQVFULSW DQG SURWHLQ TXDQWLWDWLRQ PHWKRGV ZLWK PRUH FRPSOH[ KXPDQ DQG DQLPDO VNLQ PRGHOV LV UHTXLUHG WR XQGHUVWDQG WKH SDUWLFLSDWLRQ RI WKHVH SURLQÁDP PDWRU\ SURWHLQV SURGXFHG IURP WKHVH WUDQVFULSWV LQ KXPDQ 60 SDWKRORJ\ 7KHVH SUHVHQWGDWDZLOOEHXVHGDVEHWWHUVHOHFWLRQFULWHULDIRUDSSURSULDWHLQYLWURDQGLQ YLYRPRGHOVWRWHVWWUHDWPHQWVDQGWKHUDS\DQGWRHYDOXDWHWKHLUH[SUHVVLRQPRGXODWLRQ IROORZLQJGUXJWUHDWPHQWRIWKH60OHVLRQIRUPDWLRQDQGVXEVHTXHQWKHDOLQJ
278
ALTERNATIVE TOXICOLOGICAL METHODS
REFERENCES %R[PDQ ,/ 5XZKRI & %RHUPDQ 2& /RZLN &: DQG 3RQHF 0 5ROH RI ÀEUREODVWVLQWKHUHJXODWLRQRISURLQÁDPPDWRU\LQWHUOHXNLQ,/,/DQG,/OHYHOV LQGXFHGE\NHUDWLQRF\WHGHULYHG,/$UFK'HUPDWRO5HV² &KRQJ ,: /LQ 65 +ZDQJ -- +XDQJ 06:DQJ7+ 7VDL 06 +RX -- DQG 3DXODXVNLV-' ([SUHVVLRQDQGUHJXODWLRQRIPDFURSKDJHLQÁDPPDWRU\SUR WHLQJHQHE\YDQDGLXPLQPRXVHPDFURSKDJHV,QÁDPPDWLRQ² 'LDWFKHQNR//DX<)&&DPSEHOO$3&KHQFKLN$0RTDGDP)+XDQJ%/XN\ DQRY 6 /XN\DQRY . *XUVND\D 1 6YHUGORY (' DQG 6LHEHUW 3' 6XSSUHVVLRQ VXEWUDFWLRQ K\EULGL]DWLRQ D PHWKRG IRU JHQHUDWLQJ GLIIHUHQWLDOO\ UHJX ODWHGRUWLVVXHVSHFLÀFF'1$SUREHVDQGOLEUDULHV3URF1DWO$FDG6FL86$ ² )DUUHOO 5( -U 51$ 0HWKRGRORJLHV $ *XLGH IRU ,VRODWLRQ DQG &KDUDFWHUL]DWLRQ $FDGHPLF3UHVV6DQ'LHJR +DUW%:DQG6FKODJHU-- 2NDGDLFDFLGDQGFDO\FXOLQ$UHYHUVHVXOIXUPXVWDUGLQGXFHG *0FHOOF\FOHEORFNLQKXPDQNHUDWLQRF\WHV-$P&ROOHJH7R[LFRO6²6 +RULQR.1LVKLXUD+2KVDNR76KLEX\D<+LUDRND7.LWDPXUD1DQG
HUMAN KERATINOCYTE SM INFLAMMATORY TRANSCRIPT GENE ACTIVITY
279
8JXFFLRQL0'·$SX]]R0/RHWVFKHU0'HZDOG%DQG%DJJLROLQL0 $FWLRQV RIWKHFKHPRWDFWLFF\WRNLQHV0&30&30&35$17(60,3DOSKDDQG 0,3EHWDRQKXPDQPRQRF\WHV(XU-,PPXQRO² 9DQ.RRWHQ&DQG%DQFKHUHDX- )XQFWLRQVRI&'RQ%FHOOVGHQGULWLFFHOOVDQG RWKHUFHOOV&XUU2S,PPXQRO² :LOPHU-/DQG/XVWHU0, &KHPLFDOLQGXFWLRQRILQWHUOHXNLQDSURLQÁDPPDWRU\ FKHPRNLQHLQKXPDQHSLGHUPDONHUDWLQRF\WHFXOWXUHVDQGLWVUHODWLRQWRF\WRJHQHWLF WR[LFLW\&HOO%LRO7R[LFRO²
CHAPTER
24
Evaluation of Cytotoxicity Assays of Human Epidermal Keratinocytes Exposed In Vitro to Sulfur Mustard 6XVDQ$.HOO\-XDQLWD-*X]PDQ&ODUN/*URVVDQG:LOOLDP-6PLWK
CONTENTS ,QWURGXFWLRQ ([SHULPHQW 5HDJHQWV .HUDWLQRF\WH*URZWK $JHQW([SRVXUH &DOFHLQ$0 $ODPDU%OXH 1HXWUDO5HG 076 3URSLGLXP,RGLGH 5HVXOWV 'LVFXVVLRQ 5HIHUHQFHV
INTRODUCTION 6XOIXUPXVWDUGdGLFKORURGLHWK\OVXOÀGH+' LVDYHVLFDWLQJFKHPLFDOZDU IDUHDJHQWWKDWSURGXFHVLQMXU\WRWKHVNLQH\HVDQGOXQJV,WKDVEHHQDPLOLWDU\ WKUHDW VLQFH :RUOG :DU , 7R GHYHORS WKHUDSHXWLF UHJLPHQV 3%/ DQG +(.V KDYH EHHQ XVHG DV PRGHOV WR VWXG\ WKH F\WRWR[LF HIIHFWV RI +' 3UHYLRXV VWXGLHV KDYH GHPRQVWUDWHGWKDWFHOOYLDELOLW\GHFUHDVHVZKHQFHOOVDUHH[SRVHGWR+'6PLWKHW
281
282
ALTERNATIVE TOXICOLOGICAL METHODS
DO +RZHYHUWKHUHKDYHEHHQSUREOHPVZLWKG\HXSWDNHDVDPHDVXUH RI F\WRWR[LF\ LQ +(.V 6PLWK HW DO 7KLV G\H XSWDNH SUREOHP PD\ EH WKH UHVXOWRIWKHWU\SVLQL]DWLRQSURFHVVUHTXLUHGIRULVRODWLRQRI WKH+(.V7KHDVVD\V ZHVFUHHQHGDOORZHGWKHFHOOVWRUHPDLQLQZHOOSODWHVIRUWKHHQWLUHSURFHGXUH EXPERIMENT Reagents .HUDWLQRF\WHJURZWKPHGLD.*0 DQG+(.VZHUHSXUFKDVHGIURP&ORQHWLFV &RUSRUDWLRQ6DQ'LHJR&$&DOFHLQ$0ZDVSXUFKDVHGIURP0ROHFXODU3UREHV (XJHQH25$ODPDUEOXHZDVSXUFKDVHGIURP$FFX0HG,QWHUQDWLRQDO,QF&KLFDJR ,/1HXWUDOUHGSURSLGLXPLRGLGHDQGRWKHUODERUDWRU\FKHPLFDOVZHUHSXUFKDVHG IURP6LJPD&KHPLFDO&R6W/RXLV026XOIXUPXVWDUG+'&$6UHJLVWU\ SXUH ZDVREWDLQHGIURP7KH86$UP\(GJHZRRG5HVHDUFK'HYHORS PHQWDQG(QJLQHHULQJ&HQWHU$EHUGHHQ3URYLQJ*URXQG0' Keratinocyte Growth 1RUPDOKXPDQHSLGHUPDONHUDWLQRF\WHVZHUHSXUFKDVHGDVVHFRQGSDVVDJHFHOOV IURP&ORQHWLFV7KHFHOOVZHUHJURZQDQGVXEFXOWXUHGDQGWKHQGLVSHQVHGLQWRWLVVXH FXOWXUHSODWHVDWWKHDSSURSULDWHGHQVLW\IRUH[SHULPHQWDWLRQ Agent Exposure +'SXUHREWDLQHGIURPWKH(GJHZRRG&KHPLFDO%LRORJLFDO&HQWHU$EHU GHHQ 3URYLQJ *URXQG 0' ZDV GLOXWHG ZLWK .*0 .HUDWLQRF\WH JURZWK PHGLD DQGDGGHGWRWKHFHOOFXOWXUHSODWHVWR\LHOGDÀQDOFRQFHQWUDWLRQIURP%Q0 $IWHUKUDWURRPWHPSHUDWXUHLQDFKHPLFDOVXUHW\KRRGWKHWLVVXHFXOWXUHSODWHV ZHUHWUDQVIHUUHGWRDS&LQFXEDWRUIRUWKHGXUDWLRQRIWKHSRVWH[SRVXUHLQFXEDWLRQ SHULRG Calcein AM $W KU SRVWH[SRVXUH WKH PHGLD ZHUH UHPRYHG IURP HDFK ZHOO ,Q WKH GDUN PORIFDOFHLQ$0Q0 ZDVDGGHGWRHDFKZHOO7KHWUD\VZHUHLQFXEDWHGIRU KU DW S& 7KH FDOFHLQ$0 ZDV WKHQ UHPRYHG IURP HDFK ZHOO DQG QO RI 530,ZLWKRXWSKHQROUHG ZDVDGGHG7KHSODWHVZHUHUHDG RQD&\WRÁXRU PXOWLZHOOSODWHUHDGHUZLWKWKHH[FLWDWLRQVHWDWQPDQGHPLVVLRQUHDGDWQP Alamar Blue $W KU SRVWH[SRVXUH WKH PHGLD ZHUH UHPRYHG DQG HDFK ZHOO ZDV ULQVHG WKUHH WLPHV ZLWK 530, ZLWKRXW SKHQRO UHG $IWHU WKH WKLUG ULQVH QO RI DODPDU EOXHYY ZHUHDGGHGWRHDFKZHOOLQWKHGDUN7KHSODWHZDVWKHQLQFXEDWHGDW
CYTOTOXICITY ASSAYS OF KERATINOCYTES EXPOSED TO SULFUR MUSTARD
283
S&IRUPLQ$WWKHHQGRIWKHLQFXEDWLRQWLPHWKHFHOOFXOWXUHSODWHZDVUHDGRQ D&\WRÁXRUPXOWLZHOOSODWHUHDGHUZLWKWKHH[FLWDWLRQVHWDWQPDQGHPLVVLRQUHDG DWQP Neutral Red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ropidium Iodide $WKUSRVWH[SRVXUHWR+'Q/RIHDFKVDPSOHZDVWUDQVIHUUHGWRDv PPWHVWWXEH7ZRKXQGUHGPLFUROLWHUVRI.*0ZDVDGGHGWRHDFKWXEH)LIW\ PLFUROLWHUVRISURSLGLXPLRGLGHPJPO ZDVDGGHGWRHDFKWXEHDQGLQFXEDWHG DWURRPWHPSHUDWXUHIRUDSSUR[LPDWHO\WRPLQ7KHWXEHVZHUHWKHQSODFHGLQ WKHÁRZF\WRPHWHUDQGYLDELOLWLHVZHUHGHWHUPLQHGZLWKH[FLWDWLRQDWQPDQG HPLVVLRQEHWZHHQDQGQP
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
284
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 24.1 HEKs were exposed to the indicated HD concentrations and then incubated for 24 hr at 37SC. Viabilities were determined by using these dyes as described in the Experimental section.
DISCUSSION %RWKFKURPRJHQLFDQGÁXRURPHWULFG\HVFDQEHXVHGWRDVVHVVYLDELOLW\LQ+(.V H[SRVHGLQYLWURWR+'6L[GLIIHUHQWPHDVXUHVRIFHOOYLDELOLW\KDYHEHHQDQDO\]HG 9LDEOH FHOO QXPEHU DSSHDUV WR EH WKH PRVW VHQVLWLYH LQGLFDWRU RI +' F\WRWR[LFLW\ 7KHÁ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
REFERENCES *URVV&/&RUXQ&0.HOO\6$DQG6PLWK:- $5DSLG$VVD\IRU&\WR[LFLW\ LQ 6XOIXU 0XVWDUG ([SRVHG ,VRODWHG +XPDQ 3HULSKHUDO %ORRG /\PSKRF\WHV SDSHU SUHVHQWHGDWWKH3URFHHGLQJVRIWKH0HGLFDO'HIHQVH%LRVFLHQFH5HYLHZ
CYTOTOXICITY ASSAYS OF KERATINOCYTES EXPOSED TO SULFUR MUSTARD
285
6PLWK:-%ODQN-$6WDUQHU5$0HQWRQ5*DQG+DUULV- (IIHFWRI6XOIXU 0XVWDUG([SRVXUHRQ+XPDQ(SLGHUPDO.HUDWLQRF\WH9LDELOLW\DQG3URWHLQ&RQWHQW SDSHUSUHVHQWHGDWWKH3URFHHGLQJVRIWKH0HGLFDO'HIHQVH%LRVFLHQFH5HYLHZ '7,&DFFHVVLRQ$'$ 6PLWK :- *URVV &/ &KDQ 3 DQG 0HLHU +/ 7KH XVH RI KXPDQ HSLGHUPDO NHUDWLQRF\WHVLQFXOWXUHDVDPRGHOIRUVWXG\LQJWKHELRFKHPLFDOPHFKDQLVPVRIVXOIXU PXVWDUGWR[LFLW\&HOO%LRO7R[LFRO² 6PLWK:-6DQGHUV.0*DOHV<$DQG*URVV&/ )ORZF\WRPHWULFDQDO\VLVRI WR[LFLW\ E\ YHVLFDWLQJ DJHQWV LQ KXPDQ FHOOV LQ YLWUR -7R[LFRO &XWDQHRXV 2FXODU 7R[LFRO²
CHAPTER
25
Comparison of Spectrophotometric and Fluorometric Assays of Proteolysis in Cultured Human Cells Exposed to Sulfur Mustard 6XVDQ$.HOO\&KDUOHQH0&RUXQ0DULDQ51HOVRQ&ODUN/*URVV DQG:LOOLDP-6PLWK
CONTENTS ,QWURGXFWLRQ 0DWHULDOVDQG0HWKRGV 5HDJHQWV /\PSKRF\WH,VRODWLRQ .HUDWLQRF\WH*URZWK +'([SRVXUH &KURPR]\P$VVD\KU3RVWH[SRVXUHWR+' .HUDWLQRF\WHV /\PSKRF\WHV ,QWUDFHOOXODU3URWHDVH$FWLYLW\ 5HVXOWV &KURPR]\P$VVD\ &HOO3UREH$VVD\ 6XPPDU\ 5HIHUHQFHV
287
288
ALTERNATIVE TOXICOLOGICAL METHODS
INTRODUCTION 6XOIXUPXVWDUGdGLFKORURGLHWK\OVXOÀGH+' LVDSRWHQWYHVLFDWLQJDJHQW ZKRVHPHFKDQLVPRIEOLVWHUIRUPDWLRQLVSRRUO\XQGHUVWRRG0LFURVFRSLFH[DPL QDWLRQ RI WKH OHVLRQ LQWLPDWHV WKH LQYROYHPHQW RI SURWHRO\VLV LQ WKH FDVFDGH RI HYHQWV OHDGLQJ WR WKH HSLGHUPDO²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ÀFDF\7KHVFUHHQLQJSURFHVVGHPDQGVWKHGHYHORSPHQWRIERWKVHQVLWLYH DQG UHSURGXFLEOH LQ YLWUR DVVD\V WKDW FDQ EH XVHG WR TXDQWLWDWH WKH ELRPDUNHUV IRUPHG DV WKH UHVXOW RI +' H[SRVXUH LQ WDUJHW WLVVXHV:H KDYH LQYHVWLJDWHG WKH XVH RI FRPPHUFLDO SURWHDVH VXEVWUDWHV ZLWK HLWKHU FKURPRJHQLF RU ÁXRURJHQLF SURSHUWLHVWRPHDVXUHWKHELRPDUNHUSURWHRO\WLFDFWLYLW\LQERWK3%/VDQG+(.V WKDW KDYH EHHQ H[SRVHG WR +' 7KH PHDVXUHPHQW RI SURWHRO\WLF DFWLYLW\ ZDV TXDQWLWDWHG E\ ERWK VSHFWURSKRWRPHWULF DQG ÁXRURPHWULF PHWKRGV 6XLWDELOLW\ RI WKHVH DVVD\V IRU WKH VFUHHQLQJ RI SRWHQWLDO PHGLFDO FRXQWHUPHDVXUH HIÀFDF\ ZLOO EHDVVHVVHG
MATERIALS AND METHODS Reagents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ymphocyte Isolation +XPDQ 3%/V ZHUH REWDLQHG IURP ZKROH EORRG E\ YHQLSXQFWXUH IURP KXPDQ YROXQWHHUVXQGHUDQDSSURYHGKXPDQXVHSURWRFRO7KHO\PSKRF\WHVZHUHLVRODWHG E\ 3HUFROO GHQVLW\ FHQWULIXJDWLRQ 0HLHU DQG -RKQVRQ DQG WKH PRQRQXFOHDU OD\HU ZDV FROOHFWHG ZDVKHG DQG GLOXWHG LQ 530, FRQWDLQLQJ JHQWD P\FLQ QJPO WR D ÀQDO FRQFHQWUDWLRQ RI v FHOOVPO &HOOV ZHUH WKHQ GLVSHQVHGLQWRWLVVXHFXOWXUHSODWHVDWWKHDSSURSULDWHGHQVLW\IRUH[SHULPHQWDWLRQ
ASSAYS OF PROTEOLYSIS INDUCED BY SULFUR MUSTARD
289
Keratinocyte Growth 1RUPDOKXPDQHSLGHUPDONHUDWLQRF\WHVZHUHSXUFKDVHGDVVHFRQGSDVVDJHFHOOV IURP&ORQHWLFV7KHFHOOVZHUHJURZQVXEFXOWXUHGDQGWKHQGLVSHQVHGLQWRWLVVXH FXOWXUHSODWHVDWWKHDSSURSULDWHGHQVLW\IRUH[SHULPHQWDWLRQ6PLWKHWDO HD Exposure +'ZDVGLOXWHGLQWRHLWKHU.*0IRUNHUDWLQRF\WHV RU530,IRUO\PSKRF\WHV DQGDGGHGWRWKHDSSURSULDWHFHOOFXOWXUHSODWHVLQDFKHPLFDO VXUHW\KRRGWR\LHOG ÀQDO+'FRQFHQWUDWLRQVUDQJLQJIURPWRQ0$IWHUKUDWURRPWHPSHUDWXUH WR DOORZ K\GURO\VLV RI DJHQW WKH WLVVXH FXOWXUH SODWHV ZHUH WUDQVIHUUHG WR D S& LQFXEDWRUXQGHUDKXPLGLÀHG&2DWPRVSKHUHIRUWKHGXUDWLRQRIWKHSRVWH[SR VXUHLQFXEDWLRQSHULRG Chromozym® Assay (24 hr Postexposure to HD) Keratinocytes 7ZHQW\PLFUROLWHUVRIWKHDSSURSULDWH&KURPR]\PVXEVWUDWHZDVDGGHGWRHDFK ZHOORIWKHZHOOSODWH7KHSODWHVZHUHLQFXEDWHGIRUKUDWS&)LIW\PLFUROLWHUV RIVXSHUQDWHZDVUHPRYHGIURPHDFKVDPSOHDQGSODFHGLQWRDZHOOSODWH7KH ZHOO SODWH ZDV UHWXUQHG WR WKH LQFXEDWRU 7KH ZHOO SODWH ZDV SODFHG LQ WKH PLFURSODWH VFDQQLQJ VSHFWURSKRWRPHWHU DQG WKH DEVRUEDQFH DW QP ZDV GHWHU PLQHG7KHODVWWZRVWHSVZHUHUHSHDWHGDJDLQDWKU Lymphocytes 6XSHUQDWHQOZDVUHPRYHGDQGGLVFDUGHGIURPHDFKZHOO$QDOLTXRWRI QO RI v ² 0 &KURPR]\P 7+ ZDV DGGHG WR HDFK ZHOO IRU D ÀQDO YROXPHRIQO7KHSODWHZDVLQFXEDWHGDWS&IRUKU$QDOLTXRWRIQO RIVXSHUQDWHZDVUHPRYHGDQGDGGHGWRDFOHDQZHOOSODWH7KHZHOOSODWH ZDVSODFHGLQWKHPLFURSODWHVFDQQLQJVSHFWURSKRWRPHWHUDQGWKHDEVRUEDQFHDW QPZDVGHWHUPLQHG Intracellular Protease Activity $W KU SRVWH[SRVXUH WR +' QO RI HDFK &HOO3UREH HQ]\PH VXEVWUDWH ZDV DGGHGWRWKHDSSURSULDWHZHOOVRIWKHZHOOSODWH7KHSODWHVZHUHWKHQLQFXEDWHG IRU KU DW S& )OXRUHVFHQFH ZDV WKHQ PHDVXUHG XVLQJ WKH &\WR)OXRU PXOWLZHOO SODWHUHDGHUZLWKH[FLWDWLRQVHWDWQPDQGHPLVVLRQUHDGDWQP
RESULTS 7KHFRPSRXQGVXVHGLQWKLVLQYHVWLJDWLRQDUHIRXQGLQ)LJXUH
290
ALTERNATIVE TOXICOLOGICAL METHODS
Chromozym® Substrates Chromozym® TH Tosyl-glycyl-prolyl-arginine-4-nitranilide acetate N-Methylsulfonyl-D-Phe-Gly-Arg-4-nitranilide acetate Chromozym® t-PA Carbobenzoxy- valyl-glycyl-arginine-4-nitrilanilide acetate Chromozym® TRY Benzoyl-β-alanyl-glycyl-arginine-4-nitranilide acetate Chromozym® U CellProbe® Enzyme Substrates: Nonfluorescent (aa)x -Fl Substrate-Dye complex ➾➾➾
Enzyme AAPV- Elastase (AAPV) D-aminopeptidase A (DAA) K-Aminopeptidase B (KAB) G-Aminopeptidase (GA) L- Aminopeptidase (LA) A- Aminopeptidase M (AAM) R- Aminopeptidase B (RAB)
Fluorescent Dye + Nonfluorescent Substrate leaving group Substrate Dl-Alanyl-Alanyl-Prolyl-Rho 110 Asp-Asp-Rho 110 Lysine-Lysine-Rho 110 Gly-Gly-Rho 100 Leu-Leu-Rho Alanine-Alanine-Rho 110 Arginine-Arginine-Rho 110
Figure 25.1 Substrate descriptions.
Chromozym® Assay 3URWHDVH DFWLYLW\ RI 3%/ ZDV PHDVXUHG LQ WZR GRQRUV DV D IXQFWLRQ RI FHOO QXPEHUDQG vFHOOVZHOOH[KLELWHGDEHWWHUUHVSRQVHWKDQ vFHOOVZHOO )LJXUH :KHQ WKH FRQFHQWUDWLRQ ZDV LQFUHDVHG WR v FHOOVZHOO WKH UHVSRQVHZDVQREHWWHUWKDQvFHOOVZHOO 7KH UHVSRQVH ZDV DOVR IRXQG WR EH GRQRU GHSHQGHQW 2XW RI WKH GRQRUV WKDW ZHUH VFUHHQHG H[KLELWHG D UHSURGXFLEOH SRVLWLYH UHVSRQVH DQG KDG FRQ VLVWHQWUHVSRQVHVIURPVWXG\WRVWXG\7KH3%/VIURPWKHVHGRQRUVZHUHWKHQ H[SRVHGWR+'DQGLQFXEDWHGIRUKUDQGWKHSURWHDVHDFWLYLW\ZDVPHDVXUHG E\XVLQJWKH&KURPR]\P7+VXEVWUDWHDVGHVFULEHGLQWKH0DWHULDOVDQG0HWKRGV VHFWLRQ 7KHUH ZDV D VLJQLÀFDQW UHSURGXFLEOH LQFUHDVH LQ SURWHDVH DFWLYLW\ DV VKRZQLQ)LJXUH +(.WKDWKDGEHHQH[SRVHGWR+'DQGLQFXEDWHGIRUKUVKRZHGDVLJQLÀFDQW LQFUHDVHLQXURNLQDVHDQGWLVVXHSODVPLQRJHQDFWLYDWRUOLNHDFWLYLW\DWQ0+' )LJXUH 7KHUHZDVOLWWOHFKDQJHLQWKHWU\SVLQDQGWKURPELQOHYHOV$VFRQ VLVWHQW ZLWK SUHYLRXV UHSRUWLQJV NHUDWLQRF\WHV RQO\ VKRZ UHVSRQVH LQ RI WKH VWXGLHVFRQGXFWHGEXWWKHUHDVRQIRUWKLVYDULDWLRQLVFXUUHQWO\XQNQRZQ CellProbe® Assay 3URWHDVHDFWLYLW\LQ+(.DIWHU+'H[SRVXUHZDVPHDVXUHGÁXRURPHWULFDOO\ DVGHVFULEHGLQWKH0DWHULDOVDQG0HWKRGVVHFWLRQ6XEVWUDWHV.DPLQRSHSWLGDVH %DQG*DPLQRSHSWLGDVHZHUHK\GURO\]HGVLJQLÀFDQWO\DERYHWKHFRQWUROYDOXHV ZKLOH HODVWDVH $$39 DQG ' DPLQRSHSWLGDVH VKRZHG D GHFUHDVH LQ HQ]\PH DFWLYLW\ )LJXUH 6XEVWUDWHV$$PLQRSHSWLGDVH DQG 5$PLQRSHSWLGDVH % H[KLELWHGDVPDOOLQFUHDVHLQDFWLYLW\ZKLOHVXEVWUDWH/$PLQRSHSWLGDVHVKRZHG QRUHVSRQVH
ASSAYS OF PROTEOLYSIS INDUCED BY SULFUR MUSTARD
291
Figure 25.2 Protease activity was measured in two donors as a function of cell number. Increasing the cell concentration above 2 v 106/well did not increase protease activity and this concentration was used in all subsequent studies.
Figure 25.3 PBL from five different donors were exposed to 250 QM HD and then incubated for 24 hr. Protease activity using the Chromozym® TH substrate was measured as described in Material and Methods. Significant protease activity occurred reproducibly. All assays were run in triplicate and all donors were evaluated multiple times on different days.
292
ALTERNATIVE TOXICOLOGICAL METHODS
Figure 25.4 HEK were exposed to indicated HD concentrations and incubated for 20 hr. Chromogenic protease assays were performed as described in the Materials and Methods. The protease activity was only evident at the highest concentration of HD, and only the Chromozym® U and Chromozym® t-PA substrates were significantly hydrolyzed.
Figure 25.5 HEK were exposed to HD at the indicated concentrations, and protease activity was measured fluorometrically 24 hr later as described in the Material and Methods section. KAB and GA substrates were significantly hydrolyzed above the control values while elastase (AAPV) and DAA were decreased.
SUMMARY 3URWHDVH SURÀOHV ZHUH GLIIHUHQW LQ WKH WZR LQ YLWUR PRGHOV WHVWHG KHUH 3%/V VKRZHG D VLJQLÀFDQW LQFUHDVH LQ SURWHRO\VLV XVLQJ WKH VHULQH SURWHDVH VXEVWUDWHV
ASSAYS OF PROTEOLYSIS INDUCED BY SULFUR MUSTARD
293
&KURPR]\P7+DQG&KURPR]\P75<5HSURGXFLEOHSURWHDVHDFWLYLW\ZDVIRXQG LQ RXW RI WKH GRQRUV WHVWHG :H KDYH SUHYLRXVO\ UHSRUWHG WKDW 3%/V VKRZ D JHQHUDO GHFOLQH LQ DOO DPLQRSHSWLGDVH DFWLYLW\ WHVWHG ZKHQ XVLQJ ÁXRUHVFHQW VXE VWUDWHV 6PLWK HW DO 3URWHDVH SURÀOHV ZHUH PRUH FRPSOLFDWHG ZKHQ +(.V ZHUHDVVHVVHG1RFKDQJHVLQDPLQRSHSWLGDVHDFWLYLWLHVZHUHGHWHFWHGDIWHUH[SRVXUH WR +' ZKHQ +(.V ZHUH WU\SVLQL]HG DQG DQDO\]HG E\ ÁRZ F\WRPHWU\ +RZHYHU +(.VDVVD\HGLQVLWXLQPLFURSODWHVVKRZHGDQLQFUHDVHLQ.DPLQRSHSWLGDVH%DQG *DPLQRSHSWLGDVHDQGDGHFUHDVHLQHODVWDVHDQG'DPLQRSHSWLGDVH$EXW/DPL QRSHSWLGDVHZDVXQFKDQJHG7KHUHDVRQIRUWKLVYDULDELOLW\LVXQNQRZQEXWPD\EH GXHWRFXOWXULQJDQGKDQGOLQJSURFHGXUHV%HIRUH+(.FDQEHXVHGDVDQLQYLWUR PHWKRGWRVFUHHQFRPSRXQGVDFRQVLGHUDEOHDPRXQWRIUHVHDUFKPXVWEHGRQHWR GHWHUPLQHWKHFDXVHRIWKHVHYDULDELOLWLHV
REFERENCES &RZDQ)0%RQJLRYDQQL5%URRPÀHOG&$6KXOW]60DQG6PLWK:- 6XOIXU PXVWDUGLQFUHDVHVHODVWDVHOLNHDFWLYLWLHVLQKRPRJHQDWHVRIKDLUOHVVJXLQHDSLJVNLQ -7R[LFRO&XWDQHRXV2FXODU7R[LFRO² &RZDQ )0
CHAPTER
26
Effects of Low Dose Sulfur Mustard on Growth and DNA Damage in Human Cells in Culture :LOOLDP-6PLWK%HWKDQ\67ROLYHU2IÀH(&ODUN,,,-DQHW0RVHU (ULF:1HDOOH\-XDQLWD-*X]PDQDQG&ODUN/*URVV
CONTENTS ,QWURGXFWLRQ 3XUSRVH 0DWHULDOVDQG0HWKRGV 3%/,VRODWLRQ 3%/([SRVXUH +(.&XOWXUHV +(.([SRVXUH &RPHW$VVD\ 9LDELOLW\$VVD\V *URZWK&XUYH$VVD\ 5HVXOWV &RQFOXVLRQV 5HIHUHQFHV INTRODUCTION 6XOIXU PXVWDUG dGLFKORURHWK\O VXOÀGH $UP\ GHVLJQDWLRQ +' LV D SRWHQW F\WRWR[LF FKHPLFDO DJHQW ZLWK YHVLFDWLQJ EOLVWHULQJ SURSHUWLHV XSRQ FRQWDFW ZLWK KXPDQVNLQ'HYHORSPHQWRIPHGLFDOFRXQWHUPHDVXUHVWRSURWHFWLQGLYLGXDOVIURP LQMXU\IROORZLQJDWWDFNE\WKLVFKHPLFDOZDUIDUHZHDSRQUHTXLUHVDQXQGHUVWDQGLQJ RIWKHPHFKDQLVPVE\ZKLFKWKHSDWKRORJ\LVJHQHUDWHG'1$LVEHOLHYHGWREHD 295
296
ALTERNATIVE TOXICOLOGICAL METHODS
PDMRU PDFURPROHFXODU WDUJHW RI +' LQ WKH HSLGHUPLV 8VLQJ KXPDQ HSLGHUPDO NHUDWLQRF\WHV+(.V DQGKXPDQSHULSKHUDOEORRGO\PSKRF\WHV3%/V LQFXOWXUH ZH HYDOXDWHG WKH HIIHFWV RI +' RQ '1$ DV DVVHVVHG E\ WKH FRPHW VLQJOH FHOO HOHFWURSKRUHVLVDVVD\,QDGGLWLRQZHHYDOXDWHGVXUYLYDODQGJURZWKRI+(.VWKURXJK WKHPHDVXUHPHQWRIYLDEOHFHOOQXPEHUPHWDEROLFÁXRUHVFHQFHRIDODPDUEOXHDQG PHPEUDQH LQWHJULW\ DVVHVVPHQW E\ FDOFHLQ$0 DW YDULRXV WLPHV DIWHU H[SRVXUH WR ORZGRVHVWRQ0 RI+'$WQ0+'JURZWKRI+(.VLVUHWDUGHGIRU KU EXW WKHQ UHWXUQV WR FRQWURO OHYHOV %HORZ Q0 QR LQKLELWLRQ RI JURZWK LV GHWHFWHG$W Q0 +' FURVVOLQNV IRUPHG LQ 3%/ '1$ LQKLELW WKH H[SUHVVLRQ RI +2LQGXFHG VLQJOH VWUDQG EUHDNV LQ WKH FRPHW DVVD\ %HORZ Q0 LQKLELWLRQ RI VLQJOH VWUDQG EUHDNV LV QRW REVHUYHG 0RVW UHVHDUFK ZLWK PXVWDUG WR[LFLW\ LV FRQ GXFWHG DW VLJQLÀFDQWO\ KLJKHU GRVH UDQJHV ! Q0 VXFK FRQFHQWUDWLRQV DUH EHOLHYHGWREHHTXLYDOHQWWRWKHYHVLFDWLQJGRVHVRQVNLQ$WWKRVHKLJKGRVHVLWLV GLIÀFXOWWRDVVHVVWKHJHQRWR[LFLW\RUJURZWKSRWHQWLDORI+(.VH[SRVHGWR+'LQ YLWUR7KHVHVWXGLHVVXJJHVWWKDWFHOOVFDQEHH[SRVHGWRDFRQFHQWUDWLRQRI+' WRQ0 WKDWVKRXOGJHQHUDWHVLJQLÀFDQW'1$GDPDJHDQGVWLOOVXUYLYHWKHLQVXOW 8QGHUVWDQGLQJWKHELRFKHPLFDOHIIHFWVDWWKLVORZHUOHYHORIH[SRVXUHPD\OHDGWR PHGLFDOFRXQWHUPHDVXUHVDJDLQVWWKHKLJKHULQMXULRXVOHYHOVRI+'GDPDJHVHHQLQ EDWWOHÀHOGFRQGLWLRQV PURPOSE 'HYHORSFRQFHQWUDWLRQUHVSRQVHUDQJHIRU+'LQGXFHGLQKLELWLRQRIFRPHWDVVD\ GHWHFWLRQRIVLQJOHVWUDQGEUHDNVE\+20RVHUHWDO 'HWHUPLQHZKHWKHU+(.VEHKDYHVLPLODUO\WR3%/VLQWKHFRPHWDVVD\ 'HWHUPLQHZKHWKHUPRQRIXQFWLRQDODON\ODWLQJDJHQWVLHFKORURHWK\OHWK\OVXO ÀGH&((6 EHKDYHOLNHELIXQFWLRQDODON\ODWRUVLH+'LQWKHFRPHWDVVD\ 'HWHUPLQHWKHKLJKHVW+'FRQFHQWUDWLRQWKDWZLOODOORZIXOO+(.JURZWKUHFRYHU\
MATERIALS AND METHODS PBL Isolation +XPDQ 3%/V ZHUH FROOHFWHG IURP YROXQWHHUV XVLQJ DQ DSSURYHG KXPDQ XVH SURWRFRODQGWKHQLVRODWHGE\EXR\DQWGHQVLW\FHQWULIXJDWLRQ PBL Exposure +' RU LWV VLQJOHDUP PXVWDUG DQDORJ FKORURHWK\O HWK\O VXOÀGH &((6 ZDV GLOXWHG LQ 530, PHGLXP DQG DGGHG WR WKH WXEHV \LHOGLQJ ÀQDO FRQFHQWUDWLRQV RI WRQ07KHWXEHVZHUHOHIWLQWKHFKHPLFDOKRRGDWURRPWHPSHUDWXUHIRU KU WKHQ SODFHG LQ D r& &2 LQFXEDWRU IRU WKH UHPDLQGHU RI WKH KU WLPH SHULRG,PPHGLDWHO\IROORZLQJWKLVHQGSRLQWKDOIRIWKHFHOOVIURPHDFKWXEHZHUH H[SRVHGWR+2IRUPLQDQGWKHRWKHUKDOIRIWKHFHOOVVHUYHGDVDJHQW H[SRVHGFRQWUROV
EFFECTS OF LOW DOSE SULFUR MUSTARD ON HUMAN CELLS
297
HEK Cultures 3ULPDU\FXOWXUHVRIKXPDQHSLGHUPDONHUDWLQRF\WHV+(.V ZHUHREWDLQHGIURP &ORQHWLFV'LY&DPEUH[:DONHUVYLOOH0' 6HFRQGDU\FXOWXUHVZHUHVHWXSLQ FPWLVVXHFXOWXUHÁDVNVXVLQJNHUDWLQRF\WHJURZWKPHGLXP.*0&DPEUH[ DQG WKHQ VXEFXOWXUHG DV WHUWLDU\ FXOWXUHV LQWR WLVVXH FXOWXUH ÁDVNV RU PXOWLZHOO SODWHV $OOFXOWXUHVZHUHPDLQWDLQHGLQDQLQFXEDWRUDW&DQG&2 HEK Exposure +' RU &((6 ZDV GLOXWHG LQ .*0 DQG DGGHG WR WKH FXOWXUH YHVVHOV \LHOGLQJ ÀQDOFRQFHQWUDWLRQVRIWRQ07KHYHVVHOVZHUHOHIWLQWKHFKHPLFDOKRRG DW URRP WHPSHUDWXUH IRU KU WKHQ SODFHG LQ D r& &2 LQFXEDWRU IRU WKH UHPDLQGHU RI WKH LQFXEDWLRQ SHULRG ,PPHGLDWHO\ IROORZLQJ WKH LQFXEDWLRQ SHULRG WKH+(.VZHUHHLWKHUKDUYHVWHGE\WU\SVLQL]DWLRQIRUWKHFRPHW DQGJURZWKFXUYH DVVD\VRUOHIWLQWKHZHOOVIRUWKHDODPDUEOXHDQGFDOFHLQYLDELOLW\DVVD\V)RUWKH FRPHW VWXGLHV KDOI RI WKH FHOOV IURP HDFK FRQFHQWUDWLRQ ZHUH H[SRVHG WR +2IRUPLQDQGWKHRWKHUKDOIRIWKHFHOOVVHUYHGDVDJHQWH[SRVHGFRQWUROV Comet Assay %RWK FHOO W\SHV XQGHUZHQW D VOLJKWO\ PRGLÀHG YHUVLRQ RI 6LQJK·V FRPHW DVVD\ SURWRFRO6LQJKHWDO '1$GDPDJHZDVDQDO\]HGXVLQJ.RPHWLPDJLQJ VRIWZDUH.LQHWLF,PDJLQJ&KHVKLUH8. DQGWKHUHVXOWVZHUHH[SUHVVHGDV´FRPHW PRPHQWµ LH SHUFHQWDJH '1$ LQ WDLO v WDLO OHQJWK 8QH[SRVHG FHOOV VHUYHG DV QHJDWLYHFRQWUROVFHOOVH[SRVHGVROHO\WR+2ZHUHWKHSRVLWLYHFRQWUROV Viability Assays $W RU KU DIWHU +' H[SRVXUH WKH PHGLD ZHUH UHPRYHG DQG WKH ZHOOVZHUHZDVKHGWKUHHWLPHVZLWK530,(LWKHUDODPDUEOXHYY RUFDOFHLQ $0QJP/ ZDVDGGHGWRHDFKZHOODQGWKHSODWHVZHUHUHWXUQHGWRWKHLQFXEDWRU IRUWRKU7KHSODWHVZHUHWKHQUHDGRQD&\WRÁXRUPXOWLZHOOSODWHUHDGHU([ (PIRUDODPDUEOXH([(PIRUFDOFHLQ Growth Curve Assay 7KH FHOO VXVSHQVLRQ ZDV UHPRYHG IURP HDFK ZHOO DQG ZDVKHG LQ SKRVSKDWH EXIIHUHG VDOLQH &HOO QXPEHUV ZHUH GHWHUPLQHG XVLQJ D &RXOWHU PRGHO =0 FHOO FRXQWHU &HOO YLDELOLW\ ZDV GHWHUPLQHG E\ SURSLGLXP LRGLGH 3, DQDO\VLV RQ D )$&6RUWÁRZF\WRPHWHU%HFWRQ'LFNLQVRQ6DQ-RVH&$ 9LDEOHFHOOQXPEHUZDV FDOFXODWHGDVWKHSURGXFWRIFHOOQXPEHUDQGSHUFHQW3,SRVLWLYH RESULTS $W FRQFHQWUDWLRQV JUHDWHU WKDQ Q0 +' LQ KXPDQ 3%/V WKH H[SUHVVLRQ RI K\GURJHQ SHUR[LGH '1$ IUDJPHQWDWLRQ LQ WKH FRPHW DVVD\ LV EORFNHG )LJXUH
298
ALTERNATIVE TOXICOLOGICAL METHODS
$VLPLODUSDWWHUQLVREVHUYHGLQ+(.V)LJXUH :KHQFHOOVDUHH[SRVHG WRWKHVLQJOHDUPPXVWDUG&((6QREORFNDJHRI'1$IUDJPHQWDWLRQGHWHFWLRQLV REVHUYHG LQ HLWKHU 3%/V )LJXUH RU +(.V )LJXUH :KHQ WKH FRPHW 40
Comet Moment
30
20
10
0 0
10
20
30
40
50
60
µM HD HD HD-HP
Figure 26.1 PBLs were exposed to buffer or to buffer plus HD. Four hours following exposure, cells were harvested and treated with 0.001% H2O2 or buffer. HD concentrations of 5 QM or greater inhibited expression of SSB in the comet assay. Points represent mean ±SEM from two experiments. 40
Comet Moment
30
20
10
0 0
10
20
30
40
50
60
µM HD HD HD-HP
Figure 26.2 HEKs were exposed to buffer or to buffer plus HD. Four hours following exposure, cells were harvested and treated with 0.002% H2O2 or buffer. Results are similar to those seen with PBLs. Points represent mean ±SEM from two experiments.
EFFECTS